data_2i3b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i3b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 121.075 0.464 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -58.49 156.28 10.74 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.608 1.963 . . . . 0.0 111.729 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.23 130.56 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.29 139.93 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.413 0.685 . . . . 0.0 111.399 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.52 155.15 33.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.347 1.459 . . . . 0.0 107.991 167.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -152.12 175.84 12.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.86 -163.47 25.02 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.6 146.73 15.29 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.62 2.213 . . . . 0.0 110.321 168.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.77 153.7 77.05 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.722 1.615 . . . . 0.0 109.421 165.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.61 5.83 0.03 OUTLIER Glycine 0 CA--C 1.524 0.63 0 CA-C-O 119.053 -0.859 . . . . 0.0 112.491 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.254 97.1 t 65.56 115.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 127.027 2.131 . . . . 0.0 112.503 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.41 -41.9 0.21 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.962 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -50.18 -31.86 14.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.719 1.607 . . . . 0.0 112.535 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -45.23 -47.27 12.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 129.005 2.922 . . . . 0.0 110.038 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -86.06 -23.99 26.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.774 1.23 . . . . 0.0 110.728 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.07 -37.04 78.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 118.211 -0.9 . . . . 0.0 109.693 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.4 -46.32 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 117.902 -1.046 . . . . 0.0 108.732 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -53.62 -44.82 69.8 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.616 1.553 . . . . 0.0 111.428 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -62.05 -40.28 95.22 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.449 0.7 . . . . 0.0 110.769 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.82 -23.64 65.24 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.426 0.557 . . . . 0.0 112.019 172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 m -89.62 12.06 17.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.072 1.749 . . . . 0.0 112.183 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -113.05 -23.36 10.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.912 1.685 . . . . 0.0 111.838 168.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.44 -44.09 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.273 -0.892 . . . . 0.0 113.199 -161.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.72 -35.4 72.63 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 166.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.19 -39.6 82.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.97 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -70.48 -18.11 62.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.467 0.707 . . . . 0.0 111.21 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -96.03 6.02 49.82 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.155 2.182 . . . . 0.0 111.856 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.4 18.61 75.71 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.281 -0.887 . . . . 0.0 113.518 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.29 100.31 15.18 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.731 2.012 . . . . 0.0 106.758 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.52 90.38 1.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.933 2.422 . . . . 0.0 110.73 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.47 154.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.519 1.928 . . . . 0.0 109.518 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.33 176.6 9.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.085 0.954 . . . . 0.0 110.469 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.91 -149.97 17.08 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.02 1.295 . . . . 0.0 111.147 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -145.4 160.85 40.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.777 0.831 . . . . 0.0 111.697 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -144.18 131.19 20.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.56 1.544 . . . . 0.0 106.96 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 p -74.25 146.7 43.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 117.62 -1.181 . . . . 0.0 107.882 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.57 159.12 35.58 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.605 1.548 . . . . 0.0 109.102 167.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.38 96.01 7.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.565 1.146 . . . . 0.0 107.972 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.56 101.63 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.567 1.175 . . . . 0.0 108.806 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -121.95 84.95 2.33 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 125.758 1.623 . . . . 0.0 108.64 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -58.99 109.67 0.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.71 34.63 21.71 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.652 -0.527 . . . . 0.0 113.129 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.42 38.45 14.63 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.556 1.678 . . . . 0.0 115.273 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 136.09 45.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.357 2.078 . . . . 0.0 107.663 159.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -67.28 111.82 4.2 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.901 0.88 . . . . 0.0 108.872 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 pt -115.62 -10.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.942 0.897 . . . . 0.0 112.483 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -165.4 35.84 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 107.996 -2.041 . . . . 0.0 107.996 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -124.48 167.53 14.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.701 1.6 . . . . 0.0 107.644 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -120.67 -178.83 3.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.544 1.538 . . . . 0.0 109.584 167.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.83 96.34 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 162.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.33 151.0 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 p -115.8 154.6 29.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.43 -6.78 15.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.174 0.897 . . . . 0.0 111.909 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -86.39 3.14 44.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.155 2.582 . . . . 0.0 111.784 171.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.71 5.83 88.37 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.277 -1.515 . . . . 0.0 114.377 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 151.23 30.7 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 169.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 136.79 26.96 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.796 1.18 . . . . 0.0 111.496 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.16 176.41 47.02 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 121.398 0.443 . . . . 0.0 112.945 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.18 167.5 21.8 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 146.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -142.92 -69.98 0.33 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -128.45 161.5 29.35 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.906 0.882 . . . . 0.0 109.936 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -149.7 169.52 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.813 1.245 . . . . 0.0 108.118 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 t -60.29 149.81 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.498 0.719 . . . . 0.0 109.382 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.08 165.2 32.54 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 160.67 16.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.493 1.117 . . . . 0.0 109.586 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.99 155.62 93.19 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.6 124.82 11.09 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.994 2.463 . . . . 0.0 108.014 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.36 162.95 36.5 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 108.549 -1.366 . . . . 0.0 108.549 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.92 -11.34 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.766 1.644 . . . . 0.0 113.783 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.16 -40.72 4.77 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.192 1.377 . . . . 0.0 113.707 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.0 112.45 25.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.977 1.389 . . . . 0.0 107.688 -170.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -71.19 135.42 47.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.91 176.16 11.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.539 1.936 . . . . 0.0 106.342 166.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 83.0 m -124.4 74.79 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.559 0.695 . . . . 0.0 111.001 -165.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 138.99 33.88 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.479 1.112 . . . . 0.0 108.664 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.8 -27.65 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.325 0.584 . . . . 0.0 111.334 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.82 -71.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 105.136 -3.186 . . . . 0.0 105.136 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -108.43 -51.84 2.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.616 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.06 163.13 28.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.888 1.222 . . . . 0.0 109.249 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.68 119.94 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.53 172.92 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.665 0.786 . . . . 0.0 108.928 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.52 146.26 31.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 162.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.23 -32.42 71.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.236 0.615 . . . . 0.0 110.737 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 m -64.55 -32.71 74.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.156 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.2 m -61.37 -34.94 76.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.682 1.128 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.472 0.709 . . . . 0.0 110.139 167.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -24.02 9.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.444 1.097 . . . . 0.0 113.477 -170.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -50.17 -35.59 26.81 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.994 1.318 . . . . 0.0 113.158 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 -33.84 0.35 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.026 -0.512 . . . . 0.0 112.005 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.57 1.948 . . . . 0.0 111.508 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.69 -55.16 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.43 1.492 . . . . 0.0 110.168 -173.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.97 -37.57 8.49 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.751 1.634 . . . . 0.0 112.318 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.26 -24.64 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -45.14 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.999 0.519 . . . . 0.0 110.649 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.62 70.89 0.91 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 165.683 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -155.07 165.56 36.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.479 1.512 . . . . 0.0 107.19 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.47 136.35 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.0 t -123.52 108.57 12.79 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.569 1.148 . . . . 0.0 109.519 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.85 130.14 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 125.643 1.577 . . . . 0.0 109.572 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.39 86.61 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.51 158.47 35.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 163.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER 51.14 90.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.959 2.504 . . . . 0.0 112.587 -174.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.89 75.72 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 164.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.88 -45.95 0.02 OUTLIER Glycine 0 C--N 1.334 0.437 0 O-C-N 120.952 -1.092 . . . . 0.0 113.383 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 9.4 tptt -66.49 -37.33 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.74 0.77 . . . . 0.0 110.39 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.5 mmt -79.46 0.52 29.15 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 115.559 -2.162 . . . . 0.0 114.253 -172.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.26 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 -170.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tp -117.85 -44.76 2.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.916 1.686 . . . . 0.0 110.131 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -73.89 -20.57 60.37 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.267 1.027 . . . . 0.0 111.41 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 p -53.4 115.29 1.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.379 2.272 . . . . 0.0 109.986 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.23 -71.49 0.54 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.585 1.154 . . . . 0.0 108.884 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.3 -21.4 59.74 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.424 1.09 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -69.14 0.12 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.309 1.443 . . . . 0.0 110.19 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' H ' ' A' ' 125' ' ' ILE . 4.2 mp -37.73 -48.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.388 1.875 . . . . 0.0 112.683 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -63.89 -64.88 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.699 0.799 . . . . 0.0 112.48 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.5 90.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.072 0.949 . . . . 0.0 110.452 -170.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.55 -44.61 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.556 1.142 . . . . 0.0 109.367 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -67.66 -31.99 72.36 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.011 -1.681 . . . . 0.0 112.353 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -37.73 83.57 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.981 1.718 . . . . 0.0 110.512 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 m -65.92 -47.89 73.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.881 0.472 . . . . 0.0 110.866 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.33 -19.74 66.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 111.261 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -39.58 78.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.044 0.938 . . . . 0.0 109.477 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.7 m -64.81 134.02 95.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 123.565 0.746 . . . . 0.0 109.414 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.0 -29.27 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.661 2.907 . . . . 0.0 112.025 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.7 -53.75 7.09 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 145.03 54.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.222 1.011 . . . . 0.0 112.28 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.16 98.76 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 102.949 -2.982 . . . . 0.0 102.949 -169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.06 131.65 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.41 116.26 8.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.566 1.947 . . . . 0.0 106.508 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.05 -179.61 39.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.7 m -123.53 100.28 6.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.9 pt -97.19 161.74 25.13 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 179.98 4.54 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.401 2.734 . . . . 0.0 110.47 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.5 150.36 79.45 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 121.172 -0.955 . . . . 0.0 110.773 164.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.01 109.47 2.7 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 123.188 2.592 . . . . 0.0 108.883 164.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.16 119.72 15.0 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 164.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.09 -131.02 36.0 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.59 137.55 96.46 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.845 -158.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 131.27 22.71 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.621 2.214 . . . . 0.0 109.009 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.98 121.87 21.71 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 13.33 0.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.122 2.569 . . . . 0.0 115.634 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.4 tp -131.67 -39.83 1.11 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.388 1.875 . . . . 0.0 109.39 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.83 -23.77 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 120.825 -1.172 . . . . 0.0 109.006 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.54 -40.43 78.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.578 1.151 . . . . 0.0 110.73 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.82 -31.03 72.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.689 1.996 . . . . 0.0 110.471 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.4 mp -90.56 -41.61 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.535 1.534 . . . . 0.0 109.337 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -52.56 -39.05 61.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.971 1.709 . . . . 0.0 109.823 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -33.4 -47.54 0.22 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 127.968 2.507 . . . . 0.0 113.033 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -66.5 -40.75 89.41 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.342 -1.313 . . . . 0.0 112.436 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.75 -40.71 0.22 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.53 1.932 . . . . 0.0 113.482 -167.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.94 -22.49 60.1 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.68 2.392 . . . . 0.0 113.563 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.6 m -66.0 138.79 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.477 ' HE3' ' CE1' ' A' ' 166' ' ' PHE . 28.3 tptt -65.07 142.73 58.3 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.85 102.29 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.477 ' CE1' ' HE3' ' A' ' 164' ' ' LYS . 13.7 m-85 -93.53 96.69 10.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.042 1.337 . . . . 0.0 111.051 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 104.94 2.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 172.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.59 163.05 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.988 0.813 . . . . 0.0 108.816 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.4 p -123.57 169.04 11.84 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.205 1.802 . . . . 0.0 106.305 160.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -77.51 -10.6 59.58 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.344 1.458 . . . . 0.0 112.275 158.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -79.99 -74.0 0.33 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.79 32.39 0.74 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.221 1.408 . . . . 0.0 109.913 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -54.91 -51.76 65.03 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.732 -1.23 . . . . 0.0 110.405 -169.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -75.33 4.04 7.92 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.95 -19.0 31.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.707 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -21.58 45.79 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.913 -164.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.71 -63.13 1.6 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.951 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.72 -28.78 76.69 Favored 'Trans proline' 0 C--N 1.35 0.616 0 CA-C-N 121.853 1.697 . . . . 0.0 112.929 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -33.97 75.0 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.608 0.763 . . . . 0.0 109.678 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.16 -52.17 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.071 0.948 . . . . 0.0 109.82 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.89 -34.77 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 118.42 0.554 . . . . 0.0 110.225 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.7 m -55.92 -44.61 78.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.389 1.076 . . . . 0.0 110.263 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -70.97 -41.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.684 -0.635 . . . . 0.0 110.278 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.27 -59.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 123.405 0.682 . . . . 0.0 109.811 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -3.18 20.42 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.273 1.029 . . . . 0.0 112.684 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -60.47 -21.35 62.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.883 -1.135 . . . . 0.0 110.592 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.342 0.268 0 CA-C-N 119.999 1.272 . . . . 0.0 107.636 164.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -24.63 119.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.55 3.14 . . . . 0.0 111.624 166.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 t -105.08 137.86 32.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.443 ' CE1' HG21 ' A' ' 157' ' ' ILE . 54.5 m-85 -127.86 153.91 46.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.576 0.75 . . . . 0.0 109.151 163.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 164.24 12.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.838 2.055 . . . . 0.0 108.313 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -159.5 -173.45 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.11 53.7 6.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 127.214 2.34 . . . . 0.0 112.136 -160.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.11 123.51 8.88 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 119.786 1.793 . . . . 0.0 110.266 -171.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.6 -1.6 8.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.511 2.141 . . . . 0.0 112.238 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.93 4.03 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -170.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.4 97.99 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 125.396 2.522 . . . . 0.0 107.48 -168.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.85 -45.49 0.55 Allowed Glycine 0 C--N 1.309 -0.938 0 CA-C-N 111.345 -2.661 . . . . 0.0 108.414 163.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.31 -48.42 25.13 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.327 1.851 . . . . 0.0 112.958 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.3 m -60.31 -52.93 63.19 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.207 0.912 . . . . 0.0 108.898 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 m -59.67 -40.29 87.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.736 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -53.14 48.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.468 1.485 . . . . 0.0 109.284 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.25 -26.07 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.581 0.752 . . . . 0.0 111.06 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -66.12 -57.16 8.3 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.034 -1.666 . . . . 0.0 109.332 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -11.29 29.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.01 45.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.908 1.283 . . . . 0.0 112.468 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.2 p -67.23 -47.51 70.6 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -171.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.07 -39.98 66.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.199 1.8 . . . . 0.0 112.246 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.87 -54.41 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.457 1.103 . . . . 0.0 109.236 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.9 mt -69.6 -36.57 76.32 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.316 0.646 . . . . 0.0 109.351 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.68 -39.0 86.84 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.971 -1.706 . . . . 0.0 109.89 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.97 -34.66 70.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.512 1.525 . . . . 0.0 110.342 168.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 4.32 4.99 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.308 2.243 . . . . 0.0 115.389 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.62 20.22 55.84 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.282 0.946 . . . . 0.0 112.204 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.55 140.85 73.46 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.918 1.287 . . . . 0.0 108.741 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -79.16 84.72 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 CA-C-N 121.701 1.643 . . . . 0.0 111.347 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.07 156.78 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.159 0.983 . . . . 0.0 109.127 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -156.25 174.25 15.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.984 1.713 . . . . 0.0 107.471 164.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.43 -148.14 19.07 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 125.487 1.518 . . . . 0.0 111.31 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -148.68 171.56 16.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 111.216 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' CG ' ' A' ' 38' ' ' GLU . 9.1 p90 -146.22 172.38 13.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.29 1.436 . . . . 0.0 108.349 165.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.5 90.6 2.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.158 1.783 . . . . 0.0 106.326 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' CG ' ' CE1' ' A' ' 36' ' ' TYR . 18.8 mt-10 -74.89 -22.73 58.47 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.462 -0.774 . . . . 0.0 112.705 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 96.17 164.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.347 4.259 . . . . 0.0 109.747 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.32 104.01 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -121.42 105.25 10.33 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.831 1.253 . . . . 0.0 107.754 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -79.65 116.12 19.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.95 -56.03 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 120.529 1.513 . . . . 0.0 114.115 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.21 11.44 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.837 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 137.15 28.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.189 1.995 . . . . 0.0 109.484 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -66.61 144.92 56.12 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.28 -12.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.79 1.236 . . . . 0.0 112.965 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.91 -168.56 41.69 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -129.46 138.04 51.19 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -114.84 158.45 21.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.2 p -116.67 94.84 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -166.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.14 116.53 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.94 1.696 . . . . 0.0 108.235 -162.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.4 p -88.75 150.77 22.79 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.398 0.999 . . . . 0.0 109.271 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -24.94 67.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.051 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -32.9 72.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.492 1.117 . . . . 0.0 109.302 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.99 -14.85 2.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.702 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 163.59 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.969 2.108 . . . . 0.0 110.785 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.25 156.63 42.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 121.379 -0.826 . . . . 0.0 109.534 156.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.28 159.75 21.36 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.82 64.9 7.31 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.66 3.574 . . . . 0.0 111.642 -166.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.64 -56.08 2.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 127.079 2.152 . . . . 0.0 110.677 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 147.8 34.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 109.516 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -147.4 161.67 40.57 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.029 1.332 . . . . 0.0 108.691 172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -62.55 159.95 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.833 0.853 . . . . 0.0 109.744 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.55 -155.88 7.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.75 166.11 22.84 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.81 149.31 40.14 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.993 0.815 . . . . 0.0 109.457 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.01 124.45 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.066 1.844 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.62 164.7 33.21 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.525 2.816 . . . . 0.0 110.891 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.16 -12.43 27.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.475 2.116 . . . . 0.0 113.749 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.28 7.87 73.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.258 0.932 . . . . 0.0 112.879 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -140.65 170.13 16.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 130.389 3.476 . . . . 0.0 104.221 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -139.47 149.65 44.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 153.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -151.24 149.95 30.01 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.14 97.88 4.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.093 1.357 . . . . 0.0 110.113 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.2 161.8 19.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.049 1.295 . . . . 0.0 111.168 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.66 -4.13 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -161.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.22 77.21 0.09 OUTLIER Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 86.59 -31.44 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.076 2.95 . . . . 0.0 111.491 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -105.94 146.11 30.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.11 132.32 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.33 175.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.624 1.57 . . . . 0.0 108.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.68 135.51 22.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.54 -37.86 85.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 164.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -51.29 -42.46 61.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.081 1.352 . . . . 0.0 110.802 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.8 m -75.98 -15.27 60.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.614 -1.304 . . . . 0.0 112.914 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.5 -59.03 2.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.791 -1.1 . . . . 0.0 108.444 161.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -57.79 -17.27 14.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.481 1.491 . . . . 0.0 114.009 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -52.61 -41.48 63.72 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.26 -37.54 0.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.831 0.852 . . . . 0.0 112.688 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.98 51.02 0.92 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.159 1.784 . . . . 0.0 109.373 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.03 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.894 2.477 . . . . 0.0 105.698 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.55 -35.7 37.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.817 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -62.28 -21.08 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.883 1.219 . . . . 0.0 113.303 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.11 -33.86 68.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.197 0.453 . . . . 0.0 109.781 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.42 107.02 3.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.786 -1.196 . . . . 0.0 111.545 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 159.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 122.241 1.019 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -84.28 162.79 19.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.099 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.06 154.95 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.31 149.85 52.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.254 1.022 . . . . 0.0 108.698 163.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.68 122.55 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 123.17 0.588 . . . . 0.0 109.423 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.02 84.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -171.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -74.09 171.15 14.05 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.39 -1.444 . . . . 0.0 109.785 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 34.33 69.23 0.16 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.882 3.273 . . . . 0.0 114.301 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.27 91.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.41 -81.05 0.04 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 118.473 0.579 . . . . 0.0 112.032 -170.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -53.4 -35.43 60.36 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.614 1.166 . . . . 0.0 113.06 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -3.43 16.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.963 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -39.44 -52.43 2.1 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 121.514 1.961 . . . . 0.0 112.389 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -45.3 95.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.524 0.73 . . . . 0.0 111.375 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.49 -9.65 55.78 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.23 2.212 . . . . 0.0 113.6 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.5 m -55.64 109.87 0.63 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.351 1.46 . . . . 0.0 112.017 -164.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -120.35 -83.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.491 0.587 . . . . 0.0 111.189 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.57 -19.66 63.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.886 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -74.26 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.765 2.026 . . . . 0.0 110.339 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -33.99 -58.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-N 120.169 1.35 . . . . 0.0 112.737 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.92 -58.04 10.16 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.354 0.979 . . . . 0.0 111.911 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.01 91.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.002 0.814 . . . . 0.0 109.513 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.1 t -55.97 -50.91 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.432 1.493 . . . . 0.0 109.247 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -65.3 -28.97 69.69 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.729 -1.232 . . . . 0.0 112.563 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -54.18 -58.53 7.01 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 m -60.51 -38.51 84.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.128 2.571 . . . . 0.0 112.453 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.33 -33.83 75.46 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.88 0.472 . . . . 0.0 110.285 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.4 -8.11 58.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.849 0.46 . . . . 0.0 111.231 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 m -89.97 133.72 33.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.5 -37.15 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.275 2.65 . . . . 0.0 112.76 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -48.52 80.64 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -63.49 153.67 34.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.157 1.783 . . . . 0.0 111.497 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.8 mt -139.29 106.28 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.6 mm -65.43 147.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -144.32 94.49 2.58 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.909 2.083 . . . . 0.0 106.581 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.68 173.97 19.95 Favored Glycine 0 N--CA 1.465 0.628 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.455 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 29.2 m -131.36 98.87 4.66 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.632 1.216 . . . . 0.0 112.52 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.6 pt -80.15 140.81 53.42 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.827 -1.17 . . . . 0.0 111.375 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.8 137.9 43.16 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.044 1.83 . . . . 0.0 108.435 166.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.89 134.45 95.92 Favored Pre-proline 0 N--CA 1.444 -0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.166 -166.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.78 129.92 19.58 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.818 2.345 . . . . 0.0 108.958 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.95 -61.24 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.731 1.213 . . . . 0.0 108.426 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.88 -126.91 0.74 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 157.03 90.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.569 0.685 . . . . 0.0 111.313 -170.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.63 103.2 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.785 2.323 . . . . 0.0 108.711 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.04 124.46 21.67 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.682 -0.636 . . . . 0.0 110.131 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.53 -59.82 4.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.166 1.386 . . . . 0.0 113.3 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 65.0 tp -63.5 -30.59 71.68 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.478 -1.389 . . . . 0.0 111.259 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.16 -44.24 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 121.297 -0.877 . . . . 0.0 108.888 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.01 -37.66 66.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.988 1.715 . . . . 0.0 110.829 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -57.85 -28.61 64.29 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.659 0.663 . . . . 0.0 112.344 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 5' ' ' PHE . 9.2 mt -107.56 -32.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.602 1.161 . . . . 0.0 109.975 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -32.99 72.25 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.033 -1.042 . . . . 0.0 109.166 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.28 -6.45 23.97 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -76.53 -39.65 52.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 120.884 1.674 . . . . 0.0 110.057 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? 62.2 -23.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.121 2.169 . . . . 0.0 114.648 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.59 -28.7 69.54 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.288 1.435 . . . . 0.0 111.997 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.36 135.82 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.451 1.5 . . . . 0.0 110.566 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.74 145.63 54.55 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 168.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.23 89.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.406 ' CD2' HG12 ' A' ' 180' ' ' ILE . 30.7 m-85 -79.2 104.75 10.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.786 0.835 . . . . 0.0 109.087 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.65 105.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.91 155.84 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 164.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.3 p -134.83 162.59 31.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 154.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.76 -14.64 61.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.494 165.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.62 -54.27 4.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -101.92 10.69 39.53 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.288 1.435 . . . . 0.0 110.746 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 ptt85 -29.71 -65.16 0.11 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.034 2.134 . . . . 0.0 111.612 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -80.3 3.45 20.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -105.18 -6.97 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.099 2.16 . . . . 0.0 111.033 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.15 -45.77 15.91 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 119.189 0.904 . . . . 0.0 110.65 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.8 tp -32.51 -61.91 0.31 Allowed Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.716 2.006 . . . . 0.0 109.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.14 -28.63 28.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 122.438 1.906 . . . . 0.0 114.94 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -68.14 -35.07 77.5 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.872 1.215 . . . . 0.0 109.847 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 166' ' ' PHE . 12.0 mt -65.34 -46.34 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.835 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.89 -45.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 119.349 0.977 . . . . 0.0 108.761 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.0 m -58.53 -51.09 71.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.623 0.769 . . . . 0.0 111.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.15 -31.32 69.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.229 1.377 . . . . 0.0 112.106 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.65 -62.03 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -70.14 -18.23 63.22 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -19.06 56.32 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 119.457 1.026 . . . . 0.0 111.56 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 120.633 1.56 . . . . 0.0 111.978 175.048 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -46.39 137.96 6.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 0.0 110.511 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.33 143.2 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.927 0.891 . . . . 0.0 109.536 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -141.54 146.94 36.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.953 1.701 . . . . 0.0 108.637 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.69 157.31 17.27 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.648 1.113 . . . . 0.0 111.287 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -149.73 177.22 9.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.45 1.1 . . . . 0.0 109.092 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.28 -176.41 19.62 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.136 1.35 . . . . 0.0 112.701 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.65 166.05 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.476 3.451 . . . . 0.0 110.751 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.58 93.91 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.435 2.09 . . . . 0.0 111.054 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.18 -34.99 15.97 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.493 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.55 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.17 2.588 . . . . 0.0 110.063 -153.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.4 17.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.826 -1.541 . . . . 0.0 113.833 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -94.17 -55.82 3.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.531 1.665 . . . . 0.0 110.731 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.0 m -51.8 -41.54 61.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.329 1.851 . . . . 0.0 109.724 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -58.04 -41.7 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 113.73 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -48.28 61.24 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.71 -41.55 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -56.0 -55.95 26.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.509 -0.745 . . . . 0.0 110.214 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -59.48 -31.78 69.65 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.137 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.96 -44.28 60.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.915 0.78 . . . . 0.0 109.947 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 m -58.54 -47.29 84.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.89 -23.47 63.25 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.794 2.038 . . . . 0.0 111.73 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.4 t -83.71 -48.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.382 1.873 . . . . 0.0 109.362 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.06 -44.72 87.62 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -60.77 -43.44 98.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.882 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -62.09 -26.58 68.37 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.918 0.781 . . . . 0.0 112.279 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 t -88.69 1.7 54.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.898 1.679 . . . . 0.0 112.271 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.4 11.31 85.62 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.971 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.25 118.3 70.87 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.885 1.843 . . . . 0.0 106.979 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.39 123.19 11.98 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.909 1.739 . . . . 0.0 110.647 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.16 160.64 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.82 177.53 8.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 159.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.04 -163.82 26.59 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 119.579 -1.951 . . . . 0.0 113.199 166.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -151.03 155.19 38.5 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.234 1.016 . . . . 0.0 110.325 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.432 ' C ' ' HG1' ' A' ' 37' ' ' THR . 50.7 p90 -118.72 -179.01 3.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' ' 36' ' ' TYR . 52.4 m -161.86 94.71 0.95 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -164.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.42 156.68 17.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -167.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -68.25 109.39 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.17 109.33 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -119.29 104.74 10.66 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.932 2.093 . . . . 0.0 107.443 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -91.84 102.47 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.26 50.68 7.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.183 0.897 . . . . 0.0 113.558 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.88 -6.88 57.69 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.419 1.485 . . . . 0.0 114.925 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.43 122.05 23.96 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.061 1.931 . . . . 0.0 107.506 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 123.84 23.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 159.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -10.63 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.789 0.836 . . . . 0.0 112.729 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.13 -164.11 35.26 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -139.44 143.09 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.66 145.6 41.83 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.62 154.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.03 123.37 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.5 p -72.48 179.25 3.58 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.563 -1.336 . . . . 0.0 109.927 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.3 -13.68 40.21 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.299 -0.875 . . . . 0.0 111.492 163.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 t -70.83 -50.41 35.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 49.43 0.1 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -144.82 147.49 32.92 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.641 1.976 . . . . 0.0 107.592 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.77 161.41 20.17 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 128.494 2.717 . . . . 0.0 108.999 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.12 134.42 5.93 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.48 61.94 2.8 Favored 'Trans proline' 0 CA--C 1.55 1.284 1 C-N-CA 126.371 4.714 . . . . 0.0 114.053 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.543 ' N ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -65.3 -63.02 1.2 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.57 1.948 . . . . 0.0 111.581 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 p -130.11 136.5 49.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.306 0.957 . . . . 0.0 108.872 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -148.94 169.34 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.434 1.494 . . . . 0.0 107.889 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -56.32 152.34 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.679 1.191 . . . . 0.0 109.884 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.49 46.87 0.07 OUTLIER Glycine 0 C--N 1.333 0.403 0 CA-C-O 119.335 -0.703 . . . . 0.0 111.612 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.0 -169.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.971 1.708 . . . . 0.0 111.7 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.58 147.53 43.87 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 110.871 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -69.73 123.83 10.5 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.728 2.286 . . . . 0.0 107.971 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.24 170.49 19.47 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.627 2.885 . . . . 0.0 110.853 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.48 -9.75 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.28 1.987 . . . . 0.0 114.196 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.47 -12.49 51.0 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.535 -1.147 . . . . 0.0 114.291 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 138.1 36.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.34 2.07 . . . . 0.0 108.138 -168.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -119.07 122.32 41.84 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.104 0.562 . . . . 0.0 110.0 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 172.25 13.67 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 126.026 1.731 . . . . 0.0 107.655 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 95.3 m -68.4 147.81 51.55 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.815 -0.553 . . . . 0.0 109.725 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -153.29 143.83 22.57 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.528 -0.732 . . . . 0.0 109.472 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.766 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.37 1.06 0.15 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 127.437 2.446 . . . . 0.0 117.596 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.04 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.225 2.21 . . . . 0.0 106.713 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -80.57 166.64 20.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.339 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -110.61 133.59 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.8 166.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -139.39 105.17 5.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.6 -24.23 63.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.322 -0.861 . . . . 0.0 111.592 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -34.4 77.99 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.624 171.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 42.5 t -57.42 -48.45 79.09 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 119.989 1.268 . . . . 0.0 109.941 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -56.04 -50.62 70.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -19.67 66.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.057 0.844 . . . . 0.0 112.439 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -66.36 -45.25 80.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.721 1.146 . . . . 0.0 112.059 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.35 -39.86 2.42 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.59 51.18 2.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.072 1.749 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 -60.35 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 125.721 1.608 . . . . 0.0 108.0 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -38.36 42.37 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.607 1.538 . . . . 0.0 112.043 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -36.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 123.909 0.883 . . . . 0.0 110.591 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.148 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 108.26 0.13 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.983 1.713 . . . . 0.0 106.764 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 C--N 1.322 -0.63 0 C-N-CA 125.142 1.377 . . . . 0.0 108.129 163.242 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.379 0.609 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -89.0 97.21 11.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 126.613 1.965 . . . . 0.0 110.019 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.9 t -74.97 94.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 121.656 2.026 . . . . 0.0 107.577 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.5 m -72.24 165.24 24.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.61 139.67 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.576 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mt -152.22 103.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.651 1.219 . . . . 0.0 108.501 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -105.69 -169.61 1.61 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 42.75 48.75 4.91 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.014 2.526 . . . . 0.0 112.163 -168.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.71 110.56 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.13 -63.97 0.32 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-O 117.554 -1.692 . . . . 0.0 112.493 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -24.15 65.92 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.913 2.357 . . . . 0.0 110.44 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.3 mmt -69.02 -10.39 57.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 116.671 -1.633 . . . . 0.0 113.404 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -24.63 -68.42 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.535 2.334 . . . . 0.0 114.593 -171.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -45.96 63.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 0.0 111.361 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.66 -27.99 66.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.615 1.166 . . . . 0.0 112.181 -170.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.4 t -41.64 114.01 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 129.222 3.009 . . . . 0.0 111.715 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -127.44 -87.71 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.412 0.551 . . . . 0.0 111.465 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.6 -16.8 61.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.793 0.724 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.99 -68.02 0.22 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.839 2.055 . . . . 0.0 111.168 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -36.83 -57.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.628 1.571 . . . . 0.0 112.148 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.9 -54.49 41.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.308 0.643 . . . . 0.0 111.025 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.82 99.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 124.148 0.905 . . . . 0.0 109.299 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.13 -47.15 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.227 1.411 . . . . 0.0 109.538 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.41 -44.6 96.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.203 1.365 . . . . 0.0 111.265 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -57.62 -38.71 75.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.153 0.888 . . . . 0.0 110.435 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 m -74.24 -38.99 63.35 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.364 -0.835 . . . . 0.0 112.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.2 mt -61.06 -35.76 77.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.21 1.368 . . . . 0.0 109.932 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.8 t -71.94 -22.05 61.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.221 1.808 . . . . 0.0 110.605 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.3 m -76.26 134.0 71.05 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.03 -42.71 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.032 2.488 . . . . 0.0 112.319 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.35 -2.75 63.59 Favored Glycine 0 C--O 1.216 -0.97 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.384 -168.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.9 m -80.48 160.84 25.14 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.965 2.382 . . . . 0.0 106.139 154.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.6 mt -122.92 138.37 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.72 136.99 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tp -140.07 113.45 8.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.92 32.89 Favored Glycine 0 N--CA 1.462 0.412 0 C-N-CA 119.287 -1.435 . . . . 0.0 114.656 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.0 m -137.11 133.4 35.29 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.93 147.61 66.24 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.821 1.648 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.71 148.92 59.96 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 111.167 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.34 131.55 86.6 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.241 0.617 . . . . 0.0 110.083 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.69 108.82 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.402 2.735 . . . . 0.0 108.443 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -64.75 0.79 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -112.27 -109.47 3.02 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 166.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 149.69 98.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 118.72 1.26 . . . . 0.0 111.966 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.55 -164.9 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.37 1 C-N-CA 125.966 4.444 . . . . 0.0 112.247 164.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.79 168.25 10.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.601 1.96 . . . . 0.0 109.183 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.29 -67.07 0.31 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.037 2.535 . . . . 0.0 113.287 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -59.48 -46.32 89.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.56 -35.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.36 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.07 -28.11 68.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.869 1.668 . . . . 0.0 112.086 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.52 -34.74 77.51 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.769 0.713 . . . . 0.0 110.007 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.32 -39.09 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.3 1.44 . . . . 0.0 109.564 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.66 -26.68 65.44 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.426 -1.422 . . . . 0.0 111.105 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -59.32 -37.58 78.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.315 0.646 . . . . 0.0 111.44 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -61.58 -36.78 81.64 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.908 0.883 . . . . 0.0 112.019 -167.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -40.24 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.971 2.908 . . . . 0.0 115.676 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -59.93 -28.9 68.01 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.189 1.359 . . . . 0.0 110.626 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.0 m -50.36 108.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.503 1.521 . . . . 0.0 109.28 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -65.69 123.21 19.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 m -111.94 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 C-N-CA 124.683 1.193 . . . . 0.0 108.778 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -72.12 118.83 15.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.142 0.977 . . . . 0.0 110.538 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.61 97.81 5.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.789 1.235 . . . . 0.0 110.631 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.86 132.79 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 p -94.93 151.22 19.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 158.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -57.85 -29.8 65.28 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.064 -0.397 . . . . 0.0 110.389 165.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.07 -53.87 15.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 110.848 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.82 23.06 13.41 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.025 -1.047 . . . . 0.0 110.91 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -47.26 -44.55 23.11 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.448 1.099 . . . . 0.0 112.464 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.27 3.56 8.68 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -118.29 62.54 0.77 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.25 -39.79 0.44 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.37 160.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tp -40.03 -58.37 2.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 117.625 -1.179 . . . . 0.0 110.355 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.84 -28.24 51.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.436 1.424 . . . . 0.0 113.386 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.24 -38.26 68.96 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.282 -0.886 . . . . 0.0 109.219 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.89 -47.34 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.488 1.515 . . . . 0.0 107.974 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 92.2 t -56.04 -43.99 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.225 0.92 . . . . 0.0 109.171 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.0 m -57.97 -47.81 81.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.962 1.305 . . . . 0.0 109.129 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.45 -37.78 88.73 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.731 -0.606 . . . . 0.0 111.693 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.64 -55.52 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.911 0.778 . . . . 0.0 109.428 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -28.32 69.69 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.034 -174.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.51 -50.85 0.34 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.235 2.214 . . . . 0.0 111.637 -176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 125.594 1.557 . . . . 0.0 107.814 -175.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.227 -0.099 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -92.88 159.5 15.33 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.375 1.87 . . . . 0.0 109.282 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.65 148.41 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -144.11 158.02 43.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.909 1.684 . . . . 0.0 109.537 172.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.38 135.3 50.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.83 -172.5 3.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.82 -172.31 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.265 -0.897 . . . . 0.0 111.295 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.44 163.34 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.19 2.593 . . . . 0.0 113.611 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.82 72.05 6.29 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.804 3.67 . . . . 0.0 111.736 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.18 25.14 21.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 124.411 1.005 . . . . 0.0 112.494 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m 42.51 35.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.513 2.725 . . . . 0.0 116.308 161.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.87 9.91 3.1 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.514 1.531 . . . . 0.0 112.184 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -75.19 -49.87 18.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 109.956 -168.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -57.66 -35.25 70.31 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.391 0.676 . . . . 0.0 109.71 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.5 m -63.49 -38.78 92.46 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.284 -0.885 . . . . 0.0 112.45 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -49.55 57.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.89 1.223 . . . . 0.0 108.593 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -58.08 -40.94 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.562 0.619 . . . . 0.0 111.045 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -50.28 -45.84 54.7 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.317 0.962 . . . . 0.0 110.067 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -70.05 -20.04 63.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.23 0.612 . . . . 0.0 112.207 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.328 0.967 . . . . 0.0 110.627 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -81.51 -42.8 19.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.02 -39.22 68.89 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.103 0.561 . . . . 0.0 111.211 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.21 -51.24 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.334 1.053 . . . . 0.0 110.291 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.25 -35.5 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.33 -38.33 89.79 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.074 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -4.8 14.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.495 1.118 . . . . 0.0 112.912 172.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 m -109.61 -5.08 15.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.701 1.6 . . . . 0.0 111.638 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.72 18.46 74.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.015 1.293 . . . . 0.0 112.981 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 t -64.71 133.76 95.82 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.665 1.733 . . . . 0.0 107.131 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.22 95.22 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.575 2.183 . . . . 0.0 110.072 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.56 136.73 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.78 173.79 11.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.604 2.362 . . . . 0.0 105.883 169.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.98 -156.79 26.15 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -142.06 166.02 25.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.912 1.356 . . . . 0.0 111.434 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -142.14 179.62 6.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.4 p -134.98 136.67 42.38 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.91 27.17 4.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.278 6.8 pm0 49.81 -178.71 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.357 2.263 . . . . 0.0 112.79 -164.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.81 119.56 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -129.27 106.47 8.84 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 70.63 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.58 75.51 0.51 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -161.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.19 -40.21 2.68 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 148.47 42.38 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.719 1.76 . . . . 0.0 111.135 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -69.81 132.24 45.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 162.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.55 -27.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.72 -174.05 41.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 119.608 1.095 . . . . 0.0 110.677 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CZ ' ' HE2' ' A' ' 116' ' ' LYS . 25.1 m-85 -126.53 153.25 45.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 160.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -117.97 162.42 18.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 167.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.97 145.35 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.907 1.683 . . . . 0.0 107.923 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.2 108.95 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 120.55 1.523 . . . . 0.0 109.858 -167.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.1 p -69.61 145.05 52.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.31 -5.74 30.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -84.68 7.53 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.549 1.068 . . . . 0.0 111.32 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.67 3.41 83.75 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.223 -1.548 . . . . 0.0 114.984 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 m -80.83 166.08 21.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.783 1.291 . . . . 0.0 109.358 163.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -146.39 169.78 18.16 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.417 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -150.42 -176.23 23.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.722 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -108.93 14.41 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.116 1.21 . . . . 0.0 114.284 -144.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mt 23.61 -74.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 130.898 3.679 . . . . 0.0 116.446 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -147.83 159.93 43.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 165.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -143.58 53.12 1.32 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.845 2.058 . . . . 0.0 110.652 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 64.99 160.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.663 1.985 . . . . 0.0 111.554 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.51 150.96 11.9 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.73 150.86 26.68 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.756 1.222 . . . . 0.0 108.67 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.4 156.37 30.99 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 109.603 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.74 132.21 24.5 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.182 1.921 . . . . 0.0 110.102 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.72 155.03 59.16 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.696 2.931 . . . . 0.0 110.068 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.44 111.53 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.087 2.525 . . . . 0.0 109.823 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.64 -60.43 0.67 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 142.33 52.95 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -147.26 146.04 29.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -160.35 -175.34 4.98 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.736 0.647 . . . . 0.0 112.616 -165.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.0 m -60.67 101.7 0.15 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.779 2.032 . . . . 0.0 110.752 171.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -142.14 119.61 11.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.57 -89.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.38 -47.78 0.25 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.772 1.169 . . . . 0.0 112.013 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -144.58 4.05 1.15 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.355 . . . . 0.0 111.436 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.44 139.11 51.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.268 1.027 . . . . 0.0 108.379 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.63 88.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.2 174.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -147.56 133.17 18.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.306 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.57 -35.42 74.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.356 -0.84 . . . . 0.0 109.595 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.3 m -55.24 -43.81 74.94 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 110.923 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.5 p -63.58 -29.5 70.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.401 1.455 . . . . 0.0 110.659 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -69.4 -53.2 20.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.824 1.25 . . . . 0.0 110.477 167.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -47.47 -35.03 8.09 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.193 0.997 . . . . 0.0 112.157 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -58.55 -32.11 68.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.417 ' CD2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -144.97 -36.21 0.31 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -171.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.78 31.57 0.53 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.504 2.322 . . . . 0.0 111.447 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 126.751 2.02 . . . . 0.0 108.41 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.41 -27.03 82.12 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 121.428 1.546 . . . . 0.0 113.225 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.74 -26.46 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.245 0.93 . . . . 0.0 113.328 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.14 -23.92 60.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.335 0.97 . . . . 0.0 111.369 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -165.65 116.53 1.07 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 120.289 1.404 . . . . 0.0 108.192 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.148 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 122.489 1.137 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -91.59 173.01 8.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.67 2.788 . . . . 0.0 110.807 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -120.11 135.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 163.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.69 153.39 18.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -134.43 130.12 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -137.5 94.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.83 80.64 1.47 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 123.176 1.465 . . . . 0.0 112.768 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -158.31 -84.37 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 130.16 3.384 . . . . 0.0 104.989 165.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.363 1.5 mt 52.96 -17.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 1 C-N-CA 131.829 4.051 . . . . 0.0 114.44 -174.56 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.22 6.63 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 120.975 1.716 . . . . 0.0 113.582 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.597 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 41.6 mttp -71.36 -17.58 62.42 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 118.259 -2.906 . . . . 0.0 113.663 -165.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tpp -106.87 20.99 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.501 1.521 . . . . 0.0 110.904 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.45 -20.63 7.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.825 1.65 . . . . 0.0 114.636 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.39 -31.28 2.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.259 1.824 . . . . 0.0 110.677 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.02 -4.23 58.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.191 -0.943 . . . . 0.0 113.173 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.26 139.47 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.208 3.003 . . . . 0.0 110.347 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -40.08 0.27 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -100.71 -22.12 15.0 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.773 -1.108 . . . . 0.0 110.731 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -63.57 0.9 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.122 1.769 . . . . 0.0 110.508 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 125' ' ' ILE . 2.8 mp -33.01 -59.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.76 2.024 . . . . 0.0 113.096 170.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -68.85 -55.28 11.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.781 1.232 . . . . 0.0 108.191 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.49 76.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.443 0.697 . . . . 0.0 111.163 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.03 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.068 1.347 . . . . 0.0 107.663 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -57.75 -36.66 72.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.369 -171.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -54.66 -61.83 2.05 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.516 1.053 . . . . 0.0 109.08 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.4 m -78.64 -13.88 59.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.052 0.941 . . . . 0.0 113.205 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.52 -18.02 63.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.574 1.079 . . . . 0.0 110.321 166.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -132.46 32.36 3.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.285 1.434 . . . . 0.0 108.983 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.77 134.84 53.0 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.27 107.01 2.36 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.861 3.041 . . . . 0.0 107.885 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.34 34.57 3.87 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.931 -1.483 . . . . 0.0 114.747 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.9 m -136.23 171.19 14.84 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 161.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.3 mt -141.09 106.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.15 135.88 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 119.028 0.831 . . . . 0.0 110.241 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.5 tp -132.7 148.81 52.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.205 2.202 . . . . 0.0 106.605 159.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.36 -171.92 44.94 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 119.198 0.908 . . . . 0.0 112.26 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -118.59 154.83 31.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.9 0.85 . . . . 0.0 111.458 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.61 125.38 15.27 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.398 2.279 . . . . 0.0 108.223 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.08 150.11 87.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.59 1.527 . . . . 0.0 110.55 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.97 130.06 64.97 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.28 -51.4 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.53 2.82 . . . . 0.0 110.457 -165.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 40.51 55.97 2.8 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.999 1.72 . . . . 0.0 110.982 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 157.6 -153.02 24.28 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 126.897 2.189 . . . . 0.0 107.648 -159.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.6 OUTLIER -63.93 166.85 8.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.092 0.446 . . . . 0.0 110.237 172.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.65 168.69 22.97 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.563 1.509 . . . . 0.0 109.182 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.75 176.81 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.772 2.029 . . . . 0.0 106.259 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.17 -79.15 0.37 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.3 tp -51.02 -44.07 60.97 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.984 1.313 . . . . 0.0 112.255 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.06 -31.16 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.265 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.75 -34.24 75.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.327 1.422 . . . . 0.0 109.805 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.11 -43.8 87.36 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.262 0.937 . . . . 0.0 111.271 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.57 -39.56 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.029 0.532 . . . . 0.0 109.834 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -60.78 -32.4 71.73 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.508 -1.37 . . . . 0.0 110.338 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -74.23 8.43 2.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.513 1.525 . . . . 0.0 113.501 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -34.74 10.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.556 1.526 . . . . 0.0 111.62 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 63.1 -19.67 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 128.602 2.761 . . . . 0.0 115.339 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -72.6 -30.67 64.57 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.639 3.175 . . . . 0.0 111.615 168.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 29.5 m -54.18 125.13 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.108 1.763 . . . . 0.0 107.618 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.35 112.17 5.06 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -97.93 96.13 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 120.856 1.662 . . . . 0.0 106.575 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.52 98.25 1.11 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.037 0.935 . . . . 0.0 108.743 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.17 99.49 0.9 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.85 165.82 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.92 . . . . 0.0 109.192 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.7 p -138.68 156.38 47.47 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.836 1.303 . . . . 0.0 108.288 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -42.27 -31.64 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.867 156.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -80.29 -55.8 4.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.469 0.577 . . . . 0.0 109.79 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -119.95 16.66 12.56 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.876 0.87 . . . . 0.0 110.288 -160.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -39.71 -63.06 0.62 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.791 2.036 . . . . 0.0 111.155 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -70.56 8.48 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 113.704 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.48 15.92 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.405 2.282 . . . . 0.0 110.201 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -32.04 10.36 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.632 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -37.98 -55.99 2.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.489 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.52 -23.27 57.76 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.335 1.512 . . . . 0.0 114.59 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -80.26 -38.54 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.454 1.501 . . . . 0.0 110.425 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.6 mt -59.74 -52.14 64.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.359 -0.838 . . . . 0.0 108.863 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.74 -43.77 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.149 0.98 . . . . 0.0 109.41 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.7 m -59.06 -43.65 91.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.114 0.87 . . . . 0.0 111.032 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.0 -48.13 81.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.104 0.562 . . . . 0.0 109.676 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.43 -52.45 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.301 1.04 . . . . 0.0 109.893 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -69.46 -5.94 27.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.8 t -64.34 -71.2 0.18 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 128.276 2.63 . . . . 0.0 116.013 -164.249 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 23.43 91.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.092 2.157 . . . . 0.0 111.342 141.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.71 124.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -165.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -117.86 161.01 20.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 110.378 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.7 mt -124.84 154.57 40.82 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.203 1.401 . . . . 0.0 109.823 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -158.11 169.72 23.91 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.69 63.09 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 128.668 3.033 . . . . 0.0 111.874 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -54.21 118.49 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.468 3.445 . . . . 0.0 111.455 -166.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.24 -81.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.301 2.001 . . . . 0.0 114.451 -163.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.6 37.71 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t 50.99 68.77 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.919 1.688 . . . . 0.0 110.254 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.92 23.35 1.45 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.605 1.098 . . . . 0.0 111.039 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -83.91 -31.55 25.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.911 -0.758 . . . . 0.0 111.901 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -59.79 -38.16 81.1 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -56.99 -35.08 68.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 112.553 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -33.73 70.33 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mm -77.16 -31.07 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.6 1.091 . . . . 0.0 109.984 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -54.33 -51.42 64.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.706 1.593 . . . . 0.0 107.507 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -66.13 -15.18 62.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.7 -1.137 . . . . 0.0 112.374 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.2 64.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.45 1.023 . . . . 0.0 111.137 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -78.25 -48.35 15.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.284 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -50.34 -40.76 50.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.162 0.585 . . . . 0.0 111.172 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.65 -61.37 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 123.955 0.902 . . . . 0.0 109.486 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -55.48 -42.3 74.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 123.232 0.613 . . . . 0.0 109.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -60.39 -47.99 83.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -59.93 -42.05 93.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.168 0.987 . . . . 0.0 109.921 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -71.97 -7.28 47.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.593 1.557 . . . . 0.0 113.417 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.07 9.96 60.2 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.637 -1.09 . . . . 0.0 113.153 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.5 t -99.77 105.86 36.99 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.43 97.16 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.403 2.736 . . . . 0.0 110.948 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.59 147.27 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.686 1.194 . . . . 0.0 108.637 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -137.99 170.41 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.072 150.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.95 -162.58 28.1 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.227 0.917 . . . . 0.0 111.08 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -140.4 162.71 34.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.869 0.843 . . . . 0.0 111.128 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.2 157.83 45.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.932 1.293 . . . . 0.0 107.558 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.9 100.79 11.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -79.13 159.31 27.51 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.959 1.361 . . . . 0.0 109.086 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.17 99.78 8.73 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.348 169.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 48' ' ' GLY . 7.6 p -58.71 107.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.828 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -108.96 103.1 12.08 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 120.917 -1.115 . . . . 0.0 109.348 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.84 -37.86 89.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.786 0.721 . . . . 0.0 110.713 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.3 63.58 0.11 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.88 15.15 68.84 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.87 -1.517 . . . . 0.0 115.805 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 140.81 52.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.835 1.817 . . . . 0.0 107.075 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -78.12 98.23 5.72 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -78.18 -12.94 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 121.39 -0.819 . . . . 0.0 111.995 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' H ' HG13 ' A' ' 40' ' ' VAL . . . 172.95 -126.96 1.3 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -132.93 158.82 41.65 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.33 134.03 35.58 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.522 1.129 . . . . 0.0 109.715 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.6 101.97 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -167.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -90.03 132.76 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.3 p -95.96 156.26 16.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.2 8.99 3.4 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.291 -0.881 . . . . 0.0 112.541 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 t -109.89 4.34 21.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.996 1.319 . . . . 0.0 111.51 161.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.2 3.45 65.3 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.367 -1.458 . . . . 0.0 114.768 161.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -71.84 148.84 45.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.538 1.669 . . . . 0.0 107.194 162.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -139.32 131.79 28.62 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.926 1.29 . . . . 0.0 108.462 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.99 174.08 15.2 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.731 1.15 . . . . 0.0 113.861 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.75 165.18 21.69 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.609 1.539 . . . . 0.0 108.631 162.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 tp -140.74 -70.18 0.38 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.9 p -134.49 158.07 44.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.071 0.857 . . . . 0.0 108.927 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -147.43 157.64 43.66 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.535 1.134 . . . . 0.0 110.137 169.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 t -62.14 137.1 24.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 109.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.51 165.4 30.94 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.82 153.78 7.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.734 0.814 . . . . 0.0 109.504 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.12 163.99 56.62 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.669 0.388 . . . . 0.0 111.297 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -83.58 140.52 9.45 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.001 2.467 . . . . 0.0 110.739 -170.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.43 164.26 26.47 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.691 2.26 . . . . 0.0 110.524 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.63 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.841 2.361 . . . . 0.0 113.056 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.54 10.34 26.02 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.173 1.844 . . . . 0.0 113.114 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.63 165.67 26.33 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.951 1.875 . . . . 0.0 109.025 169.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.8 157.85 42.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.201 0.601 . . . . 0.0 110.275 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -166.92 -170.11 1.47 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 128.502 2.721 . . . . 0.0 105.95 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 92.6 m -98.02 126.73 43.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 139.7 33.19 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.884 -1.135 . . . . 0.0 108.718 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.2 92.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.871 1.669 . . . . 0.0 107.604 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.12 -73.93 1.92 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.37 0.986 . . . . 0.0 112.308 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.22 -25.65 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.439 1.495 . . . . 0.0 110.768 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.29 118.63 25.86 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.31 131.1 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 162.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.44 178.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 125.273 1.429 . . . . 0.0 108.745 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -147.28 155.53 42.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.46 161.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.79 -28.92 36.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.642 0.777 . . . . 0.0 110.448 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 m -64.28 -36.87 85.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.683 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.9 m -60.45 -31.74 70.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.591 1.087 . . . . 0.0 110.931 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -71.86 -53.9 11.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.518 167.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.05 -23.87 22.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.327 1.051 . . . . 0.0 113.488 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -42.54 -53.4 4.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.197 1.799 . . . . 0.0 112.04 167.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -31.88 0.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.369 1.068 . . . . 0.0 112.63 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.38 52.52 2.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.653 1.181 . . . . 0.0 108.664 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.47 -57.49 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 126.197 1.799 . . . . 0.0 109.606 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -37.18 5.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.834 1.689 . . . . 0.0 112.122 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 m -56.04 -35.73 42.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.935 0.894 . . . . 0.0 112.304 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -63.33 -38.29 90.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.54 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -129.5 76.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.823 1.249 . . . . 0.0 109.6 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 124.903 1.281 . . . . 0.0 111.388 -172.65 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 . . . . . 0 C--O 1.238 0.452 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 179.21 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.17 139.26 51.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 167.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.1 158.11 34.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.491 1.116 . . . . 0.0 108.461 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.7 t -142.19 127.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.411 1.085 . . . . 0.0 109.919 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 mt -149.48 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 125.659 1.583 . . . . 0.0 107.736 -167.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -79.77 174.65 11.37 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.347 -1.471 . . . . 0.0 112.476 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 57.02 20.12 5.19 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.109 2.564 . . . . 0.0 115.036 167.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mt -55.61 125.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.512 -1.368 . . . . 0.0 108.257 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.52 -34.56 1.96 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.063 1.316 . . . . 0.0 111.721 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -41.94 98.98 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.658 2.229 . . . . 0.0 110.469 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -83.48 16.72 2.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.915 1.686 . . . . 0.0 112.178 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -49.53 -39.74 35.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.644 1.565 . . . . 0.0 111.518 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.12 -49.8 6.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.544 0.738 . . . . 0.0 110.346 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -67.35 -24.02 65.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -55.66 141.32 38.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.544 1.138 . . . . 0.0 112.123 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -138.07 -82.0 0.33 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.817 0.847 . . . . 0.0 109.648 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.04 -12.45 60.33 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -60.0 3.64 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 111.482 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.401 ' H ' HD11 ' A' ' 125' ' ' ILE . 3.7 mp -35.89 -58.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 126.164 1.786 . . . . 0.0 112.338 170.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.31 -51.49 65.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.206 0.527 . . . . 0.0 110.188 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.56 83.65 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.472 -171.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.92 -46.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 121.878 -0.514 . . . . 0.0 110.148 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -52.31 -36.21 52.6 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.901 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -27.31 66.93 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 m -100.47 -31.72 11.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 116.669 -1.634 . . . . 0.0 111.49 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.74 -18.87 57.26 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.228 1.831 . . . . 0.0 111.505 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -68.33 -29.57 68.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.649 1.579 . . . . 0.0 110.082 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.6 m -63.82 142.33 98.07 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 126.435 1.894 . . . . 0.0 106.869 172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.21 16.67 0.29 Allowed 'Trans proline' 0 CA--C 1.541 0.867 1 C-N-CA 126.173 4.582 . . . . 0.0 111.608 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.79 -161.44 11.9 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -155.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.7 177.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.101 0.953 . . . . 0.0 109.808 -140.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.3 mt -137.25 103.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 1 N-CA-C 99.614 -4.217 . . . . 0.0 99.614 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 141.31 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.6 133.76 50.96 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.35 45.4 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.463 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 40.0 m -129.32 123.29 31.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.446 0.698 . . . . 0.0 109.177 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.67 165.46 32.93 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.945 1.698 . . . . 0.0 108.809 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.54 165.46 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.378 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.94 142.4 76.3 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.525 1.13 . . . . 0.0 108.518 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.35 104.09 1.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 121.409 1.406 . . . . 0.0 111.331 -156.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -99.44 162.04 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.479 1.112 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -24.88 -77.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 127.25 2.357 . . . . 0.0 114.967 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 138.08 22.63 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.86 164.23 35.42 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.809 1.673 . . . . 0.0 109.512 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.06 171.59 7.29 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.704 1.601 . . . . 0.0 109.31 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.53 -77.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 114.032 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.02 -33.09 70.34 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.68 -35.54 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 O-C-N 121.149 -0.969 . . . . 0.0 110.412 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.46 -23.08 65.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.39 1.476 . . . . 0.0 111.291 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -70.67 -42.36 70.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.737 1.153 . . . . 0.0 109.542 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.07 -48.28 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.769 0.828 . . . . 0.0 109.654 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.44 -22.24 66.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 110.486 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -28.56 68.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.994 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -65.63 -34.15 77.56 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.766 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? 67.66 -57.15 0.46 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.183 2.593 . . . . 0.0 111.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.87 77.68 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.248 1.819 . . . . 0.0 107.693 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.73 135.99 48.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 128.748 2.819 . . . . 0.0 105.064 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.87 136.76 38.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 164.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.33 96.8 4.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 120.157 1.344 . . . . 0.0 107.767 170.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -76.95 104.36 7.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.802 0.81 . . . . 0.0 109.039 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.71 106.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 160.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.14 154.05 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 167.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 22.5 p -102.88 159.93 15.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 157.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.22 -16.98 56.91 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.602 166.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -98.38 -56.77 2.37 Favored 'General case' 0 N--CA 1.458 -0.038 0 CA-C-N 118.386 0.539 . . . . 0.0 111.147 -166.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.5 17.66 5.19 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.484 1.114 . . . . 0.0 110.121 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -40.91 -46.11 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.283 1.833 . . . . 0.0 111.595 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.8 6.16 9.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 114.204 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.23 43.43 3.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.438 1.895 . . . . 0.0 109.887 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.6 tp -118.68 -42.2 2.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.23 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.96 -55.41 6.18 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.867 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.22 -27.21 56.4 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.419 1.9 . . . . 0.0 113.398 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -72.66 -42.07 64.73 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.704 1.202 . . . . 0.0 109.804 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.76 -52.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.912 1.685 . . . . 0.0 108.486 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.55 -44.01 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.388 0.994 . . . . 0.0 109.686 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.2 m -62.03 -49.22 76.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.898 0.772 . . . . 0.0 109.703 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.4 -42.17 91.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.504 1.122 . . . . 0.0 112.151 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.51 -53.74 29.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.576 1.951 . . . . 0.0 109.529 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -68.07 -23.49 64.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.849 0.86 . . . . 0.0 111.544 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.08 -52.45 4.27 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 127.698 2.399 . . . . 0.0 112.685 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 CA--C 1.54 0.58 0 CA-C-N 120.052 1.296 . . . . 0.0 110.891 -158.764 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -64.42 146.75 54.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.934 1.694 . . . . 0.0 109.249 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -127.55 144.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -141.38 123.05 15.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.401 0.68 . . . . 0.0 110.784 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.4 152.5 44.01 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 t -152.93 -174.7 5.02 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.07 176.55 15.15 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.086 1.803 . . . . 0.0 111.316 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -73.98 156.02 47.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.528 2.152 . . . . 0.0 109.464 164.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 154.71 48.87 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.566 2.178 . . . . 0.0 111.103 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.96 8.51 6.38 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.315 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.274 82.2 t 66.29 120.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 127.536 2.334 . . . . 0.0 111.341 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.9 29.75 14.74 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.75 1.167 . . . . 0.0 112.586 -173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -63.77 -49.07 74.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.153 1.477 . . . . 0.0 111.838 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -45.13 -38.78 5.44 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.566 1.947 . . . . 0.0 111.221 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.3 m -49.31 -43.57 43.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.163 1.785 . . . . 0.0 111.9 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -32.79 64.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.165 1.348 . . . . 0.0 110.345 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.37 -45.13 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -50.6 72.57 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.957 1.703 . . . . 0.0 109.15 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.97 -34.4 78.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.25 60.5 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.734 1.152 . . . . 0.0 111.62 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -71.58 -48.93 45.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.354 0.662 . . . . 0.0 111.117 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.03 -33.88 69.45 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.34 1.056 . . . . 0.0 111.64 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.67 -53.71 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.419 1.488 . . . . 0.0 108.431 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.53 -38.9 89.1 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.456 0.703 . . . . 0.0 109.823 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.74 -43.48 94.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.911 0.778 . . . . 0.0 110.25 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -23.27 56.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.366 1.066 . . . . 0.0 111.837 169.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 m -97.72 18.08 16.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.825 2.05 . . . . 0.0 115.487 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.09 35.12 86.6 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.811 1.187 . . . . 0.0 111.435 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.24 158.79 87.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 120.846 -1.385 . . . . 0.0 109.884 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.23 101.7 0.63 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.588 2.859 . . . . 0.0 110.249 145.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.11 149.62 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 163.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 -179.03 7.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.533 0.733 . . . . 0.0 110.085 155.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.35 -151.0 22.31 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.893 1.235 . . . . 0.0 110.034 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -138.06 174.25 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.185 1.794 . . . . 0.0 109.457 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -143.6 159.49 42.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -116.15 74.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -157.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -71.89 137.97 47.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.861 0.838 . . . . 0.0 110.772 -163.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -68.95 113.77 6.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.626 1.571 . . . . 0.0 108.554 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.18 91.08 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -109.42 102.38 11.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.34 62.18 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.94 0.896 . . . . 0.0 110.168 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 66.4 1.92 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -162.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.66 -22.12 15.25 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -169.43 0.83 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.569 1.685 . . . . 0.0 110.561 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 89.79 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.685 1.584 . . . . 0.0 111.354 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.44 -10.07 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.195 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 -167.96 40.96 Favored Glycine 0 C--N 1.337 0.583 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.7 158.65 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.033 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -137.73 159.64 41.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.841 1.656 . . . . 0.0 108.288 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.9 100.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 121.236 1.835 . . . . 0.0 107.806 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -82.25 123.8 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -89.19 163.45 15.41 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.188 -0.945 . . . . 0.0 108.546 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.56 -16.63 60.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 120.637 -1.29 . . . . 0.0 112.005 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 t -63.21 -36.89 85.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.689 1.131 . . . . 0.0 108.334 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.79 6.26 17.09 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.108 0.861 . . . . 0.0 112.465 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.6 25.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -144.13 135.79 25.99 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.5 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.48 135.64 12.25 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.04 67.71 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 125.129 3.886 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.36 -67.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 125.317 1.447 . . . . 0.0 112.719 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 p -139.7 154.85 47.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.207 1.004 . . . . 0.0 110.657 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.07 159.72 43.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.268 1.827 . . . . 0.0 106.419 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -54.9 160.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 121.913 -0.492 . . . . 0.0 110.457 160.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.67 -142.15 3.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.22 174.55 7.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.529 1.132 . . . . 0.0 109.915 164.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -124.24 156.88 66.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.216 1.406 . . . . 0.0 110.842 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.05 142.55 8.8 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.037 1.824 . . . . 0.0 110.544 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.79 166.26 20.81 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.115 2.543 . . . . 0.0 110.699 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.92 69.19 4.67 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.427 3.418 . . . . 0.0 112.931 -172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -55.35 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 125.447 1.499 . . . . 0.0 109.691 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -55.54 157.73 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.839 2.056 . . . . 0.0 110.15 163.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.93 153.74 37.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.667 1.987 . . . . 0.0 106.98 159.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -155.18 96.23 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 96.1 m 46.03 35.45 2.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.269 2.628 . . . . 0.0 115.665 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.19 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.542 -1.349 . . . . 0.0 108.008 -170.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.49 87.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 -67.78 1.36 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.823 1.201 . . . . 0.0 112.242 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -137.1 -36.0 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.151 2.18 . . . . 0.0 111.22 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.68 170.02 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.348 0.976 . . . . 0.0 108.937 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.59 120.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.33 176.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.914 0.864 . . . . 0.0 110.136 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -142.62 109.94 5.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -32.49 74.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.589 1.156 . . . . 0.0 109.609 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -54.0 -48.97 69.87 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.26 1.824 . . . . 0.0 108.618 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.6 t -55.88 -22.44 25.57 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 120.409 1.458 . . . . 0.0 113.316 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -79.11 -60.84 2.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.521 1.055 . . . . 0.0 109.182 168.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.51 -26.78 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.745 2.018 . . . . 0.0 113.139 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -61.8 -28.36 69.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 114.676 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.39 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.616 0.766 . . . . 0.0 112.924 -171.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.55 52.81 1.01 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.563 1.145 . . . . 0.0 108.798 166.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.62 -61.1 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 126.437 1.895 . . . . 0.0 108.444 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -42.01 36.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.187 1.925 . . . . 0.0 112.459 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.28 -20.62 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.898 0.772 . . . . 0.0 113.037 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.74 74.28 6.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.19 94.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.443 2.697 . . . . 0.0 111.741 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 125.681 1.592 . . . . 0.0 108.132 174.1 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 120.464 0.173 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -142.47 170.34 15.89 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 127.209 2.204 . . . . 0.0 108.121 -169.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.19 128.27 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 36.6 t -108.85 154.22 22.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -137.73 123.35 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.616 0.767 . . . . 0.0 110.203 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.4 mt -148.46 85.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.455 1.502 . . . . 0.0 108.693 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -86.46 164.75 16.79 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.918 -1.739 . . . . 0.0 111.164 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 56.6 58.02 4.43 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.587 2.355 . . . . 0.0 111.992 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.3 mt -87.12 49.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 121.03 -1.044 . . . . 0.0 108.687 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.74 3.93 1.38 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-O 118.257 -1.302 . . . . 0.0 115.082 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -103.64 -77.76 0.56 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.455 2.127 . . . . 0.0 110.848 -173.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -52.46 -18.76 1.81 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.317 1.447 . . . . 0.0 113.771 168.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -32.24 -60.6 0.27 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.523 2.329 . . . . 0.0 113.105 -167.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.55 -29.34 69.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.318 0.963 . . . . 0.0 112.254 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -95.34 -17.64 21.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.807 1.643 . . . . 0.0 112.746 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.0 p -54.56 151.94 7.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.915 1.286 . . . . 0.0 110.88 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -132.54 -89.68 0.42 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.468 1.107 . . . . 0.0 109.27 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -56.08 -21.33 21.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 117.098 -1.43 . . . . 0.0 112.296 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -62.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 120.906 1.685 . . . . 0.0 110.707 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.5 mp -41.81 -58.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.135 1.374 . . . . 0.0 110.364 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -65.31 -39.15 92.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -166.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.05 -51.91 12.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.14 0.9 . . . . 0.0 108.936 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.57 -34.07 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 O-C-N 121.909 -0.494 . . . . 0.0 111.054 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.33 -43.45 61.73 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.217 169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.19 -45.35 83.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.568 1.531 . . . . 0.0 111.167 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.7 m -65.74 -46.86 77.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.945 0.898 . . . . 0.0 110.892 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.2 mt -62.87 -25.7 68.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 110.938 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 t -76.9 -9.08 58.44 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.588 1.555 . . . . 0.0 110.766 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.0 m -91.41 134.24 29.92 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.34 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.949 2.432 . . . . 0.0 111.577 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.7 -32.57 49.93 Favored Glycine 0 C--O 1.218 -0.896 0 CA-C-O 117.242 -1.866 . . . . 0.0 112.811 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.0 m -66.74 138.69 57.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 122.101 2.951 . . . . 0.0 107.975 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -122.65 84.44 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 101.51 -3.515 . . . . 0.0 101.51 -166.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.98 117.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mt -102.87 133.09 48.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 151.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.68 171.23 29.06 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 44.2 m -122.23 101.67 7.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.906 0.853 . . . . 0.0 108.72 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.9 pt -86.35 151.22 53.32 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.036 0.934 . . . . 0.0 108.785 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.7 145.3 36.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.927 2.418 . . . . 0.0 110.043 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.86 139.65 93.63 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 165.27 32.5 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.171 2.581 . . . . 0.0 110.601 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.77 -38.24 0.28 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.154 0.981 . . . . 0.0 111.041 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.77 139.5 4.69 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.479 -1.849 . . . . 0.0 108.479 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.09 163.75 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.729 1.611 . . . . 0.0 113.505 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.44 165.76 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.53 3.486 . . . . 0.0 109.959 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.03 171.58 7.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.32 -82.58 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.797 0.726 . . . . 0.0 109.214 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.31 -40.88 65.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.25 -0.906 . . . . 0.0 113.166 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.86 -28.06 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.544 -0.722 . . . . 0.0 110.48 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.92 -32.05 72.41 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.915 0.78 . . . . 0.0 109.632 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -60.98 -33.88 73.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.566 1.076 . . . . 0.0 112.137 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 108.54 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -59.05 -34.74 72.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.612 0.642 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.93 -25.71 58.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.219 1.807 . . . . 0.0 112.809 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.828 1.195 . . . . 0.0 111.483 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -54.47 0.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.782 2.033 . . . . 0.0 113.758 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -72.3 42.91 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.691 2.796 . . . . 0.0 111.486 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.66 103.21 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 130.503 3.521 . . . . 0.0 104.796 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.45 131.97 48.67 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.05 116.78 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.236 1.014 . . . . 0.0 109.159 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -106.17 82.09 1.71 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.578 2.351 . . . . 0.0 107.664 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 117.81 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 120.906 -1.121 . . . . 0.0 108.102 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.43 153.78 4.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 p -110.7 158.22 18.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -66.32 -19.01 65.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.25 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -83.29 -38.02 22.68 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 118.099 0.409 . . . . 0.0 111.18 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.11 15.18 19.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.699 1.2 . . . . 0.0 111.325 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -49.49 -52.13 31.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.314 1.046 . . . . 0.0 109.315 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.3 4.57 2.78 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -124.47 3.4 8.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.132 0.973 . . . . 0.0 113.127 172.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -19.11 37.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.398 0.999 . . . . 0.0 113.624 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -56.01 26.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.52 -1.228 . . . . 0.0 110.183 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.37 -27.15 63.12 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.623 1.615 . . . . 0.0 113.302 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.76 -40.67 75.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.601 1.16 . . . . 0.0 109.435 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.9 mt -63.95 -53.05 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.701 1.2 . . . . 0.0 107.977 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.25 -42.71 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.695 1.198 . . . . 0.0 109.767 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -55.13 39.13 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 125.479 1.512 . . . . 0.0 108.857 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 9.1 t -52.99 -41.3 64.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.123 0.874 . . . . 0.0 111.311 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.92 -53.51 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.691 1.196 . . . . 0.0 108.994 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -62.52 -34.59 77.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.075 1.307 . . . . 0.0 113.124 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.3 m -64.9 8.25 0.13 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 129.987 3.315 . . . . 0.0 113.482 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.2 p . . . . . 0 C--O 1.236 0.359 0 O-C-N 120.856 -1.153 . . . . 0.0 108.156 172.015 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -50.37 156.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.088 2.155 . . . . 0.0 111.214 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.1 t -141.7 143.17 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -142.92 161.83 37.09 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.97 1.708 . . . . 0.0 110.006 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.25 157.57 16.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 160.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -141.78 -178.96 5.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.815 1.646 . . . . 0.0 107.469 162.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.86 -170.73 14.99 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.02 115.86 4.51 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.356 2.704 . . . . 0.0 108.669 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.32 97.28 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.654 1.569 . . . . 0.0 110.601 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.39 -57.95 16.75 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t 176.09 -45.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 129.086 2.954 . . . . 0.0 109.309 163.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.44 8.99 30.42 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 123.706 0.669 . . . . 0.0 114.22 -167.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -38.67 75.43 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.728 1.264 . . . . 0.0 111.759 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.0 m -64.8 -37.12 86.53 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.34 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -64.77 -33.58 76.31 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.498 1.499 . . . . 0.0 110.222 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 177' ' ' LEU . 59.9 mt -60.65 -57.52 12.35 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.199 0.599 . . . . 0.0 109.754 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 mm -70.76 -38.39 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 122.989 0.516 . . . . 0.0 109.693 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.93 -61.93 1.86 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.159 2.184 . . . . 0.0 108.587 172.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.3 -32.15 72.85 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.435 -1.269 . . . . 0.0 111.853 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.31 78.45 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 120.16 1.346 . . . . 0.0 109.265 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.7 p -70.96 -45.1 64.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.097 -0.954 . . . . 0.0 108.991 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.35 -37.54 70.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.49 1.495 . . . . 0.0 112.139 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.56 -54.85 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 125.879 1.672 . . . . 0.0 108.848 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.18 -32.94 74.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.76 -0.588 . . . . 0.0 109.92 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -62.68 -36.39 82.77 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.008 -1.683 . . . . 0.0 110.738 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -38.13 85.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 110.081 165.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.52 5.36 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.121 1.369 . . . . 0.0 114.251 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.16 52.56 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 120.274 1.397 . . . . 0.0 111.662 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.03 142.06 57.79 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.62 94.26 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.316 1.344 . . . . 0.0 109.086 160.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.15 139.58 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.268 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.02 169.6 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.461 1.505 . . . . 0.0 107.818 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.44 25.74 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -143.83 162.93 34.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.002 1.321 . . . . 0.0 107.513 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -140.59 110.28 6.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -70.23 134.41 48.01 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.05 44.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.52 -0.737 . . . . 0.0 110.832 -171.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.34 146.15 50.69 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -122.58 105.22 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -123.14 80.06 1.73 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 126.486 1.915 . . . . 0.0 110.005 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -65.04 -24.26 67.43 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.836 -1.165 . . . . 0.0 112.666 -166.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.97 45.64 0.73 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 166.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.31 89.24 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.717 -1.046 . . . . 0.0 114.21 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.64 124.7 46.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 119.55 1.675 . . . . 0.0 108.459 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -60.75 92.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.675 1.59 . . . . 0.0 110.608 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.64 -16.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 111.127 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.49 -166.17 39.37 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -130.9 160.98 32.87 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.084 1.753 . . . . 0.0 106.404 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.86 161.49 30.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.775 2.03 . . . . 0.0 105.998 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.97 110.02 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 167.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.32 162.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.976 1.262 . . . . 0.0 108.06 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -125.43 160.0 30.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.011 1.324 . . . . 0.0 108.154 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.18 -21.38 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.452 172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -62.25 -26.48 68.41 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.63 1.105 . . . . 0.0 111.062 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.01 5.77 57.22 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.187 1.375 . . . . 0.0 111.864 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -84.34 159.77 20.82 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 120.987 -1.302 . . . . 0.0 107.774 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 147.83 26.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -174.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.82 -178.09 21.03 Favored Glycine 0 CA--C 1.521 0.44 0 O-C-N 123.948 0.78 . . . . 0.0 112.726 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.24 169.31 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.737 2.958 . . . . 0.0 112.429 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tp -150.0 -66.93 0.21 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.98 -1.075 . . . . 0.0 109.705 161.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -150.11 125.62 10.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -128.55 165.71 20.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.617 1.167 . . . . 0.0 108.198 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.6 120.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.73 -119.73 2.06 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.77 157.3 47.19 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.39 1.476 . . . . 0.0 107.44 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -86.65 166.43 27.4 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.641 1.576 . . . . 0.0 110.808 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.77 139.47 14.01 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.434 2.756 . . . . 0.0 108.699 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.43 172.22 14.83 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.766 2.311 . . . . 0.0 110.765 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.21 99.54 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.86 1.706 . . . . 0.0 108.245 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.44 -79.11 0.35 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 124.902 1.239 . . . . 0.0 110.494 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.73 125.56 23.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.364 1.082 . . . . 0.0 108.752 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 138.47 32.56 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.62 -163.16 1.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.42 -178.31 3.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 157.41 167.16 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 131.133 3.773 . . . . 0.0 105.849 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 -13.21 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 123.866 0.729 . . . . 0.0 109.663 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.96 134.43 3.57 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.044 -2.822 . . . . 0.0 106.044 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.51 -68.02 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.626 2.37 . . . . 0.0 111.571 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.03 149.38 30.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.857 1.663 . . . . 0.0 108.205 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.01 132.05 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.45 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.773 0.829 . . . . 0.0 110.275 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -154.39 105.39 2.66 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -21.62 65.06 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.149 -0.97 . . . . 0.0 111.865 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.1 m -37.24 -45.82 0.68 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.526 1.93 . . . . 0.0 112.243 156.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 p -76.66 -34.43 58.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.395 0.998 . . . . 0.0 109.175 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.2 -41.81 93.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.98 -1.075 . . . . 0.0 109.718 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.84 -9.1 58.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.832 1.196 . . . . 0.0 113.625 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.46 -68.18 0.38 Allowed 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 161.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mp -102.22 -44.8 5.32 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.814 -0.554 . . . . 0.0 111.539 -158.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.48 49.3 1.77 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.463 1.905 . . . . 0.0 108.553 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.52 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 109.864 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.61 -33.47 45.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.883 1.722 . . . . 0.0 112.517 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -59.82 -24.73 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.533 1.133 . . . . 0.0 112.868 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.06 -11.17 60.45 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.301 0.501 . . . . 0.0 111.269 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 88.02 1.99 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.321 -0.649 0 C-N-CA 123.86 0.864 . . . . 0.0 109.166 167.059 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 121.924 0.868 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 164.9 4.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.517 1.127 . . . . 0.0 108.812 172.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.69 146.82 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 139' ' ' ILE . 5.7 p -115.84 163.78 15.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.938 0.875 . . . . 0.0 110.449 161.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.8 125.88 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -141.52 74.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.04 167.47 21.75 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.88 27.95 10.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 114.103 164.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.7 mt -70.14 75.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.186 1.394 . . . . 0.0 108.227 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.2 -47.58 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.826 -1.171 . . . . 0.0 113.45 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -69.75 -40.14 76.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.345 2.073 . . . . 0.0 111.914 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -12.72 60.94 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 116.291 -1.814 . . . . 0.0 112.618 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -47.07 -24.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -156.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 -22.19 13.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.426 1.09 . . . . 0.0 112.119 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -99.06 -29.01 13.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.964 1.706 . . . . 0.0 109.745 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -45.45 114.5 0.76 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.803 2.841 . . . . 0.0 108.348 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.13 -86.59 0.5 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 119.864 1.211 . . . . 0.0 111.16 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.54 -10.35 57.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.934 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -53.06 -52.14 59.5 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 120.866 1.666 . . . . 0.0 112.151 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mt -39.17 -54.63 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 127.384 2.274 . . . . 0.0 112.552 164.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -63.63 -54.26 38.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.904 1.229 . . . . 0.0 110.593 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.48 -49.26 78.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 123.24 0.338 . . . . 0.0 111.095 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.62 -30.06 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.907 0.883 . . . . 0.0 111.611 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -40.02 60.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.493 168.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -38.07 86.9 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.663 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.51 -48.8 63.45 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.923 1.238 . . . . 0.0 110.472 175.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.3 mt -58.02 -32.47 67.98 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.464 1.906 . . . . 0.0 111.98 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.5 m -129.32 30.24 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.62 1.568 . . . . 0.0 110.019 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.45 165.1 55.39 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 149.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -87.33 126.48 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.541 2.828 . . . . 0.0 109.298 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.07 89.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 116.929 -2.039 . . . . 0.0 116.263 158.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 m -72.14 166.9 21.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 121.827 2.814 . . . . 0.0 108.492 155.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.0 mt -131.83 104.25 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.402 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 41.2 mm -67.5 132.08 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.42 1.075 . . . . 0.0 108.117 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tp -140.56 136.06 32.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 107.82 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.61 41.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 113.341 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -128.56 130.73 47.8 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.169 0.987 . . . . 0.0 108.863 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.73 163.87 18.22 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.967 1.707 . . . . 0.0 108.152 165.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.01 161.07 11.72 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.37 2.713 . . . . 0.0 111.332 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.61 139.34 93.95 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 165.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.01 159.5 33.99 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.489 2.793 . . . . 0.0 108.891 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -142.3 -65.94 0.4 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.81 -122.93 0.94 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 125.208 1.385 . . . . 0.0 111.096 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.52 171.1 1.88 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.38 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.52 168.0 19.3 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.271 1.314 . . . . 0.0 109.099 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.54 137.07 52.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.84 -63.36 1.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.93 0.892 . . . . 0.0 111.751 -156.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.95 -40.8 98.75 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.93 -28.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.686 -0.634 . . . . 0.0 110.269 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.83 -29.92 63.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.724 0.81 . . . . 0.0 110.807 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.17 -38.79 90.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.539 1.063 . . . . 0.0 112.095 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.95 -41.94 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.86 1.264 . . . . 0.0 108.338 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -18.36 65.34 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.087 -1.633 . . . . 0.0 111.532 -174.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.76 -22.01 61.66 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.825 0.739 . . . . 0.0 110.273 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -73.9 83.93 1.7 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.35 -28.77 69.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.851 -1.156 . . . . 0.0 109.305 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -76.12 56.62 1.03 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.47 3.108 . . . . 0.0 110.651 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.77 126.5 62.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 105.05 1.34 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 161.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.1 t -88.91 98.1 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -68.41 147.24 52.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.77 125.06 48.36 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.67 159.87 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 167.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 p -128.13 149.76 50.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -58.23 -16.08 12.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.953 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -80.68 -68.75 0.65 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.195 0.907 . . . . 0.0 108.569 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.19 28.46 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.887 1.275 . . . . 0.0 109.523 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -59.58 -23.44 62.94 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.24 9.75 21.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.749 1.62 . . . . 0.0 112.057 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.63 -13.48 15.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 115.94 -1.981 . . . . 0.0 113.86 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 tt -84.58 -20.04 32.11 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 116.167 -2.213 . . . . 0.0 111.795 -154.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.444 ' H ' HD23 ' A' ' 17' ' ' LEU . 12.1 tp -25.27 -64.99 0.1 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 128.872 2.869 . . . . 0.0 113.529 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.09 -28.03 85.15 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.854 2.369 . . . . 0.0 113.18 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.84 -42.53 90.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.676 1.125 . . . . 0.0 109.538 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.62 -50.07 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 125.382 1.473 . . . . 0.0 108.032 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.83 -37.0 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.5 1.045 . . . . 0.0 111.035 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 86.8 m -60.46 -47.51 85.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 6.9 t -62.8 -29.02 70.4 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.004 0.82 . . . . 0.0 111.344 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.65 -52.19 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.232 1.013 . . . . 0.0 110.316 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -34.4 71.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.98 1.264 . . . . 0.0 111.368 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 -8.81 48.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.677 1.991 . . . . 0.0 111.813 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 O-C-N 120.647 -1.283 . . . . 0.0 111.452 166.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 123.25 1.5 . . . . 0.0 107.555 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -72.99 149.61 43.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.99 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.5 t -126.78 133.85 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -136.37 121.16 18.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.501 0.667 . . . . 0.0 110.611 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.21 155.75 34.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.908 1.283 . . . . 0.0 109.101 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -161.46 -179.43 7.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.978 164.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.57 -107.29 1.12 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.383 1.944 . . . . 0.0 109.465 170.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.06 174.67 8.57 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.811 3.007 . . . . 0.0 111.746 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.21 -177.8 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.817 2.344 . . . . 0.0 110.681 164.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.73 55.44 1.32 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 126.764 2.126 . . . . 0.0 110.771 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.27 52.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.004 1.321 . . . . 0.0 107.857 156.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.63 59.78 1.41 Allowed Glycine 0 C--N 1.335 0.481 0 O-C-N 119.801 -1.812 . . . . 0.0 110.364 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -38.99 4.15 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.5 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.2 m -55.44 -44.0 75.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.71 1.204 . . . . 0.0 109.893 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.7 m -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.355 -1.466 . . . . 0.0 113.295 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -44.54 72.39 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 120.722 1.601 . . . . 0.0 108.559 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.34 -37.41 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.945 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -53.12 -47.81 68.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.386 0.994 . . . . 0.0 110.361 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -30.41 70.68 Favored 'General case' 0 C--O 1.227 -0.088 0 O-C-N 122.338 -0.226 . . . . 0.0 110.95 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -27.2 69.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.379 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.9 p -74.91 -53.38 9.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.656 1.116 . . . . 0.0 108.02 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -48.88 -45.47 41.21 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.582 1.953 . . . . 0.0 112.11 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.64 -45.51 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.258 0.551 . . . . 0.0 110.956 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.69 -37.0 76.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.024 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.77 -43.66 81.02 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -26.77 67.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.667 1.187 . . . . 0.0 112.81 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -5.73 53.45 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.761 0.824 . . . . 0.0 112.092 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.12 88.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.763 1.173 . . . . 0.0 113.643 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.32 127.6 85.99 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 119.589 1.694 . . . . 0.0 107.681 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.98 130.31 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.844 2.363 . . . . 0.0 109.577 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.65 137.6 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.78 167.87 16.68 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.528 1.531 . . . . 0.0 107.673 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' H ' HG23 ' A' ' 94' ' ' VAL . . . 129.92 -160.76 22.93 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.35 165.44 27.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -128.09 -178.6 4.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 162.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -140.12 137.43 34.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.35 156.3 44.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.56 111.97 7.29 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.72 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.71 124.91 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -124.61 125.42 44.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.91 1.684 . . . . 0.0 107.627 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -69.18 -39.4 78.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.944 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.21 39.16 0.41 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.969 1.747 . . . . 0.0 109.545 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.14 26.07 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.536 1.541 . . . . 0.0 114.855 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 142.84 35.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.816 1.308 . . . . 0.0 110.833 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -64.82 129.98 41.76 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 125.162 1.538 . . . . 0.0 111.539 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.5 pt -137.23 -11.77 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.874 1.67 . . . . 0.0 112.973 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.18 -167.37 36.09 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 119.255 0.934 . . . . 0.0 112.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -139.26 123.97 18.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.127 2.171 . . . . 0.0 106.79 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.74 144.72 25.4 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.37 111.96 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 119.729 1.15 . . . . 0.0 108.367 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.34 110.46 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.603 0.361 . . . . 0.0 110.056 -152.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -74.74 155.65 37.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.713 1.244 . . . . 0.0 108.808 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.19 -13.63 62.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.103 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.98 9.85 15.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.904 1.682 . . . . 0.0 111.791 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.1 82.4 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 120.738 -1.226 . . . . 0.0 114.27 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.21 161.21 19.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.839 1.319 . . . . 0.0 107.589 169.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.98 144.38 26.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 117.737 -1.125 . . . . 0.0 109.534 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.94 154.19 21.23 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.16 1.345 . . . . 0.0 111.89 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.07 66.98 8.76 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.022 3.815 . . . . 0.0 111.98 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -57.8 8.9 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 126.761 2.024 . . . . 0.0 111.128 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.507 ' HG ' ' HA ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -144.87 141.38 29.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.02 164.65 31.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.086 0.954 . . . . 0.0 109.55 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.62 136.79 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.21 165.55 30.37 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.753 -2.939 . . . . 0.0 105.753 171.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 165.54 13.64 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -69.04 153.41 96.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.658 -0.652 . . . . 0.0 109.67 166.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.17 125.56 10.4 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.735 2.957 . . . . 0.0 110.98 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.01 174.84 11.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.557 2.838 . . . . 0.0 111.446 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.65 125.61 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 108.835 -1.256 . . . . 0.0 108.835 169.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.31 5.2 82.9 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.833 -0.981 . . . . 0.0 114.755 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 132.59 20.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.189 1.995 . . . . 0.0 105.618 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -152.55 -179.46 7.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 164.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.89 -160.8 1.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 7.4 m -88.84 160.66 17.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.653 1.115 . . . . 0.0 108.879 162.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 158.91 40.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -165.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.98 99.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 32.16 81.32 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.104 2.288 . . . . 0.0 115.605 166.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 97.06 -57.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.431 0 C-N-CA 130.168 3.387 . . . . 0.0 109.554 -171.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -82.58 155.98 24.19 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.917 -0.489 . . . . 0.0 110.346 -169.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.92 133.58 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 165.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.507 ' HA ' ' HG ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -87.0 167.84 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.81 116.0 7.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.229 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -27.6 66.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.233 0.47 . . . . 0.0 111.247 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -41.18 -47.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.136 1.774 . . . . 0.0 111.103 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.8 p -70.15 -36.69 74.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.538 -0.726 . . . . 0.0 111.135 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.39 -52.01 67.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -66.69 -10.11 43.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.922 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.61 -38.25 83.69 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 120.717 -1.24 . . . . 0.0 113.05 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 -41.62 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.609 0.64 . . . . 0.0 110.129 -167.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.32 53.38 2.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.013 0.925 . . . . 0.0 109.441 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.4 -66.09 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.66 1.184 . . . . 0.0 109.325 156.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.43 -11.11 30.54 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.798 2.332 . . . . 0.0 113.126 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -67.64 -26.06 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.143 -1.598 . . . . 0.0 110.651 172.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.8 -13.53 60.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.537 1.135 . . . . 0.0 111.634 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -179.44 119.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.824 2.45 . . . . 0.0 109.154 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 127.427 2.291 . . . . 0.0 107.308 176.616 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 122.399 1.095 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -108.01 172.47 6.82 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.536 2.335 . . . . 0.0 108.886 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.35 149.48 28.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.8 t -123.27 107.75 12.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.4 0.68 . . . . 0.0 109.351 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.1 124.88 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.431 1.092 . . . . 0.0 108.305 165.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -142.26 125.18 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -145.26 -179.39 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.417 -0.802 . . . . 0.0 109.665 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.27 40.64 10.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.752 1.621 . . . . 0.0 110.573 -167.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.51 78.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.38 -83.77 0.05 OUTLIER Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -61.34 -19.15 61.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.167 1.484 . . . . 0.0 113.98 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 89.3 mmm -76.31 7.06 4.66 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.196 -1.383 . . . . 0.0 112.526 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -47.68 -26.82 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.12 -18.76 12.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.361 1.064 . . . . 0.0 111.912 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -19.97 18.03 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.648 0.779 . . . . 0.0 110.568 -171.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 m -50.17 116.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.556 1.543 . . . . 0.0 107.963 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.21 -80.7 0.37 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.256 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.44 -23.95 66.21 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.82 1.191 . . . . 0.0 110.694 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -65.12 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.907 2.083 . . . . 0.0 111.472 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.512 ' H ' HD12 ' A' ' 125' ' ' ILE . 3.6 mp -39.45 -62.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 126.204 1.802 . . . . 0.0 111.932 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.81 -50.8 72.4 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.43 0.559 . . . . 0.0 110.641 -172.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.45 -50.14 68.69 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.181 0.992 . . . . 0.0 109.715 -170.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.24 -46.34 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.149 0.979 . . . . 0.0 108.466 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.055 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -58.01 -49.88 75.32 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.111 1.323 . . . . 0.0 110.941 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -63.24 -29.08 70.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.448 -0.783 . . . . 0.0 111.132 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.6 -30.63 67.36 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.909 -1.12 . . . . 0.0 111.053 173.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -23.56 64.1 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.26 0.936 . . . . 0.0 110.934 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.8 m -79.96 133.7 57.7 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -32.67 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.21 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.45 -17.63 33.26 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.879 -1.512 . . . . 0.0 114.643 -166.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.6 m -77.72 165.55 24.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.107 2.453 . . . . 0.0 107.697 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.0 mt -136.94 101.83 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -172.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.3 mm -72.08 135.24 28.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.56 124.23 19.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.257 1.823 . . . . 0.0 106.988 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.12 28.81 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-N 120.909 1.686 . . . . 0.0 114.826 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -129.25 113.21 14.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.86 152.73 42.5 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.63 0.772 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -70.42 149.97 63.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.784 1.656 . . . . 0.0 108.476 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.03 126.07 92.21 Favored Pre-proline 0 N--CA 1.441 -0.906 0 O-C-N 121.925 -0.485 . . . . 0.0 110.617 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.18 108.39 2.47 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 108.328 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -152.8 -36.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.778 0.831 . . . . 0.0 110.126 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.28 -66.91 0.85 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.695 1.14 . . . . 0.0 111.512 -167.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 158.2 75.69 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 124.286 1.034 . . . . 0.0 108.242 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.38 149.51 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.956 3.104 . . . . 0.0 109.875 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.51 135.44 52.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -64.37 0.84 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.304 1.442 . . . . 0.0 111.528 -172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.29 -35.4 75.46 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.648 -0.657 . . . . 0.0 111.417 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 -43.65 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 119.109 0.868 . . . . 0.0 109.4 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -55.43 -41.55 72.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -55.76 -28.81 57.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.667 1.121 . . . . 0.0 113.087 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.14 -39.64 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.486 1.514 . . . . 0.0 109.415 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.19 62.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.768 1.227 . . . . 0.0 110.19 177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.71 -39.77 5.41 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 127.786 2.434 . . . . 0.0 112.769 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.77 -32.13 70.47 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.062 -1.023 . . . . 0.0 111.093 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.7 -36.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.63 2.372 . . . . 0.0 113.389 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -63.32 -30.19 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.548 1.539 . . . . 0.0 114.154 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.2 m -55.2 130.37 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.124 1.329 . . . . 0.0 110.793 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HE3' ' CD1' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -55.15 115.81 2.44 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.67 102.08 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 171.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.523 ' CD1' ' HE3' ' A' ' 164' ' ' LYS . 32.0 m-85 -83.38 87.11 6.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 162.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 94.07 0.3 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 162.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.89 167.08 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p -124.6 153.07 42.74 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 165.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -61.46 -14.4 28.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.616 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.19 -62.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.824 1.193 . . . . 0.0 108.696 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.36 18.92 3.49 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 124.601 1.16 . . . . 0.0 111.561 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -50.11 -43.84 51.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.979 -1.075 . . . . 0.0 113.305 -161.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -86.34 13.88 7.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.934 2.493 . . . . 0.0 114.806 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -131.66 16.94 4.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.511 1.924 . . . . 0.0 111.813 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.6 tp -84.09 -42.98 15.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.094 172.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -42.88 -58.78 3.55 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.377 1.871 . . . . 0.0 110.781 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.8 -25.02 78.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.036 2.491 . . . . 0.0 115.44 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.8 -46.6 57.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.431 1.493 . . . . 0.0 108.247 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.79 -53.37 45.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.245 1.418 . . . . 0.0 109.847 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.88 -45.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.823 0.738 . . . . 0.0 109.691 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.2 m -57.9 -45.63 86.14 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.57 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.95 -40.59 76.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.016 1.28 . . . . 0.0 110.859 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.06 -51.61 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.338 1.055 . . . . 0.0 109.83 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -31.2 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.519 0.728 . . . . 0.0 112.116 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 m -57.05 -51.72 68.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.549 1.14 . . . . 0.0 108.197 170.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.541 0.611 0 O-C-N 120.554 -1.341 . . . . 0.0 113.818 178.243 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -67.07 158.45 31.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.008 1.723 . . . . 0.0 108.377 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.45 139.09 48.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' CE2' ' HA3' ' A' ' 141' ' ' GLY . 17.7 m-85 -130.63 136.74 49.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.281 1.032 . . . . 0.0 109.265 172.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -78.17 157.82 29.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -152.07 169.44 22.37 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.543 0.687 . . . . 0.0 110.887 163.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.94 -171.93 37.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.09 168.37 22.17 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.785 2.323 . . . . 0.0 110.104 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.51 160.08 49.55 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.836 1.691 . . . . 0.0 111.074 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 39.73 72.88 0.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 126.999 2.238 . . . . 0.0 112.937 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.319 0.9 OUTLIER -131.11 -2.54 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.551 0.741 . . . . 0.0 112.835 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.29 19.24 19.27 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.973 -1.079 . . . . 0.0 112.634 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -51.75 67.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.432 1.616 . . . . 0.0 109.265 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -64.36 -29.56 70.63 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.788 -0.625 . . . . 0.0 109.666 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -58.48 -47.57 83.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.836 1.198 . . . . 0.0 111.681 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -46.92 87.27 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -68.2 -38.51 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.272 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -53.44 -55.9 21.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.148 1.379 . . . . 0.0 108.269 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -51.2 -42.82 61.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.065 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.81 57.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.368 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -60.9 -56.98 14.77 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.933 0.788 . . . . 0.0 108.982 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.84 -31.8 68.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.319 2.248 . . . . 0.0 110.982 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.75 -50.96 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.848 1.659 . . . . 0.0 110.537 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.56 -34.47 77.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.982 0.81 . . . . 0.0 109.311 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -71.08 -20.9 62.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.649 1.18 . . . . 0.0 113.199 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -86.8 -7.56 58.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.873 1.669 . . . . 0.0 111.82 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -114.4 2.66 14.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.789 1.236 . . . . 0.0 112.792 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.43 43.18 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 119.657 1.117 . . . . 0.0 112.07 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.15 108.19 24.52 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.26 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.335 2.69 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.59 169.03 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.145 0.978 . . . . 0.0 109.987 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 162.48 39.97 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.994 154.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.97 -165.66 31.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.353 0.977 . . . . 0.0 111.032 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.08 168.09 20.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.452 0.644 . . . . 0.0 111.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -143.31 152.97 42.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 108.352 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.0 p -77.11 124.9 28.47 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 157.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -104.7 139.11 40.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 160.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -73.67 147.03 44.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.602 0.715 . . . . 0.0 110.052 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.41 98.7 4.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -125.53 153.39 43.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -128.29 -60.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.083 1.353 . . . . 0.0 107.728 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.57 31.87 8.21 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.703 1.62 . . . . 0.0 110.69 167.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.61 14.67 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.288 1.423 . . . . 0.0 114.409 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 142.89 34.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.498 1.649 . . . . 0.0 108.691 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.08 135.23 55.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.952 0.796 . . . . 0.0 108.893 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -124.67 -17.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.776 1.23 . . . . 0.0 111.997 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.09 -152.99 21.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.69 161.89 36.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.286 5.9 p30 -131.26 142.8 50.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -90.28 93.55 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 125.457 1.503 . . . . 0.0 108.004 -173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 t -84.97 147.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -107.23 162.89 13.48 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.751 1.22 . . . . 0.0 109.223 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -31.41 72.13 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.343 -0.848 . . . . 0.0 111.56 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.8 t -65.09 -25.29 67.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.229 1.011 . . . . 0.0 110.101 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.0 -2.64 44.5 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.666 -1.074 . . . . 0.0 112.976 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.9 m -60.74 151.09 30.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.3 1.55 . . . . 0.0 108.478 163.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 155.33 50.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.891 1.277 . . . . 0.0 111.685 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -139.22 164.71 25.85 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.034 0.834 . . . . 0.0 113.685 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.13 -2.56 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.945 3.097 . . . . 0.0 115.109 -165.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 24.93 -79.26 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.76 3.624 . . . . 0.0 115.311 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 p -130.2 147.87 51.98 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.006 0.821 . . . . 0.0 110.279 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -148.17 158.87 44.32 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.097 1.359 . . . . 0.0 108.67 -172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -62.57 148.76 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.44 71.55 0.02 OUTLIER Glycine 0 C--N 1.34 0.781 0 CA-C-N 119.487 1.039 . . . . 0.0 114.503 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.42 -159.34 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.789 1.236 . . . . 0.0 110.163 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.71 156.67 62.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.907 1.683 . . . . 0.0 109.848 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 132.72 22.39 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 110.7 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -66.7 175.64 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.651 2.234 . . . . 0.0 111.708 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.43 -36.43 15.55 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.05 1.833 . . . . 0.0 111.318 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.33 -59.31 6.37 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -168.42 1.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.438 0.619 . . . . 0.0 110.985 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.37 147.75 32.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.0 0.92 . . . . 0.0 109.314 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -165.01 -163.69 0.72 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.361 1.465 . . . . 0.0 107.668 151.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 78.4 m -109.61 110.73 21.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.423 1.889 . . . . 0.0 108.97 -172.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.69 136.67 53.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.966 1.257 . . . . 0.0 108.746 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 t -125.63 102.75 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 24.91 84.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 C-N-CA 128.139 2.781 . . . . 0.0 114.781 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 95.73 -59.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.675 3.59 . . . . 0.0 109.219 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.46 146.91 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.648 1.179 . . . . 0.0 109.761 -166.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.12 112.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 166.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.7 p -71.98 -179.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 O-C-N 121.266 -0.896 . . . . 0.0 109.012 166.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 86' ' ' SER . 6.2 t0 -150.75 145.64 25.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 161.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.5 -39.12 77.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.843 1.257 . . . . 0.0 107.709 167.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.6 m -54.02 -44.89 71.34 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.114 0.566 . . . . 0.0 109.875 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 70.6 m -64.31 -17.69 63.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.19 0.905 . . . . 0.0 112.43 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.24 -60.42 2.37 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.715 0.806 . . . . 0.0 109.928 161.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -45.05 -33.05 1.94 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.09 2.156 . . . . 0.0 113.525 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.65 -40.36 62.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.696 0.68 . . . . 0.0 112.021 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' CD2' ' HA3' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -140.48 -32.29 0.59 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -168.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 41.1 0.96 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.768 2.027 . . . . 0.0 109.557 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.82 -59.63 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 125.544 1.538 . . . . 0.0 108.496 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.48 -37.78 96.2 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.951 1.767 . . . . 0.0 111.926 170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.4 m -55.64 -31.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.91 0.777 . . . . 0.0 112.435 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.69 -36.42 60.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.412 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -156.1 92.43 1.35 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.198 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.098 0.475 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -139.09 -179.38 5.82 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.547 1.139 . . . . 0.0 108.993 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.0 t -127.48 144.37 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.5 t -125.85 143.08 51.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.873 2.069 . . . . 0.0 106.977 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.3 t -138.96 132.87 40.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.28 135.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 33.5 t0 -133.06 -172.95 3.06 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.125 -1.609 . . . . 0.0 107.462 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 115' ' ' GLY . 2.3 mm-40 56.45 -81.46 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 129.202 3.001 . . . . 0.0 110.675 -156.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.291 38.4 mt 53.98 -10.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 128.133 2.573 . . . . 0.0 112.944 -169.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 113' ' ' GLU . . . -83.46 -59.78 2.09 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.942 2.211 . . . . 0.0 111.103 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -52.54 -29.19 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.387 1.475 . . . . 0.0 114.035 -168.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.35 4.73 41.82 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.216 -1.373 . . . . 0.0 112.657 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -24.81 -64.24 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 129.108 2.963 . . . . 0.0 114.594 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.86 -34.31 17.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.928 0.491 . . . . 0.0 111.16 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.75 -27.34 61.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.571 1.148 . . . . 0.0 112.444 -169.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.3 p -51.16 120.48 5.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.367 1.867 . . . . 0.0 111.727 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.7 -92.92 0.52 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.74 -6.36 15.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.752 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -65.38 0.6 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.331 1.453 . . . . 0.0 110.386 171.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 125' ' ' ILE . 3.5 mp -35.76 -59.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.158 1.783 . . . . 0.0 112.724 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -59.75 -52.12 66.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.48 87.54 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.83 -59.07 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.858 1.263 . . . . 0.0 109.253 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -57.9 -37.91 74.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.504 1.047 . . . . 0.0 111.913 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -34.44 76.8 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.804 -0.56 . . . . 0.0 110.712 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.0 m -81.53 -30.29 33.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.27 0.941 . . . . 0.0 111.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.83 -21.33 63.07 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.41 1.005 . . . . 0.0 110.83 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 t -93.16 -8.97 41.0 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.458 2.303 . . . . 0.0 112.363 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.5 m -62.06 135.5 94.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.19 -36.32 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.401 2.067 . . . . 0.0 111.425 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.09 6.28 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.9 m 43.52 166.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.784 2.434 . . . . 0.0 113.272 -154.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.8 mt -144.91 114.0 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.9 131.69 34.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.4 96.46 5.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 158.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -113.95 171.9 14.05 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.26 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.4 m -134.63 134.22 40.97 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.34 156.93 66.3 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.712 1.605 . . . . 0.0 109.572 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.13 150.31 37.42 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.86 1.707 . . . . 0.0 110.209 169.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.69 151.75 60.82 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 123.77 0.828 . . . . 0.0 110.733 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.1 162.73 38.84 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.702 2.935 . . . . 0.0 108.901 166.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -156.97 -61.01 0.09 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -118.45 -118.67 2.84 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 151.85 88.77 Favored Pre-proline 0 C--O 1.237 0.436 0 CA-C-N 117.966 0.883 . . . . 0.0 111.329 -172.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -59.04 156.25 35.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.173 2.582 . . . . 0.0 109.936 167.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.95 139.38 49.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.057 1.343 . . . . 0.0 107.408 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -70.35 0.11 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.901 1.68 . . . . 0.0 113.174 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 tp -56.7 -39.77 74.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.522 -0.736 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.0 -31.13 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.218 0.917 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -61.78 -29.4 70.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.378 1.444 . . . . 0.0 110.289 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.07 -23.07 67.28 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.317 0.962 . . . . 0.0 112.089 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.05 -47.0 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -68.1 -11.55 59.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.989 -1.07 . . . . 0.0 112.393 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -76.58 -10.51 59.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 123.911 0.884 . . . . 0.0 113.144 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -74.56 87.54 2.12 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.728 1.149 . . . . 0.0 109.292 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 52.02 0.49 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.482 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -153.48 -12.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 111.2 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.51 137.84 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.566 -1.334 . . . . 0.0 109.965 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.47 134.46 43.92 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.7 t -115.22 79.49 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.31 91.09 0.24 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.676 1.59 . . . . 0.0 110.765 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.75 147.18 52.36 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 164.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.8 p -122.31 171.69 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 123.253 1.501 . . . . 0.0 109.238 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.21 128.18 29.5 Favored 'General case' 0 N--CA 1.435 -1.214 1 C-N-CA 131.864 4.066 . . . . 0.0 102.888 -178.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -46.05 -24.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.288 1.835 . . . . 0.0 112.248 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.69 -70.76 0.41 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.911 0.884 . . . . 0.0 109.472 -172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.09 17.58 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.352 2.261 . . . . 0.0 111.852 -173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -52.5 -44.93 65.97 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -162.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -77.66 3.43 13.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -87.93 -8.04 56.3 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.608 1.163 . . . . 0.0 111.72 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.1 -34.34 26.15 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 120.672 1.578 . . . . 0.0 112.441 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -57.6 7.39 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.17 -1.395 . . . . 0.0 109.89 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.97 -27.48 58.2 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.179 1.814 . . . . 0.0 113.114 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.4 -42.35 65.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.343 0.974 . . . . 0.0 109.261 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.6 mt -53.12 -55.86 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 125.313 1.445 . . . . 0.0 109.297 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.12 -33.84 66.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.785 0.72 . . . . 0.0 110.523 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 88.6 m -63.78 -48.96 74.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.876 0.87 . . . . 0.0 108.715 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -56.32 -37.24 69.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.161 1.384 . . . . 0.0 110.12 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.25 -55.92 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.988 0.915 . . . . 0.0 110.681 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.46 -21.46 65.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.722 1.146 . . . . 0.0 112.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 73.9 m -58.0 -33.78 69.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.261 0.937 . . . . 0.0 113.045 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 CA--C 1.539 0.54 0 CA-C-N 119.238 0.927 . . . . 0.0 112.42 175.315 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.409 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.435 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 59.38 164.75 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.016 2.526 . . . . 0.0 112.116 173.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -138.74 139.96 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 O-C-N 120.139 -1.6 . . . . 0.0 107.953 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -138.65 157.01 46.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.022 0.929 . . . . 0.0 110.993 168.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.04 131.02 55.41 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.627 1.171 . . . . 0.0 108.257 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.57 165.5 25.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.797 0.439 . . . . 0.0 110.375 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 68.56 1.61 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.01 1.29 . . . . 0.0 112.431 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.55 121.55 8.06 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 CA-C-N 120.652 2.226 . . . . 0.0 109.616 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.57 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.968 1.778 . . . . 0.0 113.148 -171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.47 15.59 6.35 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.141 -0.81 . . . . 0.0 111.726 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t 65.75 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.985 1.85 . . . . 0.0 109.412 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.43 -11.51 0.04 OUTLIER Glycine 0 CA--C 1.529 0.937 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.753 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE2' ' H ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -57.19 -15.99 7.03 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.27 -1.135 . . . . 0.0 113.225 172.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.402 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -56.01 -38.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.066 2.146 . . . . 0.0 110.608 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 m -71.05 -29.59 65.52 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.286 -0.884 . . . . 0.0 109.103 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.78 -52.81 62.7 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mm -58.96 -43.9 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -49.17 -63.59 1.06 Allowed 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -36.68 77.17 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.67 0.606 . . . . 0.0 111.754 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.77 88.57 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 120.262 1.392 . . . . 0.0 109.723 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -67.89 -47.69 68.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.751 0.82 . . . . 0.0 109.458 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.3 -36.56 61.34 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.678 1.191 . . . . 0.0 112.234 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.5 -45.32 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.592 -0.693 . . . . 0.0 110.494 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.17 -36.75 80.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.82 -44.74 90.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.4 t -58.76 -36.47 74.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.89 1.676 . . . . 0.0 110.446 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 t -77.24 -2.37 34.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.813 1.645 . . . . 0.0 112.556 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.04 13.04 72.38 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.589 1.086 . . . . 0.0 113.102 -174.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.8 122.95 87.36 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 119.247 1.524 . . . . 0.0 107.19 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.14 118.83 5.87 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.842 2.362 . . . . 0.0 109.63 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -115.66 141.12 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 107.761 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.09 167.88 16.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 163.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.11 -161.96 25.98 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -145.07 166.95 23.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.783 1.292 . . . . 0.0 111.794 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -137.43 177.82 7.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.445 1.02 . . . . 0.0 110.004 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.6 p -139.65 74.62 1.48 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.016 1.389 . . . . 0.0 110.534 -168.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -76.35 23.63 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.118 2.167 . . . . 0.0 115.581 -163.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.316 7.8 pt-20 51.72 113.67 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.795 2.838 . . . . 0.0 114.023 -162.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.86 121.28 21.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.087 -1.008 . . . . 0.0 108.439 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -131.6 120.71 23.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -86.62 -2.61 58.65 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.359 0.6 . . . . 0.0 111.186 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.66 65.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 -171.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.61 -5.36 1.7 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.486 2.469 . . . . 0.0 117.075 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 147.5 22.91 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 120.023 1.912 . . . . 0.0 108.278 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -74.4 139.21 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 161.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -17.53 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.863 1.265 . . . . 0.0 111.587 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.6 -128.63 1.73 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 165.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -138.91 153.62 48.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 171.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -130.39 152.63 49.59 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.294 2.638 . . . . 0.0 106.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.52 107.91 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 119.539 1.063 . . . . 0.0 110.511 -162.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.1 109.4 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.879 -157.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.3 p -75.97 145.79 40.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -15.54 62.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.643 . . . . 0.0 111.735 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t -62.05 -45.41 93.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 108.912 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.78 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.037 0.827 . . . . 0.0 112.587 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 169.35 15.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.125 1.37 . . . . 0.0 110.167 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -152.65 138.7 18.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.109 1.764 . . . . 0.0 107.881 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.85 173.08 22.01 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 120.142 1.337 . . . . 0.0 112.022 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 168.04 18.35 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.607 2.205 . . . . 0.0 109.176 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.54 -59.33 0.08 Allowed 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -141.42 153.4 44.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.461 0.573 . . . . 0.0 109.711 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -138.47 159.26 42.52 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.334 1.054 . . . . 0.0 109.296 170.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.97 128.89 24.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.8 164.27 26.77 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.56 167.03 4.68 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.751 0.786 . . . . 0.0 109.45 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.83 144.95 80.26 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.59 132.7 27.76 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.279 1.986 . . . . 0.0 109.175 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 165.8 29.64 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.548 2.165 . . . . 0.0 110.009 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 80.16 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.75 2.3 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.02 -83.65 0.11 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 131.72 49.82 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -146.67 137.41 23.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -159.26 63.23 0.39 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.7 m 59.45 -159.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.573 1.549 . . . . 0.0 109.585 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER 157.57 155.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 1 C-N-CA 131.75 4.02 . . . . 0.0 109.758 166.268 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.33 100.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -170.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.36 -63.4 2.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.296 1.427 . . . . 0.0 113.684 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.33 -18.94 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 111.556 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.09 169.35 10.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 25.6 t -110.68 115.08 48.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 166.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.5 170.63 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 166.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.41 141.77 39.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 163.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.11 -34.6 73.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.905 0.882 . . . . 0.0 109.298 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -36.72 84.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.695 0.679 . . . . 0.0 111.27 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 m -61.08 -34.99 75.8 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.538 1.063 . . . . 0.0 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.51 -61.87 2.04 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.219 0.208 . . . . 0.0 110.614 165.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -22.42 25.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.196 1.398 . . . . 0.0 113.216 -169.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -45.87 -48.98 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.086 0.954 . . . . 0.0 112.121 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -31.21 0.95 Allowed 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.84 1.256 . . . . 0.0 111.239 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.96 86.04 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 119.615 1.098 . . . . 0.0 110.587 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -52.38 68.11 Favored Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 120.285 -1.509 . . . . 0.0 112.168 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.32 -16.94 21.79 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.503 1.469 . . . . 0.0 113.797 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -41.97 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 122.022 2.192 . . . . 0.0 109.042 169.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.39 -38.48 78.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -155.39 91.02 1.29 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.993 1.269 . . . . 0.0 111.172 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 t30 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 154.252 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.283 0.563 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 -137.54 171.52 14.33 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.138 1.775 . . . . 0.0 108.103 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.96 151.26 34.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.12 153.0 39.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.9 t -135.89 117.84 20.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 108.223 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.69 63.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -65.98 -48.72 70.32 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.74 65.64 2.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.467 1.507 . . . . 0.0 112.668 -167.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 90.8 mt -108.64 147.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 120.159 -1.588 . . . . 0.0 107.016 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 -80.14 0.36 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-O 118.827 -0.985 . . . . 0.0 111.353 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -59.65 -25.58 64.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.205 1.503 . . . . 0.0 111.842 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.86 -10.29 51.82 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 115.118 -2.372 . . . . 0.0 113.353 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -49.62 -17.32 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -159.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.82 -23.17 9.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.831 1.252 . . . . 0.0 112.557 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -87.88 -31.33 19.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.356 1.462 . . . . 0.0 111.154 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.53 117.8 2.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.944 1.698 . . . . 0.0 109.553 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -120.56 -64.21 1.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.642 0.656 . . . . 0.0 111.808 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.37 -14.86 60.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.552 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.56 -73.42 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.646 1.978 . . . . 0.0 112.128 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -42.66 -37.41 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.856 1.662 . . . . 0.0 113.294 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -73.58 -68.97 0.46 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.187 0.903 . . . . 0.0 110.558 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.65 -41.65 77.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 112.29 -167.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.3 -51.46 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.201 1.4 . . . . 0.0 108.407 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -63.3 -30.99 72.02 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.062 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.05 -57.02 14.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.245 1.384 . . . . 0.0 108.943 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 m -65.51 -29.51 70.16 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.845 -0.534 . . . . 0.0 112.359 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.0 -30.15 66.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.711 0.687 . . . . 0.0 110.495 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.9 t -64.12 -35.2 80.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.322 1.049 . . . . 0.0 109.543 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.0 m -73.16 133.08 81.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.807 0.731 . . . . 0.0 109.906 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.09 -30.21 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.824 2.349 . . . . 0.0 112.854 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.48 -31.25 34.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.208 -1.329 . . . . 0.0 113.398 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 m -73.26 162.87 28.87 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.672 1.736 . . . . 0.0 108.395 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.0 mt -140.57 98.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.74 145.49 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.426 0.557 . . . . 0.0 109.715 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 115.24 11.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.042 2.137 . . . . 0.0 106.495 167.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.12 25.01 Favored Glycine 0 N--CA 1.464 0.543 0 CA-C-N 120.34 1.427 . . . . 0.0 112.708 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.9 m -117.36 87.42 2.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.34 110.73 16.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.36 158.52 57.17 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.79 153.11 95.68 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.36 -77.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.413 2.075 . . . . 0.0 107.926 166.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? 153.45 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.392 1 C-N-CA 131.798 4.039 . . . . 0.0 104.234 -168.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.53 0.05 OUTLIER Glycine 0 CA--C 1.5 -0.845 0 O-C-N 124.105 0.878 . . . . 0.0 114.908 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.433 ' HE3' ' N ' ' A' ' 149' ' ' LYS 0.33 0.0 OUTLIER -165.31 172.28 4.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 130.391 3.476 . . . . 0.0 105.903 163.067 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 149' ' ' LYS . 57.2 Cg_endo -67.96 162.16 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 1 C-N-CA 125.337 4.025 . . . . 0.0 109.466 165.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.52 175.27 5.54 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.054 -1.029 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.62 16.75 25.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 112.447 172.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.48 -53.52 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.421 1.088 . . . . 0.0 108.268 168.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.78 -21.14 27.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.661 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -48.18 -39.9 22.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.472 1.109 . . . . 0.0 111.357 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -25.72 66.21 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.848 1.259 . . . . 0.0 111.136 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.01 -38.05 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.244 1.418 . . . . 0.0 108.901 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -28.44 69.33 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.802 -1.186 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -52.71 -47.93 66.96 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 125.069 1.348 . . . . 0.0 110.565 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 78.2 5.9 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -56.94 -13.48 2.71 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.559 0.743 . . . . 0.0 111.557 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -39.04 56.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.193 2.197 . . . . 0.0 111.955 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -48.55 128.82 4.77 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 125.602 1.561 . . . . 0.0 109.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 46.8 tptt -61.13 106.68 0.63 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 166.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -83.52 105.34 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 163.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.436 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 36.8 m-85 -75.9 92.89 3.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 163.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 107.15 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 162.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.76 163.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.6 p -122.92 154.33 38.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.217 0.917 . . . . 0.0 108.999 164.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.65 1.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.784 1.633 . . . . 0.0 113.034 162.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -92.58 -36.81 12.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.347 0.976 . . . . 0.0 111.243 171.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -127.0 7.57 6.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 113.665 -159.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -44.36 -55.36 5.03 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.613 1.565 . . . . 0.0 115.064 -164.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -83.8 18.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.923 1.238 . . . . 0.0 113.164 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -131.56 13.95 4.96 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 117.244 -1.36 . . . . 0.0 113.788 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.1 -13.9 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.663 1.574 . . . . 0.0 112.483 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.1 tp -30.44 -62.06 0.24 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.826 2.05 . . . . 0.0 111.627 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.78 -27.81 43.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.935 1.756 . . . . 0.0 112.774 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -70.05 -39.54 75.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.363 0.983 . . . . 0.0 108.988 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.419 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 3.7 mt -57.93 -58.8 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 117.583 -1.199 . . . . 0.0 107.942 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.457 ' HA ' ' CG2' ' A' ' 184' ' ' VAL . 9.1 t -57.12 -27.55 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.897 0.771 . . . . 0.0 111.521 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.7 m -67.48 -29.16 68.52 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.756 -1.215 . . . . 0.0 112.35 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 25.9 t -90.66 -33.72 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.393 -1.442 . . . . 0.0 108.514 -167.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -63.9 -63.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 125.244 1.418 . . . . 0.0 108.423 164.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -15.43 63.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 112.984 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.3 t -49.56 -37.97 29.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.229 1.412 . . . . 0.0 110.138 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-N 118.84 0.746 . . . . 0.0 112.078 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -131.57 153.11 50.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.47 140.85 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.937 1.244 . . . . 0.0 108.9 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -133.87 146.92 51.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.152 0.981 . . . . 0.0 109.799 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.44 151.38 19.78 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 123.897 0.748 . . . . 0.0 109.265 157.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -151.08 179.89 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.29 1.436 . . . . 0.0 107.994 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.92 -176.92 24.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 122.22 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.856 2.371 . . . . 0.0 112.337 -167.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.82 91.09 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.944 3.763 . . . . 0.0 112.972 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.96 74.76 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.263 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 10.2 p 22.8 78.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.568 2.747 . . . . 0.0 113.542 159.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.31 -36.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.901 1.715 . . . . 0.0 109.348 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -34.85 76.77 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.25 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 m -56.48 -44.5 80.69 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.323 -1.322 . . . . 0.0 108.948 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -53.9 -36.97 63.29 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 120.067 1.303 . . . . 0.0 111.904 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.17 69.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.942 1.247 . . . . 0.0 110.614 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.24 -43.36 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -52.42 65.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.214 1.406 . . . . 0.0 109.37 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -53.03 -45.68 68.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.655 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.85 27.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.638 -1.173 . . . . 0.0 113.943 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.5 p -80.54 -51.53 8.66 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 120.056 1.298 . . . . 0.0 110.296 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.87 -32.46 67.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.06 0.544 . . . . 0.0 111.067 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.87 -64.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.006 1.322 . . . . 0.0 108.367 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 mt -52.22 -41.31 62.62 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.965 1.306 . . . . 0.0 110.09 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -66.47 -46.26 76.96 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -34.29 75.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.019 0.927 . . . . 0.0 110.54 172.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 m -61.8 -41.73 98.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.446 1.021 . . . . 0.0 110.433 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.44 9.21 10.5 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 126.343 1.925 . . . . 0.0 112.745 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.46 130.81 73.15 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.04 139.61 43.17 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.908 1.739 . . . . 0.0 109.106 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.65 157.35 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.574 1.55 . . . . 0.0 107.804 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 174.76 13.71 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.109 -0.37 . . . . 0.0 111.916 163.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.83 -158.07 22.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 124.92 1.248 . . . . 0.0 111.087 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -146.13 162.82 37.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.115 1.366 . . . . 0.0 108.753 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -149.54 125.36 10.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.687 1.195 . . . . 0.0 107.961 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -84.73 70.46 10.81 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 120.919 -1.113 . . . . 0.0 109.559 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -79.44 48.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -166.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 52.14 -174.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.431 2.062 . . . . 0.0 112.62 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.0 t -125.13 93.58 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 150.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -91.42 103.5 16.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 160.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -79.6 104.4 10.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 165.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.93 50.71 11.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.33 0.968 . . . . 0.0 111.713 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.27 -13.95 18.33 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 117.369 -1.795 . . . . 0.0 115.891 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.73 129.43 39.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.254 2.527 . . . . 0.0 109.369 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -86.35 68.18 10.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.433 1.111 . . . . 0.0 112.735 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 pt -89.63 -2.46 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -168.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.67 -166.07 32.22 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 120.187 1.358 . . . . 0.0 111.797 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -138.54 149.54 45.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.9 153.65 51.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.86 154.47 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 164.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -140.32 154.81 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.841 2.057 . . . . 0.0 106.639 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.7 p -117.77 174.95 5.89 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.755 2.07 . . . . 0.0 110.7 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.81 21.3 0.55 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.915 -1.115 . . . . 0.0 112.537 168.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -126.38 -12.76 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 -2.31 27.74 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.61 1.096 . . . . 0.0 112.935 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.87 160.41 32.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.865 1.832 . . . . 0.0 110.065 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.22 164.22 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.517 1.927 . . . . 0.0 107.251 165.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.75 140.63 9.66 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -82.78 63.89 8.01 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.282 3.988 . . . . 0.0 111.745 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' N ' ' HG ' ' A' ' 86' ' ' SER . 1.4 tp -54.96 -63.66 1.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.104 1.761 . . . . 0.0 111.598 -170.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 p -143.59 152.49 41.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.867 1.212 . . . . 0.0 109.764 172.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 168.83 18.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.04 129.08 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.17 45.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 -164.74 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.701 1.6 . . . . 0.0 109.219 -175.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -129.11 154.87 80.52 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 168.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.09 125.31 12.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.604 2.203 . . . . 0.0 111.612 -163.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.56 162.94 39.98 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.225 1.95 . . . . 0.0 110.488 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.47 137.35 46.41 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.038 1.825 . . . . 0.0 109.639 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.36 -1.99 73.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.968 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -99.43 163.0 12.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.534 1.667 . . . . 0.0 107.544 163.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -141.3 145.66 35.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 162.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -155.23 -175.33 5.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.9 2.08 . . . . 0.0 107.179 166.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.68 162.56 28.78 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 119.679 -1.888 . . . . 0.0 109.98 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -168.87 135.04 1.75 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.757 1.223 . . . . 0.0 107.705 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.27 15.59 6.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 118.112 0.414 . . . . 0.0 110.294 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 76' ' ' ARG . . . 94.9 114.76 2.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.837 -2.505 . . . . 0.0 106.837 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 68.32 -51.42 0.55 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.588 2.355 . . . . 0.0 113.602 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.54 157.7 16.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.737 2.015 . . . . 0.0 108.391 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.86 123.17 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 171.26 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 110.555 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -156.61 107.71 2.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.918 0.781 . . . . 0.0 112.881 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.6 -35.48 4.05 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.857 1.662 . . . . 0.0 113.054 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -34.45 74.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.936 -1.102 . . . . 0.0 112.048 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 28.8 t -58.15 -38.66 77.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.622 1.556 . . . . 0.0 110.562 174.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -64.46 -46.63 82.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.513 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -52.38 -30.1 27.26 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.739 0.699 . . . . 0.0 111.91 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.76 -29.97 67.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.23 -0.919 . . . . 0.0 113.184 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.15 -44.68 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.439 0.563 . . . . 0.0 111.862 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.97 37.54 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.998 1.719 . . . . 0.0 112.05 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.99 -65.18 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 127.068 2.147 . . . . 0.0 108.053 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.09 -27.48 79.07 Favored 'Trans proline' 0 C--N 1.351 0.676 0 CA-C-N 121.562 1.593 . . . . 0.0 112.965 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.31 -24.71 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.727 0.811 . . . . 0.0 112.599 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.109 0.868 . . . . 0.0 111.335 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -133.31 72.95 1.49 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.692 1.234 . . . . 0.0 108.705 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.367 169.593 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -115.52 98.18 6.58 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.253 1.021 . . . . 0.0 109.991 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.53 110.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 t -108.0 108.22 19.24 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.84 127.88 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.463 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.04 74.97 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -77.14 174.9 10.18 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.099 1.318 . . . . 0.0 110.015 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 42.38 67.19 0.63 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.893 2.477 . . . . 0.0 114.368 169.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.258 6.7 mt -86.6 -0.39 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 120.521 -1.362 . . . . 0.0 111.707 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.01 -61.68 2.62 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.703 -1.248 . . . . 0.0 113.527 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -54.74 -41.69 70.72 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.583 1.691 . . . . 0.0 114.304 -160.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mmt -78.9 -5.54 53.91 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.289 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -41.16 -41.49 1.81 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -161.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.426 ' H ' HD11 ' A' ' 119' ' ' LEU . 4.4 mp -68.44 -60.1 2.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.009 0.924 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.18 -30.07 71.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.761 1.624 . . . . 0.0 111.826 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 t -39.84 107.92 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.032 2.933 . . . . 0.0 110.1 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -128.71 -78.6 0.56 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.622 1.169 . . . . 0.0 109.276 -176.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.27 -31.21 61.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.623 0.769 . . . . 0.0 110.782 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -60.01 3.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 125.474 1.51 . . . . 0.0 111.424 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 125' ' ' ILE . 2.0 mp -41.14 -58.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.113 1.765 . . . . 0.0 111.922 172.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -65.05 -47.37 77.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 118.588 0.631 . . . . 0.0 110.483 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.83 66.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 124.144 0.903 . . . . 0.0 110.083 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.05 -32.38 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 121.527 -0.733 . . . . 0.0 110.24 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.49 -35.57 60.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.41 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -38.77 79.01 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.564 1.074 . . . . 0.0 110.486 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.53 -44.28 24.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.328 1.051 . . . . 0.0 110.41 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.82 -18.19 64.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.537 1.062 . . . . 0.0 112.543 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.7 m -82.12 -22.15 36.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.046 0.839 . . . . 0.0 111.92 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.5 m -87.31 133.17 39.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -79.35 -27.47 4.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.547 2.831 . . . . 0.0 111.487 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.07 81.95 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.993 -0.893 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -67.08 150.09 49.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.056 1.928 . . . . 0.0 110.068 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.77 107.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -69.82 133.35 32.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.4 tp -142.56 97.82 3.18 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.799 1.312 . . . . 0.0 108.25 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.6 -172.1 17.35 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 114.616 0.606 . . . . 0.0 114.616 -169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.8 m -136.63 112.0 9.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.66 1.184 . . . . 0.0 113.296 175.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.89 154.32 41.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.251 1.02 . . . . 0.0 110.906 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.03 159.73 52.15 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.727 1.618 . . . . 0.0 111.749 172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.71 149.79 97.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.456 168.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.5 104.09 1.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.155 1.903 . . . . 0.0 109.489 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -82.77 -63.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.06 107.9 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.99 168.52 0.11 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.602 1.961 . . . . 0.0 111.483 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.68 169.78 1.62 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.335 3.357 . . . . 0.0 111.292 165.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mp -126.42 153.71 44.63 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.13 -44.9 83.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -165.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -33.77 36.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.928 0.785 . . . . 0.0 109.362 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.57 -23.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.213 -1.555 . . . . 0.0 110.348 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -58.02 10.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.904 2.082 . . . . 0.0 109.398 166.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.48 63.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.896 1.279 . . . . 0.0 111.534 177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mm -73.98 -51.39 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 118.465 0.575 . . . . 0.0 110.268 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -24.56 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.723 0.809 . . . . 0.0 110.322 -170.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -55.88 -26.43 47.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.754 1.222 . . . . 0.0 111.611 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -66.45 -35.87 81.37 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.824 -1.173 . . . . 0.0 111.514 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 53.87 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.657 2.783 . . . . 0.0 115.758 -167.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.4 41.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.736 2.014 . . . . 0.0 111.273 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.3 m -87.2 134.15 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 119.853 -1.78 . . . . 0.0 106.734 166.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -74.22 112.0 9.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 165.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.83 90.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -75.05 118.95 18.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 167.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 89.56 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.29 143.98 14.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.5 p -121.29 147.99 44.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -54.96 -14.66 1.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.366 166.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -81.82 -56.68 3.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.1 0.864 . . . . 0.0 108.882 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.7 6.01 49.53 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.606 -171.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -32.36 -57.26 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.276 2.23 . . . . 0.0 112.219 -172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -84.09 5.05 27.55 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.29 -17.35 21.73 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.05 1.34 . . . . 0.0 112.231 165.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -23.63 39.33 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.042 -169.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -57.9 9.27 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.196 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.45 -22.35 52.17 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.75 2.3 . . . . 0.0 114.271 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.22 73.64 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -67.72 -46.63 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.196 0.998 . . . . 0.0 109.262 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.8 t -50.41 -49.15 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.26 1.024 . . . . 0.0 109.21 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 97.6 m -58.14 -51.28 70.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.15 0.887 . . . . 0.0 108.857 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.95 -27.09 69.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.64 -68.4 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 117.294 -1.336 . . . . 0.0 107.944 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -53.54 -24.54 13.75 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.477 1.511 . . . . 0.0 112.558 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.81 -41.97 5.32 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.179 1.792 . . . . 0.0 112.073 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.053 1.341 . . . . 0.0 107.465 -162.744 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.82 174.6 6.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.046 0.938 . . . . 0.0 110.232 -167.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.86 143.98 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -139.88 150.38 44.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.608 1.163 . . . . 0.0 109.036 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.09 142.62 38.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 125.445 1.498 . . . . 0.0 107.817 -171.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 t -156.82 -169.69 3.06 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 123.541 0.526 . . . . 0.0 110.694 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' H ' ' HB ' ' A' ' 145' ' ' VAL . . . 110.69 -174.9 17.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.826 1.679 . . . . 0.0 110.378 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.45 161.45 45.97 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.339 2.026 . . . . 0.0 110.14 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 140.94 46.94 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.33 2.02 . . . . 0.0 110.848 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.24 16.39 4.15 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.713 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.297 5.8 m 44.23 33.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.485 2.314 . . . . 0.0 115.543 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.1 20.54 0.25 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.03 -1.428 . . . . 0.0 113.085 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -69.25 0.21 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.148 1.474 . . . . 0.0 110.308 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.419 ' HG1' ' CG ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -62.38 -30.5 71.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.333 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 97.1 m -52.51 -52.21 55.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.293 1.406 . . . . 0.0 109.187 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -48.52 78.9 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.389 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -66.39 -45.65 88.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.861 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -44.72 84.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.024 1.283 . . . . 0.0 107.893 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -64.69 -23.76 67.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 124.135 0.897 . . . . 0.0 111.417 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.1 -38.81 26.67 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 125.331 1.453 . . . . 0.0 110.323 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -62.89 -53.12 59.0 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.28 -34.56 72.43 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.07 -49.08 85.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.786 0.834 . . . . 0.0 109.178 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.93 -39.39 76.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -57.31 -49.12 77.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.428 1.013 . . . . 0.0 109.406 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 t -49.92 -51.57 39.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.381 2.273 . . . . 0.0 106.949 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -65.56 15.67 0.03 OUTLIER 'General case' 0 C--O 1.236 0.35 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 173.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.8 19.78 56.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.913 1.244 . . . . 0.0 112.84 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -56.87 149.8 41.59 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.78 109.68 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.799 1.666 . . . . 0.0 109.613 159.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.95 171.85 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.596 0.758 . . . . 0.0 109.102 169.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.07 172.61 18.1 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.067 2.547 . . . . 0.0 105.109 165.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.82 -159.11 22.1 Favored Glycine 0 C--O 1.237 0.304 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.68 169.72 17.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.522 0.661 . . . . 0.0 111.994 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -135.73 165.86 24.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -125.62 80.52 1.9 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.9 155.23 40.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 167.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -71.18 125.92 28.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.9 t -80.26 126.36 39.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -127.38 167.18 16.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.533 1.133 . . . . 0.0 110.295 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.48 29.34 2.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.349 1.46 . . . . 0.0 109.728 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.48 -21.19 0.4 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.456 -1.402 . . . . 0.0 114.045 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.22 6.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.416 1.484 . . . . 0.0 110.308 -163.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 140.01 46.43 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 118.522 1.161 . . . . 0.0 108.467 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.457 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.28 135.34 51.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 160.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.0 pt -133.41 -2.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 111.548 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.6 -157.93 27.55 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.22 135.04 30.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.112 2.165 . . . . 0.0 106.12 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.55 164.04 13.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.931 1.293 . . . . 0.0 107.945 168.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.3 p -113.73 104.8 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.02 112.26 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 123.872 0.869 . . . . 0.0 109.889 -160.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -68.59 152.63 45.1 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 109.219 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.73 -2.6 9.66 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.808 170.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -110.56 18.94 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.254 1.822 . . . . 0.0 111.531 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.89 0.96 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.371 -0.83 . . . . 0.0 114.709 160.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 m -115.29 166.12 12.2 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.702 1.251 . . . . 0.0 108.133 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -154.09 142.61 20.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.31 -1.494 . . . . 0.0 108.377 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.26 142.7 14.29 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 118.457 -1.191 . . . . 0.0 111.656 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.84 64.78 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 126.144 4.563 . . . . 0.0 113.565 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.467 ' N ' ' HG ' ' A' ' 86' ' ' SER . 29.6 tp -59.93 -59.89 4.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 112.231 -175.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.8 p -146.75 140.28 25.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 120.608 1.549 . . . . 0.0 108.227 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptt-85 -155.81 65.28 0.59 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.845 0.748 . . . . 0.0 110.725 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' H ' ' A' ' 65' ' ' GLY 0.335 41.8 t 58.71 -153.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -170.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.631 ' H ' ' CG1' ' A' ' 64' ' ' VAL . . . 134.08 141.88 4.58 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 129.21 3.291 . . . . 0.0 107.333 -166.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 147.23 53.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 155.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 146.65 99.06 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.54 127.75 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.003 1.802 . . . . 0.0 110.233 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.34 169.2 22.22 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.682 2.921 . . . . 0.0 110.718 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.94 -0.92 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.523 2.148 . . . . 0.0 114.306 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.48 5.34 29.76 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.987 1.28 . . . . 0.0 113.844 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 156.87 43.19 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 120.599 2.199 . . . . 0.0 109.598 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -154.13 155.69 35.84 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 162.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -149.68 26.04 0.84 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.188 1.795 . . . . 0.0 107.808 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.3 m 55.67 -179.39 0.04 OUTLIER 'General case' 0 C--N 1.345 0.405 0 C-N-CA 127.699 2.399 . . . . 0.0 112.501 -165.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.04 170.19 13.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 109.737 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.97 77.62 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 107.822 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.54 -113.36 4.14 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -162.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -29.2 54.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -166.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.81 146.15 23.99 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 121.601 2.0 . . . . 0.0 107.368 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.2 t -95.08 137.93 22.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.03 177.25 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 123.612 0.765 . . . . 0.0 109.815 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -148.85 113.59 5.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 157.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -25.06 67.38 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.949 -1.094 . . . . 0.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 m -55.85 -31.76 63.04 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.814 1.246 . . . . 0.0 110.235 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 44.4 t -62.0 -37.23 84.04 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.931 1.241 . . . . 0.0 110.203 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -64.62 -50.83 65.61 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -18.7 37.41 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.103 -0.998 . . . . 0.0 113.53 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -64.47 -57.88 7.98 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.86 -1.15 . . . . 0.0 110.47 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -33.32 2.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.786 1.234 . . . . 0.0 112.334 -166.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.17 46.92 0.75 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.68 1.192 . . . . 0.0 108.895 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -61.05 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.051 2.14 . . . . 0.0 107.844 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.17 -21.68 48.15 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.779 1.653 . . . . 0.0 112.962 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.67 -34.32 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 119.394 0.997 . . . . 0.0 112.053 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.85 3.83 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -168.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -112.12 87.19 2.51 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.864 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.806 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.53 168.07 12.89 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.626 0.771 . . . . 0.0 110.772 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.2 158.03 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 159.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.21 153.58 50.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 163.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.9 120.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -166.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.32 86.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -171.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.419 ' CG ' ' HG1' ' A' ' 15' ' ' THR . 4.0 t70 -102.47 175.62 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.242 -0.912 . . . . 0.0 109.898 -169.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 56.25 39.8 30.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.416 1.086 . . . . 0.0 112.352 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.4 mt -81.68 59.35 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 119.725 -1.859 . . . . 0.0 109.685 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.48 -54.64 0.26 Allowed Glycine 0 N--CA 1.465 0.598 0 O-C-N 120.164 -1.585 . . . . 0.0 113.649 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 8.23 3.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -114.81 13.36 17.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.867 1.212 . . . . 0.0 110.266 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -40.51 -42.19 1.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.635 2.374 . . . . 0.0 113.0 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.62 -17.03 10.67 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 124.048 0.939 . . . . 0.0 111.997 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.76 -12.72 23.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.569 0.622 . . . . 0.0 111.069 -171.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -61.24 101.61 0.17 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 119.215 0.916 . . . . 0.0 109.907 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -99.7 -78.33 0.51 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.4 mt -56.42 -24.78 47.36 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.88 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -71.5 0.07 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.2 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.418 HD11 ' H ' ' A' ' 125' ' ' ILE . 3.3 mp -30.9 -54.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.969 1.708 . . . . 0.0 112.238 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -71.14 -62.77 1.27 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.569 0.348 . . . . 0.0 111.347 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.59 91.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.903 0.858 . . . . 0.0 109.902 -167.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.77 -54.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 117.328 -1.32 . . . . 0.0 107.943 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -57.69 -31.2 66.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.287 2.312 . . . . 0.0 113.799 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -59.62 -45.65 91.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.031 0.932 . . . . 0.0 108.944 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.8 m -63.42 -42.5 98.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.408 1.483 . . . . 0.0 111.078 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.15 -35.28 74.96 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.169 -0.957 . . . . 0.0 110.63 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.7 m -90.27 1.47 56.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.474 1.51 . . . . 0.0 112.992 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.7 m -72.18 134.08 83.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.2 118.14 5.52 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 123.154 2.569 . . . . 0.0 108.051 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.37 -3.96 86.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 117.36 -1.8 . . . . 0.0 114.64 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.3 m -67.68 153.24 44.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.555 2.178 . . . . 0.0 107.468 163.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.7 mt -134.64 95.2 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -166.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.49 140.57 19.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.2 100.95 5.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.374 1.87 . . . . 0.0 106.207 163.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -124.38 166.78 16.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.4 m -124.21 117.49 24.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.01 132.84 24.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.485 2.314 . . . . 0.0 109.448 -173.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.36 137.5 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.429 2.086 . . . . 0.0 110.557 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 8' ' ' GLY . 4.5 p -64.49 122.1 76.5 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 110.695 -168.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.42 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.411 2.741 . . . . 0.0 109.411 -171.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -138.6 110.14 7.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 166.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.02 -26.08 6.37 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-O 116.544 -2.253 . . . . 0.0 114.909 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 132.82 24.39 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 121.684 2.742 . . . . 0.0 112.274 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.26 96.44 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.701 2.934 . . . . 0.0 108.538 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 112.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.72 -59.77 3.74 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 113.997 -168.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.44 -41.42 98.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.898 0.772 . . . . 0.0 109.925 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.29 -30.05 47.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.716 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.75 -35.51 74.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.621 172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.71 -56.59 17.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.766 1.621 . . . . 0.0 109.062 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.73 -29.61 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.159 0.984 . . . . 0.0 111.125 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.79 -37.85 76.47 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 120.606 -1.309 . . . . 0.0 109.516 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.63 -19.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.174 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -23.25 50.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.934 1.243 . . . . 0.0 110.886 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.37 -55.26 0.26 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 127.623 2.369 . . . . 0.0 113.43 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -60.26 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 1 C-N-CA 132.726 4.411 . . . . 0.0 113.077 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 t -138.95 121.52 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 15.2 tptm -64.94 123.16 18.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.6 t -102.33 91.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.538 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 9.7 m-85 -81.92 102.88 11.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.837 0.855 . . . . 0.0 110.216 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.62 98.13 6.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.125 0.97 . . . . 0.0 109.105 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.32 158.3 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 50.0 p -121.54 158.72 27.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -57.87 -24.42 57.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.111 163.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.65 -72.43 0.43 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.825 0.85 . . . . 0.0 110.539 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -86.85 30.82 0.72 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.864 1.265 . . . . 0.0 109.798 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -48.2 -60.48 2.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.679 1.592 . . . . 0.0 109.898 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -77.37 4.21 11.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -97.54 -6.01 34.49 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.843 1.657 . . . . 0.0 111.852 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.1 tp -74.13 -39.97 62.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.506 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 tp -40.87 -64.05 0.67 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 111.54 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.13 -25.22 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 121.482 1.565 . . . . 0.0 111.806 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.08 -38.63 75.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.584 1.554 . . . . 0.0 109.858 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.95 -54.09 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 109.484 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.34 -41.7 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.436 0.562 . . . . 0.0 109.54 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.5 m -56.0 -47.85 76.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.972 1.309 . . . . 0.0 109.101 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -47.79 84.29 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.944 0.793 . . . . 0.0 110.826 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.57 -48.32 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.304 0.642 . . . . 0.0 109.97 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.59 55.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.881 1.273 . . . . 0.0 110.102 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 t -55.94 -40.51 73.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.903 1.281 . . . . 0.0 109.644 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 112.745 178.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -89.32 155.84 19.11 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.287 1.435 . . . . 0.0 109.493 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -129.37 132.29 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.774 1.23 . . . . 0.0 108.989 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 5.3 m-85 -141.78 136.06 30.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.455 1.102 . . . . 0.0 108.574 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.42 147.79 22.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 t -143.35 161.89 37.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.827 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.46 -175.52 20.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.351 0.977 . . . . 0.0 111.176 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.87 166.47 29.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 111.78 -171.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.44 157.09 62.28 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.462 2.108 . . . . 0.0 110.355 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.22 -9.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 117.608 -1.662 . . . . 0.0 115.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t 61.74 102.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.217 1.807 . . . . 0.0 109.535 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.35 -7.36 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.33 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -32.69 69.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.72 1.76 . . . . 0.0 110.901 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 m -61.98 -39.82 93.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -1.11 1.55 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.133 2.573 . . . . 0.0 112.676 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.87 -66.39 0.92 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 167.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.13 -41.45 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.263 0.938 . . . . 0.0 111.797 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.6 64.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -67.89 -32.07 72.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.183 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.09 80.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.888 0.875 . . . . 0.0 110.607 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 t -63.52 -58.25 7.59 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 108.798 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.0 -45.74 32.09 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.256 1.822 . . . . 0.0 112.083 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.43 -54.77 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.98 -0.45 . . . . 0.0 110.321 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.56 -32.78 74.33 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.916 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -59.47 -44.09 93.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.351 0.978 . . . . 0.0 109.044 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -12.3 61.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.877 0.871 . . . . 0.0 111.118 172.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -93.35 8.99 38.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.284 1.834 . . . . 0.0 114.646 170.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.82 21.24 71.12 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.346 -0.846 . . . . 0.0 111.947 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.64 147.04 62.89 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.518 1.159 . . . . 0.0 109.096 169.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.81 106.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.883 2.388 . . . . 0.0 109.4 153.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.45 140.59 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -151.48 138.87 19.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.944 0.898 . . . . 0.0 109.185 173.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.93 30.38 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 106.459 -2.656 . . . . 0.0 106.459 -166.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.8 176.23 10.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.862 1.331 . . . . 0.0 112.144 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -138.36 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -131.02 76.24 1.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 152.72 40.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.62 115.93 14.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.377 1.084 . . . . 0.0 111.993 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.3 t -78.22 96.4 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -102.3 119.27 38.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 167.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -75.21 -78.74 0.1 Allowed 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.01 59.24 0.36 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.03 -9.45 1.52 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.063 -171.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 137.79 32.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.808 1.804 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 143.14 46.14 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 pt -144.06 -6.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.231 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.74 -151.85 23.43 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 119.562 1.074 . . . . 0.0 111.688 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -138.57 164.54 29.2 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.072 1.749 . . . . 0.0 109.156 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.13 142.93 48.94 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 128.336 2.654 . . . . 0.0 104.6 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.13 152.34 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.63 1.172 . . . . 0.0 109.335 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.24 111.81 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 120.198 1.363 . . . . 0.0 112.048 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.6 p -63.78 145.97 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.634 0.773 . . . . 0.0 109.954 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.53 -16.88 63.32 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.55 -0.719 . . . . 0.0 112.336 169.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 t -66.48 -32.47 73.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.792 1.637 . . . . 0.0 109.635 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.78 21.23 3.28 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.053 -0.859 . . . . 0.0 114.827 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.6 m -128.71 152.2 48.68 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.661 1.73 . . . . 0.0 109.516 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -128.83 168.81 15.38 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.89 1.276 . . . . 0.0 112.087 -173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.67 179.97 26.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.898 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.6 174.48 6.38 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.809 3.006 . . . . 0.0 111.439 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -165.14 -64.51 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.806 -1.184 . . . . 0.0 110.135 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.91 141.43 29.04 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.3 38.55 0.25 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.251 15.2 t 62.54 176.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.499 1.519 . . . . 0.0 109.246 -167.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.93 152.13 6.05 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.428 1.966 . . . . 0.0 108.782 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 158.65 16.7 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.592 0.757 . . . . 0.0 111.522 -174.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.41 145.04 99.11 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.595 -0.691 . . . . 0.0 109.64 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.91 132.26 15.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.552 2.168 . . . . 0.0 110.105 -168.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 158.5 56.65 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.496 2.131 . . . . 0.0 110.659 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.36 121.52 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.41 2.073 . . . . 0.0 110.489 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.05 9.55 59.39 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.777 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -120.35 156.48 31.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.084 1.354 . . . . 0.0 107.62 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 156.35 40.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.381 1.472 . . . . 0.0 108.057 160.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -135.52 174.48 10.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.951 2.5 . . . . 0.0 105.334 160.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.9 m -73.17 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.342 1.057 . . . . 0.0 108.388 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.58 148.12 28.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.696 -1.252 . . . . 0.0 110.412 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.7 19.83 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -151.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.01 98.28 2.27 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 61.29 -69.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.551 1.94 . . . . 0.0 110.907 -159.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.86 139.04 57.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 111.237 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.23 132.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 159.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.15 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.774 1.23 . . . . 0.0 108.833 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.31 112.61 10.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.032 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.6 -35.77 79.6 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.025 -1.047 . . . . 0.0 109.86 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -64.63 -36.22 83.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.924 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.4 p -62.51 -33.99 75.99 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.08 1.309 . . . . 0.0 109.939 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.71 -55.37 17.72 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.28 1.032 . . . . 0.0 109.65 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.34 -13.38 0.34 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.252 1.421 . . . . 0.0 113.495 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -78.23 -24.97 46.76 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.351 -1.468 . . . . 0.0 114.277 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.15 -35.37 0.24 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.12 46.24 0.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.41 1.884 . . . . 0.0 111.498 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -64.92 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 116.877 -1.535 . . . . 0.0 108.095 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.95 -23.96 46.36 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.681 2.254 . . . . 0.0 113.511 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.4 m -58.47 -31.56 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 120.283 -1.511 . . . . 0.0 111.569 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.84 -10.35 59.42 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.473 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 167.95 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.943 2.497 . . . . 0.0 107.545 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 N--CA 1.451 -0.382 0 C-N-CA 123.756 0.823 . . . . 0.0 110.582 176.567 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.238 0.484 0 CA-C-O 121.392 0.615 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.32 164.43 38.77 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.007 2.523 . . . . 0.0 106.089 166.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -120.15 146.32 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 139' ' ' ILE . 3.7 p -118.93 168.78 10.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.39 123.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -148.74 92.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -77.54 171.28 15.15 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.663 1.185 . . . . 0.0 109.804 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.8 27.28 4.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.482 1.513 . . . . 0.0 114.56 161.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.34 76.94 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.887 1.327 . . . . 0.0 108.227 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.54 -42.99 0.04 OUTLIER Glycine 0 C--O 1.221 -0.684 0 CA-C-O 117.249 -1.862 . . . . 0.0 115.844 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -32.02 71.25 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 122.391 3.095 . . . . 0.0 111.181 175.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.1 mmt -78.35 1.52 21.63 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 116.863 -1.541 . . . . 0.0 114.003 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -34.97 -51.17 0.51 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.565 1.946 . . . . 0.0 114.593 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.57 -27.89 13.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 112.283 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.28 -23.23 51.17 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.023 0.929 . . . . 0.0 111.969 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.553 ' HG ' ' CD1' ' A' ' 125' ' ' ILE . 47.5 t -49.81 128.46 18.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.518 2.327 . . . . 0.0 111.149 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.15 -95.88 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.99 -15.99 26.93 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.993 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.92 -71.38 0.07 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 110.374 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.553 ' CD1' ' HG ' ' A' ' 121' ' ' SER . 3.5 mt -32.59 -55.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 127.658 2.383 . . . . 0.0 110.871 176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.03 -66.77 0.49 Allowed 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.31 -40.07 73.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.696 1.198 . . . . 0.0 111.515 -170.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.55 -51.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.892 2.077 . . . . 0.0 108.965 174.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -54.75 -40.7 69.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.838 1.199 . . . . 0.0 111.214 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -58.82 -46.33 87.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.78 0.832 . . . . 0.0 109.487 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 m -65.28 -40.64 94.16 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.737 0.699 . . . . 0.0 111.81 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.52 -25.16 67.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.249 0.932 . . . . 0.0 110.839 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.8 m -108.17 -5.49 16.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 0.0 112.73 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.2 m -64.8 139.53 97.8 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 125.75 1.62 . . . . 0.0 108.594 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.75 155.44 53.93 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.573 2.182 . . . . 0.0 110.721 171.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.36 -47.53 1.39 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.122 1.82 . . . . 0.0 114.072 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.3 m -59.99 155.67 16.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.467 1.633 . . . . 0.0 110.518 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.26 136.75 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.8 OUTLIER -93.4 128.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 173.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.26 135.33 54.27 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 165.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.51 -179.17 40.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.095 -1.05 . . . . 0.0 115.7 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.0 m -129.9 124.36 32.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.117 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.3 pt -117.9 154.52 51.3 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.203 1.401 . . . . 0.0 108.155 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.33 158.7 14.93 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.194 2.596 . . . . 0.0 110.497 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.21 137.45 78.68 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 165.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.08 156.01 63.52 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.575 2.85 . . . . 0.0 109.72 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -129.17 -14.34 4.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.835 1.654 . . . . 0.0 112.563 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.25 -85.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 O-C-N 120.711 -1.243 . . . . 0.0 110.02 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.29 153.79 39.39 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.453 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.74 157.15 27.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.815 1.676 . . . . 0.0 111.475 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.52 135.36 53.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.663 0.602 . . . . 0.0 111.815 -154.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.59 -46.7 88.76 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.029 0.931 . . . . 0.0 110.198 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.91 -34.86 70.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 119.209 0.913 . . . . 0.0 111.252 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -66.87 -26.65 67.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.903 1.229 . . . . 0.0 111.565 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.77 -43.83 92.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.415 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.412 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 8.5 mm -69.21 -44.09 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.568 0.747 . . . . 0.0 109.899 173.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -61.21 -27.2 68.26 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.586 -1.321 . . . . 0.0 109.83 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -5.29 21.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.012 1.725 . . . . 0.0 113.525 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -37.91 11.99 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.811 1.187 . . . . 0.0 110.927 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 61.93 -28.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.264 2.226 . . . . 0.0 114.345 -174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -28.45 33.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.215 1.37 . . . . 0.0 110.591 169.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.8 m -63.94 113.39 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.123 1.439 . . . . 0.0 109.704 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -64.48 131.32 46.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.407 1.883 . . . . 0.0 108.08 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.24 92.49 2.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -80.31 97.97 7.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.598 1.559 . . . . 0.0 108.388 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.96 104.2 8.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.557 -0.714 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.2 146.69 9.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.3 1.048 . . . . 0.0 108.735 167.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -122.82 149.82 43.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -51.63 -25.05 6.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.192 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -76.05 -25.24 55.42 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.67 0.606 . . . . 0.0 110.725 -170.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.72 28.91 3.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.545 1.538 . . . . 0.0 112.341 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -66.13 -20.18 66.07 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.17 29.04 8.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.597 1.559 . . . . 0.0 109.393 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -135.84 15.95 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.405 1.482 . . . . 0.0 113.386 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.68 -9.14 58.52 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.095 1.771 . . . . 0.0 112.364 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -58.59 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.493 1.517 . . . . 0.0 110.996 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -29.52 67.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.016 1.756 . . . . 0.0 113.716 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.82 -42.6 97.61 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -67.31 -44.1 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 108.156 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.05 -42.74 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 119.196 0.907 . . . . 0.0 109.727 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 84.9 m -59.25 -50.91 72.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.126 0.876 . . . . 0.0 109.744 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -29.61 69.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.471 0.578 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.38 -43.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.504 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -63.75 -34.77 78.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.014 1.734 . . . . 0.0 110.85 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.92 -65.61 0.48 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.368 1.867 . . . . 0.0 110.799 -167.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 126.259 1.823 . . . . 0.0 112.204 -179.247 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.007 0.432 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -49.8 155.8 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.844 2.058 . . . . 0.0 111.459 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.3 t -131.27 145.52 35.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -133.57 144.94 49.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.019 0.927 . . . . 0.0 109.193 164.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.87 146.13 31.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 t -151.98 -177.54 6.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.48 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.18 175.17 13.9 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.159 1.838 . . . . 0.0 111.351 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.77 169.22 15.03 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 125.013 3.809 . . . . 0.0 111.659 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.13 162.09 20.75 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.175 2.583 . . . . 0.0 112.314 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.09 -53.72 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.093 0 O-C-N 121.25 -0.906 . . . . 0.0 112.346 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.5 t 63.66 94.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 O-C-N 126.061 1.683 . . . . 0.0 109.13 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.28 -35.3 0.48 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.204 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -56.93 -17.79 10.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 m -34.04 -51.03 0.41 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.69 1.596 . . . . 0.0 111.23 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -53.99 -28.03 35.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 124.909 1.284 . . . . 0.0 112.54 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -56.86 6.27 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.16 -40.67 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.435 1.016 . . . . 0.0 110.181 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -48.68 65.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -73.66 -14.46 61.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.455 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.8 98.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 108.601 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.1 p -63.29 -44.02 96.24 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.593 0.633 . . . . 0.0 110.145 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.32 -42.18 84.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.86 -50.78 76.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 109.771 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.64 -38.54 69.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -72.02 -35.07 69.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 119.119 -0.467 . . . . 0.0 112.252 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 -15.17 25.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 126.426 1.89 . . . . 0.0 115.181 162.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.49 3.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.312 2.245 . . . . 0.0 112.491 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.6 72.39 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.426 1.012 . . . . 0.0 113.61 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.05 121.47 71.54 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.317 1.559 . . . . 0.0 107.259 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.82 90.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.622 -171.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -73.22 146.54 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.379 1.472 . . . . 0.0 108.545 168.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.84 175.68 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 146.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.34 -153.37 24.39 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 124.888 1.232 . . . . 0.0 110.138 170.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -136.13 165.3 26.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.921 0.888 . . . . 0.0 109.36 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -137.49 168.33 19.87 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 159.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -135.87 104.58 5.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -102.93 159.17 15.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.75 121.34 20.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.99 107.52 2.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 167.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -125.03 91.46 3.44 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.298 1.439 . . . . 0.0 108.169 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -79.21 76.97 5.73 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 124.162 0.914 . . . . 0.0 111.513 -168.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.37 60.64 6.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 -162.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.41 15.78 81.0 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -115.54 113.3 23.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.012 1.906 . . . . 0.0 111.26 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -65.73 107.13 1.68 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.192 0.997 . . . . 0.0 109.806 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 pt -130.49 -10.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.48 -167.25 40.34 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.464 1.029 . . . . 0.0 110.933 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.61 159.19 37.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.4 139.19 35.24 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.004 0.522 . . . . 0.0 110.301 170.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.06 93.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.36 152.11 8.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 p -116.6 154.77 29.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 166.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -10.84 60.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.496 -0.753 . . . . 0.0 110.257 171.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -66.33 -19.77 65.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.725 2.41 . . . . 0.0 110.485 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 1.63 57.95 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.708 1.147 . . . . 0.0 113.997 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -85.5 159.81 19.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 0.0 108.637 170.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.56 131.34 20.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.776 1.63 . . . . 0.0 108.02 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.65 149.22 18.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 118.557 -1.135 . . . . 0.0 110.453 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.58 -3.84 13.64 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.127 2.552 . . . . 0.0 114.881 -164.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 40.58 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 131.348 3.859 . . . . 0.0 116.816 168.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.427 ' HG ' ' HA ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -145.71 116.99 7.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 119.232 0.924 . . . . 0.0 109.174 179.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -126.78 145.54 50.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.845 0.858 . . . . 0.0 110.097 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.82 129.21 37.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.306 1.043 . . . . 0.0 108.854 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.28 50.94 0.67 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.299 -164.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.65 -175.5 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.175 1.488 . . . . 0.0 110.93 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -64.75 151.51 92.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.1 138.26 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.867 3.045 . . . . 0.0 110.832 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.06 159.87 47.32 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.182 2.588 . . . . 0.0 111.236 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.94 147.33 84.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.583 2.189 . . . . 0.0 111.179 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.78 4.53 20.41 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.371 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -128.35 0.11 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.278 1.539 . . . . 0.0 108.119 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 57.35 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.761 2.025 . . . . 0.0 114.067 169.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.79 -16.21 15.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -174.67 170.55 3.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.824 1.65 . . . . 0.0 108.81 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 2.1 ppt_? -170.51 160.32 7.31 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.33 1.452 . . . . 0.0 111.244 151.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.75 -8.59 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 110.701 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.92 -104.46 0.26 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.02 -37.39 76.81 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.592 0.819 . . . . 0.0 109.919 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.09 161.87 13.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.545 1.538 . . . . 0.0 111.855 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 1.0 OUTLIER -105.34 116.02 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.263 2.225 . . . . 0.0 106.334 170.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HA ' ' HG ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -73.83 162.62 4.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 168.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.02 116.36 11.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.86 -28.98 64.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.249 1.386 . . . . 0.0 110.409 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 m -59.36 -36.83 76.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.323 1.449 . . . . 0.0 112.472 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.2 p -72.31 -22.77 61.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 120.732 1.605 . . . . 0.0 112.477 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -69.98 -57.11 5.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.931 162.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.8 -29.86 20.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.076 0.853 . . . . 0.0 112.474 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -50.21 -34.03 21.41 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -44.03 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.217 0.462 . . . . 0.0 111.643 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.6 48.79 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.468 1.907 . . . . 0.0 109.88 -171.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.12 -65.12 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.396 1.478 . . . . 0.0 108.359 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.55 -24.09 75.07 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 121.287 1.495 . . . . 0.0 113.214 172.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.96 -35.52 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 119.941 1.246 . . . . 0.0 111.141 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.49 -53.05 6.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.979 1.312 . . . . 0.0 107.565 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -120.75 84.39 2.22 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 109.234 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.532 162.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.429 0.633 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.95 169.59 11.94 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 129.626 3.17 . . . . 0.0 107.006 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.27 146.66 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.2 m -128.59 150.12 50.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.202 0.456 . . . . 0.0 111.273 166.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.99 124.44 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.101 1.361 . . . . 0.0 108.344 -162.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.8 68.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.62 -35.09 76.84 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.661 -1.274 . . . . 0.0 112.331 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.12 86.55 4.62 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.06 -1.025 . . . . 0.0 110.713 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.8 mt -131.58 114.95 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 147.47 -67.49 0.39 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -57.03 -33.33 67.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.134 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mmt -85.68 3.11 42.54 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.692 -1.623 . . . . 0.0 113.042 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -32.89 -65.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.248 1.819 . . . . 0.0 113.845 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -39.48 64.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.083 0.553 . . . . 0.0 110.825 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.58 -23.42 61.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.291 0.95 . . . . 0.0 112.502 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.2 m -52.44 115.04 1.57 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.364 1.866 . . . . 0.0 110.232 -170.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.87 -86.44 0.65 Allowed 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.43 -21.32 35.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.083 0.953 . . . . 0.0 112.361 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.39 -61.56 2.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.012 1.325 . . . . 0.0 110.76 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.4 mp -39.91 -57.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.239 1.381 . . . . 0.0 112.472 171.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -55.7 31.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.018 0.826 . . . . 0.0 111.239 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.82 92.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.508 0.67 . . . . 0.0 111.21 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.98 -48.64 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.805 1.242 . . . . 0.0 107.862 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -57.69 -37.91 74.28 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -64.28 -42.92 96.18 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.134 0.425 . . . . 0.0 111.138 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -67.35 -40.83 85.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.904 0.775 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.82 -21.11 40.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.523 1.529 . . . . 0.0 111.567 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.9 m -102.55 -6.3 22.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.394 1.878 . . . . 0.0 112.826 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.1 m -70.06 133.97 87.68 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.1 -45.89 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.769 2.312 . . . . 0.0 109.872 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.45 40.57 3.04 Favored Glycine 0 C--O 1.216 -0.974 0 CA-C-O 117.389 -1.784 . . . . 0.0 113.682 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.5 m -135.8 163.84 29.29 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.934 2.367 . . . . 0.0 107.088 169.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.93 103.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.82 132.32 31.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 122.825 0.45 . . . . 0.0 110.134 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.9 tp -126.37 147.88 49.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.257 2.623 . . . . 0.0 105.579 159.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.43 168.93 37.22 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 120.8 1.636 . . . . 0.0 113.358 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.0 m -112.66 121.82 45.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.629 0.715 . . . . 0.0 109.899 -166.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.73 153.39 47.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.662 1.185 . . . . 0.0 109.727 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.89 154.06 67.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.724 1.616 . . . . 0.0 110.461 172.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.59 126.12 92.39 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.34 152.24 44.04 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.284 2.656 . . . . 0.0 111.766 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -47.38 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.593 1.557 . . . . 0.0 110.576 172.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.48 -147.08 13.38 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 124.815 1.198 . . . . 0.0 110.768 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -63.61 158.11 61.56 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 121.974 -0.721 . . . . 0.0 110.638 171.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.66 139.96 41.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.028 2.485 . . . . 0.0 109.941 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.73 145.36 27.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.469 1.508 . . . . 0.0 109.702 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.32 -84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.006 2.922 . . . . 0.0 114.769 -170.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.58 -41.1 63.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.088 0.858 . . . . 0.0 109.028 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.8 -41.21 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.629 -1.177 . . . . 0.0 110.278 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.63 -35.37 80.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.866 1.666 . . . . 0.0 110.866 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.58 -20.76 58.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.748 0.819 . . . . 0.0 111.422 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mt -103.4 -42.98 8.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.623 1.569 . . . . 0.0 109.964 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.73 -19.98 60.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.257 1.423 . . . . 0.0 110.965 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.43 -30.99 61.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.989 0.516 . . . . 0.0 111.022 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' A' ' 160' ' ' ARG . 16.2 mtp85 -83.99 -38.07 21.42 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.476 -156.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.17 -15.81 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.242 3.017 . . . . 0.0 116.726 174.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.81 -25.36 60.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.487 1.915 . . . . 0.0 111.122 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.4 m -52.73 141.12 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.407 1.883 . . . . 0.0 110.541 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 2.7 tppt? -60.56 143.46 53.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 158.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.87 100.96 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.426 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 19.2 m-85 -86.62 89.32 7.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.44 111.44 1.79 Allowed 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.48 166.7 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 119.335 0.97 . . . . 0.0 108.532 176.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.2 p -128.52 155.21 45.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 163.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -57.69 -34.58 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 162.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.94 -44.7 91.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.947 2.099 . . . . 0.0 109.996 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.01 18.26 18.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 113.237 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -38.29 -52.92 1.5 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.308 1.443 . . . . 0.0 113.664 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.94 6.48 48.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.552 1.141 . . . . 0.0 112.812 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -96.34 -3.25 44.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 111.987 166.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 tp -76.45 -35.97 58.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.179 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.3 -58.14 9.74 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.942 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.83 -25.29 53.12 Favored 'Trans proline' 0 C--N 1.352 0.725 0 CA-C-N 122.105 1.787 . . . . 0.0 112.34 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.25 -43.17 71.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 109.91 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.9 mt -56.88 -50.8 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.869 1.267 . . . . 0.0 108.67 171.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.51 -45.25 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.991 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.3 m -59.3 -43.93 92.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.521 1.055 . . . . 0.0 110.465 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.6 t -62.16 -38.77 90.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.533 0.733 . . . . 0.0 110.431 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.7 t -75.18 -45.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.951 0.9 . . . . 0.0 110.208 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -67.58 -14.28 62.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.467 1.031 . . . . 0.0 112.636 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.2 t -34.7 -50.95 0.48 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 128.103 2.561 . . . . 0.0 114.157 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.237 0.406 0 C-N-CA 124.603 1.161 . . . . 0.0 110.027 -168.542 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.481 ' HD1' ' CG1' ' A' ' 139' ' ' ILE . 31.5 m-70 -48.43 140.8 7.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.83 2.052 . . . . 0.0 109.605 166.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 96.9 t -126.72 149.58 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.886 1.221 . . . . 0.0 112.259 164.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -137.51 162.47 33.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.905 2.082 . . . . 0.0 111.38 176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.34 135.92 53.64 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.727 1.611 . . . . 0.0 108.442 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -137.24 -178.92 5.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.026 1.73 . . . . 0.0 107.206 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.64 176.05 38.49 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.743 -1.223 . . . . 0.0 112.947 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.14 138.88 34.39 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.63 2.886 . . . . 0.0 112.957 -164.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.01 92.59 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.408 3.406 . . . . 0.0 111.579 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.63 -75.51 0.37 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.81 -42.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.03 83.69 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -172.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -35.02 79.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 118.001 -0.999 . . . . 0.0 108.516 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -47.92 -63.46 1.06 Allowed 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 125.664 1.852 . . . . 0.0 107.298 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -42.21 -49.89 4.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.16 1.784 . . . . 0.0 112.671 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -47.9 57.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.681 0.673 . . . . 0.0 109.64 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -62.44 -49.12 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.82 0.736 . . . . 0.0 110.951 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -52.78 -49.68 65.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.547 1.539 . . . . 0.0 107.847 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -57.58 -42.39 83.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.618 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.27 -39.97 70.45 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.949 0.795 . . . . 0.0 110.636 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.431 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 19.5 m -67.17 -56.08 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -47.94 -39.58 19.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.609 1.563 . . . . 0.0 114.211 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.81 -61.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.516 1.126 . . . . 0.0 108.675 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 mt -61.71 -34.67 76.18 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 118.675 -0.678 . . . . 0.0 109.854 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 22' ' ' SER . 70.7 mttt -54.36 -48.49 71.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.42 1.088 . . . . 0.0 108.242 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -65.22 -24.56 67.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.711 0.404 . . . . 0.0 110.489 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -81.06 8.39 8.68 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.121 1.768 . . . . 0.0 114.831 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 18.79 68.0 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.279 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -53.32 148.62 15.91 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 118.109 0.955 . . . . 0.0 109.294 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.95 112.14 3.49 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.103 1.202 . . . . 0.0 108.991 155.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.56 144.24 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.952 0.882 . . . . 0.0 110.156 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -145.12 157.36 44.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.499 1.92 . . . . 0.0 107.636 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.56 -157.39 24.05 Favored Glycine 0 C--O 1.238 0.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -147.81 161.48 41.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 109.946 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -130.88 146.48 52.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -100.95 109.63 21.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.34 169.62 14.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.077 0.951 . . . . 0.0 111.216 -165.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.01 106.72 16.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 109.408 -162.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.0 93.79 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -111.93 113.96 26.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.529 1.531 . . . . 0.0 107.345 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.44 78.81 8.58 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 -133.52 18.92 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -166.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.69 27.17 5.44 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.598 -1.668 . . . . 0.0 115.615 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.23 159.38 44.48 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.145 2.473 . . . . 0.0 110.725 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.47 137.21 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.276 1.43 . . . . 0.0 110.158 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.73 -9.39 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.94 -172.05 38.0 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -137.71 155.0 49.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -123.82 -177.32 3.71 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 124.551 1.157 . . . . 0.0 108.268 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.97 89.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.46 117.75 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -81.08 153.99 27.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.01 6.36 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.039 -1.038 . . . . 0.0 113.083 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -95.06 5.64 51.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.766 1.626 . . . . 0.0 112.009 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.41 72.43 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.49 -1.381 . . . . 0.0 113.148 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -101.08 172.45 7.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.374 1.069 . . . . 0.0 108.2 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -152.8 130.05 11.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.992 0.917 . . . . 0.0 108.908 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.97 145.19 17.6 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.6 67.86 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.634 2.889 . . . . 0.0 111.59 -173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.29 -51.83 6.06 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.327 2.251 . . . . 0.0 111.913 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -152.36 151.79 31.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.546 0.528 . . . . 0.0 111.168 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -140.61 161.74 37.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.553 1.541 . . . . 0.0 109.122 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.48 126.69 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.51 -143.7 7.32 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 127.345 2.402 . . . . 0.0 108.746 167.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 67' ' ' GLU . 3.4 tp -88.55 168.44 12.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.485 1.143 . . . . 0.0 109.955 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' H ' ' HG ' ' A' ' 66' ' ' LEU . 10.5 mm-40 -74.89 151.16 86.43 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 158.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.78 124.65 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.232 2.621 . . . . 0.0 111.456 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -70.77 167.93 24.32 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 111.53 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.96 125.13 14.7 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.592 1.528 . . . . 0.0 109.949 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.82 80.79 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.64 -1.089 . . . . 0.0 114.313 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 118.99 10.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.209 1.505 . . . . 0.0 106.982 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -140.03 176.89 8.38 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.868 0.467 . . . . 0.0 112.148 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -149.92 -161.95 1.45 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 162.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.5 m -52.18 130.38 30.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.027 1.331 . . . . 0.0 109.401 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -147.91 125.84 12.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.455 ' HB ' ' HE2' ' A' ' 116' ' ' LYS . 16.2 m -113.74 77.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 123.409 1.576 . . . . 0.0 108.757 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.16 -2.26 1.12 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.655 2.074 . . . . 0.0 116.191 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 176.57 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.113 2.565 . . . . 0.0 109.884 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.88 160.52 21.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 109.539 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.76 112.82 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 165.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.43 165.28 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 119.651 1.114 . . . . 0.0 110.252 163.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -142.19 151.79 42.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.316 0.646 . . . . 0.0 109.538 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.17 -29.68 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.837 2.055 . . . . 0.0 110.447 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.5 m -53.22 -43.65 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.085 1.354 . . . . 0.0 108.769 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.6 t -62.25 -23.01 66.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.108 0.867 . . . . 0.0 112.726 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.23 -56.42 4.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -51.86 -30.09 22.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.637 1.575 . . . . 0.0 112.642 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -45.19 -49.33 12.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.019 2.527 . . . . 0.0 113.714 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.98 -34.17 0.15 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.51 0.724 . . . . 0.0 112.371 -166.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.85 45.18 1.13 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.792 1.637 . . . . 0.0 108.719 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.01 -63.47 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.12 1.368 . . . . 0.0 107.405 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.94 -22.45 48.42 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.748 2.299 . . . . 0.0 112.742 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.21 -34.86 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.491 1.496 . . . . 0.0 110.787 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.2 -15.57 62.6 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.875 0.87 . . . . 0.0 111.576 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -147.76 77.38 1.42 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.652 1.569 . . . . 0.0 108.826 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 . . . . . 0 C--O 1.239 0.538 0 C-N-CA 125.951 1.701 . . . . 0.0 108.054 160.681 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 . . . . . 0 C--O 1.227 -0.11 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -61.91 97.94 0.09 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.75 2.42 . . . . 0.0 110.637 -169.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.02 116.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.46 157.88 26.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.2 t -140.48 114.99 6.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -144.03 102.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.19 176.52 7.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 63.24 -77.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.954 2.502 . . . . 0.0 109.261 -149.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.324 30.2 mt 55.04 -8.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 128.063 2.545 . . . . 0.0 114.445 -169.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.97 -81.4 0.38 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 121.234 1.834 . . . . 0.0 111.477 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HE2' ' HB ' ' A' ' 77' ' ' VAL . 2.0 ttpm? -59.29 -28.35 66.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -163.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -22.47 65.41 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.843 -2.027 . . . . 0.0 111.258 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -24.85 -67.06 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.617 2.367 . . . . 0.0 113.936 -174.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.67 -15.64 60.79 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.744 2.018 . . . . 0.0 110.168 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.2 t -47.54 105.21 0.07 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 129.532 3.133 . . . . 0.0 108.439 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.18 -89.77 0.59 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -56.75 -13.35 2.45 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.073 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -66.5 0.37 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.543 1.537 . . . . 0.0 110.69 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -33.84 -55.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.698 1.199 . . . . 0.0 111.362 168.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.54 -54.66 36.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.072 0.851 . . . . 0.0 112.477 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.55 66.88 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.33 -45.8 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -56.53 -39.15 72.89 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.297 -1.502 . . . . 0.0 112.294 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.03 -16.7 33.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.806 1.185 . . . . 0.0 113.667 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.9 m -128.2 -17.91 4.2 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.429 1.092 . . . . 0.0 111.952 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.48 -49.88 73.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 146.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -82.87 49.79 1.58 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.421 1.888 . . . . 0.0 110.067 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -141.43 133.76 13.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 162.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.9 -37.37 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 121.858 1.705 . . . . 0.0 111.353 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.64 17.02 2.2 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.822 1.201 . . . . 0.0 114.989 -174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.9 m -118.31 167.16 11.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.64 1.72 . . . . 0.0 108.475 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mt -129.94 101.5 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.481 ' CG1' ' HD1' ' A' ' 3' ' ' HIS . 21.4 mm -59.9 133.16 25.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tp -132.71 147.52 52.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 159.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.81 177.89 45.2 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.2 m -114.19 148.08 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.24 127.8 19.11 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.53 145.52 76.79 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.415 1.41 . . . . 0.0 110.511 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.48 134.42 88.72 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.146 0.979 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -67.59 -55.37 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.206 2.604 . . . . 0.0 109.987 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 64.9 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.281 1.832 . . . . 0.0 108.301 -167.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.12 -102.91 0.5 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.671 1.123 . . . . 0.0 110.41 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 159.09 79.43 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 117.852 0.826 . . . . 0.0 110.364 -173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.14 -175.95 2.94 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.733 2.955 . . . . 0.0 108.918 167.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -126.48 144.89 50.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.21 -66.68 0.36 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.667 1.987 . . . . 0.0 113.119 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.2 -39.21 66.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.494 1.118 . . . . 0.0 111.254 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.54 -36.5 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.076 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -63.21 -29.19 70.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.27 1.395 . . . . 0.0 111.778 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -56.94 -39.43 74.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.555 0.693 . . . . 0.0 110.352 174.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.17 -36.81 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.913 1.685 . . . . 0.0 109.909 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -66.44 -34.17 77.33 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.225 -1.547 . . . . 0.0 110.969 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -62.7 -30.58 71.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.787 0.835 . . . . 0.0 109.682 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -58.29 -40.26 81.49 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.355 0.662 . . . . 0.0 109.473 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 -17.68 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.318 3.047 . . . . 0.0 115.677 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.88 -5.55 58.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.723 1.209 . . . . 0.0 111.652 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.36 127.49 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.043 1.337 . . . . 0.0 109.967 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 13.6 tptm -65.0 120.4 12.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 164.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 92.15 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 18.9 m-85 -66.62 98.1 0.49 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.534 1.133 . . . . 0.0 108.182 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 106.46 2.9 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.98 162.81 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.3 p -129.86 156.28 44.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 165.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -59.69 -22.91 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.335 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -83.06 -36.73 24.68 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 110.313 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.73 80.79 1.93 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.659 3.184 . . . . 0.0 102.877 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -106.59 -35.46 7.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.37 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -113.27 3.3 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.369 1.441 . . . . 0.0 113.312 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -101.61 0.2 35.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.365 1.866 . . . . 0.0 111.425 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -31.62 52.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.122 -0.986 . . . . 0.0 111.247 -173.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 tp -39.31 -61.6 0.96 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.768 1.227 . . . . 0.0 110.462 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -68.29 -23.16 39.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.589 1.603 . . . . 0.0 115.495 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.75 -45.39 82.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.917 1.235 . . . . 0.0 108.323 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.3 mt -62.38 -49.46 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.042 0.937 . . . . 0.0 109.623 173.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.93 -41.69 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 119.824 1.193 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 58.0 m -64.36 -35.77 81.96 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 7.9 t -66.34 -34.73 78.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.083 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.95 -58.56 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.346 0.976 . . . . 0.0 108.399 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.05 -12.55 3.49 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 113.789 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.7 t -57.31 -32.98 67.22 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.925 -1.11 . . . . 0.0 110.832 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.167 0 O-C-N 120.572 -1.33 . . . . 0.0 108.819 -158.079 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.75 0.309 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -34.45 143.66 0.04 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 128.065 2.546 . . . . 0.0 111.037 163.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.31 127.28 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.758 0.708 . . . . 0.0 109.634 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -140.03 134.0 30.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.874 0.87 . . . . 0.0 109.934 -173.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.08 161.47 22.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.791 1.636 . . . . 0.0 109.152 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -155.6 165.28 37.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.007 0.923 . . . . 0.0 108.818 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.69 -158.95 15.52 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.394 -1.225 . . . . 0.0 111.82 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.08 117.07 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.15 3.233 . . . . 0.0 112.248 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.47 172.51 13.44 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.771 2.981 . . . . 0.0 111.776 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.22 -63.77 0.29 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 167.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.41 125.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.31 -37.72 1.81 Allowed Glycine 0 C--O 1.223 -0.533 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 159.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.629 ' HE3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -62.3 -29.74 70.65 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 117.887 0.843 . . . . 0.0 110.387 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -61.14 -48.43 81.63 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -55.17 -40.11 70.3 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 128.123 2.569 . . . . 0.0 107.873 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.37 -61.99 2.07 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 117.9 -1.047 . . . . 0.0 109.841 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.61 -45.64 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 119.6 1.091 . . . . 0.0 110.06 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -59.24 4.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.692 1.597 . . . . 0.0 108.247 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -63.11 -30.4 71.56 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.425 -1.274 . . . . 0.0 111.954 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.36 -32.75 68.85 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 119.878 1.217 . . . . 0.0 109.802 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -71.77 -44.66 63.64 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.192 0.451 . . . . 0.0 110.103 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -61.71 -22.31 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.06 0.944 . . . . 0.0 111.639 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.08 -50.82 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 120.898 -1.126 . . . . 0.0 110.677 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.27 -36.81 84.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.505 0.722 . . . . 0.0 110.22 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -59.18 -48.83 80.18 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -67.74 -3.42 9.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.277 1.831 . . . . 0.0 112.799 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -120.38 11.78 11.52 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.786 1.634 . . . . 0.0 112.773 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.05 38.68 22.07 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 120.122 1.328 . . . . 0.0 113.689 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.46 118.63 37.11 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 107.489 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.49 99.08 0.8 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.77 2.98 . . . . 0.0 110.111 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.4 156.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.14 175.39 9.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.31 -170.64 16.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.89 156.89 46.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.465 0.65 . . . . 0.0 109.811 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -131.59 131.28 43.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 m -83.2 125.37 31.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.437 0.0 OUTLIER -103.7 -130.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 116.593 -1.67 . . . . 0.0 109.645 176.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -157.71 108.48 2.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 122.678 2.49 . . . . 0.0 110.037 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 107.52 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -128.89 113.32 15.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.47 -63.07 1.43 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.692 0.678 . . . . 0.0 109.245 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.49 68.91 0.34 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 106.409 -2.676 . . . . 0.0 106.409 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 -11.08 72.95 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.751 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 135.15 40.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.277 2.038 . . . . 0.0 109.899 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -67.45 141.18 57.07 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 167.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -148.99 -2.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.022 1.329 . . . . 0.0 112.846 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.84 -167.54 32.69 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 119.878 1.217 . . . . 0.0 110.973 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -137.97 154.04 49.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 117.141 0.47 . . . . 0.0 110.52 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -135.95 155.91 49.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 129.484 3.114 . . . . 0.0 106.221 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.76 108.34 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.72 122.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -165.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -72.1 155.24 40.5 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.58 -28.44 69.89 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.803 -1.186 . . . . 0.0 110.938 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -68.91 -20.8 64.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 128.033 2.533 . . . . 0.0 111.508 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.42 39.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.652 -1.082 . . . . 0.0 114.409 163.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.8 m -71.23 164.4 25.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.822 1.811 . . . . 0.0 107.491 160.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -141.56 136.38 31.04 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.134 0.974 . . . . 0.0 108.523 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.68 47.87 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.45 -177.53 1.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 145.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 -60.04 0.07 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 p -146.34 158.31 43.87 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.913 0.885 . . . . 0.0 109.122 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -143.37 165.43 27.54 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.863 2.065 . . . . 0.0 106.895 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.54 147.48 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 41.85 0.22 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.775 1.655 . . . . 0.0 110.706 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt 55.96 -167.62 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.798 1.299 . . . . 0.0 111.487 -173.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.4 142.54 25.13 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.836 0.854 . . . . 0.0 108.862 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.05 134.57 25.55 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.629 1.553 . . . . 0.0 109.825 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.86 159.25 54.62 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.006 2.471 . . . . 0.0 109.449 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.06 -6.37 18.09 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.521 2.147 . . . . 0.0 113.989 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.34 7.28 12.6 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.493 1.521 . . . . 0.0 113.622 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -138.49 88.07 2.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.384 2.092 . . . . 0.0 107.16 173.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.21 150.87 33.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.69 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.39 63.84 0.12 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.515 1.126 . . . . 0.0 108.534 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 59.8 m 47.78 -143.97 0.38 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.93 -1.106 . . . . 0.0 110.719 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.1 155.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 1 C-N-CA 133.701 4.801 . . . . 0.0 106.11 175.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.34 25.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 121.115 1.78 . . . . 0.0 111.017 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.2 111.73 0.94 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 64.05 -48.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.911 2.484 . . . . 0.0 113.953 -167.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.87 178.37 4.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.12 2.568 . . . . 0.0 108.717 -173.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.26 143.29 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 126.708 2.003 . . . . 0.0 106.53 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.11 176.65 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 119.708 1.14 . . . . 0.0 110.394 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -140.3 156.1 46.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 157.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.07 -33.93 38.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.88 0.872 . . . . 0.0 108.954 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.9 m -68.3 -33.35 74.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.843 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.9 m -60.69 -32.01 71.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 121.277 1.853 . . . . 0.0 109.846 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -69.11 -57.46 5.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -53.19 -24.09 10.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -48.81 -34.72 12.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.097 1.359 . . . . 0.0 112.827 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -31.98 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.3 44.08 0.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.281 1.432 . . . . 0.0 110.847 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.43 -61.69 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 127.186 2.195 . . . . 0.0 108.414 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.3 -24.18 16.94 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.04 1.827 . . . . 0.0 113.54 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.5 -30.32 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 119.463 1.029 . . . . 0.0 111.188 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.6 mt -76.46 -6.75 53.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.705 2.002 . . . . 0.0 111.316 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 92.16 2.1 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.46 1.504 . . . . 0.0 109.86 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 C--O 1.234 0.281 0 C-N-CA 125.635 1.574 . . . . 0.0 110.321 -175.016 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.27 170.47 22.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 128.247 2.619 . . . . 0.0 105.947 160.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 130.1 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 10.5 m -124.99 109.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 t -83.16 140.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 125.742 1.617 . . . . 0.0 111.203 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -151.67 85.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.516 1.126 . . . . 0.0 108.645 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.53 127.42 53.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.336 -1.478 . . . . 0.0 113.218 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 95.54 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 1 C-N-CA 133.585 4.754 . . . . 0.0 108.153 -173.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.87 57.5 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.653 2.381 . . . . 0.0 106.271 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.97 -33.96 0.03 OUTLIER Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.539 -1.351 . . . . 0.0 112.47 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -62.25 -17.98 59.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 119.612 -2.111 . . . . 0.0 113.822 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 9.81 28.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.879 1.672 . . . . 0.0 111.283 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -57.71 -13.57 4.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.65 -41.05 4.15 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.772 1.229 . . . . 0.0 111.917 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.4 -22.28 44.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.581 0.628 . . . . 0.0 112.39 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.438 ' HG ' ' CD1' ' A' ' 125' ' ' ILE . 47.7 t -50.44 135.23 22.62 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 -175.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -136.92 -77.41 0.41 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.126 0.57 . . . . 0.0 111.009 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.28 -29.88 69.59 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 116.859 -1.543 . . . . 0.0 110.549 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.91 -54.58 12.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.051 -1.452 . . . . 0.0 111.69 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.438 ' CD1' ' HG ' ' A' ' 121' ' ' SER . 4.3 mp -38.51 -63.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 126.566 1.946 . . . . 0.0 111.649 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.51 -51.59 68.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.13 72.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.0 p -87.95 -32.18 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.74 0.816 . . . . 0.0 110.373 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -36.95 32.47 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.042 165.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -48.2 -53.21 17.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.005 1.275 . . . . 0.0 109.529 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -41.63 61.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.791 2.036 . . . . 0.0 112.343 -175.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.47 -41.29 98.67 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.605 1.548 . . . . 0.0 110.606 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 t -78.46 25.26 0.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.948 1.699 . . . . 0.0 111.064 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.5 m -126.79 134.31 25.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.524 -1.36 . . . . 0.0 110.271 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.68 158.81 46.72 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.433 2.755 . . . . 0.0 109.888 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.93 3.78 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -61.84 148.03 44.62 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.227 1.014 . . . . 0.0 112.066 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.6 mt -130.2 108.26 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.6 139.29 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mt -133.7 97.03 3.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.405 1.482 . . . . 0.0 107.878 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.19 -172.45 18.15 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 118.032 0.378 . . . . 0.0 113.209 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 m -142.26 136.39 29.75 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.931 1.292 . . . . 0.0 107.62 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.78 167.56 18.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.691 1.596 . . . . 0.0 110.079 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 160.05 51.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.562 1.508 . . . . 0.0 111.116 158.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.2 152.71 96.53 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.543 -0.723 . . . . 0.0 110.075 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -26.13 18.92 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.01 2.473 . . . . 0.0 111.983 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -50.71 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 128.394 2.678 . . . . 0.0 110.029 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.54 -118.79 1.65 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -167.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 171.23 7.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.225 1.41 . . . . 0.0 110.743 -171.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -57.4 170.98 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.456 2.104 . . . . 0.0 110.39 158.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -147.9 178.6 8.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.83 2.852 . . . . 0.0 105.396 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.1 -82.0 0.11 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 118.903 0.774 . . . . 0.0 109.096 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.83 -32.68 74.34 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 120.444 -1.41 . . . . 0.0 113.073 -171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.81 -34.93 71.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 117.441 -1.266 . . . . 0.0 109.165 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.15 -34.18 73.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 111.153 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.33 -50.27 67.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.043 0.937 . . . . 0.0 109.76 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.0 -35.66 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -62.46 -25.62 68.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.13 0.877 . . . . 0.0 111.111 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.07 -14.17 61.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.258 1.023 . . . . 0.0 113.556 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -117.19 55.89 0.83 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.447 1.499 . . . . 0.0 107.898 -166.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 4.7 mmpt? -57.62 -10.32 1.51 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.426 1.491 . . . . 0.0 114.951 -166.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.0 -25.36 43.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.977 0.808 . . . . 0.0 112.163 167.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.3 m -47.73 118.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 125.901 1.68 . . . . 0.0 109.185 164.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 134.34 53.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.519 1.928 . . . . 0.0 108.501 169.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.63 80.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.168 0.894 . . . . 0.0 108.78 -168.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.15 104.21 1.39 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.179 1.792 . . . . 0.0 109.135 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.58 116.17 17.02 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.906 -1.121 . . . . 0.0 109.52 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.73 166.73 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.983 0.897 . . . . 0.0 109.577 170.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.0 p -120.05 151.19 39.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 163.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -64.49 -21.08 66.57 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.386 -0.821 . . . . 0.0 109.477 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -67.74 -74.21 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.704 2.002 . . . . 0.0 109.135 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -91.06 31.9 1.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.924 1.289 . . . . 0.0 109.998 -175.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.79 -24.31 61.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.737 1.215 . . . . 0.0 112.115 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -114.93 21.9 13.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.19 2.596 . . . . 0.0 111.593 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -136.46 6.51 3.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.588 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.42 -13.27 57.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 117.436 -1.706 . . . . 0.0 110.627 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tp -36.39 -59.91 0.79 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 127.591 2.356 . . . . 0.0 112.533 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.2 -25.29 31.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 122.108 1.789 . . . . 0.0 112.087 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.2 -43.44 78.05 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.73 -53.01 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.02 -43.73 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.22 1.408 . . . . 0.0 110.264 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.1 m -60.83 -32.72 72.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.516 1.126 . . . . 0.0 111.569 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -65.33 -45.67 83.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.948 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.28 -48.29 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.998 0.919 . . . . 0.0 109.217 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -65.95 -24.5 66.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.7 t -67.96 -24.8 65.2 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.112 0.965 . . . . 0.0 109.992 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 124.32 1.048 . . . . 0.0 113.022 167.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -64.38 139.5 58.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.475 1.11 . . . . 0.0 109.315 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.46 138.25 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 14.9 m-85 -129.03 146.76 50.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.694 0.759 . . . . 0.0 109.899 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.65 131.16 46.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -121.59 175.44 6.22 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.64 0.733 . . . . 0.0 109.4 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.86 -135.73 8.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 125.462 1.506 . . . . 0.0 109.644 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.25 159.74 52.58 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.696 2.264 . . . . 0.0 111.761 -160.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.43 -9.67 25.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.951 3.101 . . . . 0.0 114.266 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.32 19.69 14.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.103 0.858 . . . . 0.0 112.464 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.433 ' O ' ' HE2' ' A' ' 14' ' ' LYS 0.301 46.9 t 74.29 -65.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.136 3.374 . . . . 0.0 109.272 168.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.37 5.05 26.74 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.236 1.398 . . . . 0.0 110.822 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 12' ' ' VAL . 24.3 mtmt -121.76 -8.31 8.97 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 116.368 -1.777 . . . . 0.0 115.225 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.8 m -47.14 -41.19 17.13 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.769 1.622 . . . . 0.0 112.015 -166.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -43.63 -48.83 7.77 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.475 2.71 . . . . 0.0 109.906 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.596 ' CD1' ' H ' ' A' ' 176' ' ' LEU . 41.9 mt -69.54 -57.27 5.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 125.56 1.544 . . . . 0.0 109.743 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -57.74 -46.72 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.971 0.805 . . . . 0.0 109.118 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 -56.51 7.57 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.959 0.904 . . . . 0.0 111.321 171.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -68.58 -25.63 64.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.322 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.6 61.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.442 1.097 . . . . 0.0 110.224 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -70.08 -35.07 73.93 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -58.67 -45.31 89.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.879 0.872 . . . . 0.0 109.124 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -60.53 -53.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.151 0.98 . . . . 0.0 110.213 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.93 -41.02 90.86 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.143 0.577 . . . . 0.0 109.449 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -69.59 -40.72 76.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.978 0.354 . . . . 0.0 110.126 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -61.18 -30.15 70.24 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.027 169.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -84.92 1.68 46.18 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.4 1.48 . . . . 0.0 112.858 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.75 1.46 66.94 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.236 1.398 . . . . 0.0 114.282 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.44 110.52 11.69 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.079 1.94 . . . . 0.0 107.809 -172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.93 119.33 6.39 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.555 2.17 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.95 118.17 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 109.033 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.27 170.79 9.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 126.234 1.813 . . . . 0.0 109.797 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 -156.5 16.01 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 163.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -149.46 167.79 25.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -141.42 -175.97 4.55 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -118.52 133.74 55.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.822 1.647 . . . . 0.0 107.086 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.45 33.78 5.41 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.584 -1.322 . . . . 0.0 112.222 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.04 -172.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.994 2.118 . . . . 0.0 110.51 -171.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.37 144.2 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 152.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -125.22 161.63 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.278 1.831 . . . . 0.0 107.758 167.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -108.79 45.88 1.01 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.079 1.352 . . . . 0.0 107.367 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 104.95 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -163.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.69 -51.93 3.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.944 1.259 . . . . 0.0 114.56 171.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.13 139.46 30.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 110.392 -162.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -70.15 134.77 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.47 -8.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -176.34 38.43 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 119.558 1.072 . . . . 0.0 110.613 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.57 148.84 51.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.77 135.14 32.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.8 155.73 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 C-N-CA 125.953 1.701 . . . . 0.0 108.536 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 m -141.51 143.09 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.972 165.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.9 p -82.87 161.97 21.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.406 1.003 . . . . 0.0 109.871 174.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.63 -14.27 60.75 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.529 -0.732 . . . . 0.0 112.935 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 t -69.14 -25.47 64.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.935 0.789 . . . . 0.0 109.49 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.56 9.65 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.079 0.847 . . . . 0.0 112.546 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -83.66 167.22 17.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 1.3 mpt_? -137.53 163.23 31.66 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -151.18 175.47 30.09 Favored Glycine 0 C--O 1.223 -0.571 0 CA-C-N 120.843 1.656 . . . . 0.0 110.531 158.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.71 161.6 35.14 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 109.749 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.4 -59.98 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.61 144.29 49.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -143.34 162.16 36.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.263 1.425 . . . . 0.0 108.053 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 149.79 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.22 157.4 28.27 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 166.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.47 162.87 7.47 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 161.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.67 150.63 81.11 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.42 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.22 124.87 11.3 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.334 2.023 . . . . 0.0 110.447 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.04 165.84 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.945 2.43 . . . . 0.0 109.465 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.97 101.75 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 108.549 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.45 -68.18 0.48 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.562 1.077 . . . . 0.0 110.421 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -76.72 125.31 29.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.87 7.94 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -135.61 41.42 2.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.179 1.392 . . . . 0.0 107.312 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.0 m 59.1 -161.61 0.26 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.771 2.028 . . . . 0.0 112.291 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.78 157.27 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.426 3.091 . . . . 0.0 109.5 175.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.01 0.53 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.93 140.41 11.03 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 -169.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.65 -69.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.965 1.706 . . . . 0.0 110.718 -158.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.11 148.92 21.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.785 1.234 . . . . 0.0 110.164 -167.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.26 139.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 162.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.93 -175.8 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 O-C-N 120.774 -1.204 . . . . 0.0 109.066 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.39 119.82 6.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 153.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.94 -34.61 71.95 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 112.117 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.9 m -51.51 -39.67 58.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.775 1.63 . . . . 0.0 110.35 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.09 -29.05 70.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.743 0.417 . . . . 0.0 110.597 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -71.53 -60.23 2.34 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.913 1.285 . . . . 0.0 108.006 170.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -49.25 -21.42 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.675 1.99 . . . . 0.0 113.778 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -57.34 -58.26 9.03 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.709 -1.244 . . . . 0.0 112.065 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' CD2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -123.07 -34.15 3.2 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.833 1.253 . . . . 0.0 112.646 -164.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.45 55.92 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.693 1.597 . . . . 0.0 109.074 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 -58.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.679 -173.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.37 -27.06 19.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.893 2.395 . . . . 0.0 113.055 168.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 p -63.41 -27.87 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.914 -1.116 . . . . 0.0 110.659 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 84.4 1.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? 51.51 80.28 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.43 2.292 . . . . 0.0 113.163 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t30 . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 125.747 1.619 . . . . 0.0 108.124 153.657 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -79.31 156.21 28.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 160.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.2 149.31 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 150.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 19.5 t -127.93 163.56 24.21 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.898 1.226 . . . . 0.0 109.771 160.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.6 t -145.53 125.91 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.49 1.516 . . . . 0.0 107.137 -166.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.06 63.34 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.14 97.19 9.21 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.34 -31.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.128 0.571 . . . . 0.0 110.106 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.5 mt -60.26 120.31 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.537 1.135 . . . . 0.0 110.145 -159.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.41 -15.41 1.65 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.68 1.133 . . . . 0.0 112.479 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -100.22 -35.8 9.51 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.722 1.261 . . . . 0.0 110.461 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -87.92 19.97 3.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.024 1.73 . . . . 0.0 111.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -46.12 -33.43 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.677 1.126 . . . . 0.0 114.023 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -102.67 -45.32 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.518 2.327 . . . . 0.0 110.196 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.27 -21.52 63.88 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.1 m -56.17 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.522 1.529 . . . . 0.0 111.331 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -84.16 -84.18 0.14 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.12 0.568 . . . . 0.0 110.051 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -60.52 -13.58 14.71 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.306 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.77 -51.44 65.7 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 120.885 1.675 . . . . 0.0 111.61 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.4 mp -52.11 -22.02 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 112.466 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.0 -58.97 2.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.719 -1.238 . . . . 0.0 108.713 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.46 -50.6 72.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.427 1.491 . . . . 0.0 111.594 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 t -61.56 -47.53 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.379 1.072 . . . . 0.0 108.412 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -57.7 -38.55 75.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -39.88 81.21 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.307 0.958 . . . . 0.0 110.758 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -71.03 -39.59 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.94 -14.32 61.88 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.31 1.044 . . . . 0.0 111.776 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -63.07 -50.1 71.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 120.396 1.453 . . . . 0.0 110.038 164.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -60.13 134.33 90.47 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.63 -33.91 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.878 1.719 . . . . 0.0 112.763 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.74 7.68 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 118.346 -1.252 . . . . 0.0 110.781 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 51.8 m -48.51 115.5 1.25 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.097 1.359 . . . . 0.0 111.286 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.1 mt -96.25 85.91 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 102.781 -3.044 . . . . 0.0 102.781 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.1 mm -52.91 117.85 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.65 146.75 25.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 144.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.19 156.62 27.07 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 156.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -91.31 149.48 21.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.3 pt -136.33 163.02 53.01 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.837 2.055 . . . . 0.0 108.72 166.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.51 165.01 23.34 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.34 2.693 . . . . 0.0 110.443 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.29 149.16 97.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.008 -1.058 . . . . 0.0 109.544 162.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.0 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.104 2.536 . . . . 0.0 109.354 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt 48.34 38.38 10.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.801 1.64 . . . . 0.0 112.872 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.59 -121.01 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 159.61 83.05 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 117.118 0.459 . . . . 0.0 110.145 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.49 166.61 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.95 1.766 . . . . 0.0 107.931 159.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.4 -163.86 1.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.85 -61.34 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.128 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -51.75 19.99 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.04 -22.7 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.74 1.155 . . . . 0.0 111.748 -169.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -42.16 80.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.564 2.346 . . . . 0.0 111.866 171.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.314 0.3 OUTLIER -58.53 -53.35 59.29 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 121.862 0.839 . . . . 0.0 110.006 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 5.3 mt -67.98 -26.54 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.793 0.837 . . . . 0.0 111.2 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -70.73 -20.51 62.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 120.345 -1.472 . . . . 0.0 111.422 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.2 -14.57 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 111.504 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -81.72 85.38 6.61 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -63.05 -20.46 65.35 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 111.714 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.29 -35.17 59.81 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.065 1.746 . . . . 0.0 113.236 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.26 124.1 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.4 1.48 . . . . 0.0 110.854 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -59.11 147.42 35.06 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.56 97.61 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -85.04 104.11 14.67 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.479 1.911 . . . . 0.0 108.203 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.55 103.0 13.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.309 1.443 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.53 163.02 4.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.665 1.222 . . . . 0.0 111.411 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.26 134.9 45.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.566 2.347 . . . . 0.0 106.16 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -46.55 -30.2 2.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.519 1.128 . . . . 0.0 111.489 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.06 -31.14 72.22 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 125.378 1.673 . . . . 0.0 110.591 -172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -131.7 18.29 4.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.026 1.33 . . . . 0.0 111.037 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -60.51 -21.88 62.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -167.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -102.02 11.73 37.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.08 1.352 . . . . 0.0 113.416 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -127.25 24.16 6.34 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.345 1.058 . . . . 0.0 110.973 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.596 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -83.5 -12.02 56.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.511 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.0 tt -47.11 -57.34 9.53 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.566 1.946 . . . . 0.0 112.068 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.43 -22.95 24.27 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 121.56 1.593 . . . . 0.0 113.08 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.61 -45.97 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.8 mt -63.78 -52.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.49 1.516 . . . . 0.0 109.441 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -55.56 -45.53 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.3 1.409 . . . . 0.0 109.654 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.3 m -56.92 -43.49 81.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.604 1.162 . . . . 0.0 110.366 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.8 t -65.35 -38.73 90.98 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.098 0.959 . . . . 0.0 111.855 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.64 -51.61 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 119.234 0.925 . . . . 0.0 108.833 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -66.59 -12.74 59.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.314 -0.851 . . . . 0.0 112.638 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 86.2 p -48.09 -45.17 32.36 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.757 1.223 . . . . 0.0 111.167 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.339 1 C-N-CA 133.283 4.633 . . . . 0.0 115.775 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -34.18 138.84 0.08 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.29 3.036 . . . . 0.0 111.194 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 t -131.38 141.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.03 143.98 47.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.956 0.902 . . . . 0.0 109.435 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.14 151.08 24.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.695 0.798 . . . . 0.0 110.778 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -156.67 -177.87 6.92 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 123.315 0.384 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.45 -141.08 13.87 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.275 2.369 . . . . 0.0 109.443 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.31 145.14 64.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.963 1.776 . . . . 0.0 111.109 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.28 160.56 44.78 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.27 1.98 . . . . 0.0 110.259 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.95 4.23 7.15 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.072 1.32 . . . . 0.0 115.795 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 5.8 p -74.16 22.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 119.67 1.735 . . . . 0.0 115.472 -160.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.18 -0.33 78.33 Favored Glycine 0 N--CA 1.464 0.545 0 O-C-N 120.013 -1.679 . . . . 0.0 112.062 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -21.15 64.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.944 1.298 . . . . 0.0 113.73 -171.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -50.36 -37.25 36.15 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 120.026 1.285 . . . . 0.0 110.666 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.4 m -57.03 -36.28 70.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.95 1.7 . . . . 0.0 113.51 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -52.44 32.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -36.0 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 O-C-N 122.088 -0.382 . . . . 0.0 111.085 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -54.21 -51.87 63.05 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -54.64 -43.0 71.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.286 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -33.74 68.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.998 1.272 . . . . 0.0 111.476 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -68.18 -53.78 22.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.99 -34.08 77.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.5 1.12 . . . . 0.0 112.59 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -62.86 -49.27 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.45 1.5 . . . . 0.0 110.733 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.5 -40.92 98.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.8 -42.37 98.92 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.47 69.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 112.407 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -83.23 -0.62 50.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.971 -1.08 . . . . 0.0 112.136 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.02 36.08 57.3 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.786 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.77 109.13 40.09 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.3 143.92 78.69 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.88 132.52 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.55 174.51 5.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.512 1.525 . . . . 0.0 107.667 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.16 -161.76 23.1 Favored Glycine 0 CA--C 1.508 -0.402 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.79 163.72 37.94 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 117.343 0.571 . . . . 0.0 111.444 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -138.28 168.34 19.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.4 p -109.87 91.32 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.58 -4.26 22.24 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.919 -1.113 . . . . 0.0 113.664 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 84.14 167.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 130.61 3.564 . . . . 0.0 110.357 -158.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.14 118.54 11.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 164.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -111.03 148.33 32.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 163.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -142.66 116.77 9.45 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 156.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.18 26.84 64.25 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.965 0.802 . . . . 0.0 111.486 -166.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.74 -20.0 2.45 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.411 1.325 . . . . 0.0 116.411 172.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.79 7.35 2.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.073 2.437 . . . . 0.0 116.498 -157.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.651 1.98 . . . . 0.0 110.998 -165.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.63 -11.63 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.732 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.84 -147.19 16.73 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.341 -1.903 . . . . 0.0 108.341 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -141.7 163.18 33.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.554 1.542 . . . . 0.0 109.551 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -120.36 166.23 13.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.935 1.694 . . . . 0.0 106.839 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.47 104.9 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 123.849 0.859 . . . . 0.0 108.717 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.5 117.55 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -164.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 p -66.19 161.84 21.16 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 109.293 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.87 -1.32 6.98 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.83 -1.169 . . . . 0.0 112.324 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -105.14 7.21 33.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.475 1.91 . . . . 0.0 112.479 168.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.28 6.59 83.78 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 120.385 -1.447 . . . . 0.0 115.015 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 149.63 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 156.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -150.45 149.57 30.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.108 1.322 . . . . 0.0 111.041 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.8 158.74 18.43 Favored Glycine 0 C--O 1.22 -0.768 0 CA-C-O 116.879 -2.067 . . . . 0.0 111.325 -172.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.95 9.79 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.457 3.438 . . . . 0.0 113.791 -164.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 24.54 -74.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 131.415 3.886 . . . . 0.0 116.301 171.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 p -136.44 143.25 43.81 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 164.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.48 67.87 0.46 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.508 0.594 . . . . 0.0 110.039 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.5 t 48.66 134.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 130.348 3.459 . . . . 0.0 114.798 -172.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.34 52.79 0.49 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 53.5 -178.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.227 1.811 . . . . 0.0 111.783 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -80.91 158.35 70.45 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 159.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.03 140.14 14.02 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.153 2.568 . . . . 0.0 110.356 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.21 175.29 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.992 3.128 . . . . 0.0 110.578 165.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.63 150.87 86.03 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.021 1.147 . . . . 0.0 109.27 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.86 -73.26 0.66 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.059 0.837 . . . . 0.0 112.582 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 115.45 5.03 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.232 1.016 . . . . 0.0 109.049 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -173.62 153.37 2.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.89 2.076 . . . . 0.0 106.785 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.75 -27.61 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 151.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 65.8 m -152.13 143.59 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.622 1.569 . . . . 0.0 109.442 -170.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.65 139.32 4.49 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.29 85.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 172.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.38 -67.2 0.25 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.092 1.806 . . . . 0.0 112.041 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -144.72 -18.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.368 2.267 . . . . 0.0 113.402 -167.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -106.57 125.81 51.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.84 130.98 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 167.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.62 168.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.449 1.022 . . . . 0.0 108.598 165.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.11 111.13 14.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.71 -31.53 66.5 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.689 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.2 m -60.81 -38.15 84.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.707 1.603 . . . . 0.0 111.493 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.7 m -58.84 -36.38 74.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.7 1.136 . . . . 0.0 110.446 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.34 -49.8 65.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.074 0.95 . . . . 0.0 111.478 171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -53.38 -25.44 15.53 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.161 0.891 . . . . 0.0 113.1 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.68 -50.84 65.4 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.237 1.38 . . . . 0.0 111.934 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -134.18 -25.59 1.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.773 -166.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.55 59.61 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.275 1.398 . . . . 0.0 109.402 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mp -49.9 -45.96 80.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.095 -1.431 . . . . 0.0 114.045 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.87 -27.33 7.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 CA-C-N 121.733 1.655 . . . . 0.0 113.834 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.3 -29.75 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.737 1.153 . . . . 0.0 111.26 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.7 34.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.021 2.128 . . . . 0.0 111.007 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 94' ' ' VAL 0.275 4.8 mmm-85 173.84 -134.7 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 130.851 3.66 . . . . 0.0 107.238 -164.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 . . . . . 0 N--CA 1.438 -1.031 0 C-N-CA 126.041 1.736 . . . . 0.0 111.408 -153.613 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.37 163.76 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.84 145.2 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 168.01 10.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.421 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.11 129.46 50.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.367 1.067 . . . . 0.0 108.32 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -133.56 67.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -79.83 67.94 5.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.869 0.868 . . . . 0.0 109.706 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -95.06 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.286 78.6 mt 41.45 53.57 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 128.117 2.567 . . . . 0.0 109.864 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.66 -61.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 121.466 -0.771 . . . . 0.0 112.396 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -20.69 64.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.42 2.11 . . . . 0.0 113.613 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.77 18.02 21.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.615 1.566 . . . . 0.0 109.713 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.54 -18.17 2.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -166.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.41 -30.49 8.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.105 0.866 . . . . 0.0 111.321 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -90.21 -20.02 23.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.368 1.067 . . . . 0.0 112.669 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m -59.83 103.92 0.25 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.579 0.752 . . . . 0.0 110.792 -166.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.81 -81.72 0.47 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.256 0.935 . . . . 0.0 111.821 -163.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.93 -10.05 8.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.028 1.731 . . . . 0.0 112.28 169.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.53 -61.77 1.85 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.327 1.451 . . . . 0.0 110.901 174.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.454 HD11 ' H ' ' A' ' 125' ' ' ILE . 3.2 mp -38.08 -64.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.841 2.056 . . . . 0.0 112.16 172.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -53.75 54.6 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.406 0.548 . . . . 0.0 110.012 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.76 72.64 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.44 -173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.09 -55.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.296 1.839 . . . . 0.0 109.275 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -62.98 -36.5 83.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.957 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.9 -44.84 88.3 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.122 0.874 . . . . 0.0 110.068 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.1 m -65.74 -34.83 79.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.094 0.957 . . . . 0.0 111.003 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.61 -30.31 69.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.429 1.492 . . . . 0.0 112.104 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.3 m -107.9 14.29 25.49 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.626 1.57 . . . . 0.0 112.082 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.4 m -76.97 133.78 69.01 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -77.33 109.5 2.81 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 108.096 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 125.1 -87.42 0.37 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 107.246 -2.342 . . . . 0.0 107.246 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 m -43.83 146.24 0.6 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.847 1.659 . . . . 0.0 112.375 -171.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.95 107.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 134.66 26.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.45 142.48 50.78 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 163.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.97 172.24 45.31 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 120.741 -1.224 . . . . 0.0 110.673 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.9 m -121.62 135.49 54.98 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.724 1.21 . . . . 0.0 108.403 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.1 pt -125.93 151.18 70.99 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.911 1.684 . . . . 0.0 110.156 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.82 150.57 49.93 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 109.194 169.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.85 118.92 59.57 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 123.112 0.565 . . . . 0.0 110.596 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.14 117.72 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.102 2.534 . . . . 0.0 107.63 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -152.92 -35.03 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.199 0.999 . . . . 0.0 110.624 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.64 -152.9 6.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 164.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 140.34 93.81 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.543 -0.975 . . . . 0.0 109.726 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.33 120.11 4.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.812 3.675 . . . . 0.0 111.407 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.0 155.88 38.13 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.827 1.651 . . . . 0.0 113.123 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.31 -60.21 2.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.886 2.074 . . . . 0.0 113.802 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.13 -47.07 86.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.59 -41.03 52.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.09 -36.15 74.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.94 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -55.16 -49.27 72.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.944 1.247 . . . . 0.0 110.035 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.82 -46.13 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.069 0.548 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -39.49 74.74 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.402 1.081 . . . . 0.0 109.55 -174.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -60.05 -23.51 63.8 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.123 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -63.41 -42.15 98.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.576 1.08 . . . . 0.0 111.624 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 8.9 mmpt? 61.91 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.591 2.356 . . . . 0.0 115.055 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -28.63 67.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.448 1.022 . . . . 0.0 110.911 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.32 123.92 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.193 0.997 . . . . 0.0 108.845 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -71.08 106.21 3.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.5 t -84.25 95.53 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -83.46 112.95 20.42 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.55 120.61 17.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.68 164.61 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 82.8 p -122.28 163.2 20.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.07 -21.57 64.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.788 -1.195 . . . . 0.0 109.805 161.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -79.9 -47.84 14.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.67 0.788 . . . . 0.0 111.097 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.93 32.01 5.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.939 1.696 . . . . 0.0 110.433 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -48.52 -59.86 3.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.249 1.419 . . . . 0.0 109.668 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -76.63 4.15 10.04 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -116.92 4.61 12.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.002 1.721 . . . . 0.0 110.878 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -40.22 27.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.307 0.503 . . . . 0.0 112.044 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.79 -57.92 0.73 Allowed Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 126.177 1.791 . . . . 0.0 110.222 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.08 -25.21 44.08 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.203 1.936 . . . . 0.0 114.994 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.14 -38.79 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.061 -1.025 . . . . 0.0 109.587 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.9 mt -62.65 -47.95 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.38 -40.93 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.76 1.224 . . . . 0.0 110.443 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.8 m -65.13 -43.26 92.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.247 1.019 . . . . 0.0 110.04 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 10.3 t -68.61 -33.24 73.69 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.096 -1.002 . . . . 0.0 112.229 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.8 t -63.07 -64.91 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -35.86 80.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.078 -171.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 t -24.47 -86.28 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.942 2.897 . . . . 0.0 113.563 -165.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.462 0.171 0 C-N-CA 127.921 2.488 . . . . 0.0 113.198 177.271 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 . . . . . 0 C--O 1.235 0.336 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 151.79 40.53 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.37 155.95 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 109.082 170.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -142.2 165.04 28.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.289 1.036 . . . . 0.0 109.81 171.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.96 150.39 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.188 2.195 . . . . 0.0 108.736 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -156.16 -162.76 1.34 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.86 -174.07 26.28 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.18 1.848 . . . . 0.0 112.251 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.25 149.76 81.47 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.443 2.762 . . . . 0.0 111.477 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.16 119.42 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.071 2.514 . . . . 0.0 109.307 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.48 -17.15 27.33 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 117.927 -1.485 . . . . 0.0 110.583 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 64.85 113.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.051 1.74 . . . . 0.0 109.164 -169.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.39 65.86 0.75 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -97.94 -33.47 11.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.16 0.584 . . . . 0.0 110.841 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -53.28 -38.5 63.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.92 2.088 . . . . 0.0 111.983 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.9 m -62.92 -40.64 98.22 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.581 -0.699 . . . . 0.0 112.609 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -45.37 87.34 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 120.253 -1.53 . . . . 0.0 108.041 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 mm -55.56 -46.83 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.875 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -54.52 -50.9 66.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.178 1.354 . . . . 0.0 108.996 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -50.54 -43.91 56.26 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 110.627 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.6 69.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.069 0.849 . . . . 0.0 111.232 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.487 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.26 -39.32 69.65 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.001 0.92 . . . . 0.0 111.326 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.64 -48.94 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 O-C-N 121.451 -0.781 . . . . 0.0 109.745 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.4 mt -60.56 -41.44 94.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -60.58 -41.43 94.66 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -68.59 -25.27 64.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.046 1.338 . . . . 0.0 112.652 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -73.07 -24.23 60.65 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.928 173.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.69 2.75 10.42 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.124 1.821 . . . . 0.0 113.418 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.7 t -88.17 122.97 69.5 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.452 1.626 . . . . 0.0 109.616 -161.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.83 84.93 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.549 2.166 . . . . 0.0 109.001 161.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.13 141.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 125.48 1.512 . . . . 0.0 107.561 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -127.1 175.47 8.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.289 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.85 -160.88 16.16 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 120.623 1.556 . . . . 0.0 111.42 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.27 154.63 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.363 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -119.56 178.78 4.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.688 1.595 . . . . 0.0 106.903 165.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -143.38 144.25 31.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 168.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.92 161.03 36.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 109.914 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.37 129.92 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.505 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.95 97.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -117.74 97.99 6.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.995 1.718 . . . . 0.0 106.461 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -64.21 99.45 0.28 Allowed 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.82 -59.57 2.58 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.483 1.04 . . . . 0.0 111.568 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.67 40.77 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.362 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -127.8 132.28 49.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -63.08 114.61 3.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 -23.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.704 0.802 . . . . 0.0 112.876 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.95 -170.86 42.14 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 120.261 1.391 . . . . 0.0 111.716 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -119.32 170.08 9.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 157.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.265 31.4 p30 -129.85 159.75 35.62 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.114 -0.367 . . . . 0.0 110.798 158.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.51 109.92 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.33 113.77 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 p -80.04 157.38 26.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.9 3.36 3.36 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.016 -1.052 . . . . 0.0 112.44 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.4 m -72.41 -11.51 60.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.198 0.999 . . . . 0.0 111.942 160.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.15 76.77 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.289 -0.882 . . . . 0.0 111.943 -167.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -102.76 154.81 18.81 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 141.35 30.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.069 0.85 . . . . 0.0 111.0 -163.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.24 142.12 13.25 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 74.9 1.98 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 125.075 3.85 . . . . 0.0 111.405 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.536 ' N ' ' HG ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -49.16 -49.66 41.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.195 0.998 . . . . 0.0 110.18 -177.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.446 ' HG ' ' CA ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -146.41 126.06 13.37 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -144.64 92.96 2.35 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.433 4.0 m 34.86 -126.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 113.606 -174.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.02 149.32 12.48 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 120.181 1.355 . . . . 0.0 110.991 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.77 152.19 32.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -77.35 164.67 56.99 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.109 0.964 . . . . 0.0 110.009 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.98 124.49 8.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.376 2.05 . . . . 0.0 107.151 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -66.24 169.92 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.949 1.766 . . . . 0.0 108.957 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.39 119.22 6.21 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.748 1.632 . . . . 0.0 108.268 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.11 -68.71 0.54 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.621 1.105 . . . . 0.0 110.705 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -68.02 149.87 49.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 1.151 . . . . 0.0 109.013 178.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.16 156.91 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 164.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.427 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 13.9 pt-20 -158.05 -163.19 1.26 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.545 1.938 . . . . 0.0 106.839 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.18 -165.94 1.38 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.052 1.341 . . . . 0.0 108.952 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? 146.62 140.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.104 3.362 . . . . 0.0 107.428 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.22 -24.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.75 104.76 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 107.071 -2.412 . . . . 0.0 107.071 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 65.31 -55.42 0.32 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 129.031 2.932 . . . . 0.0 111.828 -163.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -84.52 137.69 33.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.777 0.831 . . . . 0.0 110.624 -168.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.07 110.91 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 172.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 ' CA ' ' HG ' ' A' ' 62' ' ' SER . 1.4 p -71.46 162.89 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -143.8 125.2 14.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 167.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.93 -26.37 65.9 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.943 0.897 . . . . 0.0 111.668 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -55.31 -35.24 64.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.778 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.536 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 22.8 t -60.86 -40.11 91.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.119 0.872 . . . . 0.0 110.521 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -61.27 -50.93 71.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.557 0.617 . . . . 0.0 109.341 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.49 -21.41 62.37 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.92 -45.67 91.82 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.747 0.703 . . . . 0.0 111.843 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.31 -28.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -161.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.26 20.59 1.59 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.628 1.171 . . . . 0.0 110.416 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.561 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -121.9 -47.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.973 2.509 . . . . 0.0 112.682 -172.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.561 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -64.3 -25.14 64.48 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.65 1.566 . . . . 0.0 111.203 166.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.0 -29.08 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.497 -0.752 . . . . 0.0 113.007 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 mm? -62.7 -51.47 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.906 0.775 . . . . 0.0 109.534 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -127.47 99.23 5.53 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 p30 . . . . . 0 N--CA 1.444 -0.757 0 C-N-CA 124.847 1.259 . . . . 0.0 111.445 179.158 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -140.2 177.63 7.85 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.458 1.903 . . . . 0.0 108.371 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.5 t -133.95 147.22 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 168.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.2 162.19 17.84 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.1 0.96 . . . . 0.0 110.047 172.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.19 130.61 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.003 1.721 . . . . 0.0 107.421 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.3 mt -149.12 106.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -98.32 177.23 5.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.272 -1.518 . . . . 0.0 108.52 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.01 27.65 15.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.406 2.682 . . . . 0.0 113.402 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.59 98.15 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.95 -77.91 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-O 118.795 -1.003 . . . . 0.0 110.748 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -53.97 -30.26 46.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.782 1.233 . . . . 0.0 113.913 -164.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -64.19 -16.17 61.41 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 126.387 1.875 . . . . 0.0 112.156 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -24.31 -59.6 0.05 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.573 2.749 . . . . 0.0 116.2 -163.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.82 -34.8 67.08 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.921 1.288 . . . . 0.0 111.904 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -81.15 -27.68 35.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.702 1.601 . . . . 0.0 111.613 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.6 m -52.09 110.52 0.49 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.467 1.507 . . . . 0.0 109.233 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.67 -8.56 0.49 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.97 -31.35 2.89 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 125.717 1.607 . . . . 0.0 108.996 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -27.64 -73.73 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 129.102 2.961 . . . . 0.0 110.928 164.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.404 HD11 ' H ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -34.33 -63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 128.22 2.608 . . . . 0.0 113.84 172.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.05 -43.05 83.68 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.866 1.212 . . . . 0.0 111.175 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.53 99.42 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.461 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.72 -36.45 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.006 0.922 . . . . 0.0 109.394 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.19 -26.75 63.17 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.232 -1.543 . . . . 0.0 113.941 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -55.49 -56.95 14.29 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.523 1.056 . . . . 0.0 108.91 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 m -66.78 -34.73 78.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.631 1.572 . . . . 0.0 112.489 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.85 -27.81 69.12 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.492 -0.755 . . . . 0.0 109.743 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 t -85.74 -23.6 27.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.709 1.603 . . . . 0.0 111.614 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.8 m -58.38 139.03 85.01 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.2 1.364 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -86.21 107.27 0.84 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.768 2.979 . . . . 0.0 109.16 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 128.87 -43.33 1.33 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.603 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.2 m -57.13 157.54 5.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.158 1.479 . . . . 0.0 110.579 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.22 102.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.91 129.73 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 166.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.25 111.65 11.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.56 174.82 25.41 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.086 0.857 . . . . 0.0 113.08 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.0 m -117.54 122.07 42.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.391 1.096 . . . . 0.0 110.092 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.51 143.25 29.03 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.618 1.167 . . . . 0.0 109.094 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.59 141.25 54.53 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.017 1.811 . . . . 0.0 108.393 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.13 114.5 12.82 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.5 149.55 27.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.367 2.711 . . . . 0.0 109.063 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -140.67 -72.11 0.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.694 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.76 -66.1 2.64 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 146.8 54.65 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 117.639 0.719 . . . . 0.0 109.44 174.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.83 161.26 21.36 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.929 2.419 . . . . 0.0 107.976 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.14 155.8 17.25 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -38.9 -50.89 1.76 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.316 2.246 . . . . 0.0 114.146 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.17 -38.19 31.82 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.063 0.545 . . . . 0.0 109.976 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.12 -17.46 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.287 -1.508 . . . . 0.0 110.279 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.64 -61.73 1.75 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.799 -1.188 . . . . 0.0 109.634 161.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.325 0.2 OUTLIER -53.73 -54.35 39.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.092 0.948 . . . . 0.0 112.709 -174.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.27 -30.8 49.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 124.903 1.281 . . . . 0.0 111.788 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -31.29 70.66 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.118 -0.989 . . . . 0.0 110.888 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.27 -6.73 31.24 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.484 0.584 . . . . 0.0 110.718 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -69.24 -30.28 68.38 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.368 -0.833 . . . . 0.0 112.878 170.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -43.67 0.28 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.355 2.262 . . . . 0.0 115.322 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -89.46 64.1 6.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.375 2.27 . . . . 0.0 108.638 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.58 122.95 48.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -65.23 110.51 2.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 158.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 m -96.94 88.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 180' ' ' ILE . 19.4 m-85 -61.2 101.58 0.17 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.505 1.122 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.32 93.73 1.53 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.11 166.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.0 p -131.72 162.45 30.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 165.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -61.07 -30.7 70.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.733 -0.604 . . . . 0.0 109.393 159.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.82 -67.07 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.348 1.859 . . . . 0.0 110.266 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.0 33.57 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.891 1.676 . . . . 0.0 110.141 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -56.42 -62.82 1.46 Allowed 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.028 -1.045 . . . . 0.0 111.066 -170.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.77 3.29 12.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.82 -1.24 56.94 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.66 1.584 . . . . 0.0 111.364 172.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.37 -32.23 19.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 118.822 -1.151 . . . . 0.0 112.369 -172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.4 -58.31 3.06 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.739 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.87 -21.92 27.7 Favored 'Trans proline' 0 C--N 1.354 0.85 0 CA-C-N 121.383 1.529 . . . . 0.0 112.798 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -40.66 75.69 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.662 1.985 . . . . 0.0 109.005 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.516 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 4.3 mt -66.76 -50.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.212 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 184' ' ' VAL . 42.0 t -50.9 -29.94 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.741 1.617 . . . . 0.0 109.473 174.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.8 m -75.09 -18.32 60.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 119.999 -1.688 . . . . 0.0 112.973 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -52.71 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -56.61 -60.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.694 1.998 . . . . 0.0 109.453 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.64 -22.02 61.29 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.069 -1.02 . . . . 0.0 113.19 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 37.1 m -73.08 -59.76 2.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.906 0.882 . . . . 0.0 111.316 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.837 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 8.4 tpp180 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.44 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 83.3 m-70 -51.32 156.08 1.27 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.613 1.565 . . . . 0.0 111.076 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -129.94 142.13 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -135.55 158.34 44.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 160.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mt -93.21 150.62 20.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -154.41 -172.48 4.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.28 -175.12 24.59 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.971 1.272 . . . . 0.0 110.951 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.12 162.02 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.239 2.626 . . . . 0.0 111.557 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.02 153.95 67.19 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.288 1.325 . . . . 0.0 109.481 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.33 -5.64 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 126.61 2.052 . . . . 0.0 110.712 162.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.26 30.2 t 67.1 126.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.616 1.198 . . . . 0.0 110.527 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.41 -9.94 10.8 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.27 164.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -54.9 -31.12 59.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.224 1.012 . . . . 0.0 111.141 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -56.48 -35.72 68.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.646 1.578 . . . . 0.0 110.31 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -67.44 -24.23 65.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.301 -1.499 . . . . 0.0 113.09 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -55.22 20.48 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 170.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -57.05 -46.07 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.319 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -47.83 -57.79 5.18 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.736 0.814 . . . . 0.0 110.023 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -62.57 -40.8 98.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.67 55.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.089 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 p -71.59 -47.81 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.976 1.262 . . . . 0.0 109.97 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.9 -36.42 74.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 110.727 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.45 -53.03 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 125.383 1.473 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -57.81 -42.4 84.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -63.05 -36.31 83.14 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.351 0.26 . . . . 0.0 110.661 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 m -77.37 -10.78 59.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.586 1.954 . . . . 0.0 112.714 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.9 m -100.08 6.08 44.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.627 2.371 . . . . 0.0 111.676 168.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.47 11.79 84.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.708 -1.051 . . . . 0.0 114.633 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.51 139.06 44.28 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 119.557 1.678 . . . . 0.0 109.242 -170.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.82 89.6 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.91 3.073 . . . . 0.0 111.608 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.93 148.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.154 1.382 . . . . 0.0 109.297 172.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -147.53 -176.0 5.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.044 2.138 . . . . 0.0 109.984 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.43 -156.81 17.8 Favored Glycine 0 C--O 1.24 0.514 0 C-N-CA 127.88 2.657 . . . . 0.0 108.138 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.52 171.3 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.976 0.888 . . . . 0.0 110.231 171.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -137.08 -178.41 5.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 165.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.5 p -130.41 154.32 47.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 160.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.47 13.69 3.78 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 112.63 -172.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.275 12.6 pt-20 50.65 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 127.1 2.16 . . . . 0.0 110.783 -156.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.11 138.61 22.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -122.97 164.81 17.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.668 1.187 . . . . 0.0 108.404 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.67 96.67 2.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.34 -66.45 1.49 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.61 12.11 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.652 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.96 143.17 47.19 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 118.597 1.198 . . . . 0.0 109.1 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -63.09 154.75 29.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 124.671 1.232 . . . . 0.0 108.873 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.3 -13.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.791 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.27 -142.82 8.94 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.141 -2.383 . . . . 0.0 107.141 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -142.35 66.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.229 1.515 . . . . 0.0 110.602 -172.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -53.15 143.88 16.91 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.55 114.85 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 118.568 0.622 . . . . 0.0 109.559 -160.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.33 109.68 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -150.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -59.87 146.02 43.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.02 -11.51 39.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.278 168.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 -14.56 61.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.516 1.926 . . . . 0.0 111.618 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' C ' ' HG1' ' A' ' 57' ' ' THR . . . 82.61 67.82 1.47 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 119.412 1.005 . . . . 0.0 111.148 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 56' ' ' GLY . 10.1 m -157.32 151.43 24.73 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.707 3.203 . . . . 0.0 104.706 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 154.44 44.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 121.278 1.853 . . . . 0.0 109.714 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.02 156.86 19.78 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.083 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.98 54.32 4.82 Favored 'Trans proline' 0 CA--C 1.539 0.762 1 C-N-CA 125.695 4.264 . . . . 0.0 113.21 -173.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -51.44 -52.36 46.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.656 1.582 . . . . 0.0 111.137 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 p -150.16 133.05 16.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.34 43.15 0.52 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.351 0.26 . . . . 0.0 110.624 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t 60.43 154.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 129.045 2.938 . . . . 0.0 110.641 -167.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.02 160.1 31.7 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 105.481 -3.048 . . . . 0.0 105.481 166.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.28 164.78 12.77 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.006 0.908 . . . . 0.0 110.461 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -63.83 148.65 94.42 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.134 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.32 133.24 17.41 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.452 2.768 . . . . 0.0 110.184 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.34 174.26 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.347 2.698 . . . . 0.0 110.875 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.4 -24.69 64.05 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.095 1.196 . . . . 0.0 113.282 -176.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.22 -1.68 47.95 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.698 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -148.06 143.98 27.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.137 1.969 . . . . 0.0 108.581 -172.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.01 149.89 27.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' HE2' ' A' ' 72' ' ' LYS . 22.2 mt-10 -132.47 162.36 31.36 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.359 1.863 . . . . 0.0 109.537 168.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.71 136.26 57.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.687 1.195 . . . . 0.0 109.211 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.39 154.64 41.86 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.263 -172.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.96 119.74 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.25 -107.3 1.64 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.49 -10.76 15.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 112.868 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.09 140.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.87 163.22 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 160.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.55 173.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 O-C-N 120.501 -1.374 . . . . 0.0 109.889 171.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.77 98.71 4.25 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.89 -35.7 71.37 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.101 -0.999 . . . . 0.0 110.701 173.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -66.35 -30.63 71.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.616 0.766 . . . . 0.0 109.966 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.8 t -62.01 -23.91 66.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 120.041 1.291 . . . . 0.0 111.891 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -73.09 -62.73 1.36 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.24 -13.7 13.94 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -53.82 -42.71 68.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 111.623 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.64 -35.67 0.49 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.052 0.541 . . . . 0.0 112.242 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 63.67 4.46 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -65.25 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 127.708 2.403 . . . . 0.0 105.766 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 -18.11 36.93 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.383 2.055 . . . . 0.0 114.348 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 95' ' ' LEU . 20.0 m -67.5 -64.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.595 1.089 . . . . 0.0 108.697 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.402 ' H ' ' CG2' ' A' ' 94' ' ' VAL . 76.5 mt -45.62 -56.13 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.657 2.383 . . . . 0.0 108.506 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.16 89.16 3.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.13 0.491 . . . . 0.0 110.742 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.442 -0.864 0 C-N-CA 118.044 -1.463 . . . . 0.0 107.62 158.556 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 . . . . . 0 CA--C 1.525 0.006 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -124.6 164.77 19.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.899 1.68 . . . . 0.0 107.209 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -124.42 141.4 44.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.14 128.95 22.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.486 1.514 . . . . 0.0 107.138 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.52 68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.19 -168.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.81 18.85 0.55 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.037 1.735 . . . . 0.0 114.634 -171.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -67.51 129.47 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 119.327 -2.108 . . . . 0.0 107.404 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.05 -75.63 0.22 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-O 119.496 -0.614 . . . . 0.0 112.141 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -64.54 -26.9 68.62 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.074 0.937 . . . . 0.0 112.022 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.8 mmm -63.66 -7.68 8.06 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 116.55 -1.69 . . . . 0.0 114.03 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -42.23 -44.73 3.89 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.519 1.963 . . . . 0.0 114.517 -165.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.51 -39.1 28.51 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.422 0.689 . . . . 0.0 111.736 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -84.06 -21.21 31.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.24 1.016 . . . . 0.0 110.987 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.493 ' HG ' ' CD1' ' A' ' 125' ' ' ILE . 17.2 t -42.16 123.09 2.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 129.762 3.225 . . . . 0.0 110.569 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.45 -88.61 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 107.605 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.88 -1.86 8.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.587 -0.72 . . . . 0.0 112.131 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -71.82 0.11 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.654 1.115 . . . . 0.0 110.188 160.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CD1' ' HG ' ' A' ' 121' ' ' SER . 3.4 mp -46.33 -31.42 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 126.002 1.721 . . . . 0.0 113.105 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -60.56 2.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 120.664 -1.273 . . . . 0.0 112.813 171.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.26 67.23 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 111.828 -166.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.86 -51.17 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -57.78 -40.14 79.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 120.301 1.41 . . . . 0.0 113.412 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -56.73 -20.53 22.5 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.313 1.045 . . . . 0.0 112.515 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -108.71 -27.87 9.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.977 1.311 . . . . 0.0 110.234 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.187 1.395 . . . . 0.0 111.633 168.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.7 t -58.3 -44.68 88.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.477 0.711 . . . . 0.0 109.442 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.1 m -77.3 133.43 68.15 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.92 -30.04 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.439 2.76 . . . . 0.0 111.3 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.75 -65.38 3.62 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.712 2.101 . . . . 0.0 111.634 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.1 m -59.46 143.33 50.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.91 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.19 96.8 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mm -56.7 130.9 19.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 142.33 50.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.726 2.411 . . . . 0.0 105.304 167.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.37 175.28 45.58 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.281 0.946 . . . . 0.0 110.945 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.1 m -115.94 94.64 4.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.151 1.476 . . . . 0.0 113.105 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.84 122.44 67.95 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.094 -1.004 . . . . 0.0 111.91 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.12 153.13 67.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.827 1.684 . . . . 0.0 110.532 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.84 151.88 95.13 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 122.057 -0.402 . . . . 0.0 110.431 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.15 -55.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.135 3.223 . . . . 0.0 111.907 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 26.17 77.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.48 2.712 . . . . 0.0 110.923 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.03 -111.53 3.13 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 135.03 90.38 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 117.584 0.692 . . . . 0.0 109.654 -170.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.72 171.07 12.67 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.237 1.958 . . . . 0.0 110.619 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.83 160.93 28.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.952 2.501 . . . . 0.0 105.193 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.34 -66.27 0.91 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.852 0.861 . . . . 0.0 110.082 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.18 -46.79 87.48 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.42 0.688 . . . . 0.0 109.203 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.95 -41.68 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.292 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.55 -17.66 60.01 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.593 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -36.08 76.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.686 1.194 . . . . 0.0 108.771 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.72 -52.18 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 109.487 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -23.44 65.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.932 1.293 . . . . 0.0 110.265 -172.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -40.05 13.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 174.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 162' ' ' ASP . 30.0 mtp85 -68.9 -36.09 77.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 123.88 0.872 . . . . 0.0 110.545 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? 60.63 -18.67 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.675 1.99 . . . . 0.0 113.86 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -71.85 48.77 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 1 C-N-CA 133.124 4.569 . . . . 0.0 110.755 173.628 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.77 128.89 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.71 105.45 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 160.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.38 87.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -58.5 100.19 0.06 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 107.64 5.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.05 147.81 10.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.8 p -99.02 166.12 11.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 158.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.83 -14.01 61.85 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 120.002 -1.686 . . . . 0.0 111.031 161.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -88.66 -65.03 1.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.07 0.948 . . . . 0.0 110.416 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.66 29.14 2.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.96 2.104 . . . . 0.0 108.146 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -50.28 -57.02 8.79 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.561 1.144 . . . . 0.0 108.009 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -82.92 17.67 1.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -116.55 48.19 1.32 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.6 tp -129.0 -37.36 1.71 Allowed 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.158 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -55.04 13.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 117.305 -1.331 . . . . 0.0 109.629 176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.64 -26.06 39.91 Favored 'Trans proline' 0 C--N 1.356 0.962 0 CA-C-N 121.926 1.724 . . . . 0.0 113.482 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.49 -45.11 63.37 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.22 1.408 . . . . 0.0 109.85 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.5 mt -54.82 -52.78 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 125.406 1.482 . . . . 0.0 109.19 167.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.74 -44.59 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.458 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.1 m -62.04 -42.23 98.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.564 1.075 . . . . 0.0 109.726 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.4 t -67.03 -44.18 80.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.017 0.826 . . . . 0.0 110.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.56 -53.73 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.595 -0.691 . . . . 0.0 109.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -16.08 63.63 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.997 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -57.29 10.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 -167.427 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -145.73 172.85 12.7 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.447 1.021 . . . . 0.0 110.535 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -58.49 156.28 10.74 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.608 1.963 . . . . 0.0 111.729 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.23 130.56 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.29 139.93 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.413 0.685 . . . . 0.0 111.399 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.52 155.15 33.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.347 1.459 . . . . 0.0 107.991 167.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -152.12 175.84 12.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.86 -163.47 25.02 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.6 146.73 15.29 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.62 2.213 . . . . 0.0 110.321 168.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.77 153.7 77.05 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.722 1.615 . . . . 0.0 109.421 165.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.61 5.83 0.03 OUTLIER Glycine 0 CA--C 1.524 0.63 0 CA-C-O 119.053 -0.859 . . . . 0.0 112.491 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.254 97.1 t 65.56 115.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 127.027 2.131 . . . . 0.0 112.503 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.41 -41.9 0.21 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.962 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -50.18 -31.86 14.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.719 1.607 . . . . 0.0 112.535 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -45.23 -47.27 12.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 129.005 2.922 . . . . 0.0 110.038 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -86.06 -23.99 26.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.774 1.23 . . . . 0.0 110.728 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.07 -37.04 78.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 118.211 -0.9 . . . . 0.0 109.693 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.4 -46.32 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 117.902 -1.046 . . . . 0.0 108.732 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -53.62 -44.82 69.8 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.616 1.553 . . . . 0.0 111.428 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -62.05 -40.28 95.22 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.449 0.7 . . . . 0.0 110.769 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.82 -23.64 65.24 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.426 0.557 . . . . 0.0 112.019 172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 m -89.62 12.06 17.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.072 1.749 . . . . 0.0 112.183 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -113.05 -23.36 10.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.912 1.685 . . . . 0.0 111.838 168.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.44 -44.09 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.273 -0.892 . . . . 0.0 113.199 -161.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.72 -35.4 72.63 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 166.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.19 -39.6 82.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.97 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -70.48 -18.11 62.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.467 0.707 . . . . 0.0 111.21 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -96.03 6.02 49.82 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.155 2.182 . . . . 0.0 111.856 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.4 18.61 75.71 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.281 -0.887 . . . . 0.0 113.518 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.29 100.31 15.18 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.731 2.012 . . . . 0.0 106.758 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.52 90.38 1.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.933 2.422 . . . . 0.0 110.73 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.47 154.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.519 1.928 . . . . 0.0 109.518 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.33 176.6 9.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.085 0.954 . . . . 0.0 110.469 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.91 -149.97 17.08 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.02 1.295 . . . . 0.0 111.147 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -145.4 160.85 40.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.777 0.831 . . . . 0.0 111.697 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -144.18 131.19 20.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.56 1.544 . . . . 0.0 106.96 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 p -74.25 146.7 43.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 117.62 -1.181 . . . . 0.0 107.882 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.57 159.12 35.58 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.605 1.548 . . . . 0.0 109.102 167.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.38 96.01 7.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.565 1.146 . . . . 0.0 107.972 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.56 101.63 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.567 1.175 . . . . 0.0 108.806 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -121.95 84.95 2.33 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 125.758 1.623 . . . . 0.0 108.64 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -58.99 109.67 0.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.71 34.63 21.71 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.652 -0.527 . . . . 0.0 113.129 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.42 38.45 14.63 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.556 1.678 . . . . 0.0 115.273 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 136.09 45.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.357 2.078 . . . . 0.0 107.663 159.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -67.28 111.82 4.2 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.901 0.88 . . . . 0.0 108.872 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 pt -115.62 -10.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.942 0.897 . . . . 0.0 112.483 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -165.4 35.84 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 107.996 -2.041 . . . . 0.0 107.996 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -124.48 167.53 14.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.701 1.6 . . . . 0.0 107.644 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -120.67 -178.83 3.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.544 1.538 . . . . 0.0 109.584 167.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.83 96.34 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 162.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.33 151.0 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 p -115.8 154.6 29.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.43 -6.78 15.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.174 0.897 . . . . 0.0 111.909 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -86.39 3.14 44.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.155 2.582 . . . . 0.0 111.784 171.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.71 5.83 88.37 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.277 -1.515 . . . . 0.0 114.377 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 151.23 30.7 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 169.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 136.79 26.96 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.796 1.18 . . . . 0.0 111.496 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.16 176.41 47.02 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 121.398 0.443 . . . . 0.0 112.945 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.18 167.5 21.8 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 146.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -142.92 -69.98 0.33 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -128.45 161.5 29.35 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.906 0.882 . . . . 0.0 109.936 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -149.7 169.52 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.813 1.245 . . . . 0.0 108.118 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 t -60.29 149.81 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.498 0.719 . . . . 0.0 109.382 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.08 165.2 32.54 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 160.67 16.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.493 1.117 . . . . 0.0 109.586 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.99 155.62 93.19 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.6 124.82 11.09 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.994 2.463 . . . . 0.0 108.014 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.36 162.95 36.5 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 108.549 -1.366 . . . . 0.0 108.549 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.92 -11.34 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.766 1.644 . . . . 0.0 113.783 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.16 -40.72 4.77 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.192 1.377 . . . . 0.0 113.707 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.0 112.45 25.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.977 1.389 . . . . 0.0 107.688 -170.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -71.19 135.42 47.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.91 176.16 11.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.539 1.936 . . . . 0.0 106.342 166.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 83.0 m -124.4 74.79 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.559 0.695 . . . . 0.0 111.001 -165.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 138.99 33.88 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.479 1.112 . . . . 0.0 108.664 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.8 -27.65 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.325 0.584 . . . . 0.0 111.334 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.82 -71.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 105.136 -3.186 . . . . 0.0 105.136 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -108.43 -51.84 2.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.616 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.06 163.13 28.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.888 1.222 . . . . 0.0 109.249 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.68 119.94 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.53 172.92 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.665 0.786 . . . . 0.0 108.928 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.52 146.26 31.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 162.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.23 -32.42 71.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.236 0.615 . . . . 0.0 110.737 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 m -64.55 -32.71 74.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.156 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.2 m -61.37 -34.94 76.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.682 1.128 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.472 0.709 . . . . 0.0 110.139 167.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -24.02 9.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.444 1.097 . . . . 0.0 113.477 -170.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -50.17 -35.59 26.81 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.994 1.318 . . . . 0.0 113.158 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 -33.84 0.35 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.026 -0.512 . . . . 0.0 112.005 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.57 1.948 . . . . 0.0 111.508 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.69 -55.16 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.43 1.492 . . . . 0.0 110.168 -173.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.97 -37.57 8.49 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.751 1.634 . . . . 0.0 112.318 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.26 -24.64 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -45.14 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.999 0.519 . . . . 0.0 110.649 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.62 70.89 0.91 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.38 120.18 19.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 165.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.29 174.09 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.784 2.034 . . . . 0.0 114.387 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -161.79 148.14 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.419 2.688 . . . . 0.0 104.047 160.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.8 -170.23 0.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.175 2.19 . . . . 0.0 106.623 157.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m 71.36 -67.69 0.25 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.503 1.921 . . . . 0.0 113.879 158.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.61 -174.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.89 2.076 . . . . 0.0 111.64 -169.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.24 -127.3 8.09 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.66 137.35 38.61 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 119.853 1.826 . . . . 0.0 109.216 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.97 -61.37 0.62 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.349 -1.901 . . . . 0.0 108.349 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 51.51 -156.97 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -167.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -155.07 165.56 36.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.479 1.512 . . . . 0.0 107.19 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.47 136.35 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.0 t -123.52 108.57 12.79 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.569 1.148 . . . . 0.0 109.519 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.85 130.14 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 125.643 1.577 . . . . 0.0 109.572 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.39 86.61 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.51 158.47 35.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 163.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER 51.14 90.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.959 2.504 . . . . 0.0 112.587 -174.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.89 75.72 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 164.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.88 -45.95 0.02 OUTLIER Glycine 0 C--N 1.334 0.437 0 O-C-N 120.952 -1.092 . . . . 0.0 113.383 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 9.4 tptt -66.49 -37.33 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.74 0.77 . . . . 0.0 110.39 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.5 mmt -79.46 0.52 29.15 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 115.559 -2.162 . . . . 0.0 114.253 -172.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.26 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 -170.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tp -117.85 -44.76 2.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.916 1.686 . . . . 0.0 110.131 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -73.89 -20.57 60.37 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.267 1.027 . . . . 0.0 111.41 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 p -53.4 115.29 1.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.379 2.272 . . . . 0.0 109.986 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.23 -71.49 0.54 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.585 1.154 . . . . 0.0 108.884 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.3 -21.4 59.74 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.424 1.09 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -69.14 0.12 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.309 1.443 . . . . 0.0 110.19 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' H ' ' A' ' 125' ' ' ILE . 4.2 mp -37.73 -48.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.388 1.875 . . . . 0.0 112.683 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -63.89 -64.88 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.699 0.799 . . . . 0.0 112.48 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.5 90.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.072 0.949 . . . . 0.0 110.452 -170.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.55 -44.61 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.556 1.142 . . . . 0.0 109.367 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -67.66 -31.99 72.36 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.011 -1.681 . . . . 0.0 112.353 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -37.73 83.57 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.981 1.718 . . . . 0.0 110.512 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 m -65.92 -47.89 73.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.881 0.472 . . . . 0.0 110.866 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.33 -19.74 66.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 111.261 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -39.58 78.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.044 0.938 . . . . 0.0 109.477 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.7 m -64.81 134.02 95.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 123.565 0.746 . . . . 0.0 109.414 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.0 -29.27 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.661 2.907 . . . . 0.0 112.025 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.7 -53.75 7.09 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 145.03 54.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.222 1.011 . . . . 0.0 112.28 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.16 98.76 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 102.949 -2.982 . . . . 0.0 102.949 -169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.06 131.65 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.41 116.26 8.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.566 1.947 . . . . 0.0 106.508 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.05 -179.61 39.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.7 m -123.53 100.28 6.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.9 pt -97.19 161.74 25.13 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 179.98 4.54 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.401 2.734 . . . . 0.0 110.47 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.5 150.36 79.45 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 121.172 -0.955 . . . . 0.0 110.773 164.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.01 109.47 2.7 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 123.188 2.592 . . . . 0.0 108.883 164.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.16 119.72 15.0 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 164.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.09 -131.02 36.0 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.59 137.55 96.46 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.845 -158.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 131.27 22.71 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.621 2.214 . . . . 0.0 109.009 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.98 121.87 21.71 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 13.33 0.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.122 2.569 . . . . 0.0 115.634 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.4 tp -131.67 -39.83 1.11 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.388 1.875 . . . . 0.0 109.39 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.83 -23.77 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 120.825 -1.172 . . . . 0.0 109.006 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.54 -40.43 78.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.578 1.151 . . . . 0.0 110.73 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.82 -31.03 72.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.689 1.996 . . . . 0.0 110.471 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.4 mp -90.56 -41.61 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.535 1.534 . . . . 0.0 109.337 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -52.56 -39.05 61.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.971 1.709 . . . . 0.0 109.823 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -33.4 -47.54 0.22 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 127.968 2.507 . . . . 0.0 113.033 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -66.5 -40.75 89.41 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.342 -1.313 . . . . 0.0 112.436 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.75 -40.71 0.22 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.53 1.932 . . . . 0.0 113.482 -167.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.94 -22.49 60.1 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.68 2.392 . . . . 0.0 113.563 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.6 m -66.0 138.79 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.477 ' HE3' ' CE1' ' A' ' 166' ' ' PHE . 28.3 tptt -65.07 142.73 58.3 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.85 102.29 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.477 ' CE1' ' HE3' ' A' ' 164' ' ' LYS . 13.7 m-85 -93.53 96.69 10.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.042 1.337 . . . . 0.0 111.051 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 104.94 2.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 172.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.59 163.05 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.988 0.813 . . . . 0.0 108.816 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.4 p -123.57 169.04 11.84 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.205 1.802 . . . . 0.0 106.305 160.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -77.51 -10.6 59.58 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.344 1.458 . . . . 0.0 112.275 158.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -79.99 -74.0 0.33 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.79 32.39 0.74 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.221 1.408 . . . . 0.0 109.913 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -54.91 -51.76 65.03 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.732 -1.23 . . . . 0.0 110.405 -169.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -75.33 4.04 7.92 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.95 -19.0 31.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.707 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -21.58 45.79 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.913 -164.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.71 -63.13 1.6 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.951 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.72 -28.78 76.69 Favored 'Trans proline' 0 C--N 1.35 0.616 0 CA-C-N 121.853 1.697 . . . . 0.0 112.929 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -33.97 75.0 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.608 0.763 . . . . 0.0 109.678 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.16 -52.17 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.071 0.948 . . . . 0.0 109.82 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.89 -34.77 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 118.42 0.554 . . . . 0.0 110.225 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.7 m -55.92 -44.61 78.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.389 1.076 . . . . 0.0 110.263 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -70.97 -41.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.684 -0.635 . . . . 0.0 110.278 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.27 -59.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 123.405 0.682 . . . . 0.0 109.811 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -3.18 20.42 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.273 1.029 . . . . 0.0 112.684 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -60.47 -21.35 62.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.883 -1.135 . . . . 0.0 110.592 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.82 126.54 29.74 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.999 1.272 . . . . 0.0 107.636 164.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -40.58 109.28 0.11 Allowed 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.022 1.329 . . . . 0.0 111.994 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.465 ' CE ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 156.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.5 178.79 9.19 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 163.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -24.63 119.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.55 3.14 . . . . 0.0 111.624 166.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 t -105.08 137.86 32.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.443 ' CE1' HG21 ' A' ' 157' ' ' ILE . 54.5 m-85 -127.86 153.91 46.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.576 0.75 . . . . 0.0 109.151 163.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 164.24 12.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.838 2.055 . . . . 0.0 108.313 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -159.5 -173.45 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.11 53.7 6.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 127.214 2.34 . . . . 0.0 112.136 -160.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.11 123.51 8.88 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 119.786 1.793 . . . . 0.0 110.266 -171.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.6 -1.6 8.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.511 2.141 . . . . 0.0 112.238 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.93 4.03 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -170.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.4 97.99 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 125.396 2.522 . . . . 0.0 107.48 -168.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.85 -45.49 0.55 Allowed Glycine 0 C--N 1.309 -0.938 0 CA-C-N 111.345 -2.661 . . . . 0.0 108.414 163.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.31 -48.42 25.13 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.327 1.851 . . . . 0.0 112.958 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.3 m -60.31 -52.93 63.19 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.207 0.912 . . . . 0.0 108.898 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 m -59.67 -40.29 87.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.736 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -53.14 48.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.468 1.485 . . . . 0.0 109.284 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.25 -26.07 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.581 0.752 . . . . 0.0 111.06 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -66.12 -57.16 8.3 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.034 -1.666 . . . . 0.0 109.332 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -11.29 29.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.01 45.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.908 1.283 . . . . 0.0 112.468 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.2 p -67.23 -47.51 70.6 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -171.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.07 -39.98 66.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.199 1.8 . . . . 0.0 112.246 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.87 -54.41 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.457 1.103 . . . . 0.0 109.236 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.9 mt -69.6 -36.57 76.32 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.316 0.646 . . . . 0.0 109.351 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.68 -39.0 86.84 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.971 -1.706 . . . . 0.0 109.89 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.97 -34.66 70.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.512 1.525 . . . . 0.0 110.342 168.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 4.32 4.99 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.308 2.243 . . . . 0.0 115.389 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.62 20.22 55.84 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.282 0.946 . . . . 0.0 112.204 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.55 140.85 73.46 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.918 1.287 . . . . 0.0 108.741 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -79.16 84.72 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 CA-C-N 121.701 1.643 . . . . 0.0 111.347 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.07 156.78 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.159 0.983 . . . . 0.0 109.127 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -156.25 174.25 15.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.984 1.713 . . . . 0.0 107.471 164.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.43 -148.14 19.07 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 125.487 1.518 . . . . 0.0 111.31 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -148.68 171.56 16.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 111.216 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' CG ' ' A' ' 38' ' ' GLU . 9.1 p90 -146.22 172.38 13.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.29 1.436 . . . . 0.0 108.349 165.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.5 90.6 2.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.158 1.783 . . . . 0.0 106.326 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' CG ' ' CE1' ' A' ' 36' ' ' TYR . 18.8 mt-10 -74.89 -22.73 58.47 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.462 -0.774 . . . . 0.0 112.705 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 96.17 164.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.347 4.259 . . . . 0.0 109.747 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.32 104.01 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -121.42 105.25 10.33 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.831 1.253 . . . . 0.0 107.754 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -79.65 116.12 19.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.95 -56.03 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 120.529 1.513 . . . . 0.0 114.115 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.21 11.44 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.837 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 137.15 28.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.189 1.995 . . . . 0.0 109.484 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -66.61 144.92 56.12 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.28 -12.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.79 1.236 . . . . 0.0 112.965 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.91 -168.56 41.69 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -129.46 138.04 51.19 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -114.84 158.45 21.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.2 p -116.67 94.84 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -166.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.14 116.53 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.94 1.696 . . . . 0.0 108.235 -162.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.4 p -88.75 150.77 22.79 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.398 0.999 . . . . 0.0 109.271 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -24.94 67.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.051 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -32.9 72.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.492 1.117 . . . . 0.0 109.302 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.99 -14.85 2.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.702 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 163.59 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.969 2.108 . . . . 0.0 110.785 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.25 156.63 42.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 121.379 -0.826 . . . . 0.0 109.534 156.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.28 159.75 21.36 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.82 64.9 7.31 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.66 3.574 . . . . 0.0 111.642 -166.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.64 -56.08 2.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 127.079 2.152 . . . . 0.0 110.677 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 147.8 34.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 109.516 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -147.4 161.67 40.57 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.029 1.332 . . . . 0.0 108.691 172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -62.55 159.95 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.833 0.853 . . . . 0.0 109.744 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.55 -155.88 7.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.75 166.11 22.84 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.81 149.31 40.14 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.993 0.815 . . . . 0.0 109.457 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.01 124.45 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.066 1.844 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.62 164.7 33.21 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.525 2.816 . . . . 0.0 110.891 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.16 -12.43 27.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.475 2.116 . . . . 0.0 113.749 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.28 7.87 73.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.258 0.932 . . . . 0.0 112.879 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -140.65 170.13 16.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 130.389 3.476 . . . . 0.0 104.221 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -139.47 149.65 44.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 153.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -151.24 149.95 30.01 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.14 97.88 4.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.093 1.357 . . . . 0.0 110.113 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.2 161.8 19.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.049 1.295 . . . . 0.0 111.168 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.66 -4.13 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -161.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.22 77.21 0.09 OUTLIER Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 86.59 -31.44 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.076 2.95 . . . . 0.0 111.491 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -105.94 146.11 30.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.11 132.32 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.33 175.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.624 1.57 . . . . 0.0 108.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.68 135.51 22.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.54 -37.86 85.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 164.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -51.29 -42.46 61.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.081 1.352 . . . . 0.0 110.802 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.8 m -75.98 -15.27 60.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.614 -1.304 . . . . 0.0 112.914 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.5 -59.03 2.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.791 -1.1 . . . . 0.0 108.444 161.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -57.79 -17.27 14.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.481 1.491 . . . . 0.0 114.009 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -52.61 -41.48 63.72 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.26 -37.54 0.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.831 0.852 . . . . 0.0 112.688 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.98 51.02 0.92 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.159 1.784 . . . . 0.0 109.373 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.03 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.894 2.477 . . . . 0.0 105.698 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.55 -35.7 37.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.817 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -62.28 -21.08 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.883 1.219 . . . . 0.0 113.303 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.11 -33.86 68.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.197 0.453 . . . . 0.0 109.781 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.42 107.02 3.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.786 -1.196 . . . . 0.0 111.545 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -78.59 144.84 35.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 159.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.1 122.91 12.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 109.885 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -109.82 -65.84 1.12 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 58.8 m 53.53 -156.68 0.19 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.31 1.044 . . . . 0.0 109.928 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.6 m -84.26 77.63 9.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.169 0.895 . . . . 0.0 110.613 -166.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.4 p -86.07 -170.44 3.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.985 2.514 . . . . 0.0 111.464 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.27 179.7 53.42 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.362 -1.461 . . . . 0.0 111.989 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.95 150.84 87.55 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.786 2.324 . . . . 0.0 109.039 166.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.9 84.08 0.08 OUTLIER Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.0 130.54 42.1 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.241 1.019 . . . . 0.0 109.487 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -84.28 162.79 19.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.099 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.06 154.95 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.31 149.85 52.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.254 1.022 . . . . 0.0 108.698 163.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.68 122.55 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 123.17 0.588 . . . . 0.0 109.423 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.02 84.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -171.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -74.09 171.15 14.05 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.39 -1.444 . . . . 0.0 109.785 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 34.33 69.23 0.16 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.882 3.273 . . . . 0.0 114.301 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.27 91.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.41 -81.05 0.04 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 118.473 0.579 . . . . 0.0 112.032 -170.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -53.4 -35.43 60.36 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.614 1.166 . . . . 0.0 113.06 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -3.43 16.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.963 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -39.44 -52.43 2.1 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 121.514 1.961 . . . . 0.0 112.389 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -45.3 95.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.524 0.73 . . . . 0.0 111.375 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.49 -9.65 55.78 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.23 2.212 . . . . 0.0 113.6 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.5 m -55.64 109.87 0.63 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.351 1.46 . . . . 0.0 112.017 -164.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -120.35 -83.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.491 0.587 . . . . 0.0 111.189 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.57 -19.66 63.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.886 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -74.26 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.765 2.026 . . . . 0.0 110.339 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -33.99 -58.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-N 120.169 1.35 . . . . 0.0 112.737 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.92 -58.04 10.16 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.354 0.979 . . . . 0.0 111.911 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.01 91.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.002 0.814 . . . . 0.0 109.513 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.1 t -55.97 -50.91 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.432 1.493 . . . . 0.0 109.247 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -65.3 -28.97 69.69 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.729 -1.232 . . . . 0.0 112.563 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -54.18 -58.53 7.01 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 m -60.51 -38.51 84.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.128 2.571 . . . . 0.0 112.453 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.33 -33.83 75.46 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.88 0.472 . . . . 0.0 110.285 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.4 -8.11 58.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.849 0.46 . . . . 0.0 111.231 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 m -89.97 133.72 33.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.5 -37.15 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.275 2.65 . . . . 0.0 112.76 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -48.52 80.64 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -63.49 153.67 34.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.157 1.783 . . . . 0.0 111.497 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.8 mt -139.29 106.28 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.6 mm -65.43 147.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -144.32 94.49 2.58 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.909 2.083 . . . . 0.0 106.581 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.68 173.97 19.95 Favored Glycine 0 N--CA 1.465 0.628 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.455 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 29.2 m -131.36 98.87 4.66 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.632 1.216 . . . . 0.0 112.52 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.6 pt -80.15 140.81 53.42 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.827 -1.17 . . . . 0.0 111.375 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.8 137.9 43.16 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.044 1.83 . . . . 0.0 108.435 166.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.89 134.45 95.92 Favored Pre-proline 0 N--CA 1.444 -0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.166 -166.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.78 129.92 19.58 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.818 2.345 . . . . 0.0 108.958 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.95 -61.24 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.731 1.213 . . . . 0.0 108.426 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.88 -126.91 0.74 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 157.03 90.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.569 0.685 . . . . 0.0 111.313 -170.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.63 103.2 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.785 2.323 . . . . 0.0 108.711 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.04 124.46 21.67 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.682 -0.636 . . . . 0.0 110.131 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.53 -59.82 4.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.166 1.386 . . . . 0.0 113.3 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 65.0 tp -63.5 -30.59 71.68 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.478 -1.389 . . . . 0.0 111.259 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.16 -44.24 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 121.297 -0.877 . . . . 0.0 108.888 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.01 -37.66 66.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.988 1.715 . . . . 0.0 110.829 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -57.85 -28.61 64.29 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.659 0.663 . . . . 0.0 112.344 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 5' ' ' PHE . 9.2 mt -107.56 -32.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.602 1.161 . . . . 0.0 109.975 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -32.99 72.25 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.033 -1.042 . . . . 0.0 109.166 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.28 -6.45 23.97 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -76.53 -39.65 52.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 120.884 1.674 . . . . 0.0 110.057 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? 62.2 -23.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.121 2.169 . . . . 0.0 114.648 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.59 -28.7 69.54 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.288 1.435 . . . . 0.0 111.997 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.36 135.82 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.451 1.5 . . . . 0.0 110.566 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.74 145.63 54.55 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 168.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.23 89.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.406 ' CD2' HG12 ' A' ' 180' ' ' ILE . 30.7 m-85 -79.2 104.75 10.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.786 0.835 . . . . 0.0 109.087 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.65 105.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.91 155.84 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 164.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.3 p -134.83 162.59 31.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 154.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.76 -14.64 61.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.494 165.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.62 -54.27 4.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -101.92 10.69 39.53 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.288 1.435 . . . . 0.0 110.746 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 ptt85 -29.71 -65.16 0.11 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.034 2.134 . . . . 0.0 111.612 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -80.3 3.45 20.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -105.18 -6.97 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.099 2.16 . . . . 0.0 111.033 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.15 -45.77 15.91 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 119.189 0.904 . . . . 0.0 110.65 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.8 tp -32.51 -61.91 0.31 Allowed Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.716 2.006 . . . . 0.0 109.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.14 -28.63 28.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 122.438 1.906 . . . . 0.0 114.94 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -68.14 -35.07 77.5 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.872 1.215 . . . . 0.0 109.847 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 166' ' ' PHE . 12.0 mt -65.34 -46.34 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.835 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.89 -45.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 119.349 0.977 . . . . 0.0 108.761 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.0 m -58.53 -51.09 71.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.623 0.769 . . . . 0.0 111.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.15 -31.32 69.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.229 1.377 . . . . 0.0 112.106 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.65 -62.03 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -70.14 -18.23 63.22 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -19.06 56.32 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 119.457 1.026 . . . . 0.0 111.56 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.0 t -70.57 -14.67 62.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.633 1.56 . . . . 0.0 111.978 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -86.51 -48.65 8.2 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.899 0.88 . . . . 0.0 109.821 167.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 11.0 mmpt? . . . . . 0 C--O 1.25 1.094 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.944 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 183' ' ' CYS . . . . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 -166.05 1.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.356 2.262 . . . . 0.0 107.256 161.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -46.39 137.96 6.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 0.0 110.511 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.33 143.2 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.927 0.891 . . . . 0.0 109.536 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -141.54 146.94 36.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.953 1.701 . . . . 0.0 108.637 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.69 157.31 17.27 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.648 1.113 . . . . 0.0 111.287 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -149.73 177.22 9.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.45 1.1 . . . . 0.0 109.092 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.28 -176.41 19.62 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.136 1.35 . . . . 0.0 112.701 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.65 166.05 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.476 3.451 . . . . 0.0 110.751 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.58 93.91 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.435 2.09 . . . . 0.0 111.054 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.18 -34.99 15.97 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.493 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.55 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.17 2.588 . . . . 0.0 110.063 -153.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.4 17.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.826 -1.541 . . . . 0.0 113.833 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -94.17 -55.82 3.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.531 1.665 . . . . 0.0 110.731 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.0 m -51.8 -41.54 61.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.329 1.851 . . . . 0.0 109.724 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -58.04 -41.7 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 113.73 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -48.28 61.24 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.71 -41.55 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -56.0 -55.95 26.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.509 -0.745 . . . . 0.0 110.214 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -59.48 -31.78 69.65 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.137 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.96 -44.28 60.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.915 0.78 . . . . 0.0 109.947 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 m -58.54 -47.29 84.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.89 -23.47 63.25 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.794 2.038 . . . . 0.0 111.73 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.4 t -83.71 -48.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.382 1.873 . . . . 0.0 109.362 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.06 -44.72 87.62 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -60.77 -43.44 98.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.882 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -62.09 -26.58 68.37 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.918 0.781 . . . . 0.0 112.279 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 t -88.69 1.7 54.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.898 1.679 . . . . 0.0 112.271 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.4 11.31 85.62 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.971 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.25 118.3 70.87 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.885 1.843 . . . . 0.0 106.979 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.39 123.19 11.98 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.909 1.739 . . . . 0.0 110.647 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.16 160.64 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.82 177.53 8.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 159.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.04 -163.82 26.59 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 119.579 -1.951 . . . . 0.0 113.199 166.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -151.03 155.19 38.5 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.234 1.016 . . . . 0.0 110.325 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.432 ' C ' ' HG1' ' A' ' 37' ' ' THR . 50.7 p90 -118.72 -179.01 3.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' ' 36' ' ' TYR . 52.4 m -161.86 94.71 0.95 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -164.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.42 156.68 17.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -167.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -68.25 109.39 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.17 109.33 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -119.29 104.74 10.66 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.932 2.093 . . . . 0.0 107.443 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -91.84 102.47 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.26 50.68 7.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.183 0.897 . . . . 0.0 113.558 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.88 -6.88 57.69 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.419 1.485 . . . . 0.0 114.925 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.43 122.05 23.96 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.061 1.931 . . . . 0.0 107.506 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 123.84 23.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 159.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -10.63 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.789 0.836 . . . . 0.0 112.729 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.13 -164.11 35.26 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -139.44 143.09 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.66 145.6 41.83 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.62 154.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.03 123.37 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.5 p -72.48 179.25 3.58 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.563 -1.336 . . . . 0.0 109.927 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.3 -13.68 40.21 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.299 -0.875 . . . . 0.0 111.492 163.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 t -70.83 -50.41 35.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 49.43 0.1 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -144.82 147.49 32.92 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.641 1.976 . . . . 0.0 107.592 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.77 161.41 20.17 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 128.494 2.717 . . . . 0.0 108.999 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.12 134.42 5.93 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.841 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.48 61.94 2.8 Favored 'Trans proline' 0 CA--C 1.55 1.284 1 C-N-CA 126.371 4.714 . . . . 0.0 114.053 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.543 ' N ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -65.3 -63.02 1.2 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.57 1.948 . . . . 0.0 111.581 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 p -130.11 136.5 49.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.306 0.957 . . . . 0.0 108.872 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -148.94 169.34 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.434 1.494 . . . . 0.0 107.889 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -56.32 152.34 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.679 1.191 . . . . 0.0 109.884 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.49 46.87 0.07 OUTLIER Glycine 0 C--N 1.333 0.403 0 CA-C-O 119.335 -0.703 . . . . 0.0 111.612 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.0 -169.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.971 1.708 . . . . 0.0 111.7 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.58 147.53 43.87 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 110.871 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -69.73 123.83 10.5 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.728 2.286 . . . . 0.0 107.971 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.24 170.49 19.47 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.627 2.885 . . . . 0.0 110.853 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.48 -9.75 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.28 1.987 . . . . 0.0 114.196 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.47 -12.49 51.0 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.535 -1.147 . . . . 0.0 114.291 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 138.1 36.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.34 2.07 . . . . 0.0 108.138 -168.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -119.07 122.32 41.84 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.104 0.562 . . . . 0.0 110.0 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 172.25 13.67 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 126.026 1.731 . . . . 0.0 107.655 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 95.3 m -68.4 147.81 51.55 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.815 -0.553 . . . . 0.0 109.725 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -153.29 143.83 22.57 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.528 -0.732 . . . . 0.0 109.472 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.766 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.37 1.06 0.15 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 127.437 2.446 . . . . 0.0 117.596 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.04 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.225 2.21 . . . . 0.0 106.713 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -80.57 166.64 20.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.339 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -110.61 133.59 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.8 166.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -139.39 105.17 5.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.6 -24.23 63.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.322 -0.861 . . . . 0.0 111.592 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -34.4 77.99 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.624 171.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 42.5 t -57.42 -48.45 79.09 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 119.989 1.268 . . . . 0.0 109.941 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -56.04 -50.62 70.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -19.67 66.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.057 0.844 . . . . 0.0 112.439 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -66.36 -45.25 80.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.721 1.146 . . . . 0.0 112.059 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.35 -39.86 2.42 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.59 51.18 2.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.072 1.749 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 -60.35 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 125.721 1.608 . . . . 0.0 108.0 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -38.36 42.37 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.607 1.538 . . . . 0.0 112.043 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -36.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 123.909 0.883 . . . . 0.0 110.591 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.148 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 108.26 0.13 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.983 1.713 . . . . 0.0 106.764 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -103.3 166.9 10.16 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.142 1.377 . . . . 0.0 108.129 163.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -150.12 51.95 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.512 -0.743 . . . . 0.0 111.242 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.97 169.7 17.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.414 1.486 . . . . 0.0 109.924 -169.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 15.5 t 62.85 107.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.718 2.407 . . . . 0.0 111.35 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 p -73.49 49.53 0.29 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.147 2.579 . . . . 0.0 113.233 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -101.34 169.19 9.05 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.67 1.188 . . . . 0.0 110.389 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -37.84 140.46 0.43 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 128.017 2.722 . . . . 0.0 116.213 -171.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.55 -176.13 2.93 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 125.202 3.935 . . . . 0.0 111.836 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 132.52 -141.4 12.76 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 104.798 -3.321 . . . . 0.0 104.798 -159.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -138.27 153.39 49.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.702 1.601 . . . . 0.0 111.528 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -89.0 97.21 11.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 126.613 1.965 . . . . 0.0 110.019 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.9 t -74.97 94.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 121.656 2.026 . . . . 0.0 107.577 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.5 m -72.24 165.24 24.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.61 139.67 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.576 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mt -152.22 103.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.651 1.219 . . . . 0.0 108.501 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -105.69 -169.61 1.61 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 42.75 48.75 4.91 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.014 2.526 . . . . 0.0 112.163 -168.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.71 110.56 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.13 -63.97 0.32 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-O 117.554 -1.692 . . . . 0.0 112.493 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -24.15 65.92 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.913 2.357 . . . . 0.0 110.44 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.3 mmt -69.02 -10.39 57.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 116.671 -1.633 . . . . 0.0 113.404 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -24.63 -68.42 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.535 2.334 . . . . 0.0 114.593 -171.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -45.96 63.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 0.0 111.361 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.66 -27.99 66.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.615 1.166 . . . . 0.0 112.181 -170.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.4 t -41.64 114.01 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 129.222 3.009 . . . . 0.0 111.715 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -127.44 -87.71 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.412 0.551 . . . . 0.0 111.465 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.6 -16.8 61.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.793 0.724 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.99 -68.02 0.22 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.839 2.055 . . . . 0.0 111.168 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -36.83 -57.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.628 1.571 . . . . 0.0 112.148 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.9 -54.49 41.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.308 0.643 . . . . 0.0 111.025 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.82 99.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 124.148 0.905 . . . . 0.0 109.299 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.13 -47.15 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.227 1.411 . . . . 0.0 109.538 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.41 -44.6 96.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.203 1.365 . . . . 0.0 111.265 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -57.62 -38.71 75.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.153 0.888 . . . . 0.0 110.435 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 m -74.24 -38.99 63.35 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.364 -0.835 . . . . 0.0 112.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.2 mt -61.06 -35.76 77.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.21 1.368 . . . . 0.0 109.932 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.8 t -71.94 -22.05 61.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.221 1.808 . . . . 0.0 110.605 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.3 m -76.26 134.0 71.05 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.03 -42.71 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.032 2.488 . . . . 0.0 112.319 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.35 -2.75 63.59 Favored Glycine 0 C--O 1.216 -0.97 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.384 -168.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.9 m -80.48 160.84 25.14 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.965 2.382 . . . . 0.0 106.139 154.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.6 mt -122.92 138.37 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.72 136.99 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tp -140.07 113.45 8.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.92 32.89 Favored Glycine 0 N--CA 1.462 0.412 0 C-N-CA 119.287 -1.435 . . . . 0.0 114.656 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.0 m -137.11 133.4 35.29 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.93 147.61 66.24 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.821 1.648 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.71 148.92 59.96 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 111.167 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.34 131.55 86.6 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.241 0.617 . . . . 0.0 110.083 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.69 108.82 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.402 2.735 . . . . 0.0 108.443 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -64.75 0.79 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -112.27 -109.47 3.02 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 166.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 149.69 98.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 118.72 1.26 . . . . 0.0 111.966 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.55 -164.9 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.37 1 C-N-CA 125.966 4.444 . . . . 0.0 112.247 164.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.79 168.25 10.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.601 1.96 . . . . 0.0 109.183 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.29 -67.07 0.31 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.037 2.535 . . . . 0.0 113.287 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -59.48 -46.32 89.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.56 -35.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.36 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.07 -28.11 68.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.869 1.668 . . . . 0.0 112.086 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.52 -34.74 77.51 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.769 0.713 . . . . 0.0 110.007 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.32 -39.09 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.3 1.44 . . . . 0.0 109.564 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.66 -26.68 65.44 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.426 -1.422 . . . . 0.0 111.105 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -59.32 -37.58 78.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.315 0.646 . . . . 0.0 111.44 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -61.58 -36.78 81.64 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.908 0.883 . . . . 0.0 112.019 -167.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -40.24 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.971 2.908 . . . . 0.0 115.676 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -59.93 -28.9 68.01 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.189 1.359 . . . . 0.0 110.626 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.0 m -50.36 108.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.503 1.521 . . . . 0.0 109.28 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -65.69 123.21 19.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 m -111.94 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 C-N-CA 124.683 1.193 . . . . 0.0 108.778 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -72.12 118.83 15.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.142 0.977 . . . . 0.0 110.538 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.61 97.81 5.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.789 1.235 . . . . 0.0 110.631 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.86 132.79 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 p -94.93 151.22 19.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 158.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -57.85 -29.8 65.28 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.064 -0.397 . . . . 0.0 110.389 165.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.07 -53.87 15.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 110.848 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.82 23.06 13.41 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.025 -1.047 . . . . 0.0 110.91 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -47.26 -44.55 23.11 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.448 1.099 . . . . 0.0 112.464 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.27 3.56 8.68 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -118.29 62.54 0.77 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.25 -39.79 0.44 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.37 160.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tp -40.03 -58.37 2.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 117.625 -1.179 . . . . 0.0 110.355 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.84 -28.24 51.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.436 1.424 . . . . 0.0 113.386 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.24 -38.26 68.96 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.282 -0.886 . . . . 0.0 109.219 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.89 -47.34 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.488 1.515 . . . . 0.0 107.974 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 92.2 t -56.04 -43.99 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.225 0.92 . . . . 0.0 109.171 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.0 m -57.97 -47.81 81.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.962 1.305 . . . . 0.0 109.129 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 1' ' ' ALA . 3.8 t -64.45 -37.78 88.73 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.731 -0.606 . . . . 0.0 111.693 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.64 -55.52 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.911 0.778 . . . . 0.0 109.428 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -28.32 69.69 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.034 -174.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.51 -50.85 0.34 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.235 2.214 . . . . 0.0 111.637 -176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 t 61.98 -86.01 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.594 1.557 . . . . 0.0 107.814 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -75.7 -44.57 41.42 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 119.194 0.907 . . . . 0.0 111.343 162.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.111 0.964 . . . . 0.0 112.321 -116.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.423 ' H1 ' ' NH1' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.423 ' NH1' ' H1 ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -128.7 -105.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -92.88 159.5 15.33 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.375 1.87 . . . . 0.0 109.282 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.65 148.41 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -144.11 158.02 43.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.909 1.684 . . . . 0.0 109.537 172.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.38 135.3 50.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.83 -172.5 3.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.82 -172.31 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.265 -0.897 . . . . 0.0 111.295 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.44 163.34 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.19 2.593 . . . . 0.0 113.611 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.82 72.05 6.29 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.804 3.67 . . . . 0.0 111.736 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.18 25.14 21.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 124.411 1.005 . . . . 0.0 112.494 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m 42.51 35.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.513 2.725 . . . . 0.0 116.308 161.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.87 9.91 3.1 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.514 1.531 . . . . 0.0 112.184 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -75.19 -49.87 18.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 109.956 -168.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -57.66 -35.25 70.31 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.391 0.676 . . . . 0.0 109.71 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.5 m -63.49 -38.78 92.46 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.284 -0.885 . . . . 0.0 112.45 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -49.55 57.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.89 1.223 . . . . 0.0 108.593 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -58.08 -40.94 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.562 0.619 . . . . 0.0 111.045 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -50.28 -45.84 54.7 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.317 0.962 . . . . 0.0 110.067 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -70.05 -20.04 63.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.23 0.612 . . . . 0.0 112.207 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.328 0.967 . . . . 0.0 110.627 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -81.51 -42.8 19.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.02 -39.22 68.89 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.103 0.561 . . . . 0.0 111.211 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.21 -51.24 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.334 1.053 . . . . 0.0 110.291 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.25 -35.5 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.33 -38.33 89.79 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.074 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -4.8 14.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.495 1.118 . . . . 0.0 112.912 172.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 m -109.61 -5.08 15.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.701 1.6 . . . . 0.0 111.638 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.72 18.46 74.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.015 1.293 . . . . 0.0 112.981 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 t -64.71 133.76 95.82 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.665 1.733 . . . . 0.0 107.131 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.22 95.22 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.575 2.183 . . . . 0.0 110.072 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.56 136.73 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.78 173.79 11.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.604 2.362 . . . . 0.0 105.883 169.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.98 -156.79 26.15 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -142.06 166.02 25.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.912 1.356 . . . . 0.0 111.434 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -142.14 179.62 6.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.4 p -134.98 136.67 42.38 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.91 27.17 4.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.278 6.8 pm0 49.81 -178.71 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.357 2.263 . . . . 0.0 112.79 -164.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.81 119.56 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -129.27 106.47 8.84 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 70.63 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.58 75.51 0.51 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -161.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.19 -40.21 2.68 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 148.47 42.38 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.719 1.76 . . . . 0.0 111.135 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -69.81 132.24 45.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 162.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.55 -27.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.72 -174.05 41.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 119.608 1.095 . . . . 0.0 110.677 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CZ ' ' HE2' ' A' ' 116' ' ' LYS . 25.1 m-85 -126.53 153.25 45.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 160.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -117.97 162.42 18.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 167.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.97 145.35 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.907 1.683 . . . . 0.0 107.923 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.2 108.95 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 120.55 1.523 . . . . 0.0 109.858 -167.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.1 p -69.61 145.05 52.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.31 -5.74 30.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -84.68 7.53 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.549 1.068 . . . . 0.0 111.32 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.67 3.41 83.75 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.223 -1.548 . . . . 0.0 114.984 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 m -80.83 166.08 21.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.783 1.291 . . . . 0.0 109.358 163.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -146.39 169.78 18.16 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.417 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -150.42 -176.23 23.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.722 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -108.93 14.41 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.116 1.21 . . . . 0.0 114.284 -144.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mt 23.61 -74.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 130.898 3.679 . . . . 0.0 116.446 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -147.83 159.93 43.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 165.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -143.58 53.12 1.32 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.845 2.058 . . . . 0.0 110.652 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 64.99 160.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.663 1.985 . . . . 0.0 111.554 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.51 150.96 11.9 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.73 150.86 26.68 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.756 1.222 . . . . 0.0 108.67 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.4 156.37 30.99 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 109.603 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.74 132.21 24.5 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.182 1.921 . . . . 0.0 110.102 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.72 155.03 59.16 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.696 2.931 . . . . 0.0 110.068 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.44 111.53 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.087 2.525 . . . . 0.0 109.823 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.64 -60.43 0.67 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 142.33 52.95 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -147.26 146.04 29.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -160.35 -175.34 4.98 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.736 0.647 . . . . 0.0 112.616 -165.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.0 m -60.67 101.7 0.15 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.779 2.032 . . . . 0.0 110.752 171.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -142.14 119.61 11.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.57 -89.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.38 -47.78 0.25 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.772 1.169 . . . . 0.0 112.013 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -144.58 4.05 1.15 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.355 . . . . 0.0 111.436 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.44 139.11 51.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.268 1.027 . . . . 0.0 108.379 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.63 88.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.2 174.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -147.56 133.17 18.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.306 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.57 -35.42 74.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.356 -0.84 . . . . 0.0 109.595 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.3 m -55.24 -43.81 74.94 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 110.923 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.5 p -63.58 -29.5 70.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.401 1.455 . . . . 0.0 110.659 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -69.4 -53.2 20.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.824 1.25 . . . . 0.0 110.477 167.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -47.47 -35.03 8.09 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.193 0.997 . . . . 0.0 112.157 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -58.55 -32.11 68.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.417 ' CD2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -144.97 -36.21 0.31 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -171.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.78 31.57 0.53 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.504 2.322 . . . . 0.0 111.447 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 126.751 2.02 . . . . 0.0 108.41 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.41 -27.03 82.12 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 121.428 1.546 . . . . 0.0 113.225 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.74 -26.46 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.245 0.93 . . . . 0.0 113.328 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.14 -23.92 60.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.335 0.97 . . . . 0.0 111.369 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -165.65 116.53 1.07 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 120.289 1.404 . . . . 0.0 108.192 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -106.23 156.59 18.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 91.7 3.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -159.34 120.05 3.18 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.258 1.423 . . . . 0.0 107.806 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.72 58.5 4.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.767 0.827 . . . . 0.0 110.397 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -47.95 122.09 4.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.693 1.997 . . . . 0.0 109.682 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 m -54.06 130.31 37.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 109.96 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.6 77.85 1.01 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.735 1.159 . . . . 0.0 110.347 -164.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -53.67 -172.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.413 3.408 . . . . 0.0 114.329 159.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.16 -111.96 1.62 Allowed Glycine 0 N--CA 1.437 -1.254 1 N-CA-C 102.046 -4.421 . . . . 0.0 102.046 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -146.4 153.22 40.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.645 1.223 . . . . 0.0 112.785 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -91.59 173.01 8.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.67 2.788 . . . . 0.0 110.807 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -120.11 135.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 163.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.69 153.39 18.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -134.43 130.12 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -137.5 94.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.83 80.64 1.47 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 123.176 1.465 . . . . 0.0 112.768 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -158.31 -84.37 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 130.16 3.384 . . . . 0.0 104.989 165.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.363 1.5 mt 52.96 -17.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 1 C-N-CA 131.829 4.051 . . . . 0.0 114.44 -174.56 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.22 6.63 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 120.975 1.716 . . . . 0.0 113.582 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.597 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 41.6 mttp -71.36 -17.58 62.42 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 118.259 -2.906 . . . . 0.0 113.663 -165.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tpp -106.87 20.99 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.501 1.521 . . . . 0.0 110.904 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.45 -20.63 7.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.825 1.65 . . . . 0.0 114.636 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.39 -31.28 2.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.259 1.824 . . . . 0.0 110.677 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.02 -4.23 58.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.191 -0.943 . . . . 0.0 113.173 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.26 139.47 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.208 3.003 . . . . 0.0 110.347 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -40.08 0.27 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -100.71 -22.12 15.0 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.773 -1.108 . . . . 0.0 110.731 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -63.57 0.9 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.122 1.769 . . . . 0.0 110.508 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 125' ' ' ILE . 2.8 mp -33.01 -59.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.76 2.024 . . . . 0.0 113.096 170.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -68.85 -55.28 11.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.781 1.232 . . . . 0.0 108.191 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.49 76.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.443 0.697 . . . . 0.0 111.163 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.03 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.068 1.347 . . . . 0.0 107.663 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -57.75 -36.66 72.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.369 -171.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -54.66 -61.83 2.05 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.516 1.053 . . . . 0.0 109.08 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.4 m -78.64 -13.88 59.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.052 0.941 . . . . 0.0 113.205 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.52 -18.02 63.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.574 1.079 . . . . 0.0 110.321 166.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -132.46 32.36 3.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.285 1.434 . . . . 0.0 108.983 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.77 134.84 53.0 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.27 107.01 2.36 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.861 3.041 . . . . 0.0 107.885 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.34 34.57 3.87 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.931 -1.483 . . . . 0.0 114.747 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.9 m -136.23 171.19 14.84 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 161.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.3 mt -141.09 106.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.15 135.88 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 119.028 0.831 . . . . 0.0 110.241 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.5 tp -132.7 148.81 52.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.205 2.202 . . . . 0.0 106.605 159.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.36 -171.92 44.94 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 119.198 0.908 . . . . 0.0 112.26 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -118.59 154.83 31.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.9 0.85 . . . . 0.0 111.458 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.61 125.38 15.27 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.398 2.279 . . . . 0.0 108.223 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.08 150.11 87.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.59 1.527 . . . . 0.0 110.55 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.97 130.06 64.97 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.28 -51.4 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.53 2.82 . . . . 0.0 110.457 -165.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 40.51 55.97 2.8 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.999 1.72 . . . . 0.0 110.982 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 157.6 -153.02 24.28 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 126.897 2.189 . . . . 0.0 107.648 -159.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.6 OUTLIER -63.93 166.85 8.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.092 0.446 . . . . 0.0 110.237 172.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.65 168.69 22.97 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.563 1.509 . . . . 0.0 109.182 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.75 176.81 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.772 2.029 . . . . 0.0 106.259 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.17 -79.15 0.37 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.3 tp -51.02 -44.07 60.97 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.984 1.313 . . . . 0.0 112.255 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.06 -31.16 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.265 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.75 -34.24 75.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.327 1.422 . . . . 0.0 109.805 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.11 -43.8 87.36 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.262 0.937 . . . . 0.0 111.271 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.57 -39.56 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.029 0.532 . . . . 0.0 109.834 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -60.78 -32.4 71.73 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.508 -1.37 . . . . 0.0 110.338 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -74.23 8.43 2.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.513 1.525 . . . . 0.0 113.501 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -34.74 10.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.556 1.526 . . . . 0.0 111.62 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 63.1 -19.67 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 128.602 2.761 . . . . 0.0 115.339 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -72.6 -30.67 64.57 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.639 3.175 . . . . 0.0 111.615 168.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 29.5 m -54.18 125.13 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.108 1.763 . . . . 0.0 107.618 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.35 112.17 5.06 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -97.93 96.13 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 120.856 1.662 . . . . 0.0 106.575 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.52 98.25 1.11 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.037 0.935 . . . . 0.0 108.743 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.17 99.49 0.9 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.85 165.82 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.92 . . . . 0.0 109.192 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.7 p -138.68 156.38 47.47 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.836 1.303 . . . . 0.0 108.288 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -42.27 -31.64 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.867 156.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -80.29 -55.8 4.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.469 0.577 . . . . 0.0 109.79 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -119.95 16.66 12.56 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.876 0.87 . . . . 0.0 110.288 -160.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -39.71 -63.06 0.62 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.791 2.036 . . . . 0.0 111.155 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -70.56 8.48 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 113.704 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.48 15.92 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.405 2.282 . . . . 0.0 110.201 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -32.04 10.36 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.632 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -37.98 -55.99 2.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.489 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.52 -23.27 57.76 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.335 1.512 . . . . 0.0 114.59 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -80.26 -38.54 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.454 1.501 . . . . 0.0 110.425 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.6 mt -59.74 -52.14 64.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.359 -0.838 . . . . 0.0 108.863 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.74 -43.77 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.149 0.98 . . . . 0.0 109.41 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.7 m -59.06 -43.65 91.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.114 0.87 . . . . 0.0 111.032 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.0 -48.13 81.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.104 0.562 . . . . 0.0 109.676 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.43 -52.45 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.301 1.04 . . . . 0.0 109.893 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -69.46 -5.94 27.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 188' ' ' ARG . 27.8 t -64.34 -71.2 0.18 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.6 t 48.75 -12.82 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.276 2.63 . . . . 0.0 116.013 -164.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 186' ' ' SER . 0.8 OUTLIER -151.05 -15.14 0.21 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 120.332 1.424 . . . . 0.0 113.604 -157.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 C--O 1.246 0.88 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.904 -175.395 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 113.47 26.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 166.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 23.43 91.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.092 2.157 . . . . 0.0 111.342 141.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.71 124.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -165.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -117.86 161.01 20.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 110.378 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.7 mt -124.84 154.57 40.82 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.203 1.401 . . . . 0.0 109.823 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -158.11 169.72 23.91 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.69 63.09 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 128.668 3.033 . . . . 0.0 111.874 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -54.21 118.49 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.468 3.445 . . . . 0.0 111.455 -166.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.24 -81.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.301 2.001 . . . . 0.0 114.451 -163.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.6 37.71 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t 50.99 68.77 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.919 1.688 . . . . 0.0 110.254 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.92 23.35 1.45 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.605 1.098 . . . . 0.0 111.039 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -83.91 -31.55 25.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.911 -0.758 . . . . 0.0 111.901 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -59.79 -38.16 81.1 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -56.99 -35.08 68.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 112.553 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -33.73 70.33 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mm -77.16 -31.07 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.6 1.091 . . . . 0.0 109.984 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -54.33 -51.42 64.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.706 1.593 . . . . 0.0 107.507 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -66.13 -15.18 62.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.7 -1.137 . . . . 0.0 112.374 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.2 64.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.45 1.023 . . . . 0.0 111.137 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -78.25 -48.35 15.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.284 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -50.34 -40.76 50.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.162 0.585 . . . . 0.0 111.172 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.65 -61.37 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 123.955 0.902 . . . . 0.0 109.486 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -55.48 -42.3 74.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 123.232 0.613 . . . . 0.0 109.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -60.39 -47.99 83.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -59.93 -42.05 93.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.168 0.987 . . . . 0.0 109.921 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -71.97 -7.28 47.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.593 1.557 . . . . 0.0 113.417 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.07 9.96 60.2 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.637 -1.09 . . . . 0.0 113.153 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.5 t -99.77 105.86 36.99 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.43 97.16 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.403 2.736 . . . . 0.0 110.948 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.59 147.27 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.686 1.194 . . . . 0.0 108.637 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -137.99 170.41 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.072 150.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.95 -162.58 28.1 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.227 0.917 . . . . 0.0 111.08 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -140.4 162.71 34.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.869 0.843 . . . . 0.0 111.128 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.2 157.83 45.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.932 1.293 . . . . 0.0 107.558 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.9 100.79 11.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -79.13 159.31 27.51 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.959 1.361 . . . . 0.0 109.086 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.17 99.78 8.73 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.348 169.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 48' ' ' GLY . 7.6 p -58.71 107.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.828 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -108.96 103.1 12.08 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 120.917 -1.115 . . . . 0.0 109.348 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.84 -37.86 89.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.786 0.721 . . . . 0.0 110.713 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.3 63.58 0.11 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.88 15.15 68.84 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.87 -1.517 . . . . 0.0 115.805 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 140.81 52.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.835 1.817 . . . . 0.0 107.075 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -78.12 98.23 5.72 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -78.18 -12.94 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 121.39 -0.819 . . . . 0.0 111.995 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' H ' HG13 ' A' ' 40' ' ' VAL . . . 172.95 -126.96 1.3 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -132.93 158.82 41.65 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.33 134.03 35.58 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.522 1.129 . . . . 0.0 109.715 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.6 101.97 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -167.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -90.03 132.76 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.3 p -95.96 156.26 16.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.2 8.99 3.4 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.291 -0.881 . . . . 0.0 112.541 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 t -109.89 4.34 21.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.996 1.319 . . . . 0.0 111.51 161.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.2 3.45 65.3 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.367 -1.458 . . . . 0.0 114.768 161.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -71.84 148.84 45.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.538 1.669 . . . . 0.0 107.194 162.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -139.32 131.79 28.62 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.926 1.29 . . . . 0.0 108.462 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.99 174.08 15.2 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.731 1.15 . . . . 0.0 113.861 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.75 165.18 21.69 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.609 1.539 . . . . 0.0 108.631 162.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 tp -140.74 -70.18 0.38 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.9 p -134.49 158.07 44.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.071 0.857 . . . . 0.0 108.927 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -147.43 157.64 43.66 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.535 1.134 . . . . 0.0 110.137 169.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 t -62.14 137.1 24.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 109.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.51 165.4 30.94 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.82 153.78 7.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.734 0.814 . . . . 0.0 109.504 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.12 163.99 56.62 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.669 0.388 . . . . 0.0 111.297 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -83.58 140.52 9.45 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.001 2.467 . . . . 0.0 110.739 -170.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.43 164.26 26.47 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.691 2.26 . . . . 0.0 110.524 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.63 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.841 2.361 . . . . 0.0 113.056 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.54 10.34 26.02 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.173 1.844 . . . . 0.0 113.114 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.63 165.67 26.33 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.951 1.875 . . . . 0.0 109.025 169.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.8 157.85 42.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.201 0.601 . . . . 0.0 110.275 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -166.92 -170.11 1.47 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 128.502 2.721 . . . . 0.0 105.95 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 92.6 m -98.02 126.73 43.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 139.7 33.19 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.884 -1.135 . . . . 0.0 108.718 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.2 92.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.871 1.669 . . . . 0.0 107.604 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.12 -73.93 1.92 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.37 0.986 . . . . 0.0 112.308 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.22 -25.65 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.439 1.495 . . . . 0.0 110.768 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.29 118.63 25.86 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.31 131.1 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 162.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.44 178.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 125.273 1.429 . . . . 0.0 108.745 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -147.28 155.53 42.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.46 161.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.79 -28.92 36.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.642 0.777 . . . . 0.0 110.448 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 m -64.28 -36.87 85.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.683 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.9 m -60.45 -31.74 70.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.591 1.087 . . . . 0.0 110.931 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -71.86 -53.9 11.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.518 167.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.05 -23.87 22.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.327 1.051 . . . . 0.0 113.488 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -42.54 -53.4 4.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.197 1.799 . . . . 0.0 112.04 167.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -31.88 0.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.369 1.068 . . . . 0.0 112.63 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.38 52.52 2.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.653 1.181 . . . . 0.0 108.664 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.47 -57.49 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 126.197 1.799 . . . . 0.0 109.606 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -37.18 5.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.834 1.689 . . . . 0.0 112.122 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 m -56.04 -35.73 42.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.935 0.894 . . . . 0.0 112.304 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -63.33 -38.29 90.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.54 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -129.5 76.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.823 1.249 . . . . 0.0 109.6 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -118.02 9.57 12.8 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.903 1.281 . . . . 0.0 111.388 -172.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.3 166.29 31.55 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.037 0.935 . . . . 0.0 112.042 160.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.83 -43.55 5.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.511 1.524 . . . . 0.0 110.768 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 6.0 t 60.09 54.13 4.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.124 2.169 . . . . 0.0 111.846 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -14.38 62.73 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -172.97 175.77 3.19 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.274 2.23 . . . . 0.0 108.325 168.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.36 130.88 5.7 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.322 1.439 . . . . 0.0 109.535 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.58 -179.72 3.95 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.304 2.003 . . . . 0.0 110.478 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.77 83.06 1.61 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 105.904 -2.878 . . . . 0.0 105.904 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -56.73 133.83 54.38 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 179.21 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.17 139.26 51.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 167.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.1 158.11 34.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.491 1.116 . . . . 0.0 108.461 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.7 t -142.19 127.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.411 1.085 . . . . 0.0 109.919 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 mt -149.48 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 125.659 1.583 . . . . 0.0 107.736 -167.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -79.77 174.65 11.37 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.347 -1.471 . . . . 0.0 112.476 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 57.02 20.12 5.19 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.109 2.564 . . . . 0.0 115.036 167.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mt -55.61 125.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.512 -1.368 . . . . 0.0 108.257 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.52 -34.56 1.96 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.063 1.316 . . . . 0.0 111.721 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -41.94 98.98 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.658 2.229 . . . . 0.0 110.469 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -83.48 16.72 2.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.915 1.686 . . . . 0.0 112.178 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -49.53 -39.74 35.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.644 1.565 . . . . 0.0 111.518 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.12 -49.8 6.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.544 0.738 . . . . 0.0 110.346 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -67.35 -24.02 65.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -55.66 141.32 38.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.544 1.138 . . . . 0.0 112.123 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -138.07 -82.0 0.33 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.817 0.847 . . . . 0.0 109.648 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.04 -12.45 60.33 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -60.0 3.64 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 111.482 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.401 ' H ' HD11 ' A' ' 125' ' ' ILE . 3.7 mp -35.89 -58.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 126.164 1.786 . . . . 0.0 112.338 170.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.31 -51.49 65.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.206 0.527 . . . . 0.0 110.188 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.56 83.65 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.472 -171.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.92 -46.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 121.878 -0.514 . . . . 0.0 110.148 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -52.31 -36.21 52.6 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.901 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -27.31 66.93 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 m -100.47 -31.72 11.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 116.669 -1.634 . . . . 0.0 111.49 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.74 -18.87 57.26 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.228 1.831 . . . . 0.0 111.505 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -68.33 -29.57 68.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.649 1.579 . . . . 0.0 110.082 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.6 m -63.82 142.33 98.07 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 126.435 1.894 . . . . 0.0 106.869 172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.21 16.67 0.29 Allowed 'Trans proline' 0 CA--C 1.541 0.867 1 C-N-CA 126.173 4.582 . . . . 0.0 111.608 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.79 -161.44 11.9 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -155.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.7 177.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.101 0.953 . . . . 0.0 109.808 -140.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.3 mt -137.25 103.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 1 N-CA-C 99.614 -4.217 . . . . 0.0 99.614 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 141.31 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.6 133.76 50.96 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.35 45.4 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.463 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 40.0 m -129.32 123.29 31.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.446 0.698 . . . . 0.0 109.177 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.67 165.46 32.93 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.945 1.698 . . . . 0.0 108.809 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.54 165.46 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.378 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.94 142.4 76.3 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.525 1.13 . . . . 0.0 108.518 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.35 104.09 1.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 121.409 1.406 . . . . 0.0 111.331 -156.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -99.44 162.04 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.479 1.112 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -24.88 -77.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 127.25 2.357 . . . . 0.0 114.967 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 138.08 22.63 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.86 164.23 35.42 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.809 1.673 . . . . 0.0 109.512 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.06 171.59 7.29 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.704 1.601 . . . . 0.0 109.31 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.53 -77.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 114.032 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -59.02 -33.09 70.34 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.68 -35.54 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 O-C-N 121.149 -0.969 . . . . 0.0 110.412 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.46 -23.08 65.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.39 1.476 . . . . 0.0 111.291 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -70.67 -42.36 70.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.737 1.153 . . . . 0.0 109.542 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.07 -48.28 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.769 0.828 . . . . 0.0 109.654 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.44 -22.24 66.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 110.486 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -28.56 68.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.994 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -65.63 -34.15 77.56 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.766 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? 67.66 -57.15 0.46 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.183 2.593 . . . . 0.0 111.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.87 77.68 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.248 1.819 . . . . 0.0 107.693 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.73 135.99 48.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 128.748 2.819 . . . . 0.0 105.064 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.87 136.76 38.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 164.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.33 96.8 4.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 120.157 1.344 . . . . 0.0 107.767 170.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -76.95 104.36 7.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.802 0.81 . . . . 0.0 109.039 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.71 106.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 160.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.14 154.05 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 167.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 22.5 p -102.88 159.93 15.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 157.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.22 -16.98 56.91 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.602 166.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -98.38 -56.77 2.37 Favored 'General case' 0 N--CA 1.458 -0.038 0 CA-C-N 118.386 0.539 . . . . 0.0 111.147 -166.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.5 17.66 5.19 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.484 1.114 . . . . 0.0 110.121 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -40.91 -46.11 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.283 1.833 . . . . 0.0 111.595 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.8 6.16 9.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 114.204 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.23 43.43 3.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.438 1.895 . . . . 0.0 109.887 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.6 tp -118.68 -42.2 2.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.23 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.96 -55.41 6.18 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.867 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.22 -27.21 56.4 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.419 1.9 . . . . 0.0 113.398 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -72.66 -42.07 64.73 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.704 1.202 . . . . 0.0 109.804 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.76 -52.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.912 1.685 . . . . 0.0 108.486 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.55 -44.01 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.388 0.994 . . . . 0.0 109.686 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.2 m -62.03 -49.22 76.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.898 0.772 . . . . 0.0 109.703 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.4 -42.17 91.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.504 1.122 . . . . 0.0 112.151 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.51 -53.74 29.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.576 1.951 . . . . 0.0 109.529 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -68.07 -23.49 64.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.849 0.86 . . . . 0.0 111.544 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.08 -52.45 4.27 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 127.698 2.399 . . . . 0.0 112.685 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.1 m 46.18 -96.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.052 1.296 . . . . 0.0 110.891 -158.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -122.33 -0.11 9.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.635 2.374 . . . . 0.0 112.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? . . . . . 0 C--O 1.245 0.835 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.833 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.82 140.48 44.24 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 126.119 1.768 . . . . 0.0 108.397 -171.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -64.42 146.75 54.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.934 1.694 . . . . 0.0 109.249 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -127.55 144.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -141.38 123.05 15.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.401 0.68 . . . . 0.0 110.784 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.4 152.5 44.01 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 t -152.93 -174.7 5.02 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.07 176.55 15.15 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.086 1.803 . . . . 0.0 111.316 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -73.98 156.02 47.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.528 2.152 . . . . 0.0 109.464 164.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 154.71 48.87 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.566 2.178 . . . . 0.0 111.103 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.96 8.51 6.38 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.315 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.274 82.2 t 66.29 120.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 127.536 2.334 . . . . 0.0 111.341 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.9 29.75 14.74 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.75 1.167 . . . . 0.0 112.586 -173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -63.77 -49.07 74.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.153 1.477 . . . . 0.0 111.838 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -45.13 -38.78 5.44 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.566 1.947 . . . . 0.0 111.221 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.3 m -49.31 -43.57 43.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.163 1.785 . . . . 0.0 111.9 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -32.79 64.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.165 1.348 . . . . 0.0 110.345 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.37 -45.13 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -50.6 72.57 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.957 1.703 . . . . 0.0 109.15 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.97 -34.4 78.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.25 60.5 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.734 1.152 . . . . 0.0 111.62 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -71.58 -48.93 45.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.354 0.662 . . . . 0.0 111.117 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.03 -33.88 69.45 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.34 1.056 . . . . 0.0 111.64 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.67 -53.71 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.419 1.488 . . . . 0.0 108.431 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.53 -38.9 89.1 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.456 0.703 . . . . 0.0 109.823 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.74 -43.48 94.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.911 0.778 . . . . 0.0 110.25 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -23.27 56.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.366 1.066 . . . . 0.0 111.837 169.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 m -97.72 18.08 16.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.825 2.05 . . . . 0.0 115.487 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.09 35.12 86.6 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.811 1.187 . . . . 0.0 111.435 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.24 158.79 87.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 120.846 -1.385 . . . . 0.0 109.884 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.23 101.7 0.63 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.588 2.859 . . . . 0.0 110.249 145.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.11 149.62 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 163.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 -179.03 7.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.533 0.733 . . . . 0.0 110.085 155.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.35 -151.0 22.31 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.893 1.235 . . . . 0.0 110.034 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -138.06 174.25 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.185 1.794 . . . . 0.0 109.457 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -143.6 159.49 42.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -116.15 74.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -157.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -71.89 137.97 47.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.861 0.838 . . . . 0.0 110.772 -163.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -68.95 113.77 6.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.626 1.571 . . . . 0.0 108.554 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.18 91.08 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -109.42 102.38 11.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.34 62.18 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.94 0.896 . . . . 0.0 110.168 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 66.4 1.92 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -162.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.66 -22.12 15.25 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -169.43 0.83 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.569 1.685 . . . . 0.0 110.561 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 89.79 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.685 1.584 . . . . 0.0 111.354 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.44 -10.07 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.195 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 -167.96 40.96 Favored Glycine 0 C--N 1.337 0.583 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.7 158.65 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.033 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -137.73 159.64 41.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.841 1.656 . . . . 0.0 108.288 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.9 100.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 121.236 1.835 . . . . 0.0 107.806 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -82.25 123.8 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -89.19 163.45 15.41 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.188 -0.945 . . . . 0.0 108.546 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.56 -16.63 60.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 120.637 -1.29 . . . . 0.0 112.005 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 t -63.21 -36.89 85.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.689 1.131 . . . . 0.0 108.334 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.79 6.26 17.09 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.108 0.861 . . . . 0.0 112.465 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.6 25.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -144.13 135.79 25.99 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.5 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.48 135.64 12.25 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.04 67.71 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 125.129 3.886 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.36 -67.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 125.317 1.447 . . . . 0.0 112.719 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 p -139.7 154.85 47.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.207 1.004 . . . . 0.0 110.657 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.07 159.72 43.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.268 1.827 . . . . 0.0 106.419 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -54.9 160.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 121.913 -0.492 . . . . 0.0 110.457 160.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.67 -142.15 3.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.22 174.55 7.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.529 1.132 . . . . 0.0 109.915 164.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -124.24 156.88 66.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.216 1.406 . . . . 0.0 110.842 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.05 142.55 8.8 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.037 1.824 . . . . 0.0 110.544 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.79 166.26 20.81 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.115 2.543 . . . . 0.0 110.699 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.92 69.19 4.67 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.427 3.418 . . . . 0.0 112.931 -172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -55.35 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 125.447 1.499 . . . . 0.0 109.691 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -55.54 157.73 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.839 2.056 . . . . 0.0 110.15 163.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.93 153.74 37.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.667 1.987 . . . . 0.0 106.98 159.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -155.18 96.23 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 96.1 m 46.03 35.45 2.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.269 2.628 . . . . 0.0 115.665 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.19 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.542 -1.349 . . . . 0.0 108.008 -170.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.49 87.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 -67.78 1.36 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.823 1.201 . . . . 0.0 112.242 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -137.1 -36.0 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.151 2.18 . . . . 0.0 111.22 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.68 170.02 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.348 0.976 . . . . 0.0 108.937 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.59 120.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.33 176.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.914 0.864 . . . . 0.0 110.136 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -142.62 109.94 5.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -32.49 74.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.589 1.156 . . . . 0.0 109.609 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -54.0 -48.97 69.87 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.26 1.824 . . . . 0.0 108.618 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.6 t -55.88 -22.44 25.57 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 120.409 1.458 . . . . 0.0 113.316 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -79.11 -60.84 2.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.521 1.055 . . . . 0.0 109.182 168.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.51 -26.78 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.745 2.018 . . . . 0.0 113.139 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -61.8 -28.36 69.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 114.676 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.39 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.616 0.766 . . . . 0.0 112.924 -171.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.55 52.81 1.01 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.563 1.145 . . . . 0.0 108.798 166.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.62 -61.1 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 126.437 1.895 . . . . 0.0 108.444 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -42.01 36.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.187 1.925 . . . . 0.0 112.459 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.28 -20.62 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.898 0.772 . . . . 0.0 113.037 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.74 74.28 6.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.19 94.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.443 2.697 . . . . 0.0 111.741 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -128.19 120.17 26.72 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.681 1.592 . . . . 0.0 108.132 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.47 15.56 2.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.75 -30.31 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.187 3.795 . . . . 0.0 116.885 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 23.5 t -69.28 -77.6 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -154.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.4 m 57.5 -26.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.187 2.291 . . . . 0.0 117.187 -168.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m 58.17 163.8 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.5 1.5 . . . . 0.0 111.894 -145.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.31 -87.04 0.52 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.64 145.49 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 119.781 1.791 . . . . 0.0 109.556 168.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.62 -7.53 55.55 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -147.55 166.1 28.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.195 0.997 . . . . 0.0 111.428 -169.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -142.47 170.34 15.89 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 127.209 2.204 . . . . 0.0 108.121 -169.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.19 128.27 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 36.6 t -108.85 154.22 22.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -137.73 123.35 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.616 0.767 . . . . 0.0 110.203 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.4 mt -148.46 85.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.455 1.502 . . . . 0.0 108.693 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -86.46 164.75 16.79 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.918 -1.739 . . . . 0.0 111.164 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 56.6 58.02 4.43 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.587 2.355 . . . . 0.0 111.992 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.3 mt -87.12 49.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 121.03 -1.044 . . . . 0.0 108.687 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.74 3.93 1.38 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-O 118.257 -1.302 . . . . 0.0 115.082 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -103.64 -77.76 0.56 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.455 2.127 . . . . 0.0 110.848 -173.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -52.46 -18.76 1.81 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.317 1.447 . . . . 0.0 113.771 168.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -32.24 -60.6 0.27 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.523 2.329 . . . . 0.0 113.105 -167.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.55 -29.34 69.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.318 0.963 . . . . 0.0 112.254 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -95.34 -17.64 21.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.807 1.643 . . . . 0.0 112.746 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.0 p -54.56 151.94 7.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.915 1.286 . . . . 0.0 110.88 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -132.54 -89.68 0.42 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.468 1.107 . . . . 0.0 109.27 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -56.08 -21.33 21.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 117.098 -1.43 . . . . 0.0 112.296 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -62.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 120.906 1.685 . . . . 0.0 110.707 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.5 mp -41.81 -58.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.135 1.374 . . . . 0.0 110.364 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -65.31 -39.15 92.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -166.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.05 -51.91 12.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.14 0.9 . . . . 0.0 108.936 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.57 -34.07 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 O-C-N 121.909 -0.494 . . . . 0.0 111.054 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.33 -43.45 61.73 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.217 169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.19 -45.35 83.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.568 1.531 . . . . 0.0 111.167 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.7 m -65.74 -46.86 77.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.945 0.898 . . . . 0.0 110.892 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.2 mt -62.87 -25.7 68.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 110.938 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 t -76.9 -9.08 58.44 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.588 1.555 . . . . 0.0 110.766 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.0 m -91.41 134.24 29.92 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.34 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.949 2.432 . . . . 0.0 111.577 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.7 -32.57 49.93 Favored Glycine 0 C--O 1.218 -0.896 0 CA-C-O 117.242 -1.866 . . . . 0.0 112.811 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.0 m -66.74 138.69 57.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 122.101 2.951 . . . . 0.0 107.975 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -122.65 84.44 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 101.51 -3.515 . . . . 0.0 101.51 -166.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.98 117.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mt -102.87 133.09 48.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 151.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.68 171.23 29.06 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 44.2 m -122.23 101.67 7.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.906 0.853 . . . . 0.0 108.72 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.9 pt -86.35 151.22 53.32 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.036 0.934 . . . . 0.0 108.785 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.7 145.3 36.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.927 2.418 . . . . 0.0 110.043 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.86 139.65 93.63 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 165.27 32.5 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.171 2.581 . . . . 0.0 110.601 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.77 -38.24 0.28 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.154 0.981 . . . . 0.0 111.041 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.77 139.5 4.69 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.479 -1.849 . . . . 0.0 108.479 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.09 163.75 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.729 1.611 . . . . 0.0 113.505 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.44 165.76 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.53 3.486 . . . . 0.0 109.959 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.03 171.58 7.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.32 -82.58 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.797 0.726 . . . . 0.0 109.214 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.31 -40.88 65.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.25 -0.906 . . . . 0.0 113.166 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.86 -28.06 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.544 -0.722 . . . . 0.0 110.48 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.92 -32.05 72.41 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.915 0.78 . . . . 0.0 109.632 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -60.98 -33.88 73.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.566 1.076 . . . . 0.0 112.137 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 108.54 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -59.05 -34.74 72.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.612 0.642 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.93 -25.71 58.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.219 1.807 . . . . 0.0 112.809 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.828 1.195 . . . . 0.0 111.483 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -54.47 0.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.782 2.033 . . . . 0.0 113.758 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -72.3 42.91 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.691 2.796 . . . . 0.0 111.486 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.66 103.21 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 130.503 3.521 . . . . 0.0 104.796 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.45 131.97 48.67 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.05 116.78 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.236 1.014 . . . . 0.0 109.159 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -106.17 82.09 1.71 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.578 2.351 . . . . 0.0 107.664 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 117.81 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 120.906 -1.121 . . . . 0.0 108.102 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.43 153.78 4.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 p -110.7 158.22 18.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -66.32 -19.01 65.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.25 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -83.29 -38.02 22.68 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 118.099 0.409 . . . . 0.0 111.18 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.11 15.18 19.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.699 1.2 . . . . 0.0 111.325 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -49.49 -52.13 31.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.314 1.046 . . . . 0.0 109.315 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.3 4.57 2.78 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -124.47 3.4 8.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.132 0.973 . . . . 0.0 113.127 172.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.2 -19.11 37.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.398 0.999 . . . . 0.0 113.624 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -56.01 26.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.52 -1.228 . . . . 0.0 110.183 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.37 -27.15 63.12 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.623 1.615 . . . . 0.0 113.302 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.76 -40.67 75.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.601 1.16 . . . . 0.0 109.435 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.9 mt -63.95 -53.05 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.701 1.2 . . . . 0.0 107.977 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.25 -42.71 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.695 1.198 . . . . 0.0 109.767 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -55.13 39.13 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 125.479 1.512 . . . . 0.0 108.857 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 9.1 t -52.99 -41.3 64.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.123 0.874 . . . . 0.0 111.311 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.92 -53.51 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.691 1.196 . . . . 0.0 108.994 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -62.52 -34.59 77.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.075 1.307 . . . . 0.0 113.124 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.3 m -64.9 8.25 0.13 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 129.987 3.315 . . . . 0.0 113.482 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.2 p -123.12 145.94 48.16 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.856 -1.153 . . . . 0.0 108.156 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 58.76 -20.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.418 2.687 . . . . 0.0 115.528 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt . . . . . 0 C--O 1.251 1.15 0 CA-C-N 121.156 1.798 . . . . 0.0 106.952 164.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -163.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.052 1.741 . . . . 0.0 108.43 160.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -50.37 156.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.088 2.155 . . . . 0.0 111.214 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.1 t -141.7 143.17 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -142.92 161.83 37.09 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.97 1.708 . . . . 0.0 110.006 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.25 157.57 16.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 160.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -141.78 -178.96 5.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.815 1.646 . . . . 0.0 107.469 162.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.86 -170.73 14.99 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.02 115.86 4.51 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.356 2.704 . . . . 0.0 108.669 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.32 97.28 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.654 1.569 . . . . 0.0 110.601 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.39 -57.95 16.75 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t 176.09 -45.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 129.086 2.954 . . . . 0.0 109.309 163.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.44 8.99 30.42 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 123.706 0.669 . . . . 0.0 114.22 -167.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -38.67 75.43 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.728 1.264 . . . . 0.0 111.759 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.0 m -64.8 -37.12 86.53 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.34 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -64.77 -33.58 76.31 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.498 1.499 . . . . 0.0 110.222 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 177' ' ' LEU . 59.9 mt -60.65 -57.52 12.35 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.199 0.599 . . . . 0.0 109.754 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 mm -70.76 -38.39 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 122.989 0.516 . . . . 0.0 109.693 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.93 -61.93 1.86 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.159 2.184 . . . . 0.0 108.587 172.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.3 -32.15 72.85 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.435 -1.269 . . . . 0.0 111.853 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.31 78.45 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 120.16 1.346 . . . . 0.0 109.265 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.7 p -70.96 -45.1 64.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.097 -0.954 . . . . 0.0 108.991 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.35 -37.54 70.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.49 1.495 . . . . 0.0 112.139 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.56 -54.85 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 125.879 1.672 . . . . 0.0 108.848 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.18 -32.94 74.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.76 -0.588 . . . . 0.0 109.92 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -62.68 -36.39 82.77 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.008 -1.683 . . . . 0.0 110.738 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -38.13 85.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 110.081 165.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.52 5.36 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.121 1.369 . . . . 0.0 114.251 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.16 52.56 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 120.274 1.397 . . . . 0.0 111.662 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.03 142.06 57.79 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.62 94.26 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.316 1.344 . . . . 0.0 109.086 160.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.15 139.58 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.268 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.02 169.6 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.461 1.505 . . . . 0.0 107.818 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.44 25.74 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -143.83 162.93 34.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.002 1.321 . . . . 0.0 107.513 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -140.59 110.28 6.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -70.23 134.41 48.01 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.05 44.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.52 -0.737 . . . . 0.0 110.832 -171.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.34 146.15 50.69 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -122.58 105.22 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -123.14 80.06 1.73 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 126.486 1.915 . . . . 0.0 110.005 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -65.04 -24.26 67.43 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.836 -1.165 . . . . 0.0 112.666 -166.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.97 45.64 0.73 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 166.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.31 89.24 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.717 -1.046 . . . . 0.0 114.21 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.64 124.7 46.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 119.55 1.675 . . . . 0.0 108.459 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -60.75 92.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.675 1.59 . . . . 0.0 110.608 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.64 -16.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 111.127 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.49 -166.17 39.37 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -130.9 160.98 32.87 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.084 1.753 . . . . 0.0 106.404 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.86 161.49 30.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.775 2.03 . . . . 0.0 105.998 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.97 110.02 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 167.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.32 162.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.976 1.262 . . . . 0.0 108.06 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -125.43 160.0 30.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.011 1.324 . . . . 0.0 108.154 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.18 -21.38 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.452 172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -62.25 -26.48 68.41 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.63 1.105 . . . . 0.0 111.062 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.01 5.77 57.22 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.187 1.375 . . . . 0.0 111.864 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -84.34 159.77 20.82 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 120.987 -1.302 . . . . 0.0 107.774 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 147.83 26.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -174.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.82 -178.09 21.03 Favored Glycine 0 CA--C 1.521 0.44 0 O-C-N 123.948 0.78 . . . . 0.0 112.726 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.24 169.31 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.737 2.958 . . . . 0.0 112.429 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tp -150.0 -66.93 0.21 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.98 -1.075 . . . . 0.0 109.705 161.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -150.11 125.62 10.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -128.55 165.71 20.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.617 1.167 . . . . 0.0 108.198 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.6 120.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.73 -119.73 2.06 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.77 157.3 47.19 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.39 1.476 . . . . 0.0 107.44 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -86.65 166.43 27.4 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.641 1.576 . . . . 0.0 110.808 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.77 139.47 14.01 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.434 2.756 . . . . 0.0 108.699 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.43 172.22 14.83 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.766 2.311 . . . . 0.0 110.765 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.21 99.54 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.86 1.706 . . . . 0.0 108.245 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.44 -79.11 0.35 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 124.902 1.239 . . . . 0.0 110.494 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.73 125.56 23.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.364 1.082 . . . . 0.0 108.752 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 138.47 32.56 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.62 -163.16 1.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.42 -178.31 3.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 157.41 167.16 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 131.133 3.773 . . . . 0.0 105.849 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 -13.21 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 123.866 0.729 . . . . 0.0 109.663 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.96 134.43 3.57 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.044 -2.822 . . . . 0.0 106.044 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.51 -68.02 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.626 2.37 . . . . 0.0 111.571 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.03 149.38 30.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.857 1.663 . . . . 0.0 108.205 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.01 132.05 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.45 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.773 0.829 . . . . 0.0 110.275 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -154.39 105.39 2.66 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -21.62 65.06 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.149 -0.97 . . . . 0.0 111.865 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.1 m -37.24 -45.82 0.68 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.526 1.93 . . . . 0.0 112.243 156.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 p -76.66 -34.43 58.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.395 0.998 . . . . 0.0 109.175 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.2 -41.81 93.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.98 -1.075 . . . . 0.0 109.718 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.84 -9.1 58.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.832 1.196 . . . . 0.0 113.625 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.46 -68.18 0.38 Allowed 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 161.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mp -102.22 -44.8 5.32 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.814 -0.554 . . . . 0.0 111.539 -158.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.48 49.3 1.77 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.463 1.905 . . . . 0.0 108.553 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.52 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 109.864 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.61 -33.47 45.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.883 1.722 . . . . 0.0 112.517 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -59.82 -24.73 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.533 1.133 . . . . 0.0 112.868 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.06 -11.17 60.45 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.301 0.501 . . . . 0.0 111.269 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 88.02 1.99 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.97 159.42 15.33 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.86 0.864 . . . . 0.0 109.166 167.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.81 157.38 45.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.609 1.164 . . . . 0.0 110.13 167.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.43 ' N ' HH12 ' A' ' 107' ' ' ARG . 2.1 m-20 -159.05 -67.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.629 1.571 . . . . 0.0 107.446 167.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.16 -176.95 5.3 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.264 1.425 . . . . 0.0 109.628 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.4 t -65.74 157.46 30.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.449 0.7 . . . . 0.0 109.172 165.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.8 m -50.86 -54.08 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.824 1.649 . . . . 0.0 112.134 -164.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.09 -169.64 1.8 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.245 1.402 . . . . 0.0 113.093 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.33 110.71 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 108.08 -1.546 . . . . 0.0 108.08 162.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 154.7 -81.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 68.4 124.46 0.03 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.012 2.125 . . . . 0.0 108.845 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.43 HH12 ' N ' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -60.61 164.9 4.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.517 1.127 . . . . 0.0 108.812 172.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.69 146.82 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 139' ' ' ILE . 5.7 p -115.84 163.78 15.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.938 0.875 . . . . 0.0 110.449 161.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.8 125.88 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -141.52 74.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.04 167.47 21.75 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.88 27.95 10.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 114.103 164.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.7 mt -70.14 75.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.186 1.394 . . . . 0.0 108.227 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.2 -47.58 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.826 -1.171 . . . . 0.0 113.45 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -69.75 -40.14 76.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.345 2.073 . . . . 0.0 111.914 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -12.72 60.94 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 116.291 -1.814 . . . . 0.0 112.618 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -47.07 -24.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -156.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 -22.19 13.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.426 1.09 . . . . 0.0 112.119 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -99.06 -29.01 13.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.964 1.706 . . . . 0.0 109.745 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -45.45 114.5 0.76 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.803 2.841 . . . . 0.0 108.348 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.13 -86.59 0.5 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 119.864 1.211 . . . . 0.0 111.16 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.54 -10.35 57.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.934 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -53.06 -52.14 59.5 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 120.866 1.666 . . . . 0.0 112.151 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mt -39.17 -54.63 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 127.384 2.274 . . . . 0.0 112.552 164.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -63.63 -54.26 38.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.904 1.229 . . . . 0.0 110.593 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.48 -49.26 78.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 123.24 0.338 . . . . 0.0 111.095 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.62 -30.06 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.907 0.883 . . . . 0.0 111.611 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -40.02 60.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.493 168.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -38.07 86.9 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.663 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.51 -48.8 63.45 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.923 1.238 . . . . 0.0 110.472 175.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.3 mt -58.02 -32.47 67.98 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.464 1.906 . . . . 0.0 111.98 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.5 m -129.32 30.24 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.62 1.568 . . . . 0.0 110.019 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.45 165.1 55.39 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 149.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -87.33 126.48 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.541 2.828 . . . . 0.0 109.298 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.07 89.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 116.929 -2.039 . . . . 0.0 116.263 158.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 m -72.14 166.9 21.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 121.827 2.814 . . . . 0.0 108.492 155.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.0 mt -131.83 104.25 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.402 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 41.2 mm -67.5 132.08 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.42 1.075 . . . . 0.0 108.117 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tp -140.56 136.06 32.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 107.82 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.61 41.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 113.341 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -128.56 130.73 47.8 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.169 0.987 . . . . 0.0 108.863 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.73 163.87 18.22 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.967 1.707 . . . . 0.0 108.152 165.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.01 161.07 11.72 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.37 2.713 . . . . 0.0 111.332 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.61 139.34 93.95 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 165.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.01 159.5 33.99 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.489 2.793 . . . . 0.0 108.891 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -142.3 -65.94 0.4 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.81 -122.93 0.94 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 125.208 1.385 . . . . 0.0 111.096 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.52 171.1 1.88 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.38 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.52 168.0 19.3 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.271 1.314 . . . . 0.0 109.099 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.54 137.07 52.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.84 -63.36 1.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.93 0.892 . . . . 0.0 111.751 -156.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.95 -40.8 98.75 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.93 -28.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.686 -0.634 . . . . 0.0 110.269 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.83 -29.92 63.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.724 0.81 . . . . 0.0 110.807 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.17 -38.79 90.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.539 1.063 . . . . 0.0 112.095 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.95 -41.94 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.86 1.264 . . . . 0.0 108.338 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -18.36 65.34 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.087 -1.633 . . . . 0.0 111.532 -174.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.76 -22.01 61.66 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.825 0.739 . . . . 0.0 110.273 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -73.9 83.93 1.7 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.35 -28.77 69.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.851 -1.156 . . . . 0.0 109.305 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -76.12 56.62 1.03 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.47 3.108 . . . . 0.0 110.651 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.77 126.5 62.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 105.05 1.34 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 161.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.1 t -88.91 98.1 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -68.41 147.24 52.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.77 125.06 48.36 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.67 159.87 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 167.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 p -128.13 149.76 50.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -58.23 -16.08 12.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.953 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -80.68 -68.75 0.65 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.195 0.907 . . . . 0.0 108.569 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.19 28.46 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.887 1.275 . . . . 0.0 109.523 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -59.58 -23.44 62.94 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.24 9.75 21.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.749 1.62 . . . . 0.0 112.057 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.63 -13.48 15.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 115.94 -1.981 . . . . 0.0 113.86 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 tt -84.58 -20.04 32.11 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 116.167 -2.213 . . . . 0.0 111.795 -154.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.444 ' H ' HD23 ' A' ' 17' ' ' LEU . 12.1 tp -25.27 -64.99 0.1 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 128.872 2.869 . . . . 0.0 113.529 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.09 -28.03 85.15 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.854 2.369 . . . . 0.0 113.18 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.84 -42.53 90.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.676 1.125 . . . . 0.0 109.538 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.62 -50.07 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 125.382 1.473 . . . . 0.0 108.032 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.83 -37.0 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.5 1.045 . . . . 0.0 111.035 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 86.8 m -60.46 -47.51 85.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 6.9 t -62.8 -29.02 70.4 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.004 0.82 . . . . 0.0 111.344 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.65 -52.19 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.232 1.013 . . . . 0.0 110.316 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -34.4 71.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.98 1.264 . . . . 0.0 111.368 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 -8.81 48.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.677 1.991 . . . . 0.0 111.813 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.13 -15.84 57.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.647 -1.283 . . . . 0.0 111.452 166.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -85.43 -53.72 5.02 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.97 163.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.429 -1.748 . . . . 0.0 109.073 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 187' ' ' SER . . . . . . . . 0 CA--C 1.504 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.44 173.7 3.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 123.25 1.5 . . . . 0.0 107.555 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -72.99 149.61 43.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.99 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.5 t -126.78 133.85 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -136.37 121.16 18.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.501 0.667 . . . . 0.0 110.611 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.21 155.75 34.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.908 1.283 . . . . 0.0 109.101 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -161.46 -179.43 7.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.978 164.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.57 -107.29 1.12 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.383 1.944 . . . . 0.0 109.465 170.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.06 174.67 8.57 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.811 3.007 . . . . 0.0 111.746 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.21 -177.8 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.817 2.344 . . . . 0.0 110.681 164.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.73 55.44 1.32 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 126.764 2.126 . . . . 0.0 110.771 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.27 52.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.004 1.321 . . . . 0.0 107.857 156.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.63 59.78 1.41 Allowed Glycine 0 C--N 1.335 0.481 0 O-C-N 119.801 -1.812 . . . . 0.0 110.364 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -38.99 4.15 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.5 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.2 m -55.44 -44.0 75.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.71 1.204 . . . . 0.0 109.893 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.7 m -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.355 -1.466 . . . . 0.0 113.295 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -44.54 72.39 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 120.722 1.601 . . . . 0.0 108.559 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.34 -37.41 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.945 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -53.12 -47.81 68.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.386 0.994 . . . . 0.0 110.361 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -30.41 70.68 Favored 'General case' 0 C--O 1.227 -0.088 0 O-C-N 122.338 -0.226 . . . . 0.0 110.95 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -27.2 69.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.379 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.9 p -74.91 -53.38 9.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.656 1.116 . . . . 0.0 108.02 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -48.88 -45.47 41.21 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.582 1.953 . . . . 0.0 112.11 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.64 -45.51 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.258 0.551 . . . . 0.0 110.956 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.69 -37.0 76.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.024 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.77 -43.66 81.02 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -26.77 67.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.667 1.187 . . . . 0.0 112.81 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -5.73 53.45 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.761 0.824 . . . . 0.0 112.092 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.12 88.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.763 1.173 . . . . 0.0 113.643 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.32 127.6 85.99 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 119.589 1.694 . . . . 0.0 107.681 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.98 130.31 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.844 2.363 . . . . 0.0 109.577 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.65 137.6 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.78 167.87 16.68 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.528 1.531 . . . . 0.0 107.673 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' H ' HG23 ' A' ' 94' ' ' VAL . . . 129.92 -160.76 22.93 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.35 165.44 27.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -128.09 -178.6 4.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 162.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -140.12 137.43 34.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.35 156.3 44.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.56 111.97 7.29 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.72 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.71 124.91 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -124.61 125.42 44.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.91 1.684 . . . . 0.0 107.627 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -69.18 -39.4 78.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.944 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.21 39.16 0.41 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.969 1.747 . . . . 0.0 109.545 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.14 26.07 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.536 1.541 . . . . 0.0 114.855 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 142.84 35.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.816 1.308 . . . . 0.0 110.833 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -64.82 129.98 41.76 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 125.162 1.538 . . . . 0.0 111.539 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.5 pt -137.23 -11.77 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.874 1.67 . . . . 0.0 112.973 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.18 -167.37 36.09 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 119.255 0.934 . . . . 0.0 112.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -139.26 123.97 18.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.127 2.171 . . . . 0.0 106.79 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.74 144.72 25.4 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.37 111.96 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 119.729 1.15 . . . . 0.0 108.367 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.34 110.46 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.603 0.361 . . . . 0.0 110.056 -152.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -74.74 155.65 37.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.713 1.244 . . . . 0.0 108.808 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.19 -13.63 62.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.103 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.98 9.85 15.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.904 1.682 . . . . 0.0 111.791 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.1 82.4 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 120.738 -1.226 . . . . 0.0 114.27 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.21 161.21 19.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.839 1.319 . . . . 0.0 107.589 169.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.98 144.38 26.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 117.737 -1.125 . . . . 0.0 109.534 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.94 154.19 21.23 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.16 1.345 . . . . 0.0 111.89 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.07 66.98 8.76 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.022 3.815 . . . . 0.0 111.98 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -57.8 8.9 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 126.761 2.024 . . . . 0.0 111.128 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.507 ' HG ' ' HA ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -144.87 141.38 29.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.02 164.65 31.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.086 0.954 . . . . 0.0 109.55 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.62 136.79 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.21 165.55 30.37 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.753 -2.939 . . . . 0.0 105.753 171.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 165.54 13.64 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -69.04 153.41 96.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.658 -0.652 . . . . 0.0 109.67 166.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.17 125.56 10.4 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.735 2.957 . . . . 0.0 110.98 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.01 174.84 11.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.557 2.838 . . . . 0.0 111.446 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.65 125.61 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 108.835 -1.256 . . . . 0.0 108.835 169.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.31 5.2 82.9 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.833 -0.981 . . . . 0.0 114.755 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 132.59 20.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.189 1.995 . . . . 0.0 105.618 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -152.55 -179.46 7.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 164.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.89 -160.8 1.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 7.4 m -88.84 160.66 17.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.653 1.115 . . . . 0.0 108.879 162.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 158.91 40.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -165.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.98 99.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 32.16 81.32 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.104 2.288 . . . . 0.0 115.605 166.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 97.06 -57.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.431 0 C-N-CA 130.168 3.387 . . . . 0.0 109.554 -171.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -82.58 155.98 24.19 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.917 -0.489 . . . . 0.0 110.346 -169.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.92 133.58 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 165.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.507 ' HA ' ' HG ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -87.0 167.84 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.81 116.0 7.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.229 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -27.6 66.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.233 0.47 . . . . 0.0 111.247 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -41.18 -47.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.136 1.774 . . . . 0.0 111.103 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.8 p -70.15 -36.69 74.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.538 -0.726 . . . . 0.0 111.135 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.39 -52.01 67.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -66.69 -10.11 43.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.922 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.61 -38.25 83.69 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 120.717 -1.24 . . . . 0.0 113.05 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 -41.62 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.609 0.64 . . . . 0.0 110.129 -167.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.32 53.38 2.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.013 0.925 . . . . 0.0 109.441 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.4 -66.09 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.66 1.184 . . . . 0.0 109.325 156.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.43 -11.11 30.54 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.798 2.332 . . . . 0.0 113.126 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -67.64 -26.06 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.143 -1.598 . . . . 0.0 110.651 172.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.8 -13.53 60.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.537 1.135 . . . . 0.0 111.634 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -179.44 119.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.824 2.45 . . . . 0.0 109.154 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.23 139.08 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.427 2.291 . . . . 0.0 107.308 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 50.48 -160.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.273 1.029 . . . . 0.0 110.863 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 156.78 88.04 0.0 OUTLIER 'General case' 0 C--O 1.234 0.276 0 C-N-CA 130.308 3.443 . . . . 0.0 108.573 164.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.27 170.85 15.49 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.972 2.509 . . . . 0.0 108.695 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 p -72.35 98.16 2.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.528 1.058 . . . . 0.0 109.218 170.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 m -151.49 -60.94 0.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.009 -1.057 . . . . 0.0 111.548 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.73 65.89 0.42 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-O 117.725 -1.597 . . . . 0.0 110.935 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.13 177.05 8.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.377 3.385 . . . . 0.0 111.213 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 103.35 -154.95 18.04 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -150.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -141.27 152.88 44.87 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.048 -1.266 . . . . 0.0 111.324 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -108.01 172.47 6.82 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.536 2.335 . . . . 0.0 108.886 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.6 t -135.35 149.48 28.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.8 t -123.27 107.75 12.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.4 0.68 . . . . 0.0 109.351 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.1 124.88 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.431 1.092 . . . . 0.0 108.305 165.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -142.26 125.18 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -145.26 -179.39 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.417 -0.802 . . . . 0.0 109.665 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.27 40.64 10.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.752 1.621 . . . . 0.0 110.573 -167.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.51 78.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.38 -83.77 0.05 OUTLIER Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -61.34 -19.15 61.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.167 1.484 . . . . 0.0 113.98 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 89.3 mmm -76.31 7.06 4.66 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.196 -1.383 . . . . 0.0 112.526 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -47.68 -26.82 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.12 -18.76 12.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.361 1.064 . . . . 0.0 111.912 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -19.97 18.03 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.648 0.779 . . . . 0.0 110.568 -171.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 m -50.17 116.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.556 1.543 . . . . 0.0 107.963 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.21 -80.7 0.37 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.256 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.44 -23.95 66.21 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.82 1.191 . . . . 0.0 110.694 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -65.12 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.907 2.083 . . . . 0.0 111.472 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.512 ' H ' HD12 ' A' ' 125' ' ' ILE . 3.6 mp -39.45 -62.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 126.204 1.802 . . . . 0.0 111.932 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.81 -50.8 72.4 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.43 0.559 . . . . 0.0 110.641 -172.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.45 -50.14 68.69 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.181 0.992 . . . . 0.0 109.715 -170.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.24 -46.34 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.149 0.979 . . . . 0.0 108.466 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.055 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -58.01 -49.88 75.32 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.111 1.323 . . . . 0.0 110.941 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -63.24 -29.08 70.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.448 -0.783 . . . . 0.0 111.132 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.6 -30.63 67.36 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.909 -1.12 . . . . 0.0 111.053 173.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -23.56 64.1 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.26 0.936 . . . . 0.0 110.934 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.8 m -79.96 133.7 57.7 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -32.67 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.21 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.45 -17.63 33.26 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.879 -1.512 . . . . 0.0 114.643 -166.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.6 m -77.72 165.55 24.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.107 2.453 . . . . 0.0 107.697 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.0 mt -136.94 101.83 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -172.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.3 mm -72.08 135.24 28.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.56 124.23 19.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.257 1.823 . . . . 0.0 106.988 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.12 28.81 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-N 120.909 1.686 . . . . 0.0 114.826 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -129.25 113.21 14.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.86 152.73 42.5 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.63 0.772 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -70.42 149.97 63.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.784 1.656 . . . . 0.0 108.476 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.03 126.07 92.21 Favored Pre-proline 0 N--CA 1.441 -0.906 0 O-C-N 121.925 -0.485 . . . . 0.0 110.617 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.18 108.39 2.47 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 108.328 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -152.8 -36.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.778 0.831 . . . . 0.0 110.126 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.28 -66.91 0.85 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.695 1.14 . . . . 0.0 111.512 -167.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 158.2 75.69 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 124.286 1.034 . . . . 0.0 108.242 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.38 149.51 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.956 3.104 . . . . 0.0 109.875 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.51 135.44 52.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -64.37 0.84 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.304 1.442 . . . . 0.0 111.528 -172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.29 -35.4 75.46 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.648 -0.657 . . . . 0.0 111.417 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 -43.65 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 119.109 0.868 . . . . 0.0 109.4 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -55.43 -41.55 72.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -55.76 -28.81 57.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.667 1.121 . . . . 0.0 113.087 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.14 -39.64 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.486 1.514 . . . . 0.0 109.415 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.19 62.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.768 1.227 . . . . 0.0 110.19 177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.71 -39.77 5.41 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 127.786 2.434 . . . . 0.0 112.769 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.77 -32.13 70.47 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.062 -1.023 . . . . 0.0 111.093 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.7 -36.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.63 2.372 . . . . 0.0 113.389 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -63.32 -30.19 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.548 1.539 . . . . 0.0 114.154 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.2 m -55.2 130.37 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.124 1.329 . . . . 0.0 110.793 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HE3' ' CD1' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -55.15 115.81 2.44 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.67 102.08 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 171.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.523 ' CD1' ' HE3' ' A' ' 164' ' ' LYS . 32.0 m-85 -83.38 87.11 6.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 162.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 94.07 0.3 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 162.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.89 167.08 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p -124.6 153.07 42.74 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 165.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -61.46 -14.4 28.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.616 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.19 -62.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.824 1.193 . . . . 0.0 108.696 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.36 18.92 3.49 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 124.601 1.16 . . . . 0.0 111.561 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -50.11 -43.84 51.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.979 -1.075 . . . . 0.0 113.305 -161.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -86.34 13.88 7.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.934 2.493 . . . . 0.0 114.806 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -131.66 16.94 4.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.511 1.924 . . . . 0.0 111.813 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.6 tp -84.09 -42.98 15.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.094 172.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -42.88 -58.78 3.55 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.377 1.871 . . . . 0.0 110.781 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.8 -25.02 78.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.036 2.491 . . . . 0.0 115.44 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.8 -46.6 57.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.431 1.493 . . . . 0.0 108.247 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.79 -53.37 45.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.245 1.418 . . . . 0.0 109.847 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.88 -45.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.823 0.738 . . . . 0.0 109.691 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.2 m -57.9 -45.63 86.14 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.57 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.95 -40.59 76.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.016 1.28 . . . . 0.0 110.859 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.06 -51.61 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.338 1.055 . . . . 0.0 109.83 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.576 ' NE2' ' HZ3' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -66.25 -31.2 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.519 0.728 . . . . 0.0 112.116 -177.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 m -57.05 -51.72 68.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.549 1.14 . . . . 0.0 108.197 170.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.466 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 8.4 t -63.07 -14.33 46.89 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.554 -1.341 . . . . 0.0 113.818 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -75.86 -51.96 11.4 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 120.474 1.488 . . . . 0.0 110.812 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.576 ' HZ3' ' NE2' ' A' ' 185' ' ' GLN . 5.9 ptpt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.485 -1.245 . . . . 0.0 110.176 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -77.66 127.58 32.7 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 161.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -67.07 158.45 31.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.008 1.723 . . . . 0.0 108.377 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.45 139.09 48.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' CE2' ' HA3' ' A' ' 141' ' ' GLY . 17.7 m-85 -130.63 136.74 49.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.281 1.032 . . . . 0.0 109.265 172.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -78.17 157.82 29.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -152.07 169.44 22.37 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.543 0.687 . . . . 0.0 110.887 163.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.94 -171.93 37.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.09 168.37 22.17 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.785 2.323 . . . . 0.0 110.104 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.51 160.08 49.55 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.836 1.691 . . . . 0.0 111.074 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 39.73 72.88 0.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 126.999 2.238 . . . . 0.0 112.937 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.319 0.9 OUTLIER -131.11 -2.54 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.551 0.741 . . . . 0.0 112.835 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.29 19.24 19.27 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.973 -1.079 . . . . 0.0 112.634 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -51.75 67.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.432 1.616 . . . . 0.0 109.265 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -64.36 -29.56 70.63 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.788 -0.625 . . . . 0.0 109.666 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -58.48 -47.57 83.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.836 1.198 . . . . 0.0 111.681 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -46.92 87.27 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -68.2 -38.51 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.272 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -53.44 -55.9 21.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.148 1.379 . . . . 0.0 108.269 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -51.2 -42.82 61.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.065 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.81 57.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.368 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -60.9 -56.98 14.77 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.933 0.788 . . . . 0.0 108.982 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.84 -31.8 68.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.319 2.248 . . . . 0.0 110.982 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.75 -50.96 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.848 1.659 . . . . 0.0 110.537 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.56 -34.47 77.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.982 0.81 . . . . 0.0 109.311 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -71.08 -20.9 62.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.649 1.18 . . . . 0.0 113.199 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -86.8 -7.56 58.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.873 1.669 . . . . 0.0 111.82 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -114.4 2.66 14.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.789 1.236 . . . . 0.0 112.792 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.43 43.18 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 119.657 1.117 . . . . 0.0 112.07 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.15 108.19 24.52 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.26 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.335 2.69 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.59 169.03 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.145 0.978 . . . . 0.0 109.987 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 162.48 39.97 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.994 154.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.97 -165.66 31.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.353 0.977 . . . . 0.0 111.032 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.08 168.09 20.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.452 0.644 . . . . 0.0 111.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -143.31 152.97 42.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 108.352 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.0 p -77.11 124.9 28.47 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 157.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -104.7 139.11 40.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 160.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -73.67 147.03 44.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.602 0.715 . . . . 0.0 110.052 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.41 98.7 4.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -125.53 153.39 43.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -128.29 -60.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.083 1.353 . . . . 0.0 107.728 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.57 31.87 8.21 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.703 1.62 . . . . 0.0 110.69 167.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.61 14.67 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.288 1.423 . . . . 0.0 114.409 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 142.89 34.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.498 1.649 . . . . 0.0 108.691 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.08 135.23 55.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.952 0.796 . . . . 0.0 108.893 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -124.67 -17.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.776 1.23 . . . . 0.0 111.997 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.09 -152.99 21.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.69 161.89 36.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.286 5.9 p30 -131.26 142.8 50.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -90.28 93.55 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 125.457 1.503 . . . . 0.0 108.004 -173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 t -84.97 147.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -107.23 162.89 13.48 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.751 1.22 . . . . 0.0 109.223 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -31.41 72.13 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.343 -0.848 . . . . 0.0 111.56 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.8 t -65.09 -25.29 67.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.229 1.011 . . . . 0.0 110.101 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.0 -2.64 44.5 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.666 -1.074 . . . . 0.0 112.976 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.9 m -60.74 151.09 30.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.3 1.55 . . . . 0.0 108.478 163.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 155.33 50.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.891 1.277 . . . . 0.0 111.685 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.404 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -139.22 164.71 25.85 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.034 0.834 . . . . 0.0 113.685 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.13 -2.56 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.945 3.097 . . . . 0.0 115.109 -165.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 24.93 -79.26 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.76 3.624 . . . . 0.0 115.311 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 p -130.2 147.87 51.98 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.006 0.821 . . . . 0.0 110.279 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -148.17 158.87 44.32 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.097 1.359 . . . . 0.0 108.67 -172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -62.57 148.76 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.44 71.55 0.02 OUTLIER Glycine 0 C--N 1.34 0.781 0 CA-C-N 119.487 1.039 . . . . 0.0 114.503 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.42 -159.34 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.789 1.236 . . . . 0.0 110.163 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.71 156.67 62.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.907 1.683 . . . . 0.0 109.848 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 132.72 22.39 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 110.7 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -66.7 175.64 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.651 2.234 . . . . 0.0 111.708 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.43 -36.43 15.55 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.05 1.833 . . . . 0.0 111.318 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.33 -59.31 6.37 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -168.42 1.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.438 0.619 . . . . 0.0 110.985 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.37 147.75 32.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.0 0.92 . . . . 0.0 109.314 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -165.01 -163.69 0.72 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.361 1.465 . . . . 0.0 107.668 151.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 78.4 m -109.61 110.73 21.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.423 1.889 . . . . 0.0 108.97 -172.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.69 136.67 53.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.966 1.257 . . . . 0.0 108.746 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 t -125.63 102.75 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 24.91 84.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 C-N-CA 128.139 2.781 . . . . 0.0 114.781 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 95.73 -59.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.675 3.59 . . . . 0.0 109.219 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.46 146.91 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.648 1.179 . . . . 0.0 109.761 -166.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.12 112.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 166.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.7 p -71.98 -179.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 O-C-N 121.266 -0.896 . . . . 0.0 109.012 166.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 86' ' ' SER . 6.2 t0 -150.75 145.64 25.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 161.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.5 -39.12 77.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.843 1.257 . . . . 0.0 107.709 167.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.6 m -54.02 -44.89 71.34 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.114 0.566 . . . . 0.0 109.875 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 70.6 m -64.31 -17.69 63.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.19 0.905 . . . . 0.0 112.43 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.24 -60.42 2.37 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.715 0.806 . . . . 0.0 109.928 161.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -45.05 -33.05 1.94 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.09 2.156 . . . . 0.0 113.525 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.65 -40.36 62.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.696 0.68 . . . . 0.0 112.021 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' CD2' ' HA3' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -140.48 -32.29 0.59 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -168.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 41.1 0.96 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.768 2.027 . . . . 0.0 109.557 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.82 -59.63 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 125.544 1.538 . . . . 0.0 108.496 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.48 -37.78 96.2 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.951 1.767 . . . . 0.0 111.926 170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.4 m -55.64 -31.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.91 0.777 . . . . 0.0 112.435 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.69 -36.42 60.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.412 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -156.1 92.43 1.35 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -71.98 164.39 26.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.41 119.92 23.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.723 0.809 . . . . 0.0 109.652 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -80.18 127.98 32.97 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.382 0.673 . . . . 0.0 111.867 -163.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.17 164.26 36.11 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.704 1.202 . . . . 0.0 109.467 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.01 127.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.236 2.615 . . . . 0.0 111.722 172.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.6 p -66.63 163.17 19.47 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.594 0.758 . . . . 0.0 111.162 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 150.45 -97.93 0.18 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.63 -177.7 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.411 2.741 . . . . 0.0 110.769 168.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -117.67 -62.26 0.3 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -70.84 167.6 18.6 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.059 0.944 . . . . 0.0 110.232 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -139.09 -179.38 5.82 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.547 1.139 . . . . 0.0 108.993 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.0 t -127.48 144.37 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.5 t -125.85 143.08 51.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.873 2.069 . . . . 0.0 106.977 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.3 t -138.96 132.87 40.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.28 135.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 33.5 t0 -133.06 -172.95 3.06 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.125 -1.609 . . . . 0.0 107.462 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 115' ' ' GLY . 2.3 mm-40 56.45 -81.46 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 129.202 3.001 . . . . 0.0 110.675 -156.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.291 38.4 mt 53.98 -10.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 128.133 2.573 . . . . 0.0 112.944 -169.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 113' ' ' GLU . . . -83.46 -59.78 2.09 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.942 2.211 . . . . 0.0 111.103 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -52.54 -29.19 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.387 1.475 . . . . 0.0 114.035 -168.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.35 4.73 41.82 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.216 -1.373 . . . . 0.0 112.657 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -24.81 -64.24 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 129.108 2.963 . . . . 0.0 114.594 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.86 -34.31 17.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.928 0.491 . . . . 0.0 111.16 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.75 -27.34 61.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.571 1.148 . . . . 0.0 112.444 -169.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.3 p -51.16 120.48 5.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.367 1.867 . . . . 0.0 111.727 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.7 -92.92 0.52 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.74 -6.36 15.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.752 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -65.38 0.6 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.331 1.453 . . . . 0.0 110.386 171.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 125' ' ' ILE . 3.5 mp -35.76 -59.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.158 1.783 . . . . 0.0 112.724 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -59.75 -52.12 66.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.48 87.54 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.83 -59.07 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.858 1.263 . . . . 0.0 109.253 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -57.9 -37.91 74.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.504 1.047 . . . . 0.0 111.913 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -34.44 76.8 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.804 -0.56 . . . . 0.0 110.712 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.0 m -81.53 -30.29 33.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.27 0.941 . . . . 0.0 111.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.83 -21.33 63.07 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.41 1.005 . . . . 0.0 110.83 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 t -93.16 -8.97 41.0 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.458 2.303 . . . . 0.0 112.363 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.5 m -62.06 135.5 94.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.19 -36.32 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.401 2.067 . . . . 0.0 111.425 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.09 6.28 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.9 m 43.52 166.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.784 2.434 . . . . 0.0 113.272 -154.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.8 mt -144.91 114.0 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.9 131.69 34.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.4 96.46 5.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 158.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -113.95 171.9 14.05 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.26 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.4 m -134.63 134.22 40.97 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.34 156.93 66.3 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.712 1.605 . . . . 0.0 109.572 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.13 150.31 37.42 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.86 1.707 . . . . 0.0 110.209 169.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.69 151.75 60.82 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 123.77 0.828 . . . . 0.0 110.733 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.1 162.73 38.84 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.702 2.935 . . . . 0.0 108.901 166.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -156.97 -61.01 0.09 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -118.45 -118.67 2.84 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 151.85 88.77 Favored Pre-proline 0 C--O 1.237 0.436 0 CA-C-N 117.966 0.883 . . . . 0.0 111.329 -172.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -59.04 156.25 35.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.173 2.582 . . . . 0.0 109.936 167.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.95 139.38 49.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.057 1.343 . . . . 0.0 107.408 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -70.35 0.11 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.901 1.68 . . . . 0.0 113.174 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 tp -56.7 -39.77 74.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.522 -0.736 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.0 -31.13 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.218 0.917 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -61.78 -29.4 70.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.378 1.444 . . . . 0.0 110.289 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.07 -23.07 67.28 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.317 0.962 . . . . 0.0 112.089 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.05 -47.0 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -68.1 -11.55 59.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.989 -1.07 . . . . 0.0 112.393 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -76.58 -10.51 59.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 123.911 0.884 . . . . 0.0 113.144 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -74.56 87.54 2.12 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.728 1.149 . . . . 0.0 109.292 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 52.02 0.49 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.482 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -153.48 -12.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 111.2 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.51 137.84 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.566 -1.334 . . . . 0.0 109.965 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.47 134.46 43.92 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.7 t -115.22 79.49 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.31 91.09 0.24 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.676 1.59 . . . . 0.0 110.765 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.75 147.18 52.36 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 164.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.8 p -122.31 171.69 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 123.253 1.501 . . . . 0.0 109.238 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.21 128.18 29.5 Favored 'General case' 0 N--CA 1.435 -1.214 1 C-N-CA 131.864 4.066 . . . . 0.0 102.888 -178.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -46.05 -24.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.288 1.835 . . . . 0.0 112.248 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.69 -70.76 0.41 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.911 0.884 . . . . 0.0 109.472 -172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.09 17.58 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.352 2.261 . . . . 0.0 111.852 -173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -52.5 -44.93 65.97 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -162.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -77.66 3.43 13.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -87.93 -8.04 56.3 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.608 1.163 . . . . 0.0 111.72 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.1 -34.34 26.15 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 120.672 1.578 . . . . 0.0 112.441 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -57.6 7.39 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.17 -1.395 . . . . 0.0 109.89 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.97 -27.48 58.2 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.179 1.814 . . . . 0.0 113.114 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.4 -42.35 65.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.343 0.974 . . . . 0.0 109.261 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.6 mt -53.12 -55.86 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 125.313 1.445 . . . . 0.0 109.297 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.12 -33.84 66.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.785 0.72 . . . . 0.0 110.523 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 88.6 m -63.78 -48.96 74.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.876 0.87 . . . . 0.0 108.715 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -56.32 -37.24 69.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.161 1.384 . . . . 0.0 110.12 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.25 -55.92 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.988 0.915 . . . . 0.0 110.681 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.46 -21.46 65.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.722 1.146 . . . . 0.0 112.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 73.9 m -58.0 -33.78 69.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.261 0.937 . . . . 0.0 113.045 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.436 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 47.5 m -92.01 -5.89 52.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.238 0.927 . . . . 0.0 112.42 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -86.44 -51.74 6.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.117 -0.989 . . . . 0.0 110.356 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 O-C-N 123.944 0.777 . . . . 0.0 110.985 -156.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.89 73.25 7.91 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 59.38 164.75 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.016 2.526 . . . . 0.0 112.116 173.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -138.74 139.96 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 O-C-N 120.139 -1.6 . . . . 0.0 107.953 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -138.65 157.01 46.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.022 0.929 . . . . 0.0 110.993 168.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.04 131.02 55.41 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.627 1.171 . . . . 0.0 108.257 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.57 165.5 25.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.797 0.439 . . . . 0.0 110.375 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 68.56 1.61 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.01 1.29 . . . . 0.0 112.431 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.55 121.55 8.06 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 CA-C-N 120.652 2.226 . . . . 0.0 109.616 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.57 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.968 1.778 . . . . 0.0 113.148 -171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.47 15.59 6.35 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.141 -0.81 . . . . 0.0 111.726 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t 65.75 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.985 1.85 . . . . 0.0 109.412 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.43 -11.51 0.04 OUTLIER Glycine 0 CA--C 1.529 0.937 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.753 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE2' ' H ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -57.19 -15.99 7.03 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.27 -1.135 . . . . 0.0 113.225 172.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.402 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -56.01 -38.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.066 2.146 . . . . 0.0 110.608 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 m -71.05 -29.59 65.52 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.286 -0.884 . . . . 0.0 109.103 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.78 -52.81 62.7 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mm -58.96 -43.9 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -49.17 -63.59 1.06 Allowed 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -36.68 77.17 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.67 0.606 . . . . 0.0 111.754 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.77 88.57 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 120.262 1.392 . . . . 0.0 109.723 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -67.89 -47.69 68.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.751 0.82 . . . . 0.0 109.458 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.3 -36.56 61.34 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.678 1.191 . . . . 0.0 112.234 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.5 -45.32 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.592 -0.693 . . . . 0.0 110.494 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.17 -36.75 80.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.82 -44.74 90.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.4 t -58.76 -36.47 74.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.89 1.676 . . . . 0.0 110.446 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 t -77.24 -2.37 34.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.813 1.645 . . . . 0.0 112.556 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.04 13.04 72.38 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.589 1.086 . . . . 0.0 113.102 -174.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.8 122.95 87.36 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 119.247 1.524 . . . . 0.0 107.19 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.14 118.83 5.87 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.842 2.362 . . . . 0.0 109.63 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -115.66 141.12 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 107.761 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.09 167.88 16.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 163.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.11 -161.96 25.98 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -145.07 166.95 23.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.783 1.292 . . . . 0.0 111.794 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -137.43 177.82 7.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.445 1.02 . . . . 0.0 110.004 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.6 p -139.65 74.62 1.48 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.016 1.389 . . . . 0.0 110.534 -168.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -76.35 23.63 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.118 2.167 . . . . 0.0 115.581 -163.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.316 7.8 pt-20 51.72 113.67 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.795 2.838 . . . . 0.0 114.023 -162.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.86 121.28 21.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.087 -1.008 . . . . 0.0 108.439 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -131.6 120.71 23.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -86.62 -2.61 58.65 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.359 0.6 . . . . 0.0 111.186 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.66 65.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 -171.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.61 -5.36 1.7 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.486 2.469 . . . . 0.0 117.075 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 147.5 22.91 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 120.023 1.912 . . . . 0.0 108.278 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -74.4 139.21 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 161.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -17.53 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.863 1.265 . . . . 0.0 111.587 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.6 -128.63 1.73 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 165.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -138.91 153.62 48.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 171.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -130.39 152.63 49.59 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.294 2.638 . . . . 0.0 106.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.52 107.91 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 119.539 1.063 . . . . 0.0 110.511 -162.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.1 109.4 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.879 -157.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.3 p -75.97 145.79 40.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -15.54 62.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.643 . . . . 0.0 111.735 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t -62.05 -45.41 93.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 108.912 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.78 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.037 0.827 . . . . 0.0 112.587 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 169.35 15.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.125 1.37 . . . . 0.0 110.167 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -152.65 138.7 18.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.109 1.764 . . . . 0.0 107.881 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.85 173.08 22.01 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 120.142 1.337 . . . . 0.0 112.022 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 168.04 18.35 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.607 2.205 . . . . 0.0 109.176 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.54 -59.33 0.08 Allowed 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -141.42 153.4 44.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.461 0.573 . . . . 0.0 109.711 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -138.47 159.26 42.52 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.334 1.054 . . . . 0.0 109.296 170.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.97 128.89 24.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.8 164.27 26.77 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.56 167.03 4.68 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.751 0.786 . . . . 0.0 109.45 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.83 144.95 80.26 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.59 132.7 27.76 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.279 1.986 . . . . 0.0 109.175 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 165.8 29.64 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.548 2.165 . . . . 0.0 110.009 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 80.16 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.75 2.3 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.02 -83.65 0.11 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 131.72 49.82 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -146.67 137.41 23.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -159.26 63.23 0.39 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.7 m 59.45 -159.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.573 1.549 . . . . 0.0 109.585 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER 157.57 155.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 1 C-N-CA 131.75 4.02 . . . . 0.0 109.758 166.268 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.33 100.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -170.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.36 -63.4 2.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.296 1.427 . . . . 0.0 113.684 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.33 -18.94 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 111.556 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.09 169.35 10.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 25.6 t -110.68 115.08 48.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 166.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.5 170.63 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 166.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.41 141.77 39.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 163.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.11 -34.6 73.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.905 0.882 . . . . 0.0 109.298 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -36.72 84.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.695 0.679 . . . . 0.0 111.27 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 m -61.08 -34.99 75.8 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.538 1.063 . . . . 0.0 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.51 -61.87 2.04 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.219 0.208 . . . . 0.0 110.614 165.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -22.42 25.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.196 1.398 . . . . 0.0 113.216 -169.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -45.87 -48.98 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.086 0.954 . . . . 0.0 112.121 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -31.21 0.95 Allowed 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.84 1.256 . . . . 0.0 111.239 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.96 86.04 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 119.615 1.098 . . . . 0.0 110.587 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -52.38 68.11 Favored Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 120.285 -1.509 . . . . 0.0 112.168 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.32 -16.94 21.79 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.503 1.469 . . . . 0.0 113.797 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -41.97 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 122.022 2.192 . . . . 0.0 109.042 169.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.39 -38.48 78.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -155.39 91.02 1.29 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.993 1.269 . . . . 0.0 111.172 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -95.73 163.81 13.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 154.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 23.97 101.88 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.33 2.652 . . . . 0.0 115.1 158.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.59 -61.14 2.63 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.8 p 36.79 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.351 3.46 . . . . 0.0 118.088 159.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 m -41.59 -44.71 3.13 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.638 1.975 . . . . 0.0 112.361 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 m 46.68 83.58 0.03 OUTLIER 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.47 2.308 . . . . 0.0 111.58 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.97 -167.58 34.49 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -160.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.12 119.2 6.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.234 2.622 . . . . 0.0 109.573 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -136.64 99.2 0.3 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -73.38 159.05 33.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.382 1.091 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 -137.54 171.52 14.33 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.138 1.775 . . . . 0.0 108.103 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.96 151.26 34.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.12 153.0 39.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.9 t -135.89 117.84 20.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 108.223 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.69 63.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -65.98 -48.72 70.32 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.74 65.64 2.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.467 1.507 . . . . 0.0 112.668 -167.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 90.8 mt -108.64 147.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 120.159 -1.588 . . . . 0.0 107.016 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 -80.14 0.36 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-O 118.827 -0.985 . . . . 0.0 111.353 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -59.65 -25.58 64.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.205 1.503 . . . . 0.0 111.842 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.86 -10.29 51.82 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 115.118 -2.372 . . . . 0.0 113.353 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -49.62 -17.32 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -159.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.82 -23.17 9.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.831 1.252 . . . . 0.0 112.557 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -87.88 -31.33 19.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.356 1.462 . . . . 0.0 111.154 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.53 117.8 2.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.944 1.698 . . . . 0.0 109.553 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -120.56 -64.21 1.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.642 0.656 . . . . 0.0 111.808 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.37 -14.86 60.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.552 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.56 -73.42 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.646 1.978 . . . . 0.0 112.128 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -42.66 -37.41 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.856 1.662 . . . . 0.0 113.294 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -73.58 -68.97 0.46 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.187 0.903 . . . . 0.0 110.558 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.65 -41.65 77.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 112.29 -167.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.3 -51.46 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.201 1.4 . . . . 0.0 108.407 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -63.3 -30.99 72.02 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.062 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.05 -57.02 14.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.245 1.384 . . . . 0.0 108.943 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 m -65.51 -29.51 70.16 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.845 -0.534 . . . . 0.0 112.359 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.0 -30.15 66.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.711 0.687 . . . . 0.0 110.495 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.9 t -64.12 -35.2 80.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.322 1.049 . . . . 0.0 109.543 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.0 m -73.16 133.08 81.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.807 0.731 . . . . 0.0 109.906 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.09 -30.21 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.824 2.349 . . . . 0.0 112.854 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.48 -31.25 34.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.208 -1.329 . . . . 0.0 113.398 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 m -73.26 162.87 28.87 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.672 1.736 . . . . 0.0 108.395 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.0 mt -140.57 98.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.74 145.49 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.426 0.557 . . . . 0.0 109.715 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 115.24 11.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.042 2.137 . . . . 0.0 106.495 167.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.12 25.01 Favored Glycine 0 N--CA 1.464 0.543 0 CA-C-N 120.34 1.427 . . . . 0.0 112.708 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.9 m -117.36 87.42 2.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.34 110.73 16.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.36 158.52 57.17 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.79 153.11 95.68 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.36 -77.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.413 2.075 . . . . 0.0 107.926 166.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? 153.45 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.392 1 C-N-CA 131.798 4.039 . . . . 0.0 104.234 -168.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.53 0.05 OUTLIER Glycine 0 CA--C 1.5 -0.845 0 O-C-N 124.105 0.878 . . . . 0.0 114.908 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.433 ' HE3' ' N ' ' A' ' 149' ' ' LYS 0.33 0.0 OUTLIER -165.31 172.28 4.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 130.391 3.476 . . . . 0.0 105.903 163.067 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 149' ' ' LYS . 57.2 Cg_endo -67.96 162.16 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 1 C-N-CA 125.337 4.025 . . . . 0.0 109.466 165.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.52 175.27 5.54 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.054 -1.029 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.62 16.75 25.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 112.447 172.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.48 -53.52 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.421 1.088 . . . . 0.0 108.268 168.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.78 -21.14 27.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.661 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -48.18 -39.9 22.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.472 1.109 . . . . 0.0 111.357 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -25.72 66.21 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.848 1.259 . . . . 0.0 111.136 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.01 -38.05 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.244 1.418 . . . . 0.0 108.901 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -28.44 69.33 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.802 -1.186 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -52.71 -47.93 66.96 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 125.069 1.348 . . . . 0.0 110.565 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 78.2 5.9 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -56.94 -13.48 2.71 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.559 0.743 . . . . 0.0 111.557 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -39.04 56.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.193 2.197 . . . . 0.0 111.955 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -48.55 128.82 4.77 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 125.602 1.561 . . . . 0.0 109.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 46.8 tptt -61.13 106.68 0.63 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 166.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -83.52 105.34 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 163.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.436 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 36.8 m-85 -75.9 92.89 3.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 163.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 107.15 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 162.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.76 163.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.6 p -122.92 154.33 38.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.217 0.917 . . . . 0.0 108.999 164.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.65 1.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.784 1.633 . . . . 0.0 113.034 162.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -92.58 -36.81 12.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.347 0.976 . . . . 0.0 111.243 171.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -127.0 7.57 6.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 113.665 -159.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -44.36 -55.36 5.03 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.613 1.565 . . . . 0.0 115.064 -164.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -83.8 18.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.923 1.238 . . . . 0.0 113.164 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -131.56 13.95 4.96 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 117.244 -1.36 . . . . 0.0 113.788 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.1 -13.9 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.663 1.574 . . . . 0.0 112.483 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.1 tp -30.44 -62.06 0.24 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.826 2.05 . . . . 0.0 111.627 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.78 -27.81 43.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.935 1.756 . . . . 0.0 112.774 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -70.05 -39.54 75.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.363 0.983 . . . . 0.0 108.988 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.419 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 3.7 mt -57.93 -58.8 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 117.583 -1.199 . . . . 0.0 107.942 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.457 ' HA ' ' CG2' ' A' ' 184' ' ' VAL . 9.1 t -57.12 -27.55 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.897 0.771 . . . . 0.0 111.521 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.7 m -67.48 -29.16 68.52 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.756 -1.215 . . . . 0.0 112.35 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 25.9 t -90.66 -33.72 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.393 -1.442 . . . . 0.0 108.514 -167.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -63.9 -63.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 125.244 1.418 . . . . 0.0 108.423 164.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -15.43 63.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 112.984 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.3 t -49.56 -37.97 29.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.229 1.412 . . . . 0.0 110.138 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -30.53 70.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.84 0.746 . . . . 0.0 112.078 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.71 -3.08 58.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.8 1.24 . . . . 0.0 112.003 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? . . . . . 0 C--O 1.249 1.079 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 167.07 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 -104.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -131.57 153.11 50.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.47 140.85 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.937 1.244 . . . . 0.0 108.9 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -133.87 146.92 51.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.152 0.981 . . . . 0.0 109.799 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.44 151.38 19.78 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 123.897 0.748 . . . . 0.0 109.265 157.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -151.08 179.89 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.29 1.436 . . . . 0.0 107.994 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.92 -176.92 24.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 122.22 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.856 2.371 . . . . 0.0 112.337 -167.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.82 91.09 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.944 3.763 . . . . 0.0 112.972 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.96 74.76 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.263 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 10.2 p 22.8 78.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.568 2.747 . . . . 0.0 113.542 159.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.31 -36.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.901 1.715 . . . . 0.0 109.348 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -34.85 76.77 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.25 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 m -56.48 -44.5 80.69 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.323 -1.322 . . . . 0.0 108.948 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -53.9 -36.97 63.29 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 120.067 1.303 . . . . 0.0 111.904 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.17 69.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.942 1.247 . . . . 0.0 110.614 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.24 -43.36 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -52.42 65.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.214 1.406 . . . . 0.0 109.37 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -53.03 -45.68 68.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.655 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.85 27.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.638 -1.173 . . . . 0.0 113.943 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.5 p -80.54 -51.53 8.66 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 120.056 1.298 . . . . 0.0 110.296 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.87 -32.46 67.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.06 0.544 . . . . 0.0 111.067 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.87 -64.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.006 1.322 . . . . 0.0 108.367 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 mt -52.22 -41.31 62.62 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.965 1.306 . . . . 0.0 110.09 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -66.47 -46.26 76.96 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -34.29 75.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.019 0.927 . . . . 0.0 110.54 172.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 m -61.8 -41.73 98.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.446 1.021 . . . . 0.0 110.433 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.44 9.21 10.5 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 126.343 1.925 . . . . 0.0 112.745 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.46 130.81 73.15 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.04 139.61 43.17 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.908 1.739 . . . . 0.0 109.106 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.65 157.35 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.574 1.55 . . . . 0.0 107.804 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 174.76 13.71 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.109 -0.37 . . . . 0.0 111.916 163.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.83 -158.07 22.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 124.92 1.248 . . . . 0.0 111.087 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -146.13 162.82 37.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.115 1.366 . . . . 0.0 108.753 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -149.54 125.36 10.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.687 1.195 . . . . 0.0 107.961 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -84.73 70.46 10.81 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 120.919 -1.113 . . . . 0.0 109.559 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -79.44 48.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -166.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 52.14 -174.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.431 2.062 . . . . 0.0 112.62 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.0 t -125.13 93.58 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 150.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -91.42 103.5 16.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 160.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -79.6 104.4 10.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 165.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.93 50.71 11.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.33 0.968 . . . . 0.0 111.713 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.27 -13.95 18.33 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 117.369 -1.795 . . . . 0.0 115.891 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.73 129.43 39.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.254 2.527 . . . . 0.0 109.369 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -86.35 68.18 10.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.433 1.111 . . . . 0.0 112.735 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 pt -89.63 -2.46 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -168.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.67 -166.07 32.22 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 120.187 1.358 . . . . 0.0 111.797 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -138.54 149.54 45.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.9 153.65 51.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.86 154.47 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 164.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -140.32 154.81 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.841 2.057 . . . . 0.0 106.639 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.7 p -117.77 174.95 5.89 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.755 2.07 . . . . 0.0 110.7 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.81 21.3 0.55 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.915 -1.115 . . . . 0.0 112.537 168.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -126.38 -12.76 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 -2.31 27.74 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.61 1.096 . . . . 0.0 112.935 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.87 160.41 32.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.865 1.832 . . . . 0.0 110.065 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.22 164.22 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.517 1.927 . . . . 0.0 107.251 165.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.75 140.63 9.66 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -82.78 63.89 8.01 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.282 3.988 . . . . 0.0 111.745 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.539 ' N ' ' HG ' ' A' ' 86' ' ' SER . 1.4 tp -54.96 -63.66 1.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.104 1.761 . . . . 0.0 111.598 -170.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 p -143.59 152.49 41.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.867 1.212 . . . . 0.0 109.764 172.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 168.83 18.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.04 129.08 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.17 45.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 -164.74 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.701 1.6 . . . . 0.0 109.219 -175.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -129.11 154.87 80.52 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 168.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.09 125.31 12.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.604 2.203 . . . . 0.0 111.612 -163.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.56 162.94 39.98 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.225 1.95 . . . . 0.0 110.488 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.47 137.35 46.41 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.038 1.825 . . . . 0.0 109.639 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.36 -1.99 73.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.968 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -99.43 163.0 12.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.534 1.667 . . . . 0.0 107.544 163.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -141.3 145.66 35.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 162.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -155.23 -175.33 5.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.9 2.08 . . . . 0.0 107.179 166.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.68 162.56 28.78 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 119.679 -1.888 . . . . 0.0 109.98 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -168.87 135.04 1.75 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.757 1.223 . . . . 0.0 107.705 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.27 15.59 6.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 118.112 0.414 . . . . 0.0 110.294 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 76' ' ' ARG . . . 94.9 114.76 2.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.837 -2.505 . . . . 0.0 106.837 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 68.32 -51.42 0.55 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.588 2.355 . . . . 0.0 113.602 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.54 157.7 16.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.737 2.015 . . . . 0.0 108.391 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.86 123.17 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 171.26 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 110.555 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -156.61 107.71 2.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.918 0.781 . . . . 0.0 112.881 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.6 -35.48 4.05 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.857 1.662 . . . . 0.0 113.054 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -34.45 74.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.936 -1.102 . . . . 0.0 112.048 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 28.8 t -58.15 -38.66 77.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.622 1.556 . . . . 0.0 110.562 174.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -64.46 -46.63 82.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.513 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -52.38 -30.1 27.26 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.739 0.699 . . . . 0.0 111.91 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.76 -29.97 67.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.23 -0.919 . . . . 0.0 113.184 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.15 -44.68 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.439 0.563 . . . . 0.0 111.862 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.97 37.54 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.998 1.719 . . . . 0.0 112.05 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.99 -65.18 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 127.068 2.147 . . . . 0.0 108.053 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.09 -27.48 79.07 Favored 'Trans proline' 0 C--N 1.351 0.676 0 CA-C-N 121.562 1.593 . . . . 0.0 112.965 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.31 -24.71 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.727 0.811 . . . . 0.0 112.599 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.109 0.868 . . . . 0.0 111.335 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -133.31 72.95 1.49 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.692 1.234 . . . . 0.0 108.705 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.11 129.49 34.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.367 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.83 166.87 18.23 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.743 168.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -166.26 -174.62 2.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.332 1.853 . . . . 0.0 106.788 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 5.3 p 52.27 -0.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 131.369 3.868 . . . . 0.0 117.855 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t 87.74 15.0 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.809 2.844 . . . . 0.0 110.879 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.35 33.4 p 77.87 108.13 0.08 Allowed 'General case' 0 N--CA 1.458 -0.073 1 C-N-CA 132.196 4.198 . . . . 0.0 114.186 176.391 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 176.48 -151.21 11.16 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.684 -168.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.55 170.58 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.998 3.799 . . . . 0.0 112.163 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.61 106.19 3.09 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 105.785 -2.926 . . . . 0.0 105.785 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -66.59 151.9 46.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -115.52 98.18 6.58 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.253 1.021 . . . . 0.0 109.991 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.53 110.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 t -108.0 108.22 19.24 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.84 127.88 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.463 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.04 74.97 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -77.14 174.9 10.18 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.099 1.318 . . . . 0.0 110.015 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 42.38 67.19 0.63 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.893 2.477 . . . . 0.0 114.368 169.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.258 6.7 mt -86.6 -0.39 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 120.521 -1.362 . . . . 0.0 111.707 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.01 -61.68 2.62 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.703 -1.248 . . . . 0.0 113.527 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -54.74 -41.69 70.72 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.583 1.691 . . . . 0.0 114.304 -160.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mmt -78.9 -5.54 53.91 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.289 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -41.16 -41.49 1.81 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -161.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.426 ' H ' HD11 ' A' ' 119' ' ' LEU . 4.4 mp -68.44 -60.1 2.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.009 0.924 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.18 -30.07 71.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.761 1.624 . . . . 0.0 111.826 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 t -39.84 107.92 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.032 2.933 . . . . 0.0 110.1 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -128.71 -78.6 0.56 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.622 1.169 . . . . 0.0 109.276 -176.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.27 -31.21 61.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.623 0.769 . . . . 0.0 110.782 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -60.01 3.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 125.474 1.51 . . . . 0.0 111.424 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 125' ' ' ILE . 2.0 mp -41.14 -58.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.113 1.765 . . . . 0.0 111.922 172.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -65.05 -47.37 77.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 118.588 0.631 . . . . 0.0 110.483 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.83 66.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 124.144 0.903 . . . . 0.0 110.083 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.05 -32.38 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 121.527 -0.733 . . . . 0.0 110.24 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.49 -35.57 60.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.41 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -38.77 79.01 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.564 1.074 . . . . 0.0 110.486 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.53 -44.28 24.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.328 1.051 . . . . 0.0 110.41 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.82 -18.19 64.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.537 1.062 . . . . 0.0 112.543 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.7 m -82.12 -22.15 36.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.046 0.839 . . . . 0.0 111.92 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.5 m -87.31 133.17 39.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -79.35 -27.47 4.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.547 2.831 . . . . 0.0 111.487 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.07 81.95 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.993 -0.893 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -67.08 150.09 49.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.056 1.928 . . . . 0.0 110.068 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.77 107.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -69.82 133.35 32.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.4 tp -142.56 97.82 3.18 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.799 1.312 . . . . 0.0 108.25 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.6 -172.1 17.35 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 114.616 0.606 . . . . 0.0 114.616 -169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.8 m -136.63 112.0 9.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.66 1.184 . . . . 0.0 113.296 175.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.89 154.32 41.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.251 1.02 . . . . 0.0 110.906 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.03 159.73 52.15 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.727 1.618 . . . . 0.0 111.749 172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.71 149.79 97.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.456 168.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.5 104.09 1.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.155 1.903 . . . . 0.0 109.489 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -82.77 -63.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.06 107.9 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.99 168.52 0.11 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.602 1.961 . . . . 0.0 111.483 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.68 169.78 1.62 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.335 3.357 . . . . 0.0 111.292 165.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mp -126.42 153.71 44.63 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.13 -44.9 83.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -165.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -33.77 36.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.928 0.785 . . . . 0.0 109.362 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.57 -23.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.213 -1.555 . . . . 0.0 110.348 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -58.02 10.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.904 2.082 . . . . 0.0 109.398 166.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.48 63.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.896 1.279 . . . . 0.0 111.534 177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mm -73.98 -51.39 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 118.465 0.575 . . . . 0.0 110.268 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -24.56 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.723 0.809 . . . . 0.0 110.322 -170.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -55.88 -26.43 47.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.754 1.222 . . . . 0.0 111.611 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -66.45 -35.87 81.37 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.824 -1.173 . . . . 0.0 111.514 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 53.87 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.657 2.783 . . . . 0.0 115.758 -167.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.4 41.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.736 2.014 . . . . 0.0 111.273 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.3 m -87.2 134.15 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 119.853 -1.78 . . . . 0.0 106.734 166.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -74.22 112.0 9.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 165.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.83 90.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -75.05 118.95 18.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 167.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 89.56 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.29 143.98 14.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.5 p -121.29 147.99 44.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -54.96 -14.66 1.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.366 166.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -81.82 -56.68 3.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.1 0.864 . . . . 0.0 108.882 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.7 6.01 49.53 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.606 -171.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -32.36 -57.26 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.276 2.23 . . . . 0.0 112.219 -172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -84.09 5.05 27.55 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.29 -17.35 21.73 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.05 1.34 . . . . 0.0 112.231 165.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -23.63 39.33 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.042 -169.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -57.9 9.27 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.196 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.45 -22.35 52.17 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.75 2.3 . . . . 0.0 114.271 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.22 73.64 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -67.72 -46.63 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.196 0.998 . . . . 0.0 109.262 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.8 t -50.41 -49.15 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.26 1.024 . . . . 0.0 109.21 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 97.6 m -58.14 -51.28 70.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.15 0.887 . . . . 0.0 108.857 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.95 -27.09 69.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.64 -68.4 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 117.294 -1.336 . . . . 0.0 107.944 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -53.54 -24.54 13.75 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.477 1.511 . . . . 0.0 112.558 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.81 -41.97 5.32 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.179 1.792 . . . . 0.0 112.073 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 t 44.88 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.053 1.341 . . . . 0.0 107.465 -162.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -50.21 -57.12 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.328 2.251 . . . . 0.0 115.428 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.007 -1.949 . . . . 0.0 112.729 -146.847 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.992 -0.527 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -131.8 171.06 13.98 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.006 0.821 . . . . 0.0 111.751 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.82 174.6 6.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.046 0.938 . . . . 0.0 110.232 -167.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.86 143.98 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -139.88 150.38 44.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.608 1.163 . . . . 0.0 109.036 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.09 142.62 38.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 125.445 1.498 . . . . 0.0 107.817 -171.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 t -156.82 -169.69 3.06 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 123.541 0.526 . . . . 0.0 110.694 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' H ' ' HB ' ' A' ' 145' ' ' VAL . . . 110.69 -174.9 17.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.826 1.679 . . . . 0.0 110.378 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.45 161.45 45.97 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.339 2.026 . . . . 0.0 110.14 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 140.94 46.94 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.33 2.02 . . . . 0.0 110.848 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.24 16.39 4.15 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.713 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.297 5.8 m 44.23 33.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.485 2.314 . . . . 0.0 115.543 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.1 20.54 0.25 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.03 -1.428 . . . . 0.0 113.085 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -69.25 0.21 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.148 1.474 . . . . 0.0 110.308 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.419 ' HG1' ' CG ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -62.38 -30.5 71.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.333 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 97.1 m -52.51 -52.21 55.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.293 1.406 . . . . 0.0 109.187 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -48.52 78.9 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.389 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -66.39 -45.65 88.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.861 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -44.72 84.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.024 1.283 . . . . 0.0 107.893 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -64.69 -23.76 67.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 124.135 0.897 . . . . 0.0 111.417 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.1 -38.81 26.67 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 125.331 1.453 . . . . 0.0 110.323 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -62.89 -53.12 59.0 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.28 -34.56 72.43 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.07 -49.08 85.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.786 0.834 . . . . 0.0 109.178 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.93 -39.39 76.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -57.31 -49.12 77.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.428 1.013 . . . . 0.0 109.406 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 t -49.92 -51.57 39.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.381 2.273 . . . . 0.0 106.949 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -65.56 15.67 0.03 OUTLIER 'General case' 0 C--O 1.236 0.35 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 173.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.8 19.78 56.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.913 1.244 . . . . 0.0 112.84 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -56.87 149.8 41.59 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.78 109.68 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.799 1.666 . . . . 0.0 109.613 159.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.95 171.85 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.596 0.758 . . . . 0.0 109.102 169.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.07 172.61 18.1 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.067 2.547 . . . . 0.0 105.109 165.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.82 -159.11 22.1 Favored Glycine 0 C--O 1.237 0.304 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.68 169.72 17.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.522 0.661 . . . . 0.0 111.994 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -135.73 165.86 24.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -125.62 80.52 1.9 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.9 155.23 40.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 167.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -71.18 125.92 28.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.9 t -80.26 126.36 39.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -127.38 167.18 16.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.533 1.133 . . . . 0.0 110.295 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.48 29.34 2.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.349 1.46 . . . . 0.0 109.728 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.48 -21.19 0.4 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.456 -1.402 . . . . 0.0 114.045 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.22 6.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.416 1.484 . . . . 0.0 110.308 -163.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 140.01 46.43 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 118.522 1.161 . . . . 0.0 108.467 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.28 135.34 51.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 160.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.0 pt -133.41 -2.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 111.548 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.6 -157.93 27.55 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.22 135.04 30.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.112 2.165 . . . . 0.0 106.12 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.55 164.04 13.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.931 1.293 . . . . 0.0 107.945 168.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.3 p -113.73 104.8 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.02 112.26 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 123.872 0.869 . . . . 0.0 109.889 -160.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -68.59 152.63 45.1 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 109.219 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.73 -2.6 9.66 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.808 170.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -110.56 18.94 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.254 1.822 . . . . 0.0 111.531 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.89 0.96 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.371 -0.83 . . . . 0.0 114.709 160.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 m -115.29 166.12 12.2 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.702 1.251 . . . . 0.0 108.133 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -154.09 142.61 20.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.31 -1.494 . . . . 0.0 108.377 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.26 142.7 14.29 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 118.457 -1.191 . . . . 0.0 111.656 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.84 64.78 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 126.144 4.563 . . . . 0.0 113.565 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.467 ' N ' ' HG ' ' A' ' 86' ' ' SER . 29.6 tp -59.93 -59.89 4.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 112.231 -175.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.8 p -146.75 140.28 25.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 120.608 1.549 . . . . 0.0 108.227 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptt-85 -155.81 65.28 0.59 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.845 0.748 . . . . 0.0 110.725 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' H ' ' A' ' 65' ' ' GLY 0.335 41.8 t 58.71 -153.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -170.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.631 ' H ' ' CG1' ' A' ' 64' ' ' VAL . . . 134.08 141.88 4.58 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 129.21 3.291 . . . . 0.0 107.333 -166.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 147.23 53.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 155.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 146.65 99.06 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.54 127.75 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.003 1.802 . . . . 0.0 110.233 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.34 169.2 22.22 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.682 2.921 . . . . 0.0 110.718 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.94 -0.92 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.523 2.148 . . . . 0.0 114.306 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.48 5.34 29.76 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.987 1.28 . . . . 0.0 113.844 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 156.87 43.19 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 120.599 2.199 . . . . 0.0 109.598 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -154.13 155.69 35.84 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 162.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -149.68 26.04 0.84 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.188 1.795 . . . . 0.0 107.808 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.3 m 55.67 -179.39 0.04 OUTLIER 'General case' 0 C--N 1.345 0.405 0 C-N-CA 127.699 2.399 . . . . 0.0 112.501 -165.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.04 170.19 13.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 109.737 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.97 77.62 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 107.822 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.54 -113.36 4.14 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -162.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -29.2 54.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -166.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.81 146.15 23.99 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 121.601 2.0 . . . . 0.0 107.368 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.2 t -95.08 137.93 22.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.03 177.25 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 123.612 0.765 . . . . 0.0 109.815 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -148.85 113.59 5.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 157.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -25.06 67.38 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.949 -1.094 . . . . 0.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 m -55.85 -31.76 63.04 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.814 1.246 . . . . 0.0 110.235 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 44.4 t -62.0 -37.23 84.04 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.931 1.241 . . . . 0.0 110.203 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -64.62 -50.83 65.61 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -18.7 37.41 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.103 -0.998 . . . . 0.0 113.53 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -64.47 -57.88 7.98 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.86 -1.15 . . . . 0.0 110.47 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -33.32 2.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.786 1.234 . . . . 0.0 112.334 -166.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.17 46.92 0.75 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.68 1.192 . . . . 0.0 108.895 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -61.05 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.051 2.14 . . . . 0.0 107.844 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.17 -21.68 48.15 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.779 1.653 . . . . 0.0 112.962 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.67 -34.32 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 119.394 0.997 . . . . 0.0 112.053 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.85 3.83 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -168.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -112.12 87.19 2.51 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.59 143.69 56.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.806 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 33.05 -113.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.456 2.303 . . . . 0.0 111.225 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.18 -76.63 0.41 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.6 t -157.99 -54.04 0.07 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.768 0.713 . . . . 0.0 110.068 159.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.2 m 50.23 40.2 21.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.712 1.205 . . . . 0.0 111.476 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.8 m -155.25 -74.52 0.11 Allowed 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.114 1.366 . . . . 0.0 109.363 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.76 -117.02 2.65 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.3 173.88 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.888 2.392 . . . . 0.0 111.756 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 139.75 -50.4 0.77 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.733 2.111 . . . . 0.0 107.977 -166.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 62.4 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 129.08 2.952 . . . . 0.0 112.481 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.53 168.07 12.89 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.626 0.771 . . . . 0.0 110.772 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.2 158.03 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 159.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.21 153.58 50.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 163.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.9 120.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -166.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.32 86.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -171.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.419 ' CG ' ' HG1' ' A' ' 15' ' ' THR . 4.0 t70 -102.47 175.62 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.242 -0.912 . . . . 0.0 109.898 -169.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 56.25 39.8 30.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.416 1.086 . . . . 0.0 112.352 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.4 mt -81.68 59.35 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 119.725 -1.859 . . . . 0.0 109.685 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.48 -54.64 0.26 Allowed Glycine 0 N--CA 1.465 0.598 0 O-C-N 120.164 -1.585 . . . . 0.0 113.649 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 8.23 3.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -114.81 13.36 17.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.867 1.212 . . . . 0.0 110.266 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -40.51 -42.19 1.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.635 2.374 . . . . 0.0 113.0 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.62 -17.03 10.67 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 124.048 0.939 . . . . 0.0 111.997 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.76 -12.72 23.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.569 0.622 . . . . 0.0 111.069 -171.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -61.24 101.61 0.17 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 119.215 0.916 . . . . 0.0 109.907 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -99.7 -78.33 0.51 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.4 mt -56.42 -24.78 47.36 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.88 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -71.5 0.07 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.2 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.418 HD11 ' H ' ' A' ' 125' ' ' ILE . 3.3 mp -30.9 -54.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.969 1.708 . . . . 0.0 112.238 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -71.14 -62.77 1.27 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.569 0.348 . . . . 0.0 111.347 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.59 91.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.903 0.858 . . . . 0.0 109.902 -167.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.77 -54.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 117.328 -1.32 . . . . 0.0 107.943 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -57.69 -31.2 66.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.287 2.312 . . . . 0.0 113.799 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -59.62 -45.65 91.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.031 0.932 . . . . 0.0 108.944 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.8 m -63.42 -42.5 98.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.408 1.483 . . . . 0.0 111.078 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.15 -35.28 74.96 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.169 -0.957 . . . . 0.0 110.63 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.7 m -90.27 1.47 56.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.474 1.51 . . . . 0.0 112.992 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.7 m -72.18 134.08 83.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.2 118.14 5.52 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 123.154 2.569 . . . . 0.0 108.051 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.37 -3.96 86.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 117.36 -1.8 . . . . 0.0 114.64 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.3 m -67.68 153.24 44.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.555 2.178 . . . . 0.0 107.468 163.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.7 mt -134.64 95.2 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -166.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.49 140.57 19.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.2 100.95 5.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.374 1.87 . . . . 0.0 106.207 163.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -124.38 166.78 16.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.4 m -124.21 117.49 24.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.01 132.84 24.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.485 2.314 . . . . 0.0 109.448 -173.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.36 137.5 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.429 2.086 . . . . 0.0 110.557 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 8' ' ' GLY . 4.5 p -64.49 122.1 76.5 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 110.695 -168.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.42 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.411 2.741 . . . . 0.0 109.411 -171.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -138.6 110.14 7.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 166.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.02 -26.08 6.37 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-O 116.544 -2.253 . . . . 0.0 114.909 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 132.82 24.39 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 121.684 2.742 . . . . 0.0 112.274 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.26 96.44 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.701 2.934 . . . . 0.0 108.538 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 112.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.72 -59.77 3.74 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 113.997 -168.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.44 -41.42 98.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.898 0.772 . . . . 0.0 109.925 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.29 -30.05 47.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.716 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.75 -35.51 74.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.621 172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.71 -56.59 17.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.766 1.621 . . . . 0.0 109.062 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.73 -29.61 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.159 0.984 . . . . 0.0 111.125 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.79 -37.85 76.47 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 120.606 -1.309 . . . . 0.0 109.516 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.63 -19.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.174 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -23.25 50.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.934 1.243 . . . . 0.0 110.886 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.37 -55.26 0.26 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 127.623 2.369 . . . . 0.0 113.43 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -60.26 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 1 C-N-CA 132.726 4.411 . . . . 0.0 113.077 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 t -138.95 121.52 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 15.2 tptm -64.94 123.16 18.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.6 t -102.33 91.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.538 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 9.7 m-85 -81.92 102.88 11.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.837 0.855 . . . . 0.0 110.216 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.62 98.13 6.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.125 0.97 . . . . 0.0 109.105 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.32 158.3 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 50.0 p -121.54 158.72 27.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -57.87 -24.42 57.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.111 163.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.65 -72.43 0.43 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.825 0.85 . . . . 0.0 110.539 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -86.85 30.82 0.72 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.864 1.265 . . . . 0.0 109.798 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -48.2 -60.48 2.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.679 1.592 . . . . 0.0 109.898 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -77.37 4.21 11.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -97.54 -6.01 34.49 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.843 1.657 . . . . 0.0 111.852 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.1 tp -74.13 -39.97 62.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.506 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 tp -40.87 -64.05 0.67 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 111.54 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.13 -25.22 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 121.482 1.565 . . . . 0.0 111.806 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.08 -38.63 75.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.584 1.554 . . . . 0.0 109.858 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.95 -54.09 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 109.484 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.34 -41.7 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.436 0.562 . . . . 0.0 109.54 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.5 m -56.0 -47.85 76.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.972 1.309 . . . . 0.0 109.101 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -47.79 84.29 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.944 0.793 . . . . 0.0 110.826 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.57 -48.32 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.304 0.642 . . . . 0.0 109.97 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.59 55.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.881 1.273 . . . . 0.0 110.102 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 t -55.94 -40.51 73.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.903 1.281 . . . . 0.0 109.644 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.5 t -72.23 -2.13 17.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 112.745 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -111.11 -7.39 14.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.903 1.281 . . . . 0.0 112.686 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? . . . . . 0 C--O 1.252 1.22 0 CA-C-N 119.505 1.048 . . . . 0.0 108.202 166.506 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 162.46 32.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.263 0.938 . . . . 0.0 109.811 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -89.32 155.84 19.11 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.287 1.435 . . . . 0.0 109.493 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -129.37 132.29 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.774 1.23 . . . . 0.0 108.989 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 5.3 m-85 -141.78 136.06 30.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.455 1.102 . . . . 0.0 108.574 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.42 147.79 22.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 t -143.35 161.89 37.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.827 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.46 -175.52 20.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.351 0.977 . . . . 0.0 111.176 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.87 166.47 29.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 111.78 -171.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.44 157.09 62.28 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.462 2.108 . . . . 0.0 110.355 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.22 -9.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 117.608 -1.662 . . . . 0.0 115.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t 61.74 102.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.217 1.807 . . . . 0.0 109.535 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.35 -7.36 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.33 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -32.69 69.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.72 1.76 . . . . 0.0 110.901 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 m -61.98 -39.82 93.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -1.11 1.55 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.133 2.573 . . . . 0.0 112.676 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.87 -66.39 0.92 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 167.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.13 -41.45 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.263 0.938 . . . . 0.0 111.797 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.6 64.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -67.89 -32.07 72.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.183 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.09 80.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.888 0.875 . . . . 0.0 110.607 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 t -63.52 -58.25 7.59 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 108.798 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.0 -45.74 32.09 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.256 1.822 . . . . 0.0 112.083 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.43 -54.77 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.98 -0.45 . . . . 0.0 110.321 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.56 -32.78 74.33 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.916 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -59.47 -44.09 93.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.351 0.978 . . . . 0.0 109.044 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -12.3 61.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.877 0.871 . . . . 0.0 111.118 172.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -93.35 8.99 38.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.284 1.834 . . . . 0.0 114.646 170.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.82 21.24 71.12 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.346 -0.846 . . . . 0.0 111.947 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.64 147.04 62.89 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.518 1.159 . . . . 0.0 109.096 169.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.81 106.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.883 2.388 . . . . 0.0 109.4 153.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.45 140.59 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -151.48 138.87 19.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.944 0.898 . . . . 0.0 109.185 173.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.93 30.38 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 106.459 -2.656 . . . . 0.0 106.459 -166.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.8 176.23 10.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.862 1.331 . . . . 0.0 112.144 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -138.36 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -131.02 76.24 1.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 152.72 40.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.62 115.93 14.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.377 1.084 . . . . 0.0 111.993 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.3 t -78.22 96.4 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -102.3 119.27 38.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 167.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -75.21 -78.74 0.1 Allowed 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.01 59.24 0.36 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.03 -9.45 1.52 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.063 -171.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 137.79 32.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.808 1.804 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 143.14 46.14 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 pt -144.06 -6.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.231 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.74 -151.85 23.43 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 119.562 1.074 . . . . 0.0 111.688 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -138.57 164.54 29.2 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.072 1.749 . . . . 0.0 109.156 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.13 142.93 48.94 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 128.336 2.654 . . . . 0.0 104.6 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.13 152.34 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.63 1.172 . . . . 0.0 109.335 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.24 111.81 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 120.198 1.363 . . . . 0.0 112.048 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.6 p -63.78 145.97 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.634 0.773 . . . . 0.0 109.954 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.53 -16.88 63.32 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.55 -0.719 . . . . 0.0 112.336 169.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 t -66.48 -32.47 73.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.792 1.637 . . . . 0.0 109.635 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.78 21.23 3.28 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.053 -0.859 . . . . 0.0 114.827 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.6 m -128.71 152.2 48.68 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.661 1.73 . . . . 0.0 109.516 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -128.83 168.81 15.38 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.89 1.276 . . . . 0.0 112.087 -173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.67 179.97 26.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.898 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.6 174.48 6.38 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.809 3.006 . . . . 0.0 111.439 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -165.14 -64.51 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.806 -1.184 . . . . 0.0 110.135 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.91 141.43 29.04 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.3 38.55 0.25 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.251 15.2 t 62.54 176.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.499 1.519 . . . . 0.0 109.246 -167.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.93 152.13 6.05 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.428 1.966 . . . . 0.0 108.782 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 158.65 16.7 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.592 0.757 . . . . 0.0 111.522 -174.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.41 145.04 99.11 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.595 -0.691 . . . . 0.0 109.64 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.91 132.26 15.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.552 2.168 . . . . 0.0 110.105 -168.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 158.5 56.65 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.496 2.131 . . . . 0.0 110.659 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.36 121.52 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.41 2.073 . . . . 0.0 110.489 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.05 9.55 59.39 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.777 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -120.35 156.48 31.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.084 1.354 . . . . 0.0 107.62 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 156.35 40.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.381 1.472 . . . . 0.0 108.057 160.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -135.52 174.48 10.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.951 2.5 . . . . 0.0 105.334 160.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.9 m -73.17 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.342 1.057 . . . . 0.0 108.388 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.58 148.12 28.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.696 -1.252 . . . . 0.0 110.412 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.7 19.83 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -151.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.01 98.28 2.27 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 61.29 -69.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.551 1.94 . . . . 0.0 110.907 -159.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.86 139.04 57.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 111.237 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.23 132.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 159.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.15 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.774 1.23 . . . . 0.0 108.833 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.31 112.61 10.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.032 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.6 -35.77 79.6 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.025 -1.047 . . . . 0.0 109.86 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -64.63 -36.22 83.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.924 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.4 p -62.51 -33.99 75.99 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.08 1.309 . . . . 0.0 109.939 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.71 -55.37 17.72 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.28 1.032 . . . . 0.0 109.65 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.34 -13.38 0.34 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.252 1.421 . . . . 0.0 113.495 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -78.23 -24.97 46.76 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.351 -1.468 . . . . 0.0 114.277 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.15 -35.37 0.24 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.12 46.24 0.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.41 1.884 . . . . 0.0 111.498 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -64.92 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 116.877 -1.535 . . . . 0.0 108.095 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.95 -23.96 46.36 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.681 2.254 . . . . 0.0 113.511 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.4 m -58.47 -31.56 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 120.283 -1.511 . . . . 0.0 111.569 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.84 -10.35 59.42 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.473 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 167.95 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.943 2.497 . . . . 0.0 107.545 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -143.42 112.95 6.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.756 0.823 . . . . 0.0 110.582 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 56.43 44.2 24.78 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.214 2.205 . . . . 0.0 114.242 166.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 90.44 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 109.764 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.5 t -163.07 11.15 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 159.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.49 -38.0 0.41 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.577 1.535 . . . . 0.0 112.444 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.0 t -57.57 144.8 35.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.106 0.866 . . . . 0.0 110.849 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -50.76 134.76 30.48 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.93 1.252 . . . . 0.0 112.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.75 139.53 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.902 2.401 . . . . 0.0 109.675 174.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.73 37.77 0.02 OUTLIER Glycine 0 CA--C 1.518 0.224 0 O-C-N 121.59 -0.694 . . . . 0.0 111.371 -171.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 52.09 -169.34 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.888 1.675 . . . . 0.0 110.828 -162.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.32 164.43 38.77 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.007 2.523 . . . . 0.0 106.089 166.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -120.15 146.32 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 139' ' ' ILE . 3.7 p -118.93 168.78 10.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.39 123.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -148.74 92.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -77.54 171.28 15.15 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.663 1.185 . . . . 0.0 109.804 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.8 27.28 4.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.482 1.513 . . . . 0.0 114.56 161.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.34 76.94 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.887 1.327 . . . . 0.0 108.227 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.54 -42.99 0.04 OUTLIER Glycine 0 C--O 1.221 -0.684 0 CA-C-O 117.249 -1.862 . . . . 0.0 115.844 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -32.02 71.25 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 122.391 3.095 . . . . 0.0 111.181 175.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.1 mmt -78.35 1.52 21.63 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 116.863 -1.541 . . . . 0.0 114.003 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -34.97 -51.17 0.51 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.565 1.946 . . . . 0.0 114.593 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.57 -27.89 13.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 112.283 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.28 -23.23 51.17 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.023 0.929 . . . . 0.0 111.969 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.553 ' HG ' ' CD1' ' A' ' 125' ' ' ILE . 47.5 t -49.81 128.46 18.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.518 2.327 . . . . 0.0 111.149 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.15 -95.88 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.99 -15.99 26.93 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.993 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.92 -71.38 0.07 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 110.374 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.553 ' CD1' ' HG ' ' A' ' 121' ' ' SER . 3.5 mt -32.59 -55.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 127.658 2.383 . . . . 0.0 110.871 176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.03 -66.77 0.49 Allowed 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.31 -40.07 73.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.696 1.198 . . . . 0.0 111.515 -170.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.55 -51.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.892 2.077 . . . . 0.0 108.965 174.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -54.75 -40.7 69.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.838 1.199 . . . . 0.0 111.214 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -58.82 -46.33 87.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.78 0.832 . . . . 0.0 109.487 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 m -65.28 -40.64 94.16 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.737 0.699 . . . . 0.0 111.81 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.52 -25.16 67.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.249 0.932 . . . . 0.0 110.839 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.8 m -108.17 -5.49 16.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 0.0 112.73 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.2 m -64.8 139.53 97.8 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 125.75 1.62 . . . . 0.0 108.594 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.75 155.44 53.93 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.573 2.182 . . . . 0.0 110.721 171.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.36 -47.53 1.39 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.122 1.82 . . . . 0.0 114.072 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.3 m -59.99 155.67 16.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.467 1.633 . . . . 0.0 110.518 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.26 136.75 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.8 OUTLIER -93.4 128.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 173.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.26 135.33 54.27 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 165.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.51 -179.17 40.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.095 -1.05 . . . . 0.0 115.7 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.0 m -129.9 124.36 32.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.117 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.3 pt -117.9 154.52 51.3 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.203 1.401 . . . . 0.0 108.155 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.33 158.7 14.93 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.194 2.596 . . . . 0.0 110.497 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.21 137.45 78.68 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 165.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.08 156.01 63.52 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.575 2.85 . . . . 0.0 109.72 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -129.17 -14.34 4.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.835 1.654 . . . . 0.0 112.563 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.25 -85.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 O-C-N 120.711 -1.243 . . . . 0.0 110.02 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.29 153.79 39.39 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.453 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.74 157.15 27.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.815 1.676 . . . . 0.0 111.475 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.52 135.36 53.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.663 0.602 . . . . 0.0 111.815 -154.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.59 -46.7 88.76 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.029 0.931 . . . . 0.0 110.198 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.91 -34.86 70.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 119.209 0.913 . . . . 0.0 111.252 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -66.87 -26.65 67.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.903 1.229 . . . . 0.0 111.565 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.77 -43.83 92.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.415 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.412 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 8.5 mm -69.21 -44.09 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.568 0.747 . . . . 0.0 109.899 173.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -61.21 -27.2 68.26 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.586 -1.321 . . . . 0.0 109.83 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -5.29 21.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.012 1.725 . . . . 0.0 113.525 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -37.91 11.99 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.811 1.187 . . . . 0.0 110.927 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 61.93 -28.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.264 2.226 . . . . 0.0 114.345 -174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -28.45 33.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.215 1.37 . . . . 0.0 110.591 169.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.8 m -63.94 113.39 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.123 1.439 . . . . 0.0 109.704 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -64.48 131.32 46.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.407 1.883 . . . . 0.0 108.08 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.24 92.49 2.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -80.31 97.97 7.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.598 1.559 . . . . 0.0 108.388 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.96 104.2 8.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.557 -0.714 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.2 146.69 9.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.3 1.048 . . . . 0.0 108.735 167.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -122.82 149.82 43.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -51.63 -25.05 6.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.192 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -76.05 -25.24 55.42 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.67 0.606 . . . . 0.0 110.725 -170.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.72 28.91 3.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.545 1.538 . . . . 0.0 112.341 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -66.13 -20.18 66.07 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.17 29.04 8.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.597 1.559 . . . . 0.0 109.393 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -135.84 15.95 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.405 1.482 . . . . 0.0 113.386 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.68 -9.14 58.52 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.095 1.771 . . . . 0.0 112.364 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -58.59 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.493 1.517 . . . . 0.0 110.996 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -29.52 67.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.016 1.756 . . . . 0.0 113.716 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.82 -42.6 97.61 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -67.31 -44.1 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 108.156 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.05 -42.74 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 119.196 0.907 . . . . 0.0 109.727 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 84.9 m -59.25 -50.91 72.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.126 0.876 . . . . 0.0 109.744 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -29.61 69.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.471 0.578 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.38 -43.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.504 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -63.75 -34.77 78.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.014 1.734 . . . . 0.0 110.85 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.407 ' O ' ' HE3' ' A' ' 189' ' ' LYS . 0.6 OUTLIER -43.92 -65.61 0.48 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.368 1.867 . . . . 0.0 110.799 -167.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 t 65.55 -59.8 0.28 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.259 1.823 . . . . 0.0 112.204 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 -8.43 6.74 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.949 2.499 . . . . 0.0 113.075 -170.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 186' ' ' SER . 5.7 ptpt . . . . . 0 C--O 1.248 0.976 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -150.45 166.55 29.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.704 0.684 . . . . 0.0 110.541 161.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -49.8 155.8 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.844 2.058 . . . . 0.0 111.459 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.3 t -131.27 145.52 35.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -133.57 144.94 49.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.019 0.927 . . . . 0.0 109.193 164.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.87 146.13 31.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 t -151.98 -177.54 6.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.48 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.18 175.17 13.9 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.159 1.838 . . . . 0.0 111.351 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.77 169.22 15.03 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 125.013 3.809 . . . . 0.0 111.659 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.13 162.09 20.75 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.175 2.583 . . . . 0.0 112.314 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.09 -53.72 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.093 0 O-C-N 121.25 -0.906 . . . . 0.0 112.346 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.5 t 63.66 94.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 O-C-N 126.061 1.683 . . . . 0.0 109.13 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.28 -35.3 0.48 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.204 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -56.93 -17.79 10.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 m -34.04 -51.03 0.41 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.69 1.596 . . . . 0.0 111.23 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -53.99 -28.03 35.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 124.909 1.284 . . . . 0.0 112.54 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -56.86 6.27 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.16 -40.67 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.435 1.016 . . . . 0.0 110.181 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -48.68 65.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -73.66 -14.46 61.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.455 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.8 98.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 108.601 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.1 p -63.29 -44.02 96.24 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.593 0.633 . . . . 0.0 110.145 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.32 -42.18 84.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.86 -50.78 76.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 109.771 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.64 -38.54 69.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -72.02 -35.07 69.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 119.119 -0.467 . . . . 0.0 112.252 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 -15.17 25.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 126.426 1.89 . . . . 0.0 115.181 162.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.49 3.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.312 2.245 . . . . 0.0 112.491 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.6 72.39 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.426 1.012 . . . . 0.0 113.61 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.05 121.47 71.54 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.317 1.559 . . . . 0.0 107.259 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.82 90.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.622 -171.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -73.22 146.54 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.379 1.472 . . . . 0.0 108.545 168.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.84 175.68 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 146.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.34 -153.37 24.39 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 124.888 1.232 . . . . 0.0 110.138 170.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -136.13 165.3 26.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.921 0.888 . . . . 0.0 109.36 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -137.49 168.33 19.87 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 159.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -135.87 104.58 5.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -102.93 159.17 15.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.75 121.34 20.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.99 107.52 2.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 167.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -125.03 91.46 3.44 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.298 1.439 . . . . 0.0 108.169 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -79.21 76.97 5.73 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 124.162 0.914 . . . . 0.0 111.513 -168.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.37 60.64 6.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 -162.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.41 15.78 81.0 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -115.54 113.3 23.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.012 1.906 . . . . 0.0 111.26 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -65.73 107.13 1.68 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.192 0.997 . . . . 0.0 109.806 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 pt -130.49 -10.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.48 -167.25 40.34 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.464 1.029 . . . . 0.0 110.933 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.61 159.19 37.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.4 139.19 35.24 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.004 0.522 . . . . 0.0 110.301 170.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.06 93.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.36 152.11 8.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 p -116.6 154.77 29.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 166.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -10.84 60.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.496 -0.753 . . . . 0.0 110.257 171.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -66.33 -19.77 65.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.725 2.41 . . . . 0.0 110.485 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 1.63 57.95 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.708 1.147 . . . . 0.0 113.997 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -85.5 159.81 19.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 0.0 108.637 170.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.56 131.34 20.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.776 1.63 . . . . 0.0 108.02 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.65 149.22 18.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 118.557 -1.135 . . . . 0.0 110.453 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.58 -3.84 13.64 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.127 2.552 . . . . 0.0 114.881 -164.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 40.58 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 131.348 3.859 . . . . 0.0 116.816 168.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.427 ' HG ' ' HA ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -145.71 116.99 7.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 119.232 0.924 . . . . 0.0 109.174 179.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -126.78 145.54 50.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.845 0.858 . . . . 0.0 110.097 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.82 129.21 37.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.306 1.043 . . . . 0.0 108.854 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.28 50.94 0.67 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.299 -164.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.65 -175.5 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.175 1.488 . . . . 0.0 110.93 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -64.75 151.51 92.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.1 138.26 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.867 3.045 . . . . 0.0 110.832 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.06 159.87 47.32 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.182 2.588 . . . . 0.0 111.236 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.94 147.33 84.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.583 2.189 . . . . 0.0 111.179 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.78 4.53 20.41 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.371 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -128.35 0.11 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.278 1.539 . . . . 0.0 108.119 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 57.35 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.761 2.025 . . . . 0.0 114.067 169.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.79 -16.21 15.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -174.67 170.55 3.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.824 1.65 . . . . 0.0 108.81 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 2.1 ppt_? -170.51 160.32 7.31 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.33 1.452 . . . . 0.0 111.244 151.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.75 -8.59 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 110.701 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.92 -104.46 0.26 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.02 -37.39 76.81 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.592 0.819 . . . . 0.0 109.919 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.09 161.87 13.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.545 1.538 . . . . 0.0 111.855 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 1.0 OUTLIER -105.34 116.02 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.263 2.225 . . . . 0.0 106.334 170.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HA ' ' HG ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -73.83 162.62 4.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 168.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.02 116.36 11.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.86 -28.98 64.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.249 1.386 . . . . 0.0 110.409 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 m -59.36 -36.83 76.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.323 1.449 . . . . 0.0 112.472 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.2 p -72.31 -22.77 61.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 120.732 1.605 . . . . 0.0 112.477 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -69.98 -57.11 5.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.931 162.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.8 -29.86 20.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.076 0.853 . . . . 0.0 112.474 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -50.21 -34.03 21.41 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -44.03 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.217 0.462 . . . . 0.0 111.643 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.6 48.79 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.468 1.907 . . . . 0.0 109.88 -171.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.12 -65.12 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.396 1.478 . . . . 0.0 108.359 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.55 -24.09 75.07 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 121.287 1.495 . . . . 0.0 113.214 172.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.96 -35.52 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 119.941 1.246 . . . . 0.0 111.141 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.49 -53.05 6.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.979 1.312 . . . . 0.0 107.565 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -120.75 84.39 2.22 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 109.234 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -78.05 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.532 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.34 134.53 55.13 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 96.14 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 128.092 2.557 . . . . 0.0 115.122 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 48.1 t -144.82 110.93 5.5 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.389 1.075 . . . . 0.0 109.539 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -159.41 164.88 34.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -151.04 -30.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.371 1.069 . . . . 0.0 112.616 160.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -139.04 -81.9 0.08 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.442 1.019 . . . . 0.0 112.502 -171.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.67 -179.7 4.41 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.471 2.781 . . . . 0.0 111.101 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.98 -62.73 1.65 Allowed Glycine 0 CA--C 1.519 0.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 170.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -69.7 153.78 42.91 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.664 0.786 . . . . 0.0 112.019 -168.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.95 169.59 11.94 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 129.626 3.17 . . . . 0.0 107.006 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.27 146.66 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.2 m -128.59 150.12 50.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.202 0.456 . . . . 0.0 111.273 166.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.99 124.44 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.101 1.361 . . . . 0.0 108.344 -162.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.8 68.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.62 -35.09 76.84 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.661 -1.274 . . . . 0.0 112.331 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.12 86.55 4.62 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.06 -1.025 . . . . 0.0 110.713 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.8 mt -131.58 114.95 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 147.47 -67.49 0.39 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -57.03 -33.33 67.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.134 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mmt -85.68 3.11 42.54 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.692 -1.623 . . . . 0.0 113.042 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -32.89 -65.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.248 1.819 . . . . 0.0 113.845 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -39.48 64.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.083 0.553 . . . . 0.0 110.825 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.58 -23.42 61.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.291 0.95 . . . . 0.0 112.502 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.2 m -52.44 115.04 1.57 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.364 1.866 . . . . 0.0 110.232 -170.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.87 -86.44 0.65 Allowed 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.43 -21.32 35.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.083 0.953 . . . . 0.0 112.361 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.39 -61.56 2.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.012 1.325 . . . . 0.0 110.76 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.4 mp -39.91 -57.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.239 1.381 . . . . 0.0 112.472 171.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -55.7 31.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.018 0.826 . . . . 0.0 111.239 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.82 92.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.508 0.67 . . . . 0.0 111.21 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.98 -48.64 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.805 1.242 . . . . 0.0 107.862 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -57.69 -37.91 74.28 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -64.28 -42.92 96.18 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.134 0.425 . . . . 0.0 111.138 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -67.35 -40.83 85.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.904 0.775 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.82 -21.11 40.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.523 1.529 . . . . 0.0 111.567 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.9 m -102.55 -6.3 22.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.394 1.878 . . . . 0.0 112.826 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.1 m -70.06 133.97 87.68 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.1 -45.89 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.769 2.312 . . . . 0.0 109.872 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.45 40.57 3.04 Favored Glycine 0 C--O 1.216 -0.974 0 CA-C-O 117.389 -1.784 . . . . 0.0 113.682 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.5 m -135.8 163.84 29.29 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.934 2.367 . . . . 0.0 107.088 169.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.93 103.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.82 132.32 31.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 122.825 0.45 . . . . 0.0 110.134 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.9 tp -126.37 147.88 49.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.257 2.623 . . . . 0.0 105.579 159.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.43 168.93 37.22 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 120.8 1.636 . . . . 0.0 113.358 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.0 m -112.66 121.82 45.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.629 0.715 . . . . 0.0 109.899 -166.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.73 153.39 47.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.662 1.185 . . . . 0.0 109.727 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.89 154.06 67.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.724 1.616 . . . . 0.0 110.461 172.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.59 126.12 92.39 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.34 152.24 44.04 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.284 2.656 . . . . 0.0 111.766 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -47.38 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.593 1.557 . . . . 0.0 110.576 172.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.48 -147.08 13.38 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 124.815 1.198 . . . . 0.0 110.768 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -63.61 158.11 61.56 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 121.974 -0.721 . . . . 0.0 110.638 171.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.66 139.96 41.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.028 2.485 . . . . 0.0 109.941 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.73 145.36 27.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.469 1.508 . . . . 0.0 109.702 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.32 -84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.006 2.922 . . . . 0.0 114.769 -170.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.58 -41.1 63.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.088 0.858 . . . . 0.0 109.028 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.8 -41.21 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.629 -1.177 . . . . 0.0 110.278 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.63 -35.37 80.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.866 1.666 . . . . 0.0 110.866 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.58 -20.76 58.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.748 0.819 . . . . 0.0 111.422 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mt -103.4 -42.98 8.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.623 1.569 . . . . 0.0 109.964 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.73 -19.98 60.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.257 1.423 . . . . 0.0 110.965 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.43 -30.99 61.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.989 0.516 . . . . 0.0 111.022 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' A' ' 160' ' ' ARG . 16.2 mtp85 -83.99 -38.07 21.42 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.476 -156.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.17 -15.81 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.242 3.017 . . . . 0.0 116.726 174.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.81 -25.36 60.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.487 1.915 . . . . 0.0 111.122 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.4 m -52.73 141.12 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.407 1.883 . . . . 0.0 110.541 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 2.7 tppt? -60.56 143.46 53.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 158.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.87 100.96 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.426 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 19.2 m-85 -86.62 89.32 7.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.44 111.44 1.79 Allowed 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.48 166.7 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 119.335 0.97 . . . . 0.0 108.532 176.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.2 p -128.52 155.21 45.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 163.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -57.69 -34.58 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 162.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.94 -44.7 91.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.947 2.099 . . . . 0.0 109.996 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.01 18.26 18.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 113.237 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -38.29 -52.92 1.5 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.308 1.443 . . . . 0.0 113.664 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.94 6.48 48.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.552 1.141 . . . . 0.0 112.812 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -96.34 -3.25 44.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 111.987 166.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 tp -76.45 -35.97 58.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.179 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.3 -58.14 9.74 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.942 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.83 -25.29 53.12 Favored 'Trans proline' 0 C--N 1.352 0.725 0 CA-C-N 122.105 1.787 . . . . 0.0 112.34 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.25 -43.17 71.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 109.91 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.9 mt -56.88 -50.8 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.869 1.267 . . . . 0.0 108.67 171.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.51 -45.25 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.991 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.3 m -59.3 -43.93 92.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.521 1.055 . . . . 0.0 110.465 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.6 t -62.16 -38.77 90.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.533 0.733 . . . . 0.0 110.431 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.7 t -75.18 -45.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.951 0.9 . . . . 0.0 110.208 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -67.58 -14.28 62.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.467 1.031 . . . . 0.0 112.636 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.2 t -34.7 -50.95 0.48 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 128.103 2.561 . . . . 0.0 114.157 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.8 m 38.16 -101.11 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.603 1.161 . . . . 0.0 110.027 -168.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 ptt85 -147.99 61.1 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.539 1.536 . . . . 0.0 112.01 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.018 128.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.54 -155.7 0.62 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.292 0.637 . . . . 0.0 110.133 -164.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.481 ' HD1' ' CG1' ' A' ' 139' ' ' ILE . 31.5 m-70 -48.43 140.8 7.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.83 2.052 . . . . 0.0 109.605 166.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 96.9 t -126.72 149.58 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.886 1.221 . . . . 0.0 112.259 164.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -137.51 162.47 33.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.905 2.082 . . . . 0.0 111.38 176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.34 135.92 53.64 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.727 1.611 . . . . 0.0 108.442 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -137.24 -178.92 5.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.026 1.73 . . . . 0.0 107.206 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.64 176.05 38.49 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.743 -1.223 . . . . 0.0 112.947 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.14 138.88 34.39 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.63 2.886 . . . . 0.0 112.957 -164.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.01 92.59 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.408 3.406 . . . . 0.0 111.579 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.63 -75.51 0.37 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.81 -42.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.03 83.69 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -172.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -35.02 79.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 118.001 -0.999 . . . . 0.0 108.516 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -47.92 -63.46 1.06 Allowed 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 125.664 1.852 . . . . 0.0 107.298 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -42.21 -49.89 4.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.16 1.784 . . . . 0.0 112.671 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -47.9 57.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.681 0.673 . . . . 0.0 109.64 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -62.44 -49.12 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.82 0.736 . . . . 0.0 110.951 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -52.78 -49.68 65.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.547 1.539 . . . . 0.0 107.847 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -57.58 -42.39 83.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.618 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.27 -39.97 70.45 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.949 0.795 . . . . 0.0 110.636 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.431 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 19.5 m -67.17 -56.08 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -47.94 -39.58 19.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.609 1.563 . . . . 0.0 114.211 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.81 -61.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.516 1.126 . . . . 0.0 108.675 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 mt -61.71 -34.67 76.18 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 118.675 -0.678 . . . . 0.0 109.854 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 22' ' ' SER . 70.7 mttt -54.36 -48.49 71.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.42 1.088 . . . . 0.0 108.242 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -65.22 -24.56 67.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.711 0.404 . . . . 0.0 110.489 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -81.06 8.39 8.68 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.121 1.768 . . . . 0.0 114.831 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 18.79 68.0 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.279 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -53.32 148.62 15.91 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 118.109 0.955 . . . . 0.0 109.294 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.95 112.14 3.49 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.103 1.202 . . . . 0.0 108.991 155.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.56 144.24 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.952 0.882 . . . . 0.0 110.156 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -145.12 157.36 44.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.499 1.92 . . . . 0.0 107.636 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.56 -157.39 24.05 Favored Glycine 0 C--O 1.238 0.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -147.81 161.48 41.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 109.946 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -130.88 146.48 52.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -100.95 109.63 21.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.34 169.62 14.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.077 0.951 . . . . 0.0 111.216 -165.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.01 106.72 16.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 109.408 -162.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.0 93.79 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -111.93 113.96 26.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.529 1.531 . . . . 0.0 107.345 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.44 78.81 8.58 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 -133.52 18.92 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -166.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.69 27.17 5.44 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.598 -1.668 . . . . 0.0 115.615 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.23 159.38 44.48 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.145 2.473 . . . . 0.0 110.725 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.47 137.21 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.276 1.43 . . . . 0.0 110.158 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.73 -9.39 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.94 -172.05 38.0 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -137.71 155.0 49.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -123.82 -177.32 3.71 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 124.551 1.157 . . . . 0.0 108.268 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.97 89.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.46 117.75 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -81.08 153.99 27.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.01 6.36 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.039 -1.038 . . . . 0.0 113.083 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -95.06 5.64 51.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.766 1.626 . . . . 0.0 112.009 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.41 72.43 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.49 -1.381 . . . . 0.0 113.148 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -101.08 172.45 7.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.374 1.069 . . . . 0.0 108.2 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -152.8 130.05 11.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.992 0.917 . . . . 0.0 108.908 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.97 145.19 17.6 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.6 67.86 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.634 2.889 . . . . 0.0 111.59 -173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.29 -51.83 6.06 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.327 2.251 . . . . 0.0 111.913 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -152.36 151.79 31.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.546 0.528 . . . . 0.0 111.168 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -140.61 161.74 37.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.553 1.541 . . . . 0.0 109.122 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.48 126.69 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.51 -143.7 7.32 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 127.345 2.402 . . . . 0.0 108.746 167.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 67' ' ' GLU . 3.4 tp -88.55 168.44 12.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.485 1.143 . . . . 0.0 109.955 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' H ' ' HG ' ' A' ' 66' ' ' LEU . 10.5 mm-40 -74.89 151.16 86.43 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 158.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.78 124.65 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.232 2.621 . . . . 0.0 111.456 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -70.77 167.93 24.32 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 111.53 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.96 125.13 14.7 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.592 1.528 . . . . 0.0 109.949 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.82 80.79 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.64 -1.089 . . . . 0.0 114.313 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 118.99 10.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.209 1.505 . . . . 0.0 106.982 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -140.03 176.89 8.38 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.868 0.467 . . . . 0.0 112.148 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -149.92 -161.95 1.45 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 162.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.5 m -52.18 130.38 30.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.027 1.331 . . . . 0.0 109.401 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -147.91 125.84 12.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.455 ' HB ' ' HE2' ' A' ' 116' ' ' LYS . 16.2 m -113.74 77.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 123.409 1.576 . . . . 0.0 108.757 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.16 -2.26 1.12 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.655 2.074 . . . . 0.0 116.191 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 176.57 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.113 2.565 . . . . 0.0 109.884 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.88 160.52 21.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 109.539 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.76 112.82 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 165.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.43 165.28 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 119.651 1.114 . . . . 0.0 110.252 163.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -142.19 151.79 42.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.316 0.646 . . . . 0.0 109.538 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.17 -29.68 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.837 2.055 . . . . 0.0 110.447 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.5 m -53.22 -43.65 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.085 1.354 . . . . 0.0 108.769 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.6 t -62.25 -23.01 66.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.108 0.867 . . . . 0.0 112.726 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.23 -56.42 4.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -51.86 -30.09 22.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.637 1.575 . . . . 0.0 112.642 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -45.19 -49.33 12.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.019 2.527 . . . . 0.0 113.714 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.98 -34.17 0.15 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.51 0.724 . . . . 0.0 112.371 -166.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.85 45.18 1.13 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.792 1.637 . . . . 0.0 108.719 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.01 -63.47 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.12 1.368 . . . . 0.0 107.405 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.94 -22.45 48.42 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.748 2.299 . . . . 0.0 112.742 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.21 -34.86 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.491 1.496 . . . . 0.0 110.787 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.2 -15.57 62.6 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.875 0.87 . . . . 0.0 111.576 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -147.76 77.38 1.42 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.652 1.569 . . . . 0.0 108.826 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.61 159.53 24.02 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.951 1.701 . . . . 0.0 108.054 160.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.71 143.55 41.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.57 0.748 . . . . 0.0 110.451 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.88 175.93 9.84 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.931 1.293 . . . . 0.0 109.464 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.43 47.24 1.59 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 111.897 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.91 145.29 53.79 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.822 -1.174 . . . . 0.0 109.112 153.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -74.43 167.17 22.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.56 1.144 . . . . 0.0 108.227 165.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.42 171.89 36.5 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.21 1.386 . . . . 0.0 112.235 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.68 113.01 3.69 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.849 2.366 . . . . 0.0 109.638 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.25 75.33 0.26 Allowed Glycine 0 C--O 1.225 -0.467 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -72.48 125.97 28.72 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -61.91 97.94 0.09 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.75 2.42 . . . . 0.0 110.637 -169.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.02 116.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.46 157.88 26.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.2 t -140.48 114.99 6.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -144.03 102.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.19 176.52 7.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 63.24 -77.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.954 2.502 . . . . 0.0 109.261 -149.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.324 30.2 mt 55.04 -8.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 128.063 2.545 . . . . 0.0 114.445 -169.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.97 -81.4 0.38 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 121.234 1.834 . . . . 0.0 111.477 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HE2' ' HB ' ' A' ' 77' ' ' VAL . 2.0 ttpm? -59.29 -28.35 66.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -163.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -22.47 65.41 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.843 -2.027 . . . . 0.0 111.258 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -24.85 -67.06 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.617 2.367 . . . . 0.0 113.936 -174.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.67 -15.64 60.79 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.744 2.018 . . . . 0.0 110.168 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.2 t -47.54 105.21 0.07 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 129.532 3.133 . . . . 0.0 108.439 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.18 -89.77 0.59 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -56.75 -13.35 2.45 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.073 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -66.5 0.37 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.543 1.537 . . . . 0.0 110.69 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -33.84 -55.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.698 1.199 . . . . 0.0 111.362 168.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.54 -54.66 36.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.072 0.851 . . . . 0.0 112.477 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.55 66.88 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.33 -45.8 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -56.53 -39.15 72.89 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.297 -1.502 . . . . 0.0 112.294 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.03 -16.7 33.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.806 1.185 . . . . 0.0 113.667 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.9 m -128.2 -17.91 4.2 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.429 1.092 . . . . 0.0 111.952 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.48 -49.88 73.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 146.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -82.87 49.79 1.58 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.421 1.888 . . . . 0.0 110.067 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -141.43 133.76 13.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 162.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.9 -37.37 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 121.858 1.705 . . . . 0.0 111.353 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.64 17.02 2.2 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.822 1.201 . . . . 0.0 114.989 -174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.9 m -118.31 167.16 11.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.64 1.72 . . . . 0.0 108.475 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mt -129.94 101.5 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.481 ' CG1' ' HD1' ' A' ' 3' ' ' HIS . 21.4 mm -59.9 133.16 25.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tp -132.71 147.52 52.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 159.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.81 177.89 45.2 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.2 m -114.19 148.08 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.24 127.8 19.11 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.53 145.52 76.79 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.415 1.41 . . . . 0.0 110.511 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.48 134.42 88.72 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.146 0.979 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -67.59 -55.37 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.206 2.604 . . . . 0.0 109.987 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 64.9 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.281 1.832 . . . . 0.0 108.301 -167.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.12 -102.91 0.5 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.671 1.123 . . . . 0.0 110.41 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 159.09 79.43 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 117.852 0.826 . . . . 0.0 110.364 -173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.14 -175.95 2.94 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.733 2.955 . . . . 0.0 108.918 167.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -126.48 144.89 50.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.21 -66.68 0.36 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.667 1.987 . . . . 0.0 113.119 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.2 -39.21 66.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.494 1.118 . . . . 0.0 111.254 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.54 -36.5 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.076 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -63.21 -29.19 70.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.27 1.395 . . . . 0.0 111.778 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -56.94 -39.43 74.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.555 0.693 . . . . 0.0 110.352 174.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.17 -36.81 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.913 1.685 . . . . 0.0 109.909 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -66.44 -34.17 77.33 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.225 -1.547 . . . . 0.0 110.969 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -62.7 -30.58 71.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.787 0.835 . . . . 0.0 109.682 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -58.29 -40.26 81.49 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.355 0.662 . . . . 0.0 109.473 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 -17.68 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.318 3.047 . . . . 0.0 115.677 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.88 -5.55 58.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.723 1.209 . . . . 0.0 111.652 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.36 127.49 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.043 1.337 . . . . 0.0 109.967 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 13.6 tptm -65.0 120.4 12.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 164.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 92.15 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 18.9 m-85 -66.62 98.1 0.49 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.534 1.133 . . . . 0.0 108.182 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 106.46 2.9 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.98 162.81 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.3 p -129.86 156.28 44.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 165.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -59.69 -22.91 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.335 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -83.06 -36.73 24.68 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 110.313 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.73 80.79 1.93 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.659 3.184 . . . . 0.0 102.877 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -106.59 -35.46 7.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.37 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -113.27 3.3 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.369 1.441 . . . . 0.0 113.312 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -101.61 0.2 35.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.365 1.866 . . . . 0.0 111.425 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -31.62 52.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.122 -0.986 . . . . 0.0 111.247 -173.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 tp -39.31 -61.6 0.96 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.768 1.227 . . . . 0.0 110.462 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -68.29 -23.16 39.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.589 1.603 . . . . 0.0 115.495 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.75 -45.39 82.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.917 1.235 . . . . 0.0 108.323 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.3 mt -62.38 -49.46 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.042 0.937 . . . . 0.0 109.623 173.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.93 -41.69 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 119.824 1.193 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 58.0 m -64.36 -35.77 81.96 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 7.9 t -66.34 -34.73 78.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.083 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.95 -58.56 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.346 0.976 . . . . 0.0 108.399 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.05 -12.55 3.49 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 113.789 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.7 t -57.31 -32.98 67.22 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.925 -1.11 . . . . 0.0 110.832 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 t -137.45 93.2 2.78 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.572 -1.33 . . . . 0.0 108.819 -158.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.444 ' C ' ' HE2' ' A' ' 189' ' ' LYS . 53.3 mtt180 54.72 160.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.585 2.354 . . . . 0.0 112.653 -159.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.444 ' HE2' ' C ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 118.637 -0.696 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -125.95 176.65 6.84 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.714 1.143 . . . . 0.0 110.571 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -34.45 143.66 0.04 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 128.065 2.546 . . . . 0.0 111.037 163.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.31 127.28 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.758 0.708 . . . . 0.0 109.634 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -140.03 134.0 30.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.874 0.87 . . . . 0.0 109.934 -173.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.08 161.47 22.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.791 1.636 . . . . 0.0 109.152 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -155.6 165.28 37.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.007 0.923 . . . . 0.0 108.818 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.69 -158.95 15.52 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.394 -1.225 . . . . 0.0 111.82 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.08 117.07 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.15 3.233 . . . . 0.0 112.248 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.47 172.51 13.44 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.771 2.981 . . . . 0.0 111.776 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.22 -63.77 0.29 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 167.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.41 125.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.31 -37.72 1.81 Allowed Glycine 0 C--O 1.223 -0.533 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 159.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.629 ' HE3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -62.3 -29.74 70.65 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 117.887 0.843 . . . . 0.0 110.387 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -61.14 -48.43 81.63 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -55.17 -40.11 70.3 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 128.123 2.569 . . . . 0.0 107.873 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.37 -61.99 2.07 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 117.9 -1.047 . . . . 0.0 109.841 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.61 -45.64 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 119.6 1.091 . . . . 0.0 110.06 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -59.24 4.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.692 1.597 . . . . 0.0 108.247 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -63.11 -30.4 71.56 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.425 -1.274 . . . . 0.0 111.954 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.36 -32.75 68.85 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 119.878 1.217 . . . . 0.0 109.802 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -71.77 -44.66 63.64 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.192 0.451 . . . . 0.0 110.103 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -61.71 -22.31 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.06 0.944 . . . . 0.0 111.639 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.08 -50.82 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 120.898 -1.126 . . . . 0.0 110.677 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.27 -36.81 84.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.505 0.722 . . . . 0.0 110.22 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -59.18 -48.83 80.18 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -67.74 -3.42 9.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.277 1.831 . . . . 0.0 112.799 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -120.38 11.78 11.52 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.786 1.634 . . . . 0.0 112.773 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.05 38.68 22.07 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 120.122 1.328 . . . . 0.0 113.689 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.46 118.63 37.11 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 107.489 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.49 99.08 0.8 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.77 2.98 . . . . 0.0 110.111 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.4 156.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.14 175.39 9.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.31 -170.64 16.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.89 156.89 46.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.465 0.65 . . . . 0.0 109.811 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -131.59 131.28 43.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 m -83.2 125.37 31.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.437 0.0 OUTLIER -103.7 -130.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 116.593 -1.67 . . . . 0.0 109.645 176.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -157.71 108.48 2.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 122.678 2.49 . . . . 0.0 110.037 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 107.52 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -128.89 113.32 15.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.47 -63.07 1.43 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.692 0.678 . . . . 0.0 109.245 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.49 68.91 0.34 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 106.409 -2.676 . . . . 0.0 106.409 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 -11.08 72.95 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.751 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 135.15 40.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.277 2.038 . . . . 0.0 109.899 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -67.45 141.18 57.07 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 167.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -148.99 -2.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.022 1.329 . . . . 0.0 112.846 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.84 -167.54 32.69 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 119.878 1.217 . . . . 0.0 110.973 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -137.97 154.04 49.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 117.141 0.47 . . . . 0.0 110.52 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -135.95 155.91 49.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 129.484 3.114 . . . . 0.0 106.221 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.76 108.34 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.72 122.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -165.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -72.1 155.24 40.5 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.58 -28.44 69.89 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.803 -1.186 . . . . 0.0 110.938 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -68.91 -20.8 64.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 128.033 2.533 . . . . 0.0 111.508 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.42 39.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.652 -1.082 . . . . 0.0 114.409 163.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.8 m -71.23 164.4 25.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.822 1.811 . . . . 0.0 107.491 160.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -141.56 136.38 31.04 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.134 0.974 . . . . 0.0 108.523 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.68 47.87 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.45 -177.53 1.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 145.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 -60.04 0.07 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 p -146.34 158.31 43.87 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.913 0.885 . . . . 0.0 109.122 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -143.37 165.43 27.54 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.863 2.065 . . . . 0.0 106.895 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.54 147.48 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 41.85 0.22 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.775 1.655 . . . . 0.0 110.706 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt 55.96 -167.62 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.798 1.299 . . . . 0.0 111.487 -173.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.4 142.54 25.13 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.836 0.854 . . . . 0.0 108.862 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.05 134.57 25.55 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.629 1.553 . . . . 0.0 109.825 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.86 159.25 54.62 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.006 2.471 . . . . 0.0 109.449 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.06 -6.37 18.09 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.521 2.147 . . . . 0.0 113.989 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.34 7.28 12.6 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.493 1.521 . . . . 0.0 113.622 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -138.49 88.07 2.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.384 2.092 . . . . 0.0 107.16 173.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.21 150.87 33.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.69 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.39 63.84 0.12 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.515 1.126 . . . . 0.0 108.534 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 59.8 m 47.78 -143.97 0.38 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.93 -1.106 . . . . 0.0 110.719 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.1 155.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 1 C-N-CA 133.701 4.801 . . . . 0.0 106.11 175.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.34 25.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 121.115 1.78 . . . . 0.0 111.017 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.2 111.73 0.94 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 64.05 -48.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.911 2.484 . . . . 0.0 113.953 -167.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.87 178.37 4.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.12 2.568 . . . . 0.0 108.717 -173.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.26 143.29 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 126.708 2.003 . . . . 0.0 106.53 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.11 176.65 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 119.708 1.14 . . . . 0.0 110.394 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -140.3 156.1 46.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 157.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.07 -33.93 38.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.88 0.872 . . . . 0.0 108.954 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.9 m -68.3 -33.35 74.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.843 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.9 m -60.69 -32.01 71.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 121.277 1.853 . . . . 0.0 109.846 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -69.11 -57.46 5.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -53.19 -24.09 10.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -48.81 -34.72 12.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.097 1.359 . . . . 0.0 112.827 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -31.98 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.3 44.08 0.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.281 1.432 . . . . 0.0 110.847 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.43 -61.69 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 127.186 2.195 . . . . 0.0 108.414 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.3 -24.18 16.94 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.04 1.827 . . . . 0.0 113.54 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.5 -30.32 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 119.463 1.029 . . . . 0.0 111.188 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.6 mt -76.46 -6.75 53.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.705 2.002 . . . . 0.0 111.316 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 92.16 2.1 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.46 1.504 . . . . 0.0 109.86 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.59 135.79 54.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.635 1.574 . . . . 0.0 110.321 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.57 126.82 32.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.851 1.26 . . . . 0.0 111.552 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -109.01 -88.51 0.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.908 1.283 . . . . 0.0 109.036 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.9 t 95.19 102.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.816 3.246 . . . . 0.0 107.246 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.4 m -142.74 104.1 4.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.653 1.181 . . . . 0.0 108.083 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 m -66.73 -14.44 62.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.256 1.023 . . . . 0.0 112.731 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.65 -133.22 2.93 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -61.8 149.46 89.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.432 2.088 . . . . 0.0 110.356 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.66 -62.92 0.19 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -164.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 48.07 -152.25 0.11 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.901 0.851 . . . . 0.0 108.914 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.27 170.47 22.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 128.247 2.619 . . . . 0.0 105.947 160.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 130.1 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 10.5 m -124.99 109.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 t -83.16 140.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 125.742 1.617 . . . . 0.0 111.203 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -151.67 85.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.516 1.126 . . . . 0.0 108.645 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.53 127.42 53.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.336 -1.478 . . . . 0.0 113.218 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 95.54 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 1 C-N-CA 133.585 4.754 . . . . 0.0 108.153 -173.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.87 57.5 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.653 2.381 . . . . 0.0 106.271 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.97 -33.96 0.03 OUTLIER Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.539 -1.351 . . . . 0.0 112.47 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -62.25 -17.98 59.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 119.612 -2.111 . . . . 0.0 113.822 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 9.81 28.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.879 1.672 . . . . 0.0 111.283 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -57.71 -13.57 4.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.65 -41.05 4.15 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.772 1.229 . . . . 0.0 111.917 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.4 -22.28 44.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.581 0.628 . . . . 0.0 112.39 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.438 ' HG ' ' CD1' ' A' ' 125' ' ' ILE . 47.7 t -50.44 135.23 22.62 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 -175.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -136.92 -77.41 0.41 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.126 0.57 . . . . 0.0 111.009 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.28 -29.88 69.59 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 116.859 -1.543 . . . . 0.0 110.549 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.91 -54.58 12.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.051 -1.452 . . . . 0.0 111.69 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.438 ' CD1' ' HG ' ' A' ' 121' ' ' SER . 4.3 mp -38.51 -63.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 126.566 1.946 . . . . 0.0 111.649 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.51 -51.59 68.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.13 72.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.0 p -87.95 -32.18 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.74 0.816 . . . . 0.0 110.373 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -36.95 32.47 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.042 165.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -48.2 -53.21 17.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.005 1.275 . . . . 0.0 109.529 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -41.63 61.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.791 2.036 . . . . 0.0 112.343 -175.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.47 -41.29 98.67 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.605 1.548 . . . . 0.0 110.606 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 t -78.46 25.26 0.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.948 1.699 . . . . 0.0 111.064 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.5 m -126.79 134.31 25.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.524 -1.36 . . . . 0.0 110.271 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.68 158.81 46.72 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.433 2.755 . . . . 0.0 109.888 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.93 3.78 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -61.84 148.03 44.62 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.227 1.014 . . . . 0.0 112.066 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.6 mt -130.2 108.26 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.0 mm -66.6 139.29 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mt -133.7 97.03 3.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.405 1.482 . . . . 0.0 107.878 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.19 -172.45 18.15 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 118.032 0.378 . . . . 0.0 113.209 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 m -142.26 136.39 29.75 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.931 1.292 . . . . 0.0 107.62 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.78 167.56 18.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.691 1.596 . . . . 0.0 110.079 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 160.05 51.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.562 1.508 . . . . 0.0 111.116 158.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.2 152.71 96.53 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.543 -0.723 . . . . 0.0 110.075 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -26.13 18.92 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.01 2.473 . . . . 0.0 111.983 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -50.71 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 128.394 2.678 . . . . 0.0 110.029 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.54 -118.79 1.65 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -167.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 171.23 7.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.225 1.41 . . . . 0.0 110.743 -171.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -57.4 170.98 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.456 2.104 . . . . 0.0 110.39 158.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -147.9 178.6 8.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.83 2.852 . . . . 0.0 105.396 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.1 -82.0 0.11 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 118.903 0.774 . . . . 0.0 109.096 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.83 -32.68 74.34 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 120.444 -1.41 . . . . 0.0 113.073 -171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.81 -34.93 71.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 117.441 -1.266 . . . . 0.0 109.165 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.15 -34.18 73.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 111.153 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.33 -50.27 67.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.043 0.937 . . . . 0.0 109.76 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.0 -35.66 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -62.46 -25.62 68.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.13 0.877 . . . . 0.0 111.111 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.07 -14.17 61.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.258 1.023 . . . . 0.0 113.556 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -117.19 55.89 0.83 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.447 1.499 . . . . 0.0 107.898 -166.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 4.7 mmpt? -57.62 -10.32 1.51 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.426 1.491 . . . . 0.0 114.951 -166.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.0 -25.36 43.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.977 0.808 . . . . 0.0 112.163 167.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.3 m -47.73 118.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 125.901 1.68 . . . . 0.0 109.185 164.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 134.34 53.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.519 1.928 . . . . 0.0 108.501 169.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.63 80.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.168 0.894 . . . . 0.0 108.78 -168.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.15 104.21 1.39 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.179 1.792 . . . . 0.0 109.135 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.58 116.17 17.02 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.906 -1.121 . . . . 0.0 109.52 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.73 166.73 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.983 0.897 . . . . 0.0 109.577 170.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.0 p -120.05 151.19 39.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 163.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -64.49 -21.08 66.57 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.386 -0.821 . . . . 0.0 109.477 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -67.74 -74.21 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.704 2.002 . . . . 0.0 109.135 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -91.06 31.9 1.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.924 1.289 . . . . 0.0 109.998 -175.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.79 -24.31 61.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.737 1.215 . . . . 0.0 112.115 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -114.93 21.9 13.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.19 2.596 . . . . 0.0 111.593 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -136.46 6.51 3.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.588 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.42 -13.27 57.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 117.436 -1.706 . . . . 0.0 110.627 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tp -36.39 -59.91 0.79 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 127.591 2.356 . . . . 0.0 112.533 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.2 -25.29 31.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 122.108 1.789 . . . . 0.0 112.087 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.2 -43.44 78.05 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.73 -53.01 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.02 -43.73 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.22 1.408 . . . . 0.0 110.264 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.1 m -60.83 -32.72 72.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.516 1.126 . . . . 0.0 111.569 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -65.33 -45.67 83.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.948 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.28 -48.29 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.998 0.919 . . . . 0.0 109.217 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -65.95 -24.5 66.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.7 t -67.96 -24.8 65.2 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.112 0.965 . . . . 0.0 109.992 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 21.46 0.06 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.32 1.048 . . . . 0.0 113.022 167.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.28 83.13 0.07 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.691 1.996 . . . . 0.0 110.409 -167.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 C-N-CA 130.959 3.704 . . . . 0.0 114.839 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.75 172.6 11.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 170.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -64.38 139.5 58.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.475 1.11 . . . . 0.0 109.315 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.46 138.25 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 14.9 m-85 -129.03 146.76 50.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.694 0.759 . . . . 0.0 109.899 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.65 131.16 46.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -121.59 175.44 6.22 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.64 0.733 . . . . 0.0 109.4 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.86 -135.73 8.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 125.462 1.506 . . . . 0.0 109.644 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.25 159.74 52.58 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.696 2.264 . . . . 0.0 111.761 -160.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.43 -9.67 25.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.951 3.101 . . . . 0.0 114.266 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.32 19.69 14.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.103 0.858 . . . . 0.0 112.464 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.433 ' O ' ' HE2' ' A' ' 14' ' ' LYS 0.301 46.9 t 74.29 -65.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.136 3.374 . . . . 0.0 109.272 168.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.37 5.05 26.74 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.236 1.398 . . . . 0.0 110.822 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 12' ' ' VAL . 24.3 mtmt -121.76 -8.31 8.97 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 116.368 -1.777 . . . . 0.0 115.225 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.8 m -47.14 -41.19 17.13 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.769 1.622 . . . . 0.0 112.015 -166.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -43.63 -48.83 7.77 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.475 2.71 . . . . 0.0 109.906 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.596 ' CD1' ' H ' ' A' ' 176' ' ' LEU . 41.9 mt -69.54 -57.27 5.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 125.56 1.544 . . . . 0.0 109.743 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mm -57.74 -46.72 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.971 0.805 . . . . 0.0 109.118 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 -56.51 7.57 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.959 0.904 . . . . 0.0 111.321 171.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -68.58 -25.63 64.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.322 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.6 61.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.442 1.097 . . . . 0.0 110.224 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -70.08 -35.07 73.93 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -58.67 -45.31 89.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.879 0.872 . . . . 0.0 109.124 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -60.53 -53.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.151 0.98 . . . . 0.0 110.213 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.93 -41.02 90.86 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.143 0.577 . . . . 0.0 109.449 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -69.59 -40.72 76.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.978 0.354 . . . . 0.0 110.126 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -61.18 -30.15 70.24 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.027 169.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -84.92 1.68 46.18 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.4 1.48 . . . . 0.0 112.858 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.75 1.46 66.94 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.236 1.398 . . . . 0.0 114.282 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.44 110.52 11.69 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.079 1.94 . . . . 0.0 107.809 -172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.93 119.33 6.39 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.555 2.17 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.95 118.17 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 109.033 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.27 170.79 9.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 126.234 1.813 . . . . 0.0 109.797 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 -156.5 16.01 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 163.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -149.46 167.79 25.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -141.42 -175.97 4.55 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -118.52 133.74 55.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.822 1.647 . . . . 0.0 107.086 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.45 33.78 5.41 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.584 -1.322 . . . . 0.0 112.222 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.04 -172.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.994 2.118 . . . . 0.0 110.51 -171.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.37 144.2 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 152.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -125.22 161.63 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.278 1.831 . . . . 0.0 107.758 167.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -108.79 45.88 1.01 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.079 1.352 . . . . 0.0 107.367 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 104.95 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -163.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.69 -51.93 3.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.944 1.259 . . . . 0.0 114.56 171.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.13 139.46 30.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 110.392 -162.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -70.15 134.77 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.47 -8.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -176.34 38.43 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 119.558 1.072 . . . . 0.0 110.613 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.57 148.84 51.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.77 135.14 32.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.8 155.73 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 C-N-CA 125.953 1.701 . . . . 0.0 108.536 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 m -141.51 143.09 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.972 165.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.9 p -82.87 161.97 21.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.406 1.003 . . . . 0.0 109.871 174.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.63 -14.27 60.75 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.529 -0.732 . . . . 0.0 112.935 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 t -69.14 -25.47 64.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.935 0.789 . . . . 0.0 109.49 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.56 9.65 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.079 0.847 . . . . 0.0 112.546 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -83.66 167.22 17.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 1.3 mpt_? -137.53 163.23 31.66 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -151.18 175.47 30.09 Favored Glycine 0 C--O 1.223 -0.571 0 CA-C-N 120.843 1.656 . . . . 0.0 110.531 158.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.71 161.6 35.14 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 109.749 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.4 -59.98 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.61 144.29 49.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -143.34 162.16 36.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.263 1.425 . . . . 0.0 108.053 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 149.79 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.22 157.4 28.27 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 166.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.47 162.87 7.47 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 161.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.67 150.63 81.11 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.42 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.22 124.87 11.3 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.334 2.023 . . . . 0.0 110.447 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.04 165.84 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.945 2.43 . . . . 0.0 109.465 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.97 101.75 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 108.549 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.45 -68.18 0.48 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.562 1.077 . . . . 0.0 110.421 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -76.72 125.31 29.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.87 7.94 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -135.61 41.42 2.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.179 1.392 . . . . 0.0 107.312 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.0 m 59.1 -161.61 0.26 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.771 2.028 . . . . 0.0 112.291 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.78 157.27 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.426 3.091 . . . . 0.0 109.5 175.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.01 0.53 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.93 140.41 11.03 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 -169.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.65 -69.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.965 1.706 . . . . 0.0 110.718 -158.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.11 148.92 21.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.785 1.234 . . . . 0.0 110.164 -167.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.26 139.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 162.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.93 -175.8 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 O-C-N 120.774 -1.204 . . . . 0.0 109.066 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.39 119.82 6.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 153.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.94 -34.61 71.95 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 112.117 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.9 m -51.51 -39.67 58.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.775 1.63 . . . . 0.0 110.35 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.09 -29.05 70.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.743 0.417 . . . . 0.0 110.597 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -71.53 -60.23 2.34 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.913 1.285 . . . . 0.0 108.006 170.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -49.25 -21.42 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.675 1.99 . . . . 0.0 113.778 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -57.34 -58.26 9.03 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.709 -1.244 . . . . 0.0 112.065 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' CD2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -123.07 -34.15 3.2 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.833 1.253 . . . . 0.0 112.646 -164.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.45 55.92 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.693 1.597 . . . . 0.0 109.074 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 -58.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.679 -173.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.37 -27.06 19.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.893 2.395 . . . . 0.0 113.055 168.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 p -63.41 -27.87 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.914 -1.116 . . . . 0.0 110.659 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 84.4 1.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? 51.51 80.28 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.43 2.292 . . . . 0.0 113.163 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -62.09 136.4 57.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.747 1.619 . . . . 0.0 108.124 153.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.49 62.3 7.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.183 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -90.25 -54.73 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 109.609 -163.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.72 165.78 27.58 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.554 1.141 . . . . 0.0 109.989 165.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -161.42 106.18 1.31 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.742 162.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 m -155.06 152.06 29.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.797 1.18 . . . . 0.0 110.547 168.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.78 -157.44 52.15 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.103 0.859 . . . . 0.0 113.413 164.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.15 111.9 1.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.377 2.051 . . . . 0.0 107.702 164.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 153.24 68.51 0.01 OUTLIER Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -173.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -75.42 161.93 28.8 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -79.31 156.21 28.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 160.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.2 149.31 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 150.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 19.5 t -127.93 163.56 24.21 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.898 1.226 . . . . 0.0 109.771 160.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.6 t -145.53 125.91 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.49 1.516 . . . . 0.0 107.137 -166.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.06 63.34 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.14 97.19 9.21 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.34 -31.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.128 0.571 . . . . 0.0 110.106 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.5 mt -60.26 120.31 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.537 1.135 . . . . 0.0 110.145 -159.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.41 -15.41 1.65 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.68 1.133 . . . . 0.0 112.479 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -100.22 -35.8 9.51 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.722 1.261 . . . . 0.0 110.461 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -87.92 19.97 3.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.024 1.73 . . . . 0.0 111.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -46.12 -33.43 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.677 1.126 . . . . 0.0 114.023 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -102.67 -45.32 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.518 2.327 . . . . 0.0 110.196 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.27 -21.52 63.88 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.1 m -56.17 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.522 1.529 . . . . 0.0 111.331 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -84.16 -84.18 0.14 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.12 0.568 . . . . 0.0 110.051 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -60.52 -13.58 14.71 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.306 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.77 -51.44 65.7 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 120.885 1.675 . . . . 0.0 111.61 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.4 mp -52.11 -22.02 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 112.466 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.0 -58.97 2.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.719 -1.238 . . . . 0.0 108.713 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.46 -50.6 72.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.427 1.491 . . . . 0.0 111.594 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 t -61.56 -47.53 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.379 1.072 . . . . 0.0 108.412 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -57.7 -38.55 75.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -39.88 81.21 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.307 0.958 . . . . 0.0 110.758 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -71.03 -39.59 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.94 -14.32 61.88 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.31 1.044 . . . . 0.0 111.776 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -63.07 -50.1 71.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 120.396 1.453 . . . . 0.0 110.038 164.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -60.13 134.33 90.47 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.63 -33.91 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.878 1.719 . . . . 0.0 112.763 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.74 7.68 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 118.346 -1.252 . . . . 0.0 110.781 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 51.8 m -48.51 115.5 1.25 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.097 1.359 . . . . 0.0 111.286 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.1 mt -96.25 85.91 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 102.781 -3.044 . . . . 0.0 102.781 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.1 mm -52.91 117.85 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.65 146.75 25.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 144.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.19 156.62 27.07 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 156.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -91.31 149.48 21.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.3 pt -136.33 163.02 53.01 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.837 2.055 . . . . 0.0 108.72 166.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.51 165.01 23.34 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.34 2.693 . . . . 0.0 110.443 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.29 149.16 97.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.008 -1.058 . . . . 0.0 109.544 162.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.0 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.104 2.536 . . . . 0.0 109.354 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt 48.34 38.38 10.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.801 1.64 . . . . 0.0 112.872 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.59 -121.01 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 159.61 83.05 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 117.118 0.459 . . . . 0.0 110.145 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.49 166.61 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.95 1.766 . . . . 0.0 107.931 159.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.4 -163.86 1.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.85 -61.34 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.128 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -51.75 19.99 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.04 -22.7 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.74 1.155 . . . . 0.0 111.748 -169.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -42.16 80.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.564 2.346 . . . . 0.0 111.866 171.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.314 0.3 OUTLIER -58.53 -53.35 59.29 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 121.862 0.839 . . . . 0.0 110.006 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 5.3 mt -67.98 -26.54 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.793 0.837 . . . . 0.0 111.2 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -70.73 -20.51 62.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 120.345 -1.472 . . . . 0.0 111.422 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.2 -14.57 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 111.504 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -81.72 85.38 6.61 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -63.05 -20.46 65.35 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 111.714 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.29 -35.17 59.81 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.065 1.746 . . . . 0.0 113.236 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.26 124.1 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.4 1.48 . . . . 0.0 110.854 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -59.11 147.42 35.06 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.56 97.61 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -85.04 104.11 14.67 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.479 1.911 . . . . 0.0 108.203 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.55 103.0 13.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.309 1.443 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.53 163.02 4.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.665 1.222 . . . . 0.0 111.411 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.26 134.9 45.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.566 2.347 . . . . 0.0 106.16 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -46.55 -30.2 2.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.519 1.128 . . . . 0.0 111.489 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.06 -31.14 72.22 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 125.378 1.673 . . . . 0.0 110.591 -172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -131.7 18.29 4.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.026 1.33 . . . . 0.0 111.037 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -60.51 -21.88 62.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -167.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -102.02 11.73 37.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.08 1.352 . . . . 0.0 113.416 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -127.25 24.16 6.34 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.345 1.058 . . . . 0.0 110.973 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.596 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -83.5 -12.02 56.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.511 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.0 tt -47.11 -57.34 9.53 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.566 1.946 . . . . 0.0 112.068 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.43 -22.95 24.27 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 121.56 1.593 . . . . 0.0 113.08 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.61 -45.97 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.8 mt -63.78 -52.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.49 1.516 . . . . 0.0 109.441 174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -55.56 -45.53 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.3 1.409 . . . . 0.0 109.654 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.3 m -56.92 -43.49 81.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.604 1.162 . . . . 0.0 110.366 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.8 t -65.35 -38.73 90.98 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.098 0.959 . . . . 0.0 111.855 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.64 -51.61 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 119.234 0.925 . . . . 0.0 108.833 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -66.59 -12.74 59.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.314 -0.851 . . . . 0.0 112.638 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 86.2 p -48.09 -45.17 32.36 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.757 1.223 . . . . 0.0 111.167 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.72 -58.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 1 C-N-CA 133.283 4.633 . . . . 0.0 115.775 -175.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -92.63 -29.19 16.25 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 114.09 172.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? . . . . . 0 C--O 1.248 0.998 0 CA-C-O 116.698 -1.62 . . . . 0.0 109.996 -173.587 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -140.77 135.36 31.42 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.338 0.972 . . . . 0.0 109.107 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -34.18 138.84 0.08 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.29 3.036 . . . . 0.0 111.194 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 t -131.38 141.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.03 143.98 47.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.956 0.902 . . . . 0.0 109.435 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.14 151.08 24.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.695 0.798 . . . . 0.0 110.778 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -156.67 -177.87 6.92 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 123.315 0.384 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.45 -141.08 13.87 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.275 2.369 . . . . 0.0 109.443 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.31 145.14 64.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.963 1.776 . . . . 0.0 111.109 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.28 160.56 44.78 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.27 1.98 . . . . 0.0 110.259 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.95 4.23 7.15 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.072 1.32 . . . . 0.0 115.795 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 5.8 p -74.16 22.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 119.67 1.735 . . . . 0.0 115.472 -160.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.18 -0.33 78.33 Favored Glycine 0 N--CA 1.464 0.545 0 O-C-N 120.013 -1.679 . . . . 0.0 112.062 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -21.15 64.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.944 1.298 . . . . 0.0 113.73 -171.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -50.36 -37.25 36.15 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 120.026 1.285 . . . . 0.0 110.666 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.4 m -57.03 -36.28 70.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.95 1.7 . . . . 0.0 113.51 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -52.44 32.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -36.0 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 O-C-N 122.088 -0.382 . . . . 0.0 111.085 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -54.21 -51.87 63.05 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -54.64 -43.0 71.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.286 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -33.74 68.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.998 1.272 . . . . 0.0 111.476 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -68.18 -53.78 22.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.99 -34.08 77.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.5 1.12 . . . . 0.0 112.59 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -62.86 -49.27 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.45 1.5 . . . . 0.0 110.733 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.5 -40.92 98.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.8 -42.37 98.92 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.47 69.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 112.407 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -83.23 -0.62 50.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.971 -1.08 . . . . 0.0 112.136 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.02 36.08 57.3 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.786 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.77 109.13 40.09 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.3 143.92 78.69 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.88 132.52 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.55 174.51 5.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.512 1.525 . . . . 0.0 107.667 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.16 -161.76 23.1 Favored Glycine 0 CA--C 1.508 -0.402 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.79 163.72 37.94 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 117.343 0.571 . . . . 0.0 111.444 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -138.28 168.34 19.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.4 p -109.87 91.32 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.58 -4.26 22.24 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.919 -1.113 . . . . 0.0 113.664 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 84.14 167.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 130.61 3.564 . . . . 0.0 110.357 -158.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.14 118.54 11.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 164.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -111.03 148.33 32.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 163.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -142.66 116.77 9.45 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 156.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.18 26.84 64.25 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.965 0.802 . . . . 0.0 111.486 -166.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.74 -20.0 2.45 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.411 1.325 . . . . 0.0 116.411 172.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.79 7.35 2.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.073 2.437 . . . . 0.0 116.498 -157.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.651 1.98 . . . . 0.0 110.998 -165.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.63 -11.63 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.732 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.84 -147.19 16.73 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.341 -1.903 . . . . 0.0 108.341 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -141.7 163.18 33.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.554 1.542 . . . . 0.0 109.551 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -120.36 166.23 13.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.935 1.694 . . . . 0.0 106.839 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.47 104.9 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 123.849 0.859 . . . . 0.0 108.717 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.5 117.55 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -164.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 p -66.19 161.84 21.16 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 109.293 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.87 -1.32 6.98 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.83 -1.169 . . . . 0.0 112.324 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -105.14 7.21 33.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.475 1.91 . . . . 0.0 112.479 168.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.28 6.59 83.78 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 120.385 -1.447 . . . . 0.0 115.015 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 149.63 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 156.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -150.45 149.57 30.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.108 1.322 . . . . 0.0 111.041 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.8 158.74 18.43 Favored Glycine 0 C--O 1.22 -0.768 0 CA-C-O 116.879 -2.067 . . . . 0.0 111.325 -172.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.95 9.79 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.457 3.438 . . . . 0.0 113.791 -164.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 24.54 -74.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 131.415 3.886 . . . . 0.0 116.301 171.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 p -136.44 143.25 43.81 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 164.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.48 67.87 0.46 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.508 0.594 . . . . 0.0 110.039 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.5 t 48.66 134.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 130.348 3.459 . . . . 0.0 114.798 -172.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.34 52.79 0.49 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 53.5 -178.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.227 1.811 . . . . 0.0 111.783 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -80.91 158.35 70.45 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 159.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.03 140.14 14.02 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.153 2.568 . . . . 0.0 110.356 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.21 175.29 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.992 3.128 . . . . 0.0 110.578 165.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.63 150.87 86.03 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.021 1.147 . . . . 0.0 109.27 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.86 -73.26 0.66 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.059 0.837 . . . . 0.0 112.582 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 115.45 5.03 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.232 1.016 . . . . 0.0 109.049 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -173.62 153.37 2.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.89 2.076 . . . . 0.0 106.785 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.75 -27.61 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 151.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 65.8 m -152.13 143.59 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.622 1.569 . . . . 0.0 109.442 -170.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.65 139.32 4.49 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.29 85.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 172.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.38 -67.2 0.25 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.092 1.806 . . . . 0.0 112.041 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -144.72 -18.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.368 2.267 . . . . 0.0 113.402 -167.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -106.57 125.81 51.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.84 130.98 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 167.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.62 168.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.449 1.022 . . . . 0.0 108.598 165.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.11 111.13 14.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.71 -31.53 66.5 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.689 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.2 m -60.81 -38.15 84.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.707 1.603 . . . . 0.0 111.493 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.7 m -58.84 -36.38 74.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.7 1.136 . . . . 0.0 110.446 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.34 -49.8 65.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.074 0.95 . . . . 0.0 111.478 171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -53.38 -25.44 15.53 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.161 0.891 . . . . 0.0 113.1 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.68 -50.84 65.4 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.237 1.38 . . . . 0.0 111.934 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -134.18 -25.59 1.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.773 -166.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.55 59.61 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.275 1.398 . . . . 0.0 109.402 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mp -49.9 -45.96 80.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.095 -1.431 . . . . 0.0 114.045 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.87 -27.33 7.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 CA-C-N 121.733 1.655 . . . . 0.0 113.834 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.3 -29.75 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.737 1.153 . . . . 0.0 111.26 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.7 34.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.021 2.128 . . . . 0.0 111.007 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 94' ' ' VAL 0.275 4.8 mmm-85 173.84 -134.7 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 130.851 3.66 . . . . 0.0 107.238 -164.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 63.79 167.82 0.15 Allowed 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.041 1.736 . . . . 0.0 111.408 -153.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.65 107.95 5.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.611 1.165 . . . . 0.0 109.174 -170.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -150.04 175.92 11.27 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.455 1.902 . . . . 0.0 107.919 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.2 t -178.12 -34.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 0.0 108.715 157.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t 59.41 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 127.741 2.417 . . . . 0.0 111.302 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 p -71.46 -179.06 2.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.374 1.469 . . . . 0.0 110.392 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.95 -88.11 1.94 Allowed Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.08 -1.012 . . . . 0.0 113.393 -165.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.61 116.92 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.556 2.171 . . . . 0.0 108.944 173.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.29 -33.55 0.15 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 57.19 -150.7 0.44 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.131 0.973 . . . . 0.0 109.083 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.37 163.76 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.84 145.2 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 168.01 10.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.421 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.11 129.46 50.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.367 1.067 . . . . 0.0 108.32 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -133.56 67.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -79.83 67.94 5.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.869 0.868 . . . . 0.0 109.706 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -95.06 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.286 78.6 mt 41.45 53.57 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 128.117 2.567 . . . . 0.0 109.864 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.66 -61.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 121.466 -0.771 . . . . 0.0 112.396 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -20.69 64.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.42 2.11 . . . . 0.0 113.613 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.77 18.02 21.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.615 1.566 . . . . 0.0 109.713 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.54 -18.17 2.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -166.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.41 -30.49 8.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.105 0.866 . . . . 0.0 111.321 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -90.21 -20.02 23.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.368 1.067 . . . . 0.0 112.669 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m -59.83 103.92 0.25 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.579 0.752 . . . . 0.0 110.792 -166.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.81 -81.72 0.47 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.256 0.935 . . . . 0.0 111.821 -163.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.93 -10.05 8.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.028 1.731 . . . . 0.0 112.28 169.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.53 -61.77 1.85 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.327 1.451 . . . . 0.0 110.901 174.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.454 HD11 ' H ' ' A' ' 125' ' ' ILE . 3.2 mp -38.08 -64.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.841 2.056 . . . . 0.0 112.16 172.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -53.75 54.6 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.406 0.548 . . . . 0.0 110.012 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.76 72.64 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.44 -173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.09 -55.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.296 1.839 . . . . 0.0 109.275 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -62.98 -36.5 83.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.957 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.9 -44.84 88.3 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.122 0.874 . . . . 0.0 110.068 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.1 m -65.74 -34.83 79.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.094 0.957 . . . . 0.0 111.003 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.61 -30.31 69.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.429 1.492 . . . . 0.0 112.104 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.3 m -107.9 14.29 25.49 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.626 1.57 . . . . 0.0 112.082 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.4 m -76.97 133.78 69.01 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -77.33 109.5 2.81 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 108.096 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 125.1 -87.42 0.37 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 107.246 -2.342 . . . . 0.0 107.246 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 m -43.83 146.24 0.6 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.847 1.659 . . . . 0.0 112.375 -171.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.95 107.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 134.66 26.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.45 142.48 50.78 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 163.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.97 172.24 45.31 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 120.741 -1.224 . . . . 0.0 110.673 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.9 m -121.62 135.49 54.98 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.724 1.21 . . . . 0.0 108.403 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.1 pt -125.93 151.18 70.99 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.911 1.684 . . . . 0.0 110.156 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.82 150.57 49.93 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 109.194 169.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.85 118.92 59.57 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 123.112 0.565 . . . . 0.0 110.596 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.14 117.72 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.102 2.534 . . . . 0.0 107.63 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -152.92 -35.03 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.199 0.999 . . . . 0.0 110.624 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.64 -152.9 6.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 164.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 140.34 93.81 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.543 -0.975 . . . . 0.0 109.726 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.33 120.11 4.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.812 3.675 . . . . 0.0 111.407 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.0 155.88 38.13 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.827 1.651 . . . . 0.0 113.123 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.31 -60.21 2.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.886 2.074 . . . . 0.0 113.802 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.13 -47.07 86.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.59 -41.03 52.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.09 -36.15 74.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.94 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -55.16 -49.27 72.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.944 1.247 . . . . 0.0 110.035 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.82 -46.13 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.069 0.548 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -39.49 74.74 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.402 1.081 . . . . 0.0 109.55 -174.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -60.05 -23.51 63.8 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.123 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -63.41 -42.15 98.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.576 1.08 . . . . 0.0 111.624 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 8.9 mmpt? 61.91 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.591 2.356 . . . . 0.0 115.055 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -28.63 67.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.448 1.022 . . . . 0.0 110.911 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.32 123.92 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.193 0.997 . . . . 0.0 108.845 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -71.08 106.21 3.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.5 t -84.25 95.53 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -83.46 112.95 20.42 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.55 120.61 17.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.68 164.61 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 82.8 p -122.28 163.2 20.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.07 -21.57 64.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.788 -1.195 . . . . 0.0 109.805 161.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -79.9 -47.84 14.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.67 0.788 . . . . 0.0 111.097 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.93 32.01 5.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.939 1.696 . . . . 0.0 110.433 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -48.52 -59.86 3.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.249 1.419 . . . . 0.0 109.668 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -76.63 4.15 10.04 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -116.92 4.61 12.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.002 1.721 . . . . 0.0 110.878 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -40.22 27.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.307 0.503 . . . . 0.0 112.044 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.79 -57.92 0.73 Allowed Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 126.177 1.791 . . . . 0.0 110.222 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.08 -25.21 44.08 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.203 1.936 . . . . 0.0 114.994 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.14 -38.79 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.061 -1.025 . . . . 0.0 109.587 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.9 mt -62.65 -47.95 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.38 -40.93 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.76 1.224 . . . . 0.0 110.443 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.8 m -65.13 -43.26 92.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.247 1.019 . . . . 0.0 110.04 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 10.3 t -68.61 -33.24 73.69 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.096 -1.002 . . . . 0.0 112.229 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.8 t -63.07 -64.91 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -35.86 80.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.078 -171.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 t -24.47 -86.28 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.942 2.897 . . . . 0.0 113.563 -165.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.5 m 64.35 -64.79 0.14 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.921 2.488 . . . . 0.0 113.198 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.24 -5.72 9.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 117.168 -1.396 . . . . 0.0 112.291 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-N 121.082 1.765 . . . . 0.0 109.222 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -167.81 139.18 2.95 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 147.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 151.79 40.53 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.37 155.95 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 109.082 170.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -142.2 165.04 28.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.289 1.036 . . . . 0.0 109.81 171.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.96 150.39 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.188 2.195 . . . . 0.0 108.736 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -156.16 -162.76 1.34 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.86 -174.07 26.28 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.18 1.848 . . . . 0.0 112.251 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.25 149.76 81.47 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.443 2.762 . . . . 0.0 111.477 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.16 119.42 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.071 2.514 . . . . 0.0 109.307 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.48 -17.15 27.33 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 117.927 -1.485 . . . . 0.0 110.583 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 64.85 113.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.051 1.74 . . . . 0.0 109.164 -169.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.39 65.86 0.75 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -97.94 -33.47 11.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.16 0.584 . . . . 0.0 110.841 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -53.28 -38.5 63.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.92 2.088 . . . . 0.0 111.983 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.9 m -62.92 -40.64 98.22 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.581 -0.699 . . . . 0.0 112.609 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -45.37 87.34 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 120.253 -1.53 . . . . 0.0 108.041 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 mm -55.56 -46.83 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.875 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -54.52 -50.9 66.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.178 1.354 . . . . 0.0 108.996 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -50.54 -43.91 56.26 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 110.627 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.6 69.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.069 0.849 . . . . 0.0 111.232 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.487 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.26 -39.32 69.65 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.001 0.92 . . . . 0.0 111.326 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.64 -48.94 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 O-C-N 121.451 -0.781 . . . . 0.0 109.745 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.4 mt -60.56 -41.44 94.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -60.58 -41.43 94.66 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -68.59 -25.27 64.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.046 1.338 . . . . 0.0 112.652 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -73.07 -24.23 60.65 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.928 173.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.69 2.75 10.42 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.124 1.821 . . . . 0.0 113.418 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.7 t -88.17 122.97 69.5 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.452 1.626 . . . . 0.0 109.616 -161.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.83 84.93 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.549 2.166 . . . . 0.0 109.001 161.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.13 141.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 125.48 1.512 . . . . 0.0 107.561 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -127.1 175.47 8.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.289 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.85 -160.88 16.16 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 120.623 1.556 . . . . 0.0 111.42 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.27 154.63 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.363 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -119.56 178.78 4.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.688 1.595 . . . . 0.0 106.903 165.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -143.38 144.25 31.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 168.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.92 161.03 36.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 109.914 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.37 129.92 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.505 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.95 97.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -117.74 97.99 6.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.995 1.718 . . . . 0.0 106.461 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -64.21 99.45 0.28 Allowed 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.82 -59.57 2.58 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.483 1.04 . . . . 0.0 111.568 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.67 40.77 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.362 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -127.8 132.28 49.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -63.08 114.61 3.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 -23.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.704 0.802 . . . . 0.0 112.876 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.95 -170.86 42.14 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 120.261 1.391 . . . . 0.0 111.716 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -119.32 170.08 9.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 157.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.265 31.4 p30 -129.85 159.75 35.62 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.114 -0.367 . . . . 0.0 110.798 158.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.51 109.92 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.33 113.77 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 p -80.04 157.38 26.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.9 3.36 3.36 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.016 -1.052 . . . . 0.0 112.44 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.4 m -72.41 -11.51 60.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.198 0.999 . . . . 0.0 111.942 160.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.15 76.77 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.289 -0.882 . . . . 0.0 111.943 -167.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -102.76 154.81 18.81 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 141.35 30.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.069 0.85 . . . . 0.0 111.0 -163.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.24 142.12 13.25 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 74.9 1.98 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 125.075 3.85 . . . . 0.0 111.405 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.536 ' N ' ' HG ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -49.16 -49.66 41.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.195 0.998 . . . . 0.0 110.18 -177.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.446 ' HG ' ' CA ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -146.41 126.06 13.37 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -144.64 92.96 2.35 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.433 4.0 m 34.86 -126.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 113.606 -174.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.02 149.32 12.48 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 120.181 1.355 . . . . 0.0 110.991 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.77 152.19 32.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -77.35 164.67 56.99 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.109 0.964 . . . . 0.0 110.009 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.98 124.49 8.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.376 2.05 . . . . 0.0 107.151 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -66.24 169.92 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.949 1.766 . . . . 0.0 108.957 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.39 119.22 6.21 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.748 1.632 . . . . 0.0 108.268 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.11 -68.71 0.54 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.621 1.105 . . . . 0.0 110.705 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -68.02 149.87 49.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 1.151 . . . . 0.0 109.013 178.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.16 156.91 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 164.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.427 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 13.9 pt-20 -158.05 -163.19 1.26 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.545 1.938 . . . . 0.0 106.839 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.18 -165.94 1.38 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.052 1.341 . . . . 0.0 108.952 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? 146.62 140.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.104 3.362 . . . . 0.0 107.428 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.22 -24.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.75 104.76 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 107.071 -2.412 . . . . 0.0 107.071 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 65.31 -55.42 0.32 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 129.031 2.932 . . . . 0.0 111.828 -163.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -84.52 137.69 33.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.777 0.831 . . . . 0.0 110.624 -168.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.07 110.91 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 172.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' CA ' ' HG ' ' A' ' 62' ' ' SER . 1.4 p -71.46 162.89 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -143.8 125.2 14.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 167.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.93 -26.37 65.9 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.943 0.897 . . . . 0.0 111.668 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -55.31 -35.24 64.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.778 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.536 ' HG ' ' N ' ' A' ' 61' ' ' LEU . 22.8 t -60.86 -40.11 91.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.119 0.872 . . . . 0.0 110.521 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -61.27 -50.93 71.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.557 0.617 . . . . 0.0 109.341 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.49 -21.41 62.37 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.92 -45.67 91.82 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.747 0.703 . . . . 0.0 111.843 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.31 -28.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -161.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.26 20.59 1.59 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.628 1.171 . . . . 0.0 110.416 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.561 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -121.9 -47.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.973 2.509 . . . . 0.0 112.682 -172.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.561 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -64.3 -25.14 64.48 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.65 1.566 . . . . 0.0 111.203 166.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.0 -29.08 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.497 -0.752 . . . . 0.0 113.007 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 mm? -62.7 -51.47 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.906 0.775 . . . . 0.0 109.534 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -127.47 99.23 5.53 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -74.13 177.17 5.93 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.847 1.259 . . . . 0.0 111.445 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.49 104.56 16.68 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.9 1.28 . . . . 0.0 109.536 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -157.17 143.38 17.93 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.625 1.97 . . . . 0.0 106.044 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.9 m 37.76 -141.86 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.42 2.288 . . . . 0.0 113.002 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.3 p -138.97 176.29 8.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.806 0.843 . . . . 0.0 108.883 161.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -66.81 109.62 2.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.249 1.42 . . . . 0.0 110.079 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.19 -104.88 0.18 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.771 -1.572 . . . . 0.0 109.435 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.78 179.38 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.436 3.424 . . . . 0.0 110.83 168.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.69 86.22 1.73 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -73.0 152.12 41.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.519 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -140.2 177.63 7.85 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.458 1.903 . . . . 0.0 108.371 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.5 t -133.95 147.22 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 168.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.2 162.19 17.84 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.1 0.96 . . . . 0.0 110.047 172.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.19 130.61 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.003 1.721 . . . . 0.0 107.421 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.3 mt -149.12 106.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -98.32 177.23 5.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.272 -1.518 . . . . 0.0 108.52 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.01 27.65 15.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.406 2.682 . . . . 0.0 113.402 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.59 98.15 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.95 -77.91 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-O 118.795 -1.003 . . . . 0.0 110.748 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -53.97 -30.26 46.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.782 1.233 . . . . 0.0 113.913 -164.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -64.19 -16.17 61.41 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 126.387 1.875 . . . . 0.0 112.156 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -24.31 -59.6 0.05 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.573 2.749 . . . . 0.0 116.2 -163.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.82 -34.8 67.08 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.921 1.288 . . . . 0.0 111.904 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -81.15 -27.68 35.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.702 1.601 . . . . 0.0 111.613 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.6 m -52.09 110.52 0.49 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.467 1.507 . . . . 0.0 109.233 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.67 -8.56 0.49 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.97 -31.35 2.89 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 125.717 1.607 . . . . 0.0 108.996 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -27.64 -73.73 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 129.102 2.961 . . . . 0.0 110.928 164.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.404 HD11 ' H ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -34.33 -63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 128.22 2.608 . . . . 0.0 113.84 172.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.05 -43.05 83.68 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.866 1.212 . . . . 0.0 111.175 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.53 99.42 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.461 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.72 -36.45 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.006 0.922 . . . . 0.0 109.394 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.19 -26.75 63.17 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.232 -1.543 . . . . 0.0 113.941 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -55.49 -56.95 14.29 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.523 1.056 . . . . 0.0 108.91 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 m -66.78 -34.73 78.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.631 1.572 . . . . 0.0 112.489 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.85 -27.81 69.12 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.492 -0.755 . . . . 0.0 109.743 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 t -85.74 -23.6 27.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.709 1.603 . . . . 0.0 111.614 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.8 m -58.38 139.03 85.01 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.2 1.364 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -86.21 107.27 0.84 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.768 2.979 . . . . 0.0 109.16 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 128.87 -43.33 1.33 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.603 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.2 m -57.13 157.54 5.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.158 1.479 . . . . 0.0 110.579 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.22 102.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.91 129.73 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 166.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.25 111.65 11.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.56 174.82 25.41 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.086 0.857 . . . . 0.0 113.08 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.0 m -117.54 122.07 42.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.391 1.096 . . . . 0.0 110.092 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.51 143.25 29.03 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.618 1.167 . . . . 0.0 109.094 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.59 141.25 54.53 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.017 1.811 . . . . 0.0 108.393 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.13 114.5 12.82 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.5 149.55 27.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.367 2.711 . . . . 0.0 109.063 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -140.67 -72.11 0.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.694 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.76 -66.1 2.64 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 146.8 54.65 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 117.639 0.719 . . . . 0.0 109.44 174.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.83 161.26 21.36 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.929 2.419 . . . . 0.0 107.976 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.14 155.8 17.25 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -38.9 -50.89 1.76 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.316 2.246 . . . . 0.0 114.146 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.17 -38.19 31.82 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.063 0.545 . . . . 0.0 109.976 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.12 -17.46 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.287 -1.508 . . . . 0.0 110.279 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.64 -61.73 1.75 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.799 -1.188 . . . . 0.0 109.634 161.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.325 0.2 OUTLIER -53.73 -54.35 39.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.092 0.948 . . . . 0.0 112.709 -174.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.27 -30.8 49.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 124.903 1.281 . . . . 0.0 111.788 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -31.29 70.66 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.118 -0.989 . . . . 0.0 110.888 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.27 -6.73 31.24 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.484 0.584 . . . . 0.0 110.718 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -69.24 -30.28 68.38 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.368 -0.833 . . . . 0.0 112.878 170.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -43.67 0.28 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.355 2.262 . . . . 0.0 115.322 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -89.46 64.1 6.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.375 2.27 . . . . 0.0 108.638 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.58 122.95 48.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -65.23 110.51 2.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 158.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 m -96.94 88.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 180' ' ' ILE . 19.4 m-85 -61.2 101.58 0.17 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.505 1.122 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.32 93.73 1.53 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.11 166.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.0 p -131.72 162.45 30.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 165.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -61.07 -30.7 70.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.733 -0.604 . . . . 0.0 109.393 159.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.82 -67.07 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.348 1.859 . . . . 0.0 110.266 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.0 33.57 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.891 1.676 . . . . 0.0 110.141 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -56.42 -62.82 1.46 Allowed 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.028 -1.045 . . . . 0.0 111.066 -170.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.77 3.29 12.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.82 -1.24 56.94 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.66 1.584 . . . . 0.0 111.364 172.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.37 -32.23 19.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 118.822 -1.151 . . . . 0.0 112.369 -172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.4 -58.31 3.06 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.739 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.87 -21.92 27.7 Favored 'Trans proline' 0 C--N 1.354 0.85 0 CA-C-N 121.383 1.529 . . . . 0.0 112.798 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -40.66 75.69 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.662 1.985 . . . . 0.0 109.005 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.516 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 4.3 mt -66.76 -50.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.212 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 184' ' ' VAL . 42.0 t -50.9 -29.94 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.741 1.617 . . . . 0.0 109.473 174.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.8 m -75.09 -18.32 60.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 119.999 -1.688 . . . . 0.0 112.973 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -52.71 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -56.61 -60.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.694 1.998 . . . . 0.0 109.453 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.64 -22.02 61.29 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.069 -1.02 . . . . 0.0 113.19 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 189' ' ' LYS . 37.1 m -73.08 -59.76 2.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.906 0.882 . . . . 0.0 111.316 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.79 17.95 0.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.837 -168.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -157.39 -37.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.378 1.471 . . . . 0.0 112.199 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.404 ' H ' ' HB3' ' A' ' 186' ' ' SER . 26.0 mmtt . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.395 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.795 0.807 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 8.4 tpp180 -151.29 179.0 8.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 149.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.44 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 83.3 m-70 -51.32 156.08 1.27 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.613 1.565 . . . . 0.0 111.076 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -129.94 142.13 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -135.55 158.34 44.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 160.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mt -93.21 150.62 20.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -154.41 -172.48 4.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.28 -175.12 24.59 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.971 1.272 . . . . 0.0 110.951 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.12 162.02 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.239 2.626 . . . . 0.0 111.557 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.02 153.95 67.19 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.288 1.325 . . . . 0.0 109.481 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.33 -5.64 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 126.61 2.052 . . . . 0.0 110.712 162.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.26 30.2 t 67.1 126.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.616 1.198 . . . . 0.0 110.527 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.41 -9.94 10.8 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.27 164.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -54.9 -31.12 59.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.224 1.012 . . . . 0.0 111.141 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -56.48 -35.72 68.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.646 1.578 . . . . 0.0 110.31 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -67.44 -24.23 65.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.301 -1.499 . . . . 0.0 113.09 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -55.22 20.48 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 170.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -57.05 -46.07 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.319 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -47.83 -57.79 5.18 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.736 0.814 . . . . 0.0 110.023 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -62.57 -40.8 98.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.67 55.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.089 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 p -71.59 -47.81 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.976 1.262 . . . . 0.0 109.97 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.9 -36.42 74.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 110.727 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.45 -53.03 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 125.383 1.473 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -57.81 -42.4 84.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -63.05 -36.31 83.14 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.351 0.26 . . . . 0.0 110.661 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 m -77.37 -10.78 59.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.586 1.954 . . . . 0.0 112.714 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.9 m -100.08 6.08 44.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.627 2.371 . . . . 0.0 111.676 168.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.47 11.79 84.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.708 -1.051 . . . . 0.0 114.633 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.51 139.06 44.28 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 119.557 1.678 . . . . 0.0 109.242 -170.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.82 89.6 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.91 3.073 . . . . 0.0 111.608 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.93 148.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.154 1.382 . . . . 0.0 109.297 172.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -147.53 -176.0 5.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.044 2.138 . . . . 0.0 109.984 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.43 -156.81 17.8 Favored Glycine 0 C--O 1.24 0.514 0 C-N-CA 127.88 2.657 . . . . 0.0 108.138 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.52 171.3 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.976 0.888 . . . . 0.0 110.231 171.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -137.08 -178.41 5.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 165.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.5 p -130.41 154.32 47.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 160.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.47 13.69 3.78 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 112.63 -172.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.275 12.6 pt-20 50.65 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 127.1 2.16 . . . . 0.0 110.783 -156.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.11 138.61 22.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -122.97 164.81 17.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.668 1.187 . . . . 0.0 108.404 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.67 96.67 2.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.34 -66.45 1.49 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.61 12.11 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.652 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.96 143.17 47.19 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 118.597 1.198 . . . . 0.0 109.1 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -63.09 154.75 29.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 124.671 1.232 . . . . 0.0 108.873 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.3 -13.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.791 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.27 -142.82 8.94 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.141 -2.383 . . . . 0.0 107.141 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -142.35 66.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.229 1.515 . . . . 0.0 110.602 -172.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -53.15 143.88 16.91 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.55 114.85 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 118.568 0.622 . . . . 0.0 109.559 -160.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.33 109.68 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -150.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -59.87 146.02 43.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.02 -11.51 39.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.278 168.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 -14.56 61.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.516 1.926 . . . . 0.0 111.618 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' C ' ' HG1' ' A' ' 57' ' ' THR . . . 82.61 67.82 1.47 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 119.412 1.005 . . . . 0.0 111.148 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 56' ' ' GLY . 10.1 m -157.32 151.43 24.73 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.707 3.203 . . . . 0.0 104.706 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 154.44 44.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 121.278 1.853 . . . . 0.0 109.714 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.02 156.86 19.78 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.083 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.98 54.32 4.82 Favored 'Trans proline' 0 CA--C 1.539 0.762 1 C-N-CA 125.695 4.264 . . . . 0.0 113.21 -173.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -51.44 -52.36 46.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.656 1.582 . . . . 0.0 111.137 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 p -150.16 133.05 16.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.34 43.15 0.52 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.351 0.26 . . . . 0.0 110.624 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t 60.43 154.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 129.045 2.938 . . . . 0.0 110.641 -167.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.02 160.1 31.7 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 105.481 -3.048 . . . . 0.0 105.481 166.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.28 164.78 12.77 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.006 0.908 . . . . 0.0 110.461 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -63.83 148.65 94.42 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.134 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.32 133.24 17.41 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.452 2.768 . . . . 0.0 110.184 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.34 174.26 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.347 2.698 . . . . 0.0 110.875 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.4 -24.69 64.05 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.095 1.196 . . . . 0.0 113.282 -176.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.22 -1.68 47.95 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.698 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -148.06 143.98 27.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.137 1.969 . . . . 0.0 108.581 -172.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.01 149.89 27.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' HE2' ' A' ' 72' ' ' LYS . 22.2 mt-10 -132.47 162.36 31.36 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.359 1.863 . . . . 0.0 109.537 168.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.71 136.26 57.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.687 1.195 . . . . 0.0 109.211 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.39 154.64 41.86 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.263 -172.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.96 119.74 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.25 -107.3 1.64 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.49 -10.76 15.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 112.868 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.09 140.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.87 163.22 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 160.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.55 173.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 O-C-N 120.501 -1.374 . . . . 0.0 109.889 171.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.77 98.71 4.25 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.89 -35.7 71.37 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.101 -0.999 . . . . 0.0 110.701 173.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -66.35 -30.63 71.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.616 0.766 . . . . 0.0 109.966 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.8 t -62.01 -23.91 66.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 120.041 1.291 . . . . 0.0 111.891 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -73.09 -62.73 1.36 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.24 -13.7 13.94 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -53.82 -42.71 68.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 111.623 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.64 -35.67 0.49 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.052 0.541 . . . . 0.0 112.242 -168.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 63.67 4.46 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -65.25 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 127.708 2.403 . . . . 0.0 105.766 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 -18.11 36.93 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.383 2.055 . . . . 0.0 114.348 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 95' ' ' LEU . 20.0 m -67.5 -64.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.595 1.089 . . . . 0.0 108.697 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.402 ' H ' ' CG2' ' A' ' 94' ' ' VAL . 76.5 mt -45.62 -56.13 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.657 2.383 . . . . 0.0 108.506 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.16 89.16 3.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.13 0.491 . . . . 0.0 110.742 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.91 127.17 30.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 118.044 -1.463 . . . . 0.0 107.62 158.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.41 8.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.532 1.133 . . . . 0.0 108.793 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -156.04 142.86 18.83 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 6.8 t -146.88 76.79 1.44 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.527 1.058 . . . . 0.0 110.916 -167.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -123.77 134.57 53.63 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 125.125 1.37 . . . . 0.0 107.709 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -74.92 151.37 38.9 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 160.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 136.14 173.53 13.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.486 1.517 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.63 136.29 17.05 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.084 2.523 . . . . 0.0 110.399 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.46 66.13 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 121.194 -0.941 . . . . 0.0 112.29 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -60.1 150.88 28.23 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 110.357 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -124.6 164.77 19.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.899 1.68 . . . . 0.0 107.209 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -124.42 141.4 44.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.14 128.95 22.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.486 1.514 . . . . 0.0 107.138 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.52 68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.19 -168.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.81 18.85 0.55 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.037 1.735 . . . . 0.0 114.634 -171.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -67.51 129.47 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 119.327 -2.108 . . . . 0.0 107.404 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.05 -75.63 0.22 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-O 119.496 -0.614 . . . . 0.0 112.141 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -64.54 -26.9 68.62 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.074 0.937 . . . . 0.0 112.022 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.8 mmm -63.66 -7.68 8.06 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 116.55 -1.69 . . . . 0.0 114.03 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -42.23 -44.73 3.89 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.519 1.963 . . . . 0.0 114.517 -165.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.51 -39.1 28.51 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.422 0.689 . . . . 0.0 111.736 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -84.06 -21.21 31.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.24 1.016 . . . . 0.0 110.987 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.493 ' HG ' ' CD1' ' A' ' 125' ' ' ILE . 17.2 t -42.16 123.09 2.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 129.762 3.225 . . . . 0.0 110.569 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.45 -88.61 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 107.605 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.88 -1.86 8.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.587 -0.72 . . . . 0.0 112.131 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -71.82 0.11 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.654 1.115 . . . . 0.0 110.188 160.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CD1' ' HG ' ' A' ' 121' ' ' SER . 3.4 mp -46.33 -31.42 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 126.002 1.721 . . . . 0.0 113.105 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -60.56 2.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 120.664 -1.273 . . . . 0.0 112.813 171.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.26 67.23 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 111.828 -166.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.86 -51.17 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -57.78 -40.14 79.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 120.301 1.41 . . . . 0.0 113.412 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -56.73 -20.53 22.5 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.313 1.045 . . . . 0.0 112.515 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -108.71 -27.87 9.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.977 1.311 . . . . 0.0 110.234 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.187 1.395 . . . . 0.0 111.633 168.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.7 t -58.3 -44.68 88.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.477 0.711 . . . . 0.0 109.442 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.1 m -77.3 133.43 68.15 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.92 -30.04 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.439 2.76 . . . . 0.0 111.3 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.75 -65.38 3.62 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.712 2.101 . . . . 0.0 111.634 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.1 m -59.46 143.33 50.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.91 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.19 96.8 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mm -56.7 130.9 19.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 142.33 50.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.726 2.411 . . . . 0.0 105.304 167.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.37 175.28 45.58 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.281 0.946 . . . . 0.0 110.945 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.1 m -115.94 94.64 4.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.151 1.476 . . . . 0.0 113.105 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.84 122.44 67.95 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.094 -1.004 . . . . 0.0 111.91 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.12 153.13 67.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.827 1.684 . . . . 0.0 110.532 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.84 151.88 95.13 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 122.057 -0.402 . . . . 0.0 110.431 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.15 -55.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.135 3.223 . . . . 0.0 111.907 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 26.17 77.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.48 2.712 . . . . 0.0 110.923 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.03 -111.53 3.13 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 135.03 90.38 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 117.584 0.692 . . . . 0.0 109.654 -170.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.72 171.07 12.67 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.237 1.958 . . . . 0.0 110.619 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.83 160.93 28.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.952 2.501 . . . . 0.0 105.193 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.34 -66.27 0.91 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.852 0.861 . . . . 0.0 110.082 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.18 -46.79 87.48 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.42 0.688 . . . . 0.0 109.203 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.95 -41.68 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.292 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.55 -17.66 60.01 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.593 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -36.08 76.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.686 1.194 . . . . 0.0 108.771 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.72 -52.18 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 109.487 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -23.44 65.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.932 1.293 . . . . 0.0 110.265 -172.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -40.05 13.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 174.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 162' ' ' ASP . 30.0 mtp85 -68.9 -36.09 77.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 123.88 0.872 . . . . 0.0 110.545 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? 60.63 -18.67 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.675 1.99 . . . . 0.0 113.86 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -71.85 48.77 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 1 C-N-CA 133.124 4.569 . . . . 0.0 110.755 173.628 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.77 128.89 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.71 105.45 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 160.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.38 87.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -58.5 100.19 0.06 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 107.64 5.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.05 147.81 10.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.8 p -99.02 166.12 11.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 158.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.83 -14.01 61.85 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 120.002 -1.686 . . . . 0.0 111.031 161.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -88.66 -65.03 1.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.07 0.948 . . . . 0.0 110.416 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.66 29.14 2.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.96 2.104 . . . . 0.0 108.146 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -50.28 -57.02 8.79 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.561 1.144 . . . . 0.0 108.009 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -82.92 17.67 1.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -116.55 48.19 1.32 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.6 tp -129.0 -37.36 1.71 Allowed 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.158 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -55.04 13.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 117.305 -1.331 . . . . 0.0 109.629 176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.64 -26.06 39.91 Favored 'Trans proline' 0 C--N 1.356 0.962 0 CA-C-N 121.926 1.724 . . . . 0.0 113.482 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.49 -45.11 63.37 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.22 1.408 . . . . 0.0 109.85 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.5 mt -54.82 -52.78 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 125.406 1.482 . . . . 0.0 109.19 167.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.74 -44.59 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.458 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.1 m -62.04 -42.23 98.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.564 1.075 . . . . 0.0 109.726 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.4 t -67.03 -44.18 80.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.017 0.826 . . . . 0.0 110.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.56 -53.73 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.595 -0.691 . . . . 0.0 109.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -16.08 63.63 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.997 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -57.29 10.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m 55.1 -73.8 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 -167.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -117.98 5.14 12.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.629 1.104 . . . . 0.0 112.843 173.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? . . . . . 0 C--O 1.247 0.934 0 CA-C-N 120.479 1.491 . . . . 0.0 108.756 164.776 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 121.075 0.464 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.648 ' HB2' HG12 ' A' ' 163' ' ' VAL . 17.7 m-70 -58.49 156.28 10.74 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.608 1.963 . . . . 0.0 111.729 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.23 130.56 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CE1' HG21 ' A' ' 157' ' ' ILE . 38.9 m-85 -125.29 139.93 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.413 0.685 . . . . 0.0 111.399 173.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.52 155.15 33.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.347 1.459 . . . . 0.0 107.991 167.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -152.12 175.84 12.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.86 -163.47 25.02 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.6 146.73 15.29 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.62 2.213 . . . . 0.0 110.321 168.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.77 153.7 77.05 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.722 1.615 . . . . 0.0 109.421 165.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.61 5.83 0.03 OUTLIER Glycine 0 CA--C 1.524 0.63 0 CA-C-O 119.053 -0.859 . . . . 0.0 112.491 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.254 97.1 t 65.56 115.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 127.027 2.131 . . . . 0.0 112.503 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.41 -41.9 0.21 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.962 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -50.18 -31.86 14.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.719 1.607 . . . . 0.0 112.535 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -45.23 -47.27 12.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 129.005 2.922 . . . . 0.0 110.038 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -86.06 -23.99 26.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.774 1.23 . . . . 0.0 110.728 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.07 -37.04 78.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 118.211 -0.9 . . . . 0.0 109.693 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.4 -46.32 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 117.902 -1.046 . . . . 0.0 108.732 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -53.62 -44.82 69.8 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.616 1.553 . . . . 0.0 111.428 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -62.05 -40.28 95.22 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.449 0.7 . . . . 0.0 110.769 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 177' ' ' LEU . . . -60.82 -23.64 65.24 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.426 0.557 . . . . 0.0 112.019 172.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 m -89.62 12.06 17.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.072 1.749 . . . . 0.0 112.183 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -113.05 -23.36 10.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.912 1.685 . . . . 0.0 111.838 168.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.44 -44.09 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.273 -0.892 . . . . 0.0 113.199 -161.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.72 -35.4 72.63 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 166.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.19 -39.6 82.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.97 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -70.48 -18.11 62.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.467 0.707 . . . . 0.0 111.21 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -96.03 6.02 49.82 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.155 2.182 . . . . 0.0 111.856 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.4 18.61 75.71 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.281 -0.887 . . . . 0.0 113.518 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.29 100.31 15.18 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.731 2.012 . . . . 0.0 106.758 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.52 90.38 1.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.933 2.422 . . . . 0.0 110.73 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.47 154.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.519 1.928 . . . . 0.0 109.518 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.33 176.6 9.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.085 0.954 . . . . 0.0 110.469 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.91 -149.97 17.08 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.02 1.295 . . . . 0.0 111.147 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -145.4 160.85 40.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.777 0.831 . . . . 0.0 111.697 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -144.18 131.19 20.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.56 1.544 . . . . 0.0 106.96 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 p -74.25 146.7 43.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 117.62 -1.181 . . . . 0.0 107.882 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.57 159.12 35.58 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.605 1.548 . . . . 0.0 109.102 167.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.38 96.01 7.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.565 1.146 . . . . 0.0 107.972 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.56 101.63 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.567 1.175 . . . . 0.0 108.806 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -121.95 84.95 2.33 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 125.758 1.623 . . . . 0.0 108.64 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -58.99 109.67 0.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.71 34.63 21.71 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.652 -0.527 . . . . 0.0 113.129 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.42 38.45 14.63 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.556 1.678 . . . . 0.0 115.273 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 136.09 45.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.357 2.078 . . . . 0.0 107.663 159.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -67.28 111.82 4.2 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.901 0.88 . . . . 0.0 108.872 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 pt -115.62 -10.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.942 0.897 . . . . 0.0 112.483 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -165.4 35.84 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 107.996 -2.041 . . . . 0.0 107.996 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -124.48 167.53 14.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.701 1.6 . . . . 0.0 107.644 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -120.67 -178.83 3.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.544 1.538 . . . . 0.0 109.584 167.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.83 96.34 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 162.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.33 151.0 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 p -115.8 154.6 29.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.43 -6.78 15.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.174 0.897 . . . . 0.0 111.909 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -86.39 3.14 44.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.155 2.582 . . . . 0.0 111.784 171.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.71 5.83 88.37 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.277 -1.515 . . . . 0.0 114.377 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 151.23 30.7 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 169.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 136.79 26.96 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.796 1.18 . . . . 0.0 111.496 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -87.16 176.41 47.02 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 121.398 0.443 . . . . 0.0 112.945 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.18 167.5 21.8 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 146.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -142.92 -69.98 0.33 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -128.45 161.5 29.35 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.906 0.882 . . . . 0.0 109.936 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -149.7 169.52 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.813 1.245 . . . . 0.0 108.118 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 t -60.29 149.81 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.498 0.719 . . . . 0.0 109.382 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.08 165.2 32.54 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 160.67 16.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.493 1.117 . . . . 0.0 109.586 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.99 155.62 93.19 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.6 124.82 11.09 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.994 2.463 . . . . 0.0 108.014 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.36 162.95 36.5 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 108.549 -1.366 . . . . 0.0 108.549 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.92 -11.34 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.766 1.644 . . . . 0.0 113.783 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.16 -40.72 4.77 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.192 1.377 . . . . 0.0 113.707 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.0 112.45 25.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.977 1.389 . . . . 0.0 107.688 -170.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -71.19 135.42 47.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.91 176.16 11.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.539 1.936 . . . . 0.0 106.342 166.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 83.0 m -124.4 74.79 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.559 0.695 . . . . 0.0 111.001 -165.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 138.99 33.88 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.479 1.112 . . . . 0.0 108.664 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.8 -27.65 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.325 0.584 . . . . 0.0 111.334 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.82 -71.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 105.136 -3.186 . . . . 0.0 105.136 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -108.43 -51.84 2.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.616 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.06 163.13 28.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.888 1.222 . . . . 0.0 109.249 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.68 119.94 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.53 172.92 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.665 0.786 . . . . 0.0 108.928 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.52 146.26 31.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 162.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.23 -32.42 71.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.236 0.615 . . . . 0.0 110.737 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 m -64.55 -32.71 74.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.156 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.2 m -61.37 -34.94 76.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.682 1.128 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.472 0.709 . . . . 0.0 110.139 167.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -24.02 9.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.444 1.097 . . . . 0.0 113.477 -170.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -50.17 -35.59 26.81 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.994 1.318 . . . . 0.0 113.158 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -145.23 -33.84 0.35 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.026 -0.512 . . . . 0.0 112.005 -175.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.57 1.948 . . . . 0.0 111.508 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -135.69 -55.16 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.43 1.492 . . . . 0.0 110.168 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 49.3 Cg_endo -69.97 -37.57 8.49 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.751 1.634 . . . . 0.0 112.318 170.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.26 -24.64 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -45.14 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.999 0.519 . . . . 0.0 110.649 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.62 70.89 0.91 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 165.683 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -155.07 165.56 36.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.479 1.512 . . . . 0.0 107.19 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.47 136.35 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.0 t -123.52 108.57 12.79 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.569 1.148 . . . . 0.0 109.519 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.85 130.14 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 125.643 1.577 . . . . 0.0 109.572 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.39 86.61 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.51 158.47 35.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 163.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER 51.14 90.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.959 2.504 . . . . 0.0 112.587 -174.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.89 75.72 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 164.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.88 -45.95 0.02 OUTLIER Glycine 0 C--N 1.334 0.437 0 O-C-N 120.952 -1.092 . . . . 0.0 113.383 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 9.4 tptt -66.49 -37.33 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.74 0.77 . . . . 0.0 110.39 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.5 mmt -79.46 0.52 29.15 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 115.559 -2.162 . . . . 0.0 114.253 -172.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.26 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 -170.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tp -117.85 -44.76 2.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.916 1.686 . . . . 0.0 110.131 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -73.89 -20.57 60.37 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.267 1.027 . . . . 0.0 111.41 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 p -53.4 115.29 1.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.379 2.272 . . . . 0.0 109.986 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.23 -71.49 0.54 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.585 1.154 . . . . 0.0 108.884 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.3 -21.4 59.74 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.424 1.09 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -69.14 0.12 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.309 1.443 . . . . 0.0 110.19 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.2 mp -37.73 -48.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.388 1.875 . . . . 0.0 112.683 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -63.89 -64.88 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.699 0.799 . . . . 0.0 112.48 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.5 90.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.072 0.949 . . . . 0.0 110.452 -170.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.55 -44.61 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.556 1.142 . . . . 0.0 109.367 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -67.66 -31.99 72.36 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.011 -1.681 . . . . 0.0 112.353 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -37.73 83.57 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.981 1.718 . . . . 0.0 110.512 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.434 ' CG2' HD11 ' A' ' 139' ' ' ILE . 1.5 m -65.92 -47.89 73.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.881 0.472 . . . . 0.0 110.866 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.33 -19.74 66.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 111.261 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -39.58 78.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.044 0.938 . . . . 0.0 109.477 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.7 m -64.81 134.02 95.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 123.565 0.746 . . . . 0.0 109.414 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.0 -29.27 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.661 2.907 . . . . 0.0 112.025 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.7 -53.75 7.09 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 145.03 54.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.222 1.011 . . . . 0.0 112.28 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.16 98.76 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 102.949 -2.982 . . . . 0.0 102.949 -169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 131' ' ' THR . 44.0 mm -61.06 131.65 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.41 116.26 8.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.566 1.947 . . . . 0.0 106.508 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.05 -179.61 39.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.7 m -123.53 100.28 6.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.9 pt -97.19 161.74 25.13 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 179.98 4.54 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.401 2.734 . . . . 0.0 110.47 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.5 150.36 79.45 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 121.172 -0.955 . . . . 0.0 110.773 164.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.01 109.47 2.7 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 123.188 2.592 . . . . 0.0 108.883 164.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.16 119.72 15.0 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 164.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.09 -131.02 36.0 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.59 137.55 96.46 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.845 -158.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 131.27 22.71 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.621 2.214 . . . . 0.0 109.009 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.98 121.87 21.71 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 13.33 0.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.122 2.569 . . . . 0.0 115.634 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.4 tp -131.67 -39.83 1.11 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.388 1.875 . . . . 0.0 109.39 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.83 -23.77 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 120.825 -1.172 . . . . 0.0 109.006 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.54 -40.43 78.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.578 1.151 . . . . 0.0 110.73 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.82 -31.03 72.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.689 1.996 . . . . 0.0 110.471 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.481 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.4 mp -90.56 -41.61 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.535 1.534 . . . . 0.0 109.337 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -52.56 -39.05 61.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.971 1.709 . . . . 0.0 109.823 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -33.4 -47.54 0.22 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 127.968 2.507 . . . . 0.0 113.033 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -66.5 -40.75 89.41 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.342 -1.313 . . . . 0.0 112.436 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.75 -40.71 0.22 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.53 1.932 . . . . 0.0 113.482 -167.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.94 -22.49 60.1 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.68 2.392 . . . . 0.0 113.563 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 3' ' ' HIS . 5.6 m -66.0 138.79 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.487 ' HE3' ' CE1' ' A' ' 166' ' ' PHE . 28.3 tptt -65.07 142.73 58.3 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.85 102.29 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.487 ' CE1' ' HE3' ' A' ' 164' ' ' LYS . 13.7 m-85 -93.53 96.69 10.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.042 1.337 . . . . 0.0 111.051 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 104.94 2.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 172.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.59 163.05 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.988 0.813 . . . . 0.0 108.816 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.4 p -123.57 169.04 11.84 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.205 1.802 . . . . 0.0 106.305 160.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -77.51 -10.6 59.58 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.344 1.458 . . . . 0.0 112.275 158.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -79.99 -74.0 0.33 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.79 32.39 0.74 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.221 1.408 . . . . 0.0 109.913 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -54.91 -51.76 65.03 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.732 -1.23 . . . . 0.0 110.405 -169.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -75.33 4.04 7.92 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.95 -19.0 31.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.707 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -21.58 45.79 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.913 -164.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -47.71 -63.13 1.6 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.951 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.72 -28.78 76.69 Favored 'Trans proline' 0 C--N 1.35 0.616 0 CA-C-N 121.853 1.697 . . . . 0.0 112.929 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -33.97 75.0 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.608 0.763 . . . . 0.0 109.678 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.16 -52.17 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.071 0.948 . . . . 0.0 109.82 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.89 -34.77 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 118.42 0.554 . . . . 0.0 110.225 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.7 m -55.92 -44.61 78.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.389 1.076 . . . . 0.0 110.263 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -70.97 -41.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.684 -0.635 . . . . 0.0 110.278 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.27 -59.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 123.405 0.682 . . . . 0.0 109.811 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -3.18 20.42 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.273 1.029 . . . . 0.0 112.684 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -60.47 -21.35 62.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.883 -1.135 . . . . 0.0 110.592 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.342 0.268 0 CA-C-N 119.999 1.272 . . . . 0.0 107.636 164.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HB2' HG12 ' A' ' 163' ' ' VAL . 40.3 m-70 -24.63 119.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.55 3.14 . . . . 0.0 111.624 166.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 t -105.08 137.86 32.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 157' ' ' ILE . 54.5 m-85 -127.86 153.91 46.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.576 0.75 . . . . 0.0 109.151 163.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 164.24 12.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.838 2.055 . . . . 0.0 108.313 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -159.5 -173.45 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.11 53.7 6.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 127.214 2.34 . . . . 0.0 112.136 -160.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.11 123.51 8.88 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 119.786 1.793 . . . . 0.0 110.266 -171.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.6 -1.6 8.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.511 2.141 . . . . 0.0 112.238 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.93 4.03 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -170.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.4 97.99 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 125.396 2.522 . . . . 0.0 107.48 -168.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.85 -45.49 0.55 Allowed Glycine 0 C--N 1.309 -0.938 0 CA-C-N 111.345 -2.661 . . . . 0.0 108.414 163.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.533 ' HD3' HG21 ' A' ' 142' ' ' THR . 0.1 OUTLIER -47.31 -48.42 25.13 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.327 1.851 . . . . 0.0 112.958 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.3 m -60.31 -52.93 63.19 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.207 0.912 . . . . 0.0 108.898 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 m -59.67 -40.29 87.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.736 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -53.14 48.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.468 1.485 . . . . 0.0 109.284 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.25 -26.07 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.581 0.752 . . . . 0.0 111.06 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -66.12 -57.16 8.3 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.034 -1.666 . . . . 0.0 109.332 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -11.29 29.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.01 45.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.908 1.283 . . . . 0.0 112.468 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.2 p -67.23 -47.51 70.6 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -171.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.07 -39.98 66.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.199 1.8 . . . . 0.0 112.246 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.87 -54.41 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.457 1.103 . . . . 0.0 109.236 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 30' ' ' VAL . 25.9 mt -69.6 -36.57 76.32 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.316 0.646 . . . . 0.0 109.351 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.68 -39.0 86.84 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.971 -1.706 . . . . 0.0 109.89 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.97 -34.66 70.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.512 1.525 . . . . 0.0 110.342 168.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 4.32 4.99 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.308 2.243 . . . . 0.0 115.389 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.62 20.22 55.84 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.282 0.946 . . . . 0.0 112.204 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 25' ' ' LEU . 5.7 p -56.55 140.85 73.46 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.918 1.287 . . . . 0.0 108.741 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -79.16 84.72 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 CA-C-N 121.701 1.643 . . . . 0.0 111.347 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.07 156.78 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.159 0.983 . . . . 0.0 109.127 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -156.25 174.25 15.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.984 1.713 . . . . 0.0 107.471 164.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.43 -148.14 19.07 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 125.487 1.518 . . . . 0.0 111.31 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -148.68 171.56 16.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 111.216 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 9.1 p90 -146.22 172.38 13.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.29 1.436 . . . . 0.0 108.349 165.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.5 90.6 2.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.158 1.783 . . . . 0.0 106.326 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 18.8 mt-10 -74.89 -22.73 58.47 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.462 -0.774 . . . . 0.0 112.705 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 96.17 164.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.347 4.259 . . . . 0.0 109.747 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.32 104.01 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -121.42 105.25 10.33 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.831 1.253 . . . . 0.0 107.754 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -79.65 116.12 19.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.95 -56.03 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 120.529 1.513 . . . . 0.0 114.115 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.21 11.44 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.837 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 137.15 28.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.189 1.995 . . . . 0.0 109.484 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -66.61 144.92 56.12 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.28 -12.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.79 1.236 . . . . 0.0 112.965 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.91 -168.56 41.69 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -129.46 138.04 51.19 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -114.84 158.45 21.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD13 ' A' ' 90' ' ' LEU . 14.2 p -116.67 94.84 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -166.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.14 116.53 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.94 1.696 . . . . 0.0 108.235 -162.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.4 p -88.75 150.77 22.79 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.398 0.999 . . . . 0.0 109.271 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -24.94 67.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.051 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -32.9 72.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.492 1.117 . . . . 0.0 109.302 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.99 -14.85 2.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.702 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 163.59 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.969 2.108 . . . . 0.0 110.785 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.25 156.63 42.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 121.379 -0.826 . . . . 0.0 109.534 156.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -127.28 159.75 21.36 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.82 64.9 7.31 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.66 3.574 . . . . 0.0 111.642 -166.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.64 -56.08 2.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 127.079 2.152 . . . . 0.0 110.677 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 147.8 34.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 109.516 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -147.4 161.67 40.57 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.029 1.332 . . . . 0.0 108.691 172.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -62.55 159.95 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.833 0.853 . . . . 0.0 109.744 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.55 -155.88 7.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.75 166.11 22.84 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.81 149.31 40.14 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.993 0.815 . . . . 0.0 109.457 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.01 124.45 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.066 1.844 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.62 164.7 33.21 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.525 2.816 . . . . 0.0 110.891 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.16 -12.43 27.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.475 2.116 . . . . 0.0 113.749 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.28 7.87 73.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.258 0.932 . . . . 0.0 112.879 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -140.65 170.13 16.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 130.389 3.476 . . . . 0.0 104.221 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -139.47 149.65 44.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 153.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -151.24 149.95 30.01 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.14 97.88 4.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.093 1.357 . . . . 0.0 110.113 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.2 161.8 19.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.049 1.295 . . . . 0.0 111.168 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.66 -4.13 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -161.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.22 77.21 0.09 OUTLIER Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 86.59 -31.44 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.076 2.95 . . . . 0.0 111.491 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -105.94 146.11 30.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.11 132.32 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.33 175.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.624 1.57 . . . . 0.0 108.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.68 135.51 22.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.54 -37.86 85.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 164.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -51.29 -42.46 61.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.081 1.352 . . . . 0.0 110.802 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.8 m -75.98 -15.27 60.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.614 -1.304 . . . . 0.0 112.914 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.5 -59.03 2.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.791 -1.1 . . . . 0.0 108.444 161.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -57.79 -17.27 14.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.481 1.491 . . . . 0.0 114.009 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -52.61 -41.48 63.72 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.665 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -142.26 -37.54 0.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.831 0.852 . . . . 0.0 112.688 -171.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 94' ' ' VAL . . . -77.98 51.02 0.92 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.159 1.784 . . . . 0.0 109.373 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.03 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.894 2.477 . . . . 0.0 105.698 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.55 -35.7 37.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.817 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 91' ' ' ALA . 22.5 m -62.28 -21.08 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.883 1.219 . . . . 0.0 113.303 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.11 -33.86 68.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.197 0.453 . . . . 0.0 109.781 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.42 107.02 3.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.786 -1.196 . . . . 0.0 111.545 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 159.804 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 122.241 1.019 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -84.28 162.79 19.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.099 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.06 154.95 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.31 149.85 52.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.254 1.022 . . . . 0.0 108.698 163.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.68 122.55 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 123.17 0.588 . . . . 0.0 109.423 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.02 84.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -171.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -74.09 171.15 14.05 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.39 -1.444 . . . . 0.0 109.785 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 34.33 69.23 0.16 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.882 3.273 . . . . 0.0 114.301 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.424 HG23 HD23 ' A' ' 153' ' ' LEU . 19.7 mt -89.27 91.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.41 -81.05 0.04 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 118.473 0.579 . . . . 0.0 112.032 -170.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -53.4 -35.43 60.36 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.614 1.166 . . . . 0.0 113.06 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -3.43 16.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.963 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -39.44 -52.43 2.1 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 121.514 1.961 . . . . 0.0 112.389 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -45.3 95.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.524 0.73 . . . . 0.0 111.375 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.49 -9.65 55.78 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.23 2.212 . . . . 0.0 113.6 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.5 m -55.64 109.87 0.63 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.351 1.46 . . . . 0.0 112.017 -164.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.35 -83.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.491 0.587 . . . . 0.0 111.189 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.57 -19.66 63.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.886 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -74.26 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.765 2.026 . . . . 0.0 110.339 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.8 mp -33.99 -58.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-N 120.169 1.35 . . . . 0.0 112.737 170.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.92 -58.04 10.16 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.354 0.979 . . . . 0.0 111.911 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.01 91.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.002 0.814 . . . . 0.0 109.513 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 157' ' ' ILE . 41.1 t -55.97 -50.91 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.432 1.493 . . . . 0.0 109.247 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -65.3 -28.97 69.69 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.729 -1.232 . . . . 0.0 112.563 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -54.18 -58.53 7.01 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 m -60.51 -38.51 84.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.128 2.571 . . . . 0.0 112.453 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.33 -33.83 75.46 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.88 0.472 . . . . 0.0 110.285 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.4 -8.11 58.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.849 0.46 . . . . 0.0 111.231 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 m -89.97 133.72 33.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.5 -37.15 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.275 2.65 . . . . 0.0 112.76 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -48.52 80.64 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -63.49 153.67 34.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.157 1.783 . . . . 0.0 111.497 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.8 mt -139.29 106.28 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.6 mm -65.43 147.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -144.32 94.49 2.58 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.909 2.083 . . . . 0.0 106.581 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.68 173.97 19.95 Favored Glycine 0 N--CA 1.465 0.628 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.455 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.533 HG21 ' HD3' ' A' ' 14' ' ' LYS . 29.2 m -131.36 98.87 4.66 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.632 1.216 . . . . 0.0 112.52 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.6 pt -80.15 140.81 53.42 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.827 -1.17 . . . . 0.0 111.375 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.8 137.9 43.16 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.044 1.83 . . . . 0.0 108.435 166.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.89 134.45 95.92 Favored Pre-proline 0 N--CA 1.444 -0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.166 -166.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.78 129.92 19.58 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.818 2.345 . . . . 0.0 108.958 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.95 -61.24 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.731 1.213 . . . . 0.0 108.426 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.88 -126.91 0.74 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 157.03 90.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.569 0.685 . . . . 0.0 111.313 -170.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.63 103.2 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.785 2.323 . . . . 0.0 108.711 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.04 124.46 21.67 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.682 -0.636 . . . . 0.0 110.131 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.53 -59.82 4.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.166 1.386 . . . . 0.0 113.3 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 114' ' ' ILE . 65.0 tp -63.5 -30.59 71.68 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.478 -1.389 . . . . 0.0 111.259 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.16 -44.24 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 121.297 -0.877 . . . . 0.0 108.888 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.01 -37.66 66.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.988 1.715 . . . . 0.0 110.829 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -57.85 -28.61 64.29 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.659 0.663 . . . . 0.0 112.344 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.512 HG21 ' CE1' ' A' ' 5' ' ' PHE . 9.2 mt -107.56 -32.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.602 1.161 . . . . 0.0 109.975 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -32.99 72.25 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.033 -1.042 . . . . 0.0 109.166 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.28 -6.45 23.97 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -76.53 -39.65 52.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 120.884 1.674 . . . . 0.0 110.057 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? 62.2 -23.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.121 2.169 . . . . 0.0 114.648 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.59 -28.7 69.54 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.288 1.435 . . . . 0.0 111.997 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 3' ' ' HIS . 27.7 m -55.36 135.82 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.451 1.5 . . . . 0.0 110.566 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.74 145.63 54.55 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 168.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.23 89.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 180' ' ' ILE . 30.7 m-85 -79.2 104.75 10.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.786 0.835 . . . . 0.0 109.087 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.65 105.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.429 HG23 HD22 ' A' ' 176' ' ' LEU . 0.7 OUTLIER -59.91 155.84 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 164.203 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.3 p -134.83 162.59 31.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 154.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.76 -14.64 61.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.494 165.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.62 -54.27 4.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -101.92 10.69 39.53 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.288 1.435 . . . . 0.0 110.746 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 ptt85 -29.71 -65.16 0.11 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.034 2.134 . . . . 0.0 111.612 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -80.3 3.45 20.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -169.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -105.18 -6.97 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.099 2.16 . . . . 0.0 111.033 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 168' ' ' VAL . 6.8 tp -81.15 -45.77 15.91 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 119.189 0.904 . . . . 0.0 110.65 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.8 tp -32.51 -61.91 0.31 Allowed Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.716 2.006 . . . . 0.0 109.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.14 -28.63 28.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 122.438 1.906 . . . . 0.0 114.94 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -68.14 -35.07 77.5 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.872 1.215 . . . . 0.0 109.847 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.51 HG12 ' CD2' ' A' ' 166' ' ' PHE . 12.0 mt -65.34 -46.34 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.835 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.89 -45.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 119.349 0.977 . . . . 0.0 108.761 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.0 m -58.53 -51.09 71.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.623 0.769 . . . . 0.0 111.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.15 -31.32 69.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.229 1.377 . . . . 0.0 112.106 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.65 -62.03 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -70.14 -18.23 63.22 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -19.06 56.32 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 119.457 1.026 . . . . 0.0 111.56 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 120.633 1.56 . . . . 0.0 111.978 175.048 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -46.39 137.96 6.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 0.0 110.511 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.33 143.2 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.927 0.891 . . . . 0.0 109.536 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -141.54 146.94 36.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.953 1.701 . . . . 0.0 108.637 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -104.69 157.31 17.27 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.648 1.113 . . . . 0.0 111.287 173.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -149.73 177.22 9.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.45 1.1 . . . . 0.0 109.092 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.28 -176.41 19.62 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.136 1.35 . . . . 0.0 112.701 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.65 166.05 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.476 3.451 . . . . 0.0 110.751 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.58 93.91 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.435 2.09 . . . . 0.0 111.054 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.18 -34.99 15.97 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.493 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.55 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.17 2.588 . . . . 0.0 110.063 -153.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.4 17.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.826 -1.541 . . . . 0.0 113.833 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -94.17 -55.82 3.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.531 1.665 . . . . 0.0 110.731 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.0 m -51.8 -41.54 61.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.329 1.851 . . . . 0.0 109.724 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -58.04 -41.7 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 113.73 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -48.28 61.24 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.1 mm -57.71 -41.55 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -56.0 -55.95 26.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.509 -0.745 . . . . 0.0 110.214 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -59.48 -31.78 69.65 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.137 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -50.96 -44.28 60.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.915 0.78 . . . . 0.0 109.947 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 m -58.54 -47.29 84.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.89 -23.47 63.25 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.794 2.038 . . . . 0.0 111.73 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.4 t -83.71 -48.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.382 1.873 . . . . 0.0 109.362 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.06 -44.72 87.62 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -60.77 -43.44 98.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.882 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -62.09 -26.58 68.37 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.918 0.781 . . . . 0.0 112.279 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 t -88.69 1.7 54.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.898 1.679 . . . . 0.0 112.271 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.4 11.31 85.62 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.971 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.25 118.3 70.87 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.885 1.843 . . . . 0.0 106.979 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.39 123.19 11.98 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.909 1.739 . . . . 0.0 110.647 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.16 160.64 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.82 177.53 8.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 159.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 110' ' ' VAL . . . 141.04 -163.82 26.59 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 119.579 -1.951 . . . . 0.0 113.199 166.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -151.03 155.19 38.5 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.234 1.016 . . . . 0.0 110.325 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -118.72 -179.01 3.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.4 m -161.86 94.71 0.95 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -164.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.42 156.68 17.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -68.25 109.39 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.17 109.33 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -119.29 104.74 10.66 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.932 2.093 . . . . 0.0 107.443 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -91.84 102.47 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.26 50.68 7.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.183 0.897 . . . . 0.0 113.558 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.88 -6.88 57.69 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.419 1.485 . . . . 0.0 114.925 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.43 122.05 23.96 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.061 1.931 . . . . 0.0 107.506 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 123.84 23.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 159.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -10.63 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.789 0.836 . . . . 0.0 112.729 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.13 -164.11 35.26 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -139.44 143.09 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.66 145.6 41.83 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.62 154.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.03 123.37 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.5 p -72.48 179.25 3.58 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.563 -1.336 . . . . 0.0 109.927 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.51 HD21 ' CG1' ' A' ' 110' ' ' VAL . 1.2 mm? -88.3 -13.68 40.21 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.299 -0.875 . . . . 0.0 111.492 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 t -70.83 -50.41 35.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 49.43 0.1 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -144.82 147.49 32.92 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.641 1.976 . . . . 0.0 107.592 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.77 161.41 20.17 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 128.494 2.717 . . . . 0.0 108.999 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -143.12 134.42 5.93 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.841 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.48 61.94 2.8 Favored 'Trans proline' 0 CA--C 1.55 1.284 1 C-N-CA 126.371 4.714 . . . . 0.0 114.053 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.3 -63.02 1.2 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.57 1.948 . . . . 0.0 111.581 -169.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 p -130.11 136.5 49.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.306 0.957 . . . . 0.0 108.872 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -148.94 169.34 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.434 1.494 . . . . 0.0 107.889 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -56.32 152.34 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.679 1.191 . . . . 0.0 109.884 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.49 46.87 0.07 OUTLIER Glycine 0 C--N 1.333 0.403 0 CA-C-O 119.335 -0.703 . . . . 0.0 111.612 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.0 -169.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.971 1.708 . . . . 0.0 111.7 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.58 147.53 43.87 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 110.871 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -69.73 123.83 10.5 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.728 2.286 . . . . 0.0 107.971 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.24 170.49 19.47 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.627 2.885 . . . . 0.0 110.853 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.48 -9.75 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.28 1.987 . . . . 0.0 114.196 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.47 -12.49 51.0 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.535 -1.147 . . . . 0.0 114.291 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 138.1 36.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.34 2.07 . . . . 0.0 108.138 -168.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -119.07 122.32 41.84 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.104 0.562 . . . . 0.0 110.0 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 172.25 13.67 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 126.026 1.731 . . . . 0.0 107.655 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 95.3 m -68.4 147.81 51.55 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.815 -0.553 . . . . 0.0 109.725 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -153.29 143.83 22.57 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.528 -0.732 . . . . 0.0 109.472 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.766 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.37 1.06 0.15 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 127.437 2.446 . . . . 0.0 117.596 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.225 2.21 . . . . 0.0 106.713 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -80.57 166.64 20.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.339 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -110.61 133.59 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.8 166.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -139.39 105.17 5.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.6 -24.23 63.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.322 -0.861 . . . . 0.0 111.592 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -34.4 77.99 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.624 171.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -57.42 -48.45 79.09 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 119.989 1.268 . . . . 0.0 109.941 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -56.04 -50.62 70.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -19.67 66.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.057 0.844 . . . . 0.0 112.439 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.66 ' HB2' HD23 ' A' ' 90' ' ' LEU . 19.5 mt-30 -66.36 -45.25 80.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.721 1.146 . . . . 0.0 112.059 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -123.35 -39.86 2.42 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.59 51.18 2.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.072 1.749 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 -60.35 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 125.721 1.608 . . . . 0.0 108.0 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -38.36 42.37 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.607 1.538 . . . . 0.0 112.043 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -36.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 123.909 0.883 . . . . 0.0 110.591 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.148 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 108.26 0.13 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.983 1.713 . . . . 0.0 106.764 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 C--N 1.322 -0.63 0 C-N-CA 125.142 1.377 . . . . 0.0 108.129 163.242 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.379 0.609 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -89.0 97.21 11.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 126.613 1.965 . . . . 0.0 110.019 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.9 t -74.97 94.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 121.656 2.026 . . . . 0.0 107.577 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.5 m -72.24 165.24 24.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.51 ' CG1' HD21 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -144.61 139.67 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.576 -177.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mt -152.22 103.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.651 1.219 . . . . 0.0 108.501 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -105.69 -169.61 1.61 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 42.75 48.75 4.91 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.014 2.526 . . . . 0.0 112.163 -168.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.71 110.56 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.13 -63.97 0.32 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-O 117.554 -1.692 . . . . 0.0 112.493 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -24.15 65.92 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.913 2.357 . . . . 0.0 110.44 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.3 mmt -69.02 -10.39 57.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 116.671 -1.633 . . . . 0.0 113.404 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -24.63 -68.42 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.535 2.334 . . . . 0.0 114.593 -171.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -45.96 63.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 0.0 111.361 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.66 -27.99 66.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.615 1.166 . . . . 0.0 112.181 -170.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.4 t -41.64 114.01 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 129.222 3.009 . . . . 0.0 111.715 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -127.44 -87.71 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.412 0.551 . . . . 0.0 111.465 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.6 -16.8 61.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.793 0.724 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.99 -68.02 0.22 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.839 2.055 . . . . 0.0 111.168 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -36.83 -57.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.628 1.571 . . . . 0.0 112.148 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.9 -54.49 41.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.308 0.643 . . . . 0.0 111.025 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.82 99.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 124.148 0.905 . . . . 0.0 109.299 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.13 -47.15 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.227 1.411 . . . . 0.0 109.538 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.41 -44.6 96.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.203 1.365 . . . . 0.0 111.265 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -57.62 -38.71 75.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.153 0.888 . . . . 0.0 110.435 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 137' ' ' THR . 63.4 m -74.24 -38.99 63.35 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.364 -0.835 . . . . 0.0 112.103 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.2 mt -61.06 -35.76 77.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.21 1.368 . . . . 0.0 109.932 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.8 t -71.94 -22.05 61.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.221 1.808 . . . . 0.0 110.605 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 137' ' ' THR . 96.3 m -76.26 134.0 71.05 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.03 -42.71 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.032 2.488 . . . . 0.0 112.319 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.35 -2.75 63.59 Favored Glycine 0 C--O 1.216 -0.97 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.384 -168.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.534 HG21 ' CG2' ' A' ' 131' ' ' THR . 21.9 m -80.48 160.84 25.14 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.965 2.382 . . . . 0.0 106.139 154.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.6 mt -122.92 138.37 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.72 136.99 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' CG2' ' A' ' 180' ' ' ILE . 10.5 tp -140.07 113.45 8.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.92 32.89 Favored Glycine 0 N--CA 1.462 0.412 0 C-N-CA 119.287 -1.435 . . . . 0.0 114.656 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.0 m -137.11 133.4 35.29 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.93 147.61 66.24 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.821 1.648 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.71 148.92 59.96 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 111.167 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.34 131.55 86.6 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.241 0.617 . . . . 0.0 110.083 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.69 108.82 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.402 2.735 . . . . 0.0 108.443 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -64.75 0.79 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -112.27 -109.47 3.02 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 166.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 149.69 98.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 118.72 1.26 . . . . 0.0 111.966 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.55 -164.9 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.37 1 C-N-CA 125.966 4.444 . . . . 0.0 112.247 164.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.79 168.25 10.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.601 1.96 . . . . 0.0 109.183 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.29 -67.07 0.31 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.037 2.535 . . . . 0.0 113.287 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.4 tm? -59.48 -46.32 89.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.56 -35.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.36 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.07 -28.11 68.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.869 1.668 . . . . 0.0 112.086 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.52 -34.74 77.51 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.769 0.713 . . . . 0.0 110.007 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.32 -39.09 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.3 1.44 . . . . 0.0 109.564 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.66 -26.68 65.44 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.426 -1.422 . . . . 0.0 111.105 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -59.32 -37.58 78.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.315 0.646 . . . . 0.0 111.44 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -61.58 -36.78 81.64 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.908 0.883 . . . . 0.0 112.019 -167.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -40.24 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.971 2.908 . . . . 0.0 115.676 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -59.93 -28.9 68.01 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.189 1.359 . . . . 0.0 110.626 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.0 m -50.36 108.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.503 1.521 . . . . 0.0 109.28 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -65.69 123.21 19.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 m -111.94 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 C-N-CA 124.683 1.193 . . . . 0.0 108.778 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -72.12 118.83 15.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.142 0.977 . . . . 0.0 110.538 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.61 97.81 5.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.789 1.235 . . . . 0.0 110.631 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.427 HG23 HD12 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -67.86 132.79 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 p -94.93 151.22 19.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 158.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -57.85 -29.8 65.28 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.064 -0.397 . . . . 0.0 110.389 165.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.07 -53.87 15.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 110.848 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.82 23.06 13.41 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.025 -1.047 . . . . 0.0 110.91 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -47.26 -44.55 23.11 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.448 1.099 . . . . 0.0 112.464 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.27 3.56 8.68 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -118.29 62.54 0.77 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 168' ' ' VAL . 0.5 OUTLIER -140.25 -39.79 0.44 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.37 160.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tp -40.03 -58.37 2.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 117.625 -1.179 . . . . 0.0 110.355 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.84 -28.24 51.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.436 1.424 . . . . 0.0 113.386 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.24 -38.26 68.96 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.282 -0.886 . . . . 0.0 109.219 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.595 HD11 HD11 ' A' ' 6' ' ' LEU . 14.4 mt -66.89 -47.34 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.488 1.515 . . . . 0.0 107.974 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 92.2 t -56.04 -43.99 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.225 0.92 . . . . 0.0 109.171 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.0 m -57.97 -47.81 81.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.962 1.305 . . . . 0.0 109.129 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.45 -37.78 88.73 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.731 -0.606 . . . . 0.0 111.693 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.64 -55.52 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.911 0.778 . . . . 0.0 109.428 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -28.32 69.69 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.034 -174.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.51 -50.85 0.34 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.235 2.214 . . . . 0.0 111.637 -176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 125.594 1.557 . . . . 0.0 107.814 -175.525 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.227 -0.099 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.507 ' HB2' HG12 ' A' ' 163' ' ' VAL . 48.7 m-70 -92.88 159.5 15.33 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.375 1.87 . . . . 0.0 109.282 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.65 148.41 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 19.9 m-85 -144.11 158.02 43.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.909 1.684 . . . . 0.0 109.537 172.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.916 HD11 HD11 ' A' ' 180' ' ' ILE . 4.2 mm? -109.38 135.3 50.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.83 -172.5 3.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.82 -172.31 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.265 -0.897 . . . . 0.0 111.295 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.44 163.34 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.19 2.593 . . . . 0.0 113.611 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.82 72.05 6.29 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.804 3.67 . . . . 0.0 111.736 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.18 25.14 21.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 124.411 1.005 . . . . 0.0 112.494 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m 42.51 35.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.513 2.725 . . . . 0.0 116.308 161.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.87 9.91 3.1 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.514 1.531 . . . . 0.0 112.184 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -75.19 -49.87 18.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 109.956 -168.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -57.66 -35.25 70.31 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.391 0.676 . . . . 0.0 109.71 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.5 m -63.49 -38.78 92.46 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.284 -0.885 . . . . 0.0 112.45 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -49.55 57.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.89 1.223 . . . . 0.0 108.593 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.689 HD11 HD23 ' A' ' 6' ' ' LEU . 5.8 mm -58.08 -40.94 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.562 0.619 . . . . 0.0 111.045 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -45.84 54.7 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.317 0.962 . . . . 0.0 110.067 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -70.05 -20.04 63.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.23 0.612 . . . . 0.0 112.207 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.328 0.967 . . . . 0.0 110.627 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -81.51 -42.8 19.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.02 -39.22 68.89 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.103 0.561 . . . . 0.0 111.211 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.21 -51.24 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.334 1.053 . . . . 0.0 110.291 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 61.3 mt -63.25 -35.5 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.33 -38.33 89.79 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.074 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -4.8 14.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.495 1.118 . . . . 0.0 112.912 172.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 m -109.61 -5.08 15.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.701 1.6 . . . . 0.0 111.638 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.72 18.46 74.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.015 1.293 . . . . 0.0 112.981 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 24.7 t -64.71 133.76 95.82 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.665 1.733 . . . . 0.0 107.131 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.22 95.22 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.575 2.183 . . . . 0.0 110.072 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.56 136.73 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.78 173.79 11.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.604 2.362 . . . . 0.0 105.883 169.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.98 -156.79 26.15 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -142.06 166.02 25.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.912 1.356 . . . . 0.0 111.434 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -142.14 179.62 6.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.4 p -134.98 136.67 42.38 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.91 27.17 4.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.278 6.8 pm0 49.81 -178.71 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.357 2.263 . . . . 0.0 112.79 -164.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.81 119.56 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -129.27 106.47 8.84 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 70.63 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.58 75.51 0.51 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -161.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.19 -40.21 2.68 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 148.47 42.38 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.719 1.76 . . . . 0.0 111.135 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -69.81 132.24 45.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 162.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.55 -27.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.72 -174.05 41.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 119.608 1.095 . . . . 0.0 110.677 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CZ ' ' HE2' ' A' ' 116' ' ' LYS . 25.1 m-85 -126.53 153.25 45.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 160.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -117.97 162.42 18.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 167.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 90' ' ' LEU . 2.1 p -114.97 145.35 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.907 1.683 . . . . 0.0 107.923 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.2 108.95 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 120.55 1.523 . . . . 0.0 109.858 -167.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.483 HG23 HD12 ' A' ' 90' ' ' LEU . 76.1 p -69.61 145.05 52.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.31 -5.74 30.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -84.68 7.53 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.549 1.068 . . . . 0.0 111.32 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.67 3.41 83.75 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.223 -1.548 . . . . 0.0 114.984 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 m -80.83 166.08 21.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.783 1.291 . . . . 0.0 109.358 163.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -146.39 169.78 18.16 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -150.42 -176.23 23.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.722 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -108.93 14.41 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.116 1.21 . . . . 0.0 114.284 -144.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mt 23.61 -74.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 130.898 3.679 . . . . 0.0 116.446 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -147.83 159.93 43.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 165.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -143.58 53.12 1.32 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.845 2.058 . . . . 0.0 110.652 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 64.99 160.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.663 1.985 . . . . 0.0 111.554 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.51 150.96 11.9 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.73 150.86 26.68 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.756 1.222 . . . . 0.0 108.67 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.4 156.37 30.99 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 109.603 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.74 132.21 24.5 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.182 1.921 . . . . 0.0 110.102 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.72 155.03 59.16 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.696 2.931 . . . . 0.0 110.068 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.44 111.53 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.087 2.525 . . . . 0.0 109.823 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.64 -60.43 0.67 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 142.33 52.95 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -147.26 146.04 29.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -160.35 -175.34 4.98 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.736 0.647 . . . . 0.0 112.616 -165.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.0 m -60.67 101.7 0.15 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.779 2.032 . . . . 0.0 110.752 171.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -142.14 119.61 11.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.57 -89.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.38 -47.78 0.25 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.772 1.169 . . . . 0.0 112.013 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -144.58 4.05 1.15 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.355 . . . . 0.0 111.436 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.44 139.11 51.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.268 1.027 . . . . 0.0 108.379 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.63 88.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.2 174.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -147.56 133.17 18.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.306 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.57 -35.42 74.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.356 -0.84 . . . . 0.0 109.595 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.3 m -55.24 -43.81 74.94 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 110.923 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.5 p -63.58 -29.5 70.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.401 1.455 . . . . 0.0 110.659 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -69.4 -53.2 20.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.824 1.25 . . . . 0.0 110.477 167.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -47.47 -35.03 8.09 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.193 0.997 . . . . 0.0 112.157 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 10.9 mt-30 -58.55 -32.11 68.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -144.97 -36.21 0.31 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -171.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.78 31.57 0.53 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.504 2.322 . . . . 0.0 111.447 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -124.65 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 126.751 2.02 . . . . 0.0 108.41 178.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 30.2 Cg_endo -61.41 -27.03 82.12 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 121.428 1.546 . . . . 0.0 113.225 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.74 -26.46 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.245 0.93 . . . . 0.0 113.328 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 127' ' ' ALA . 1.2 mm? -73.14 -23.92 60.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.335 0.97 . . . . 0.0 111.369 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -165.65 116.53 1.07 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 120.289 1.404 . . . . 0.0 108.192 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.148 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 122.489 1.137 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -91.59 173.01 8.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.67 2.788 . . . . 0.0 110.807 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -120.11 135.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 163.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.69 153.39 18.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -134.43 130.12 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -137.5 94.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.83 80.64 1.47 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 123.176 1.465 . . . . 0.0 112.768 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -158.31 -84.37 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 130.16 3.384 . . . . 0.0 104.989 165.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.402 HG21 HG22 ' A' ' 143' ' ' ILE 0.363 1.5 mt 52.96 -17.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 1 C-N-CA 131.829 4.051 . . . . 0.0 114.44 -174.56 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.22 6.63 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 120.975 1.716 . . . . 0.0 113.582 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 41.6 mttp -71.36 -17.58 62.42 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 118.259 -2.906 . . . . 0.0 113.663 -165.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tpp -106.87 20.99 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.501 1.521 . . . . 0.0 110.904 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.45 -20.63 7.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.825 1.65 . . . . 0.0 114.636 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.39 -31.28 2.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.259 1.824 . . . . 0.0 110.677 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.02 -4.23 58.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.191 -0.943 . . . . 0.0 113.173 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.26 139.47 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.208 3.003 . . . . 0.0 110.347 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -40.08 0.27 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -100.71 -22.12 15.0 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.773 -1.108 . . . . 0.0 110.731 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -63.57 0.9 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.122 1.769 . . . . 0.0 110.508 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' H ' ' A' ' 125' ' ' ILE . 2.8 mp -33.01 -59.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.76 2.024 . . . . 0.0 113.096 170.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -68.85 -55.28 11.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.781 1.232 . . . . 0.0 108.191 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 95' ' ' LEU . . . -62.45 -34.49 76.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.443 0.697 . . . . 0.0 111.163 -172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.03 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.068 1.347 . . . . 0.0 107.663 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -57.75 -36.66 72.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.369 -171.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -54.66 -61.83 2.05 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.516 1.053 . . . . 0.0 109.08 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.4 m -78.64 -13.88 59.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.052 0.941 . . . . 0.0 113.205 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.52 -18.02 63.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.574 1.079 . . . . 0.0 110.321 166.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -132.46 32.36 3.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.285 1.434 . . . . 0.0 108.983 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.77 134.84 53.0 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.27 107.01 2.36 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.861 3.041 . . . . 0.0 107.885 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.34 34.57 3.87 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.931 -1.483 . . . . 0.0 114.747 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.9 m -136.23 171.19 14.84 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 161.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.3 mt -141.09 106.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.15 135.88 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 119.028 0.831 . . . . 0.0 110.241 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.5 tp -132.7 148.81 52.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.205 2.202 . . . . 0.0 106.605 159.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.36 -171.92 44.94 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 119.198 0.908 . . . . 0.0 112.26 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -118.59 154.83 31.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.9 0.85 . . . . 0.0 111.458 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.402 HG22 HG21 ' A' ' 114' ' ' ILE . 8.7 pt -136.61 125.38 15.27 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.398 2.279 . . . . 0.0 108.223 170.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.08 150.11 87.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.59 1.527 . . . . 0.0 110.55 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.97 130.06 64.97 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.28 -51.4 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.53 2.82 . . . . 0.0 110.457 -165.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 40.51 55.97 2.8 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.999 1.72 . . . . 0.0 110.982 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 157.6 -153.02 24.28 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 126.897 2.189 . . . . 0.0 107.648 -159.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.6 OUTLIER -63.93 166.85 8.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.092 0.446 . . . . 0.0 110.237 172.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.65 168.69 22.97 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.563 1.509 . . . . 0.0 109.182 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.75 176.81 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.772 2.029 . . . . 0.0 106.259 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.17 -79.15 0.37 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.3 tp -51.02 -44.07 60.97 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.984 1.313 . . . . 0.0 112.255 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.06 -31.16 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.265 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.75 -34.24 75.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.327 1.422 . . . . 0.0 109.805 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.11 -43.8 87.36 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.262 0.937 . . . . 0.0 111.271 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.6 mp -80.57 -39.56 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.029 0.532 . . . . 0.0 109.834 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -60.78 -32.4 71.73 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.508 -1.37 . . . . 0.0 110.338 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -74.23 8.43 2.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.513 1.525 . . . . 0.0 113.501 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -34.74 10.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.556 1.526 . . . . 0.0 111.62 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 63.1 -19.67 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 128.602 2.761 . . . . 0.0 115.339 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -72.6 -30.67 64.57 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.639 3.175 . . . . 0.0 111.615 168.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' A' ' 3' ' ' HIS . 29.5 m -54.18 125.13 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.108 1.763 . . . . 0.0 107.618 169.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.35 112.17 5.06 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -97.93 96.13 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 120.856 1.662 . . . . 0.0 106.575 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.3 m-85 -69.52 98.25 1.11 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.037 0.935 . . . . 0.0 108.743 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.17 99.49 0.9 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.85 165.82 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.92 . . . . 0.0 109.192 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.7 p -138.68 156.38 47.47 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.836 1.303 . . . . 0.0 108.288 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -42.27 -31.64 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.867 156.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -80.29 -55.8 4.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.469 0.577 . . . . 0.0 109.79 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -119.95 16.66 12.56 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.876 0.87 . . . . 0.0 110.288 -160.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -39.71 -63.06 0.62 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.791 2.036 . . . . 0.0 111.155 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -70.56 8.48 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 113.704 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.48 15.92 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.405 2.282 . . . . 0.0 110.201 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -32.04 10.36 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.632 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -37.98 -55.99 2.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.489 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.52 -23.27 57.76 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.335 1.512 . . . . 0.0 114.59 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -80.26 -38.54 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.454 1.501 . . . . 0.0 110.425 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.916 HD11 HD11 ' A' ' 6' ' ' LEU . 7.6 mt -59.74 -52.14 64.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.359 -0.838 . . . . 0.0 108.863 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.74 -43.77 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.149 0.98 . . . . 0.0 109.41 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.7 m -59.06 -43.65 91.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.114 0.87 . . . . 0.0 111.032 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.0 -48.13 81.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.104 0.562 . . . . 0.0 109.676 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.43 -52.45 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.301 1.04 . . . . 0.0 109.893 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -69.46 -5.94 27.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.8 t -64.34 -71.2 0.18 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 128.276 2.63 . . . . 0.0 116.013 -164.249 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 23.43 91.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.092 2.157 . . . . 0.0 111.342 141.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.71 124.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -165.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -117.86 161.01 20.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 110.378 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 18' ' ' ILE . 45.7 mt -124.84 154.57 40.82 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.203 1.401 . . . . 0.0 109.823 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -158.11 169.72 23.91 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.69 63.09 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 128.668 3.033 . . . . 0.0 111.874 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -54.21 118.49 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.468 3.445 . . . . 0.0 111.455 -166.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.24 -81.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.301 2.001 . . . . 0.0 114.451 -163.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.6 37.71 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t 50.99 68.77 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.919 1.688 . . . . 0.0 110.254 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.92 23.35 1.45 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.605 1.098 . . . . 0.0 111.039 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 142' ' ' THR . 2.0 pttm -83.91 -31.55 25.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.911 -0.758 . . . . 0.0 111.901 -170.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -59.79 -38.16 81.1 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -56.99 -35.08 68.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 112.553 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -33.73 70.33 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 HD11 HD11 ' A' ' 6' ' ' LEU . 4.4 mm -77.16 -31.07 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.6 1.091 . . . . 0.0 109.984 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -54.33 -51.42 64.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.706 1.593 . . . . 0.0 107.507 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -66.13 -15.18 62.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.7 -1.137 . . . . 0.0 112.374 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.2 64.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.45 1.023 . . . . 0.0 111.137 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -78.25 -48.35 15.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.284 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -50.34 -40.76 50.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.162 0.585 . . . . 0.0 111.172 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.65 -61.37 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 123.955 0.902 . . . . 0.0 109.486 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -55.48 -42.3 74.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 123.232 0.613 . . . . 0.0 109.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -60.39 -47.99 83.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -59.93 -42.05 93.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.168 0.987 . . . . 0.0 109.921 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -71.97 -7.28 47.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.593 1.557 . . . . 0.0 113.417 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.07 9.96 60.2 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.637 -1.09 . . . . 0.0 113.153 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.5 t -99.77 105.86 36.99 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.43 97.16 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.403 2.736 . . . . 0.0 110.948 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.59 147.27 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.686 1.194 . . . . 0.0 108.637 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -137.99 170.41 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.072 150.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.95 -162.58 28.1 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.227 0.917 . . . . 0.0 111.08 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -140.4 162.71 34.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.869 0.843 . . . . 0.0 111.128 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.2 157.83 45.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.932 1.293 . . . . 0.0 107.558 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.9 100.79 11.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -79.13 159.31 27.51 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.959 1.361 . . . . 0.0 109.086 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.17 99.78 8.73 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.348 169.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 47' ' ' ILE . 7.6 p -58.71 107.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.828 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -108.96 103.1 12.08 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 120.917 -1.115 . . . . 0.0 109.348 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.639 ' HB2' HD13 ' A' ' 47' ' ' ILE . 23.7 tp60 -64.84 -37.86 89.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.786 0.721 . . . . 0.0 110.713 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.3 63.58 0.11 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.88 15.15 68.84 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.87 -1.517 . . . . 0.0 115.805 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 140.81 52.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.835 1.817 . . . . 0.0 107.075 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -78.12 98.23 5.72 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 42' ' ' GLN . 35.2 pt -78.18 -12.94 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 121.39 -0.819 . . . . 0.0 111.995 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.95 -126.96 1.3 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 165.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -132.93 158.82 41.65 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.33 134.03 35.58 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.522 1.129 . . . . 0.0 109.715 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.6 101.97 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -167.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -90.03 132.76 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.3 p -95.96 156.26 16.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.2 8.99 3.4 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.291 -0.881 . . . . 0.0 112.541 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 t -109.89 4.34 21.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.996 1.319 . . . . 0.0 111.51 161.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.2 3.45 65.3 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.367 -1.458 . . . . 0.0 114.768 161.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -71.84 148.84 45.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.538 1.669 . . . . 0.0 107.194 162.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -139.32 131.79 28.62 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.926 1.29 . . . . 0.0 108.462 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -118.99 174.08 15.2 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.731 1.15 . . . . 0.0 113.861 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.75 165.18 21.69 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.609 1.539 . . . . 0.0 108.631 162.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 tp -140.74 -70.18 0.38 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.9 p -134.49 158.07 44.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.071 0.857 . . . . 0.0 108.927 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -147.43 157.64 43.66 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.535 1.134 . . . . 0.0 110.137 169.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 t -62.14 137.1 24.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 109.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.51 165.4 30.94 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.82 153.78 7.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.734 0.814 . . . . 0.0 109.504 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.12 163.99 56.62 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.669 0.388 . . . . 0.0 111.297 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -83.58 140.52 9.45 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.001 2.467 . . . . 0.0 110.739 -170.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.43 164.26 26.47 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.691 2.26 . . . . 0.0 110.524 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.63 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.841 2.361 . . . . 0.0 113.056 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.54 10.34 26.02 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.173 1.844 . . . . 0.0 113.114 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.63 165.67 26.33 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.951 1.875 . . . . 0.0 109.025 169.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.8 157.85 42.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.201 0.601 . . . . 0.0 110.275 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -166.92 -170.11 1.47 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 128.502 2.721 . . . . 0.0 105.95 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 92.6 m -98.02 126.73 43.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 139.7 33.19 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.884 -1.135 . . . . 0.0 108.718 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.2 92.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.871 1.669 . . . . 0.0 107.604 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.12 -73.93 1.92 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.37 0.986 . . . . 0.0 112.308 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.22 -25.65 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.439 1.495 . . . . 0.0 110.768 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.29 118.63 25.86 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.31 131.1 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 162.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.44 178.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 125.273 1.429 . . . . 0.0 108.745 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -147.28 155.53 42.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.46 161.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.79 -28.92 36.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.642 0.777 . . . . 0.0 110.448 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 m -64.28 -36.87 85.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.683 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.9 m -60.45 -31.74 70.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.591 1.087 . . . . 0.0 110.931 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -71.86 -53.9 11.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.518 167.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.05 -23.87 22.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.327 1.051 . . . . 0.0 113.488 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -42.54 -53.4 4.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.197 1.799 . . . . 0.0 112.04 167.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.714 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.12 -31.88 0.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.369 1.068 . . . . 0.0 112.63 -167.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.38 52.52 2.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.653 1.181 . . . . 0.0 108.664 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.417 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -146.47 -57.49 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 126.197 1.799 . . . . 0.0 109.606 -176.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 72.6 Cg_endo -71.47 -37.18 5.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.834 1.689 . . . . 0.0 112.122 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 m -56.04 -35.73 42.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.935 0.894 . . . . 0.0 112.304 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -63.33 -38.29 90.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.54 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -129.5 76.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.823 1.249 . . . . 0.0 109.6 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 124.903 1.281 . . . . 0.0 111.388 -172.65 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 . . . . . 0 C--O 1.238 0.452 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 179.21 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.17 139.26 51.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 167.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.1 158.11 34.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.491 1.116 . . . . 0.0 108.461 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.7 t -142.19 127.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.411 1.085 . . . . 0.0 109.919 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CG2' HD11 ' A' ' 114' ' ' ILE . 8.9 mt -149.48 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 125.659 1.583 . . . . 0.0 107.736 -167.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -79.77 174.65 11.37 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.347 -1.471 . . . . 0.0 112.476 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 57.02 20.12 5.19 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.109 2.564 . . . . 0.0 115.036 167.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 111' ' ' ILE . 38.6 mt -55.61 125.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.512 -1.368 . . . . 0.0 108.257 174.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.52 -34.56 1.96 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.063 1.316 . . . . 0.0 111.721 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -41.94 98.98 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.658 2.229 . . . . 0.0 110.469 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -83.48 16.72 2.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.915 1.686 . . . . 0.0 112.178 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -49.53 -39.74 35.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.644 1.565 . . . . 0.0 111.518 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.12 -49.8 6.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.544 0.738 . . . . 0.0 110.346 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -67.35 -24.02 65.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -55.66 141.32 38.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.544 1.138 . . . . 0.0 112.123 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -138.07 -82.0 0.33 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.817 0.847 . . . . 0.0 109.648 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.04 -12.45 60.33 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -60.0 3.64 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 111.482 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.7 mp -35.89 -58.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 126.164 1.786 . . . . 0.0 112.338 170.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.31 -51.49 65.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.206 0.527 . . . . 0.0 110.188 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.56 83.65 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.472 -171.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.92 -46.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 121.878 -0.514 . . . . 0.0 110.148 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -52.31 -36.21 52.6 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.901 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -27.31 66.93 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 m -100.47 -31.72 11.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 116.669 -1.634 . . . . 0.0 111.49 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.74 -18.87 57.26 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.228 1.831 . . . . 0.0 111.505 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -68.33 -29.57 68.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.649 1.579 . . . . 0.0 110.082 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.6 m -63.82 142.33 98.07 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 126.435 1.894 . . . . 0.0 106.869 172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.21 16.67 0.29 Allowed 'Trans proline' 0 CA--C 1.541 0.867 1 C-N-CA 126.173 4.582 . . . . 0.0 111.608 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.79 -161.44 11.9 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -155.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.7 177.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.101 0.953 . . . . 0.0 109.808 -140.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.3 mt -137.25 103.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 1 N-CA-C 99.614 -4.217 . . . . 0.0 99.614 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 141.31 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.6 133.76 50.96 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.35 45.4 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.463 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.434 HG21 ' HE2' ' A' ' 14' ' ' LYS . 40.0 m -129.32 123.29 31.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.446 0.698 . . . . 0.0 109.177 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.67 165.46 32.93 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.945 1.698 . . . . 0.0 108.809 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.54 165.46 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.378 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.94 142.4 76.3 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.525 1.13 . . . . 0.0 108.518 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.35 104.09 1.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 121.409 1.406 . . . . 0.0 111.331 -156.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -99.44 162.04 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.479 1.112 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -24.88 -77.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 127.25 2.357 . . . . 0.0 114.967 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 138.08 22.63 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.86 164.23 35.42 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.809 1.673 . . . . 0.0 109.512 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.06 171.59 7.29 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.704 1.601 . . . . 0.0 109.31 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.53 -77.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 114.032 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 114' ' ' ILE . 1.7 tm? -59.02 -33.09 70.34 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.68 -35.54 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 O-C-N 121.149 -0.969 . . . . 0.0 110.412 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.46 -23.08 65.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.39 1.476 . . . . 0.0 111.291 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -70.67 -42.36 70.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.737 1.153 . . . . 0.0 109.542 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.07 -48.28 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.769 0.828 . . . . 0.0 109.654 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.44 -22.24 66.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 110.486 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -28.56 68.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.994 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -65.63 -34.15 77.56 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.766 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? 67.66 -57.15 0.46 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.183 2.593 . . . . 0.0 111.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.87 77.68 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.248 1.819 . . . . 0.0 107.693 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.73 135.99 48.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 128.748 2.819 . . . . 0.0 105.064 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.87 136.76 38.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 164.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.33 96.8 4.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 120.157 1.344 . . . . 0.0 107.767 170.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.451 ' HB3' HD11 ' A' ' 176' ' ' LEU . 32.4 m-85 -76.95 104.36 7.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.802 0.81 . . . . 0.0 109.039 173.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.71 106.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 160.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.14 154.05 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 167.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 22.5 p -102.88 159.93 15.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 157.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.22 -16.98 56.91 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.602 166.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -98.38 -56.77 2.37 Favored 'General case' 0 N--CA 1.458 -0.038 0 CA-C-N 118.386 0.539 . . . . 0.0 111.147 -166.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.5 17.66 5.19 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.484 1.114 . . . . 0.0 110.121 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -40.91 -46.11 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.283 1.833 . . . . 0.0 111.595 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.8 6.16 9.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 114.204 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.23 43.43 3.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.438 1.895 . . . . 0.0 109.887 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 166' ' ' PHE . 9.6 tp -118.68 -42.2 2.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.23 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.96 -55.41 6.18 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.867 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.22 -27.21 56.4 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.419 1.9 . . . . 0.0 113.398 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -72.66 -42.07 64.73 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.704 1.202 . . . . 0.0 109.804 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.76 -52.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.912 1.685 . . . . 0.0 108.486 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.55 -44.01 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.388 0.994 . . . . 0.0 109.686 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.2 m -62.03 -49.22 76.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.898 0.772 . . . . 0.0 109.703 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.4 -42.17 91.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.504 1.122 . . . . 0.0 112.151 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.51 -53.74 29.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.576 1.951 . . . . 0.0 109.529 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -68.07 -23.49 64.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.849 0.86 . . . . 0.0 111.544 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.08 -52.45 4.27 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 127.698 2.399 . . . . 0.0 112.685 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 CA--C 1.54 0.58 0 CA-C-N 120.052 1.296 . . . . 0.0 110.891 -158.764 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 163' ' ' VAL . 27.4 m-70 -64.42 146.75 54.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.934 1.694 . . . . 0.0 109.249 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -127.55 144.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD2' HG13 ' A' ' 163' ' ' VAL . 15.1 m-85 -141.38 123.05 15.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.401 0.68 . . . . 0.0 110.784 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.468 HD21 HD11 ' A' ' 180' ' ' ILE . 11.1 mt -70.4 152.5 44.01 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 t -152.93 -174.7 5.02 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.07 176.55 15.15 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.086 1.803 . . . . 0.0 111.316 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -73.98 156.02 47.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.528 2.152 . . . . 0.0 109.464 164.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 154.71 48.87 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.566 2.178 . . . . 0.0 111.103 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.96 8.51 6.38 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.315 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.274 82.2 t 66.29 120.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 127.536 2.334 . . . . 0.0 111.341 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.9 29.75 14.74 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.75 1.167 . . . . 0.0 112.586 -173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -63.77 -49.07 74.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.153 1.477 . . . . 0.0 111.838 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -45.13 -38.78 5.44 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.566 1.947 . . . . 0.0 111.221 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.3 m -49.31 -43.57 43.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.163 1.785 . . . . 0.0 111.9 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -32.79 64.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.165 1.348 . . . . 0.0 110.345 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.37 -45.13 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -50.6 72.57 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.957 1.703 . . . . 0.0 109.15 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.3 mttm -65.97 -34.4 78.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.994 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.25 60.5 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.734 1.152 . . . . 0.0 111.62 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -71.58 -48.93 45.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.354 0.662 . . . . 0.0 111.117 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.03 -33.88 69.45 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.34 1.056 . . . . 0.0 111.64 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 20' ' ' LYS . 53.0 t -58.67 -53.71 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.419 1.488 . . . . 0.0 108.431 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.53 -38.9 89.1 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.456 0.703 . . . . 0.0 109.823 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HA ' HG12 ' A' ' 30' ' ' VAL . 11.9 mttt -59.74 -43.48 94.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.911 0.778 . . . . 0.0 110.25 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -23.27 56.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.366 1.066 . . . . 0.0 111.837 169.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 m -97.72 18.08 16.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.825 2.05 . . . . 0.0 115.487 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.09 35.12 86.6 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.811 1.187 . . . . 0.0 111.435 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.4 p -71.24 158.79 87.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 120.846 -1.385 . . . . 0.0 109.884 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.23 101.7 0.63 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.588 2.859 . . . . 0.0 110.249 145.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 30' ' ' VAL . 18.6 t -105.11 149.62 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 -179.03 7.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.533 0.733 . . . . 0.0 110.085 155.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.35 -151.0 22.31 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.893 1.235 . . . . 0.0 110.034 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' CZ ' HG23 ' A' ' 111' ' ' ILE . 55.2 p90 -138.06 174.25 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.185 1.794 . . . . 0.0 109.457 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -143.6 159.49 42.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -116.15 74.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -157.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -71.89 137.97 47.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.861 0.838 . . . . 0.0 110.772 -163.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -68.95 113.77 6.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.626 1.571 . . . . 0.0 108.554 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.18 91.08 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -109.42 102.38 11.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.34 62.18 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.94 0.896 . . . . 0.0 110.168 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 66.4 1.92 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -162.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.66 -22.12 15.25 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -169.43 0.83 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.569 1.685 . . . . 0.0 110.561 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 89.79 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.685 1.584 . . . . 0.0 111.354 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.44 -10.07 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.195 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 -167.96 40.96 Favored Glycine 0 C--N 1.337 0.583 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.7 158.65 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.033 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -137.73 159.64 41.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.841 1.656 . . . . 0.0 108.288 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -100.9 100.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 121.236 1.835 . . . . 0.0 107.806 169.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -82.25 123.8 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -89.19 163.45 15.41 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.188 -0.945 . . . . 0.0 108.546 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.56 -16.63 60.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 120.637 -1.29 . . . . 0.0 112.005 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 t -63.21 -36.89 85.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.689 1.131 . . . . 0.0 108.334 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.79 6.26 17.09 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.108 0.861 . . . . 0.0 112.465 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.6 25.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.432 ' C ' HD21 ' A' ' 90' ' ' LEU . 25.5 ptt180 -144.13 135.79 25.99 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.5 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.48 135.64 12.25 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.04 67.71 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 125.129 3.886 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.588 HD21 ' CE2' ' A' ' 87' ' ' PHE . 2.6 mt -55.36 -67.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 125.317 1.447 . . . . 0.0 112.719 -164.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 p -139.7 154.85 47.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.207 1.004 . . . . 0.0 110.657 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.07 159.72 43.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.268 1.827 . . . . 0.0 106.419 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 64' ' ' VAL . 3.8 m -54.9 160.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 121.913 -0.492 . . . . 0.0 110.457 160.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.67 -142.15 3.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.22 174.55 7.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.529 1.132 . . . . 0.0 109.915 164.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -124.24 156.88 66.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.216 1.406 . . . . 0.0 110.842 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.05 142.55 8.8 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.037 1.824 . . . . 0.0 110.544 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.79 166.26 20.81 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.115 2.543 . . . . 0.0 110.699 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.92 69.19 4.67 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.427 3.418 . . . . 0.0 112.931 -172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -55.35 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 125.447 1.499 . . . . 0.0 109.691 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -55.54 157.73 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.839 2.056 . . . . 0.0 110.15 163.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.93 153.74 37.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.667 1.987 . . . . 0.0 106.98 159.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -155.18 96.23 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 96.1 m 46.03 35.45 2.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.269 2.628 . . . . 0.0 115.665 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.19 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.542 -1.349 . . . . 0.0 108.008 -170.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.49 87.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 -67.78 1.36 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.823 1.201 . . . . 0.0 112.242 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -137.1 -36.0 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.151 2.18 . . . . 0.0 111.22 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.68 170.02 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.348 0.976 . . . . 0.0 108.937 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.59 120.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.555 HG22 ' H ' ' A' ' 83' ' ' ASP . 1.4 p -81.33 176.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.914 0.864 . . . . 0.0 110.136 170.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.555 ' H ' HG22 ' A' ' 82' ' ' VAL . 28.9 t70 -142.62 109.94 5.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -32.49 74.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.589 1.156 . . . . 0.0 109.609 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -54.0 -48.97 69.87 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.26 1.824 . . . . 0.0 108.618 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.6 t -55.88 -22.44 25.57 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 120.409 1.458 . . . . 0.0 113.316 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 61' ' ' LEU . 20.9 m-85 -79.11 -60.84 2.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.521 1.055 . . . . 0.0 109.182 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.51 -26.78 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.745 2.018 . . . . 0.0 113.139 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -61.8 -28.36 69.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 114.676 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -163.39 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.616 0.766 . . . . 0.0 112.924 -171.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.55 52.81 1.01 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.563 1.145 . . . . 0.0 108.798 166.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -140.62 -61.1 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 126.437 1.895 . . . . 0.0 108.444 -177.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -42.01 36.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.187 1.925 . . . . 0.0 112.459 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.28 -20.62 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.898 0.772 . . . . 0.0 113.037 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.74 74.28 6.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.19 94.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.443 2.697 . . . . 0.0 111.741 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 125.681 1.592 . . . . 0.0 108.132 174.1 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 120.464 0.173 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -142.47 170.34 15.89 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 127.209 2.204 . . . . 0.0 108.121 -169.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.19 128.27 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 36.6 t -108.85 154.22 22.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -137.73 123.35 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.616 0.767 . . . . 0.0 110.203 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.456 HG23 ' CZ ' ' A' ' 35' ' ' PHE . 21.4 mt -148.46 85.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.455 1.502 . . . . 0.0 108.693 -169.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -86.46 164.75 16.79 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.918 -1.739 . . . . 0.0 111.164 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 56.6 58.02 4.43 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.587 2.355 . . . . 0.0 111.992 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.3 mt -87.12 49.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 121.03 -1.044 . . . . 0.0 108.687 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.74 3.93 1.38 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-O 118.257 -1.302 . . . . 0.0 115.082 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -103.64 -77.76 0.56 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.455 2.127 . . . . 0.0 110.848 -173.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -52.46 -18.76 1.81 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.317 1.447 . . . . 0.0 113.771 168.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -32.24 -60.6 0.27 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.523 2.329 . . . . 0.0 113.105 -167.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.55 -29.34 69.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.318 0.963 . . . . 0.0 112.254 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -95.34 -17.64 21.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.807 1.643 . . . . 0.0 112.746 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.0 p -54.56 151.94 7.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.915 1.286 . . . . 0.0 110.88 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -132.54 -89.68 0.42 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.468 1.107 . . . . 0.0 109.27 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -56.08 -21.33 21.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 117.098 -1.43 . . . . 0.0 112.296 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -62.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 120.906 1.685 . . . . 0.0 110.707 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.402 HG23 ' HG3' ' A' ' 156' ' ' GLU . 3.5 mp -41.81 -58.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.135 1.374 . . . . 0.0 110.364 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -65.31 -39.15 92.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -166.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.05 -51.91 12.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.14 0.9 . . . . 0.0 108.936 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.57 -34.07 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 O-C-N 121.909 -0.494 . . . . 0.0 111.054 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.33 -43.45 61.73 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.217 169.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.19 -45.35 83.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.568 1.531 . . . . 0.0 111.167 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.7 m -65.74 -46.86 77.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.945 0.898 . . . . 0.0 110.892 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.2 mt -62.87 -25.7 68.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 110.938 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 t -76.9 -9.08 58.44 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.588 1.555 . . . . 0.0 110.766 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.0 m -91.41 134.24 29.92 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.34 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.949 2.432 . . . . 0.0 111.577 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.7 -32.57 49.93 Favored Glycine 0 C--O 1.218 -0.896 0 CA-C-O 117.242 -1.866 . . . . 0.0 112.811 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.0 m -66.74 138.69 57.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 122.101 2.951 . . . . 0.0 107.975 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -122.65 84.44 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 101.51 -3.515 . . . . 0.0 101.51 -166.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.98 117.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mt -102.87 133.09 48.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 151.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.68 171.23 29.06 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 44.2 m -122.23 101.67 7.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.906 0.853 . . . . 0.0 108.72 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.9 pt -86.35 151.22 53.32 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.036 0.934 . . . . 0.0 108.785 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.7 145.3 36.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.927 2.418 . . . . 0.0 110.043 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.86 139.65 93.63 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 165.27 32.5 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.171 2.581 . . . . 0.0 110.601 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.77 -38.24 0.28 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.154 0.981 . . . . 0.0 111.041 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.77 139.5 4.69 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.479 -1.849 . . . . 0.0 108.479 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.09 163.75 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.729 1.611 . . . . 0.0 113.505 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.44 165.76 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.53 3.486 . . . . 0.0 109.959 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.03 171.58 7.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.32 -82.58 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.797 0.726 . . . . 0.0 109.214 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.31 -40.88 65.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.25 -0.906 . . . . 0.0 113.166 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.86 -28.06 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.544 -0.722 . . . . 0.0 110.48 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.92 -32.05 72.41 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.915 0.78 . . . . 0.0 109.632 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 125' ' ' ILE . 64.8 mm-40 -60.98 -33.88 73.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.566 1.076 . . . . 0.0 112.137 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 108.54 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -59.05 -34.74 72.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.612 0.642 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.93 -25.71 58.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.219 1.807 . . . . 0.0 112.809 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.828 1.195 . . . . 0.0 111.483 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -54.47 0.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.782 2.033 . . . . 0.0 113.758 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -72.3 42.91 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.691 2.796 . . . . 0.0 111.486 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 3' ' ' HIS . 1.9 t -120.66 103.21 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 130.503 3.521 . . . . 0.0 104.796 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.45 131.97 48.67 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.05 116.78 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.236 1.014 . . . . 0.0 109.159 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -106.17 82.09 1.71 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.578 2.351 . . . . 0.0 107.664 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 117.81 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 120.906 -1.121 . . . . 0.0 108.102 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.49 HG23 HD13 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -81.43 153.78 4.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 p -110.7 158.22 18.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -66.32 -19.01 65.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.25 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -83.29 -38.02 22.68 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 118.099 0.409 . . . . 0.0 111.18 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.11 15.18 19.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.699 1.2 . . . . 0.0 111.325 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -49.49 -52.13 31.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.314 1.046 . . . . 0.0 109.315 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.3 4.57 2.78 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -124.47 3.4 8.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.132 0.973 . . . . 0.0 113.127 172.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.49 HD13 HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -83.2 -19.11 37.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.398 0.999 . . . . 0.0 113.624 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -56.01 26.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.52 -1.228 . . . . 0.0 110.183 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.37 -27.15 63.12 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.623 1.615 . . . . 0.0 113.302 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.76 -40.67 75.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.601 1.16 . . . . 0.0 109.435 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.468 HD11 HD21 ' A' ' 6' ' ' LEU . 25.9 mt -63.95 -53.05 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.701 1.2 . . . . 0.0 107.977 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.25 -42.71 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.695 1.198 . . . . 0.0 109.767 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -55.13 39.13 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 125.479 1.512 . . . . 0.0 108.857 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 9.1 t -52.99 -41.3 64.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.123 0.874 . . . . 0.0 111.311 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.92 -53.51 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.691 1.196 . . . . 0.0 108.994 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -62.52 -34.59 77.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.075 1.307 . . . . 0.0 113.124 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.3 m -64.9 8.25 0.13 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 129.987 3.315 . . . . 0.0 113.482 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.2 p . . . . . 0 C--O 1.236 0.359 0 O-C-N 120.856 -1.153 . . . . 0.0 108.156 172.015 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -50.37 156.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.088 2.155 . . . . 0.0 111.214 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.1 t -141.7 143.17 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -142.92 161.83 37.09 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.97 1.708 . . . . 0.0 110.006 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -98.25 157.57 16.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 160.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -141.78 -178.96 5.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.815 1.646 . . . . 0.0 107.469 162.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.86 -170.73 14.99 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.02 115.86 4.51 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.356 2.704 . . . . 0.0 108.669 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.32 97.28 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.654 1.569 . . . . 0.0 110.601 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.39 -57.95 16.75 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t 176.09 -45.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 129.086 2.954 . . . . 0.0 109.309 163.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.44 8.99 30.42 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 123.706 0.669 . . . . 0.0 114.22 -167.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE3' ' H ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -57.64 -38.67 75.43 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.728 1.264 . . . . 0.0 111.759 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.472 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 55.0 m -64.8 -37.12 86.53 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.34 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -64.77 -33.58 76.31 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.498 1.499 . . . . 0.0 110.222 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.664 HD13 ' HB3' ' A' ' 176' ' ' LEU . 59.9 mt -60.65 -57.52 12.35 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.199 0.599 . . . . 0.0 109.754 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 mm -70.76 -38.39 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 122.989 0.516 . . . . 0.0 109.693 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.93 -61.93 1.86 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.159 2.184 . . . . 0.0 108.587 172.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.3 -32.15 72.85 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.435 -1.269 . . . . 0.0 111.853 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.31 78.45 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 120.16 1.346 . . . . 0.0 109.265 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.434 ' C ' ' HE3' ' A' ' 26' ' ' LYS . 58.7 p -70.96 -45.1 64.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.097 -0.954 . . . . 0.0 108.991 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.35 -37.54 70.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.49 1.495 . . . . 0.0 112.139 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.56 -54.85 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 125.879 1.672 . . . . 0.0 108.848 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.18 -32.94 74.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.76 -0.588 . . . . 0.0 109.92 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 30' ' ' VAL . 26.8 mtmt -62.68 -36.39 82.77 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.008 -1.683 . . . . 0.0 110.738 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -38.13 85.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 110.081 165.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.52 5.36 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.121 1.369 . . . . 0.0 114.251 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.16 52.56 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 120.274 1.397 . . . . 0.0 111.662 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.5 p -55.03 142.06 57.79 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.62 94.26 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.316 1.344 . . . . 0.0 109.086 160.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.15 139.58 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.268 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.02 169.6 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.461 1.505 . . . . 0.0 107.818 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.44 25.74 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -143.83 162.93 34.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.002 1.321 . . . . 0.0 107.513 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -140.59 110.28 6.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.402 ' CG2' HD22 ' A' ' 61' ' ' LEU . 9.1 m -70.23 134.41 48.01 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.05 44.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.52 -0.737 . . . . 0.0 110.832 -171.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.34 146.15 50.69 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -122.58 105.22 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -123.14 80.06 1.73 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 126.486 1.915 . . . . 0.0 110.005 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -65.04 -24.26 67.43 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.836 -1.165 . . . . 0.0 112.666 -166.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.97 45.64 0.73 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 166.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.31 89.24 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.717 -1.046 . . . . 0.0 114.21 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.64 124.7 46.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 119.55 1.675 . . . . 0.0 108.459 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -60.75 92.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.675 1.59 . . . . 0.0 110.608 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.64 -16.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 111.127 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.49 -166.17 39.37 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -130.9 160.98 32.87 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.084 1.753 . . . . 0.0 106.404 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.86 161.49 30.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.775 2.03 . . . . 0.0 105.998 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.97 110.02 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 167.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.32 162.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.976 1.262 . . . . 0.0 108.06 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -125.43 160.0 30.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.011 1.324 . . . . 0.0 108.154 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.9 mm? -68.18 -21.38 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.452 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -62.25 -26.48 68.41 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.63 1.105 . . . . 0.0 111.062 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.01 5.77 57.22 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.187 1.375 . . . . 0.0 111.864 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -84.34 159.77 20.82 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 120.987 -1.302 . . . . 0.0 107.774 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 147.83 26.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -174.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -145.82 -178.09 21.03 Favored Glycine 0 CA--C 1.521 0.44 0 O-C-N 123.948 0.78 . . . . 0.0 112.726 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.24 169.31 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.737 2.958 . . . . 0.0 112.429 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 7.6 tp -150.0 -66.93 0.21 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.98 -1.075 . . . . 0.0 109.705 161.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -150.11 125.62 10.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -128.55 165.71 20.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.617 1.167 . . . . 0.0 108.198 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.6 120.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.73 -119.73 2.06 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.77 157.3 47.19 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.39 1.476 . . . . 0.0 107.44 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -86.65 166.43 27.4 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.641 1.576 . . . . 0.0 110.808 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.77 139.47 14.01 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.434 2.756 . . . . 0.0 108.699 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.43 172.22 14.83 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.766 2.311 . . . . 0.0 110.765 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.21 99.54 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.86 1.706 . . . . 0.0 108.245 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.44 -79.11 0.35 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 124.902 1.239 . . . . 0.0 110.494 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.73 125.56 23.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.364 1.082 . . . . 0.0 108.752 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 138.47 32.56 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.62 -163.16 1.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.42 -178.31 3.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 157.41 167.16 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 131.133 3.773 . . . . 0.0 105.849 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 -13.21 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 123.866 0.729 . . . . 0.0 109.663 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.96 134.43 3.57 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.044 -2.822 . . . . 0.0 106.044 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.51 -68.02 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.626 2.37 . . . . 0.0 111.571 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.03 149.38 30.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.857 1.663 . . . . 0.0 108.205 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 2.1 p -121.01 132.05 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.45 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.773 0.829 . . . . 0.0 110.275 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -154.39 105.39 2.66 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -21.62 65.06 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.149 -0.97 . . . . 0.0 111.865 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.1 m -37.24 -45.82 0.68 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.526 1.93 . . . . 0.0 112.243 156.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 p -76.66 -34.43 58.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.395 0.998 . . . . 0.0 109.175 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 14.5 m-85 -60.2 -41.81 93.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.98 -1.075 . . . . 0.0 109.718 173.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 92' ' ' LEU . 11.2 pt-20 -76.84 -9.1 58.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.832 1.196 . . . . 0.0 113.625 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.46 -68.18 0.38 Allowed 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 161.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 59' ' ' GLY . 2.1 mp -102.22 -44.8 5.32 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.814 -0.554 . . . . 0.0 111.539 -158.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.48 49.3 1.77 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.463 1.905 . . . . 0.0 108.553 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.852 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -134.52 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 109.864 -176.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 41.1 Cg_endo -65.61 -33.47 45.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.883 1.722 . . . . 0.0 112.517 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -59.82 -24.73 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.533 1.133 . . . . 0.0 112.868 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.06 -11.17 60.45 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.301 0.501 . . . . 0.0 111.269 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 88.02 1.99 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.321 -0.649 0 C-N-CA 123.86 0.864 . . . . 0.0 109.166 167.059 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 121.924 0.868 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' HD3' ' H ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -60.61 164.9 4.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.517 1.127 . . . . 0.0 108.812 172.122 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.69 146.82 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 139' ' ' ILE . 5.7 p -115.84 163.78 15.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.938 0.875 . . . . 0.0 110.449 161.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.8 125.88 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.508 HD13 ' CG2' ' A' ' 128' ' ' VAL . 2.5 mt -141.52 74.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.04 167.47 21.75 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.88 27.95 10.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 114.103 164.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 153' ' ' LEU . 16.7 mt -70.14 75.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.186 1.394 . . . . 0.0 108.227 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.2 -47.58 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.826 -1.171 . . . . 0.0 113.45 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -69.75 -40.14 76.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.345 2.073 . . . . 0.0 111.914 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -12.72 60.94 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 116.291 -1.814 . . . . 0.0 112.618 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -47.07 -24.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -156.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 -22.19 13.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.426 1.09 . . . . 0.0 112.119 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -99.06 -29.01 13.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.964 1.706 . . . . 0.0 109.745 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -45.45 114.5 0.76 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.803 2.841 . . . . 0.0 108.348 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.13 -86.59 0.5 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 119.864 1.211 . . . . 0.0 111.16 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.852 HD11 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -69.54 -10.35 57.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.934 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -53.06 -52.14 59.5 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 120.866 1.666 . . . . 0.0 112.151 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mt -39.17 -54.63 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 127.384 2.274 . . . . 0.0 112.552 164.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -63.63 -54.26 38.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.904 1.229 . . . . 0.0 110.593 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.48 -49.26 78.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 123.24 0.338 . . . . 0.0 111.095 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.508 ' CG2' HD13 ' A' ' 111' ' ' ILE . 2.5 p -65.62 -30.06 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.907 0.883 . . . . 0.0 111.611 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -40.02 60.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.493 168.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -38.07 86.9 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.663 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.51 -48.8 63.45 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.923 1.238 . . . . 0.0 110.472 175.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 139' ' ' ILE . 12.3 mt -58.02 -32.47 67.98 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.464 1.906 . . . . 0.0 111.98 -175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.5 m -129.32 30.24 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.62 1.568 . . . . 0.0 110.019 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.437 HG23 ' HD2' ' A' ' 135' ' ' PRO . 1.3 m -76.45 165.1 55.39 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 149.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 134' ' ' THR . 44.3 Cg_endo -87.33 126.48 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.541 2.828 . . . . 0.0 109.298 168.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.07 89.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 116.929 -2.039 . . . . 0.0 116.263 158.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 m -72.14 166.9 21.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 121.827 2.814 . . . . 0.0 108.492 155.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.0 mt -131.83 104.25 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.539 HD13 ' SG ' ' A' ' 109' ' ' CYS . 41.2 mm -67.5 132.08 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.42 1.075 . . . . 0.0 108.117 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tp -140.56 136.06 32.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 107.82 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.61 41.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 113.341 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -128.56 130.73 47.8 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.169 0.987 . . . . 0.0 108.863 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.73 163.87 18.22 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.967 1.707 . . . . 0.0 108.152 165.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.01 161.07 11.72 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.37 2.713 . . . . 0.0 111.332 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.61 139.34 93.95 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 165.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.01 159.5 33.99 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.489 2.793 . . . . 0.0 108.891 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -142.3 -65.94 0.4 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.81 -122.93 0.94 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 125.208 1.385 . . . . 0.0 111.096 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.402 ' HE3' ' CA ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -62.52 171.1 1.88 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.38 172.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.52 168.0 19.3 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.271 1.314 . . . . 0.0 109.099 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.54 137.07 52.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.84 -63.36 1.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.93 0.892 . . . . 0.0 111.751 -156.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 114' ' ' ILE . 3.5 tp -62.95 -40.8 98.75 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 114' ' ' ILE . 76.4 t -65.93 -28.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.686 -0.634 . . . . 0.0 110.269 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.83 -29.92 63.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.724 0.81 . . . . 0.0 110.807 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.17 -38.79 90.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.539 1.063 . . . . 0.0 112.095 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.95 -41.94 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.86 1.264 . . . . 0.0 108.338 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -18.36 65.34 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.087 -1.633 . . . . 0.0 111.532 -174.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.76 -22.01 61.66 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.825 0.739 . . . . 0.0 110.273 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -73.9 83.93 1.7 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.35 -28.77 69.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.851 -1.156 . . . . 0.0 109.305 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -76.12 56.62 1.03 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.47 3.108 . . . . 0.0 110.651 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.77 126.5 62.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 105.05 1.34 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 161.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.1 t -88.91 98.1 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -68.41 147.24 52.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.77 125.06 48.36 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.67 159.87 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 167.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 p -128.13 149.76 50.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -58.23 -16.08 12.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.953 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -80.68 -68.75 0.65 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.195 0.907 . . . . 0.0 108.569 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.19 28.46 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.887 1.275 . . . . 0.0 109.523 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -59.58 -23.44 62.94 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.24 9.75 21.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.749 1.62 . . . . 0.0 112.057 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.63 -13.48 15.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 115.94 -1.981 . . . . 0.0 113.86 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.664 ' HB3' HD13 ' A' ' 17' ' ' LEU . 1.1 tt -84.58 -20.04 32.11 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 116.167 -2.213 . . . . 0.0 111.795 -154.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 17' ' ' LEU . 12.1 tp -25.27 -64.99 0.1 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 128.872 2.869 . . . . 0.0 113.529 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.09 -28.03 85.15 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.854 2.369 . . . . 0.0 113.18 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.84 -42.53 90.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.676 1.125 . . . . 0.0 109.538 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 6' ' ' LEU . 8.6 mt -68.62 -50.07 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 125.382 1.473 . . . . 0.0 108.032 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.83 -37.0 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.5 1.045 . . . . 0.0 111.035 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 86.8 m -60.46 -47.51 85.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 6.9 t -62.8 -29.02 70.4 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.004 0.82 . . . . 0.0 111.344 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.65 -52.19 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.232 1.013 . . . . 0.0 110.316 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -34.4 71.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.98 1.264 . . . . 0.0 111.368 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 -8.81 48.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.677 1.991 . . . . 0.0 111.813 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 O-C-N 120.647 -1.283 . . . . 0.0 111.452 166.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 123.25 1.5 . . . . 0.0 107.555 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.617 ' HB2' HG12 ' A' ' 163' ' ' VAL . 24.2 m-70 -72.99 149.61 43.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.99 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.5 t -126.78 133.85 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.499 ' CE1' HG21 ' A' ' 157' ' ' ILE . 15.6 m-85 -136.37 121.16 18.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.501 0.667 . . . . 0.0 110.611 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.21 155.75 34.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.908 1.283 . . . . 0.0 109.101 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -161.46 -179.43 7.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.978 164.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.57 -107.29 1.12 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.383 1.944 . . . . 0.0 109.465 170.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.06 174.67 8.57 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.811 3.007 . . . . 0.0 111.746 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.21 -177.8 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.817 2.344 . . . . 0.0 110.681 164.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.73 55.44 1.32 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 126.764 2.126 . . . . 0.0 110.771 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.27 52.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.004 1.321 . . . . 0.0 107.857 156.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.63 59.78 1.41 Allowed Glycine 0 C--N 1.335 0.481 0 O-C-N 119.801 -1.812 . . . . 0.0 110.364 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -38.99 4.15 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.5 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.2 m -55.44 -44.0 75.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.71 1.204 . . . . 0.0 109.893 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.7 m -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.355 -1.466 . . . . 0.0 113.295 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -44.54 72.39 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 120.722 1.601 . . . . 0.0 108.559 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.34 -37.41 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.945 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -53.12 -47.81 68.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.386 0.994 . . . . 0.0 110.361 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -30.41 70.68 Favored 'General case' 0 C--O 1.227 -0.088 0 O-C-N 122.338 -0.226 . . . . 0.0 110.95 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -27.2 69.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.379 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.9 p -74.91 -53.38 9.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.656 1.116 . . . . 0.0 108.02 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -48.88 -45.47 41.21 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.582 1.953 . . . . 0.0 112.11 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.64 -45.51 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.258 0.551 . . . . 0.0 110.956 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 108' ' ' VAL . 84.1 mt -69.69 -37.0 76.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.024 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.77 -43.66 81.02 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -26.77 67.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.667 1.187 . . . . 0.0 112.81 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -5.73 53.45 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.761 0.824 . . . . 0.0 112.092 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.12 88.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.763 1.173 . . . . 0.0 113.643 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.32 127.6 85.99 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 119.589 1.694 . . . . 0.0 107.681 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.98 130.31 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.844 2.363 . . . . 0.0 109.577 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.65 137.6 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.78 167.87 16.68 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.528 1.531 . . . . 0.0 107.673 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 94' ' ' VAL . . . 129.92 -160.76 22.93 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.35 165.44 27.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -128.09 -178.6 4.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 162.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -140.12 137.43 34.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.35 156.3 44.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.56 111.97 7.29 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.72 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.71 124.91 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -124.61 125.42 44.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.91 1.684 . . . . 0.0 107.627 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -69.18 -39.4 78.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.944 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.21 39.16 0.41 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.969 1.747 . . . . 0.0 109.545 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.14 26.07 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.536 1.541 . . . . 0.0 114.855 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 142.84 35.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.816 1.308 . . . . 0.0 110.833 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -64.82 129.98 41.76 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 125.162 1.538 . . . . 0.0 111.539 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.5 pt -137.23 -11.77 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.874 1.67 . . . . 0.0 112.973 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.18 -167.37 36.09 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 119.255 0.934 . . . . 0.0 112.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -139.26 123.97 18.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.127 2.171 . . . . 0.0 106.79 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.74 144.72 25.4 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.37 111.96 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 119.729 1.15 . . . . 0.0 108.367 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.34 110.46 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.603 0.361 . . . . 0.0 110.056 -152.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -74.74 155.65 37.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.713 1.244 . . . . 0.0 108.808 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.8 mm? -69.19 -13.63 62.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.103 169.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.98 9.85 15.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.904 1.682 . . . . 0.0 111.791 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.1 82.4 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 120.738 -1.226 . . . . 0.0 114.27 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.21 161.21 19.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.839 1.319 . . . . 0.0 107.589 169.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.98 144.38 26.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 117.737 -1.125 . . . . 0.0 109.534 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.94 154.19 21.23 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.16 1.345 . . . . 0.0 111.89 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.07 66.98 8.76 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.022 3.815 . . . . 0.0 111.98 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -57.8 8.9 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 126.761 2.024 . . . . 0.0 111.128 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.87 141.38 29.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.02 164.65 31.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.086 0.954 . . . . 0.0 109.55 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.62 136.79 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.21 165.55 30.37 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.753 -2.939 . . . . 0.0 105.753 171.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 165.54 13.64 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -69.04 153.41 96.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.658 -0.652 . . . . 0.0 109.67 166.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.17 125.56 10.4 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.735 2.957 . . . . 0.0 110.98 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.01 174.84 11.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.557 2.838 . . . . 0.0 111.446 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.65 125.61 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 108.835 -1.256 . . . . 0.0 108.835 169.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.31 5.2 82.9 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.833 -0.981 . . . . 0.0 114.755 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 132.59 20.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.189 1.995 . . . . 0.0 105.618 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -152.55 -179.46 7.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 164.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.89 -160.8 1.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 7.4 m -88.84 160.66 17.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.653 1.115 . . . . 0.0 108.879 162.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 158.91 40.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -165.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.98 99.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 32.16 81.32 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.104 2.288 . . . . 0.0 115.605 166.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 97.06 -57.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.431 0 C-N-CA 130.168 3.387 . . . . 0.0 109.554 -171.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -82.58 155.98 24.19 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.917 -0.489 . . . . 0.0 110.346 -169.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.92 133.58 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 165.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.0 167.84 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.81 116.0 7.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.229 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -27.6 66.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.233 0.47 . . . . 0.0 111.247 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -41.18 -47.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.136 1.774 . . . . 0.0 111.103 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.8 p -70.15 -36.69 74.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.538 -0.726 . . . . 0.0 111.135 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.39 -52.01 67.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -66.69 -10.11 43.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.922 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.61 -38.25 83.69 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 120.717 -1.24 . . . . 0.0 113.05 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 -41.62 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.609 0.64 . . . . 0.0 110.129 -167.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.32 53.38 2.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.013 0.925 . . . . 0.0 109.441 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 12.2 mt -116.4 -66.09 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.66 1.184 . . . . 0.0 109.325 156.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 98.8 Cg_endo -69.43 -11.11 30.54 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.798 2.332 . . . . 0.0 113.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -67.64 -26.06 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.143 -1.598 . . . . 0.0 110.651 172.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.8 -13.53 60.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.537 1.135 . . . . 0.0 111.634 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -179.44 119.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.824 2.45 . . . . 0.0 109.154 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 127.427 2.291 . . . . 0.0 107.308 176.616 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 122.399 1.095 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -108.01 172.47 6.82 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.536 2.335 . . . . 0.0 108.886 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 25' ' ' LEU . 29.6 t -135.35 149.48 28.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.8 t -123.27 107.75 12.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.4 0.68 . . . . 0.0 109.351 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.1 124.88 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.431 1.092 . . . . 0.0 108.305 165.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -142.26 125.18 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -145.26 -179.39 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.417 -0.802 . . . . 0.0 109.665 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.27 40.64 10.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.752 1.621 . . . . 0.0 110.573 -167.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.51 78.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.38 -83.77 0.05 OUTLIER Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -61.34 -19.15 61.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.167 1.484 . . . . 0.0 113.98 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 89.3 mmm -76.31 7.06 4.66 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.196 -1.383 . . . . 0.0 112.526 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -47.68 -26.82 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.12 -18.76 12.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.361 1.064 . . . . 0.0 111.912 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -19.97 18.03 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.648 0.779 . . . . 0.0 110.568 -171.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 m -50.17 116.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.556 1.543 . . . . 0.0 107.963 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.21 -80.7 0.37 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.256 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.44 -23.95 66.21 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.82 1.191 . . . . 0.0 110.694 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -65.12 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.907 2.083 . . . . 0.0 111.472 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -39.45 -62.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 126.204 1.802 . . . . 0.0 111.932 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.81 -50.8 72.4 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.43 0.559 . . . . 0.0 110.641 -172.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.45 -50.14 68.69 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.181 0.992 . . . . 0.0 109.715 -170.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 HD13 ' A' ' 132' ' ' LEU . 82.4 t -60.24 -46.34 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.149 0.979 . . . . 0.0 108.466 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.055 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -58.01 -49.88 75.32 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.111 1.323 . . . . 0.0 110.941 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -63.24 -29.08 70.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.448 -0.783 . . . . 0.0 111.132 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.44 HD13 HG12 ' A' ' 128' ' ' VAL . 7.9 mp -70.6 -30.63 67.36 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.909 -1.12 . . . . 0.0 111.053 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -23.56 64.1 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.26 0.936 . . . . 0.0 110.934 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.8 m -79.96 133.7 57.7 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -32.67 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.21 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.45 -17.63 33.26 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.879 -1.512 . . . . 0.0 114.643 -166.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.6 m -77.72 165.55 24.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.107 2.453 . . . . 0.0 107.697 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.0 mt -136.94 101.83 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -172.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.3 mm -72.08 135.24 28.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.56 124.23 19.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.257 1.823 . . . . 0.0 106.988 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.12 28.81 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-N 120.909 1.686 . . . . 0.0 114.826 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -129.25 113.21 14.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.86 152.73 42.5 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.63 0.772 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -70.42 149.97 63.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.784 1.656 . . . . 0.0 108.476 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.03 126.07 92.21 Favored Pre-proline 0 N--CA 1.441 -0.906 0 O-C-N 121.925 -0.485 . . . . 0.0 110.617 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.18 108.39 2.47 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 108.328 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -152.8 -36.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.778 0.831 . . . . 0.0 110.126 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.28 -66.91 0.85 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.695 1.14 . . . . 0.0 111.512 -167.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 158.2 75.69 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 124.286 1.034 . . . . 0.0 108.242 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.38 149.51 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.956 3.104 . . . . 0.0 109.875 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.51 135.44 52.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -64.37 0.84 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.304 1.442 . . . . 0.0 111.528 -172.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.29 -35.4 75.46 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.648 -0.657 . . . . 0.0 111.417 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 -43.65 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 119.109 0.868 . . . . 0.0 109.4 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -55.43 -41.55 72.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -55.76 -28.81 57.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.667 1.121 . . . . 0.0 113.087 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.499 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.7 mt -100.14 -39.64 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.486 1.514 . . . . 0.0 109.415 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.19 62.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.768 1.227 . . . . 0.0 110.19 177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.71 -39.77 5.41 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 127.786 2.434 . . . . 0.0 112.769 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.77 -32.13 70.47 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.062 -1.023 . . . . 0.0 111.093 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.7 -36.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.63 2.372 . . . . 0.0 113.389 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -63.32 -30.19 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.548 1.539 . . . . 0.0 114.154 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 3' ' ' HIS . 2.2 m -55.2 130.37 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.124 1.329 . . . . 0.0 110.793 -169.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.47 ' HE3' ' CD1' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -55.15 115.81 2.44 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.67 102.08 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 171.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' HE3' ' A' ' 164' ' ' LYS . 32.0 m-85 -83.38 87.11 6.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 162.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -66.89 94.07 0.3 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 162.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 176' ' ' LEU . 3.1 p -64.89 167.08 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p -124.6 153.07 42.74 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 165.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -61.46 -14.4 28.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.616 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.19 -62.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.824 1.193 . . . . 0.0 108.696 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.36 18.92 3.49 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 124.601 1.16 . . . . 0.0 111.561 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -50.11 -43.84 51.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.979 -1.075 . . . . 0.0 113.305 -161.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -86.34 13.88 7.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.934 2.493 . . . . 0.0 114.806 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -131.66 16.94 4.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.511 1.924 . . . . 0.0 111.813 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 166' ' ' PHE . 10.6 tp -84.09 -42.98 15.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.094 172.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -42.88 -58.78 3.55 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.377 1.871 . . . . 0.0 110.781 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.8 -25.02 78.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.036 2.491 . . . . 0.0 115.44 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.8 -46.6 57.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.431 1.493 . . . . 0.0 108.247 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.79 -53.37 45.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.245 1.418 . . . . 0.0 109.847 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.88 -45.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.823 0.738 . . . . 0.0 109.691 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.2 m -57.9 -45.63 86.14 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.57 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.95 -40.59 76.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.016 1.28 . . . . 0.0 110.859 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.06 -51.61 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.338 1.055 . . . . 0.0 109.83 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -31.2 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.519 0.728 . . . . 0.0 112.116 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 m -57.05 -51.72 68.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.549 1.14 . . . . 0.0 108.197 170.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.541 0.611 0 O-C-N 120.554 -1.341 . . . . 0.0 113.818 178.243 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 3' ' ' HIS . 31.0 m-70 -67.07 158.45 31.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.008 1.723 . . . . 0.0 108.377 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.45 139.09 48.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' A' ' 141' ' ' GLY . 17.7 m-85 -130.63 136.74 49.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.281 1.032 . . . . 0.0 109.265 172.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 180' ' ' ILE . 16.2 mt -78.17 157.82 29.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -152.07 169.44 22.37 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.543 0.687 . . . . 0.0 110.887 163.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.94 -171.93 37.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.09 168.37 22.17 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.785 2.323 . . . . 0.0 110.104 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.51 160.08 49.55 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.836 1.691 . . . . 0.0 111.074 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 39.73 72.88 0.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 126.999 2.238 . . . . 0.0 112.937 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.319 0.9 OUTLIER -131.11 -2.54 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.551 0.741 . . . . 0.0 112.835 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.29 19.24 19.27 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.973 -1.079 . . . . 0.0 112.634 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -51.75 67.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.432 1.616 . . . . 0.0 109.265 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -64.36 -29.56 70.63 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.788 -0.625 . . . . 0.0 109.666 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -58.48 -47.57 83.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.836 1.198 . . . . 0.0 111.681 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -46.92 87.27 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -68.2 -38.51 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.272 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -55.9 21.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.148 1.379 . . . . 0.0 108.269 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -51.2 -42.82 61.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.065 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.81 57.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.368 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -60.9 -56.98 14.77 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.933 0.788 . . . . 0.0 108.982 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.84 -31.8 68.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.319 2.248 . . . . 0.0 110.982 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.75 -50.96 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.848 1.659 . . . . 0.0 110.537 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.56 -34.47 77.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.982 0.81 . . . . 0.0 109.311 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -71.08 -20.9 62.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.649 1.18 . . . . 0.0 113.199 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -86.8 -7.56 58.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.873 1.669 . . . . 0.0 111.82 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -114.4 2.66 14.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.789 1.236 . . . . 0.0 112.792 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.43 43.18 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 119.657 1.117 . . . . 0.0 112.07 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.15 108.19 24.52 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.26 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.335 2.69 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 32' ' ' VAL . 2.4 t -69.59 169.03 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.145 0.978 . . . . 0.0 109.987 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 162.48 39.97 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.994 154.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.97 -165.66 31.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.353 0.977 . . . . 0.0 111.032 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.08 168.09 20.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.452 0.644 . . . . 0.0 111.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -143.31 152.97 42.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 108.352 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.0 p -77.11 124.9 28.47 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 157.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -104.7 139.11 40.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 160.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -73.67 147.03 44.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.602 0.715 . . . . 0.0 110.052 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.41 98.7 4.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -125.53 153.39 43.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -128.29 -60.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.083 1.353 . . . . 0.0 107.728 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.57 31.87 8.21 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.703 1.62 . . . . 0.0 110.69 167.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.61 14.67 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.288 1.423 . . . . 0.0 114.409 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' H ' ' HD2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -80.27 142.89 34.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.498 1.649 . . . . 0.0 108.691 176.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -65.08 135.23 55.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.952 0.796 . . . . 0.0 108.893 171.53 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -124.67 -17.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.776 1.23 . . . . 0.0 111.997 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.09 -152.99 21.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.69 161.89 36.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.286 5.9 p30 -131.26 142.8 50.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 90' ' ' LEU . 2.4 p -90.28 93.55 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 125.457 1.503 . . . . 0.0 108.004 -173.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 t -84.97 147.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -107.23 162.89 13.48 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.751 1.22 . . . . 0.0 109.223 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -31.41 72.13 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.343 -0.848 . . . . 0.0 111.56 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.8 t -65.09 -25.29 67.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.229 1.011 . . . . 0.0 110.101 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.0 -2.64 44.5 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.666 -1.074 . . . . 0.0 112.976 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.9 m -60.74 151.09 30.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.3 1.55 . . . . 0.0 108.478 163.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 155.33 50.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.891 1.277 . . . . 0.0 111.685 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.615 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -139.22 164.71 25.85 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.034 0.834 . . . . 0.0 113.685 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.13 -2.56 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.945 3.097 . . . . 0.0 115.109 -165.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 24.93 -79.26 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.76 3.624 . . . . 0.0 115.311 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 p -130.2 147.87 51.98 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.006 0.821 . . . . 0.0 110.279 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -148.17 158.87 44.32 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.097 1.359 . . . . 0.0 108.67 -172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -62.57 148.76 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.44 71.55 0.02 OUTLIER Glycine 0 C--N 1.34 0.781 0 CA-C-N 119.487 1.039 . . . . 0.0 114.503 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.42 -159.34 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.789 1.236 . . . . 0.0 110.163 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.71 156.67 62.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.907 1.683 . . . . 0.0 109.848 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 132.72 22.39 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 110.7 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -66.7 175.64 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.651 2.234 . . . . 0.0 111.708 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.43 -36.43 15.55 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.05 1.833 . . . . 0.0 111.318 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.33 -59.31 6.37 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -168.42 1.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.438 0.619 . . . . 0.0 110.985 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.37 147.75 32.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.0 0.92 . . . . 0.0 109.314 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -165.01 -163.69 0.72 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.361 1.465 . . . . 0.0 107.668 151.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 78.4 m -109.61 110.73 21.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.423 1.889 . . . . 0.0 108.97 -172.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.69 136.67 53.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.966 1.257 . . . . 0.0 108.746 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 t -125.63 102.75 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 24.91 84.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 C-N-CA 128.139 2.781 . . . . 0.0 114.781 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 95.73 -59.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.675 3.59 . . . . 0.0 109.219 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.46 146.91 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.648 1.179 . . . . 0.0 109.761 -166.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.12 112.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 166.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ASP . 2.7 p -71.98 -179.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 O-C-N 121.266 -0.896 . . . . 0.0 109.012 166.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 86' ' ' SER . 6.2 t0 -150.75 145.64 25.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 161.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.5 -39.12 77.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.843 1.257 . . . . 0.0 107.709 167.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.6 m -54.02 -44.89 71.34 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.114 0.566 . . . . 0.0 109.875 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 70.6 m -64.31 -17.69 63.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.19 0.905 . . . . 0.0 112.43 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.24 -60.42 2.37 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.715 0.806 . . . . 0.0 109.928 161.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -45.05 -33.05 1.94 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.09 2.156 . . . . 0.0 113.525 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.65 -40.36 62.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.696 0.68 . . . . 0.0 112.021 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.615 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -140.48 -32.29 0.59 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -168.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 41.1 0.96 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.768 2.027 . . . . 0.0 109.557 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -137.82 -59.63 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 125.544 1.538 . . . . 0.0 108.496 -171.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 29.1 Cg_endo -57.48 -37.78 96.2 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.951 1.767 . . . . 0.0 111.926 170.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.4 m -55.64 -31.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.91 0.777 . . . . 0.0 112.435 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.69 -36.42 60.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.412 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -156.1 92.43 1.35 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.198 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.098 0.475 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -139.09 -179.38 5.82 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.547 1.139 . . . . 0.0 108.993 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.0 t -127.48 144.37 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.5 t -125.85 143.08 51.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.873 2.069 . . . . 0.0 106.977 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.3 t -138.96 132.87 40.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.28 135.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 33.5 t0 -133.06 -172.95 3.06 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.125 -1.609 . . . . 0.0 107.462 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 2.3 mm-40 56.45 -81.46 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 129.202 3.001 . . . . 0.0 110.675 -156.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.291 38.4 mt 53.98 -10.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 128.133 2.573 . . . . 0.0 112.944 -169.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 113' ' ' GLU . . . -83.46 -59.78 2.09 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.942 2.211 . . . . 0.0 111.103 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -52.54 -29.19 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.387 1.475 . . . . 0.0 114.035 -168.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.35 4.73 41.82 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.216 -1.373 . . . . 0.0 112.657 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -24.81 -64.24 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 129.108 2.963 . . . . 0.0 114.594 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.86 -34.31 17.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.928 0.491 . . . . 0.0 111.16 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.75 -27.34 61.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.571 1.148 . . . . 0.0 112.444 -169.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.3 p -51.16 120.48 5.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.367 1.867 . . . . 0.0 111.727 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.7 -92.92 0.52 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.74 -6.36 15.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.752 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -65.38 0.6 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.331 1.453 . . . . 0.0 110.386 171.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.5 mp -35.76 -59.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.158 1.783 . . . . 0.0 112.724 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -59.75 -52.12 66.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.48 87.54 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.83 -59.07 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.858 1.263 . . . . 0.0 109.253 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -57.9 -37.91 74.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.504 1.047 . . . . 0.0 111.913 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -34.44 76.8 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.804 -0.56 . . . . 0.0 110.712 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.406 ' CG2' HG21 ' A' ' 137' ' ' THR . 45.0 m -81.53 -30.29 33.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.27 0.941 . . . . 0.0 111.336 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.83 -21.33 63.07 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.41 1.005 . . . . 0.0 110.83 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 t -93.16 -8.97 41.0 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.458 2.303 . . . . 0.0 112.363 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.5 m -62.06 135.5 94.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.19 -36.32 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.401 2.067 . . . . 0.0 111.425 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.09 6.28 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.406 HG21 ' CG2' ' A' ' 131' ' ' THR . 58.9 m 43.52 166.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.784 2.434 . . . . 0.0 113.272 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.8 mt -144.91 114.0 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.9 131.69 34.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.4 96.46 5.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 158.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -113.95 171.9 14.05 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.26 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.4 m -134.63 134.22 40.97 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.34 156.93 66.3 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.712 1.605 . . . . 0.0 109.572 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.13 150.31 37.42 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.86 1.707 . . . . 0.0 110.209 169.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.69 151.75 60.82 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 123.77 0.828 . . . . 0.0 110.733 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.1 162.73 38.84 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.702 2.935 . . . . 0.0 108.901 166.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -156.97 -61.01 0.09 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -118.45 -118.67 2.84 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 151.85 88.77 Favored Pre-proline 0 C--O 1.237 0.436 0 CA-C-N 117.966 0.883 . . . . 0.0 111.329 -172.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -59.04 156.25 35.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.173 2.582 . . . . 0.0 109.936 167.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.95 139.38 49.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.057 1.343 . . . . 0.0 107.408 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -70.35 0.11 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.901 1.68 . . . . 0.0 113.174 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 tp -56.7 -39.77 74.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.522 -0.736 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.0 -31.13 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.218 0.917 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -61.78 -29.4 70.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.378 1.444 . . . . 0.0 110.289 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.07 -23.07 67.28 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.317 0.962 . . . . 0.0 112.089 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.05 -47.0 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -68.1 -11.55 59.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.989 -1.07 . . . . 0.0 112.393 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -76.58 -10.51 59.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 123.911 0.884 . . . . 0.0 113.144 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -74.56 87.54 2.12 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.728 1.149 . . . . 0.0 109.292 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 52.02 0.49 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.482 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -153.48 -12.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 111.2 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.51 137.84 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.566 -1.334 . . . . 0.0 109.965 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -73.47 134.46 43.92 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 164.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.7 t -115.22 79.49 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.466 ' CG ' HD21 ' A' ' 176' ' ' LEU . 6.2 m-85 -67.31 91.09 0.24 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.676 1.59 . . . . 0.0 110.765 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.75 147.18 52.36 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 164.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.539 HG22 ' H ' ' A' ' 169' ' ' THR . 1.8 p -122.31 171.69 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 123.253 1.501 . . . . 0.0 109.238 168.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.21 128.18 29.5 Favored 'General case' 0 N--CA 1.435 -1.214 1 C-N-CA 131.864 4.066 . . . . 0.0 102.888 -178.322 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -46.05 -24.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.288 1.835 . . . . 0.0 112.248 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.69 -70.76 0.41 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.911 0.884 . . . . 0.0 109.472 -172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.09 17.58 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.352 2.261 . . . . 0.0 111.852 -173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -52.5 -44.93 65.97 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -162.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -77.66 3.43 13.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -87.93 -8.04 56.3 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.608 1.163 . . . . 0.0 111.72 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.466 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -83.1 -34.34 26.15 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 120.672 1.578 . . . . 0.0 112.441 177.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -57.6 7.39 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.17 -1.395 . . . . 0.0 109.89 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.97 -27.48 58.2 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.179 1.814 . . . . 0.0 113.114 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.4 -42.35 65.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.343 0.974 . . . . 0.0 109.261 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 6' ' ' LEU . 15.6 mt -53.12 -55.86 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 125.313 1.445 . . . . 0.0 109.297 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.12 -33.84 66.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.785 0.72 . . . . 0.0 110.523 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 88.6 m -63.78 -48.96 74.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.876 0.87 . . . . 0.0 108.715 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -56.32 -37.24 69.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.161 1.384 . . . . 0.0 110.12 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.25 -55.92 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.988 0.915 . . . . 0.0 110.681 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.46 -21.46 65.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.722 1.146 . . . . 0.0 112.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 73.9 m -58.0 -33.78 69.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.261 0.937 . . . . 0.0 113.045 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 CA--C 1.539 0.54 0 CA-C-N 119.238 0.927 . . . . 0.0 112.42 175.315 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.435 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.516 ' HB2' HG12 ' A' ' 163' ' ' VAL . 7.9 m80 59.38 164.75 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.016 2.526 . . . . 0.0 112.116 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -138.74 139.96 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 O-C-N 120.139 -1.6 . . . . 0.0 107.953 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 20.3 m-85 -138.65 157.01 46.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.022 0.929 . . . . 0.0 110.993 168.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.811 HD11 HD11 ' A' ' 180' ' ' ILE . 2.8 mm? -111.04 131.02 55.41 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.627 1.171 . . . . 0.0 108.257 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.57 165.5 25.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.797 0.439 . . . . 0.0 110.375 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 68.56 1.61 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.01 1.29 . . . . 0.0 112.431 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.55 121.55 8.06 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 CA-C-N 120.652 2.226 . . . . 0.0 109.616 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.57 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.968 1.778 . . . . 0.0 113.148 -171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.47 15.59 6.35 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.141 -0.81 . . . . 0.0 111.726 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t 65.75 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.985 1.85 . . . . 0.0 109.412 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.43 -11.51 0.04 OUTLIER Glycine 0 CA--C 1.529 0.937 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.753 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -15.99 7.03 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.27 -1.135 . . . . 0.0 113.225 172.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -38.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.066 2.146 . . . . 0.0 110.608 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 m -71.05 -29.59 65.52 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.286 -0.884 . . . . 0.0 109.103 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 177' ' ' LEU . 69.5 mt -61.78 -52.81 62.7 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mm -58.96 -43.9 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -49.17 -63.59 1.06 Allowed 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -59.77 -36.68 77.17 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.67 0.606 . . . . 0.0 111.754 177.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.77 88.57 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 120.262 1.392 . . . . 0.0 109.723 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -67.89 -47.69 68.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.751 0.82 . . . . 0.0 109.458 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.3 -36.56 61.34 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.678 1.191 . . . . 0.0 112.234 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 20' ' ' LYS . 89.7 t -63.5 -45.32 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.592 -0.693 . . . . 0.0 110.494 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.17 -36.75 80.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.82 -44.74 90.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.4 t -58.76 -36.47 74.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.89 1.676 . . . . 0.0 110.446 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 t -77.24 -2.37 34.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.813 1.645 . . . . 0.0 112.556 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.04 13.04 72.38 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.589 1.086 . . . . 0.0 113.102 -174.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.8 122.95 87.36 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 119.247 1.524 . . . . 0.0 107.19 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.14 118.83 5.87 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.842 2.362 . . . . 0.0 109.63 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -115.66 141.12 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 107.761 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.09 167.88 16.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 163.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.11 -161.96 25.98 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -145.07 166.95 23.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.783 1.292 . . . . 0.0 111.794 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -137.43 177.82 7.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.445 1.02 . . . . 0.0 110.004 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.6 p -139.65 74.62 1.48 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.016 1.389 . . . . 0.0 110.534 -168.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -76.35 23.63 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.118 2.167 . . . . 0.0 115.581 -163.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.316 7.8 pt-20 51.72 113.67 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.795 2.838 . . . . 0.0 114.023 -162.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.566 HG13 HG13 ' A' ' 47' ' ' ILE . 8.0 p -71.86 121.28 21.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.087 -1.008 . . . . 0.0 108.439 176.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -131.6 120.71 23.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -86.62 -2.61 58.65 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.359 0.6 . . . . 0.0 111.186 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.66 65.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 -171.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.61 -5.36 1.7 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.486 2.469 . . . . 0.0 117.075 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -92.02 147.5 22.91 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 120.023 1.912 . . . . 0.0 108.278 177.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -74.4 139.21 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 161.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -132.05 -17.53 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.863 1.265 . . . . 0.0 111.587 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 168.6 -128.63 1.73 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 165.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -138.91 153.62 48.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 171.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -130.39 152.63 49.59 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.294 2.638 . . . . 0.0 106.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.52 107.91 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 119.539 1.063 . . . . 0.0 110.511 -162.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.1 109.4 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.879 -157.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.3 p -75.97 145.79 40.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -15.54 62.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.643 . . . . 0.0 111.735 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t -62.05 -45.41 93.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 108.912 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.78 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.037 0.827 . . . . 0.0 112.587 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 169.35 15.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.125 1.37 . . . . 0.0 110.167 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -152.65 138.7 18.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.109 1.764 . . . . 0.0 107.881 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.85 173.08 22.01 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 120.142 1.337 . . . . 0.0 112.022 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 168.04 18.35 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.607 2.205 . . . . 0.0 109.176 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -157.54 -59.33 0.08 Allowed 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -141.42 153.4 44.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.461 0.573 . . . . 0.0 109.711 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -138.47 159.26 42.52 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.334 1.054 . . . . 0.0 109.296 170.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.97 128.89 24.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.8 164.27 26.77 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.56 167.03 4.68 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.751 0.786 . . . . 0.0 109.45 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.83 144.95 80.26 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.59 132.7 27.76 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.279 1.986 . . . . 0.0 109.175 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 165.8 29.64 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.548 2.165 . . . . 0.0 110.009 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 80.16 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.75 2.3 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.02 -83.65 0.11 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 131.72 49.82 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -146.67 137.41 23.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -159.26 63.23 0.39 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.7 m 59.45 -159.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.573 1.549 . . . . 0.0 109.585 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER 157.57 155.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 1 C-N-CA 131.75 4.02 . . . . 0.0 109.758 166.268 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.33 100.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -170.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.36 -63.4 2.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.296 1.427 . . . . 0.0 113.684 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.33 -18.94 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 111.556 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.09 169.35 10.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 25.6 t -110.68 115.08 48.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 166.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.5 170.63 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 166.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.41 141.77 39.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 163.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.11 -34.6 73.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.905 0.882 . . . . 0.0 109.298 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -36.72 84.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.695 0.679 . . . . 0.0 111.27 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 m -61.08 -34.99 75.8 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.538 1.063 . . . . 0.0 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 61' ' ' LEU . 4.9 m-85 -63.51 -61.87 2.04 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.219 0.208 . . . . 0.0 110.614 165.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -22.42 25.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.196 1.398 . . . . 0.0 113.216 -169.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -45.87 -48.98 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.086 0.954 . . . . 0.0 112.121 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -31.21 0.95 Allowed 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.84 1.256 . . . . 0.0 111.239 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.96 86.04 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 119.615 1.098 . . . . 0.0 110.587 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -52.38 68.11 Favored Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 120.285 -1.509 . . . . 0.0 112.168 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.32 -16.94 21.79 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.503 1.469 . . . . 0.0 113.797 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -41.97 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 122.022 2.192 . . . . 0.0 109.042 169.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.39 -38.48 78.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -155.39 91.02 1.29 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.993 1.269 . . . . 0.0 111.172 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 t30 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 154.252 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.283 0.563 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 -137.54 171.52 14.33 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.138 1.775 . . . . 0.0 108.103 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.96 151.26 34.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.12 153.0 39.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.9 t -135.89 117.84 20.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 108.223 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.69 63.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -65.98 -48.72 70.32 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.74 65.64 2.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.467 1.507 . . . . 0.0 112.668 -167.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 90.8 mt -108.64 147.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 120.159 -1.588 . . . . 0.0 107.016 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 -80.14 0.36 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-O 118.827 -0.985 . . . . 0.0 111.353 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -59.65 -25.58 64.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.205 1.503 . . . . 0.0 111.842 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.86 -10.29 51.82 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 115.118 -2.372 . . . . 0.0 113.353 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -49.62 -17.32 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -159.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.82 -23.17 9.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.831 1.252 . . . . 0.0 112.557 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -87.88 -31.33 19.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.356 1.462 . . . . 0.0 111.154 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.53 117.8 2.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.944 1.698 . . . . 0.0 109.553 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -120.56 -64.21 1.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.642 0.656 . . . . 0.0 111.808 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.37 -14.86 60.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.552 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.56 -73.42 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.646 1.978 . . . . 0.0 112.128 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -42.66 -37.41 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.856 1.662 . . . . 0.0 113.294 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -73.58 -68.97 0.46 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.187 0.903 . . . . 0.0 110.558 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.65 -41.65 77.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 112.29 -167.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.3 -51.46 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.201 1.4 . . . . 0.0 108.407 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -63.3 -30.99 72.02 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.062 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.05 -57.02 14.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.245 1.384 . . . . 0.0 108.943 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 m -65.51 -29.51 70.16 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.845 -0.534 . . . . 0.0 112.359 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.0 -30.15 66.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.711 0.687 . . . . 0.0 110.495 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.9 t -64.12 -35.2 80.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.322 1.049 . . . . 0.0 109.543 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.0 m -73.16 133.08 81.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.807 0.731 . . . . 0.0 109.906 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.09 -30.21 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.824 2.349 . . . . 0.0 112.854 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.48 -31.25 34.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.208 -1.329 . . . . 0.0 113.398 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 m -73.26 162.87 28.87 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.672 1.736 . . . . 0.0 108.395 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.0 mt -140.57 98.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.74 145.49 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.426 0.557 . . . . 0.0 109.715 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 115.24 11.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.042 2.137 . . . . 0.0 106.495 167.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.12 25.01 Favored Glycine 0 N--CA 1.464 0.543 0 CA-C-N 120.34 1.427 . . . . 0.0 112.708 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.9 m -117.36 87.42 2.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.34 110.73 16.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.36 158.52 57.17 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.79 153.11 95.68 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.36 -77.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.413 2.075 . . . . 0.0 107.926 166.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? 153.45 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.392 1 C-N-CA 131.798 4.039 . . . . 0.0 104.234 -168.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.53 0.05 OUTLIER Glycine 0 CA--C 1.5 -0.845 0 O-C-N 124.105 0.878 . . . . 0.0 114.908 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.443 ' HG2' ' HD2' ' A' ' 150' ' ' PRO 0.33 0.0 OUTLIER -165.31 172.28 4.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 130.391 3.476 . . . . 0.0 105.903 163.067 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.443 ' HD2' ' HG2' ' A' ' 149' ' ' LYS . 57.2 Cg_endo -67.96 162.16 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 1 C-N-CA 125.337 4.025 . . . . 0.0 109.466 165.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.52 175.27 5.54 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.054 -1.029 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.62 16.75 25.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 112.447 172.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.48 -53.52 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.421 1.088 . . . . 0.0 108.268 168.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.78 -21.14 27.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.661 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -48.18 -39.9 22.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.472 1.109 . . . . 0.0 111.357 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -25.72 66.21 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.848 1.259 . . . . 0.0 111.136 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.5 mp -102.01 -38.05 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.244 1.418 . . . . 0.0 108.901 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -28.44 69.33 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.802 -1.186 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -52.71 -47.93 66.96 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 125.069 1.348 . . . . 0.0 110.565 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 78.2 5.9 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -56.94 -13.48 2.71 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.559 0.743 . . . . 0.0 111.557 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -39.04 56.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.193 2.197 . . . . 0.0 111.955 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 3' ' ' HIS . 18.9 m -48.55 128.82 4.77 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 125.602 1.561 . . . . 0.0 109.025 176.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 46.8 tptt -61.13 106.68 0.63 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 166.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -83.52 105.34 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 163.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 6' ' ' LEU . 36.8 m-85 -75.9 92.89 3.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 163.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 107.15 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 162.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.76 163.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.6 p -122.92 154.33 38.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.217 0.917 . . . . 0.0 108.999 164.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.65 1.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.784 1.633 . . . . 0.0 113.034 162.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -92.58 -36.81 12.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.347 0.976 . . . . 0.0 111.243 171.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.73 HD21 HD12 ' A' ' 176' ' ' LEU . 2.3 p-10 -127.0 7.57 6.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 113.665 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -44.36 -55.36 5.03 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.613 1.565 . . . . 0.0 115.064 -164.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -83.8 18.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.923 1.238 . . . . 0.0 113.164 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -131.56 13.95 4.96 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 117.244 -1.36 . . . . 0.0 113.788 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.73 HD12 HD21 ' A' ' 172' ' ' ASN . 0.7 OUTLIER -88.1 -13.9 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.663 1.574 . . . . 0.0 112.483 -177.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 17' ' ' LEU . 6.1 tp -30.44 -62.06 0.24 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.826 2.05 . . . . 0.0 111.627 173.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.78 -27.81 43.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.935 1.756 . . . . 0.0 112.774 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -70.05 -39.54 75.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.363 0.983 . . . . 0.0 108.988 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 6' ' ' LEU . 3.7 mt -57.93 -58.8 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 117.583 -1.199 . . . . 0.0 107.942 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.531 ' HA ' HG23 ' A' ' 184' ' ' VAL . 9.1 t -57.12 -27.55 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.897 0.771 . . . . 0.0 111.521 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.7 m -67.48 -29.16 68.52 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.756 -1.215 . . . . 0.0 112.35 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 25.9 t -90.66 -33.72 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.393 -1.442 . . . . 0.0 108.514 -167.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -63.9 -63.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 125.244 1.418 . . . . 0.0 108.423 164.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -15.43 63.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 112.984 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.3 t -49.56 -37.97 29.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.229 1.412 . . . . 0.0 110.138 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-N 118.84 0.746 . . . . 0.0 112.078 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.425 ' HB2' HG12 ' A' ' 163' ' ' VAL . 51.0 m-70 -131.57 153.11 50.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.47 140.85 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.937 1.244 . . . . 0.0 108.9 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 143' ' ' ILE . 16.3 m-85 -133.87 146.92 51.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.152 0.981 . . . . 0.0 109.799 177.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 180' ' ' ILE . 87.7 mt -93.44 151.38 19.78 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 123.897 0.748 . . . . 0.0 109.265 157.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -151.08 179.89 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.29 1.436 . . . . 0.0 107.994 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.92 -176.92 24.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 122.22 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.856 2.371 . . . . 0.0 112.337 -167.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.82 91.09 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.944 3.763 . . . . 0.0 112.972 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.96 74.76 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.263 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 10.2 p 22.8 78.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.568 2.747 . . . . 0.0 113.542 159.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.31 -36.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.901 1.715 . . . . 0.0 109.348 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.88 -34.85 76.77 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.25 177.103 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 m -56.48 -44.5 80.69 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.323 -1.322 . . . . 0.0 108.948 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.409 HG22 ' HD3' ' A' ' 20' ' ' LYS . 31.1 m -53.9 -36.97 63.29 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 120.067 1.303 . . . . 0.0 111.904 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.17 69.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.942 1.247 . . . . 0.0 110.614 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.24 -43.36 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -52.42 65.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.214 1.406 . . . . 0.0 109.37 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 16' ' ' THR . 4.6 mptp? -53.03 -45.68 68.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.655 171.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.85 27.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.638 -1.173 . . . . 0.0 113.943 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.5 p -80.54 -51.53 8.66 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 120.056 1.298 . . . . 0.0 110.296 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 4.0 pt-20 -57.87 -32.46 67.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.06 0.544 . . . . 0.0 111.067 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.87 -64.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.006 1.322 . . . . 0.0 108.367 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 mt -52.22 -41.31 62.62 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.965 1.306 . . . . 0.0 110.09 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 23' ' ' GLU . 45.3 mtmt -66.47 -46.26 76.96 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -34.29 75.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.019 0.927 . . . . 0.0 110.54 172.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 m -61.8 -41.73 98.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.446 1.021 . . . . 0.0 110.433 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.44 9.21 10.5 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 126.343 1.925 . . . . 0.0 112.745 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.46 130.81 73.15 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.04 139.61 43.17 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.908 1.739 . . . . 0.0 109.106 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.65 157.35 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.574 1.55 . . . . 0.0 107.804 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 174.76 13.71 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.109 -0.37 . . . . 0.0 111.916 163.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.83 -158.07 22.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 124.92 1.248 . . . . 0.0 111.087 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -146.13 162.82 37.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.115 1.366 . . . . 0.0 108.753 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -149.54 125.36 10.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.687 1.195 . . . . 0.0 107.961 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -84.73 70.46 10.81 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 120.919 -1.113 . . . . 0.0 109.559 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -79.44 48.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -166.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 52.14 -174.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.431 2.062 . . . . 0.0 112.62 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.0 t -125.13 93.58 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 150.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -91.42 103.5 16.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 160.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -79.6 104.4 10.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 165.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.93 50.71 11.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.33 0.968 . . . . 0.0 111.713 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.27 -13.95 18.33 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 117.369 -1.795 . . . . 0.0 115.891 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.73 129.43 39.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.254 2.527 . . . . 0.0 109.369 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -86.35 68.18 10.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.433 1.111 . . . . 0.0 112.735 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 pt -89.63 -2.46 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -168.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.67 -166.07 32.22 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 120.187 1.358 . . . . 0.0 111.797 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -138.54 149.54 45.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.9 153.65 51.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.86 154.47 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 164.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -140.32 154.81 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.841 2.057 . . . . 0.0 106.639 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.7 p -117.77 174.95 5.89 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.755 2.07 . . . . 0.0 110.7 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 54' ' ' LEU . 2.1 mm? -79.81 21.3 0.55 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.915 -1.115 . . . . 0.0 112.537 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -126.38 -12.76 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 -2.31 27.74 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.61 1.096 . . . . 0.0 112.935 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.87 160.41 32.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.865 1.832 . . . . 0.0 110.065 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.22 164.22 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.517 1.927 . . . . 0.0 107.251 165.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.75 140.63 9.66 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -82.78 63.89 8.01 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.282 3.988 . . . . 0.0 111.745 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.96 -63.66 1.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.104 1.761 . . . . 0.0 111.598 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 p -143.59 152.49 41.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.867 1.212 . . . . 0.0 109.764 172.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 168.83 18.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.04 129.08 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.17 45.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 -164.74 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.701 1.6 . . . . 0.0 109.219 -175.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 76' ' ' ARG . 6.6 mt-10 -129.11 154.87 80.52 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.09 125.31 12.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.604 2.203 . . . . 0.0 111.612 -163.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.56 162.94 39.98 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.225 1.95 . . . . 0.0 110.488 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.47 137.35 46.41 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.038 1.825 . . . . 0.0 109.639 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.36 -1.99 73.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.968 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -99.43 163.0 12.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.534 1.667 . . . . 0.0 107.544 163.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -141.3 145.66 35.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 162.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -155.23 -175.33 5.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.9 2.08 . . . . 0.0 107.179 166.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.68 162.56 28.78 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 119.679 -1.888 . . . . 0.0 109.98 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -168.87 135.04 1.75 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.757 1.223 . . . . 0.0 107.705 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.27 15.59 6.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 118.112 0.414 . . . . 0.0 110.294 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 76' ' ' ARG . . . 94.9 114.76 2.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.837 -2.505 . . . . 0.0 106.837 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 68.32 -51.42 0.55 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.588 2.355 . . . . 0.0 113.602 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.54 157.7 16.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.737 2.015 . . . . 0.0 108.391 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.86 123.17 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 171.26 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 110.555 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -156.61 107.71 2.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.918 0.781 . . . . 0.0 112.881 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.6 -35.48 4.05 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.857 1.662 . . . . 0.0 113.054 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -34.45 74.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.936 -1.102 . . . . 0.0 112.048 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.8 t -58.15 -38.66 77.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.622 1.556 . . . . 0.0 110.562 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -64.46 -46.63 82.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.513 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -52.38 -30.1 27.26 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.739 0.699 . . . . 0.0 111.91 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 90' ' ' LEU . 2.6 mt-30 -69.76 -29.97 67.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.23 -0.919 . . . . 0.0 113.184 -173.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -141.15 -44.68 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.439 0.563 . . . . 0.0 111.862 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.97 37.54 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.998 1.719 . . . . 0.0 112.05 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.432 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -129.99 -65.18 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 127.068 2.147 . . . . 0.0 108.053 175.768 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 31.2 Cg_endo -62.09 -27.48 79.07 Favored 'Trans proline' 0 C--N 1.351 0.676 0 CA-C-N 121.562 1.593 . . . . 0.0 112.965 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.31 -24.71 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.727 0.811 . . . . 0.0 112.599 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.109 0.868 . . . . 0.0 111.335 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -133.31 72.95 1.49 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.692 1.234 . . . . 0.0 108.705 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.367 169.593 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -115.52 98.18 6.58 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.253 1.021 . . . . 0.0 109.991 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.53 110.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 26.7 t -108.0 108.22 19.24 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.84 127.88 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.463 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.677 HD13 HG23 ' A' ' 128' ' ' VAL . 4.2 mt -141.04 74.97 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -77.14 174.9 10.18 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.099 1.318 . . . . 0.0 110.015 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 42.38 67.19 0.63 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.893 2.477 . . . . 0.0 114.368 169.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 111' ' ' ILE 0.258 6.7 mt -86.6 -0.39 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 120.521 -1.362 . . . . 0.0 111.707 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.01 -61.68 2.62 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.703 -1.248 . . . . 0.0 113.527 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -54.74 -41.69 70.72 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.583 1.691 . . . . 0.0 114.304 -160.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mmt -78.9 -5.54 53.91 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.289 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -41.16 -41.49 1.81 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -161.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 119' ' ' LEU . 4.4 mp -68.44 -60.1 2.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.009 0.924 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.18 -30.07 71.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.761 1.624 . . . . 0.0 111.826 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 t -39.84 107.92 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.032 2.933 . . . . 0.0 110.1 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -128.71 -78.6 0.56 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.622 1.169 . . . . 0.0 109.276 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.27 -31.21 61.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.623 0.769 . . . . 0.0 110.782 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -60.01 3.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 125.474 1.51 . . . . 0.0 111.424 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 mp -41.14 -58.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.113 1.765 . . . . 0.0 111.922 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -65.05 -47.37 77.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 118.588 0.631 . . . . 0.0 110.483 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.83 66.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 124.144 0.903 . . . . 0.0 110.083 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.677 HG23 HD13 ' A' ' 111' ' ' ILE . 2.4 p -62.05 -32.38 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 121.527 -0.733 . . . . 0.0 110.24 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.49 -35.57 60.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.41 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -38.77 79.01 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.564 1.074 . . . . 0.0 110.486 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.53 -44.28 24.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.328 1.051 . . . . 0.0 110.41 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.82 -18.19 64.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.537 1.062 . . . . 0.0 112.543 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.7 m -82.12 -22.15 36.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.046 0.839 . . . . 0.0 111.92 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.5 m -87.31 133.17 39.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -79.35 -27.47 4.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.547 2.831 . . . . 0.0 111.487 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.07 81.95 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.993 -0.893 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 5.4 m -67.08 150.09 49.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.056 1.928 . . . . 0.0 110.068 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.77 107.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -69.82 133.35 32.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 140' ' ' LEU . 12.4 tp -142.56 97.82 3.18 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.799 1.312 . . . . 0.0 108.25 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.6 -172.1 17.35 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 114.616 0.606 . . . . 0.0 114.616 -169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.8 m -136.63 112.0 9.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.66 1.184 . . . . 0.0 113.296 175.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 5' ' ' PHE . 19.7 pt -108.89 154.32 41.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.251 1.02 . . . . 0.0 110.906 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.03 159.73 52.15 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.727 1.618 . . . . 0.0 111.749 172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.71 149.79 97.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.456 168.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.5 104.09 1.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.155 1.903 . . . . 0.0 109.489 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -82.77 -63.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.06 107.9 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.99 168.52 0.11 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.602 1.961 . . . . 0.0 111.483 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.68 169.78 1.62 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.335 3.357 . . . . 0.0 111.292 165.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mp -126.42 153.71 44.63 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.13 -44.9 83.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -165.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.459 ' CD1' HD11 ' A' ' 157' ' ' ILE . 0.4 OUTLIER -80.43 -33.77 36.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.928 0.785 . . . . 0.0 109.362 173.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.57 -23.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.213 -1.555 . . . . 0.0 110.348 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -58.02 10.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.904 2.082 . . . . 0.0 109.398 166.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.48 63.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.896 1.279 . . . . 0.0 111.534 177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.459 HD11 ' CD1' ' A' ' 153' ' ' LEU . 4.7 mm -73.98 -51.39 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 118.465 0.575 . . . . 0.0 110.268 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -24.56 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.723 0.809 . . . . 0.0 110.322 -170.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -55.88 -26.43 47.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.754 1.222 . . . . 0.0 111.611 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -66.45 -35.87 81.37 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.824 -1.173 . . . . 0.0 111.514 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 53.87 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.657 2.783 . . . . 0.0 115.758 -167.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.4 41.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.736 2.014 . . . . 0.0 111.273 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 3' ' ' HIS . 12.3 m -87.2 134.15 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 119.853 -1.78 . . . . 0.0 106.734 166.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -74.22 112.0 9.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 165.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.83 90.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 32.7 m-85 -75.05 118.95 18.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 167.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.7 89.56 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.29 143.98 14.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.5 p -121.29 147.99 44.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -54.96 -14.66 1.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.366 166.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -81.82 -56.68 3.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.1 0.864 . . . . 0.0 108.882 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.7 6.01 49.53 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.606 -171.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -32.36 -57.26 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.276 2.23 . . . . 0.0 112.219 -172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -84.09 5.05 27.55 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.29 -17.35 21.73 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.05 1.34 . . . . 0.0 112.231 165.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -80.73 -23.63 39.33 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.042 -169.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -57.9 9.27 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.196 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.45 -22.35 52.17 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.75 2.3 . . . . 0.0 114.271 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.22 73.64 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 6' ' ' LEU . 11.3 mt -67.72 -46.63 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.196 0.998 . . . . 0.0 109.262 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.8 t -50.41 -49.15 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.26 1.024 . . . . 0.0 109.21 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 97.6 m -58.14 -51.28 70.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.15 0.887 . . . . 0.0 108.857 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.95 -27.09 69.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.64 -68.4 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 117.294 -1.336 . . . . 0.0 107.944 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -53.54 -24.54 13.75 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.477 1.511 . . . . 0.0 112.558 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.81 -41.97 5.32 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.179 1.792 . . . . 0.0 112.073 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.053 1.341 . . . . 0.0 107.465 -162.744 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.82 174.6 6.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.046 0.938 . . . . 0.0 110.232 -167.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.86 143.98 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -139.88 150.38 44.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.608 1.163 . . . . 0.0 109.036 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.09 142.62 38.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 125.445 1.498 . . . . 0.0 107.817 -171.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 t -156.82 -169.69 3.06 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 123.541 0.526 . . . . 0.0 110.694 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 145' ' ' VAL . . . 110.69 -174.9 17.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.826 1.679 . . . . 0.0 110.378 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.45 161.45 45.97 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.339 2.026 . . . . 0.0 110.14 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 140.94 46.94 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.33 2.02 . . . . 0.0 110.848 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.24 16.39 4.15 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.713 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.297 5.8 m 44.23 33.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.485 2.314 . . . . 0.0 115.543 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.1 20.54 0.25 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.03 -1.428 . . . . 0.0 113.085 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -69.25 0.21 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.148 1.474 . . . . 0.0 110.308 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -30.5 71.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.333 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 97.1 m -52.51 -52.21 55.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.293 1.406 . . . . 0.0 109.187 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -48.52 78.9 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.389 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -66.39 -45.65 88.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.861 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -44.72 84.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.024 1.283 . . . . 0.0 107.893 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -64.69 -23.76 67.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 124.135 0.897 . . . . 0.0 111.417 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.1 -38.81 26.67 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 125.331 1.453 . . . . 0.0 110.323 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -62.89 -53.12 59.0 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.28 -34.56 72.43 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.07 -49.08 85.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.786 0.834 . . . . 0.0 109.178 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.93 -39.39 76.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' A' ' 54' ' ' LEU . 76.5 mttt -57.31 -49.12 77.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.428 1.013 . . . . 0.0 109.406 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 t -49.92 -51.57 39.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.381 2.273 . . . . 0.0 106.949 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -65.56 15.67 0.03 OUTLIER 'General case' 0 C--O 1.236 0.35 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 173.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.8 19.78 56.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.913 1.244 . . . . 0.0 112.84 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 26' ' ' LYS . 6.0 p -56.87 149.8 41.59 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.78 109.68 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.799 1.666 . . . . 0.0 109.613 159.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.95 171.85 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.596 0.758 . . . . 0.0 109.102 169.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.07 172.61 18.1 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.067 2.547 . . . . 0.0 105.109 165.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.82 -159.11 22.1 Favored Glycine 0 C--O 1.237 0.304 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.68 169.72 17.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.522 0.661 . . . . 0.0 111.994 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -135.73 165.86 24.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -125.62 80.52 1.9 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.9 155.23 40.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 167.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -71.18 125.92 28.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.9 t -80.26 126.36 39.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -127.38 167.18 16.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.533 1.133 . . . . 0.0 110.295 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.48 29.34 2.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.349 1.46 . . . . 0.0 109.728 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.48 -21.19 0.4 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.456 -1.402 . . . . 0.0 114.045 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.22 6.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.416 1.484 . . . . 0.0 110.308 -163.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 140.01 46.43 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 118.522 1.161 . . . . 0.0 108.467 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.517 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.28 135.34 51.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 160.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.0 pt -133.41 -2.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 111.548 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.6 -157.93 27.55 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.22 135.04 30.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.112 2.165 . . . . 0.0 106.12 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.55 164.04 13.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.931 1.293 . . . . 0.0 107.945 168.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.3 p -113.73 104.8 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.02 112.26 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 123.872 0.869 . . . . 0.0 109.889 -160.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -68.59 152.63 45.1 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 109.219 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.3 mm? -68.73 -2.6 9.66 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.808 170.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -110.56 18.94 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.254 1.822 . . . . 0.0 111.531 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.89 0.96 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.371 -0.83 . . . . 0.0 114.709 160.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 m -115.29 166.12 12.2 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.702 1.251 . . . . 0.0 108.133 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -154.09 142.61 20.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.31 -1.494 . . . . 0.0 108.377 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.26 142.7 14.29 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 118.457 -1.191 . . . . 0.0 111.656 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.84 64.78 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 126.144 4.563 . . . . 0.0 113.565 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.93 -59.89 4.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 112.231 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.8 p -146.75 140.28 25.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 120.608 1.549 . . . . 0.0 108.227 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptt-85 -155.81 65.28 0.59 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.845 0.748 . . . . 0.0 110.725 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.827 HG12 ' H ' ' A' ' 65' ' ' GLY 0.335 41.8 t 58.71 -153.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -170.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.827 ' H ' HG12 ' A' ' 64' ' ' VAL . . . 134.08 141.88 4.58 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 129.21 3.291 . . . . 0.0 107.333 -166.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 147.23 53.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 155.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 146.65 99.06 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.54 127.75 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.003 1.802 . . . . 0.0 110.233 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.34 169.2 22.22 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.682 2.921 . . . . 0.0 110.718 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.94 -0.92 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.523 2.148 . . . . 0.0 114.306 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.48 5.34 29.76 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.987 1.28 . . . . 0.0 113.844 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 156.87 43.19 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 120.599 2.199 . . . . 0.0 109.598 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -154.13 155.69 35.84 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 162.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -149.68 26.04 0.84 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.188 1.795 . . . . 0.0 107.808 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.3 m 55.67 -179.39 0.04 OUTLIER 'General case' 0 C--N 1.345 0.405 0 C-N-CA 127.699 2.399 . . . . 0.0 112.501 -165.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.04 170.19 13.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 109.737 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 77' ' ' VAL . 24.1 m -127.97 77.62 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 107.822 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.54 -113.36 4.14 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -162.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -29.2 54.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -166.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.81 146.15 23.99 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 121.601 2.0 . . . . 0.0 107.368 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.2 t -95.08 137.93 22.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.03 177.25 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 123.612 0.765 . . . . 0.0 109.815 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -148.85 113.59 5.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 157.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -25.06 67.38 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.949 -1.094 . . . . 0.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 m -55.85 -31.76 63.04 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.814 1.246 . . . . 0.0 110.235 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.4 t -62.0 -37.23 84.04 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.931 1.241 . . . . 0.0 110.203 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -64.62 -50.83 65.61 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -18.7 37.41 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.103 -0.998 . . . . 0.0 113.53 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -64.47 -57.88 7.98 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.86 -1.15 . . . . 0.0 110.47 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -128.72 -33.32 2.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.786 1.234 . . . . 0.0 112.334 -166.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.17 46.92 0.75 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.68 1.192 . . . . 0.0 108.895 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -61.05 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.051 2.14 . . . . 0.0 107.844 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.17 -21.68 48.15 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.779 1.653 . . . . 0.0 112.962 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.67 -34.32 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 119.394 0.997 . . . . 0.0 112.053 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.85 3.83 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -168.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -112.12 87.19 2.51 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.864 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.806 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.53 168.07 12.89 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.626 0.771 . . . . 0.0 110.772 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.2 158.03 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 159.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.21 153.58 50.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 163.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.9 120.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -166.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.32 86.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -171.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.47 175.62 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.242 -0.912 . . . . 0.0 109.898 -169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 56.25 39.8 30.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.416 1.086 . . . . 0.0 112.352 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CG2' HD12 ' A' ' 153' ' ' LEU . 17.4 mt -81.68 59.35 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 119.725 -1.859 . . . . 0.0 109.685 -175.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.48 -54.64 0.26 Allowed Glycine 0 N--CA 1.465 0.598 0 O-C-N 120.164 -1.585 . . . . 0.0 113.649 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 8.23 3.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -114.81 13.36 17.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.867 1.212 . . . . 0.0 110.266 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -40.51 -42.19 1.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.635 2.374 . . . . 0.0 113.0 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.62 -17.03 10.67 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 124.048 0.939 . . . . 0.0 111.997 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.76 -12.72 23.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.569 0.622 . . . . 0.0 111.069 -171.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -61.24 101.61 0.17 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 119.215 0.916 . . . . 0.0 109.907 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -99.7 -78.33 0.51 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.4 mt -56.42 -24.78 47.36 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.88 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -71.5 0.07 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.2 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.3 mp -30.9 -54.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.969 1.708 . . . . 0.0 112.238 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -71.14 -62.77 1.27 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.569 0.348 . . . . 0.0 111.347 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.59 91.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.903 0.858 . . . . 0.0 109.902 -167.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.77 -54.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 117.328 -1.32 . . . . 0.0 107.943 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -57.69 -31.2 66.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.287 2.312 . . . . 0.0 113.799 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -59.62 -45.65 91.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.031 0.932 . . . . 0.0 108.944 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.8 m -63.42 -42.5 98.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.408 1.483 . . . . 0.0 111.078 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.15 -35.28 74.96 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.169 -0.957 . . . . 0.0 110.63 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.7 m -90.27 1.47 56.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.474 1.51 . . . . 0.0 112.992 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.7 m -72.18 134.08 83.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.2 118.14 5.52 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 123.154 2.569 . . . . 0.0 108.051 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.37 -3.96 86.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 117.36 -1.8 . . . . 0.0 114.64 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.3 m -67.68 153.24 44.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.555 2.178 . . . . 0.0 107.468 163.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.7 mt -134.64 95.2 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -166.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.49 140.57 19.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.2 100.95 5.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.374 1.87 . . . . 0.0 106.207 163.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -124.38 166.78 16.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.4 m -124.21 117.49 24.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.01 132.84 24.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.485 2.314 . . . . 0.0 109.448 -173.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.36 137.5 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.429 2.086 . . . . 0.0 110.557 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 8' ' ' GLY . 4.5 p -64.49 122.1 76.5 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 110.695 -168.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.42 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.411 2.741 . . . . 0.0 109.411 -171.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -138.6 110.14 7.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 166.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.02 -26.08 6.37 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-O 116.544 -2.253 . . . . 0.0 114.909 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 132.82 24.39 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 121.684 2.742 . . . . 0.0 112.274 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.26 96.44 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.701 2.934 . . . . 0.0 108.538 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 112.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.72 -59.77 3.74 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 113.997 -168.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 114' ' ' ILE . 1.6 tm? -63.44 -41.42 98.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.898 0.772 . . . . 0.0 109.925 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.29 -30.05 47.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.716 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.75 -35.51 74.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.621 172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.71 -56.59 17.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.766 1.621 . . . . 0.0 109.062 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.73 -29.61 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.159 0.984 . . . . 0.0 111.125 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.79 -37.85 76.47 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 120.606 -1.309 . . . . 0.0 109.516 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.63 -19.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.174 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -23.25 50.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.934 1.243 . . . . 0.0 110.886 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.37 -55.26 0.26 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 127.623 2.369 . . . . 0.0 113.43 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -60.26 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 1 C-N-CA 132.726 4.411 . . . . 0.0 113.077 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 t -138.95 121.52 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 15.2 tptm -64.94 123.16 18.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.6 t -102.33 91.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 9.7 m-85 -81.92 102.88 11.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.837 0.855 . . . . 0.0 110.216 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.62 98.13 6.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.125 0.97 . . . . 0.0 109.105 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.32 158.3 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 50.0 p -121.54 158.72 27.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -57.87 -24.42 57.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.111 163.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.65 -72.43 0.43 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.825 0.85 . . . . 0.0 110.539 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -86.85 30.82 0.72 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.864 1.265 . . . . 0.0 109.798 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -48.2 -60.48 2.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.679 1.592 . . . . 0.0 109.898 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -77.37 4.21 11.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -97.54 -6.01 34.49 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.843 1.657 . . . . 0.0 111.852 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.1 tp -74.13 -39.97 62.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.506 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 tp -40.87 -64.05 0.67 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 111.54 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.13 -25.22 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 121.482 1.565 . . . . 0.0 111.806 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.08 -38.63 75.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.584 1.554 . . . . 0.0 109.858 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.95 -54.09 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 109.484 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.34 -41.7 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.436 0.562 . . . . 0.0 109.54 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.5 m -56.0 -47.85 76.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.972 1.309 . . . . 0.0 109.101 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -47.79 84.29 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.944 0.793 . . . . 0.0 110.826 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.57 -48.32 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.304 0.642 . . . . 0.0 109.97 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.59 55.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.881 1.273 . . . . 0.0 110.102 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 t -55.94 -40.51 73.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.903 1.281 . . . . 0.0 109.644 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 112.745 178.91 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.445 ' HB2' HG12 ' A' ' 163' ' ' VAL . 66.0 m-70 -89.32 155.84 19.11 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.287 1.435 . . . . 0.0 109.493 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -129.37 132.29 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.774 1.23 . . . . 0.0 108.989 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 5.3 m-85 -141.78 136.06 30.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.455 1.102 . . . . 0.0 108.574 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.42 147.79 22.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 t -143.35 161.89 37.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.827 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.46 -175.52 20.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.351 0.977 . . . . 0.0 111.176 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.87 166.47 29.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 111.78 -171.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.44 157.09 62.28 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.462 2.108 . . . . 0.0 110.355 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.22 -9.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 117.608 -1.662 . . . . 0.0 115.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t 61.74 102.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.217 1.807 . . . . 0.0 109.535 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.35 -7.36 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.33 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -32.69 69.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.72 1.76 . . . . 0.0 110.901 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 m -61.98 -39.82 93.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -1.11 1.55 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.133 2.573 . . . . 0.0 112.676 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' A' ' 176' ' ' LEU . 19.8 mt -101.87 -66.39 0.92 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 167.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 HD22 ' A' ' 140' ' ' LEU . 1.6 mp -63.13 -41.45 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.263 0.938 . . . . 0.0 111.797 -168.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.6 64.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -67.89 -32.07 72.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.183 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.09 80.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.888 0.875 . . . . 0.0 110.607 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 t -63.52 -58.25 7.59 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 108.798 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.0 -45.74 32.09 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.256 1.822 . . . . 0.0 112.083 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.43 -54.77 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.98 -0.45 . . . . 0.0 110.321 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.56 -32.78 74.33 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.916 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 mttt -59.47 -44.09 93.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.351 0.978 . . . . 0.0 109.044 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -12.3 61.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.877 0.871 . . . . 0.0 111.118 172.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -93.35 8.99 38.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.284 1.834 . . . . 0.0 114.646 170.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.82 21.24 71.12 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.346 -0.846 . . . . 0.0 111.947 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 26' ' ' LYS . 9.0 p -57.64 147.04 62.89 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.518 1.159 . . . . 0.0 109.096 169.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.81 106.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.883 2.388 . . . . 0.0 109.4 153.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.45 140.59 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 3.5 m-20 -151.48 138.87 19.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.944 0.898 . . . . 0.0 109.185 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.93 30.38 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 106.459 -2.656 . . . . 0.0 106.459 -166.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.8 176.23 10.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.862 1.331 . . . . 0.0 112.144 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -138.36 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -131.02 76.24 1.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 152.72 40.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.62 115.93 14.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.377 1.084 . . . . 0.0 111.993 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.3 t -78.22 96.4 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -102.3 119.27 38.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 167.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -75.21 -78.74 0.1 Allowed 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.01 59.24 0.36 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.03 -9.45 1.52 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.063 -171.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 137.79 32.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.808 1.804 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 143.14 46.14 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 pt -144.06 -6.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.231 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.74 -151.85 23.43 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 119.562 1.074 . . . . 0.0 111.688 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -138.57 164.54 29.2 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.072 1.749 . . . . 0.0 109.156 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.13 142.93 48.94 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 128.336 2.654 . . . . 0.0 104.6 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.13 152.34 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.63 1.172 . . . . 0.0 109.335 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.24 111.81 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 120.198 1.363 . . . . 0.0 112.048 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.431 HG22 HG11 ' A' ' 94' ' ' VAL . 80.6 p -63.78 145.97 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.634 0.773 . . . . 0.0 109.954 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.404 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.2 mm? -64.53 -16.88 63.32 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.55 -0.719 . . . . 0.0 112.336 169.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 t -66.48 -32.47 73.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.792 1.637 . . . . 0.0 109.635 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.78 21.23 3.28 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.053 -0.859 . . . . 0.0 114.827 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.6 m -128.71 152.2 48.68 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.661 1.73 . . . . 0.0 109.516 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -128.83 168.81 15.38 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.89 1.276 . . . . 0.0 112.087 -173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -150.67 179.97 26.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.898 170.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.6 174.48 6.38 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.809 3.006 . . . . 0.0 111.439 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -165.14 -64.51 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.806 -1.184 . . . . 0.0 110.135 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.91 141.43 29.04 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.3 38.55 0.25 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.251 15.2 t 62.54 176.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.499 1.519 . . . . 0.0 109.246 -167.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.93 152.13 6.05 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.428 1.966 . . . . 0.0 108.782 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 158.65 16.7 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.592 0.757 . . . . 0.0 111.522 -174.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.41 145.04 99.11 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.595 -0.691 . . . . 0.0 109.64 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.91 132.26 15.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.552 2.168 . . . . 0.0 110.105 -168.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 158.5 56.65 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.496 2.131 . . . . 0.0 110.659 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.36 121.52 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.41 2.073 . . . . 0.0 110.489 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.05 9.55 59.39 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.777 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -120.35 156.48 31.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.084 1.354 . . . . 0.0 107.62 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 156.35 40.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.381 1.472 . . . . 0.0 108.057 160.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -135.52 174.48 10.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.951 2.5 . . . . 0.0 105.334 160.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.9 m -73.17 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.342 1.057 . . . . 0.0 108.388 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.58 148.12 28.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.696 -1.252 . . . . 0.0 110.412 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.7 19.83 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -151.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.01 98.28 2.27 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 61.29 -69.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.551 1.94 . . . . 0.0 110.907 -159.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.86 139.04 57.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 111.237 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.23 132.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 159.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.15 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.774 1.23 . . . . 0.0 108.833 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.31 112.61 10.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.032 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.6 -35.77 79.6 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.025 -1.047 . . . . 0.0 109.86 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -64.63 -36.22 83.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.924 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.4 p -62.51 -33.99 75.99 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.08 1.309 . . . . 0.0 109.939 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.71 -55.37 17.72 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.28 1.032 . . . . 0.0 109.65 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.34 -13.38 0.34 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.252 1.421 . . . . 0.0 113.495 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.443 ' HB2' HD23 ' A' ' 90' ' ' LEU . 9.5 mt-30 -78.23 -24.97 46.76 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.351 -1.468 . . . . 0.0 114.277 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -147.15 -35.37 0.24 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.12 46.24 0.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.41 1.884 . . . . 0.0 111.498 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -64.92 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 116.877 -1.535 . . . . 0.0 108.095 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.95 -23.96 46.36 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.681 2.254 . . . . 0.0 113.511 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 53' ' ' THR . 15.4 m -58.47 -31.56 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 120.283 -1.511 . . . . 0.0 111.569 175.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.84 -10.35 59.42 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.473 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 167.95 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.943 2.497 . . . . 0.0 107.545 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 N--CA 1.451 -0.382 0 C-N-CA 123.756 0.823 . . . . 0.0 110.582 176.567 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.238 0.484 0 CA-C-O 121.392 0.615 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.32 164.43 38.77 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.007 2.523 . . . . 0.0 106.089 166.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -120.15 146.32 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.7 p -118.93 168.78 10.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.39 123.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -148.74 92.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -77.54 171.28 15.15 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.663 1.185 . . . . 0.0 109.804 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.8 27.28 4.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.482 1.513 . . . . 0.0 114.56 161.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD21 ' A' ' 153' ' ' LEU . 54.2 mt -74.34 76.94 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.887 1.327 . . . . 0.0 108.227 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.54 -42.99 0.04 OUTLIER Glycine 0 C--O 1.221 -0.684 0 CA-C-O 117.249 -1.862 . . . . 0.0 115.844 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -32.02 71.25 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 122.391 3.095 . . . . 0.0 111.181 175.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.1 mmt -78.35 1.52 21.63 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 116.863 -1.541 . . . . 0.0 114.003 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -34.97 -51.17 0.51 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.565 1.946 . . . . 0.0 114.593 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.57 -27.89 13.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 112.283 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.28 -23.23 51.17 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.023 0.929 . . . . 0.0 111.969 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.5 t -49.81 128.46 18.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.518 2.327 . . . . 0.0 111.149 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.15 -95.88 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.99 -15.99 26.93 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.993 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.92 -71.38 0.07 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 110.374 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.5 mt -32.59 -55.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 127.658 2.383 . . . . 0.0 110.871 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.03 -66.77 0.49 Allowed 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.31 -40.07 73.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.696 1.198 . . . . 0.0 111.515 -170.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.55 -51.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.892 2.077 . . . . 0.0 108.965 174.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -54.75 -40.7 69.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.838 1.199 . . . . 0.0 111.214 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -58.82 -46.33 87.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.78 0.832 . . . . 0.0 109.487 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.42 ' HB ' HD11 ' A' ' 139' ' ' ILE . 5.6 m -65.28 -40.64 94.16 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.737 0.699 . . . . 0.0 111.81 173.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.52 -25.16 67.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.249 0.932 . . . . 0.0 110.839 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.8 m -108.17 -5.49 16.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 0.0 112.73 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.2 m -64.8 139.53 97.8 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 125.75 1.62 . . . . 0.0 108.594 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.75 155.44 53.93 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.573 2.182 . . . . 0.0 110.721 171.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.36 -47.53 1.39 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.122 1.82 . . . . 0.0 114.072 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.3 m -59.99 155.67 16.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.467 1.633 . . . . 0.0 110.518 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.26 136.75 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.447 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.8 OUTLIER -93.4 128.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 173.344 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -115.26 135.33 54.27 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 165.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.51 -179.17 40.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.095 -1.05 . . . . 0.0 115.7 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.0 m -129.9 124.36 32.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.117 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.3 pt -117.9 154.52 51.3 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.203 1.401 . . . . 0.0 108.155 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.33 158.7 14.93 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.194 2.596 . . . . 0.0 110.497 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.21 137.45 78.68 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 165.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.08 156.01 63.52 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.575 2.85 . . . . 0.0 109.72 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -129.17 -14.34 4.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.835 1.654 . . . . 0.0 112.563 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.25 -85.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 O-C-N 120.711 -1.243 . . . . 0.0 110.02 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.29 153.79 39.39 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.453 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.74 157.15 27.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.815 1.676 . . . . 0.0 111.475 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.52 135.36 53.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.663 0.602 . . . . 0.0 111.815 -154.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 114' ' ' ILE . 10.8 tp -61.59 -46.7 88.76 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.029 0.931 . . . . 0.0 110.198 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.91 -34.86 70.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 119.209 0.913 . . . . 0.0 111.252 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -66.87 -26.65 67.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.903 1.229 . . . . 0.0 111.565 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.77 -43.83 92.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.415 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.585 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 8.5 mm -69.21 -44.09 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.568 0.747 . . . . 0.0 109.899 173.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -61.21 -27.2 68.26 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.586 -1.321 . . . . 0.0 109.83 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -5.29 21.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.012 1.725 . . . . 0.0 113.525 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -37.91 11.99 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.811 1.187 . . . . 0.0 110.927 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 61.93 -28.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.264 2.226 . . . . 0.0 114.345 -174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -28.45 33.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.215 1.37 . . . . 0.0 110.591 169.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 3' ' ' HIS . 21.8 m -63.94 113.39 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.123 1.439 . . . . 0.0 109.704 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -64.48 131.32 46.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.407 1.883 . . . . 0.0 108.08 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.24 92.49 2.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -80.31 97.97 7.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.598 1.559 . . . . 0.0 108.388 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.96 104.2 8.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.557 -0.714 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 176' ' ' LEU . 0.4 OUTLIER -59.2 146.69 9.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.3 1.048 . . . . 0.0 108.735 167.116 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -122.82 149.82 43.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -51.63 -25.05 6.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.192 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -76.05 -25.24 55.42 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.67 0.606 . . . . 0.0 110.725 -170.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.72 28.91 3.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.545 1.538 . . . . 0.0 112.341 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 168' ' ' VAL . 28.4 ptt-85 -66.13 -20.18 66.07 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -171.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.17 29.04 8.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.597 1.559 . . . . 0.0 109.393 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -135.84 15.95 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.405 1.482 . . . . 0.0 113.386 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.677 ' HB3' HD13 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -84.68 -9.14 58.52 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.095 1.771 . . . . 0.0 112.364 -176.197 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -58.59 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.493 1.517 . . . . 0.0 110.996 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -29.52 67.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.016 1.756 . . . . 0.0 113.716 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.82 -42.6 97.61 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 140' ' ' LEU . 11.9 mt -67.31 -44.1 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 108.156 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.05 -42.74 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 119.196 0.907 . . . . 0.0 109.727 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 84.9 m -59.25 -50.91 72.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.126 0.876 . . . . 0.0 109.744 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -29.61 69.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.471 0.578 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.38 -43.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.504 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -63.75 -34.77 78.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.014 1.734 . . . . 0.0 110.85 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.92 -65.61 0.48 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.368 1.867 . . . . 0.0 110.799 -167.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 126.259 1.823 . . . . 0.0 112.204 -179.247 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.007 0.432 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -49.8 155.8 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.844 2.058 . . . . 0.0 111.459 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.3 t -131.27 145.52 35.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -133.57 144.94 49.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.019 0.927 . . . . 0.0 109.193 164.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -106.87 146.13 31.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 t -151.98 -177.54 6.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.48 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.18 175.17 13.9 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.159 1.838 . . . . 0.0 111.351 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.77 169.22 15.03 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 125.013 3.809 . . . . 0.0 111.659 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.13 162.09 20.75 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.175 2.583 . . . . 0.0 112.314 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.09 -53.72 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.093 0 O-C-N 121.25 -0.906 . . . . 0.0 112.346 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.5 t 63.66 94.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 O-C-N 126.061 1.683 . . . . 0.0 109.13 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.28 -35.3 0.48 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.204 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -56.93 -17.79 10.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 m -34.04 -51.03 0.41 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.69 1.596 . . . . 0.0 111.23 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -53.99 -28.03 35.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 124.909 1.284 . . . . 0.0 112.54 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -56.86 6.27 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -61.16 -40.67 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.435 1.016 . . . . 0.0 110.181 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -48.68 65.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.5 mttm -73.66 -14.46 61.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.455 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.8 98.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 108.601 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.1 p -63.29 -44.02 96.24 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.593 0.633 . . . . 0.0 110.145 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.32 -42.18 84.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' LYS . 71.9 t -63.86 -50.78 76.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 109.771 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.64 -38.54 69.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -72.02 -35.07 69.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 119.119 -0.467 . . . . 0.0 112.252 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 -15.17 25.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 126.426 1.89 . . . . 0.0 115.181 162.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.49 3.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.312 2.245 . . . . 0.0 112.491 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.6 72.39 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.426 1.012 . . . . 0.0 113.61 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.05 121.47 71.54 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.317 1.559 . . . . 0.0 107.259 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.82 90.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.622 -171.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -73.22 146.54 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.379 1.472 . . . . 0.0 108.545 168.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.84 175.68 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 146.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.34 -153.37 24.39 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 124.888 1.232 . . . . 0.0 110.138 170.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -136.13 165.3 26.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.921 0.888 . . . . 0.0 109.36 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -137.49 168.33 19.87 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 159.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -135.87 104.58 5.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -102.93 159.17 15.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.75 121.34 20.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.99 107.52 2.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 167.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -125.03 91.46 3.44 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.298 1.439 . . . . 0.0 108.169 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -79.21 76.97 5.73 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 124.162 0.914 . . . . 0.0 111.513 -168.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.37 60.64 6.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 -162.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.41 15.78 81.0 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -115.54 113.3 23.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.012 1.906 . . . . 0.0 111.26 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -65.73 107.13 1.68 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.192 0.997 . . . . 0.0 109.806 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 pt -130.49 -10.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.48 -167.25 40.34 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.464 1.029 . . . . 0.0 110.933 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.61 159.19 37.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.4 139.19 35.24 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.004 0.522 . . . . 0.0 110.301 170.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.06 93.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.36 152.11 8.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 p -116.6 154.77 29.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 166.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.664 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -74.16 -10.84 60.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.496 -0.753 . . . . 0.0 110.257 171.362 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -66.33 -19.77 65.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.725 2.41 . . . . 0.0 110.485 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 1.63 57.95 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.708 1.147 . . . . 0.0 113.997 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.438 HG22 HD23 ' A' ' 90' ' ' LEU . 3.8 m -85.5 159.81 19.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 0.0 108.637 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.56 131.34 20.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.776 1.63 . . . . 0.0 108.02 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -111.65 149.22 18.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 118.557 -1.135 . . . . 0.0 110.453 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.58 -3.84 13.64 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.127 2.552 . . . . 0.0 114.881 -164.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 40.58 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 131.348 3.859 . . . . 0.0 116.816 168.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.71 116.99 7.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 119.232 0.924 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -126.78 145.54 50.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.845 0.858 . . . . 0.0 110.097 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.82 129.21 37.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.306 1.043 . . . . 0.0 108.854 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.28 50.94 0.67 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.299 -164.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.65 -175.5 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.175 1.488 . . . . 0.0 110.93 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -64.75 151.51 92.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.1 138.26 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.867 3.045 . . . . 0.0 110.832 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.06 159.87 47.32 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.182 2.588 . . . . 0.0 111.236 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.94 147.33 84.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.583 2.189 . . . . 0.0 111.179 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.78 4.53 20.41 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.371 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -128.35 0.11 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.278 1.539 . . . . 0.0 108.119 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 57.35 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.761 2.025 . . . . 0.0 114.067 169.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.79 -16.21 15.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -174.67 170.55 3.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.824 1.65 . . . . 0.0 108.81 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 2.1 ppt_? -170.51 160.32 7.31 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.33 1.452 . . . . 0.0 111.244 151.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.75 -8.59 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 110.701 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.92 -104.46 0.26 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.02 -37.39 76.81 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.592 0.819 . . . . 0.0 109.919 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.09 161.87 13.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.545 1.538 . . . . 0.0 111.855 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 1.0 OUTLIER -105.34 116.02 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.263 2.225 . . . . 0.0 106.334 170.033 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.83 162.62 4.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 168.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.02 116.36 11.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.86 -28.98 64.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.249 1.386 . . . . 0.0 110.409 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 m -59.36 -36.83 76.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.323 1.449 . . . . 0.0 112.472 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.2 p -72.31 -22.77 61.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 120.732 1.605 . . . . 0.0 112.477 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -69.98 -57.11 5.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.931 162.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.8 -29.86 20.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.076 0.853 . . . . 0.0 112.474 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -50.21 -34.03 21.41 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.647 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.83 -44.03 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.217 0.462 . . . . 0.0 111.643 -174.139 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.6 48.79 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.468 1.907 . . . . 0.0 109.88 -171.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -144.12 -65.12 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.396 1.478 . . . . 0.0 108.359 -175.112 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 34.8 Cg_endo -62.55 -24.09 75.07 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 121.287 1.495 . . . . 0.0 113.214 172.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.96 -35.52 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 119.941 1.246 . . . . 0.0 111.141 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.49 -53.05 6.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.979 1.312 . . . . 0.0 107.565 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -120.75 84.39 2.22 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 109.234 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.532 162.803 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.429 0.633 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.95 169.59 11.94 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 129.626 3.17 . . . . 0.0 107.006 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.27 146.66 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.2 m -128.59 150.12 50.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.202 0.456 . . . . 0.0 111.273 166.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.99 124.44 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.101 1.361 . . . . 0.0 108.344 -162.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.8 68.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.62 -35.09 76.84 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.661 -1.274 . . . . 0.0 112.331 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.12 86.55 4.62 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.06 -1.025 . . . . 0.0 110.713 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.8 mt -131.58 114.95 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 147.47 -67.49 0.39 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -57.03 -33.33 67.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.134 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mmt -85.68 3.11 42.54 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.692 -1.623 . . . . 0.0 113.042 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -32.89 -65.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.248 1.819 . . . . 0.0 113.845 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -39.48 64.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.083 0.553 . . . . 0.0 110.825 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.58 -23.42 61.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.291 0.95 . . . . 0.0 112.502 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.2 m -52.44 115.04 1.57 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.364 1.866 . . . . 0.0 110.232 -170.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.87 -86.44 0.65 Allowed 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.43 -21.32 35.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.083 0.953 . . . . 0.0 112.361 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.39 -61.56 2.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.012 1.325 . . . . 0.0 110.76 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -39.91 -57.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.239 1.381 . . . . 0.0 112.472 171.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -55.7 31.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.018 0.826 . . . . 0.0 111.239 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.82 92.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.508 0.67 . . . . 0.0 111.21 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.98 -48.64 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.805 1.242 . . . . 0.0 107.862 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -57.69 -37.91 74.28 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -64.28 -42.92 96.18 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.134 0.425 . . . . 0.0 111.138 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -67.35 -40.83 85.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.904 0.775 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 160' ' ' ARG . 8.7 mp -57.82 -21.11 40.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.523 1.529 . . . . 0.0 111.567 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.9 m -102.55 -6.3 22.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.394 1.878 . . . . 0.0 112.826 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.1 m -70.06 133.97 87.68 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.1 -45.89 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.769 2.312 . . . . 0.0 109.872 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.45 40.57 3.04 Favored Glycine 0 C--O 1.216 -0.974 0 CA-C-O 117.389 -1.784 . . . . 0.0 113.682 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.5 m -135.8 163.84 29.29 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.934 2.367 . . . . 0.0 107.088 169.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.93 103.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.82 132.32 31.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 122.825 0.45 . . . . 0.0 110.134 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.9 tp -126.37 147.88 49.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.257 2.623 . . . . 0.0 105.579 159.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.43 168.93 37.22 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 120.8 1.636 . . . . 0.0 113.358 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.0 m -112.66 121.82 45.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.629 0.715 . . . . 0.0 109.899 -166.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.73 153.39 47.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.662 1.185 . . . . 0.0 109.727 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.89 154.06 67.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.724 1.616 . . . . 0.0 110.461 172.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.59 126.12 92.39 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.34 152.24 44.04 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.284 2.656 . . . . 0.0 111.766 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -47.38 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.593 1.557 . . . . 0.0 110.576 172.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.48 -147.08 13.38 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 124.815 1.198 . . . . 0.0 110.768 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -63.61 158.11 61.56 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 121.974 -0.721 . . . . 0.0 110.638 171.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.66 139.96 41.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.028 2.485 . . . . 0.0 109.941 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.73 145.36 27.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.469 1.508 . . . . 0.0 109.702 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.32 -84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.006 2.922 . . . . 0.0 114.769 -170.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -52.58 -41.1 63.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.088 0.858 . . . . 0.0 109.028 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.8 -41.21 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.629 -1.177 . . . . 0.0 110.278 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.63 -35.37 80.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.866 1.666 . . . . 0.0 110.866 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.58 -20.76 58.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.748 0.819 . . . . 0.0 111.422 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mt -103.4 -42.98 8.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.623 1.569 . . . . 0.0 109.964 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.73 -19.98 60.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.257 1.423 . . . . 0.0 110.965 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.43 -30.99 61.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.989 0.516 . . . . 0.0 111.022 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HD2' HD23 ' A' ' 132' ' ' LEU . 16.2 mtp85 -83.99 -38.07 21.42 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.476 -156.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.17 -15.81 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.242 3.017 . . . . 0.0 116.726 174.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.81 -25.36 60.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.487 1.915 . . . . 0.0 111.122 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.4 m -52.73 141.12 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.407 1.883 . . . . 0.0 110.541 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 2.7 tppt? -60.56 143.46 53.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 158.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.87 100.96 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 19.2 m-85 -86.62 89.32 7.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.44 111.44 1.79 Allowed 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.48 166.7 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 119.335 0.97 . . . . 0.0 108.532 176.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.2 p -128.52 155.21 45.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 163.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -57.69 -34.58 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 162.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.94 -44.7 91.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.947 2.099 . . . . 0.0 109.996 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.01 18.26 18.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 113.237 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -38.29 -52.92 1.5 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.308 1.443 . . . . 0.0 113.664 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.94 6.48 48.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.552 1.141 . . . . 0.0 112.812 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -96.34 -3.25 44.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 111.987 166.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.581 HD23 HD11 ' A' ' 180' ' ' ILE . 3.9 tp -76.45 -35.97 58.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.179 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.3 -58.14 9.74 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.942 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.83 -25.29 53.12 Favored 'Trans proline' 0 C--N 1.352 0.725 0 CA-C-N 122.105 1.787 . . . . 0.0 112.34 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.25 -43.17 71.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 109.91 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.581 HD11 HD23 ' A' ' 176' ' ' LEU . 27.9 mt -56.88 -50.8 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.869 1.267 . . . . 0.0 108.67 171.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.51 -45.25 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.991 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.3 m -59.3 -43.93 92.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.521 1.055 . . . . 0.0 110.465 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.6 t -62.16 -38.77 90.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.533 0.733 . . . . 0.0 110.431 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.7 t -75.18 -45.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.951 0.9 . . . . 0.0 110.208 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -67.58 -14.28 62.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.467 1.031 . . . . 0.0 112.636 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.2 t -34.7 -50.95 0.48 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 128.103 2.561 . . . . 0.0 114.157 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.237 0.406 0 C-N-CA 124.603 1.161 . . . . 0.0 110.027 -168.542 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.428 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 31.5 m-70 -48.43 140.8 7.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.83 2.052 . . . . 0.0 109.605 166.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 164' ' ' LYS . 96.9 t -126.72 149.58 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.886 1.221 . . . . 0.0 112.259 164.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 157' ' ' ILE . 9.8 m-85 -137.51 162.47 33.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.905 2.082 . . . . 0.0 111.38 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD11 HD11 ' A' ' 180' ' ' ILE . 3.4 mm? -115.34 135.92 53.64 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.727 1.611 . . . . 0.0 108.442 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -137.24 -178.92 5.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.026 1.73 . . . . 0.0 107.206 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.64 176.05 38.49 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.743 -1.223 . . . . 0.0 112.947 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.14 138.88 34.39 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.63 2.886 . . . . 0.0 112.957 -164.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.01 92.59 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.408 3.406 . . . . 0.0 111.579 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.63 -75.51 0.37 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.81 -42.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.03 83.69 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -172.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -35.02 79.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 118.001 -0.999 . . . . 0.0 108.516 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -47.92 -63.46 1.06 Allowed 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 125.664 1.852 . . . . 0.0 107.298 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -42.21 -49.89 4.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.16 1.784 . . . . 0.0 112.671 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -47.9 57.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.681 0.673 . . . . 0.0 109.64 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.782 HD11 HD23 ' A' ' 6' ' ' LEU . 5.0 mm -62.44 -49.12 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.82 0.736 . . . . 0.0 110.951 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.78 -49.68 65.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.547 1.539 . . . . 0.0 107.847 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -57.58 -42.39 83.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.618 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.27 -39.97 70.45 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.949 0.795 . . . . 0.0 110.636 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 19.5 m -67.17 -56.08 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -47.94 -39.58 19.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.609 1.563 . . . . 0.0 114.211 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.81 -61.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.516 1.126 . . . . 0.0 108.675 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 mt -61.71 -34.67 76.18 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 118.675 -0.678 . . . . 0.0 109.854 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HE2' HD12 ' A' ' 54' ' ' LEU . 70.7 mttt -54.36 -48.49 71.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.42 1.088 . . . . 0.0 108.242 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -65.22 -24.56 67.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.711 0.404 . . . . 0.0 110.489 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -81.06 8.39 8.68 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.121 1.768 . . . . 0.0 114.831 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 18.79 68.0 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.279 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -53.32 148.62 15.91 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 118.109 0.955 . . . . 0.0 109.294 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.95 112.14 3.49 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.103 1.202 . . . . 0.0 108.991 155.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.56 144.24 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.952 0.882 . . . . 0.0 110.156 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -145.12 157.36 44.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.499 1.92 . . . . 0.0 107.636 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.56 -157.39 24.05 Favored Glycine 0 C--O 1.238 0.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -147.81 161.48 41.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 109.946 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -130.88 146.48 52.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -100.95 109.63 21.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.34 169.62 14.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.077 0.951 . . . . 0.0 111.216 -165.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.01 106.72 16.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 109.408 -162.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.0 93.79 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -111.93 113.96 26.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.529 1.531 . . . . 0.0 107.345 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -87.44 78.81 8.58 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 -133.52 18.92 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -166.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.69 27.17 5.44 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.598 -1.668 . . . . 0.0 115.615 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.23 159.38 44.48 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.145 2.473 . . . . 0.0 110.725 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.47 137.21 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.276 1.43 . . . . 0.0 110.158 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.73 -9.39 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.94 -172.05 38.0 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -137.71 155.0 49.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -123.82 -177.32 3.71 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 124.551 1.157 . . . . 0.0 108.268 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.97 89.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.46 117.75 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -81.08 153.99 27.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.1 mm? -71.01 6.36 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.039 -1.038 . . . . 0.0 113.083 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -95.06 5.64 51.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.766 1.626 . . . . 0.0 112.009 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.41 72.43 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.49 -1.381 . . . . 0.0 113.148 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -101.08 172.45 7.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.374 1.069 . . . . 0.0 108.2 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -152.8 130.05 11.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.992 0.917 . . . . 0.0 108.908 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 90' ' ' LEU . . . -98.97 145.19 17.6 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.6 67.86 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.634 2.889 . . . . 0.0 111.59 -173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.29 -51.83 6.06 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.327 2.251 . . . . 0.0 111.913 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -152.36 151.79 31.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.546 0.528 . . . . 0.0 111.168 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -140.61 161.74 37.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.553 1.541 . . . . 0.0 109.122 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.48 126.69 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.51 -143.7 7.32 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 127.345 2.402 . . . . 0.0 108.746 167.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tp -88.55 168.44 12.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.485 1.143 . . . . 0.0 109.955 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -74.89 151.16 86.43 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 158.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.78 124.65 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.232 2.621 . . . . 0.0 111.456 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -70.77 167.93 24.32 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 111.53 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.96 125.13 14.7 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.592 1.528 . . . . 0.0 109.949 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.82 80.79 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.64 -1.089 . . . . 0.0 114.313 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 118.99 10.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.209 1.505 . . . . 0.0 106.982 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -140.03 176.89 8.38 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.868 0.467 . . . . 0.0 112.148 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -149.92 -161.95 1.45 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 162.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.5 m -52.18 130.38 30.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.027 1.331 . . . . 0.0 109.401 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -147.91 125.84 12.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HB ' ' HE2' ' A' ' 116' ' ' LYS . 16.2 m -113.74 77.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 123.409 1.576 . . . . 0.0 108.757 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.16 -2.26 1.12 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.655 2.074 . . . . 0.0 116.191 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 176.57 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.113 2.565 . . . . 0.0 109.884 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.88 160.52 21.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 109.539 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.76 112.82 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 165.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.43 165.28 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 119.651 1.114 . . . . 0.0 110.252 163.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -142.19 151.79 42.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.316 0.646 . . . . 0.0 109.538 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.17 -29.68 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.837 2.055 . . . . 0.0 110.447 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.5 m -53.22 -43.65 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.085 1.354 . . . . 0.0 108.769 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.6 t -62.25 -23.01 66.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.108 0.867 . . . . 0.0 112.726 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.23 -56.42 4.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -51.86 -30.09 22.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.637 1.575 . . . . 0.0 112.642 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -45.19 -49.33 12.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.019 2.527 . . . . 0.0 113.714 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.46 HD21 ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -150.98 -34.17 0.15 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.51 0.724 . . . . 0.0 112.371 -166.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.85 45.18 1.13 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.792 1.637 . . . . 0.0 108.719 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.436 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -133.01 -63.47 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.12 1.368 . . . . 0.0 107.405 -174.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 61.5 Cg_endo -66.94 -22.45 48.42 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.748 2.299 . . . . 0.0 112.742 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.21 -34.86 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.491 1.496 . . . . 0.0 110.787 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.2 -15.57 62.6 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.875 0.87 . . . . 0.0 111.576 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -147.76 77.38 1.42 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.652 1.569 . . . . 0.0 108.826 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 . . . . . 0 C--O 1.239 0.538 0 C-N-CA 125.951 1.701 . . . . 0.0 108.054 160.681 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 . . . . . 0 C--O 1.227 -0.11 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -61.91 97.94 0.09 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.75 2.42 . . . . 0.0 110.637 -169.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.02 116.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.46 157.88 26.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.2 t -140.48 114.99 6.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -144.03 102.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.19 176.52 7.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 63.24 -77.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.954 2.502 . . . . 0.0 109.261 -149.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.324 30.2 mt 55.04 -8.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 128.063 2.545 . . . . 0.0 114.445 -169.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.97 -81.4 0.38 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 121.234 1.834 . . . . 0.0 111.477 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 77' ' ' VAL . 2.0 ttpm? -59.29 -28.35 66.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -163.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -22.47 65.41 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.843 -2.027 . . . . 0.0 111.258 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -24.85 -67.06 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.617 2.367 . . . . 0.0 113.936 -174.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.67 -15.64 60.79 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.744 2.018 . . . . 0.0 110.168 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.2 t -47.54 105.21 0.07 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 129.532 3.133 . . . . 0.0 108.439 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.18 -89.77 0.59 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 123' ' ' LEU . 1.5 pp -56.75 -13.35 2.45 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.073 171.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -66.5 0.37 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.543 1.537 . . . . 0.0 110.69 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -33.84 -55.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.698 1.199 . . . . 0.0 111.362 168.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.54 -54.66 36.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.072 0.851 . . . . 0.0 112.477 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.55 66.88 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.33 -45.8 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -56.53 -39.15 72.89 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.297 -1.502 . . . . 0.0 112.294 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.03 -16.7 33.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.806 1.185 . . . . 0.0 113.667 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.9 m -128.2 -17.91 4.2 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.429 1.092 . . . . 0.0 111.952 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.48 -49.88 73.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 146.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -82.87 49.79 1.58 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.421 1.888 . . . . 0.0 110.067 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -141.43 133.76 13.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 162.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.9 -37.37 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 121.858 1.705 . . . . 0.0 111.353 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.64 17.02 2.2 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.822 1.201 . . . . 0.0 114.989 -174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.9 m -118.31 167.16 11.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.64 1.72 . . . . 0.0 108.475 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mt -129.94 101.5 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.9 133.16 25.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD11 ' CG2' ' A' ' 180' ' ' ILE . 6.9 tp -132.71 147.52 52.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 159.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.81 177.89 45.2 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.2 m -114.19 148.08 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.24 127.8 19.11 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.53 145.52 76.79 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.415 1.41 . . . . 0.0 110.511 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.48 134.42 88.72 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.146 0.979 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -67.59 -55.37 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.206 2.604 . . . . 0.0 109.987 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 64.9 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.281 1.832 . . . . 0.0 108.301 -167.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.12 -102.91 0.5 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.671 1.123 . . . . 0.0 110.41 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -76.92 159.09 79.43 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 117.852 0.826 . . . . 0.0 110.364 -173.769 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 149' ' ' LYS . 60.2 Cg_endo -77.14 -175.95 2.94 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.733 2.955 . . . . 0.0 108.918 167.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -126.48 144.89 50.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.21 -66.68 0.36 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.667 1.987 . . . . 0.0 113.119 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.2 -39.21 66.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.494 1.118 . . . . 0.0 111.254 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.54 -36.5 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.076 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -63.21 -29.19 70.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.27 1.395 . . . . 0.0 111.778 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -56.94 -39.43 74.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.555 0.693 . . . . 0.0 110.352 174.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.479 HG21 ' CE2' ' A' ' 5' ' ' PHE . 5.4 mt -86.17 -36.81 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.913 1.685 . . . . 0.0 109.909 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -66.44 -34.17 77.33 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.225 -1.547 . . . . 0.0 110.969 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -62.7 -30.58 71.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.787 0.835 . . . . 0.0 109.682 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -58.29 -40.26 81.49 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.355 0.662 . . . . 0.0 109.473 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 -17.68 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.318 3.047 . . . . 0.0 115.677 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.88 -5.55 58.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.723 1.209 . . . . 0.0 111.652 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.36 127.49 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.043 1.337 . . . . 0.0 109.967 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.574 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 13.6 tptm -65.0 120.4 12.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 164.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 92.15 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 18.9 m-85 -66.62 98.1 0.49 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.534 1.133 . . . . 0.0 108.182 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 106.46 2.9 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.98 162.81 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.3 p -129.86 156.28 44.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 165.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -59.69 -22.91 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.335 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -83.06 -36.73 24.68 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 110.313 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.73 80.79 1.93 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.659 3.184 . . . . 0.0 102.877 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -106.59 -35.46 7.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.37 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -113.27 3.3 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.369 1.441 . . . . 0.0 113.312 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -101.61 0.2 35.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.365 1.866 . . . . 0.0 111.425 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -77.62 -31.62 52.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.122 -0.986 . . . . 0.0 111.247 -173.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 tp -39.31 -61.6 0.96 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.768 1.227 . . . . 0.0 110.462 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -68.29 -23.16 39.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.589 1.603 . . . . 0.0 115.495 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.75 -45.39 82.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.917 1.235 . . . . 0.0 108.323 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.85 HD11 HD11 ' A' ' 6' ' ' LEU . 7.3 mt -62.38 -49.46 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.042 0.937 . . . . 0.0 109.623 173.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.93 -41.69 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 119.824 1.193 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 58.0 m -64.36 -35.77 81.96 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 7.9 t -66.34 -34.73 78.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.083 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.95 -58.56 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.346 0.976 . . . . 0.0 108.399 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.05 -12.55 3.49 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 113.789 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.7 t -57.31 -32.98 67.22 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.925 -1.11 . . . . 0.0 110.832 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.167 0 O-C-N 120.572 -1.33 . . . . 0.0 108.819 -158.079 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.75 0.309 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.451 ' HB2' HG12 ' A' ' 163' ' ' VAL . 10.1 m-70 -34.45 143.66 0.04 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 128.065 2.546 . . . . 0.0 111.037 163.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.31 127.28 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.758 0.708 . . . . 0.0 109.634 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 139' ' ' ILE . 13.9 m-85 -140.03 134.0 30.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.874 0.87 . . . . 0.0 109.934 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 18' ' ' ILE . 4.0 mm? -82.08 161.47 22.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.791 1.636 . . . . 0.0 109.152 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -155.6 165.28 37.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.007 0.923 . . . . 0.0 108.818 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.69 -158.95 15.52 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.394 -1.225 . . . . 0.0 111.82 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.08 117.07 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.15 3.233 . . . . 0.0 112.248 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.47 172.51 13.44 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.771 2.981 . . . . 0.0 111.776 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.22 -63.77 0.29 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 167.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.41 125.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.31 -37.72 1.81 Allowed Glycine 0 C--O 1.223 -0.533 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 159.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.724 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -62.3 -29.74 70.65 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 117.887 0.843 . . . . 0.0 110.387 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -61.14 -48.43 81.63 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -55.17 -40.11 70.3 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 128.123 2.569 . . . . 0.0 107.873 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD22 ' H ' ' A' ' 177' ' ' LEU . 54.5 mt -62.37 -61.99 2.07 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 117.9 -1.047 . . . . 0.0 109.841 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 6' ' ' LEU . 1.5 mp -60.61 -45.64 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 119.6 1.091 . . . . 0.0 110.06 -174.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -59.24 4.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.692 1.597 . . . . 0.0 108.247 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 24' ' ' VAL . 59.7 mttm -63.11 -30.4 71.56 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.425 -1.274 . . . . 0.0 111.954 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.36 -32.75 68.85 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 119.878 1.217 . . . . 0.0 109.802 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -71.77 -44.66 63.64 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.192 0.451 . . . . 0.0 110.103 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -61.71 -22.31 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.06 0.944 . . . . 0.0 111.639 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' LYS . 3.0 t -69.08 -50.82 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 120.898 -1.126 . . . . 0.0 110.677 169.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.27 -36.81 84.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.505 0.722 . . . . 0.0 110.22 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -59.18 -48.83 80.18 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -67.74 -3.42 9.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.277 1.831 . . . . 0.0 112.799 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -120.38 11.78 11.52 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.786 1.634 . . . . 0.0 112.773 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.05 38.68 22.07 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 120.122 1.328 . . . . 0.0 113.689 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.46 118.63 37.11 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 107.489 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.49 99.08 0.8 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.77 2.98 . . . . 0.0 110.111 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.4 156.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.14 175.39 9.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.412 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 124.31 -170.64 16.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.89 156.89 46.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.465 0.65 . . . . 0.0 109.811 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -131.59 131.28 43.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 m -83.2 125.37 31.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.437 0.0 OUTLIER -103.7 -130.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 116.593 -1.67 . . . . 0.0 109.645 176.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -157.71 108.48 2.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 122.678 2.49 . . . . 0.0 110.037 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 107.52 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -128.89 113.32 15.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.47 -63.07 1.43 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.692 0.678 . . . . 0.0 109.245 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.49 68.91 0.34 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 106.409 -2.676 . . . . 0.0 106.409 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 -11.08 72.95 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.751 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 135.15 40.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.277 2.038 . . . . 0.0 109.899 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -67.45 141.18 57.07 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 167.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -148.99 -2.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.022 1.329 . . . . 0.0 112.846 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.84 -167.54 32.69 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 119.878 1.217 . . . . 0.0 110.973 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -137.97 154.04 49.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 117.141 0.47 . . . . 0.0 110.52 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -135.95 155.91 49.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 129.484 3.114 . . . . 0.0 106.221 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.76 108.34 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.72 122.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -165.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -72.1 155.24 40.5 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.5 mm? -62.58 -28.44 69.89 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.803 -1.186 . . . . 0.0 110.938 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -68.91 -20.8 64.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 128.033 2.533 . . . . 0.0 111.508 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.42 39.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.652 -1.082 . . . . 0.0 114.409 163.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.8 m -71.23 164.4 25.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.822 1.811 . . . . 0.0 107.491 160.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -141.56 136.38 31.04 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.134 0.974 . . . . 0.0 108.523 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.68 47.87 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.45 -177.53 1.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 145.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 -60.04 0.07 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 p -146.34 158.31 43.87 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.913 0.885 . . . . 0.0 109.122 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -143.37 165.43 27.54 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.863 2.065 . . . . 0.0 106.895 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.54 147.48 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 41.85 0.22 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.775 1.655 . . . . 0.0 110.706 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt 55.96 -167.62 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.798 1.299 . . . . 0.0 111.487 -173.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.4 142.54 25.13 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.836 0.854 . . . . 0.0 108.862 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.05 134.57 25.55 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.629 1.553 . . . . 0.0 109.825 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.86 159.25 54.62 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.006 2.471 . . . . 0.0 109.449 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.06 -6.37 18.09 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.521 2.147 . . . . 0.0 113.989 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.34 7.28 12.6 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.493 1.521 . . . . 0.0 113.622 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -138.49 88.07 2.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.384 2.092 . . . . 0.0 107.16 173.536 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.21 150.87 33.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.69 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.39 63.84 0.12 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.515 1.126 . . . . 0.0 108.534 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 59.8 m 47.78 -143.97 0.38 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.93 -1.106 . . . . 0.0 110.719 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.1 155.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 1 C-N-CA 133.701 4.801 . . . . 0.0 106.11 175.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.34 25.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 121.115 1.78 . . . . 0.0 111.017 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.2 111.73 0.94 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 64.05 -48.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.911 2.484 . . . . 0.0 113.953 -167.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.87 178.37 4.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.12 2.568 . . . . 0.0 108.717 -173.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.26 143.29 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 126.708 2.003 . . . . 0.0 106.53 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.11 176.65 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 119.708 1.14 . . . . 0.0 110.394 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -140.3 156.1 46.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 157.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.07 -33.93 38.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.88 0.872 . . . . 0.0 108.954 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.9 m -68.3 -33.35 74.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.843 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.9 m -60.69 -32.01 71.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 121.277 1.853 . . . . 0.0 109.846 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -69.11 -57.46 5.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -53.19 -24.09 10.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -48.81 -34.72 12.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.097 1.359 . . . . 0.0 112.827 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -31.98 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.3 44.08 0.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.281 1.432 . . . . 0.0 110.847 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.43 -61.69 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 127.186 2.195 . . . . 0.0 108.414 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.3 -24.18 16.94 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.04 1.827 . . . . 0.0 113.54 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.5 -30.32 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 119.463 1.029 . . . . 0.0 111.188 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.6 mt -76.46 -6.75 53.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.705 2.002 . . . . 0.0 111.316 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 92.16 2.1 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.46 1.504 . . . . 0.0 109.86 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 C--O 1.234 0.281 0 C-N-CA 125.635 1.574 . . . . 0.0 110.321 -175.016 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.27 170.47 22.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 128.247 2.619 . . . . 0.0 105.947 160.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 130.1 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 10.5 m -124.99 109.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 t -83.16 140.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 125.742 1.617 . . . . 0.0 111.203 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -151.67 85.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.516 1.126 . . . . 0.0 108.645 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.53 127.42 53.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.336 -1.478 . . . . 0.0 113.218 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 95.54 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 1 C-N-CA 133.585 4.754 . . . . 0.0 108.153 -173.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.87 57.5 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.653 2.381 . . . . 0.0 106.271 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.97 -33.96 0.03 OUTLIER Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.539 -1.351 . . . . 0.0 112.47 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -62.25 -17.98 59.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 119.612 -2.111 . . . . 0.0 113.822 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 9.81 28.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.879 1.672 . . . . 0.0 111.283 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -57.71 -13.57 4.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.65 -41.05 4.15 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.772 1.229 . . . . 0.0 111.917 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.4 -22.28 44.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.581 0.628 . . . . 0.0 112.39 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -50.44 135.23 22.62 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -136.92 -77.41 0.41 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.126 0.57 . . . . 0.0 111.009 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.28 -29.88 69.59 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 116.859 -1.543 . . . . 0.0 110.549 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.91 -54.58 12.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.051 -1.452 . . . . 0.0 111.69 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.3 mp -38.51 -63.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 126.566 1.946 . . . . 0.0 111.649 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.51 -51.59 68.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.13 72.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.0 p -87.95 -32.18 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.74 0.816 . . . . 0.0 110.373 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -36.95 32.47 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.042 165.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -48.2 -53.21 17.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.005 1.275 . . . . 0.0 109.529 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -41.63 61.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.791 2.036 . . . . 0.0 112.343 -175.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.47 -41.29 98.67 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.605 1.548 . . . . 0.0 110.606 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 t -78.46 25.26 0.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.948 1.699 . . . . 0.0 111.064 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.5 m -126.79 134.31 25.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.524 -1.36 . . . . 0.0 110.271 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.68 158.81 46.72 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.433 2.755 . . . . 0.0 109.888 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.93 3.78 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -61.84 148.03 44.62 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.227 1.014 . . . . 0.0 112.066 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.6 mt -130.2 108.26 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.444 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 18.0 mm -66.6 139.29 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mt -133.7 97.03 3.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.405 1.482 . . . . 0.0 107.878 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.19 -172.45 18.15 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 118.032 0.378 . . . . 0.0 113.209 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 m -142.26 136.39 29.75 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.931 1.292 . . . . 0.0 107.62 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.78 167.56 18.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.691 1.596 . . . . 0.0 110.079 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 160.05 51.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.562 1.508 . . . . 0.0 111.116 158.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.2 152.71 96.53 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.543 -0.723 . . . . 0.0 110.075 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -26.13 18.92 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.01 2.473 . . . . 0.0 111.983 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -50.71 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 128.394 2.678 . . . . 0.0 110.029 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.54 -118.79 1.65 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -167.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 171.23 7.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.225 1.41 . . . . 0.0 110.743 -171.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -57.4 170.98 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.456 2.104 . . . . 0.0 110.39 158.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -147.9 178.6 8.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.83 2.852 . . . . 0.0 105.396 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.1 -82.0 0.11 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 118.903 0.774 . . . . 0.0 109.096 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.83 -32.68 74.34 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 120.444 -1.41 . . . . 0.0 113.073 -171.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.81 -34.93 71.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 117.441 -1.266 . . . . 0.0 109.165 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.15 -34.18 73.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 111.153 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 125' ' ' ILE . 5.3 tp10 -54.33 -50.27 67.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.043 0.937 . . . . 0.0 109.76 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.0 -35.66 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -62.46 -25.62 68.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.13 0.877 . . . . 0.0 111.111 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.07 -14.17 61.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.258 1.023 . . . . 0.0 113.556 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -117.19 55.89 0.83 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.447 1.499 . . . . 0.0 107.898 -166.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 4.7 mmpt? -57.62 -10.32 1.51 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.426 1.491 . . . . 0.0 114.951 -166.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.0 -25.36 43.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.977 0.808 . . . . 0.0 112.163 167.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 3' ' ' HIS . 34.3 m -47.73 118.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 125.901 1.68 . . . . 0.0 109.185 164.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 134.34 53.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.519 1.928 . . . . 0.0 108.501 169.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.63 80.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.168 0.894 . . . . 0.0 108.78 -168.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.15 104.21 1.39 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.179 1.792 . . . . 0.0 109.135 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.58 116.17 17.02 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.906 -1.121 . . . . 0.0 109.52 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.73 166.73 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.983 0.897 . . . . 0.0 109.577 170.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.0 p -120.05 151.19 39.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 163.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -64.49 -21.08 66.57 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.386 -0.821 . . . . 0.0 109.477 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -67.74 -74.21 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.704 2.002 . . . . 0.0 109.135 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -91.06 31.9 1.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.924 1.289 . . . . 0.0 109.998 -175.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.79 -24.31 61.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.737 1.215 . . . . 0.0 112.115 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -114.93 21.9 13.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.19 2.596 . . . . 0.0 111.593 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -136.46 6.51 3.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.588 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' LEU . 2.7 tt -82.42 -13.27 57.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 117.436 -1.706 . . . . 0.0 110.627 -170.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.3 tp -36.39 -59.91 0.79 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 127.591 2.356 . . . . 0.0 112.533 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.2 -25.29 31.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 122.108 1.789 . . . . 0.0 112.087 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.2 -43.44 78.05 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.73 -53.01 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.02 -43.73 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.22 1.408 . . . . 0.0 110.264 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.1 m -60.83 -32.72 72.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.516 1.126 . . . . 0.0 111.569 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -65.33 -45.67 83.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.948 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.28 -48.29 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.998 0.919 . . . . 0.0 109.217 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -65.95 -24.5 66.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.7 t -67.96 -24.8 65.2 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.112 0.965 . . . . 0.0 109.992 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 124.32 1.048 . . . . 0.0 113.022 167.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -64.38 139.5 58.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.475 1.11 . . . . 0.0 109.315 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.46 138.25 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 14.9 m-85 -129.03 146.76 50.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.694 0.759 . . . . 0.0 109.899 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.866 HD21 HD11 ' A' ' 18' ' ' ILE . 1.8 mm? -100.65 131.16 46.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -121.59 175.44 6.22 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.64 0.733 . . . . 0.0 109.4 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.86 -135.73 8.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 125.462 1.506 . . . . 0.0 109.644 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.25 159.74 52.58 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.696 2.264 . . . . 0.0 111.761 -160.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.43 -9.67 25.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.951 3.101 . . . . 0.0 114.266 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.32 19.69 14.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.103 0.858 . . . . 0.0 112.464 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' LYS 0.301 46.9 t 74.29 -65.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.136 3.374 . . . . 0.0 109.272 168.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.37 5.05 26.74 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.236 1.398 . . . . 0.0 110.822 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 24.3 mtmt -121.76 -8.31 8.97 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 116.368 -1.777 . . . . 0.0 115.225 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.8 m -47.14 -41.19 17.13 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.769 1.622 . . . . 0.0 112.015 -166.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -43.63 -48.83 7.77 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.475 2.71 . . . . 0.0 109.906 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.542 ' CD1' ' H ' ' A' ' 176' ' ' LEU . 41.9 mt -69.54 -57.27 5.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 125.56 1.544 . . . . 0.0 109.743 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 6' ' ' LEU . 23.1 mm -57.74 -46.72 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.971 0.805 . . . . 0.0 109.118 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 -56.51 7.57 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.959 0.904 . . . . 0.0 111.321 171.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -68.58 -25.63 64.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.322 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -52.58 -39.6 61.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.442 1.097 . . . . 0.0 110.224 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -70.08 -35.07 73.93 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -58.67 -45.31 89.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.879 0.872 . . . . 0.0 109.124 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -60.53 -53.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.151 0.98 . . . . 0.0 110.213 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.93 -41.02 90.86 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.143 0.577 . . . . 0.0 109.449 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -69.59 -40.72 76.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.978 0.354 . . . . 0.0 110.126 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -61.18 -30.15 70.24 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.027 169.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -84.92 1.68 46.18 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.4 1.48 . . . . 0.0 112.858 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.75 1.46 66.94 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.236 1.398 . . . . 0.0 114.282 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.44 110.52 11.69 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.079 1.94 . . . . 0.0 107.809 -172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.93 119.33 6.39 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.555 2.17 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.95 118.17 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 109.033 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.27 170.79 9.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 126.234 1.813 . . . . 0.0 109.797 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 120.55 -156.5 16.01 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 163.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -149.46 167.79 25.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -141.42 -175.97 4.55 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -118.52 133.74 55.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.822 1.647 . . . . 0.0 107.086 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.45 33.78 5.41 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.584 -1.322 . . . . 0.0 112.222 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.04 -172.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.994 2.118 . . . . 0.0 110.51 -171.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.37 144.2 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 152.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -125.22 161.63 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.278 1.831 . . . . 0.0 107.758 167.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -108.79 45.88 1.01 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.079 1.352 . . . . 0.0 107.367 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 104.95 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -163.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.69 -51.93 3.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.944 1.259 . . . . 0.0 114.56 171.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.13 139.46 30.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 110.392 -162.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -70.15 134.77 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.47 -8.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -176.34 38.43 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 119.558 1.072 . . . . 0.0 110.613 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.57 148.84 51.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.77 135.14 32.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.8 155.73 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 C-N-CA 125.953 1.701 . . . . 0.0 108.536 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 m -141.51 143.09 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.972 165.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.9 p -82.87 161.97 21.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.406 1.003 . . . . 0.0 109.871 174.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.1 mm? -74.63 -14.27 60.75 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.529 -0.732 . . . . 0.0 112.935 176.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 t -69.14 -25.47 64.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.935 0.789 . . . . 0.0 109.49 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.56 9.65 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.079 0.847 . . . . 0.0 112.546 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -83.66 167.22 17.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 1.3 mpt_? -137.53 163.23 31.66 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -151.18 175.47 30.09 Favored Glycine 0 C--O 1.223 -0.571 0 CA-C-N 120.843 1.656 . . . . 0.0 110.531 158.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.71 161.6 35.14 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 109.749 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.4 -59.98 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.61 144.29 49.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -143.34 162.16 36.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.263 1.425 . . . . 0.0 108.053 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 149.79 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.22 157.4 28.27 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 166.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.47 162.87 7.47 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 161.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.67 150.63 81.11 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.42 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.22 124.87 11.3 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.334 2.023 . . . . 0.0 110.447 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.04 165.84 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.945 2.43 . . . . 0.0 109.465 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.97 101.75 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 108.549 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.45 -68.18 0.48 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.562 1.077 . . . . 0.0 110.421 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -76.72 125.31 29.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.87 7.94 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -135.61 41.42 2.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.179 1.392 . . . . 0.0 107.312 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.0 m 59.1 -161.61 0.26 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.771 2.028 . . . . 0.0 112.291 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 170.78 157.27 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.426 3.091 . . . . 0.0 109.5 175.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.01 0.53 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.93 140.41 11.03 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 -169.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.65 -69.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.965 1.706 . . . . 0.0 110.718 -158.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.11 148.92 21.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.785 1.234 . . . . 0.0 110.164 -167.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.6 t -91.26 139.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 162.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.93 -175.8 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 O-C-N 120.774 -1.204 . . . . 0.0 109.066 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.39 119.82 6.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 153.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.94 -34.61 71.95 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 112.117 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.9 m -51.51 -39.67 58.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.775 1.63 . . . . 0.0 110.35 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.09 -29.05 70.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.743 0.417 . . . . 0.0 110.597 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -71.53 -60.23 2.34 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.913 1.285 . . . . 0.0 108.006 170.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -49.25 -21.42 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.675 1.99 . . . . 0.0 113.778 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -57.34 -58.26 9.03 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.709 -1.244 . . . . 0.0 112.065 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -123.07 -34.15 3.2 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.833 1.253 . . . . 0.0 112.646 -164.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.45 55.92 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.693 1.597 . . . . 0.0 109.074 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 -58.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.679 -173.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.37 -27.06 19.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.893 2.395 . . . . 0.0 113.055 168.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 p -63.41 -27.87 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.914 -1.116 . . . . 0.0 110.659 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 84.4 1.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? 51.51 80.28 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.43 2.292 . . . . 0.0 113.163 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t30 . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 125.747 1.619 . . . . 0.0 108.124 153.657 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -79.31 156.21 28.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 160.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.2 149.31 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 150.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 19.5 t -127.93 163.56 24.21 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.898 1.226 . . . . 0.0 109.771 160.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.6 t -145.53 125.91 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.49 1.516 . . . . 0.0 107.137 -166.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.06 63.34 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.14 97.19 9.21 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.34 -31.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.128 0.571 . . . . 0.0 110.106 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.5 mt -60.26 120.31 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.537 1.135 . . . . 0.0 110.145 -159.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.41 -15.41 1.65 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.68 1.133 . . . . 0.0 112.479 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -100.22 -35.8 9.51 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.722 1.261 . . . . 0.0 110.461 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -87.92 19.97 3.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.024 1.73 . . . . 0.0 111.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -46.12 -33.43 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.677 1.126 . . . . 0.0 114.023 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -102.67 -45.32 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.518 2.327 . . . . 0.0 110.196 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.27 -21.52 63.88 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 124' ' ' PHE . 4.1 m -56.17 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.522 1.529 . . . . 0.0 111.331 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -84.16 -84.18 0.14 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.12 0.568 . . . . 0.0 110.051 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -60.52 -13.58 14.71 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.306 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' SER . 3.2 m-85 -54.77 -51.44 65.7 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 120.885 1.675 . . . . 0.0 111.61 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -52.11 -22.02 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 112.466 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.0 -58.97 2.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.719 -1.238 . . . . 0.0 108.713 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.46 -50.6 72.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.427 1.491 . . . . 0.0 111.594 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 t -61.56 -47.53 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.379 1.072 . . . . 0.0 108.412 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -57.7 -38.55 75.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -39.88 81.21 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.307 0.958 . . . . 0.0 110.758 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -71.03 -39.59 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.94 -14.32 61.88 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.31 1.044 . . . . 0.0 111.776 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -63.07 -50.1 71.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 120.396 1.453 . . . . 0.0 110.038 164.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -60.13 134.33 90.47 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.63 -33.91 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.878 1.719 . . . . 0.0 112.763 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.74 7.68 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 118.346 -1.252 . . . . 0.0 110.781 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 51.8 m -48.51 115.5 1.25 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.097 1.359 . . . . 0.0 111.286 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.1 mt -96.25 85.91 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 102.781 -3.044 . . . . 0.0 102.781 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.1 mm -52.91 117.85 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.438 HD21 HG23 ' A' ' 180' ' ' ILE . 14.6 mt -97.65 146.75 25.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 144.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.19 156.62 27.07 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 156.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 12' ' ' VAL . 95.0 m -91.31 149.48 21.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 164.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.3 pt -136.33 163.02 53.01 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.837 2.055 . . . . 0.0 108.72 166.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.51 165.01 23.34 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.34 2.693 . . . . 0.0 110.443 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.29 149.16 97.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.008 -1.058 . . . . 0.0 109.544 162.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.0 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.104 2.536 . . . . 0.0 109.354 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt 48.34 38.38 10.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.801 1.64 . . . . 0.0 112.872 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.59 -121.01 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 159.61 83.05 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 117.118 0.459 . . . . 0.0 110.145 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.49 166.61 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.95 1.766 . . . . 0.0 107.931 159.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.4 -163.86 1.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.85 -61.34 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.128 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -51.75 19.99 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.04 -22.7 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.74 1.155 . . . . 0.0 111.748 -169.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -42.16 80.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.564 2.346 . . . . 0.0 111.866 171.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.314 0.3 OUTLIER -58.53 -53.35 59.29 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 121.862 0.839 . . . . 0.0 110.006 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 5.3 mt -67.98 -26.54 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.793 0.837 . . . . 0.0 111.2 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -70.73 -20.51 62.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 120.345 -1.472 . . . . 0.0 111.422 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.2 -14.57 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 111.504 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -81.72 85.38 6.61 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 11.3 mmpt? -63.05 -20.46 65.35 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 111.714 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.29 -35.17 59.81 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.065 1.746 . . . . 0.0 113.236 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.26 124.1 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.4 1.48 . . . . 0.0 110.854 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -59.11 147.42 35.06 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.56 97.61 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -85.04 104.11 14.67 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.479 1.911 . . . . 0.0 108.203 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.55 103.0 13.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.309 1.443 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.53 163.02 4.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.665 1.222 . . . . 0.0 111.411 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.26 134.9 45.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.566 2.347 . . . . 0.0 106.16 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -46.55 -30.2 2.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.519 1.128 . . . . 0.0 111.489 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.06 -31.14 72.22 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 125.378 1.673 . . . . 0.0 110.591 -172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -131.7 18.29 4.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.026 1.33 . . . . 0.0 111.037 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -60.51 -21.88 62.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -167.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -102.02 11.73 37.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.08 1.352 . . . . 0.0 113.416 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -127.25 24.16 6.34 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.345 1.058 . . . . 0.0 110.973 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.542 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -83.5 -12.02 56.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.511 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.0 tt -47.11 -57.34 9.53 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.566 1.946 . . . . 0.0 112.068 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.43 -22.95 24.27 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 121.56 1.593 . . . . 0.0 113.08 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.61 -45.97 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.438 HG23 HD21 ' A' ' 140' ' ' LEU . 14.8 mt -63.78 -52.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.49 1.516 . . . . 0.0 109.441 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -55.56 -45.53 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.3 1.409 . . . . 0.0 109.654 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.3 m -56.92 -43.49 81.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.604 1.162 . . . . 0.0 110.366 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.8 t -65.35 -38.73 90.98 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.098 0.959 . . . . 0.0 111.855 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.64 -51.61 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 119.234 0.925 . . . . 0.0 108.833 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -66.59 -12.74 59.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.314 -0.851 . . . . 0.0 112.638 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 86.2 p -48.09 -45.17 32.36 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.757 1.223 . . . . 0.0 111.167 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.339 1 C-N-CA 133.283 4.633 . . . . 0.0 115.775 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.408 ' HB2' HG12 ' A' ' 163' ' ' VAL . 12.4 m-70 -34.18 138.84 0.08 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.29 3.036 . . . . 0.0 111.194 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 t -131.38 141.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 157' ' ' ILE . 28.3 m-85 -135.03 143.98 47.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.956 0.902 . . . . 0.0 109.435 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 176' ' ' LEU . 1.4 mm? -105.14 151.08 24.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.695 0.798 . . . . 0.0 110.778 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -156.67 -177.87 6.92 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 123.315 0.384 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.45 -141.08 13.87 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.275 2.369 . . . . 0.0 109.443 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.31 145.14 64.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.963 1.776 . . . . 0.0 111.109 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.28 160.56 44.78 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.27 1.98 . . . . 0.0 110.259 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.95 4.23 7.15 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.072 1.32 . . . . 0.0 115.795 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 5.8 p -74.16 22.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 119.67 1.735 . . . . 0.0 115.472 -160.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.18 -0.33 78.33 Favored Glycine 0 N--CA 1.464 0.545 0 O-C-N 120.013 -1.679 . . . . 0.0 112.062 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -21.15 64.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.944 1.298 . . . . 0.0 113.73 -171.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -50.36 -37.25 36.15 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 120.026 1.285 . . . . 0.0 110.666 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.4 m -57.03 -36.28 70.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.95 1.7 . . . . 0.0 113.51 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD11 ' HD2' ' A' ' 173' ' ' ARG . 0.5 OUTLIER -68.47 -52.44 32.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -178.421 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -36.0 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 O-C-N 122.088 -0.382 . . . . 0.0 111.085 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -54.21 -51.87 63.05 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.4 mttm -54.64 -43.0 71.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.286 173.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -33.74 68.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.998 1.272 . . . . 0.0 111.476 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -68.18 -53.78 22.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.99 -34.08 77.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.5 1.12 . . . . 0.0 112.59 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 20' ' ' LYS . 74.2 t -62.86 -49.27 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.45 1.5 . . . . 0.0 110.733 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.5 -40.92 98.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.8 -42.37 98.92 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.47 69.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 112.407 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -83.23 -0.62 50.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.971 -1.08 . . . . 0.0 112.136 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.02 36.08 57.3 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.786 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.77 109.13 40.09 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.3 143.92 78.69 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.88 132.52 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.55 174.51 5.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.512 1.525 . . . . 0.0 107.667 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.16 -161.76 23.1 Favored Glycine 0 CA--C 1.508 -0.402 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.79 163.72 37.94 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 117.343 0.571 . . . . 0.0 111.444 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -138.28 168.34 19.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.4 p -109.87 91.32 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.58 -4.26 22.24 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.919 -1.113 . . . . 0.0 113.664 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 84.14 167.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 130.61 3.564 . . . . 0.0 110.357 -158.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.14 118.54 11.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 164.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -111.03 148.33 32.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 163.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -142.66 116.77 9.45 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 156.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.18 26.84 64.25 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.965 0.802 . . . . 0.0 111.486 -166.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.74 -20.0 2.45 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.411 1.325 . . . . 0.0 116.411 172.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.79 7.35 2.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.073 2.437 . . . . 0.0 116.498 -157.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.651 1.98 . . . . 0.0 110.998 -165.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.63 -11.63 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.732 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.84 -147.19 16.73 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.341 -1.903 . . . . 0.0 108.341 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -141.7 163.18 33.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.554 1.542 . . . . 0.0 109.551 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -120.36 166.23 13.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.935 1.694 . . . . 0.0 106.839 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -126.47 104.9 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 123.849 0.859 . . . . 0.0 108.717 174.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.5 117.55 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -164.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 p -66.19 161.84 21.16 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 109.293 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.87 -1.32 6.98 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.83 -1.169 . . . . 0.0 112.324 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -105.14 7.21 33.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.475 1.91 . . . . 0.0 112.479 168.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.28 6.59 83.78 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 120.385 -1.447 . . . . 0.0 115.015 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 149.63 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 156.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 18.9 ptt-85 -150.45 149.57 30.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.108 1.322 . . . . 0.0 111.041 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.8 158.74 18.43 Favored Glycine 0 C--O 1.22 -0.768 0 CA-C-O 116.879 -2.067 . . . . 0.0 111.325 -172.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.95 9.79 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.457 3.438 . . . . 0.0 113.791 -164.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 24.54 -74.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 131.415 3.886 . . . . 0.0 116.301 171.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 p -136.44 143.25 43.81 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 164.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.48 67.87 0.46 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.508 0.594 . . . . 0.0 110.039 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.5 t 48.66 134.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 130.348 3.459 . . . . 0.0 114.798 -172.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.34 52.79 0.49 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 53.5 -178.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.227 1.811 . . . . 0.0 111.783 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -80.91 158.35 70.45 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 159.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.03 140.14 14.02 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.153 2.568 . . . . 0.0 110.356 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.21 175.29 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.992 3.128 . . . . 0.0 110.578 165.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.63 150.87 86.03 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.021 1.147 . . . . 0.0 109.27 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.86 -73.26 0.66 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.059 0.837 . . . . 0.0 112.582 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 115.45 5.03 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.232 1.016 . . . . 0.0 109.049 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -173.62 153.37 2.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.89 2.076 . . . . 0.0 106.785 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.75 -27.61 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 151.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 65.8 m -152.13 143.59 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.622 1.569 . . . . 0.0 109.442 -170.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.65 139.32 4.49 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.29 85.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 172.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.38 -67.2 0.25 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.092 1.806 . . . . 0.0 112.041 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -144.72 -18.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.368 2.267 . . . . 0.0 113.402 -167.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -106.57 125.81 51.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.84 130.98 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 167.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.62 168.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.449 1.022 . . . . 0.0 108.598 165.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.11 111.13 14.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.71 -31.53 66.5 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.689 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.2 m -60.81 -38.15 84.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.707 1.603 . . . . 0.0 111.493 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.7 m -58.84 -36.38 74.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.7 1.136 . . . . 0.0 110.446 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.34 -49.8 65.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.074 0.95 . . . . 0.0 111.478 171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.511 ' HA ' HD13 ' A' ' 92' ' ' LEU . 52.0 mt-10 -53.38 -25.44 15.53 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.161 0.891 . . . . 0.0 113.1 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.68 -50.84 65.4 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.237 1.38 . . . . 0.0 111.934 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.18 -25.59 1.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.773 -166.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.55 59.61 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.275 1.398 . . . . 0.0 109.402 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 88' ' ' GLU . 3.1 mp -49.9 -45.96 80.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.095 -1.431 . . . . 0.0 114.045 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.87 -27.33 7.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 CA-C-N 121.733 1.655 . . . . 0.0 113.834 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.3 -29.75 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.737 1.153 . . . . 0.0 111.26 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.7 34.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.021 2.128 . . . . 0.0 111.007 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.275 4.8 mmm-85 173.84 -134.7 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 130.851 3.66 . . . . 0.0 107.238 -164.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 . . . . . 0 N--CA 1.438 -1.031 0 C-N-CA 126.041 1.736 . . . . 0.0 111.408 -153.613 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.37 163.76 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.84 145.2 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 168.01 10.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.421 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.11 129.46 50.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.367 1.067 . . . . 0.0 108.32 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -133.56 67.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -79.83 67.94 5.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.869 0.868 . . . . 0.0 109.706 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -95.06 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 153' ' ' LEU 0.286 78.6 mt 41.45 53.57 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 128.117 2.567 . . . . 0.0 109.864 177.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.66 -61.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 121.466 -0.771 . . . . 0.0 112.396 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -20.69 64.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.42 2.11 . . . . 0.0 113.613 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.77 18.02 21.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.615 1.566 . . . . 0.0 109.713 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.54 -18.17 2.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -166.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.41 -30.49 8.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.105 0.866 . . . . 0.0 111.321 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -90.21 -20.02 23.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.368 1.067 . . . . 0.0 112.669 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m -59.83 103.92 0.25 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.579 0.752 . . . . 0.0 110.792 -166.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.81 -81.72 0.47 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.256 0.935 . . . . 0.0 111.821 -163.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.93 -10.05 8.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.028 1.731 . . . . 0.0 112.28 169.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.53 -61.77 1.85 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.327 1.451 . . . . 0.0 110.901 174.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.2 mp -38.08 -64.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.841 2.056 . . . . 0.0 112.16 172.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -53.75 54.6 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.406 0.548 . . . . 0.0 110.012 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.76 72.64 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.44 -173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 157' ' ' ILE . 2.7 t -49.09 -55.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.296 1.839 . . . . 0.0 109.275 172.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -62.98 -36.5 83.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.957 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.9 -44.84 88.3 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.122 0.874 . . . . 0.0 110.068 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.1 m -65.74 -34.83 79.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.094 0.957 . . . . 0.0 111.003 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.61 -30.31 69.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.429 1.492 . . . . 0.0 112.104 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.3 m -107.9 14.29 25.49 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.626 1.57 . . . . 0.0 112.082 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.4 m -76.97 133.78 69.01 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -77.33 109.5 2.81 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 108.096 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 125.1 -87.42 0.37 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 107.246 -2.342 . . . . 0.0 107.246 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 m -43.83 146.24 0.6 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.847 1.659 . . . . 0.0 112.375 -171.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.95 107.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 134.66 26.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.45 142.48 50.78 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 163.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.97 172.24 45.31 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 120.741 -1.224 . . . . 0.0 110.673 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.9 m -121.62 135.49 54.98 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.724 1.21 . . . . 0.0 108.403 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.1 pt -125.93 151.18 70.99 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.911 1.684 . . . . 0.0 110.156 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.82 150.57 49.93 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 109.194 169.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.85 118.92 59.57 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 123.112 0.565 . . . . 0.0 110.596 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.14 117.72 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.102 2.534 . . . . 0.0 107.63 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -152.92 -35.03 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.199 0.999 . . . . 0.0 110.624 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.64 -152.9 6.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 164.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 140.34 93.81 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.543 -0.975 . . . . 0.0 109.726 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.33 120.11 4.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.812 3.675 . . . . 0.0 111.407 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.0 155.88 38.13 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.827 1.651 . . . . 0.0 113.123 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.31 -60.21 2.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.886 2.074 . . . . 0.0 113.802 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.405 HD13 HG23 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -62.13 -47.07 86.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.59 -41.03 52.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.09 -36.15 74.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.94 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -55.16 -49.27 72.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.944 1.247 . . . . 0.0 110.035 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 128' ' ' VAL . 5.2 mp -75.82 -46.13 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.069 0.548 . . . . 0.0 109.619 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -39.49 74.74 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.402 1.081 . . . . 0.0 109.55 -174.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -60.05 -23.51 63.8 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.123 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -63.41 -42.15 98.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.576 1.08 . . . . 0.0 111.624 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 8.9 mmpt? 61.91 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.591 2.356 . . . . 0.0 115.055 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -28.63 67.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.448 1.022 . . . . 0.0 110.911 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 3' ' ' HIS . 36.0 m -57.32 123.92 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.193 0.997 . . . . 0.0 108.845 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -71.08 106.21 3.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.5 t -84.25 95.53 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -83.46 112.95 20.42 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.55 120.61 17.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.406 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -65.68 164.61 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.567 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 82.8 p -122.28 163.2 20.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.07 -21.57 64.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.788 -1.195 . . . . 0.0 109.805 161.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -79.9 -47.84 14.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.67 0.788 . . . . 0.0 111.097 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.93 32.01 5.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.939 1.696 . . . . 0.0 110.433 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 17' ' ' LEU . 3.0 tmm_? -48.52 -59.86 3.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.249 1.419 . . . . 0.0 109.668 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -76.63 4.15 10.04 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -116.92 4.61 12.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.002 1.721 . . . . 0.0 110.878 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 6.0 tp -80.26 -40.22 27.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.307 0.503 . . . . 0.0 112.044 170.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.79 -57.92 0.73 Allowed Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 126.177 1.791 . . . . 0.0 110.222 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.08 -25.21 44.08 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.203 1.936 . . . . 0.0 114.994 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.14 -38.79 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.061 -1.025 . . . . 0.0 109.587 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 5.9 mt -62.65 -47.95 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.38 -40.93 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.76 1.224 . . . . 0.0 110.443 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.8 m -65.13 -43.26 92.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.247 1.019 . . . . 0.0 110.04 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 10.3 t -68.61 -33.24 73.69 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.096 -1.002 . . . . 0.0 112.229 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.8 t -63.07 -64.91 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -35.86 80.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.078 -171.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 t -24.47 -86.28 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.942 2.897 . . . . 0.0 113.563 -165.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.462 0.171 0 C-N-CA 127.921 2.488 . . . . 0.0 113.198 177.271 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 . . . . . 0 C--O 1.235 0.336 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -73.76 151.79 40.53 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.37 155.95 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 109.082 170.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -142.2 165.04 28.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.289 1.036 . . . . 0.0 109.81 171.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 18' ' ' ILE . 4.4 mm? -100.96 150.39 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.188 2.195 . . . . 0.0 108.736 169.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -156.16 -162.76 1.34 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.86 -174.07 26.28 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.18 1.848 . . . . 0.0 112.251 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.25 149.76 81.47 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.443 2.762 . . . . 0.0 111.477 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.16 119.42 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.071 2.514 . . . . 0.0 109.307 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.48 -17.15 27.33 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 117.927 -1.485 . . . . 0.0 110.583 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 64.85 113.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.051 1.74 . . . . 0.0 109.164 -169.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.39 65.86 0.75 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -97.94 -33.47 11.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.16 0.584 . . . . 0.0 110.841 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -53.28 -38.5 63.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.92 2.088 . . . . 0.0 111.983 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.9 m -62.92 -40.64 98.22 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.581 -0.699 . . . . 0.0 112.609 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -45.37 87.34 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 120.253 -1.53 . . . . 0.0 108.041 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 HD23 ' A' ' 6' ' ' LEU . 9.2 mm -55.56 -46.83 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.875 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -54.52 -50.9 66.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.178 1.354 . . . . 0.0 108.996 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -50.54 -43.91 56.26 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 110.627 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.6 69.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.069 0.849 . . . . 0.0 111.232 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.487 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.26 -39.32 69.65 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.001 0.92 . . . . 0.0 111.326 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.64 -48.94 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 O-C-N 121.451 -0.781 . . . . 0.0 109.745 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.4 mt -60.56 -41.44 94.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -60.58 -41.43 94.66 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -68.59 -25.27 64.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.046 1.338 . . . . 0.0 112.652 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -73.07 -24.23 60.65 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.928 173.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.69 2.75 10.42 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.124 1.821 . . . . 0.0 113.418 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.7 t -88.17 122.97 69.5 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.452 1.626 . . . . 0.0 109.616 -161.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.83 84.93 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.549 2.166 . . . . 0.0 109.001 161.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.13 141.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 125.48 1.512 . . . . 0.0 107.561 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -127.1 175.47 8.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.289 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.85 -160.88 16.16 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 120.623 1.556 . . . . 0.0 111.42 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.27 154.63 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.363 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -119.56 178.78 4.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.688 1.595 . . . . 0.0 106.903 165.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -143.38 144.25 31.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 168.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.92 161.03 36.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 109.914 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.37 129.92 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.505 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.95 97.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -117.74 97.99 6.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.995 1.718 . . . . 0.0 106.461 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -64.21 99.45 0.28 Allowed 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.82 -59.57 2.58 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.483 1.04 . . . . 0.0 111.568 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.67 40.77 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.362 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -127.8 132.28 49.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -63.08 114.61 3.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 -23.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.704 0.802 . . . . 0.0 112.876 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.95 -170.86 42.14 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 120.261 1.391 . . . . 0.0 111.716 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -119.32 170.08 9.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 157.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.265 31.4 p30 -129.85 159.75 35.62 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.114 -0.367 . . . . 0.0 110.798 158.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.51 109.92 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.33 113.77 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 p -80.04 157.38 26.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.9 3.36 3.36 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.016 -1.052 . . . . 0.0 112.44 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.4 m -72.41 -11.51 60.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.198 0.999 . . . . 0.0 111.942 160.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.15 76.77 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.289 -0.882 . . . . 0.0 111.943 -167.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.568 HG22 HD23 ' A' ' 90' ' ' LEU . 31.0 m -102.76 154.81 18.81 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.551 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -143.48 141.35 30.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.069 0.85 . . . . 0.0 111.0 -163.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.24 142.12 13.25 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 74.9 1.98 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 125.075 3.85 . . . . 0.0 111.405 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.4 HD22 ' CG2' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -49.16 -49.66 41.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.195 0.998 . . . . 0.0 110.18 -177.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.41 126.06 13.37 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -144.64 92.96 2.35 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 65' ' ' GLY 0.433 4.0 m 34.86 -126.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 113.606 -174.362 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' H ' HG23 ' A' ' 64' ' ' VAL . . . 110.02 149.32 12.48 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 120.181 1.355 . . . . 0.0 110.991 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.77 152.19 32.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -77.35 164.67 56.99 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.109 0.964 . . . . 0.0 110.009 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.98 124.49 8.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.376 2.05 . . . . 0.0 107.151 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -66.24 169.92 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.949 1.766 . . . . 0.0 108.957 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.39 119.22 6.21 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.748 1.632 . . . . 0.0 108.268 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.11 -68.71 0.54 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.621 1.105 . . . . 0.0 110.705 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -68.02 149.87 49.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 1.151 . . . . 0.0 109.013 178.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.16 156.91 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 164.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 13.9 pt-20 -158.05 -163.19 1.26 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.545 1.938 . . . . 0.0 106.839 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.18 -165.94 1.38 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.052 1.341 . . . . 0.0 108.952 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 3.6 tmm_? 146.62 140.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.104 3.362 . . . . 0.0 107.428 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.22 -24.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.75 104.76 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 107.071 -2.412 . . . . 0.0 107.071 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 65.31 -55.42 0.32 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 129.031 2.932 . . . . 0.0 111.828 -163.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -84.52 137.69 33.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.777 0.831 . . . . 0.0 110.624 -168.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 4.9 p -82.07 110.91 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 172.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.4 ' CG2' HD22 ' A' ' 61' ' ' LEU . 1.4 p -71.46 162.89 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -143.8 125.2 14.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 167.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.93 -26.37 65.9 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.943 0.897 . . . . 0.0 111.668 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -55.31 -35.24 64.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.778 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -60.86 -40.11 91.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.119 0.872 . . . . 0.0 110.521 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -61.27 -50.93 71.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.557 0.617 . . . . 0.0 109.341 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.49 -21.41 62.37 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.92 -45.67 91.82 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.747 0.703 . . . . 0.0 111.843 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -154.31 -28.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -161.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.26 20.59 1.59 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.628 1.171 . . . . 0.0 110.416 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.674 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -121.9 -47.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.973 2.509 . . . . 0.0 112.682 -172.352 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -64.3 -25.14 64.48 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.65 1.566 . . . . 0.0 111.203 166.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.0 -29.08 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.497 -0.752 . . . . 0.0 113.007 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 mm? -62.7 -51.47 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.906 0.775 . . . . 0.0 109.534 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -127.47 99.23 5.53 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 p30 . . . . . 0 N--CA 1.444 -0.757 0 C-N-CA 124.847 1.259 . . . . 0.0 111.445 179.158 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -140.2 177.63 7.85 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.458 1.903 . . . . 0.0 108.371 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.5 t -133.95 147.22 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 168.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.2 162.19 17.84 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.1 0.96 . . . . 0.0 110.047 172.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.19 130.61 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.003 1.721 . . . . 0.0 107.421 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.3 mt -149.12 106.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -98.32 177.23 5.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.272 -1.518 . . . . 0.0 108.52 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.01 27.65 15.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.406 2.682 . . . . 0.0 113.402 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.59 98.15 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.95 -77.91 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-O 118.795 -1.003 . . . . 0.0 110.748 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -53.97 -30.26 46.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.782 1.233 . . . . 0.0 113.913 -164.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -64.19 -16.17 61.41 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 126.387 1.875 . . . . 0.0 112.156 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -24.31 -59.6 0.05 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.573 2.749 . . . . 0.0 116.2 -163.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.82 -34.8 67.08 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.921 1.288 . . . . 0.0 111.904 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -81.15 -27.68 35.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.702 1.601 . . . . 0.0 111.613 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.6 m -52.09 110.52 0.49 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.467 1.507 . . . . 0.0 109.233 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.67 -8.56 0.49 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.97 -31.35 2.89 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 125.717 1.607 . . . . 0.0 108.996 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -27.64 -73.73 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 129.102 2.961 . . . . 0.0 110.928 164.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -34.33 -63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 128.22 2.608 . . . . 0.0 113.84 172.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.05 -43.05 83.68 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.866 1.212 . . . . 0.0 111.175 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.53 99.42 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.461 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.72 -36.45 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.006 0.922 . . . . 0.0 109.394 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.19 -26.75 63.17 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.232 -1.543 . . . . 0.0 113.941 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -55.49 -56.95 14.29 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.523 1.056 . . . . 0.0 108.91 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 m -66.78 -34.73 78.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.631 1.572 . . . . 0.0 112.489 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.85 -27.81 69.12 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.492 -0.755 . . . . 0.0 109.743 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 t -85.74 -23.6 27.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.709 1.603 . . . . 0.0 111.614 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.8 m -58.38 139.03 85.01 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.2 1.364 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -86.21 107.27 0.84 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.768 2.979 . . . . 0.0 109.16 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 128.87 -43.33 1.33 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.603 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.2 m -57.13 157.54 5.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.158 1.479 . . . . 0.0 110.579 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.22 102.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.91 129.73 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 166.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.25 111.65 11.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.56 174.82 25.41 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.086 0.857 . . . . 0.0 113.08 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.0 m -117.54 122.07 42.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.391 1.096 . . . . 0.0 110.092 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.51 143.25 29.03 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.618 1.167 . . . . 0.0 109.094 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.59 141.25 54.53 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.017 1.811 . . . . 0.0 108.393 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.13 114.5 12.82 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.5 149.55 27.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.367 2.711 . . . . 0.0 109.063 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -140.67 -72.11 0.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.694 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.76 -66.1 2.64 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 146.8 54.65 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 117.639 0.719 . . . . 0.0 109.44 174.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.83 161.26 21.36 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.929 2.419 . . . . 0.0 107.976 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -93.14 155.8 17.25 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -38.9 -50.89 1.76 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.316 2.246 . . . . 0.0 114.146 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 124' ' ' PHE . 4.4 mm? -80.17 -38.19 31.82 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.063 0.545 . . . . 0.0 109.976 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.12 -17.46 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.287 -1.508 . . . . 0.0 110.279 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.64 -61.73 1.75 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.799 -1.188 . . . . 0.0 109.634 161.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.325 0.2 OUTLIER -53.73 -54.35 39.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.092 0.948 . . . . 0.0 112.709 -174.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.27 -30.8 49.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 124.903 1.281 . . . . 0.0 111.788 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -31.29 70.66 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.118 -0.989 . . . . 0.0 110.888 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -69.27 -6.73 31.24 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.484 0.584 . . . . 0.0 110.718 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -69.24 -30.28 68.38 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.368 -0.833 . . . . 0.0 112.878 170.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -43.67 0.28 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.355 2.262 . . . . 0.0 115.322 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -89.46 64.1 6.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.375 2.27 . . . . 0.0 108.638 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.58 122.95 48.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 tppm? -65.23 110.51 2.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 158.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 m -96.94 88.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 180' ' ' ILE . 19.4 m-85 -61.2 101.58 0.17 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.505 1.122 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.32 93.73 1.53 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.57 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -57.11 166.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.0 p -131.72 162.45 30.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 165.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -61.07 -30.7 70.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.733 -0.604 . . . . 0.0 109.393 159.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.82 -67.07 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.348 1.859 . . . . 0.0 110.266 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.0 33.57 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.891 1.676 . . . . 0.0 110.141 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -56.42 -62.82 1.46 Allowed 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.028 -1.045 . . . . 0.0 111.066 -170.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.77 3.29 12.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.82 -1.24 56.94 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.66 1.584 . . . . 0.0 111.364 172.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 168' ' ' VAL . 7.3 tp -87.37 -32.23 19.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 118.822 -1.151 . . . . 0.0 112.369 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.4 -58.31 3.06 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.739 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.87 -21.92 27.7 Favored 'Trans proline' 0 C--N 1.354 0.85 0 CA-C-N 121.383 1.529 . . . . 0.0 112.798 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -40.66 75.69 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.662 1.985 . . . . 0.0 109.005 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 4.3 mt -66.76 -50.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.212 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.505 ' HA ' HG23 ' A' ' 184' ' ' VAL . 42.0 t -50.9 -29.94 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.741 1.617 . . . . 0.0 109.473 174.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.8 m -75.09 -18.32 60.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 119.999 -1.688 . . . . 0.0 112.973 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -52.71 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -56.61 -60.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.694 1.998 . . . . 0.0 109.453 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.64 -22.02 61.29 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.069 -1.02 . . . . 0.0 113.19 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 37.1 m -73.08 -59.76 2.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.906 0.882 . . . . 0.0 111.316 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.837 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 8.4 tpp180 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 83.3 m-70 -51.32 156.08 1.27 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.613 1.565 . . . . 0.0 111.076 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -129.94 142.13 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 157' ' ' ILE . 24.4 m-85 -135.55 158.34 44.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 160.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mt -93.21 150.62 20.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -154.41 -172.48 4.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.28 -175.12 24.59 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.971 1.272 . . . . 0.0 110.951 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.12 162.02 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.239 2.626 . . . . 0.0 111.557 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.02 153.95 67.19 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.288 1.325 . . . . 0.0 109.481 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.33 -5.64 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 126.61 2.052 . . . . 0.0 110.712 162.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.26 30.2 t 67.1 126.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.616 1.198 . . . . 0.0 110.527 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.41 -9.94 10.8 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.27 164.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -54.9 -31.12 59.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.224 1.012 . . . . 0.0 111.141 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -56.48 -35.72 68.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.646 1.578 . . . . 0.0 110.31 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -67.44 -24.23 65.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.301 -1.499 . . . . 0.0 113.09 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -55.22 20.48 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 170.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -57.05 -46.07 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.319 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -47.83 -57.79 5.18 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.736 0.814 . . . . 0.0 110.023 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -62.57 -40.8 98.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.67 55.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.089 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 p -71.59 -47.81 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.976 1.262 . . . . 0.0 109.97 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.9 -36.42 74.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 110.727 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.45 -53.03 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 125.383 1.473 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -57.81 -42.4 84.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -63.05 -36.31 83.14 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.351 0.26 . . . . 0.0 110.661 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 m -77.37 -10.78 59.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.586 1.954 . . . . 0.0 112.714 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.9 m -100.08 6.08 44.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.627 2.371 . . . . 0.0 111.676 168.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.47 11.79 84.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.708 -1.051 . . . . 0.0 114.633 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.51 139.06 44.28 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 119.557 1.678 . . . . 0.0 109.242 -170.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.82 89.6 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.91 3.073 . . . . 0.0 111.608 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.93 148.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.154 1.382 . . . . 0.0 109.297 172.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -147.53 -176.0 5.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.044 2.138 . . . . 0.0 109.984 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA3' ' H ' ' A' ' 110' ' ' VAL . . . 123.43 -156.81 17.8 Favored Glycine 0 C--O 1.24 0.514 0 C-N-CA 127.88 2.657 . . . . 0.0 108.138 174.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.52 171.3 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.976 0.888 . . . . 0.0 110.231 171.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -137.08 -178.41 5.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 165.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.5 p -130.41 154.32 47.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 160.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.47 13.69 3.78 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 112.63 -172.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.275 12.6 pt-20 50.65 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 127.1 2.16 . . . . 0.0 110.783 -156.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.713 HG13 HG13 ' A' ' 47' ' ' ILE . 11.0 p -63.11 138.61 22.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -122.97 164.81 17.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.668 1.187 . . . . 0.0 108.404 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.67 96.67 2.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.34 -66.45 1.49 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.61 12.11 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.652 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.96 143.17 47.19 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 118.597 1.198 . . . . 0.0 109.1 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -63.09 154.75 29.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 124.671 1.232 . . . . 0.0 108.873 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.713 HG13 HG13 ' A' ' 40' ' ' VAL . 1.1 pt -140.3 -13.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.791 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 157.27 -142.82 8.94 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.141 -2.383 . . . . 0.0 107.141 173.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -142.35 66.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.229 1.515 . . . . 0.0 110.602 -172.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -53.15 143.88 16.91 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.55 114.85 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 118.568 0.622 . . . . 0.0 109.559 -160.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.33 109.68 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -150.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -59.87 146.02 43.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.02 -11.51 39.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.278 168.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 -14.56 61.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.516 1.926 . . . . 0.0 111.618 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 67.82 1.47 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 119.412 1.005 . . . . 0.0 111.148 -177.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -157.32 151.43 24.73 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.707 3.203 . . . . 0.0 104.706 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.41 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -142.63 154.44 44.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 121.278 1.853 . . . . 0.0 109.714 -173.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.02 156.86 19.78 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.083 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.98 54.32 4.82 Favored 'Trans proline' 0 CA--C 1.539 0.762 1 C-N-CA 125.695 4.264 . . . . 0.0 113.21 -173.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -51.44 -52.36 46.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.656 1.582 . . . . 0.0 111.137 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 p -150.16 133.05 16.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.34 43.15 0.52 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.351 0.26 . . . . 0.0 110.624 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t 60.43 154.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 129.045 2.938 . . . . 0.0 110.641 -167.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.02 160.1 31.7 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 105.481 -3.048 . . . . 0.0 105.481 166.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.28 164.78 12.77 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.006 0.908 . . . . 0.0 110.461 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -63.83 148.65 94.42 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.134 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.32 133.24 17.41 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.452 2.768 . . . . 0.0 110.184 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.34 174.26 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.347 2.698 . . . . 0.0 110.875 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.4 -24.69 64.05 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.095 1.196 . . . . 0.0 113.282 -176.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.22 -1.68 47.95 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.698 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -148.06 143.98 27.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.137 1.969 . . . . 0.0 108.581 -172.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.01 149.89 27.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.507 ' HG3' ' HE2' ' A' ' 72' ' ' LYS . 22.2 mt-10 -132.47 162.36 31.36 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.359 1.863 . . . . 0.0 109.537 168.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.71 136.26 57.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.687 1.195 . . . . 0.0 109.211 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.39 154.64 41.86 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.263 -172.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.96 119.74 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.25 -107.3 1.64 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.49 -10.76 15.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 112.868 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.09 140.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.87 163.22 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 160.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.55 173.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 O-C-N 120.501 -1.374 . . . . 0.0 109.889 171.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.77 98.71 4.25 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.89 -35.7 71.37 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.101 -0.999 . . . . 0.0 110.701 173.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -66.35 -30.63 71.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.616 0.766 . . . . 0.0 109.966 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.8 t -62.01 -23.91 66.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 120.041 1.291 . . . . 0.0 111.891 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -73.09 -62.73 1.36 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.24 -13.7 13.94 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -53.82 -42.71 68.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 111.623 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.64 -35.67 0.49 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.052 0.541 . . . . 0.0 112.242 -168.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 63.67 4.46 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -65.25 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 127.708 2.403 . . . . 0.0 105.766 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 -18.11 36.93 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.383 2.055 . . . . 0.0 114.348 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 95' ' ' LEU . 20.0 m -67.5 -64.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.595 1.089 . . . . 0.0 108.697 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 94' ' ' VAL . 76.5 mt -45.62 -56.13 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.657 2.383 . . . . 0.0 108.506 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.16 89.16 3.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.13 0.491 . . . . 0.0 110.742 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.442 -0.864 0 C-N-CA 118.044 -1.463 . . . . 0.0 107.62 158.556 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 CA--C 1.525 0.006 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -124.6 164.77 19.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.899 1.68 . . . . 0.0 107.209 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -124.42 141.4 44.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.401 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 8.9 t -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.406 ' H ' ' HA3' ' A' ' 34' ' ' GLY . 90.6 t -141.14 128.95 22.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.486 1.514 . . . . 0.0 107.138 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.52 68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.19 -168.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.81 18.85 0.55 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.037 1.735 . . . . 0.0 114.634 -171.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -67.51 129.47 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 119.327 -2.108 . . . . 0.0 107.404 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.05 -75.63 0.22 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-O 119.496 -0.614 . . . . 0.0 112.141 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -64.54 -26.9 68.62 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.074 0.937 . . . . 0.0 112.022 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.8 mmm -63.66 -7.68 8.06 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 116.55 -1.69 . . . . 0.0 114.03 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -42.23 -44.73 3.89 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.519 1.963 . . . . 0.0 114.517 -165.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.51 -39.1 28.51 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.422 0.689 . . . . 0.0 111.736 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -84.06 -21.21 31.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.24 1.016 . . . . 0.0 110.987 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.2 t -42.16 123.09 2.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 129.762 3.225 . . . . 0.0 110.569 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.45 -88.61 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 107.605 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.88 -1.86 8.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.587 -0.72 . . . . 0.0 112.131 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -71.82 0.11 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.654 1.115 . . . . 0.0 110.188 160.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.33 -31.42 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 126.002 1.721 . . . . 0.0 113.105 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -60.56 2.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 120.664 -1.273 . . . . 0.0 112.813 171.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.26 67.23 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 111.828 -166.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.86 -51.17 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -57.78 -40.14 79.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 120.301 1.41 . . . . 0.0 113.412 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -56.73 -20.53 22.5 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.313 1.045 . . . . 0.0 112.515 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -108.71 -27.87 9.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.977 1.311 . . . . 0.0 110.234 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.187 1.395 . . . . 0.0 111.633 168.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.7 t -58.3 -44.68 88.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.477 0.711 . . . . 0.0 109.442 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.1 m -77.3 133.43 68.15 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.92 -30.04 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.439 2.76 . . . . 0.0 111.3 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.75 -65.38 3.62 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.712 2.101 . . . . 0.0 111.634 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 20.1 m -59.46 143.33 50.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.91 169.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.19 96.8 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mm -56.7 130.9 19.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 142.33 50.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.726 2.411 . . . . 0.0 105.304 167.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.37 175.28 45.58 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.281 0.946 . . . . 0.0 110.945 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.1 m -115.94 94.64 4.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.151 1.476 . . . . 0.0 113.105 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 5' ' ' PHE . 1.2 pp -89.84 122.44 67.95 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.094 -1.004 . . . . 0.0 111.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.12 153.13 67.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.827 1.684 . . . . 0.0 110.532 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.84 151.88 95.13 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 122.057 -0.402 . . . . 0.0 110.431 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.15 -55.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.135 3.223 . . . . 0.0 111.907 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 26.17 77.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.48 2.712 . . . . 0.0 110.923 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.03 -111.53 3.13 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 135.03 90.38 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 117.584 0.692 . . . . 0.0 109.654 -170.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.72 171.07 12.67 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.237 1.958 . . . . 0.0 110.619 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.83 160.93 28.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.952 2.501 . . . . 0.0 105.193 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.34 -66.27 0.91 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.852 0.861 . . . . 0.0 110.082 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.18 -46.79 87.48 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.42 0.688 . . . . 0.0 109.203 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.95 -41.68 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.292 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.55 -17.66 60.01 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.593 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -36.08 76.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.686 1.194 . . . . 0.0 108.771 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.3 mt -84.72 -52.18 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 109.487 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -23.44 65.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.932 1.293 . . . . 0.0 110.265 -172.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -40.05 13.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 174.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 162' ' ' ASP . 30.0 mtp85 -68.9 -36.09 77.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 123.88 0.872 . . . . 0.0 110.545 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? 60.63 -18.67 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.675 1.99 . . . . 0.0 113.86 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -71.85 48.77 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 1 C-N-CA 133.124 4.569 . . . . 0.0 110.755 173.628 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.77 128.89 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -69.71 105.45 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 160.632 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.38 87.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 16.0 m-85 -58.5 100.19 0.06 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 107.64 5.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.05 147.81 10.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.8 p -99.02 166.12 11.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 158.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.83 -14.01 61.85 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 120.002 -1.686 . . . . 0.0 111.031 161.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -88.66 -65.03 1.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.07 0.948 . . . . 0.0 110.416 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.66 29.14 2.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.96 2.104 . . . . 0.0 108.146 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -50.28 -57.02 8.79 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.561 1.144 . . . . 0.0 108.009 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -82.92 17.67 1.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -116.55 48.19 1.32 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 8.6 tp -129.0 -37.36 1.71 Allowed 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.158 174.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -55.04 13.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 117.305 -1.331 . . . . 0.0 109.629 176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.64 -26.06 39.91 Favored 'Trans proline' 0 C--N 1.356 0.962 0 CA-C-N 121.926 1.724 . . . . 0.0 113.482 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.49 -45.11 63.37 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.22 1.408 . . . . 0.0 109.85 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 14.5 mt -54.82 -52.78 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 125.406 1.482 . . . . 0.0 109.19 167.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.74 -44.59 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.458 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.1 m -62.04 -42.23 98.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.564 1.075 . . . . 0.0 109.726 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.4 t -67.03 -44.18 80.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.017 0.826 . . . . 0.0 110.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.56 -53.73 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.595 -0.691 . . . . 0.0 109.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -16.08 63.63 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.997 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -57.29 10.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 -167.427 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -145.73 172.85 12.7 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.447 1.021 . . . . 0.0 110.535 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.648 ' HB2' HG12 ' A' ' 163' ' ' VAL . 17.7 m-70 -58.49 156.28 10.74 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.608 1.963 . . . . 0.0 111.729 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.23 130.56 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CE1' HG21 ' A' ' 157' ' ' ILE . 38.9 m-85 -125.29 139.93 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.413 0.685 . . . . 0.0 111.399 173.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.52 155.15 33.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.347 1.459 . . . . 0.0 107.991 167.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -152.12 175.84 12.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.86 -163.47 25.02 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.6 146.73 15.29 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.62 2.213 . . . . 0.0 110.321 168.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.77 153.7 77.05 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.722 1.615 . . . . 0.0 109.421 165.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.61 5.83 0.03 OUTLIER Glycine 0 CA--C 1.524 0.63 0 CA-C-O 119.053 -0.859 . . . . 0.0 112.491 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.254 97.1 t 65.56 115.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 127.027 2.131 . . . . 0.0 112.503 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.41 -41.9 0.21 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.962 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -50.18 -31.86 14.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.719 1.607 . . . . 0.0 112.535 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -45.23 -47.27 12.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 129.005 2.922 . . . . 0.0 110.038 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -86.06 -23.99 26.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.774 1.23 . . . . 0.0 110.728 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.07 -37.04 78.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 118.211 -0.9 . . . . 0.0 109.693 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.4 -46.32 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 117.902 -1.046 . . . . 0.0 108.732 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -53.62 -44.82 69.8 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.616 1.553 . . . . 0.0 111.428 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -62.05 -40.28 95.22 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.449 0.7 . . . . 0.0 110.769 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 177' ' ' LEU . . . -60.82 -23.64 65.24 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.426 0.557 . . . . 0.0 112.019 172.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 m -89.62 12.06 17.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.072 1.749 . . . . 0.0 112.183 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -113.05 -23.36 10.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.912 1.685 . . . . 0.0 111.838 168.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.44 -44.09 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.273 -0.892 . . . . 0.0 113.199 -161.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.72 -35.4 72.63 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 166.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.19 -39.6 82.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.97 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -70.48 -18.11 62.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.467 0.707 . . . . 0.0 111.21 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -96.03 6.02 49.82 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.155 2.182 . . . . 0.0 111.856 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.4 18.61 75.71 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.281 -0.887 . . . . 0.0 113.518 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.29 100.31 15.18 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.731 2.012 . . . . 0.0 106.758 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.52 90.38 1.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.933 2.422 . . . . 0.0 110.73 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.47 154.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.519 1.928 . . . . 0.0 109.518 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.33 176.6 9.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.085 0.954 . . . . 0.0 110.469 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.91 -149.97 17.08 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.02 1.295 . . . . 0.0 111.147 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -145.4 160.85 40.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.777 0.831 . . . . 0.0 111.697 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -144.18 131.19 20.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.56 1.544 . . . . 0.0 106.96 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 p -74.25 146.7 43.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 117.62 -1.181 . . . . 0.0 107.882 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.57 159.12 35.58 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.605 1.548 . . . . 0.0 109.102 167.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.38 96.01 7.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.565 1.146 . . . . 0.0 107.972 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.56 101.63 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.567 1.175 . . . . 0.0 108.806 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -121.95 84.95 2.33 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 125.758 1.623 . . . . 0.0 108.64 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -58.99 109.67 0.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.71 34.63 21.71 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.652 -0.527 . . . . 0.0 113.129 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.42 38.45 14.63 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.556 1.678 . . . . 0.0 115.273 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 136.09 45.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.357 2.078 . . . . 0.0 107.663 159.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -67.28 111.82 4.2 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.901 0.88 . . . . 0.0 108.872 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 pt -115.62 -10.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.942 0.897 . . . . 0.0 112.483 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -165.4 35.84 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 107.996 -2.041 . . . . 0.0 107.996 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -124.48 167.53 14.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.701 1.6 . . . . 0.0 107.644 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -120.67 -178.83 3.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.544 1.538 . . . . 0.0 109.584 167.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.83 96.34 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 162.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.33 151.0 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 p -115.8 154.6 29.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.43 -6.78 15.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.174 0.897 . . . . 0.0 111.909 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -86.39 3.14 44.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.155 2.582 . . . . 0.0 111.784 171.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.71 5.83 88.37 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.277 -1.515 . . . . 0.0 114.377 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 151.23 30.7 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 169.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 136.79 26.96 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.796 1.18 . . . . 0.0 111.496 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -87.16 176.41 47.02 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 121.398 0.443 . . . . 0.0 112.945 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.18 167.5 21.8 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 146.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -142.92 -69.98 0.33 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -128.45 161.5 29.35 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.906 0.882 . . . . 0.0 109.936 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -149.7 169.52 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.813 1.245 . . . . 0.0 108.118 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 t -60.29 149.81 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.498 0.719 . . . . 0.0 109.382 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.08 165.2 32.54 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 160.67 16.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.493 1.117 . . . . 0.0 109.586 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.99 155.62 93.19 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.6 124.82 11.09 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.994 2.463 . . . . 0.0 108.014 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.36 162.95 36.5 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 108.549 -1.366 . . . . 0.0 108.549 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.92 -11.34 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.766 1.644 . . . . 0.0 113.783 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.16 -40.72 4.77 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.192 1.377 . . . . 0.0 113.707 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.0 112.45 25.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.977 1.389 . . . . 0.0 107.688 -170.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -71.19 135.42 47.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.91 176.16 11.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.539 1.936 . . . . 0.0 106.342 166.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 83.0 m -124.4 74.79 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.559 0.695 . . . . 0.0 111.001 -165.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 138.99 33.88 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.479 1.112 . . . . 0.0 108.664 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.8 -27.65 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.325 0.584 . . . . 0.0 111.334 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.82 -71.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 105.136 -3.186 . . . . 0.0 105.136 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -108.43 -51.84 2.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.616 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.06 163.13 28.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.888 1.222 . . . . 0.0 109.249 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.68 119.94 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.53 172.92 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.665 0.786 . . . . 0.0 108.928 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.52 146.26 31.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 162.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.23 -32.42 71.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.236 0.615 . . . . 0.0 110.737 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 m -64.55 -32.71 74.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.156 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.2 m -61.37 -34.94 76.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.682 1.128 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.472 0.709 . . . . 0.0 110.139 167.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -24.02 9.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.444 1.097 . . . . 0.0 113.477 -170.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -50.17 -35.59 26.81 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.994 1.318 . . . . 0.0 113.158 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -145.23 -33.84 0.35 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.026 -0.512 . . . . 0.0 112.005 -175.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.57 1.948 . . . . 0.0 111.508 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -135.69 -55.16 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.43 1.492 . . . . 0.0 110.168 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 49.3 Cg_endo -69.97 -37.57 8.49 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.751 1.634 . . . . 0.0 112.318 170.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.26 -24.64 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -45.14 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.999 0.519 . . . . 0.0 110.649 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.62 70.89 0.91 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.38 120.18 19.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 165.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.29 174.09 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.784 2.034 . . . . 0.0 114.387 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -161.79 148.14 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.419 2.688 . . . . 0.0 104.047 160.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.8 -170.23 0.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.175 2.19 . . . . 0.0 106.623 157.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m 71.36 -67.69 0.25 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.503 1.921 . . . . 0.0 113.879 158.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.61 -174.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.89 2.076 . . . . 0.0 111.64 -169.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.24 -127.3 8.09 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.66 137.35 38.61 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 119.853 1.826 . . . . 0.0 109.216 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.97 -61.37 0.62 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.349 -1.901 . . . . 0.0 108.349 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 51.51 -156.97 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -167.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -155.07 165.56 36.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.479 1.512 . . . . 0.0 107.19 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.47 136.35 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.0 t -123.52 108.57 12.79 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.569 1.148 . . . . 0.0 109.519 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.85 130.14 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 125.643 1.577 . . . . 0.0 109.572 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.39 86.61 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.51 158.47 35.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 163.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER 51.14 90.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.959 2.504 . . . . 0.0 112.587 -174.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.89 75.72 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 164.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.88 -45.95 0.02 OUTLIER Glycine 0 C--N 1.334 0.437 0 O-C-N 120.952 -1.092 . . . . 0.0 113.383 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 9.4 tptt -66.49 -37.33 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.74 0.77 . . . . 0.0 110.39 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.5 mmt -79.46 0.52 29.15 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 115.559 -2.162 . . . . 0.0 114.253 -172.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.26 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 -170.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tp -117.85 -44.76 2.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.916 1.686 . . . . 0.0 110.131 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -73.89 -20.57 60.37 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.267 1.027 . . . . 0.0 111.41 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 p -53.4 115.29 1.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.379 2.272 . . . . 0.0 109.986 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.23 -71.49 0.54 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.585 1.154 . . . . 0.0 108.884 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.3 -21.4 59.74 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.424 1.09 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -69.14 0.12 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.309 1.443 . . . . 0.0 110.19 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.2 mp -37.73 -48.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.388 1.875 . . . . 0.0 112.683 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -63.89 -64.88 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.699 0.799 . . . . 0.0 112.48 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.5 90.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.072 0.949 . . . . 0.0 110.452 -170.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.55 -44.61 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.556 1.142 . . . . 0.0 109.367 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -67.66 -31.99 72.36 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.011 -1.681 . . . . 0.0 112.353 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -37.73 83.57 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.981 1.718 . . . . 0.0 110.512 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.434 ' CG2' HD11 ' A' ' 139' ' ' ILE . 1.5 m -65.92 -47.89 73.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.881 0.472 . . . . 0.0 110.866 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.33 -19.74 66.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 111.261 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -39.58 78.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.044 0.938 . . . . 0.0 109.477 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.7 m -64.81 134.02 95.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 123.565 0.746 . . . . 0.0 109.414 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.0 -29.27 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.661 2.907 . . . . 0.0 112.025 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.7 -53.75 7.09 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 145.03 54.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.222 1.011 . . . . 0.0 112.28 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.16 98.76 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 102.949 -2.982 . . . . 0.0 102.949 -169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 131' ' ' THR . 44.0 mm -61.06 131.65 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.41 116.26 8.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.566 1.947 . . . . 0.0 106.508 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.05 -179.61 39.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.7 m -123.53 100.28 6.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.9 pt -97.19 161.74 25.13 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 179.98 4.54 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.401 2.734 . . . . 0.0 110.47 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.5 150.36 79.45 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 121.172 -0.955 . . . . 0.0 110.773 164.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.01 109.47 2.7 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 123.188 2.592 . . . . 0.0 108.883 164.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.16 119.72 15.0 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 164.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.09 -131.02 36.0 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.59 137.55 96.46 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.845 -158.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 131.27 22.71 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.621 2.214 . . . . 0.0 109.009 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.98 121.87 21.71 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 13.33 0.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.122 2.569 . . . . 0.0 115.634 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.4 tp -131.67 -39.83 1.11 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.388 1.875 . . . . 0.0 109.39 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.83 -23.77 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 120.825 -1.172 . . . . 0.0 109.006 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.54 -40.43 78.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.578 1.151 . . . . 0.0 110.73 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.82 -31.03 72.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.689 1.996 . . . . 0.0 110.471 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.481 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.4 mp -90.56 -41.61 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.535 1.534 . . . . 0.0 109.337 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -52.56 -39.05 61.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.971 1.709 . . . . 0.0 109.823 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -33.4 -47.54 0.22 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 127.968 2.507 . . . . 0.0 113.033 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -66.5 -40.75 89.41 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.342 -1.313 . . . . 0.0 112.436 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.75 -40.71 0.22 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.53 1.932 . . . . 0.0 113.482 -167.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.94 -22.49 60.1 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.68 2.392 . . . . 0.0 113.563 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 3' ' ' HIS . 5.6 m -66.0 138.79 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.487 ' HE3' ' CE1' ' A' ' 166' ' ' PHE . 28.3 tptt -65.07 142.73 58.3 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.85 102.29 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.487 ' CE1' ' HE3' ' A' ' 164' ' ' LYS . 13.7 m-85 -93.53 96.69 10.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.042 1.337 . . . . 0.0 111.051 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 104.94 2.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 172.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.59 163.05 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.988 0.813 . . . . 0.0 108.816 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.4 p -123.57 169.04 11.84 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.205 1.802 . . . . 0.0 106.305 160.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -77.51 -10.6 59.58 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.344 1.458 . . . . 0.0 112.275 158.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -79.99 -74.0 0.33 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.79 32.39 0.74 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.221 1.408 . . . . 0.0 109.913 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -54.91 -51.76 65.03 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.732 -1.23 . . . . 0.0 110.405 -169.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -75.33 4.04 7.92 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.95 -19.0 31.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.707 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -21.58 45.79 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.913 -164.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -47.71 -63.13 1.6 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.951 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.72 -28.78 76.69 Favored 'Trans proline' 0 C--N 1.35 0.616 0 CA-C-N 121.853 1.697 . . . . 0.0 112.929 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -33.97 75.0 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.608 0.763 . . . . 0.0 109.678 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.16 -52.17 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.071 0.948 . . . . 0.0 109.82 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.89 -34.77 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 118.42 0.554 . . . . 0.0 110.225 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.7 m -55.92 -44.61 78.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.389 1.076 . . . . 0.0 110.263 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -70.97 -41.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.684 -0.635 . . . . 0.0 110.278 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.27 -59.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 123.405 0.682 . . . . 0.0 109.811 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -3.18 20.42 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.273 1.029 . . . . 0.0 112.684 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -60.47 -21.35 62.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.883 -1.135 . . . . 0.0 110.592 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.82 126.54 29.74 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.999 1.272 . . . . 0.0 107.636 164.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -40.58 109.28 0.11 Allowed 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.022 1.329 . . . . 0.0 111.994 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.538 ' CE ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 156.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.5 178.79 9.19 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 163.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HB2' HG12 ' A' ' 163' ' ' VAL . 40.3 m-70 -24.63 119.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.55 3.14 . . . . 0.0 111.624 166.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 t -105.08 137.86 32.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 157' ' ' ILE . 54.5 m-85 -127.86 153.91 46.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.576 0.75 . . . . 0.0 109.151 163.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 164.24 12.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.838 2.055 . . . . 0.0 108.313 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -159.5 -173.45 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.11 53.7 6.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 127.214 2.34 . . . . 0.0 112.136 -160.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.11 123.51 8.88 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 119.786 1.793 . . . . 0.0 110.266 -171.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.6 -1.6 8.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.511 2.141 . . . . 0.0 112.238 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.93 4.03 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -170.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.4 97.99 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 125.396 2.522 . . . . 0.0 107.48 -168.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.85 -45.49 0.55 Allowed Glycine 0 C--N 1.309 -0.938 0 CA-C-N 111.345 -2.661 . . . . 0.0 108.414 163.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.533 ' HD3' HG21 ' A' ' 142' ' ' THR . 0.1 OUTLIER -47.31 -48.42 25.13 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.327 1.851 . . . . 0.0 112.958 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.3 m -60.31 -52.93 63.19 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.207 0.912 . . . . 0.0 108.898 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 m -59.67 -40.29 87.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.736 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -53.14 48.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.468 1.485 . . . . 0.0 109.284 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.25 -26.07 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.581 0.752 . . . . 0.0 111.06 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -66.12 -57.16 8.3 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.034 -1.666 . . . . 0.0 109.332 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -11.29 29.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.01 45.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.908 1.283 . . . . 0.0 112.468 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.2 p -67.23 -47.51 70.6 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -171.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.07 -39.98 66.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.199 1.8 . . . . 0.0 112.246 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.87 -54.41 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.457 1.103 . . . . 0.0 109.236 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 30' ' ' VAL . 25.9 mt -69.6 -36.57 76.32 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.316 0.646 . . . . 0.0 109.351 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.68 -39.0 86.84 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.971 -1.706 . . . . 0.0 109.89 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.97 -34.66 70.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.512 1.525 . . . . 0.0 110.342 168.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 4.32 4.99 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.308 2.243 . . . . 0.0 115.389 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.62 20.22 55.84 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.282 0.946 . . . . 0.0 112.204 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 25' ' ' LEU . 5.7 p -56.55 140.85 73.46 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.918 1.287 . . . . 0.0 108.741 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -79.16 84.72 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 CA-C-N 121.701 1.643 . . . . 0.0 111.347 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.07 156.78 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.159 0.983 . . . . 0.0 109.127 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -156.25 174.25 15.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.984 1.713 . . . . 0.0 107.471 164.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.43 -148.14 19.07 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 125.487 1.518 . . . . 0.0 111.31 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -148.68 171.56 16.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 111.216 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 9.1 p90 -146.22 172.38 13.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.29 1.436 . . . . 0.0 108.349 165.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.5 90.6 2.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.158 1.783 . . . . 0.0 106.326 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 18.8 mt-10 -74.89 -22.73 58.47 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.462 -0.774 . . . . 0.0 112.705 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 96.17 164.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.347 4.259 . . . . 0.0 109.747 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.32 104.01 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -121.42 105.25 10.33 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.831 1.253 . . . . 0.0 107.754 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -79.65 116.12 19.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.95 -56.03 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 120.529 1.513 . . . . 0.0 114.115 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.21 11.44 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.837 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 137.15 28.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.189 1.995 . . . . 0.0 109.484 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -66.61 144.92 56.12 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.28 -12.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.79 1.236 . . . . 0.0 112.965 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.91 -168.56 41.69 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -129.46 138.04 51.19 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -114.84 158.45 21.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD13 ' A' ' 90' ' ' LEU . 14.2 p -116.67 94.84 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -166.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.14 116.53 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.94 1.696 . . . . 0.0 108.235 -162.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.4 p -88.75 150.77 22.79 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.398 0.999 . . . . 0.0 109.271 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -24.94 67.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.051 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -32.9 72.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.492 1.117 . . . . 0.0 109.302 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.99 -14.85 2.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.702 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 163.59 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.969 2.108 . . . . 0.0 110.785 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.25 156.63 42.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 121.379 -0.826 . . . . 0.0 109.534 156.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -127.28 159.75 21.36 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.82 64.9 7.31 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.66 3.574 . . . . 0.0 111.642 -166.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.64 -56.08 2.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 127.079 2.152 . . . . 0.0 110.677 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 147.8 34.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 109.516 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -147.4 161.67 40.57 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.029 1.332 . . . . 0.0 108.691 172.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -62.55 159.95 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.833 0.853 . . . . 0.0 109.744 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.55 -155.88 7.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.75 166.11 22.84 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.81 149.31 40.14 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.993 0.815 . . . . 0.0 109.457 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.01 124.45 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.066 1.844 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.62 164.7 33.21 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.525 2.816 . . . . 0.0 110.891 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.16 -12.43 27.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.475 2.116 . . . . 0.0 113.749 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.28 7.87 73.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.258 0.932 . . . . 0.0 112.879 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -140.65 170.13 16.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 130.389 3.476 . . . . 0.0 104.221 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -139.47 149.65 44.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 153.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -151.24 149.95 30.01 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.14 97.88 4.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.093 1.357 . . . . 0.0 110.113 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.2 161.8 19.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.049 1.295 . . . . 0.0 111.168 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.66 -4.13 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -161.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.22 77.21 0.09 OUTLIER Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 86.59 -31.44 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.076 2.95 . . . . 0.0 111.491 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -105.94 146.11 30.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.11 132.32 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.33 175.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.624 1.57 . . . . 0.0 108.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.68 135.51 22.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.54 -37.86 85.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 164.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -51.29 -42.46 61.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.081 1.352 . . . . 0.0 110.802 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.8 m -75.98 -15.27 60.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.614 -1.304 . . . . 0.0 112.914 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.5 -59.03 2.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.791 -1.1 . . . . 0.0 108.444 161.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -57.79 -17.27 14.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.481 1.491 . . . . 0.0 114.009 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -52.61 -41.48 63.72 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.665 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -142.26 -37.54 0.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.831 0.852 . . . . 0.0 112.688 -171.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 94' ' ' VAL . . . -77.98 51.02 0.92 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.159 1.784 . . . . 0.0 109.373 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.03 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.894 2.477 . . . . 0.0 105.698 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.55 -35.7 37.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.817 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 91' ' ' ALA . 22.5 m -62.28 -21.08 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.883 1.219 . . . . 0.0 113.303 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.11 -33.86 68.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.197 0.453 . . . . 0.0 109.781 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.42 107.02 3.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.786 -1.196 . . . . 0.0 111.545 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -78.59 144.84 35.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 159.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.1 122.91 12.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 109.885 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -109.82 -65.84 1.12 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 58.8 m 53.53 -156.68 0.19 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.31 1.044 . . . . 0.0 109.928 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.6 m -84.26 77.63 9.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.169 0.895 . . . . 0.0 110.613 -166.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.4 p -86.07 -170.44 3.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.985 2.514 . . . . 0.0 111.464 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.27 179.7 53.42 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.362 -1.461 . . . . 0.0 111.989 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.95 150.84 87.55 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.786 2.324 . . . . 0.0 109.039 166.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.9 84.08 0.08 OUTLIER Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.0 130.54 42.1 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.241 1.019 . . . . 0.0 109.487 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -84.28 162.79 19.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.099 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.06 154.95 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.31 149.85 52.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.254 1.022 . . . . 0.0 108.698 163.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.68 122.55 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 123.17 0.588 . . . . 0.0 109.423 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.02 84.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -171.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -74.09 171.15 14.05 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.39 -1.444 . . . . 0.0 109.785 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 34.33 69.23 0.16 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.882 3.273 . . . . 0.0 114.301 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.424 HG23 HD23 ' A' ' 153' ' ' LEU . 19.7 mt -89.27 91.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.41 -81.05 0.04 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 118.473 0.579 . . . . 0.0 112.032 -170.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -53.4 -35.43 60.36 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.614 1.166 . . . . 0.0 113.06 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -3.43 16.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.963 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -39.44 -52.43 2.1 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 121.514 1.961 . . . . 0.0 112.389 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -45.3 95.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.524 0.73 . . . . 0.0 111.375 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.49 -9.65 55.78 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.23 2.212 . . . . 0.0 113.6 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.5 m -55.64 109.87 0.63 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.351 1.46 . . . . 0.0 112.017 -164.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.35 -83.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.491 0.587 . . . . 0.0 111.189 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.57 -19.66 63.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.886 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -74.26 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.765 2.026 . . . . 0.0 110.339 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.8 mp -33.99 -58.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-N 120.169 1.35 . . . . 0.0 112.737 170.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.92 -58.04 10.16 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.354 0.979 . . . . 0.0 111.911 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.01 91.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.002 0.814 . . . . 0.0 109.513 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 157' ' ' ILE . 41.1 t -55.97 -50.91 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.432 1.493 . . . . 0.0 109.247 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -65.3 -28.97 69.69 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.729 -1.232 . . . . 0.0 112.563 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -54.18 -58.53 7.01 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 m -60.51 -38.51 84.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.128 2.571 . . . . 0.0 112.453 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.33 -33.83 75.46 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.88 0.472 . . . . 0.0 110.285 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.4 -8.11 58.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.849 0.46 . . . . 0.0 111.231 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 m -89.97 133.72 33.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.5 -37.15 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.275 2.65 . . . . 0.0 112.76 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -48.52 80.64 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -63.49 153.67 34.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.157 1.783 . . . . 0.0 111.497 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.8 mt -139.29 106.28 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.6 mm -65.43 147.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -144.32 94.49 2.58 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.909 2.083 . . . . 0.0 106.581 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.68 173.97 19.95 Favored Glycine 0 N--CA 1.465 0.628 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.455 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.533 HG21 ' HD3' ' A' ' 14' ' ' LYS . 29.2 m -131.36 98.87 4.66 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.632 1.216 . . . . 0.0 112.52 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.6 pt -80.15 140.81 53.42 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.827 -1.17 . . . . 0.0 111.375 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.8 137.9 43.16 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.044 1.83 . . . . 0.0 108.435 166.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.89 134.45 95.92 Favored Pre-proline 0 N--CA 1.444 -0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.166 -166.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.78 129.92 19.58 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.818 2.345 . . . . 0.0 108.958 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.95 -61.24 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.731 1.213 . . . . 0.0 108.426 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.88 -126.91 0.74 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 157.03 90.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.569 0.685 . . . . 0.0 111.313 -170.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.63 103.2 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.785 2.323 . . . . 0.0 108.711 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.04 124.46 21.67 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.682 -0.636 . . . . 0.0 110.131 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.53 -59.82 4.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.166 1.386 . . . . 0.0 113.3 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 114' ' ' ILE . 65.0 tp -63.5 -30.59 71.68 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.478 -1.389 . . . . 0.0 111.259 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.16 -44.24 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 121.297 -0.877 . . . . 0.0 108.888 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.01 -37.66 66.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.988 1.715 . . . . 0.0 110.829 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -57.85 -28.61 64.29 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.659 0.663 . . . . 0.0 112.344 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.512 HG21 ' CE1' ' A' ' 5' ' ' PHE . 9.2 mt -107.56 -32.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.602 1.161 . . . . 0.0 109.975 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -32.99 72.25 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.033 -1.042 . . . . 0.0 109.166 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.28 -6.45 23.97 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -76.53 -39.65 52.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 120.884 1.674 . . . . 0.0 110.057 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? 62.2 -23.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.121 2.169 . . . . 0.0 114.648 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.59 -28.7 69.54 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.288 1.435 . . . . 0.0 111.997 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 3' ' ' HIS . 27.7 m -55.36 135.82 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.451 1.5 . . . . 0.0 110.566 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.74 145.63 54.55 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 168.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.23 89.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 180' ' ' ILE . 30.7 m-85 -79.2 104.75 10.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.786 0.835 . . . . 0.0 109.087 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.65 105.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.429 HG23 HD22 ' A' ' 176' ' ' LEU . 0.7 OUTLIER -59.91 155.84 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 164.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.3 p -134.83 162.59 31.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 154.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.76 -14.64 61.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.494 165.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.62 -54.27 4.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -101.92 10.69 39.53 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.288 1.435 . . . . 0.0 110.746 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 ptt85 -29.71 -65.16 0.11 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.034 2.134 . . . . 0.0 111.612 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -80.3 3.45 20.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -169.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -105.18 -6.97 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.099 2.16 . . . . 0.0 111.033 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 168' ' ' VAL . 6.8 tp -81.15 -45.77 15.91 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 119.189 0.904 . . . . 0.0 110.65 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.8 tp -32.51 -61.91 0.31 Allowed Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.716 2.006 . . . . 0.0 109.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.14 -28.63 28.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 122.438 1.906 . . . . 0.0 114.94 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -68.14 -35.07 77.5 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.872 1.215 . . . . 0.0 109.847 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.51 HG12 ' CD2' ' A' ' 166' ' ' PHE . 12.0 mt -65.34 -46.34 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.835 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.89 -45.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 119.349 0.977 . . . . 0.0 108.761 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.0 m -58.53 -51.09 71.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.623 0.769 . . . . 0.0 111.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.15 -31.32 69.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.229 1.377 . . . . 0.0 112.106 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.65 -62.03 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -70.14 -18.23 63.22 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -19.06 56.32 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 119.457 1.026 . . . . 0.0 111.56 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.0 t -70.57 -14.67 62.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.633 1.56 . . . . 0.0 111.978 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -86.51 -48.65 8.2 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.899 0.88 . . . . 0.0 109.821 167.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 11.0 mmpt? . . . . . 0 C--O 1.25 1.094 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.944 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 -166.05 1.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.356 2.262 . . . . 0.0 107.256 161.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -46.39 137.96 6.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 0.0 110.511 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.33 143.2 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.927 0.891 . . . . 0.0 109.536 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -141.54 146.94 36.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.953 1.701 . . . . 0.0 108.637 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -104.69 157.31 17.27 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.648 1.113 . . . . 0.0 111.287 173.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -149.73 177.22 9.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.45 1.1 . . . . 0.0 109.092 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.28 -176.41 19.62 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.136 1.35 . . . . 0.0 112.701 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.65 166.05 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.476 3.451 . . . . 0.0 110.751 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.58 93.91 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.435 2.09 . . . . 0.0 111.054 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.18 -34.99 15.97 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.493 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.55 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.17 2.588 . . . . 0.0 110.063 -153.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.4 17.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.826 -1.541 . . . . 0.0 113.833 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -94.17 -55.82 3.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.531 1.665 . . . . 0.0 110.731 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.0 m -51.8 -41.54 61.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.329 1.851 . . . . 0.0 109.724 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -58.04 -41.7 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 113.73 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -48.28 61.24 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.1 mm -57.71 -41.55 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -56.0 -55.95 26.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.509 -0.745 . . . . 0.0 110.214 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -59.48 -31.78 69.65 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.137 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -50.96 -44.28 60.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.915 0.78 . . . . 0.0 109.947 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 m -58.54 -47.29 84.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.89 -23.47 63.25 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.794 2.038 . . . . 0.0 111.73 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.4 t -83.71 -48.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.382 1.873 . . . . 0.0 109.362 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.06 -44.72 87.62 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -60.77 -43.44 98.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.882 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -62.09 -26.58 68.37 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.918 0.781 . . . . 0.0 112.279 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 t -88.69 1.7 54.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.898 1.679 . . . . 0.0 112.271 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.4 11.31 85.62 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.971 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.25 118.3 70.87 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.885 1.843 . . . . 0.0 106.979 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.39 123.19 11.98 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.909 1.739 . . . . 0.0 110.647 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.16 160.64 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.82 177.53 8.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 159.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 110' ' ' VAL . . . 141.04 -163.82 26.59 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 119.579 -1.951 . . . . 0.0 113.199 166.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -151.03 155.19 38.5 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.234 1.016 . . . . 0.0 110.325 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -118.72 -179.01 3.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.4 m -161.86 94.71 0.95 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -164.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.42 156.68 17.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -68.25 109.39 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.17 109.33 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -119.29 104.74 10.66 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.932 2.093 . . . . 0.0 107.443 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -91.84 102.47 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.26 50.68 7.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.183 0.897 . . . . 0.0 113.558 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.88 -6.88 57.69 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.419 1.485 . . . . 0.0 114.925 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.43 122.05 23.96 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.061 1.931 . . . . 0.0 107.506 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 123.84 23.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 159.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -10.63 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.789 0.836 . . . . 0.0 112.729 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.13 -164.11 35.26 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -139.44 143.09 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.66 145.6 41.83 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.62 154.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.03 123.37 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.5 p -72.48 179.25 3.58 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.563 -1.336 . . . . 0.0 109.927 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.51 HD21 ' CG1' ' A' ' 110' ' ' VAL . 1.2 mm? -88.3 -13.68 40.21 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.299 -0.875 . . . . 0.0 111.492 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 t -70.83 -50.41 35.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 49.43 0.1 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -144.82 147.49 32.92 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.641 1.976 . . . . 0.0 107.592 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.77 161.41 20.17 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 128.494 2.717 . . . . 0.0 108.999 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -143.12 134.42 5.93 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.841 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.48 61.94 2.8 Favored 'Trans proline' 0 CA--C 1.55 1.284 1 C-N-CA 126.371 4.714 . . . . 0.0 114.053 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.3 -63.02 1.2 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.57 1.948 . . . . 0.0 111.581 -169.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 p -130.11 136.5 49.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.306 0.957 . . . . 0.0 108.872 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -148.94 169.34 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.434 1.494 . . . . 0.0 107.889 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -56.32 152.34 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.679 1.191 . . . . 0.0 109.884 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.49 46.87 0.07 OUTLIER Glycine 0 C--N 1.333 0.403 0 CA-C-O 119.335 -0.703 . . . . 0.0 111.612 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.0 -169.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.971 1.708 . . . . 0.0 111.7 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.58 147.53 43.87 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 110.871 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -69.73 123.83 10.5 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.728 2.286 . . . . 0.0 107.971 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.24 170.49 19.47 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.627 2.885 . . . . 0.0 110.853 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.48 -9.75 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.28 1.987 . . . . 0.0 114.196 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.47 -12.49 51.0 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.535 -1.147 . . . . 0.0 114.291 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 138.1 36.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.34 2.07 . . . . 0.0 108.138 -168.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -119.07 122.32 41.84 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.104 0.562 . . . . 0.0 110.0 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 172.25 13.67 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 126.026 1.731 . . . . 0.0 107.655 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 95.3 m -68.4 147.81 51.55 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.815 -0.553 . . . . 0.0 109.725 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -153.29 143.83 22.57 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.528 -0.732 . . . . 0.0 109.472 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.766 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.37 1.06 0.15 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 127.437 2.446 . . . . 0.0 117.596 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 177.04 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.225 2.21 . . . . 0.0 106.713 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -80.57 166.64 20.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.339 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -110.61 133.59 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.8 166.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -139.39 105.17 5.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.6 -24.23 63.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.322 -0.861 . . . . 0.0 111.592 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -34.4 77.99 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.624 171.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -57.42 -48.45 79.09 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 119.989 1.268 . . . . 0.0 109.941 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -56.04 -50.62 70.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -19.67 66.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.057 0.844 . . . . 0.0 112.439 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.66 ' HB2' HD23 ' A' ' 90' ' ' LEU . 19.5 mt-30 -66.36 -45.25 80.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.721 1.146 . . . . 0.0 112.059 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -123.35 -39.86 2.42 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.59 51.18 2.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.072 1.749 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 -60.35 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 125.721 1.608 . . . . 0.0 108.0 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -38.36 42.37 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.607 1.538 . . . . 0.0 112.043 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -36.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 123.909 0.883 . . . . 0.0 110.591 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.148 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 108.26 0.13 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.983 1.713 . . . . 0.0 106.764 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -103.3 166.9 10.16 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.142 1.377 . . . . 0.0 108.129 163.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -150.12 51.95 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.512 -0.743 . . . . 0.0 111.242 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.97 169.7 17.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.414 1.486 . . . . 0.0 109.924 -169.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 15.5 t 62.85 107.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.718 2.407 . . . . 0.0 111.35 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 p -73.49 49.53 0.29 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.147 2.579 . . . . 0.0 113.233 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -101.34 169.19 9.05 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.67 1.188 . . . . 0.0 110.389 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -37.84 140.46 0.43 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 128.017 2.722 . . . . 0.0 116.213 -171.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.55 -176.13 2.93 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 125.202 3.935 . . . . 0.0 111.836 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 132.52 -141.4 12.76 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 104.798 -3.321 . . . . 0.0 104.798 -159.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -138.27 153.39 49.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.702 1.601 . . . . 0.0 111.528 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -89.0 97.21 11.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 126.613 1.965 . . . . 0.0 110.019 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.9 t -74.97 94.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 121.656 2.026 . . . . 0.0 107.577 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.5 m -72.24 165.24 24.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.51 ' CG1' HD21 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -144.61 139.67 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.576 -177.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mt -152.22 103.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.651 1.219 . . . . 0.0 108.501 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -105.69 -169.61 1.61 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 42.75 48.75 4.91 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.014 2.526 . . . . 0.0 112.163 -168.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.71 110.56 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.13 -63.97 0.32 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-O 117.554 -1.692 . . . . 0.0 112.493 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -24.15 65.92 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.913 2.357 . . . . 0.0 110.44 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.3 mmt -69.02 -10.39 57.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 116.671 -1.633 . . . . 0.0 113.404 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -24.63 -68.42 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.535 2.334 . . . . 0.0 114.593 -171.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -45.96 63.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 0.0 111.361 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.66 -27.99 66.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.615 1.166 . . . . 0.0 112.181 -170.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.4 t -41.64 114.01 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 129.222 3.009 . . . . 0.0 111.715 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -127.44 -87.71 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.412 0.551 . . . . 0.0 111.465 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.6 -16.8 61.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.793 0.724 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.99 -68.02 0.22 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.839 2.055 . . . . 0.0 111.168 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -36.83 -57.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.628 1.571 . . . . 0.0 112.148 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.9 -54.49 41.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.308 0.643 . . . . 0.0 111.025 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.82 99.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 124.148 0.905 . . . . 0.0 109.299 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.13 -47.15 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.227 1.411 . . . . 0.0 109.538 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.41 -44.6 96.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.203 1.365 . . . . 0.0 111.265 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -57.62 -38.71 75.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.153 0.888 . . . . 0.0 110.435 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 137' ' ' THR . 63.4 m -74.24 -38.99 63.35 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.364 -0.835 . . . . 0.0 112.103 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.2 mt -61.06 -35.76 77.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.21 1.368 . . . . 0.0 109.932 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.8 t -71.94 -22.05 61.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.221 1.808 . . . . 0.0 110.605 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 137' ' ' THR . 96.3 m -76.26 134.0 71.05 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.03 -42.71 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.032 2.488 . . . . 0.0 112.319 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.35 -2.75 63.59 Favored Glycine 0 C--O 1.216 -0.97 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.384 -168.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.534 HG21 ' CG2' ' A' ' 131' ' ' THR . 21.9 m -80.48 160.84 25.14 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.965 2.382 . . . . 0.0 106.139 154.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.6 mt -122.92 138.37 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.72 136.99 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' CG2' ' A' ' 180' ' ' ILE . 10.5 tp -140.07 113.45 8.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.92 32.89 Favored Glycine 0 N--CA 1.462 0.412 0 C-N-CA 119.287 -1.435 . . . . 0.0 114.656 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.0 m -137.11 133.4 35.29 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.93 147.61 66.24 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.821 1.648 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.71 148.92 59.96 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 111.167 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.34 131.55 86.6 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.241 0.617 . . . . 0.0 110.083 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.69 108.82 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.402 2.735 . . . . 0.0 108.443 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -64.75 0.79 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -112.27 -109.47 3.02 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 166.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 149.69 98.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 118.72 1.26 . . . . 0.0 111.966 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.55 -164.9 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.37 1 C-N-CA 125.966 4.444 . . . . 0.0 112.247 164.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.79 168.25 10.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.601 1.96 . . . . 0.0 109.183 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.29 -67.07 0.31 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.037 2.535 . . . . 0.0 113.287 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.4 tm? -59.48 -46.32 89.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.56 -35.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.36 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.07 -28.11 68.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.869 1.668 . . . . 0.0 112.086 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.52 -34.74 77.51 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.769 0.713 . . . . 0.0 110.007 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.32 -39.09 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.3 1.44 . . . . 0.0 109.564 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.66 -26.68 65.44 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.426 -1.422 . . . . 0.0 111.105 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -59.32 -37.58 78.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.315 0.646 . . . . 0.0 111.44 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -61.58 -36.78 81.64 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.908 0.883 . . . . 0.0 112.019 -167.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -40.24 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.971 2.908 . . . . 0.0 115.676 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -59.93 -28.9 68.01 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.189 1.359 . . . . 0.0 110.626 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.0 m -50.36 108.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.503 1.521 . . . . 0.0 109.28 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -65.69 123.21 19.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 m -111.94 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 C-N-CA 124.683 1.193 . . . . 0.0 108.778 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -72.12 118.83 15.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.142 0.977 . . . . 0.0 110.538 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.61 97.81 5.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.789 1.235 . . . . 0.0 110.631 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.427 HG23 HD12 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -67.86 132.79 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 p -94.93 151.22 19.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 158.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -57.85 -29.8 65.28 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.064 -0.397 . . . . 0.0 110.389 165.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.07 -53.87 15.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 110.848 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.82 23.06 13.41 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.025 -1.047 . . . . 0.0 110.91 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -47.26 -44.55 23.11 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.448 1.099 . . . . 0.0 112.464 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.27 3.56 8.68 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -118.29 62.54 0.77 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 168' ' ' VAL . 0.5 OUTLIER -140.25 -39.79 0.44 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.37 160.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tp -40.03 -58.37 2.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 117.625 -1.179 . . . . 0.0 110.355 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.84 -28.24 51.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.436 1.424 . . . . 0.0 113.386 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.24 -38.26 68.96 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.282 -0.886 . . . . 0.0 109.219 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.595 HD11 HD11 ' A' ' 6' ' ' LEU . 14.4 mt -66.89 -47.34 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.488 1.515 . . . . 0.0 107.974 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 92.2 t -56.04 -43.99 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.225 0.92 . . . . 0.0 109.171 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.0 m -57.97 -47.81 81.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.962 1.305 . . . . 0.0 109.129 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.45 -37.78 88.73 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.731 -0.606 . . . . 0.0 111.693 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.64 -55.52 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.911 0.778 . . . . 0.0 109.428 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -28.32 69.69 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.034 -174.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.51 -50.85 0.34 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.235 2.214 . . . . 0.0 111.637 -176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 t 61.98 -86.01 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.594 1.557 . . . . 0.0 107.814 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -75.7 -44.57 41.42 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 119.194 0.907 . . . . 0.0 111.343 162.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.111 0.964 . . . . 0.0 112.321 -116.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 -105.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.507 ' HB2' HG12 ' A' ' 163' ' ' VAL . 48.7 m-70 -92.88 159.5 15.33 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.375 1.87 . . . . 0.0 109.282 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.65 148.41 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 19.9 m-85 -144.11 158.02 43.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.909 1.684 . . . . 0.0 109.537 172.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.916 HD11 HD11 ' A' ' 180' ' ' ILE . 4.2 mm? -109.38 135.3 50.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.83 -172.5 3.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.82 -172.31 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.265 -0.897 . . . . 0.0 111.295 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.44 163.34 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.19 2.593 . . . . 0.0 113.611 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.82 72.05 6.29 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.804 3.67 . . . . 0.0 111.736 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.18 25.14 21.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 124.411 1.005 . . . . 0.0 112.494 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m 42.51 35.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.513 2.725 . . . . 0.0 116.308 161.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.87 9.91 3.1 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.514 1.531 . . . . 0.0 112.184 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -75.19 -49.87 18.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 109.956 -168.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -57.66 -35.25 70.31 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.391 0.676 . . . . 0.0 109.71 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.5 m -63.49 -38.78 92.46 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.284 -0.885 . . . . 0.0 112.45 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -49.55 57.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.89 1.223 . . . . 0.0 108.593 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.689 HD11 HD23 ' A' ' 6' ' ' LEU . 5.8 mm -58.08 -40.94 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.562 0.619 . . . . 0.0 111.045 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -45.84 54.7 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.317 0.962 . . . . 0.0 110.067 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -70.05 -20.04 63.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.23 0.612 . . . . 0.0 112.207 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.328 0.967 . . . . 0.0 110.627 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -81.51 -42.8 19.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.02 -39.22 68.89 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.103 0.561 . . . . 0.0 111.211 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.21 -51.24 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.334 1.053 . . . . 0.0 110.291 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 61.3 mt -63.25 -35.5 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.33 -38.33 89.79 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.074 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -4.8 14.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.495 1.118 . . . . 0.0 112.912 172.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 m -109.61 -5.08 15.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.701 1.6 . . . . 0.0 111.638 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.72 18.46 74.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.015 1.293 . . . . 0.0 112.981 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 24.7 t -64.71 133.76 95.82 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.665 1.733 . . . . 0.0 107.131 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.22 95.22 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.575 2.183 . . . . 0.0 110.072 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.56 136.73 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.78 173.79 11.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.604 2.362 . . . . 0.0 105.883 169.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.98 -156.79 26.15 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -142.06 166.02 25.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.912 1.356 . . . . 0.0 111.434 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -142.14 179.62 6.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.4 p -134.98 136.67 42.38 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.91 27.17 4.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.278 6.8 pm0 49.81 -178.71 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.357 2.263 . . . . 0.0 112.79 -164.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.81 119.56 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -129.27 106.47 8.84 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 70.63 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.58 75.51 0.51 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -161.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.19 -40.21 2.68 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 148.47 42.38 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.719 1.76 . . . . 0.0 111.135 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -69.81 132.24 45.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 162.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.55 -27.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.72 -174.05 41.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 119.608 1.095 . . . . 0.0 110.677 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CZ ' ' HE2' ' A' ' 116' ' ' LYS . 25.1 m-85 -126.53 153.25 45.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 160.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -117.97 162.42 18.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 167.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 90' ' ' LEU . 2.1 p -114.97 145.35 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.907 1.683 . . . . 0.0 107.923 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.2 108.95 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 120.55 1.523 . . . . 0.0 109.858 -167.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.483 HG23 HD12 ' A' ' 90' ' ' LEU . 76.1 p -69.61 145.05 52.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.31 -5.74 30.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -84.68 7.53 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.549 1.068 . . . . 0.0 111.32 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.67 3.41 83.75 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.223 -1.548 . . . . 0.0 114.984 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 m -80.83 166.08 21.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.783 1.291 . . . . 0.0 109.358 163.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -146.39 169.78 18.16 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -150.42 -176.23 23.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.722 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -108.93 14.41 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.116 1.21 . . . . 0.0 114.284 -144.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mt 23.61 -74.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 130.898 3.679 . . . . 0.0 116.446 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -147.83 159.93 43.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 165.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -143.58 53.12 1.32 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.845 2.058 . . . . 0.0 110.652 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 64.99 160.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.663 1.985 . . . . 0.0 111.554 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.51 150.96 11.9 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.73 150.86 26.68 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.756 1.222 . . . . 0.0 108.67 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.4 156.37 30.99 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 109.603 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.74 132.21 24.5 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.182 1.921 . . . . 0.0 110.102 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.72 155.03 59.16 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.696 2.931 . . . . 0.0 110.068 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.44 111.53 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.087 2.525 . . . . 0.0 109.823 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.64 -60.43 0.67 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 142.33 52.95 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -147.26 146.04 29.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -160.35 -175.34 4.98 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.736 0.647 . . . . 0.0 112.616 -165.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.0 m -60.67 101.7 0.15 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.779 2.032 . . . . 0.0 110.752 171.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -142.14 119.61 11.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.57 -89.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.38 -47.78 0.25 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.772 1.169 . . . . 0.0 112.013 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -144.58 4.05 1.15 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.355 . . . . 0.0 111.436 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.44 139.11 51.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.268 1.027 . . . . 0.0 108.379 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.63 88.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.2 174.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -147.56 133.17 18.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.306 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.57 -35.42 74.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.356 -0.84 . . . . 0.0 109.595 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.3 m -55.24 -43.81 74.94 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 110.923 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.5 p -63.58 -29.5 70.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.401 1.455 . . . . 0.0 110.659 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -69.4 -53.2 20.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.824 1.25 . . . . 0.0 110.477 167.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -47.47 -35.03 8.09 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.193 0.997 . . . . 0.0 112.157 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 10.9 mt-30 -58.55 -32.11 68.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -144.97 -36.21 0.31 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -171.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.78 31.57 0.53 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.504 2.322 . . . . 0.0 111.447 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -124.65 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 126.751 2.02 . . . . 0.0 108.41 178.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 30.2 Cg_endo -61.41 -27.03 82.12 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 121.428 1.546 . . . . 0.0 113.225 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.74 -26.46 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.245 0.93 . . . . 0.0 113.328 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 127' ' ' ALA . 1.2 mm? -73.14 -23.92 60.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.335 0.97 . . . . 0.0 111.369 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -165.65 116.53 1.07 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 120.289 1.404 . . . . 0.0 108.192 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -106.23 156.59 18.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 91.7 3.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -159.34 120.05 3.18 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.258 1.423 . . . . 0.0 107.806 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.72 58.5 4.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.767 0.827 . . . . 0.0 110.397 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -47.95 122.09 4.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.693 1.997 . . . . 0.0 109.682 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 m -54.06 130.31 37.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 109.96 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.6 77.85 1.01 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.735 1.159 . . . . 0.0 110.347 -164.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -53.67 -172.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.413 3.408 . . . . 0.0 114.329 159.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.16 -111.96 1.62 Allowed Glycine 0 N--CA 1.437 -1.254 1 N-CA-C 102.046 -4.421 . . . . 0.0 102.046 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -146.4 153.22 40.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.645 1.223 . . . . 0.0 112.785 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -91.59 173.01 8.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.67 2.788 . . . . 0.0 110.807 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -120.11 135.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 163.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.69 153.39 18.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -134.43 130.12 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -137.5 94.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.83 80.64 1.47 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 123.176 1.465 . . . . 0.0 112.768 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -158.31 -84.37 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 130.16 3.384 . . . . 0.0 104.989 165.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.402 HG21 HG22 ' A' ' 143' ' ' ILE 0.363 1.5 mt 52.96 -17.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 1 C-N-CA 131.829 4.051 . . . . 0.0 114.44 -174.56 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.22 6.63 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 120.975 1.716 . . . . 0.0 113.582 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 41.6 mttp -71.36 -17.58 62.42 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 118.259 -2.906 . . . . 0.0 113.663 -165.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tpp -106.87 20.99 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.501 1.521 . . . . 0.0 110.904 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.45 -20.63 7.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.825 1.65 . . . . 0.0 114.636 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.39 -31.28 2.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.259 1.824 . . . . 0.0 110.677 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.02 -4.23 58.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.191 -0.943 . . . . 0.0 113.173 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.26 139.47 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.208 3.003 . . . . 0.0 110.347 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -40.08 0.27 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -100.71 -22.12 15.0 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.773 -1.108 . . . . 0.0 110.731 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -63.57 0.9 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.122 1.769 . . . . 0.0 110.508 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' H ' ' A' ' 125' ' ' ILE . 2.8 mp -33.01 -59.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.76 2.024 . . . . 0.0 113.096 170.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -68.85 -55.28 11.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.781 1.232 . . . . 0.0 108.191 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 95' ' ' LEU . . . -62.45 -34.49 76.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.443 0.697 . . . . 0.0 111.163 -172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.03 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.068 1.347 . . . . 0.0 107.663 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -57.75 -36.66 72.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.369 -171.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -54.66 -61.83 2.05 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.516 1.053 . . . . 0.0 109.08 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.4 m -78.64 -13.88 59.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.052 0.941 . . . . 0.0 113.205 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.52 -18.02 63.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.574 1.079 . . . . 0.0 110.321 166.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -132.46 32.36 3.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.285 1.434 . . . . 0.0 108.983 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.77 134.84 53.0 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.27 107.01 2.36 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.861 3.041 . . . . 0.0 107.885 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.34 34.57 3.87 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.931 -1.483 . . . . 0.0 114.747 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.9 m -136.23 171.19 14.84 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 161.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.3 mt -141.09 106.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.15 135.88 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 119.028 0.831 . . . . 0.0 110.241 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.5 tp -132.7 148.81 52.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.205 2.202 . . . . 0.0 106.605 159.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.36 -171.92 44.94 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 119.198 0.908 . . . . 0.0 112.26 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -118.59 154.83 31.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.9 0.85 . . . . 0.0 111.458 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.402 HG22 HG21 ' A' ' 114' ' ' ILE . 8.7 pt -136.61 125.38 15.27 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.398 2.279 . . . . 0.0 108.223 170.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.08 150.11 87.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.59 1.527 . . . . 0.0 110.55 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.97 130.06 64.97 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.28 -51.4 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.53 2.82 . . . . 0.0 110.457 -165.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 40.51 55.97 2.8 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.999 1.72 . . . . 0.0 110.982 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 157.6 -153.02 24.28 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 126.897 2.189 . . . . 0.0 107.648 -159.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.6 OUTLIER -63.93 166.85 8.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.092 0.446 . . . . 0.0 110.237 172.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.65 168.69 22.97 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.563 1.509 . . . . 0.0 109.182 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.75 176.81 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.772 2.029 . . . . 0.0 106.259 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.17 -79.15 0.37 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.3 tp -51.02 -44.07 60.97 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.984 1.313 . . . . 0.0 112.255 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.06 -31.16 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.265 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.75 -34.24 75.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.327 1.422 . . . . 0.0 109.805 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.11 -43.8 87.36 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.262 0.937 . . . . 0.0 111.271 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.6 mp -80.57 -39.56 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.029 0.532 . . . . 0.0 109.834 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -60.78 -32.4 71.73 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.508 -1.37 . . . . 0.0 110.338 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -74.23 8.43 2.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.513 1.525 . . . . 0.0 113.501 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -34.74 10.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.556 1.526 . . . . 0.0 111.62 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 63.1 -19.67 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 128.602 2.761 . . . . 0.0 115.339 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -72.6 -30.67 64.57 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.639 3.175 . . . . 0.0 111.615 168.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' A' ' 3' ' ' HIS . 29.5 m -54.18 125.13 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.108 1.763 . . . . 0.0 107.618 169.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.35 112.17 5.06 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -97.93 96.13 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 120.856 1.662 . . . . 0.0 106.575 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.3 m-85 -69.52 98.25 1.11 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.037 0.935 . . . . 0.0 108.743 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.17 99.49 0.9 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.85 165.82 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.92 . . . . 0.0 109.192 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.7 p -138.68 156.38 47.47 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.836 1.303 . . . . 0.0 108.288 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -42.27 -31.64 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.867 156.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -80.29 -55.8 4.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.469 0.577 . . . . 0.0 109.79 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -119.95 16.66 12.56 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.876 0.87 . . . . 0.0 110.288 -160.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -39.71 -63.06 0.62 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.791 2.036 . . . . 0.0 111.155 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -70.56 8.48 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 113.704 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.48 15.92 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.405 2.282 . . . . 0.0 110.201 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -32.04 10.36 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.632 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -37.98 -55.99 2.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.489 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.52 -23.27 57.76 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.335 1.512 . . . . 0.0 114.59 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -80.26 -38.54 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.454 1.501 . . . . 0.0 110.425 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.916 HD11 HD11 ' A' ' 6' ' ' LEU . 7.6 mt -59.74 -52.14 64.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.359 -0.838 . . . . 0.0 108.863 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.74 -43.77 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.149 0.98 . . . . 0.0 109.41 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.7 m -59.06 -43.65 91.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.114 0.87 . . . . 0.0 111.032 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.0 -48.13 81.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.104 0.562 . . . . 0.0 109.676 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.43 -52.45 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.301 1.04 . . . . 0.0 109.893 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -69.46 -5.94 27.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.8 t -64.34 -71.2 0.18 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.6 t 48.75 -12.82 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.276 2.63 . . . . 0.0 116.013 -164.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.05 -15.14 0.21 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 120.332 1.424 . . . . 0.0 113.604 -157.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 C--O 1.246 0.88 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.904 -175.395 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 113.47 26.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 166.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 23.43 91.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.092 2.157 . . . . 0.0 111.342 141.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.71 124.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -165.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -117.86 161.01 20.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 110.378 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 18' ' ' ILE . 45.7 mt -124.84 154.57 40.82 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.203 1.401 . . . . 0.0 109.823 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -158.11 169.72 23.91 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.69 63.09 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 128.668 3.033 . . . . 0.0 111.874 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -54.21 118.49 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.468 3.445 . . . . 0.0 111.455 -166.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.24 -81.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.301 2.001 . . . . 0.0 114.451 -163.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.6 37.71 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t 50.99 68.77 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.919 1.688 . . . . 0.0 110.254 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.92 23.35 1.45 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.605 1.098 . . . . 0.0 111.039 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 142' ' ' THR . 2.0 pttm -83.91 -31.55 25.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.911 -0.758 . . . . 0.0 111.901 -170.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -59.79 -38.16 81.1 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -56.99 -35.08 68.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 112.553 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -33.73 70.33 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 HD11 HD11 ' A' ' 6' ' ' LEU . 4.4 mm -77.16 -31.07 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.6 1.091 . . . . 0.0 109.984 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -54.33 -51.42 64.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.706 1.593 . . . . 0.0 107.507 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -66.13 -15.18 62.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.7 -1.137 . . . . 0.0 112.374 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.2 64.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.45 1.023 . . . . 0.0 111.137 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -78.25 -48.35 15.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.284 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -50.34 -40.76 50.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.162 0.585 . . . . 0.0 111.172 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.65 -61.37 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 123.955 0.902 . . . . 0.0 109.486 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -55.48 -42.3 74.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 123.232 0.613 . . . . 0.0 109.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -60.39 -47.99 83.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -59.93 -42.05 93.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.168 0.987 . . . . 0.0 109.921 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -71.97 -7.28 47.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.593 1.557 . . . . 0.0 113.417 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.07 9.96 60.2 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.637 -1.09 . . . . 0.0 113.153 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.5 t -99.77 105.86 36.99 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.43 97.16 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.403 2.736 . . . . 0.0 110.948 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.59 147.27 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.686 1.194 . . . . 0.0 108.637 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -137.99 170.41 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.072 150.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.95 -162.58 28.1 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.227 0.917 . . . . 0.0 111.08 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -140.4 162.71 34.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.869 0.843 . . . . 0.0 111.128 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.2 157.83 45.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.932 1.293 . . . . 0.0 107.558 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.9 100.79 11.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -79.13 159.31 27.51 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.959 1.361 . . . . 0.0 109.086 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.17 99.78 8.73 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.348 169.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 47' ' ' ILE . 7.6 p -58.71 107.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.828 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -108.96 103.1 12.08 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 120.917 -1.115 . . . . 0.0 109.348 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.639 ' HB2' HD13 ' A' ' 47' ' ' ILE . 23.7 tp60 -64.84 -37.86 89.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.786 0.721 . . . . 0.0 110.713 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.3 63.58 0.11 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.88 15.15 68.84 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.87 -1.517 . . . . 0.0 115.805 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 140.81 52.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.835 1.817 . . . . 0.0 107.075 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -78.12 98.23 5.72 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 42' ' ' GLN . 35.2 pt -78.18 -12.94 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 121.39 -0.819 . . . . 0.0 111.995 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.95 -126.96 1.3 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 165.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -132.93 158.82 41.65 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.33 134.03 35.58 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.522 1.129 . . . . 0.0 109.715 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.6 101.97 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -167.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -90.03 132.76 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.3 p -95.96 156.26 16.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.2 8.99 3.4 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.291 -0.881 . . . . 0.0 112.541 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 t -109.89 4.34 21.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.996 1.319 . . . . 0.0 111.51 161.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.2 3.45 65.3 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.367 -1.458 . . . . 0.0 114.768 161.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -71.84 148.84 45.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.538 1.669 . . . . 0.0 107.194 162.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -139.32 131.79 28.62 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.926 1.29 . . . . 0.0 108.462 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -118.99 174.08 15.2 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.731 1.15 . . . . 0.0 113.861 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.75 165.18 21.69 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.609 1.539 . . . . 0.0 108.631 162.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 tp -140.74 -70.18 0.38 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.9 p -134.49 158.07 44.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.071 0.857 . . . . 0.0 108.927 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -147.43 157.64 43.66 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.535 1.134 . . . . 0.0 110.137 169.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 t -62.14 137.1 24.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 109.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.51 165.4 30.94 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.82 153.78 7.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.734 0.814 . . . . 0.0 109.504 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.12 163.99 56.62 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.669 0.388 . . . . 0.0 111.297 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -83.58 140.52 9.45 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.001 2.467 . . . . 0.0 110.739 -170.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.43 164.26 26.47 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.691 2.26 . . . . 0.0 110.524 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.63 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.841 2.361 . . . . 0.0 113.056 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.54 10.34 26.02 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.173 1.844 . . . . 0.0 113.114 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.63 165.67 26.33 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.951 1.875 . . . . 0.0 109.025 169.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.8 157.85 42.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.201 0.601 . . . . 0.0 110.275 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -166.92 -170.11 1.47 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 128.502 2.721 . . . . 0.0 105.95 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 92.6 m -98.02 126.73 43.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 139.7 33.19 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.884 -1.135 . . . . 0.0 108.718 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.2 92.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.871 1.669 . . . . 0.0 107.604 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.12 -73.93 1.92 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.37 0.986 . . . . 0.0 112.308 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.22 -25.65 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.439 1.495 . . . . 0.0 110.768 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.29 118.63 25.86 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.31 131.1 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 162.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.44 178.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 125.273 1.429 . . . . 0.0 108.745 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -147.28 155.53 42.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.46 161.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.79 -28.92 36.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.642 0.777 . . . . 0.0 110.448 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 m -64.28 -36.87 85.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.683 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.9 m -60.45 -31.74 70.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.591 1.087 . . . . 0.0 110.931 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -71.86 -53.9 11.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.518 167.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.05 -23.87 22.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.327 1.051 . . . . 0.0 113.488 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -42.54 -53.4 4.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.197 1.799 . . . . 0.0 112.04 167.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.714 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.12 -31.88 0.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.369 1.068 . . . . 0.0 112.63 -167.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.38 52.52 2.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.653 1.181 . . . . 0.0 108.664 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -146.47 -57.49 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 126.197 1.799 . . . . 0.0 109.606 -176.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 72.6 Cg_endo -71.47 -37.18 5.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.834 1.689 . . . . 0.0 112.122 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 m -56.04 -35.73 42.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.935 0.894 . . . . 0.0 112.304 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -63.33 -38.29 90.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.54 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -129.5 76.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.823 1.249 . . . . 0.0 109.6 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -118.02 9.57 12.8 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.903 1.281 . . . . 0.0 111.388 -172.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.3 166.29 31.55 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.037 0.935 . . . . 0.0 112.042 160.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.83 -43.55 5.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.511 1.524 . . . . 0.0 110.768 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 6.0 t 60.09 54.13 4.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.124 2.169 . . . . 0.0 111.846 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -14.38 62.73 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -172.97 175.77 3.19 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.274 2.23 . . . . 0.0 108.325 168.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.36 130.88 5.7 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.322 1.439 . . . . 0.0 109.535 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.58 -179.72 3.95 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.304 2.003 . . . . 0.0 110.478 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.77 83.06 1.61 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 105.904 -2.878 . . . . 0.0 105.904 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -56.73 133.83 54.38 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 179.21 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.17 139.26 51.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 167.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.1 158.11 34.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.491 1.116 . . . . 0.0 108.461 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.7 t -142.19 127.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.411 1.085 . . . . 0.0 109.919 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CG2' HD11 ' A' ' 114' ' ' ILE . 8.9 mt -149.48 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 125.659 1.583 . . . . 0.0 107.736 -167.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -79.77 174.65 11.37 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.347 -1.471 . . . . 0.0 112.476 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 57.02 20.12 5.19 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.109 2.564 . . . . 0.0 115.036 167.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 111' ' ' ILE . 38.6 mt -55.61 125.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.512 -1.368 . . . . 0.0 108.257 174.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.52 -34.56 1.96 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.063 1.316 . . . . 0.0 111.721 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -41.94 98.98 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.658 2.229 . . . . 0.0 110.469 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -83.48 16.72 2.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.915 1.686 . . . . 0.0 112.178 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -49.53 -39.74 35.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.644 1.565 . . . . 0.0 111.518 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.12 -49.8 6.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.544 0.738 . . . . 0.0 110.346 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -67.35 -24.02 65.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -55.66 141.32 38.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.544 1.138 . . . . 0.0 112.123 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -138.07 -82.0 0.33 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.817 0.847 . . . . 0.0 109.648 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.04 -12.45 60.33 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -60.0 3.64 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 111.482 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.7 mp -35.89 -58.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 126.164 1.786 . . . . 0.0 112.338 170.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.31 -51.49 65.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.206 0.527 . . . . 0.0 110.188 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.56 83.65 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.472 -171.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.92 -46.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 121.878 -0.514 . . . . 0.0 110.148 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -52.31 -36.21 52.6 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.901 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -27.31 66.93 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 m -100.47 -31.72 11.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 116.669 -1.634 . . . . 0.0 111.49 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.74 -18.87 57.26 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.228 1.831 . . . . 0.0 111.505 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -68.33 -29.57 68.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.649 1.579 . . . . 0.0 110.082 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.6 m -63.82 142.33 98.07 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 126.435 1.894 . . . . 0.0 106.869 172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.21 16.67 0.29 Allowed 'Trans proline' 0 CA--C 1.541 0.867 1 C-N-CA 126.173 4.582 . . . . 0.0 111.608 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.79 -161.44 11.9 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -155.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.7 177.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.101 0.953 . . . . 0.0 109.808 -140.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.3 mt -137.25 103.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 1 N-CA-C 99.614 -4.217 . . . . 0.0 99.614 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 141.31 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.6 133.76 50.96 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.35 45.4 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.463 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.434 HG21 ' HE2' ' A' ' 14' ' ' LYS . 40.0 m -129.32 123.29 31.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.446 0.698 . . . . 0.0 109.177 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.67 165.46 32.93 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.945 1.698 . . . . 0.0 108.809 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.54 165.46 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.378 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.94 142.4 76.3 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.525 1.13 . . . . 0.0 108.518 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.35 104.09 1.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 121.409 1.406 . . . . 0.0 111.331 -156.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -99.44 162.04 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.479 1.112 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -24.88 -77.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 127.25 2.357 . . . . 0.0 114.967 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 138.08 22.63 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.86 164.23 35.42 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.809 1.673 . . . . 0.0 109.512 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.06 171.59 7.29 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.704 1.601 . . . . 0.0 109.31 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.53 -77.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 114.032 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 114' ' ' ILE . 1.7 tm? -59.02 -33.09 70.34 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.68 -35.54 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 O-C-N 121.149 -0.969 . . . . 0.0 110.412 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.46 -23.08 65.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.39 1.476 . . . . 0.0 111.291 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -70.67 -42.36 70.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.737 1.153 . . . . 0.0 109.542 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.07 -48.28 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.769 0.828 . . . . 0.0 109.654 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.44 -22.24 66.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 110.486 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -28.56 68.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.994 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -65.63 -34.15 77.56 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.766 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? 67.66 -57.15 0.46 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.183 2.593 . . . . 0.0 111.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.87 77.68 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.248 1.819 . . . . 0.0 107.693 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.73 135.99 48.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 128.748 2.819 . . . . 0.0 105.064 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.87 136.76 38.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 164.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.33 96.8 4.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 120.157 1.344 . . . . 0.0 107.767 170.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.451 ' HB3' HD11 ' A' ' 176' ' ' LEU . 32.4 m-85 -76.95 104.36 7.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.802 0.81 . . . . 0.0 109.039 173.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.71 106.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 160.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.14 154.05 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 167.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 22.5 p -102.88 159.93 15.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 157.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.22 -16.98 56.91 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.602 166.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -98.38 -56.77 2.37 Favored 'General case' 0 N--CA 1.458 -0.038 0 CA-C-N 118.386 0.539 . . . . 0.0 111.147 -166.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.5 17.66 5.19 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.484 1.114 . . . . 0.0 110.121 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -40.91 -46.11 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.283 1.833 . . . . 0.0 111.595 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.8 6.16 9.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 114.204 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.23 43.43 3.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.438 1.895 . . . . 0.0 109.887 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 166' ' ' PHE . 9.6 tp -118.68 -42.2 2.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.23 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.96 -55.41 6.18 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.867 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.22 -27.21 56.4 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.419 1.9 . . . . 0.0 113.398 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -72.66 -42.07 64.73 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.704 1.202 . . . . 0.0 109.804 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.76 -52.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.912 1.685 . . . . 0.0 108.486 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.55 -44.01 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.388 0.994 . . . . 0.0 109.686 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.2 m -62.03 -49.22 76.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.898 0.772 . . . . 0.0 109.703 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.4 -42.17 91.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.504 1.122 . . . . 0.0 112.151 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.51 -53.74 29.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.576 1.951 . . . . 0.0 109.529 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -68.07 -23.49 64.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.849 0.86 . . . . 0.0 111.544 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.08 -52.45 4.27 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 127.698 2.399 . . . . 0.0 112.685 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.1 m 46.18 -96.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.052 1.296 . . . . 0.0 110.891 -158.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -122.33 -0.11 9.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.635 2.374 . . . . 0.0 112.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 11.4 mmpt? . . . . . 0 C--O 1.245 0.835 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.82 140.48 44.24 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 126.119 1.768 . . . . 0.0 108.397 -171.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 163' ' ' VAL . 27.4 m-70 -64.42 146.75 54.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.934 1.694 . . . . 0.0 109.249 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -127.55 144.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD2' HG13 ' A' ' 163' ' ' VAL . 15.1 m-85 -141.38 123.05 15.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.401 0.68 . . . . 0.0 110.784 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.468 HD21 HD11 ' A' ' 180' ' ' ILE . 11.1 mt -70.4 152.5 44.01 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 t -152.93 -174.7 5.02 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.07 176.55 15.15 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.086 1.803 . . . . 0.0 111.316 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -73.98 156.02 47.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.528 2.152 . . . . 0.0 109.464 164.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 154.71 48.87 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.566 2.178 . . . . 0.0 111.103 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.96 8.51 6.38 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.315 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.274 82.2 t 66.29 120.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 127.536 2.334 . . . . 0.0 111.341 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.9 29.75 14.74 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.75 1.167 . . . . 0.0 112.586 -173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -63.77 -49.07 74.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.153 1.477 . . . . 0.0 111.838 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -45.13 -38.78 5.44 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.566 1.947 . . . . 0.0 111.221 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.3 m -49.31 -43.57 43.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.163 1.785 . . . . 0.0 111.9 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -32.79 64.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.165 1.348 . . . . 0.0 110.345 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.37 -45.13 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -50.6 72.57 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.957 1.703 . . . . 0.0 109.15 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.3 mttm -65.97 -34.4 78.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.994 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.25 60.5 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.734 1.152 . . . . 0.0 111.62 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -71.58 -48.93 45.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.354 0.662 . . . . 0.0 111.117 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.03 -33.88 69.45 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.34 1.056 . . . . 0.0 111.64 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 20' ' ' LYS . 53.0 t -58.67 -53.71 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.419 1.488 . . . . 0.0 108.431 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.53 -38.9 89.1 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.456 0.703 . . . . 0.0 109.823 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HA ' HG12 ' A' ' 30' ' ' VAL . 11.9 mttt -59.74 -43.48 94.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.911 0.778 . . . . 0.0 110.25 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -23.27 56.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.366 1.066 . . . . 0.0 111.837 169.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 m -97.72 18.08 16.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.825 2.05 . . . . 0.0 115.487 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.09 35.12 86.6 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.811 1.187 . . . . 0.0 111.435 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.4 p -71.24 158.79 87.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 120.846 -1.385 . . . . 0.0 109.884 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.23 101.7 0.63 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.588 2.859 . . . . 0.0 110.249 145.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 30' ' ' VAL . 18.6 t -105.11 149.62 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 -179.03 7.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.533 0.733 . . . . 0.0 110.085 155.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.35 -151.0 22.31 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.893 1.235 . . . . 0.0 110.034 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' CZ ' HG23 ' A' ' 111' ' ' ILE . 55.2 p90 -138.06 174.25 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.185 1.794 . . . . 0.0 109.457 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -143.6 159.49 42.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -116.15 74.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -157.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -71.89 137.97 47.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.861 0.838 . . . . 0.0 110.772 -163.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -68.95 113.77 6.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.626 1.571 . . . . 0.0 108.554 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.18 91.08 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -109.42 102.38 11.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.34 62.18 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.94 0.896 . . . . 0.0 110.168 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 66.4 1.92 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -162.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.66 -22.12 15.25 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -169.43 0.83 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.569 1.685 . . . . 0.0 110.561 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 89.79 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.685 1.584 . . . . 0.0 111.354 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.44 -10.07 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.195 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 -167.96 40.96 Favored Glycine 0 C--N 1.337 0.583 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.7 158.65 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.033 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -137.73 159.64 41.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.841 1.656 . . . . 0.0 108.288 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -100.9 100.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 121.236 1.835 . . . . 0.0 107.806 169.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -82.25 123.8 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -89.19 163.45 15.41 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.188 -0.945 . . . . 0.0 108.546 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.56 -16.63 60.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 120.637 -1.29 . . . . 0.0 112.005 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 t -63.21 -36.89 85.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.689 1.131 . . . . 0.0 108.334 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.79 6.26 17.09 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.108 0.861 . . . . 0.0 112.465 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.6 25.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.432 ' C ' HD21 ' A' ' 90' ' ' LEU . 25.5 ptt180 -144.13 135.79 25.99 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.5 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.48 135.64 12.25 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.04 67.71 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 125.129 3.886 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.588 HD21 ' CE2' ' A' ' 87' ' ' PHE . 2.6 mt -55.36 -67.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 125.317 1.447 . . . . 0.0 112.719 -164.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 p -139.7 154.85 47.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.207 1.004 . . . . 0.0 110.657 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.07 159.72 43.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.268 1.827 . . . . 0.0 106.419 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 64' ' ' VAL . 3.8 m -54.9 160.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 121.913 -0.492 . . . . 0.0 110.457 160.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.67 -142.15 3.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.22 174.55 7.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.529 1.132 . . . . 0.0 109.915 164.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -124.24 156.88 66.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.216 1.406 . . . . 0.0 110.842 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.05 142.55 8.8 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.037 1.824 . . . . 0.0 110.544 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.79 166.26 20.81 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.115 2.543 . . . . 0.0 110.699 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.92 69.19 4.67 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.427 3.418 . . . . 0.0 112.931 -172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -55.35 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 125.447 1.499 . . . . 0.0 109.691 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -55.54 157.73 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.839 2.056 . . . . 0.0 110.15 163.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.93 153.74 37.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.667 1.987 . . . . 0.0 106.98 159.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -155.18 96.23 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 96.1 m 46.03 35.45 2.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.269 2.628 . . . . 0.0 115.665 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.19 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.542 -1.349 . . . . 0.0 108.008 -170.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.49 87.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 -67.78 1.36 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.823 1.201 . . . . 0.0 112.242 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -137.1 -36.0 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.151 2.18 . . . . 0.0 111.22 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.68 170.02 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.348 0.976 . . . . 0.0 108.937 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.59 120.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.555 HG22 ' H ' ' A' ' 83' ' ' ASP . 1.4 p -81.33 176.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.914 0.864 . . . . 0.0 110.136 170.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.555 ' H ' HG22 ' A' ' 82' ' ' VAL . 28.9 t70 -142.62 109.94 5.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -32.49 74.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.589 1.156 . . . . 0.0 109.609 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -54.0 -48.97 69.87 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.26 1.824 . . . . 0.0 108.618 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.6 t -55.88 -22.44 25.57 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 120.409 1.458 . . . . 0.0 113.316 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 61' ' ' LEU . 20.9 m-85 -79.11 -60.84 2.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.521 1.055 . . . . 0.0 109.182 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.51 -26.78 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.745 2.018 . . . . 0.0 113.139 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -61.8 -28.36 69.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 114.676 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -163.39 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.616 0.766 . . . . 0.0 112.924 -171.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.55 52.81 1.01 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.563 1.145 . . . . 0.0 108.798 166.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -140.62 -61.1 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 126.437 1.895 . . . . 0.0 108.444 -177.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -42.01 36.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.187 1.925 . . . . 0.0 112.459 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.28 -20.62 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.898 0.772 . . . . 0.0 113.037 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.74 74.28 6.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.19 94.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.443 2.697 . . . . 0.0 111.741 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -128.19 120.17 26.72 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.681 1.592 . . . . 0.0 108.132 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.47 15.56 2.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.75 -30.31 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.187 3.795 . . . . 0.0 116.885 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 23.5 t -69.28 -77.6 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -154.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.4 m 57.5 -26.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.187 2.291 . . . . 0.0 117.187 -168.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m 58.17 163.8 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.5 1.5 . . . . 0.0 111.894 -145.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.31 -87.04 0.52 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.64 145.49 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 119.781 1.791 . . . . 0.0 109.556 168.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.62 -7.53 55.55 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -147.55 166.1 28.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.195 0.997 . . . . 0.0 111.428 -169.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -142.47 170.34 15.89 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 127.209 2.204 . . . . 0.0 108.121 -169.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.19 128.27 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 36.6 t -108.85 154.22 22.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -137.73 123.35 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.616 0.767 . . . . 0.0 110.203 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.456 HG23 ' CZ ' ' A' ' 35' ' ' PHE . 21.4 mt -148.46 85.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.455 1.502 . . . . 0.0 108.693 -169.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -86.46 164.75 16.79 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.918 -1.739 . . . . 0.0 111.164 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 56.6 58.02 4.43 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.587 2.355 . . . . 0.0 111.992 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.3 mt -87.12 49.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 121.03 -1.044 . . . . 0.0 108.687 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.74 3.93 1.38 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-O 118.257 -1.302 . . . . 0.0 115.082 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -103.64 -77.76 0.56 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.455 2.127 . . . . 0.0 110.848 -173.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -52.46 -18.76 1.81 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.317 1.447 . . . . 0.0 113.771 168.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -32.24 -60.6 0.27 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.523 2.329 . . . . 0.0 113.105 -167.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.55 -29.34 69.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.318 0.963 . . . . 0.0 112.254 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -95.34 -17.64 21.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.807 1.643 . . . . 0.0 112.746 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.0 p -54.56 151.94 7.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.915 1.286 . . . . 0.0 110.88 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -132.54 -89.68 0.42 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.468 1.107 . . . . 0.0 109.27 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -56.08 -21.33 21.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 117.098 -1.43 . . . . 0.0 112.296 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -62.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 120.906 1.685 . . . . 0.0 110.707 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.402 HG23 ' HG3' ' A' ' 156' ' ' GLU . 3.5 mp -41.81 -58.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.135 1.374 . . . . 0.0 110.364 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -65.31 -39.15 92.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -166.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.05 -51.91 12.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.14 0.9 . . . . 0.0 108.936 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.57 -34.07 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 O-C-N 121.909 -0.494 . . . . 0.0 111.054 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.33 -43.45 61.73 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.217 169.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.19 -45.35 83.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.568 1.531 . . . . 0.0 111.167 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.7 m -65.74 -46.86 77.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.945 0.898 . . . . 0.0 110.892 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.2 mt -62.87 -25.7 68.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 110.938 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 t -76.9 -9.08 58.44 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.588 1.555 . . . . 0.0 110.766 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.0 m -91.41 134.24 29.92 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.34 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.949 2.432 . . . . 0.0 111.577 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.7 -32.57 49.93 Favored Glycine 0 C--O 1.218 -0.896 0 CA-C-O 117.242 -1.866 . . . . 0.0 112.811 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.0 m -66.74 138.69 57.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 122.101 2.951 . . . . 0.0 107.975 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -122.65 84.44 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 101.51 -3.515 . . . . 0.0 101.51 -166.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.98 117.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mt -102.87 133.09 48.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 151.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.68 171.23 29.06 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 44.2 m -122.23 101.67 7.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.906 0.853 . . . . 0.0 108.72 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.9 pt -86.35 151.22 53.32 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.036 0.934 . . . . 0.0 108.785 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.7 145.3 36.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.927 2.418 . . . . 0.0 110.043 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.86 139.65 93.63 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 165.27 32.5 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.171 2.581 . . . . 0.0 110.601 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.77 -38.24 0.28 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.154 0.981 . . . . 0.0 111.041 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.77 139.5 4.69 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.479 -1.849 . . . . 0.0 108.479 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.09 163.75 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.729 1.611 . . . . 0.0 113.505 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.44 165.76 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.53 3.486 . . . . 0.0 109.959 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.03 171.58 7.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.32 -82.58 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.797 0.726 . . . . 0.0 109.214 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.31 -40.88 65.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.25 -0.906 . . . . 0.0 113.166 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.86 -28.06 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.544 -0.722 . . . . 0.0 110.48 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.92 -32.05 72.41 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.915 0.78 . . . . 0.0 109.632 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 125' ' ' ILE . 64.8 mm-40 -60.98 -33.88 73.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.566 1.076 . . . . 0.0 112.137 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 108.54 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -59.05 -34.74 72.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.612 0.642 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.93 -25.71 58.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.219 1.807 . . . . 0.0 112.809 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.828 1.195 . . . . 0.0 111.483 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -54.47 0.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.782 2.033 . . . . 0.0 113.758 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -72.3 42.91 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.691 2.796 . . . . 0.0 111.486 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 3' ' ' HIS . 1.9 t -120.66 103.21 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 130.503 3.521 . . . . 0.0 104.796 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.45 131.97 48.67 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.05 116.78 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.236 1.014 . . . . 0.0 109.159 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -106.17 82.09 1.71 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.578 2.351 . . . . 0.0 107.664 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 117.81 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 120.906 -1.121 . . . . 0.0 108.102 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.49 HG23 HD13 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -81.43 153.78 4.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 p -110.7 158.22 18.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -66.32 -19.01 65.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.25 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -83.29 -38.02 22.68 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 118.099 0.409 . . . . 0.0 111.18 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.11 15.18 19.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.699 1.2 . . . . 0.0 111.325 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -49.49 -52.13 31.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.314 1.046 . . . . 0.0 109.315 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.3 4.57 2.78 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -124.47 3.4 8.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.132 0.973 . . . . 0.0 113.127 172.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.49 HD13 HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -83.2 -19.11 37.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.398 0.999 . . . . 0.0 113.624 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -56.01 26.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.52 -1.228 . . . . 0.0 110.183 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.37 -27.15 63.12 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.623 1.615 . . . . 0.0 113.302 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.76 -40.67 75.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.601 1.16 . . . . 0.0 109.435 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.468 HD11 HD21 ' A' ' 6' ' ' LEU . 25.9 mt -63.95 -53.05 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.701 1.2 . . . . 0.0 107.977 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.25 -42.71 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.695 1.198 . . . . 0.0 109.767 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -55.13 39.13 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 125.479 1.512 . . . . 0.0 108.857 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 9.1 t -52.99 -41.3 64.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.123 0.874 . . . . 0.0 111.311 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.92 -53.51 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.691 1.196 . . . . 0.0 108.994 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -62.52 -34.59 77.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.075 1.307 . . . . 0.0 113.124 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.3 m -64.9 8.25 0.13 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 129.987 3.315 . . . . 0.0 113.482 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.2 p -123.12 145.94 48.16 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.856 -1.153 . . . . 0.0 108.156 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 58.76 -20.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.418 2.687 . . . . 0.0 115.528 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt . . . . . 0 C--O 1.251 1.15 0 CA-C-N 121.156 1.798 . . . . 0.0 106.952 164.696 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -163.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.052 1.741 . . . . 0.0 108.43 160.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -50.37 156.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.088 2.155 . . . . 0.0 111.214 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.1 t -141.7 143.17 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -142.92 161.83 37.09 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.97 1.708 . . . . 0.0 110.006 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -98.25 157.57 16.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 160.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -141.78 -178.96 5.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.815 1.646 . . . . 0.0 107.469 162.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.86 -170.73 14.99 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.02 115.86 4.51 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.356 2.704 . . . . 0.0 108.669 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.32 97.28 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.654 1.569 . . . . 0.0 110.601 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.39 -57.95 16.75 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t 176.09 -45.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 129.086 2.954 . . . . 0.0 109.309 163.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.44 8.99 30.42 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 123.706 0.669 . . . . 0.0 114.22 -167.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE3' ' H ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -57.64 -38.67 75.43 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.728 1.264 . . . . 0.0 111.759 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.472 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 55.0 m -64.8 -37.12 86.53 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.34 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -64.77 -33.58 76.31 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.498 1.499 . . . . 0.0 110.222 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.664 HD13 ' HB3' ' A' ' 176' ' ' LEU . 59.9 mt -60.65 -57.52 12.35 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.199 0.599 . . . . 0.0 109.754 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 mm -70.76 -38.39 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 122.989 0.516 . . . . 0.0 109.693 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.93 -61.93 1.86 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.159 2.184 . . . . 0.0 108.587 172.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.3 -32.15 72.85 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.435 -1.269 . . . . 0.0 111.853 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.31 78.45 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 120.16 1.346 . . . . 0.0 109.265 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.434 ' C ' ' HE3' ' A' ' 26' ' ' LYS . 58.7 p -70.96 -45.1 64.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.097 -0.954 . . . . 0.0 108.991 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.35 -37.54 70.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.49 1.495 . . . . 0.0 112.139 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.56 -54.85 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 125.879 1.672 . . . . 0.0 108.848 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.18 -32.94 74.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.76 -0.588 . . . . 0.0 109.92 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 30' ' ' VAL . 26.8 mtmt -62.68 -36.39 82.77 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.008 -1.683 . . . . 0.0 110.738 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -38.13 85.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 110.081 165.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.52 5.36 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.121 1.369 . . . . 0.0 114.251 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.16 52.56 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 120.274 1.397 . . . . 0.0 111.662 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.5 p -55.03 142.06 57.79 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.62 94.26 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.316 1.344 . . . . 0.0 109.086 160.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.15 139.58 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.268 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.02 169.6 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.461 1.505 . . . . 0.0 107.818 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.44 25.74 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -143.83 162.93 34.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.002 1.321 . . . . 0.0 107.513 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -140.59 110.28 6.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.402 ' CG2' HD22 ' A' ' 61' ' ' LEU . 9.1 m -70.23 134.41 48.01 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.05 44.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.52 -0.737 . . . . 0.0 110.832 -171.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.34 146.15 50.69 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -122.58 105.22 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -123.14 80.06 1.73 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 126.486 1.915 . . . . 0.0 110.005 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -65.04 -24.26 67.43 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.836 -1.165 . . . . 0.0 112.666 -166.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.97 45.64 0.73 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 166.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.31 89.24 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.717 -1.046 . . . . 0.0 114.21 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.64 124.7 46.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 119.55 1.675 . . . . 0.0 108.459 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -60.75 92.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.675 1.59 . . . . 0.0 110.608 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.64 -16.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 111.127 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.49 -166.17 39.37 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -130.9 160.98 32.87 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.084 1.753 . . . . 0.0 106.404 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.86 161.49 30.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.775 2.03 . . . . 0.0 105.998 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.97 110.02 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 167.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.32 162.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.976 1.262 . . . . 0.0 108.06 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -125.43 160.0 30.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.011 1.324 . . . . 0.0 108.154 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.9 mm? -68.18 -21.38 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.452 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -62.25 -26.48 68.41 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.63 1.105 . . . . 0.0 111.062 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.01 5.77 57.22 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.187 1.375 . . . . 0.0 111.864 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -84.34 159.77 20.82 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 120.987 -1.302 . . . . 0.0 107.774 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 147.83 26.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -174.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -145.82 -178.09 21.03 Favored Glycine 0 CA--C 1.521 0.44 0 O-C-N 123.948 0.78 . . . . 0.0 112.726 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.24 169.31 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.737 2.958 . . . . 0.0 112.429 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 7.6 tp -150.0 -66.93 0.21 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.98 -1.075 . . . . 0.0 109.705 161.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -150.11 125.62 10.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -128.55 165.71 20.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.617 1.167 . . . . 0.0 108.198 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.6 120.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.73 -119.73 2.06 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.77 157.3 47.19 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.39 1.476 . . . . 0.0 107.44 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -86.65 166.43 27.4 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.641 1.576 . . . . 0.0 110.808 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.77 139.47 14.01 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.434 2.756 . . . . 0.0 108.699 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.43 172.22 14.83 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.766 2.311 . . . . 0.0 110.765 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.21 99.54 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.86 1.706 . . . . 0.0 108.245 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.44 -79.11 0.35 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 124.902 1.239 . . . . 0.0 110.494 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.73 125.56 23.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.364 1.082 . . . . 0.0 108.752 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 138.47 32.56 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.62 -163.16 1.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.42 -178.31 3.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 157.41 167.16 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 131.133 3.773 . . . . 0.0 105.849 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 -13.21 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 123.866 0.729 . . . . 0.0 109.663 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.96 134.43 3.57 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.044 -2.822 . . . . 0.0 106.044 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.51 -68.02 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.626 2.37 . . . . 0.0 111.571 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.03 149.38 30.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.857 1.663 . . . . 0.0 108.205 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 2.1 p -121.01 132.05 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.45 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.773 0.829 . . . . 0.0 110.275 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -154.39 105.39 2.66 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -21.62 65.06 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.149 -0.97 . . . . 0.0 111.865 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.1 m -37.24 -45.82 0.68 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.526 1.93 . . . . 0.0 112.243 156.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 p -76.66 -34.43 58.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.395 0.998 . . . . 0.0 109.175 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 14.5 m-85 -60.2 -41.81 93.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.98 -1.075 . . . . 0.0 109.718 173.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 92' ' ' LEU . 11.2 pt-20 -76.84 -9.1 58.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.832 1.196 . . . . 0.0 113.625 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.46 -68.18 0.38 Allowed 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 161.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 59' ' ' GLY . 2.1 mp -102.22 -44.8 5.32 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.814 -0.554 . . . . 0.0 111.539 -158.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.48 49.3 1.77 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.463 1.905 . . . . 0.0 108.553 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.852 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -134.52 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 109.864 -176.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 41.1 Cg_endo -65.61 -33.47 45.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.883 1.722 . . . . 0.0 112.517 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -59.82 -24.73 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.533 1.133 . . . . 0.0 112.868 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.06 -11.17 60.45 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.301 0.501 . . . . 0.0 111.269 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 88.02 1.99 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.97 159.42 15.33 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.86 0.864 . . . . 0.0 109.166 167.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.81 157.38 45.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.609 1.164 . . . . 0.0 110.13 167.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.459 ' N ' HH12 ' A' ' 107' ' ' ARG . 2.1 m-20 -159.05 -67.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.629 1.571 . . . . 0.0 107.446 167.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.16 -176.95 5.3 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.264 1.425 . . . . 0.0 109.628 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.4 t -65.74 157.46 30.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.449 0.7 . . . . 0.0 109.172 165.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.8 m -50.86 -54.08 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.824 1.649 . . . . 0.0 112.134 -164.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.09 -169.64 1.8 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.245 1.402 . . . . 0.0 113.093 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.33 110.71 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 108.08 -1.546 . . . . 0.0 108.08 162.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 154.7 -81.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 68.4 124.46 0.03 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.012 2.125 . . . . 0.0 108.845 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.459 HH12 ' N ' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -60.61 164.9 4.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.517 1.127 . . . . 0.0 108.812 172.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.69 146.82 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 139' ' ' ILE . 5.7 p -115.84 163.78 15.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.938 0.875 . . . . 0.0 110.449 161.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.8 125.88 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.508 HD13 ' CG2' ' A' ' 128' ' ' VAL . 2.5 mt -141.52 74.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.04 167.47 21.75 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.88 27.95 10.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 114.103 164.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 153' ' ' LEU . 16.7 mt -70.14 75.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.186 1.394 . . . . 0.0 108.227 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.2 -47.58 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.826 -1.171 . . . . 0.0 113.45 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -69.75 -40.14 76.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.345 2.073 . . . . 0.0 111.914 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -12.72 60.94 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 116.291 -1.814 . . . . 0.0 112.618 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -47.07 -24.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -156.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 -22.19 13.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.426 1.09 . . . . 0.0 112.119 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -99.06 -29.01 13.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.964 1.706 . . . . 0.0 109.745 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -45.45 114.5 0.76 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.803 2.841 . . . . 0.0 108.348 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.13 -86.59 0.5 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 119.864 1.211 . . . . 0.0 111.16 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.852 HD11 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -69.54 -10.35 57.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.934 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -53.06 -52.14 59.5 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 120.866 1.666 . . . . 0.0 112.151 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mt -39.17 -54.63 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 127.384 2.274 . . . . 0.0 112.552 164.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -63.63 -54.26 38.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.904 1.229 . . . . 0.0 110.593 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.48 -49.26 78.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 123.24 0.338 . . . . 0.0 111.095 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.508 ' CG2' HD13 ' A' ' 111' ' ' ILE . 2.5 p -65.62 -30.06 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.907 0.883 . . . . 0.0 111.611 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -40.02 60.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.493 168.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -38.07 86.9 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.663 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.51 -48.8 63.45 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.923 1.238 . . . . 0.0 110.472 175.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 139' ' ' ILE . 12.3 mt -58.02 -32.47 67.98 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.464 1.906 . . . . 0.0 111.98 -175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.5 m -129.32 30.24 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.62 1.568 . . . . 0.0 110.019 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.437 HG23 ' HD2' ' A' ' 135' ' ' PRO . 1.3 m -76.45 165.1 55.39 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 149.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 134' ' ' THR . 44.3 Cg_endo -87.33 126.48 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.541 2.828 . . . . 0.0 109.298 168.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.07 89.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 116.929 -2.039 . . . . 0.0 116.263 158.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 m -72.14 166.9 21.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 121.827 2.814 . . . . 0.0 108.492 155.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.0 mt -131.83 104.25 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.539 HD13 ' SG ' ' A' ' 109' ' ' CYS . 41.2 mm -67.5 132.08 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.42 1.075 . . . . 0.0 108.117 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tp -140.56 136.06 32.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 107.82 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.61 41.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 113.341 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -128.56 130.73 47.8 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.169 0.987 . . . . 0.0 108.863 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.73 163.87 18.22 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.967 1.707 . . . . 0.0 108.152 165.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.01 161.07 11.72 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.37 2.713 . . . . 0.0 111.332 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.61 139.34 93.95 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 165.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.01 159.5 33.99 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.489 2.793 . . . . 0.0 108.891 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -142.3 -65.94 0.4 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.81 -122.93 0.94 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 125.208 1.385 . . . . 0.0 111.096 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.402 ' HE3' ' CA ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -62.52 171.1 1.88 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.38 172.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.52 168.0 19.3 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.271 1.314 . . . . 0.0 109.099 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.54 137.07 52.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.84 -63.36 1.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.93 0.892 . . . . 0.0 111.751 -156.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 114' ' ' ILE . 3.5 tp -62.95 -40.8 98.75 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 114' ' ' ILE . 76.4 t -65.93 -28.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.686 -0.634 . . . . 0.0 110.269 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.83 -29.92 63.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.724 0.81 . . . . 0.0 110.807 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.17 -38.79 90.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.539 1.063 . . . . 0.0 112.095 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.95 -41.94 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.86 1.264 . . . . 0.0 108.338 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -18.36 65.34 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.087 -1.633 . . . . 0.0 111.532 -174.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.76 -22.01 61.66 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.825 0.739 . . . . 0.0 110.273 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -73.9 83.93 1.7 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.35 -28.77 69.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.851 -1.156 . . . . 0.0 109.305 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -76.12 56.62 1.03 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.47 3.108 . . . . 0.0 110.651 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.77 126.5 62.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 105.05 1.34 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 161.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.1 t -88.91 98.1 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -68.41 147.24 52.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.77 125.06 48.36 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.67 159.87 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 167.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 p -128.13 149.76 50.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -58.23 -16.08 12.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.953 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -80.68 -68.75 0.65 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.195 0.907 . . . . 0.0 108.569 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.19 28.46 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.887 1.275 . . . . 0.0 109.523 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -59.58 -23.44 62.94 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.24 9.75 21.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.749 1.62 . . . . 0.0 112.057 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.63 -13.48 15.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 115.94 -1.981 . . . . 0.0 113.86 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.664 ' HB3' HD13 ' A' ' 17' ' ' LEU . 1.1 tt -84.58 -20.04 32.11 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 116.167 -2.213 . . . . 0.0 111.795 -154.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 17' ' ' LEU . 12.1 tp -25.27 -64.99 0.1 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 128.872 2.869 . . . . 0.0 113.529 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.09 -28.03 85.15 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.854 2.369 . . . . 0.0 113.18 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.84 -42.53 90.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.676 1.125 . . . . 0.0 109.538 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 6' ' ' LEU . 8.6 mt -68.62 -50.07 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 125.382 1.473 . . . . 0.0 108.032 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.83 -37.0 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.5 1.045 . . . . 0.0 111.035 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 86.8 m -60.46 -47.51 85.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 6.9 t -62.8 -29.02 70.4 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.004 0.82 . . . . 0.0 111.344 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.65 -52.19 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.232 1.013 . . . . 0.0 110.316 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -34.4 71.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.98 1.264 . . . . 0.0 111.368 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 -8.81 48.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.677 1.991 . . . . 0.0 111.813 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -79.13 -15.84 57.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.647 -1.283 . . . . 0.0 111.452 166.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -85.43 -53.72 5.02 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.97 163.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.429 -1.748 . . . . 0.0 109.073 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.503 ' HA ' ' CB ' ' A' ' 187' ' ' SER . . . . . . . . 0 CA--C 1.504 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.44 173.7 3.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 123.25 1.5 . . . . 0.0 107.555 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.617 ' HB2' HG12 ' A' ' 163' ' ' VAL . 24.2 m-70 -72.99 149.61 43.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.99 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.5 t -126.78 133.85 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.499 ' CE1' HG21 ' A' ' 157' ' ' ILE . 15.6 m-85 -136.37 121.16 18.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.501 0.667 . . . . 0.0 110.611 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.21 155.75 34.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.908 1.283 . . . . 0.0 109.101 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -161.46 -179.43 7.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.978 164.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.57 -107.29 1.12 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.383 1.944 . . . . 0.0 109.465 170.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.06 174.67 8.57 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.811 3.007 . . . . 0.0 111.746 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.21 -177.8 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.817 2.344 . . . . 0.0 110.681 164.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.73 55.44 1.32 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 126.764 2.126 . . . . 0.0 110.771 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.27 52.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.004 1.321 . . . . 0.0 107.857 156.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.63 59.78 1.41 Allowed Glycine 0 C--N 1.335 0.481 0 O-C-N 119.801 -1.812 . . . . 0.0 110.364 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -38.99 4.15 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.5 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.2 m -55.44 -44.0 75.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.71 1.204 . . . . 0.0 109.893 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.7 m -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.355 -1.466 . . . . 0.0 113.295 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -44.54 72.39 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 120.722 1.601 . . . . 0.0 108.559 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.34 -37.41 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.945 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -53.12 -47.81 68.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.386 0.994 . . . . 0.0 110.361 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -30.41 70.68 Favored 'General case' 0 C--O 1.227 -0.088 0 O-C-N 122.338 -0.226 . . . . 0.0 110.95 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -27.2 69.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.379 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.9 p -74.91 -53.38 9.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.656 1.116 . . . . 0.0 108.02 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -48.88 -45.47 41.21 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.582 1.953 . . . . 0.0 112.11 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.64 -45.51 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.258 0.551 . . . . 0.0 110.956 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 108' ' ' VAL . 84.1 mt -69.69 -37.0 76.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.024 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.77 -43.66 81.02 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -26.77 67.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.667 1.187 . . . . 0.0 112.81 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -5.73 53.45 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.761 0.824 . . . . 0.0 112.092 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.12 88.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.763 1.173 . . . . 0.0 113.643 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.32 127.6 85.99 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 119.589 1.694 . . . . 0.0 107.681 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.98 130.31 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.844 2.363 . . . . 0.0 109.577 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.65 137.6 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.78 167.87 16.68 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.528 1.531 . . . . 0.0 107.673 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 94' ' ' VAL . . . 129.92 -160.76 22.93 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.35 165.44 27.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -128.09 -178.6 4.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 162.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -140.12 137.43 34.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.35 156.3 44.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.56 111.97 7.29 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.72 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.71 124.91 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -124.61 125.42 44.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.91 1.684 . . . . 0.0 107.627 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -69.18 -39.4 78.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.944 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.21 39.16 0.41 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.969 1.747 . . . . 0.0 109.545 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.14 26.07 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.536 1.541 . . . . 0.0 114.855 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 142.84 35.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.816 1.308 . . . . 0.0 110.833 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -64.82 129.98 41.76 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 125.162 1.538 . . . . 0.0 111.539 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.5 pt -137.23 -11.77 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.874 1.67 . . . . 0.0 112.973 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.18 -167.37 36.09 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 119.255 0.934 . . . . 0.0 112.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -139.26 123.97 18.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.127 2.171 . . . . 0.0 106.79 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.74 144.72 25.4 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.37 111.96 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 119.729 1.15 . . . . 0.0 108.367 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.34 110.46 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.603 0.361 . . . . 0.0 110.056 -152.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -74.74 155.65 37.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.713 1.244 . . . . 0.0 108.808 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.8 mm? -69.19 -13.63 62.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.103 169.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.98 9.85 15.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.904 1.682 . . . . 0.0 111.791 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.1 82.4 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 120.738 -1.226 . . . . 0.0 114.27 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.21 161.21 19.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.839 1.319 . . . . 0.0 107.589 169.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.98 144.38 26.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 117.737 -1.125 . . . . 0.0 109.534 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.94 154.19 21.23 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.16 1.345 . . . . 0.0 111.89 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.07 66.98 8.76 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.022 3.815 . . . . 0.0 111.98 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -57.8 8.9 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 126.761 2.024 . . . . 0.0 111.128 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.87 141.38 29.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.02 164.65 31.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.086 0.954 . . . . 0.0 109.55 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.62 136.79 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.21 165.55 30.37 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.753 -2.939 . . . . 0.0 105.753 171.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 165.54 13.64 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -69.04 153.41 96.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.658 -0.652 . . . . 0.0 109.67 166.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.17 125.56 10.4 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.735 2.957 . . . . 0.0 110.98 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.01 174.84 11.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.557 2.838 . . . . 0.0 111.446 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.65 125.61 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 108.835 -1.256 . . . . 0.0 108.835 169.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.31 5.2 82.9 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.833 -0.981 . . . . 0.0 114.755 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 132.59 20.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.189 1.995 . . . . 0.0 105.618 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -152.55 -179.46 7.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 164.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.89 -160.8 1.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 7.4 m -88.84 160.66 17.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.653 1.115 . . . . 0.0 108.879 162.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 158.91 40.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -165.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.98 99.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 32.16 81.32 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.104 2.288 . . . . 0.0 115.605 166.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 97.06 -57.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.431 0 C-N-CA 130.168 3.387 . . . . 0.0 109.554 -171.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -82.58 155.98 24.19 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.917 -0.489 . . . . 0.0 110.346 -169.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.92 133.58 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 165.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.0 167.84 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.81 116.0 7.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.229 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -27.6 66.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.233 0.47 . . . . 0.0 111.247 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -41.18 -47.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.136 1.774 . . . . 0.0 111.103 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.8 p -70.15 -36.69 74.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.538 -0.726 . . . . 0.0 111.135 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.39 -52.01 67.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -66.69 -10.11 43.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.922 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.61 -38.25 83.69 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 120.717 -1.24 . . . . 0.0 113.05 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 -41.62 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.609 0.64 . . . . 0.0 110.129 -167.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.32 53.38 2.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.013 0.925 . . . . 0.0 109.441 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 12.2 mt -116.4 -66.09 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.66 1.184 . . . . 0.0 109.325 156.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 98.8 Cg_endo -69.43 -11.11 30.54 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.798 2.332 . . . . 0.0 113.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -67.64 -26.06 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.143 -1.598 . . . . 0.0 110.651 172.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.8 -13.53 60.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.537 1.135 . . . . 0.0 111.634 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -179.44 119.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.824 2.45 . . . . 0.0 109.154 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.23 139.08 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.427 2.291 . . . . 0.0 107.308 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 50.48 -160.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.273 1.029 . . . . 0.0 110.863 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 156.78 88.04 0.0 OUTLIER 'General case' 0 C--O 1.234 0.276 0 C-N-CA 130.308 3.443 . . . . 0.0 108.573 164.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.27 170.85 15.49 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.972 2.509 . . . . 0.0 108.695 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 p -72.35 98.16 2.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.528 1.058 . . . . 0.0 109.218 170.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 m -151.49 -60.94 0.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.009 -1.057 . . . . 0.0 111.548 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.73 65.89 0.42 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-O 117.725 -1.597 . . . . 0.0 110.935 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.13 177.05 8.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.377 3.385 . . . . 0.0 111.213 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 103.35 -154.95 18.04 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -150.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -141.27 152.88 44.87 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.048 -1.266 . . . . 0.0 111.324 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -108.01 172.47 6.82 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.536 2.335 . . . . 0.0 108.886 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 25' ' ' LEU . 29.6 t -135.35 149.48 28.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.8 t -123.27 107.75 12.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.4 0.68 . . . . 0.0 109.351 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.1 124.88 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.431 1.092 . . . . 0.0 108.305 165.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -142.26 125.18 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -145.26 -179.39 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.417 -0.802 . . . . 0.0 109.665 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.27 40.64 10.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.752 1.621 . . . . 0.0 110.573 -167.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.51 78.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.38 -83.77 0.05 OUTLIER Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -61.34 -19.15 61.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.167 1.484 . . . . 0.0 113.98 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 89.3 mmm -76.31 7.06 4.66 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.196 -1.383 . . . . 0.0 112.526 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -47.68 -26.82 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.12 -18.76 12.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.361 1.064 . . . . 0.0 111.912 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -19.97 18.03 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.648 0.779 . . . . 0.0 110.568 -171.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 m -50.17 116.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.556 1.543 . . . . 0.0 107.963 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.21 -80.7 0.37 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.256 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.44 -23.95 66.21 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.82 1.191 . . . . 0.0 110.694 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -65.12 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.907 2.083 . . . . 0.0 111.472 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -39.45 -62.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 126.204 1.802 . . . . 0.0 111.932 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.81 -50.8 72.4 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.43 0.559 . . . . 0.0 110.641 -172.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.45 -50.14 68.69 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.181 0.992 . . . . 0.0 109.715 -170.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 HD13 ' A' ' 132' ' ' LEU . 82.4 t -60.24 -46.34 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.149 0.979 . . . . 0.0 108.466 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.055 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -58.01 -49.88 75.32 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.111 1.323 . . . . 0.0 110.941 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -63.24 -29.08 70.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.448 -0.783 . . . . 0.0 111.132 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.44 HD13 HG12 ' A' ' 128' ' ' VAL . 7.9 mp -70.6 -30.63 67.36 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.909 -1.12 . . . . 0.0 111.053 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -23.56 64.1 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.26 0.936 . . . . 0.0 110.934 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.8 m -79.96 133.7 57.7 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -32.67 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.21 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.45 -17.63 33.26 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.879 -1.512 . . . . 0.0 114.643 -166.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.6 m -77.72 165.55 24.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.107 2.453 . . . . 0.0 107.697 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.0 mt -136.94 101.83 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -172.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.3 mm -72.08 135.24 28.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.56 124.23 19.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.257 1.823 . . . . 0.0 106.988 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.12 28.81 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-N 120.909 1.686 . . . . 0.0 114.826 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -129.25 113.21 14.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.86 152.73 42.5 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.63 0.772 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -70.42 149.97 63.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.784 1.656 . . . . 0.0 108.476 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.03 126.07 92.21 Favored Pre-proline 0 N--CA 1.441 -0.906 0 O-C-N 121.925 -0.485 . . . . 0.0 110.617 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.18 108.39 2.47 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 108.328 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -152.8 -36.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.778 0.831 . . . . 0.0 110.126 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.28 -66.91 0.85 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.695 1.14 . . . . 0.0 111.512 -167.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 158.2 75.69 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 124.286 1.034 . . . . 0.0 108.242 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.38 149.51 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.956 3.104 . . . . 0.0 109.875 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.51 135.44 52.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -64.37 0.84 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.304 1.442 . . . . 0.0 111.528 -172.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.29 -35.4 75.46 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.648 -0.657 . . . . 0.0 111.417 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 -43.65 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 119.109 0.868 . . . . 0.0 109.4 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -55.43 -41.55 72.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -55.76 -28.81 57.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.667 1.121 . . . . 0.0 113.087 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.499 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.7 mt -100.14 -39.64 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.486 1.514 . . . . 0.0 109.415 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.19 62.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.768 1.227 . . . . 0.0 110.19 177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.71 -39.77 5.41 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 127.786 2.434 . . . . 0.0 112.769 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.77 -32.13 70.47 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.062 -1.023 . . . . 0.0 111.093 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.7 -36.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.63 2.372 . . . . 0.0 113.389 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -63.32 -30.19 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.548 1.539 . . . . 0.0 114.154 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 3' ' ' HIS . 2.2 m -55.2 130.37 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.124 1.329 . . . . 0.0 110.793 -169.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.47 ' HE3' ' CD1' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -55.15 115.81 2.44 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.67 102.08 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 171.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' HE3' ' A' ' 164' ' ' LYS . 32.0 m-85 -83.38 87.11 6.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 162.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -66.89 94.07 0.3 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 162.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 176' ' ' LEU . 3.1 p -64.89 167.08 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p -124.6 153.07 42.74 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 165.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -61.46 -14.4 28.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.616 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.19 -62.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.824 1.193 . . . . 0.0 108.696 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.36 18.92 3.49 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 124.601 1.16 . . . . 0.0 111.561 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -50.11 -43.84 51.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.979 -1.075 . . . . 0.0 113.305 -161.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -86.34 13.88 7.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.934 2.493 . . . . 0.0 114.806 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -131.66 16.94 4.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.511 1.924 . . . . 0.0 111.813 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 166' ' ' PHE . 10.6 tp -84.09 -42.98 15.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.094 172.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -42.88 -58.78 3.55 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.377 1.871 . . . . 0.0 110.781 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.8 -25.02 78.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.036 2.491 . . . . 0.0 115.44 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.8 -46.6 57.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.431 1.493 . . . . 0.0 108.247 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.79 -53.37 45.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.245 1.418 . . . . 0.0 109.847 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.88 -45.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.823 0.738 . . . . 0.0 109.691 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.2 m -57.9 -45.63 86.14 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.57 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.95 -40.59 76.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.016 1.28 . . . . 0.0 110.859 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.06 -51.61 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.338 1.055 . . . . 0.0 109.83 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -31.2 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.519 0.728 . . . . 0.0 112.116 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 m -57.05 -51.72 68.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.549 1.14 . . . . 0.0 108.197 170.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 8.4 t -63.07 -14.33 46.89 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.554 -1.341 . . . . 0.0 113.818 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -75.86 -51.96 11.4 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 120.474 1.488 . . . . 0.0 110.812 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.485 -1.245 . . . . 0.0 110.176 178.655 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' HA ' ' CB ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -77.66 127.58 32.7 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 161.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 3' ' ' HIS . 31.0 m-70 -67.07 158.45 31.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.008 1.723 . . . . 0.0 108.377 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.45 139.09 48.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' A' ' 141' ' ' GLY . 17.7 m-85 -130.63 136.74 49.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.281 1.032 . . . . 0.0 109.265 172.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 180' ' ' ILE . 16.2 mt -78.17 157.82 29.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -152.07 169.44 22.37 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.543 0.687 . . . . 0.0 110.887 163.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.94 -171.93 37.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.09 168.37 22.17 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.785 2.323 . . . . 0.0 110.104 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.51 160.08 49.55 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.836 1.691 . . . . 0.0 111.074 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 39.73 72.88 0.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 126.999 2.238 . . . . 0.0 112.937 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.319 0.9 OUTLIER -131.11 -2.54 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.551 0.741 . . . . 0.0 112.835 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.29 19.24 19.27 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.973 -1.079 . . . . 0.0 112.634 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -51.75 67.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.432 1.616 . . . . 0.0 109.265 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -64.36 -29.56 70.63 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.788 -0.625 . . . . 0.0 109.666 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -58.48 -47.57 83.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.836 1.198 . . . . 0.0 111.681 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -46.92 87.27 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -68.2 -38.51 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.272 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -55.9 21.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.148 1.379 . . . . 0.0 108.269 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -51.2 -42.82 61.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.065 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.81 57.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.368 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -60.9 -56.98 14.77 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.933 0.788 . . . . 0.0 108.982 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.84 -31.8 68.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.319 2.248 . . . . 0.0 110.982 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.75 -50.96 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.848 1.659 . . . . 0.0 110.537 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.56 -34.47 77.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.982 0.81 . . . . 0.0 109.311 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -71.08 -20.9 62.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.649 1.18 . . . . 0.0 113.199 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -86.8 -7.56 58.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.873 1.669 . . . . 0.0 111.82 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -114.4 2.66 14.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.789 1.236 . . . . 0.0 112.792 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.43 43.18 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 119.657 1.117 . . . . 0.0 112.07 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.15 108.19 24.52 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.26 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.335 2.69 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 32' ' ' VAL . 2.4 t -69.59 169.03 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.145 0.978 . . . . 0.0 109.987 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 162.48 39.97 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.994 154.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.97 -165.66 31.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.353 0.977 . . . . 0.0 111.032 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.08 168.09 20.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.452 0.644 . . . . 0.0 111.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -143.31 152.97 42.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 108.352 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.0 p -77.11 124.9 28.47 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 157.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -104.7 139.11 40.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 160.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -73.67 147.03 44.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.602 0.715 . . . . 0.0 110.052 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.41 98.7 4.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -125.53 153.39 43.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -128.29 -60.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.083 1.353 . . . . 0.0 107.728 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.57 31.87 8.21 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.703 1.62 . . . . 0.0 110.69 167.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.61 14.67 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.288 1.423 . . . . 0.0 114.409 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HD2' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -80.27 142.89 34.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.498 1.649 . . . . 0.0 108.691 176.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -65.08 135.23 55.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.952 0.796 . . . . 0.0 108.893 171.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -124.67 -17.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.776 1.23 . . . . 0.0 111.997 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.09 -152.99 21.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.69 161.89 36.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.286 5.9 p30 -131.26 142.8 50.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 90' ' ' LEU . 2.4 p -90.28 93.55 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 125.457 1.503 . . . . 0.0 108.004 -173.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 t -84.97 147.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -107.23 162.89 13.48 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.751 1.22 . . . . 0.0 109.223 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -31.41 72.13 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.343 -0.848 . . . . 0.0 111.56 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.8 t -65.09 -25.29 67.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.229 1.011 . . . . 0.0 110.101 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.0 -2.64 44.5 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.666 -1.074 . . . . 0.0 112.976 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.9 m -60.74 151.09 30.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.3 1.55 . . . . 0.0 108.478 163.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 155.33 50.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.891 1.277 . . . . 0.0 111.685 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.615 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -139.22 164.71 25.85 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.034 0.834 . . . . 0.0 113.685 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.13 -2.56 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.945 3.097 . . . . 0.0 115.109 -165.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 24.93 -79.26 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.76 3.624 . . . . 0.0 115.311 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 p -130.2 147.87 51.98 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.006 0.821 . . . . 0.0 110.279 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -148.17 158.87 44.32 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.097 1.359 . . . . 0.0 108.67 -172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -62.57 148.76 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.44 71.55 0.02 OUTLIER Glycine 0 C--N 1.34 0.781 0 CA-C-N 119.487 1.039 . . . . 0.0 114.503 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.42 -159.34 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.789 1.236 . . . . 0.0 110.163 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.71 156.67 62.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.907 1.683 . . . . 0.0 109.848 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 132.72 22.39 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 110.7 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -66.7 175.64 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.651 2.234 . . . . 0.0 111.708 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.43 -36.43 15.55 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.05 1.833 . . . . 0.0 111.318 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.33 -59.31 6.37 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -168.42 1.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.438 0.619 . . . . 0.0 110.985 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.37 147.75 32.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.0 0.92 . . . . 0.0 109.314 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -165.01 -163.69 0.72 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.361 1.465 . . . . 0.0 107.668 151.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 78.4 m -109.61 110.73 21.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.423 1.889 . . . . 0.0 108.97 -172.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.69 136.67 53.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.966 1.257 . . . . 0.0 108.746 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 t -125.63 102.75 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 24.91 84.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 C-N-CA 128.139 2.781 . . . . 0.0 114.781 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 95.73 -59.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.675 3.59 . . . . 0.0 109.219 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.46 146.91 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.648 1.179 . . . . 0.0 109.761 -166.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.12 112.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 166.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ASP . 2.7 p -71.98 -179.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 O-C-N 121.266 -0.896 . . . . 0.0 109.012 166.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 86' ' ' SER . 6.2 t0 -150.75 145.64 25.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 161.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.5 -39.12 77.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.843 1.257 . . . . 0.0 107.709 167.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.6 m -54.02 -44.89 71.34 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.114 0.566 . . . . 0.0 109.875 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 70.6 m -64.31 -17.69 63.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.19 0.905 . . . . 0.0 112.43 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.24 -60.42 2.37 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.715 0.806 . . . . 0.0 109.928 161.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -45.05 -33.05 1.94 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.09 2.156 . . . . 0.0 113.525 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.65 -40.36 62.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.696 0.68 . . . . 0.0 112.021 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.615 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -140.48 -32.29 0.59 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -168.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 41.1 0.96 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.768 2.027 . . . . 0.0 109.557 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -137.82 -59.63 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 125.544 1.538 . . . . 0.0 108.496 -171.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 29.1 Cg_endo -57.48 -37.78 96.2 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.951 1.767 . . . . 0.0 111.926 170.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.4 m -55.64 -31.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.91 0.777 . . . . 0.0 112.435 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.69 -36.42 60.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.412 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -156.1 92.43 1.35 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -71.98 164.39 26.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.41 119.92 23.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.723 0.809 . . . . 0.0 109.652 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -80.18 127.98 32.97 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.382 0.673 . . . . 0.0 111.867 -163.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.17 164.26 36.11 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.704 1.202 . . . . 0.0 109.467 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.01 127.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.236 2.615 . . . . 0.0 111.722 172.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.6 p -66.63 163.17 19.47 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.594 0.758 . . . . 0.0 111.162 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 150.45 -97.93 0.18 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.63 -177.7 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.411 2.741 . . . . 0.0 110.769 168.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -117.67 -62.26 0.3 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -70.84 167.6 18.6 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.059 0.944 . . . . 0.0 110.232 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -139.09 -179.38 5.82 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.547 1.139 . . . . 0.0 108.993 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.0 t -127.48 144.37 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.5 t -125.85 143.08 51.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.873 2.069 . . . . 0.0 106.977 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.3 t -138.96 132.87 40.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.28 135.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 33.5 t0 -133.06 -172.95 3.06 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.125 -1.609 . . . . 0.0 107.462 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 2.3 mm-40 56.45 -81.46 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 129.202 3.001 . . . . 0.0 110.675 -156.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.291 38.4 mt 53.98 -10.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 128.133 2.573 . . . . 0.0 112.944 -169.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 113' ' ' GLU . . . -83.46 -59.78 2.09 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.942 2.211 . . . . 0.0 111.103 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -52.54 -29.19 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.387 1.475 . . . . 0.0 114.035 -168.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.35 4.73 41.82 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.216 -1.373 . . . . 0.0 112.657 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -24.81 -64.24 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 129.108 2.963 . . . . 0.0 114.594 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.86 -34.31 17.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.928 0.491 . . . . 0.0 111.16 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.75 -27.34 61.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.571 1.148 . . . . 0.0 112.444 -169.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.3 p -51.16 120.48 5.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.367 1.867 . . . . 0.0 111.727 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.7 -92.92 0.52 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.74 -6.36 15.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.752 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -65.38 0.6 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.331 1.453 . . . . 0.0 110.386 171.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.5 mp -35.76 -59.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.158 1.783 . . . . 0.0 112.724 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -59.75 -52.12 66.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.48 87.54 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.83 -59.07 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.858 1.263 . . . . 0.0 109.253 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -57.9 -37.91 74.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.504 1.047 . . . . 0.0 111.913 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -34.44 76.8 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.804 -0.56 . . . . 0.0 110.712 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.406 ' CG2' HG21 ' A' ' 137' ' ' THR . 45.0 m -81.53 -30.29 33.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.27 0.941 . . . . 0.0 111.336 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.83 -21.33 63.07 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.41 1.005 . . . . 0.0 110.83 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 t -93.16 -8.97 41.0 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.458 2.303 . . . . 0.0 112.363 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.5 m -62.06 135.5 94.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.19 -36.32 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.401 2.067 . . . . 0.0 111.425 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.09 6.28 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.406 HG21 ' CG2' ' A' ' 131' ' ' THR . 58.9 m 43.52 166.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.784 2.434 . . . . 0.0 113.272 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.8 mt -144.91 114.0 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.9 131.69 34.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.4 96.46 5.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 158.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -113.95 171.9 14.05 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.26 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.4 m -134.63 134.22 40.97 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.34 156.93 66.3 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.712 1.605 . . . . 0.0 109.572 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.13 150.31 37.42 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.86 1.707 . . . . 0.0 110.209 169.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.69 151.75 60.82 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 123.77 0.828 . . . . 0.0 110.733 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.1 162.73 38.84 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.702 2.935 . . . . 0.0 108.901 166.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -156.97 -61.01 0.09 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -118.45 -118.67 2.84 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 151.85 88.77 Favored Pre-proline 0 C--O 1.237 0.436 0 CA-C-N 117.966 0.883 . . . . 0.0 111.329 -172.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -59.04 156.25 35.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.173 2.582 . . . . 0.0 109.936 167.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.95 139.38 49.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.057 1.343 . . . . 0.0 107.408 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -70.35 0.11 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.901 1.68 . . . . 0.0 113.174 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 tp -56.7 -39.77 74.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.522 -0.736 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.0 -31.13 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.218 0.917 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -61.78 -29.4 70.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.378 1.444 . . . . 0.0 110.289 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.07 -23.07 67.28 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.317 0.962 . . . . 0.0 112.089 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.05 -47.0 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -68.1 -11.55 59.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.989 -1.07 . . . . 0.0 112.393 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -76.58 -10.51 59.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 123.911 0.884 . . . . 0.0 113.144 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -74.56 87.54 2.12 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.728 1.149 . . . . 0.0 109.292 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 52.02 0.49 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.482 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -153.48 -12.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 111.2 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.51 137.84 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.566 -1.334 . . . . 0.0 109.965 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -73.47 134.46 43.92 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 164.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.7 t -115.22 79.49 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.466 ' CG ' HD21 ' A' ' 176' ' ' LEU . 6.2 m-85 -67.31 91.09 0.24 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.676 1.59 . . . . 0.0 110.765 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.75 147.18 52.36 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 164.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.539 HG22 ' H ' ' A' ' 169' ' ' THR . 1.8 p -122.31 171.69 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 123.253 1.501 . . . . 0.0 109.238 168.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.21 128.18 29.5 Favored 'General case' 0 N--CA 1.435 -1.214 1 C-N-CA 131.864 4.066 . . . . 0.0 102.888 -178.322 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -46.05 -24.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.288 1.835 . . . . 0.0 112.248 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.69 -70.76 0.41 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.911 0.884 . . . . 0.0 109.472 -172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.09 17.58 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.352 2.261 . . . . 0.0 111.852 -173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -52.5 -44.93 65.97 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -162.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -77.66 3.43 13.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -87.93 -8.04 56.3 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.608 1.163 . . . . 0.0 111.72 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.466 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -83.1 -34.34 26.15 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 120.672 1.578 . . . . 0.0 112.441 177.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -57.6 7.39 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.17 -1.395 . . . . 0.0 109.89 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.97 -27.48 58.2 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.179 1.814 . . . . 0.0 113.114 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.4 -42.35 65.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.343 0.974 . . . . 0.0 109.261 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 6' ' ' LEU . 15.6 mt -53.12 -55.86 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 125.313 1.445 . . . . 0.0 109.297 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.12 -33.84 66.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.785 0.72 . . . . 0.0 110.523 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 88.6 m -63.78 -48.96 74.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.876 0.87 . . . . 0.0 108.715 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -56.32 -37.24 69.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.161 1.384 . . . . 0.0 110.12 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.25 -55.92 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.988 0.915 . . . . 0.0 110.681 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.46 -21.46 65.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.722 1.146 . . . . 0.0 112.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 73.9 m -58.0 -33.78 69.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.261 0.937 . . . . 0.0 113.045 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.445 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 47.5 m -92.01 -5.89 52.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.238 0.927 . . . . 0.0 112.42 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -86.44 -51.74 6.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.117 -0.989 . . . . 0.0 110.356 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 O-C-N 123.944 0.777 . . . . 0.0 110.985 -156.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HD3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.89 73.25 7.91 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.358 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.516 ' HB2' HG12 ' A' ' 163' ' ' VAL . 7.9 m80 59.38 164.75 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.016 2.526 . . . . 0.0 112.116 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -138.74 139.96 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 O-C-N 120.139 -1.6 . . . . 0.0 107.953 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 20.3 m-85 -138.65 157.01 46.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.022 0.929 . . . . 0.0 110.993 168.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.811 HD11 HD11 ' A' ' 180' ' ' ILE . 2.8 mm? -111.04 131.02 55.41 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.627 1.171 . . . . 0.0 108.257 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.57 165.5 25.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.797 0.439 . . . . 0.0 110.375 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 68.56 1.61 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.01 1.29 . . . . 0.0 112.431 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.55 121.55 8.06 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 CA-C-N 120.652 2.226 . . . . 0.0 109.616 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.57 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.968 1.778 . . . . 0.0 113.148 -171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.47 15.59 6.35 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.141 -0.81 . . . . 0.0 111.726 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t 65.75 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.985 1.85 . . . . 0.0 109.412 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.43 -11.51 0.04 OUTLIER Glycine 0 CA--C 1.529 0.937 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.753 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -15.99 7.03 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.27 -1.135 . . . . 0.0 113.225 172.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -38.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.066 2.146 . . . . 0.0 110.608 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 m -71.05 -29.59 65.52 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.286 -0.884 . . . . 0.0 109.103 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 177' ' ' LEU . 69.5 mt -61.78 -52.81 62.7 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mm -58.96 -43.9 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -49.17 -63.59 1.06 Allowed 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -59.77 -36.68 77.17 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.67 0.606 . . . . 0.0 111.754 177.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.77 88.57 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 120.262 1.392 . . . . 0.0 109.723 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -67.89 -47.69 68.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.751 0.82 . . . . 0.0 109.458 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.3 -36.56 61.34 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.678 1.191 . . . . 0.0 112.234 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 20' ' ' LYS . 89.7 t -63.5 -45.32 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.592 -0.693 . . . . 0.0 110.494 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.17 -36.75 80.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.82 -44.74 90.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.4 t -58.76 -36.47 74.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.89 1.676 . . . . 0.0 110.446 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 t -77.24 -2.37 34.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.813 1.645 . . . . 0.0 112.556 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.04 13.04 72.38 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.589 1.086 . . . . 0.0 113.102 -174.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.8 122.95 87.36 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 119.247 1.524 . . . . 0.0 107.19 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.14 118.83 5.87 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.842 2.362 . . . . 0.0 109.63 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -115.66 141.12 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 107.761 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.09 167.88 16.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 163.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.11 -161.96 25.98 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -145.07 166.95 23.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.783 1.292 . . . . 0.0 111.794 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -137.43 177.82 7.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.445 1.02 . . . . 0.0 110.004 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.6 p -139.65 74.62 1.48 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.016 1.389 . . . . 0.0 110.534 -168.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -76.35 23.63 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.118 2.167 . . . . 0.0 115.581 -163.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.316 7.8 pt-20 51.72 113.67 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.795 2.838 . . . . 0.0 114.023 -162.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.566 HG13 HG13 ' A' ' 47' ' ' ILE . 8.0 p -71.86 121.28 21.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.087 -1.008 . . . . 0.0 108.439 176.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -131.6 120.71 23.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -86.62 -2.61 58.65 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.359 0.6 . . . . 0.0 111.186 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.66 65.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 -171.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.61 -5.36 1.7 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.486 2.469 . . . . 0.0 117.075 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -92.02 147.5 22.91 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 120.023 1.912 . . . . 0.0 108.278 177.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -74.4 139.21 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 161.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -132.05 -17.53 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.863 1.265 . . . . 0.0 111.587 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 168.6 -128.63 1.73 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 165.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -138.91 153.62 48.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 171.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -130.39 152.63 49.59 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.294 2.638 . . . . 0.0 106.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.52 107.91 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 119.539 1.063 . . . . 0.0 110.511 -162.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.1 109.4 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.879 -157.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.3 p -75.97 145.79 40.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -15.54 62.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.643 . . . . 0.0 111.735 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t -62.05 -45.41 93.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 108.912 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.78 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.037 0.827 . . . . 0.0 112.587 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 169.35 15.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.125 1.37 . . . . 0.0 110.167 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -152.65 138.7 18.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.109 1.764 . . . . 0.0 107.881 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.85 173.08 22.01 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 120.142 1.337 . . . . 0.0 112.022 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 168.04 18.35 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.607 2.205 . . . . 0.0 109.176 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -157.54 -59.33 0.08 Allowed 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -141.42 153.4 44.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.461 0.573 . . . . 0.0 109.711 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -138.47 159.26 42.52 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.334 1.054 . . . . 0.0 109.296 170.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.97 128.89 24.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.8 164.27 26.77 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.56 167.03 4.68 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.751 0.786 . . . . 0.0 109.45 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.83 144.95 80.26 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.59 132.7 27.76 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.279 1.986 . . . . 0.0 109.175 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 165.8 29.64 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.548 2.165 . . . . 0.0 110.009 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 80.16 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.75 2.3 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.02 -83.65 0.11 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 131.72 49.82 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -146.67 137.41 23.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -159.26 63.23 0.39 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.7 m 59.45 -159.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.573 1.549 . . . . 0.0 109.585 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER 157.57 155.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 1 C-N-CA 131.75 4.02 . . . . 0.0 109.758 166.268 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.33 100.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -170.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.36 -63.4 2.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.296 1.427 . . . . 0.0 113.684 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.33 -18.94 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 111.556 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.09 169.35 10.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 25.6 t -110.68 115.08 48.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 166.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.5 170.63 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 166.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.41 141.77 39.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 163.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.11 -34.6 73.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.905 0.882 . . . . 0.0 109.298 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -36.72 84.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.695 0.679 . . . . 0.0 111.27 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 m -61.08 -34.99 75.8 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.538 1.063 . . . . 0.0 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 61' ' ' LEU . 4.9 m-85 -63.51 -61.87 2.04 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.219 0.208 . . . . 0.0 110.614 165.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -22.42 25.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.196 1.398 . . . . 0.0 113.216 -169.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -45.87 -48.98 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.086 0.954 . . . . 0.0 112.121 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -31.21 0.95 Allowed 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.84 1.256 . . . . 0.0 111.239 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.96 86.04 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 119.615 1.098 . . . . 0.0 110.587 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -52.38 68.11 Favored Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 120.285 -1.509 . . . . 0.0 112.168 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.32 -16.94 21.79 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.503 1.469 . . . . 0.0 113.797 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -41.97 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 122.022 2.192 . . . . 0.0 109.042 169.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.39 -38.48 78.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -155.39 91.02 1.29 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.993 1.269 . . . . 0.0 111.172 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -95.73 163.81 13.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 154.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 23.97 101.88 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.33 2.652 . . . . 0.0 115.1 158.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.59 -61.14 2.63 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.8 p 36.79 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.351 3.46 . . . . 0.0 118.088 159.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 m -41.59 -44.71 3.13 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.638 1.975 . . . . 0.0 112.361 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 m 46.68 83.58 0.03 OUTLIER 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.47 2.308 . . . . 0.0 111.58 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.97 -167.58 34.49 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -160.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.12 119.2 6.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.234 2.622 . . . . 0.0 109.573 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -136.64 99.2 0.3 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -73.38 159.05 33.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.382 1.091 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 -137.54 171.52 14.33 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.138 1.775 . . . . 0.0 108.103 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.96 151.26 34.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.12 153.0 39.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.9 t -135.89 117.84 20.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 108.223 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.69 63.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -65.98 -48.72 70.32 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.74 65.64 2.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.467 1.507 . . . . 0.0 112.668 -167.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 90.8 mt -108.64 147.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 120.159 -1.588 . . . . 0.0 107.016 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 -80.14 0.36 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-O 118.827 -0.985 . . . . 0.0 111.353 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -59.65 -25.58 64.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.205 1.503 . . . . 0.0 111.842 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.86 -10.29 51.82 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 115.118 -2.372 . . . . 0.0 113.353 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -49.62 -17.32 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -159.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.82 -23.17 9.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.831 1.252 . . . . 0.0 112.557 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -87.88 -31.33 19.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.356 1.462 . . . . 0.0 111.154 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.53 117.8 2.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.944 1.698 . . . . 0.0 109.553 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -120.56 -64.21 1.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.642 0.656 . . . . 0.0 111.808 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.37 -14.86 60.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.552 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.56 -73.42 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.646 1.978 . . . . 0.0 112.128 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -42.66 -37.41 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.856 1.662 . . . . 0.0 113.294 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -73.58 -68.97 0.46 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.187 0.903 . . . . 0.0 110.558 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.65 -41.65 77.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 112.29 -167.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.3 -51.46 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.201 1.4 . . . . 0.0 108.407 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -63.3 -30.99 72.02 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.062 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.05 -57.02 14.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.245 1.384 . . . . 0.0 108.943 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 m -65.51 -29.51 70.16 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.845 -0.534 . . . . 0.0 112.359 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.0 -30.15 66.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.711 0.687 . . . . 0.0 110.495 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.9 t -64.12 -35.2 80.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.322 1.049 . . . . 0.0 109.543 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.0 m -73.16 133.08 81.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.807 0.731 . . . . 0.0 109.906 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.09 -30.21 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.824 2.349 . . . . 0.0 112.854 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.48 -31.25 34.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.208 -1.329 . . . . 0.0 113.398 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 m -73.26 162.87 28.87 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.672 1.736 . . . . 0.0 108.395 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.0 mt -140.57 98.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.74 145.49 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.426 0.557 . . . . 0.0 109.715 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 115.24 11.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.042 2.137 . . . . 0.0 106.495 167.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.12 25.01 Favored Glycine 0 N--CA 1.464 0.543 0 CA-C-N 120.34 1.427 . . . . 0.0 112.708 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.9 m -117.36 87.42 2.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.34 110.73 16.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.36 158.52 57.17 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.79 153.11 95.68 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.36 -77.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.413 2.075 . . . . 0.0 107.926 166.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? 153.45 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.392 1 C-N-CA 131.798 4.039 . . . . 0.0 104.234 -168.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.53 0.05 OUTLIER Glycine 0 CA--C 1.5 -0.845 0 O-C-N 124.105 0.878 . . . . 0.0 114.908 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.443 ' HG2' ' HD2' ' A' ' 150' ' ' PRO 0.33 0.0 OUTLIER -165.31 172.28 4.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 130.391 3.476 . . . . 0.0 105.903 163.067 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.443 ' HD2' ' HG2' ' A' ' 149' ' ' LYS . 57.2 Cg_endo -67.96 162.16 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 1 C-N-CA 125.337 4.025 . . . . 0.0 109.466 165.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.52 175.27 5.54 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.054 -1.029 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.62 16.75 25.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 112.447 172.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.48 -53.52 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.421 1.088 . . . . 0.0 108.268 168.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.78 -21.14 27.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.661 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -48.18 -39.9 22.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.472 1.109 . . . . 0.0 111.357 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -25.72 66.21 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.848 1.259 . . . . 0.0 111.136 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.5 mp -102.01 -38.05 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.244 1.418 . . . . 0.0 108.901 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -28.44 69.33 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.802 -1.186 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -52.71 -47.93 66.96 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 125.069 1.348 . . . . 0.0 110.565 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 78.2 5.9 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -56.94 -13.48 2.71 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.559 0.743 . . . . 0.0 111.557 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -39.04 56.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.193 2.197 . . . . 0.0 111.955 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 3' ' ' HIS . 18.9 m -48.55 128.82 4.77 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 125.602 1.561 . . . . 0.0 109.025 176.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 46.8 tptt -61.13 106.68 0.63 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 166.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -83.52 105.34 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 163.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 6' ' ' LEU . 36.8 m-85 -75.9 92.89 3.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 163.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 107.15 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 162.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.76 163.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.6 p -122.92 154.33 38.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.217 0.917 . . . . 0.0 108.999 164.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.65 1.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.784 1.633 . . . . 0.0 113.034 162.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -92.58 -36.81 12.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.347 0.976 . . . . 0.0 111.243 171.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.73 HD21 HD12 ' A' ' 176' ' ' LEU . 2.3 p-10 -127.0 7.57 6.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 113.665 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -44.36 -55.36 5.03 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.613 1.565 . . . . 0.0 115.064 -164.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -83.8 18.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.923 1.238 . . . . 0.0 113.164 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -131.56 13.95 4.96 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 117.244 -1.36 . . . . 0.0 113.788 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.73 HD12 HD21 ' A' ' 172' ' ' ASN . 0.7 OUTLIER -88.1 -13.9 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.663 1.574 . . . . 0.0 112.483 -177.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 17' ' ' LEU . 6.1 tp -30.44 -62.06 0.24 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.826 2.05 . . . . 0.0 111.627 173.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.78 -27.81 43.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.935 1.756 . . . . 0.0 112.774 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -70.05 -39.54 75.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.363 0.983 . . . . 0.0 108.988 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 6' ' ' LEU . 3.7 mt -57.93 -58.8 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 117.583 -1.199 . . . . 0.0 107.942 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.531 ' HA ' HG23 ' A' ' 184' ' ' VAL . 9.1 t -57.12 -27.55 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.897 0.771 . . . . 0.0 111.521 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.7 m -67.48 -29.16 68.52 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.756 -1.215 . . . . 0.0 112.35 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 25.9 t -90.66 -33.72 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.393 -1.442 . . . . 0.0 108.514 -167.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -63.9 -63.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 125.244 1.418 . . . . 0.0 108.423 164.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -15.43 63.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 112.984 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.3 t -49.56 -37.97 29.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.229 1.412 . . . . 0.0 110.138 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -30.53 70.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.84 0.746 . . . . 0.0 112.078 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.71 -3.08 58.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.8 1.24 . . . . 0.0 112.003 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? . . . . . 0 C--O 1.249 1.079 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 167.07 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 -104.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.425 ' HB2' HG12 ' A' ' 163' ' ' VAL . 51.0 m-70 -131.57 153.11 50.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.47 140.85 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.937 1.244 . . . . 0.0 108.9 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 143' ' ' ILE . 16.3 m-85 -133.87 146.92 51.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.152 0.981 . . . . 0.0 109.799 177.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 180' ' ' ILE . 87.7 mt -93.44 151.38 19.78 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 123.897 0.748 . . . . 0.0 109.265 157.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -151.08 179.89 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.29 1.436 . . . . 0.0 107.994 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.92 -176.92 24.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 122.22 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.856 2.371 . . . . 0.0 112.337 -167.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.82 91.09 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.944 3.763 . . . . 0.0 112.972 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.96 74.76 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.263 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 10.2 p 22.8 78.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.568 2.747 . . . . 0.0 113.542 159.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.31 -36.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.901 1.715 . . . . 0.0 109.348 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.88 -34.85 76.77 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.25 177.103 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 m -56.48 -44.5 80.69 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.323 -1.322 . . . . 0.0 108.948 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.409 HG22 ' HD3' ' A' ' 20' ' ' LYS . 31.1 m -53.9 -36.97 63.29 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 120.067 1.303 . . . . 0.0 111.904 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.17 69.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.942 1.247 . . . . 0.0 110.614 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.24 -43.36 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -52.42 65.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.214 1.406 . . . . 0.0 109.37 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 16' ' ' THR . 4.6 mptp? -53.03 -45.68 68.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.655 171.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.85 27.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.638 -1.173 . . . . 0.0 113.943 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.5 p -80.54 -51.53 8.66 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 120.056 1.298 . . . . 0.0 110.296 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 4.0 pt-20 -57.87 -32.46 67.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.06 0.544 . . . . 0.0 111.067 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.87 -64.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.006 1.322 . . . . 0.0 108.367 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 mt -52.22 -41.31 62.62 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.965 1.306 . . . . 0.0 110.09 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 23' ' ' GLU . 45.3 mtmt -66.47 -46.26 76.96 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -34.29 75.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.019 0.927 . . . . 0.0 110.54 172.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 m -61.8 -41.73 98.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.446 1.021 . . . . 0.0 110.433 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.44 9.21 10.5 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 126.343 1.925 . . . . 0.0 112.745 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.46 130.81 73.15 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.04 139.61 43.17 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.908 1.739 . . . . 0.0 109.106 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.65 157.35 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.574 1.55 . . . . 0.0 107.804 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 174.76 13.71 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.109 -0.37 . . . . 0.0 111.916 163.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.83 -158.07 22.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 124.92 1.248 . . . . 0.0 111.087 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -146.13 162.82 37.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.115 1.366 . . . . 0.0 108.753 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -149.54 125.36 10.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.687 1.195 . . . . 0.0 107.961 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -84.73 70.46 10.81 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 120.919 -1.113 . . . . 0.0 109.559 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -79.44 48.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -166.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 52.14 -174.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.431 2.062 . . . . 0.0 112.62 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.0 t -125.13 93.58 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 150.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -91.42 103.5 16.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 160.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -79.6 104.4 10.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 165.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.93 50.71 11.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.33 0.968 . . . . 0.0 111.713 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.27 -13.95 18.33 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 117.369 -1.795 . . . . 0.0 115.891 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.73 129.43 39.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.254 2.527 . . . . 0.0 109.369 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -86.35 68.18 10.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.433 1.111 . . . . 0.0 112.735 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 pt -89.63 -2.46 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -168.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.67 -166.07 32.22 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 120.187 1.358 . . . . 0.0 111.797 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -138.54 149.54 45.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.9 153.65 51.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.86 154.47 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 164.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -140.32 154.81 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.841 2.057 . . . . 0.0 106.639 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.7 p -117.77 174.95 5.89 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.755 2.07 . . . . 0.0 110.7 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 54' ' ' LEU . 2.1 mm? -79.81 21.3 0.55 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.915 -1.115 . . . . 0.0 112.537 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -126.38 -12.76 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 -2.31 27.74 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.61 1.096 . . . . 0.0 112.935 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.87 160.41 32.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.865 1.832 . . . . 0.0 110.065 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.22 164.22 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.517 1.927 . . . . 0.0 107.251 165.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.75 140.63 9.66 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -82.78 63.89 8.01 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.282 3.988 . . . . 0.0 111.745 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.96 -63.66 1.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.104 1.761 . . . . 0.0 111.598 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 p -143.59 152.49 41.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.867 1.212 . . . . 0.0 109.764 172.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 168.83 18.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.04 129.08 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.17 45.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 -164.74 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.701 1.6 . . . . 0.0 109.219 -175.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 76' ' ' ARG . 6.6 mt-10 -129.11 154.87 80.52 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.09 125.31 12.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.604 2.203 . . . . 0.0 111.612 -163.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.56 162.94 39.98 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.225 1.95 . . . . 0.0 110.488 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.47 137.35 46.41 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.038 1.825 . . . . 0.0 109.639 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.36 -1.99 73.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.968 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -99.43 163.0 12.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.534 1.667 . . . . 0.0 107.544 163.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -141.3 145.66 35.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 162.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -155.23 -175.33 5.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.9 2.08 . . . . 0.0 107.179 166.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.68 162.56 28.78 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 119.679 -1.888 . . . . 0.0 109.98 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -168.87 135.04 1.75 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.757 1.223 . . . . 0.0 107.705 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.27 15.59 6.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 118.112 0.414 . . . . 0.0 110.294 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 76' ' ' ARG . . . 94.9 114.76 2.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.837 -2.505 . . . . 0.0 106.837 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 68.32 -51.42 0.55 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.588 2.355 . . . . 0.0 113.602 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.54 157.7 16.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.737 2.015 . . . . 0.0 108.391 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.86 123.17 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 171.26 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 110.555 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -156.61 107.71 2.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.918 0.781 . . . . 0.0 112.881 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.6 -35.48 4.05 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.857 1.662 . . . . 0.0 113.054 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -34.45 74.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.936 -1.102 . . . . 0.0 112.048 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.8 t -58.15 -38.66 77.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.622 1.556 . . . . 0.0 110.562 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -64.46 -46.63 82.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.513 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -52.38 -30.1 27.26 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.739 0.699 . . . . 0.0 111.91 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 90' ' ' LEU . 2.6 mt-30 -69.76 -29.97 67.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.23 -0.919 . . . . 0.0 113.184 -173.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -141.15 -44.68 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.439 0.563 . . . . 0.0 111.862 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.97 37.54 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.998 1.719 . . . . 0.0 112.05 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.432 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -129.99 -65.18 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 127.068 2.147 . . . . 0.0 108.053 175.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 31.2 Cg_endo -62.09 -27.48 79.07 Favored 'Trans proline' 0 C--N 1.351 0.676 0 CA-C-N 121.562 1.593 . . . . 0.0 112.965 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.31 -24.71 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.727 0.811 . . . . 0.0 112.599 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.109 0.868 . . . . 0.0 111.335 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -133.31 72.95 1.49 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.692 1.234 . . . . 0.0 108.705 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.11 129.49 34.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.367 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.83 166.87 18.23 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.743 168.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -166.26 -174.62 2.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.332 1.853 . . . . 0.0 106.788 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 5.3 p 52.27 -0.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 131.369 3.868 . . . . 0.0 117.855 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t 87.74 15.0 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.809 2.844 . . . . 0.0 110.879 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.35 33.4 p 77.87 108.13 0.08 Allowed 'General case' 0 N--CA 1.458 -0.073 1 C-N-CA 132.196 4.198 . . . . 0.0 114.186 176.391 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 176.48 -151.21 11.16 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.684 -168.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.55 170.58 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.998 3.799 . . . . 0.0 112.163 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.61 106.19 3.09 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 105.785 -2.926 . . . . 0.0 105.785 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -66.59 151.9 46.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -115.52 98.18 6.58 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.253 1.021 . . . . 0.0 109.991 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.53 110.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 26.7 t -108.0 108.22 19.24 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.84 127.88 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.463 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.677 HD13 HG23 ' A' ' 128' ' ' VAL . 4.2 mt -141.04 74.97 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -77.14 174.9 10.18 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.099 1.318 . . . . 0.0 110.015 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 42.38 67.19 0.63 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.893 2.477 . . . . 0.0 114.368 169.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 111' ' ' ILE 0.258 6.7 mt -86.6 -0.39 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 120.521 -1.362 . . . . 0.0 111.707 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.01 -61.68 2.62 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.703 -1.248 . . . . 0.0 113.527 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -54.74 -41.69 70.72 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.583 1.691 . . . . 0.0 114.304 -160.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mmt -78.9 -5.54 53.91 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.289 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -41.16 -41.49 1.81 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -161.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 119' ' ' LEU . 4.4 mp -68.44 -60.1 2.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.009 0.924 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.18 -30.07 71.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.761 1.624 . . . . 0.0 111.826 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 t -39.84 107.92 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.032 2.933 . . . . 0.0 110.1 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -128.71 -78.6 0.56 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.622 1.169 . . . . 0.0 109.276 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.27 -31.21 61.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.623 0.769 . . . . 0.0 110.782 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -60.01 3.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 125.474 1.51 . . . . 0.0 111.424 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 mp -41.14 -58.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.113 1.765 . . . . 0.0 111.922 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -65.05 -47.37 77.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 118.588 0.631 . . . . 0.0 110.483 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.83 66.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 124.144 0.903 . . . . 0.0 110.083 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.677 HG23 HD13 ' A' ' 111' ' ' ILE . 2.4 p -62.05 -32.38 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 121.527 -0.733 . . . . 0.0 110.24 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.49 -35.57 60.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.41 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -38.77 79.01 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.564 1.074 . . . . 0.0 110.486 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.53 -44.28 24.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.328 1.051 . . . . 0.0 110.41 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.82 -18.19 64.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.537 1.062 . . . . 0.0 112.543 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.7 m -82.12 -22.15 36.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.046 0.839 . . . . 0.0 111.92 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.5 m -87.31 133.17 39.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -79.35 -27.47 4.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.547 2.831 . . . . 0.0 111.487 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.07 81.95 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.993 -0.893 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 5.4 m -67.08 150.09 49.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.056 1.928 . . . . 0.0 110.068 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.77 107.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -69.82 133.35 32.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 140' ' ' LEU . 12.4 tp -142.56 97.82 3.18 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.799 1.312 . . . . 0.0 108.25 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.6 -172.1 17.35 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 114.616 0.606 . . . . 0.0 114.616 -169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.8 m -136.63 112.0 9.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.66 1.184 . . . . 0.0 113.296 175.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 5' ' ' PHE . 19.7 pt -108.89 154.32 41.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.251 1.02 . . . . 0.0 110.906 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.03 159.73 52.15 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.727 1.618 . . . . 0.0 111.749 172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.71 149.79 97.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.456 168.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.5 104.09 1.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.155 1.903 . . . . 0.0 109.489 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -82.77 -63.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.06 107.9 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.99 168.52 0.11 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.602 1.961 . . . . 0.0 111.483 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.68 169.78 1.62 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.335 3.357 . . . . 0.0 111.292 165.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mp -126.42 153.71 44.63 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.13 -44.9 83.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -165.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.459 ' CD1' HD11 ' A' ' 157' ' ' ILE . 0.4 OUTLIER -80.43 -33.77 36.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.928 0.785 . . . . 0.0 109.362 173.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.57 -23.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.213 -1.555 . . . . 0.0 110.348 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -58.02 10.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.904 2.082 . . . . 0.0 109.398 166.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.48 63.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.896 1.279 . . . . 0.0 111.534 177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.459 HD11 ' CD1' ' A' ' 153' ' ' LEU . 4.7 mm -73.98 -51.39 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 118.465 0.575 . . . . 0.0 110.268 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -24.56 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.723 0.809 . . . . 0.0 110.322 -170.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -55.88 -26.43 47.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.754 1.222 . . . . 0.0 111.611 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -66.45 -35.87 81.37 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.824 -1.173 . . . . 0.0 111.514 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 53.87 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.657 2.783 . . . . 0.0 115.758 -167.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.4 41.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.736 2.014 . . . . 0.0 111.273 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 3' ' ' HIS . 12.3 m -87.2 134.15 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 119.853 -1.78 . . . . 0.0 106.734 166.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -74.22 112.0 9.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 165.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.83 90.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 32.7 m-85 -75.05 118.95 18.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 167.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.7 89.56 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.29 143.98 14.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.5 p -121.29 147.99 44.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -54.96 -14.66 1.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.366 166.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -81.82 -56.68 3.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.1 0.864 . . . . 0.0 108.882 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.7 6.01 49.53 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.606 -171.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -32.36 -57.26 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.276 2.23 . . . . 0.0 112.219 -172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -84.09 5.05 27.55 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.29 -17.35 21.73 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.05 1.34 . . . . 0.0 112.231 165.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -80.73 -23.63 39.33 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.042 -169.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -57.9 9.27 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.196 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.45 -22.35 52.17 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.75 2.3 . . . . 0.0 114.271 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.22 73.64 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 6' ' ' LEU . 11.3 mt -67.72 -46.63 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.196 0.998 . . . . 0.0 109.262 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.8 t -50.41 -49.15 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.26 1.024 . . . . 0.0 109.21 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 97.6 m -58.14 -51.28 70.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.15 0.887 . . . . 0.0 108.857 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.95 -27.09 69.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.64 -68.4 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 117.294 -1.336 . . . . 0.0 107.944 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -53.54 -24.54 13.75 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.477 1.511 . . . . 0.0 112.558 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.81 -41.97 5.32 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.179 1.792 . . . . 0.0 112.073 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 t 44.88 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.053 1.341 . . . . 0.0 107.465 -162.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -50.21 -57.12 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.328 2.251 . . . . 0.0 115.428 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.007 -1.949 . . . . 0.0 112.729 -146.847 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.992 -0.527 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -131.8 171.06 13.98 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.006 0.821 . . . . 0.0 111.751 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.82 174.6 6.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.046 0.938 . . . . 0.0 110.232 -167.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.86 143.98 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -139.88 150.38 44.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.608 1.163 . . . . 0.0 109.036 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.09 142.62 38.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 125.445 1.498 . . . . 0.0 107.817 -171.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 t -156.82 -169.69 3.06 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 123.541 0.526 . . . . 0.0 110.694 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 145' ' ' VAL . . . 110.69 -174.9 17.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.826 1.679 . . . . 0.0 110.378 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.45 161.45 45.97 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.339 2.026 . . . . 0.0 110.14 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 140.94 46.94 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.33 2.02 . . . . 0.0 110.848 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.24 16.39 4.15 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.713 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.297 5.8 m 44.23 33.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.485 2.314 . . . . 0.0 115.543 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.1 20.54 0.25 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.03 -1.428 . . . . 0.0 113.085 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -69.25 0.21 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.148 1.474 . . . . 0.0 110.308 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -30.5 71.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.333 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 97.1 m -52.51 -52.21 55.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.293 1.406 . . . . 0.0 109.187 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -48.52 78.9 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.389 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -66.39 -45.65 88.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.861 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -44.72 84.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.024 1.283 . . . . 0.0 107.893 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -64.69 -23.76 67.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 124.135 0.897 . . . . 0.0 111.417 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.1 -38.81 26.67 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 125.331 1.453 . . . . 0.0 110.323 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -62.89 -53.12 59.0 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.28 -34.56 72.43 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.07 -49.08 85.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.786 0.834 . . . . 0.0 109.178 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.93 -39.39 76.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' A' ' 54' ' ' LEU . 76.5 mttt -57.31 -49.12 77.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.428 1.013 . . . . 0.0 109.406 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 t -49.92 -51.57 39.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.381 2.273 . . . . 0.0 106.949 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -65.56 15.67 0.03 OUTLIER 'General case' 0 C--O 1.236 0.35 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 173.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.8 19.78 56.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.913 1.244 . . . . 0.0 112.84 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 26' ' ' LYS . 6.0 p -56.87 149.8 41.59 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.78 109.68 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.799 1.666 . . . . 0.0 109.613 159.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.95 171.85 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.596 0.758 . . . . 0.0 109.102 169.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.07 172.61 18.1 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.067 2.547 . . . . 0.0 105.109 165.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.82 -159.11 22.1 Favored Glycine 0 C--O 1.237 0.304 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.68 169.72 17.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.522 0.661 . . . . 0.0 111.994 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -135.73 165.86 24.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -125.62 80.52 1.9 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.9 155.23 40.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 167.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -71.18 125.92 28.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.9 t -80.26 126.36 39.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -127.38 167.18 16.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.533 1.133 . . . . 0.0 110.295 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.48 29.34 2.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.349 1.46 . . . . 0.0 109.728 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.48 -21.19 0.4 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.456 -1.402 . . . . 0.0 114.045 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.22 6.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.416 1.484 . . . . 0.0 110.308 -163.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 140.01 46.43 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 118.522 1.161 . . . . 0.0 108.467 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.28 135.34 51.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 160.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.0 pt -133.41 -2.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 111.548 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.6 -157.93 27.55 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.22 135.04 30.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.112 2.165 . . . . 0.0 106.12 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.55 164.04 13.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.931 1.293 . . . . 0.0 107.945 168.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.3 p -113.73 104.8 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.02 112.26 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 123.872 0.869 . . . . 0.0 109.889 -160.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -68.59 152.63 45.1 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 109.219 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.3 mm? -68.73 -2.6 9.66 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.808 170.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -110.56 18.94 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.254 1.822 . . . . 0.0 111.531 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.89 0.96 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.371 -0.83 . . . . 0.0 114.709 160.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 m -115.29 166.12 12.2 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.702 1.251 . . . . 0.0 108.133 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -154.09 142.61 20.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.31 -1.494 . . . . 0.0 108.377 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.26 142.7 14.29 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 118.457 -1.191 . . . . 0.0 111.656 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.84 64.78 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 126.144 4.563 . . . . 0.0 113.565 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.93 -59.89 4.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 112.231 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.8 p -146.75 140.28 25.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 120.608 1.549 . . . . 0.0 108.227 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptt-85 -155.81 65.28 0.59 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.845 0.748 . . . . 0.0 110.725 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.827 HG12 ' H ' ' A' ' 65' ' ' GLY 0.335 41.8 t 58.71 -153.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -170.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.827 ' H ' HG12 ' A' ' 64' ' ' VAL . . . 134.08 141.88 4.58 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 129.21 3.291 . . . . 0.0 107.333 -166.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 147.23 53.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 155.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 146.65 99.06 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.54 127.75 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.003 1.802 . . . . 0.0 110.233 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.34 169.2 22.22 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.682 2.921 . . . . 0.0 110.718 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.94 -0.92 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.523 2.148 . . . . 0.0 114.306 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.48 5.34 29.76 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.987 1.28 . . . . 0.0 113.844 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 156.87 43.19 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 120.599 2.199 . . . . 0.0 109.598 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -154.13 155.69 35.84 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 162.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -149.68 26.04 0.84 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.188 1.795 . . . . 0.0 107.808 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.3 m 55.67 -179.39 0.04 OUTLIER 'General case' 0 C--N 1.345 0.405 0 C-N-CA 127.699 2.399 . . . . 0.0 112.501 -165.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.04 170.19 13.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 109.737 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 77' ' ' VAL . 24.1 m -127.97 77.62 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 107.822 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.54 -113.36 4.14 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -162.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -29.2 54.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -166.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.81 146.15 23.99 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 121.601 2.0 . . . . 0.0 107.368 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.2 t -95.08 137.93 22.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.03 177.25 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 123.612 0.765 . . . . 0.0 109.815 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -148.85 113.59 5.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 157.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -25.06 67.38 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.949 -1.094 . . . . 0.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 m -55.85 -31.76 63.04 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.814 1.246 . . . . 0.0 110.235 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.4 t -62.0 -37.23 84.04 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.931 1.241 . . . . 0.0 110.203 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -64.62 -50.83 65.61 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -18.7 37.41 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.103 -0.998 . . . . 0.0 113.53 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -64.47 -57.88 7.98 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.86 -1.15 . . . . 0.0 110.47 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -128.72 -33.32 2.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.786 1.234 . . . . 0.0 112.334 -166.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.17 46.92 0.75 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.68 1.192 . . . . 0.0 108.895 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -61.05 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.051 2.14 . . . . 0.0 107.844 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.17 -21.68 48.15 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.779 1.653 . . . . 0.0 112.962 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.67 -34.32 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 119.394 0.997 . . . . 0.0 112.053 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.85 3.83 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -168.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -112.12 87.19 2.51 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.59 143.69 56.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.806 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 33.05 -113.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.456 2.303 . . . . 0.0 111.225 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.18 -76.63 0.41 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.6 t -157.99 -54.04 0.07 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.768 0.713 . . . . 0.0 110.068 159.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.2 m 50.23 40.2 21.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.712 1.205 . . . . 0.0 111.476 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.8 m -155.25 -74.52 0.11 Allowed 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.114 1.366 . . . . 0.0 109.363 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.76 -117.02 2.65 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.3 173.88 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.888 2.392 . . . . 0.0 111.756 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 139.75 -50.4 0.77 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.733 2.111 . . . . 0.0 107.977 -166.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 62.4 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 129.08 2.952 . . . . 0.0 112.481 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.53 168.07 12.89 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.626 0.771 . . . . 0.0 110.772 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.2 158.03 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 159.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.21 153.58 50.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 163.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.9 120.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -166.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.32 86.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -171.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.47 175.62 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.242 -0.912 . . . . 0.0 109.898 -169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 56.25 39.8 30.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.416 1.086 . . . . 0.0 112.352 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CG2' HD12 ' A' ' 153' ' ' LEU . 17.4 mt -81.68 59.35 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 119.725 -1.859 . . . . 0.0 109.685 -175.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.48 -54.64 0.26 Allowed Glycine 0 N--CA 1.465 0.598 0 O-C-N 120.164 -1.585 . . . . 0.0 113.649 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 8.23 3.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -114.81 13.36 17.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.867 1.212 . . . . 0.0 110.266 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -40.51 -42.19 1.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.635 2.374 . . . . 0.0 113.0 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.62 -17.03 10.67 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 124.048 0.939 . . . . 0.0 111.997 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.76 -12.72 23.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.569 0.622 . . . . 0.0 111.069 -171.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -61.24 101.61 0.17 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 119.215 0.916 . . . . 0.0 109.907 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -99.7 -78.33 0.51 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.4 mt -56.42 -24.78 47.36 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.88 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -71.5 0.07 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.2 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.3 mp -30.9 -54.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.969 1.708 . . . . 0.0 112.238 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -71.14 -62.77 1.27 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.569 0.348 . . . . 0.0 111.347 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.59 91.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.903 0.858 . . . . 0.0 109.902 -167.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.77 -54.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 117.328 -1.32 . . . . 0.0 107.943 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -57.69 -31.2 66.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.287 2.312 . . . . 0.0 113.799 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -59.62 -45.65 91.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.031 0.932 . . . . 0.0 108.944 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.8 m -63.42 -42.5 98.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.408 1.483 . . . . 0.0 111.078 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.15 -35.28 74.96 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.169 -0.957 . . . . 0.0 110.63 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.7 m -90.27 1.47 56.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.474 1.51 . . . . 0.0 112.992 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.7 m -72.18 134.08 83.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.2 118.14 5.52 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 123.154 2.569 . . . . 0.0 108.051 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.37 -3.96 86.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 117.36 -1.8 . . . . 0.0 114.64 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.3 m -67.68 153.24 44.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.555 2.178 . . . . 0.0 107.468 163.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.7 mt -134.64 95.2 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -166.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.49 140.57 19.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.2 100.95 5.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.374 1.87 . . . . 0.0 106.207 163.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -124.38 166.78 16.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.4 m -124.21 117.49 24.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.01 132.84 24.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.485 2.314 . . . . 0.0 109.448 -173.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.36 137.5 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.429 2.086 . . . . 0.0 110.557 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 8' ' ' GLY . 4.5 p -64.49 122.1 76.5 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 110.695 -168.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.42 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.411 2.741 . . . . 0.0 109.411 -171.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -138.6 110.14 7.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 166.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.02 -26.08 6.37 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-O 116.544 -2.253 . . . . 0.0 114.909 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 132.82 24.39 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 121.684 2.742 . . . . 0.0 112.274 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.26 96.44 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.701 2.934 . . . . 0.0 108.538 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 112.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.72 -59.77 3.74 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 113.997 -168.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 114' ' ' ILE . 1.6 tm? -63.44 -41.42 98.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.898 0.772 . . . . 0.0 109.925 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.29 -30.05 47.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.716 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.75 -35.51 74.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.621 172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.71 -56.59 17.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.766 1.621 . . . . 0.0 109.062 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.73 -29.61 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.159 0.984 . . . . 0.0 111.125 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.79 -37.85 76.47 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 120.606 -1.309 . . . . 0.0 109.516 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.63 -19.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.174 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -23.25 50.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.934 1.243 . . . . 0.0 110.886 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.37 -55.26 0.26 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 127.623 2.369 . . . . 0.0 113.43 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -60.26 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 1 C-N-CA 132.726 4.411 . . . . 0.0 113.077 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 t -138.95 121.52 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 15.2 tptm -64.94 123.16 18.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.6 t -102.33 91.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 9.7 m-85 -81.92 102.88 11.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.837 0.855 . . . . 0.0 110.216 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.62 98.13 6.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.125 0.97 . . . . 0.0 109.105 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.32 158.3 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 50.0 p -121.54 158.72 27.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -57.87 -24.42 57.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.111 163.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.65 -72.43 0.43 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.825 0.85 . . . . 0.0 110.539 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -86.85 30.82 0.72 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.864 1.265 . . . . 0.0 109.798 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -48.2 -60.48 2.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.679 1.592 . . . . 0.0 109.898 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -77.37 4.21 11.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -97.54 -6.01 34.49 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.843 1.657 . . . . 0.0 111.852 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.1 tp -74.13 -39.97 62.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.506 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 tp -40.87 -64.05 0.67 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 111.54 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.13 -25.22 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 121.482 1.565 . . . . 0.0 111.806 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.08 -38.63 75.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.584 1.554 . . . . 0.0 109.858 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.95 -54.09 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 109.484 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.34 -41.7 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.436 0.562 . . . . 0.0 109.54 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.5 m -56.0 -47.85 76.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.972 1.309 . . . . 0.0 109.101 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -47.79 84.29 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.944 0.793 . . . . 0.0 110.826 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.57 -48.32 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.304 0.642 . . . . 0.0 109.97 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.59 55.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.881 1.273 . . . . 0.0 110.102 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 t -55.94 -40.51 73.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.903 1.281 . . . . 0.0 109.644 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.5 t -72.23 -2.13 17.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 112.745 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -111.11 -7.39 14.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.903 1.281 . . . . 0.0 112.686 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? . . . . . 0 C--O 1.252 1.22 0 CA-C-N 119.505 1.048 . . . . 0.0 108.202 166.506 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 162.46 32.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.263 0.938 . . . . 0.0 109.811 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.445 ' HB2' HG12 ' A' ' 163' ' ' VAL . 66.0 m-70 -89.32 155.84 19.11 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.287 1.435 . . . . 0.0 109.493 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -129.37 132.29 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.774 1.23 . . . . 0.0 108.989 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 5.3 m-85 -141.78 136.06 30.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.455 1.102 . . . . 0.0 108.574 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.42 147.79 22.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 t -143.35 161.89 37.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.827 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.46 -175.52 20.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.351 0.977 . . . . 0.0 111.176 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.87 166.47 29.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 111.78 -171.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.44 157.09 62.28 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.462 2.108 . . . . 0.0 110.355 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.22 -9.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 117.608 -1.662 . . . . 0.0 115.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t 61.74 102.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.217 1.807 . . . . 0.0 109.535 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.35 -7.36 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.33 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -32.69 69.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.72 1.76 . . . . 0.0 110.901 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 m -61.98 -39.82 93.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -1.11 1.55 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.133 2.573 . . . . 0.0 112.676 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' A' ' 176' ' ' LEU . 19.8 mt -101.87 -66.39 0.92 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 167.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 HD22 ' A' ' 140' ' ' LEU . 1.6 mp -63.13 -41.45 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.263 0.938 . . . . 0.0 111.797 -168.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.6 64.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -67.89 -32.07 72.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.183 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.09 80.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.888 0.875 . . . . 0.0 110.607 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 t -63.52 -58.25 7.59 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 108.798 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.0 -45.74 32.09 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.256 1.822 . . . . 0.0 112.083 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.43 -54.77 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.98 -0.45 . . . . 0.0 110.321 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.56 -32.78 74.33 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.916 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 mttt -59.47 -44.09 93.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.351 0.978 . . . . 0.0 109.044 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -12.3 61.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.877 0.871 . . . . 0.0 111.118 172.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -93.35 8.99 38.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.284 1.834 . . . . 0.0 114.646 170.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.82 21.24 71.12 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.346 -0.846 . . . . 0.0 111.947 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 26' ' ' LYS . 9.0 p -57.64 147.04 62.89 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.518 1.159 . . . . 0.0 109.096 169.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.81 106.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.883 2.388 . . . . 0.0 109.4 153.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.45 140.59 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 3.5 m-20 -151.48 138.87 19.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.944 0.898 . . . . 0.0 109.185 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.93 30.38 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 106.459 -2.656 . . . . 0.0 106.459 -166.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.8 176.23 10.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.862 1.331 . . . . 0.0 112.144 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -138.36 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -131.02 76.24 1.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 152.72 40.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.62 115.93 14.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.377 1.084 . . . . 0.0 111.993 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.3 t -78.22 96.4 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -102.3 119.27 38.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 167.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -75.21 -78.74 0.1 Allowed 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.01 59.24 0.36 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.03 -9.45 1.52 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.063 -171.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 137.79 32.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.808 1.804 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 143.14 46.14 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 pt -144.06 -6.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.231 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.74 -151.85 23.43 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 119.562 1.074 . . . . 0.0 111.688 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -138.57 164.54 29.2 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.072 1.749 . . . . 0.0 109.156 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.13 142.93 48.94 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 128.336 2.654 . . . . 0.0 104.6 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.13 152.34 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.63 1.172 . . . . 0.0 109.335 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.24 111.81 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 120.198 1.363 . . . . 0.0 112.048 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.431 HG22 HG11 ' A' ' 94' ' ' VAL . 80.6 p -63.78 145.97 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.634 0.773 . . . . 0.0 109.954 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.404 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.2 mm? -64.53 -16.88 63.32 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.55 -0.719 . . . . 0.0 112.336 169.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 t -66.48 -32.47 73.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.792 1.637 . . . . 0.0 109.635 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.78 21.23 3.28 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.053 -0.859 . . . . 0.0 114.827 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.6 m -128.71 152.2 48.68 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.661 1.73 . . . . 0.0 109.516 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -128.83 168.81 15.38 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.89 1.276 . . . . 0.0 112.087 -173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -150.67 179.97 26.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.898 170.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.6 174.48 6.38 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.809 3.006 . . . . 0.0 111.439 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -165.14 -64.51 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.806 -1.184 . . . . 0.0 110.135 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.91 141.43 29.04 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.3 38.55 0.25 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.251 15.2 t 62.54 176.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.499 1.519 . . . . 0.0 109.246 -167.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.93 152.13 6.05 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.428 1.966 . . . . 0.0 108.782 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 158.65 16.7 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.592 0.757 . . . . 0.0 111.522 -174.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.41 145.04 99.11 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.595 -0.691 . . . . 0.0 109.64 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.91 132.26 15.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.552 2.168 . . . . 0.0 110.105 -168.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 158.5 56.65 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.496 2.131 . . . . 0.0 110.659 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.36 121.52 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.41 2.073 . . . . 0.0 110.489 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.05 9.55 59.39 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.777 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -120.35 156.48 31.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.084 1.354 . . . . 0.0 107.62 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 156.35 40.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.381 1.472 . . . . 0.0 108.057 160.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -135.52 174.48 10.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.951 2.5 . . . . 0.0 105.334 160.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.9 m -73.17 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.342 1.057 . . . . 0.0 108.388 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.58 148.12 28.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.696 -1.252 . . . . 0.0 110.412 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.7 19.83 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -151.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.01 98.28 2.27 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 61.29 -69.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.551 1.94 . . . . 0.0 110.907 -159.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.86 139.04 57.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 111.237 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.23 132.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 159.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.15 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.774 1.23 . . . . 0.0 108.833 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.31 112.61 10.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.032 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.6 -35.77 79.6 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.025 -1.047 . . . . 0.0 109.86 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -64.63 -36.22 83.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.924 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.4 p -62.51 -33.99 75.99 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.08 1.309 . . . . 0.0 109.939 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.71 -55.37 17.72 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.28 1.032 . . . . 0.0 109.65 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.34 -13.38 0.34 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.252 1.421 . . . . 0.0 113.495 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.443 ' HB2' HD23 ' A' ' 90' ' ' LEU . 9.5 mt-30 -78.23 -24.97 46.76 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.351 -1.468 . . . . 0.0 114.277 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -147.15 -35.37 0.24 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.12 46.24 0.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.41 1.884 . . . . 0.0 111.498 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -64.92 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 116.877 -1.535 . . . . 0.0 108.095 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.95 -23.96 46.36 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.681 2.254 . . . . 0.0 113.511 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 53' ' ' THR . 15.4 m -58.47 -31.56 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 120.283 -1.511 . . . . 0.0 111.569 175.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.84 -10.35 59.42 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.473 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 167.95 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.943 2.497 . . . . 0.0 107.545 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -143.42 112.95 6.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.756 0.823 . . . . 0.0 110.582 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 56.43 44.2 24.78 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.214 2.205 . . . . 0.0 114.242 166.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 90.44 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 109.764 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.5 t -163.07 11.15 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 159.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.49 -38.0 0.41 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.577 1.535 . . . . 0.0 112.444 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.0 t -57.57 144.8 35.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.106 0.866 . . . . 0.0 110.849 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -50.76 134.76 30.48 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.93 1.252 . . . . 0.0 112.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.75 139.53 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.902 2.401 . . . . 0.0 109.675 174.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.73 37.77 0.02 OUTLIER Glycine 0 CA--C 1.518 0.224 0 O-C-N 121.59 -0.694 . . . . 0.0 111.371 -171.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 52.09 -169.34 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.888 1.675 . . . . 0.0 110.828 -162.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.32 164.43 38.77 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.007 2.523 . . . . 0.0 106.089 166.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -120.15 146.32 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.7 p -118.93 168.78 10.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.39 123.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -148.74 92.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -77.54 171.28 15.15 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.663 1.185 . . . . 0.0 109.804 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.8 27.28 4.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.482 1.513 . . . . 0.0 114.56 161.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD21 ' A' ' 153' ' ' LEU . 54.2 mt -74.34 76.94 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.887 1.327 . . . . 0.0 108.227 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.54 -42.99 0.04 OUTLIER Glycine 0 C--O 1.221 -0.684 0 CA-C-O 117.249 -1.862 . . . . 0.0 115.844 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -32.02 71.25 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 122.391 3.095 . . . . 0.0 111.181 175.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.1 mmt -78.35 1.52 21.63 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 116.863 -1.541 . . . . 0.0 114.003 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -34.97 -51.17 0.51 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.565 1.946 . . . . 0.0 114.593 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.57 -27.89 13.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 112.283 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.28 -23.23 51.17 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.023 0.929 . . . . 0.0 111.969 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.5 t -49.81 128.46 18.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.518 2.327 . . . . 0.0 111.149 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.15 -95.88 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.99 -15.99 26.93 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.993 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.92 -71.38 0.07 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 110.374 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.5 mt -32.59 -55.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 127.658 2.383 . . . . 0.0 110.871 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.03 -66.77 0.49 Allowed 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.31 -40.07 73.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.696 1.198 . . . . 0.0 111.515 -170.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.55 -51.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.892 2.077 . . . . 0.0 108.965 174.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -54.75 -40.7 69.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.838 1.199 . . . . 0.0 111.214 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -58.82 -46.33 87.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.78 0.832 . . . . 0.0 109.487 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.42 ' HB ' HD11 ' A' ' 139' ' ' ILE . 5.6 m -65.28 -40.64 94.16 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.737 0.699 . . . . 0.0 111.81 173.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.52 -25.16 67.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.249 0.932 . . . . 0.0 110.839 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.8 m -108.17 -5.49 16.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 0.0 112.73 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.2 m -64.8 139.53 97.8 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 125.75 1.62 . . . . 0.0 108.594 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.75 155.44 53.93 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.573 2.182 . . . . 0.0 110.721 171.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.36 -47.53 1.39 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.122 1.82 . . . . 0.0 114.072 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.3 m -59.99 155.67 16.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.467 1.633 . . . . 0.0 110.518 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.26 136.75 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.447 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.8 OUTLIER -93.4 128.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 173.344 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -115.26 135.33 54.27 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 165.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.51 -179.17 40.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.095 -1.05 . . . . 0.0 115.7 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.0 m -129.9 124.36 32.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.117 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.3 pt -117.9 154.52 51.3 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.203 1.401 . . . . 0.0 108.155 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.33 158.7 14.93 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.194 2.596 . . . . 0.0 110.497 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.21 137.45 78.68 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 165.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.08 156.01 63.52 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.575 2.85 . . . . 0.0 109.72 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -129.17 -14.34 4.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.835 1.654 . . . . 0.0 112.563 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.25 -85.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 O-C-N 120.711 -1.243 . . . . 0.0 110.02 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.29 153.79 39.39 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.453 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.74 157.15 27.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.815 1.676 . . . . 0.0 111.475 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.52 135.36 53.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.663 0.602 . . . . 0.0 111.815 -154.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 114' ' ' ILE . 10.8 tp -61.59 -46.7 88.76 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.029 0.931 . . . . 0.0 110.198 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.91 -34.86 70.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 119.209 0.913 . . . . 0.0 111.252 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -66.87 -26.65 67.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.903 1.229 . . . . 0.0 111.565 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.77 -43.83 92.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.415 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.585 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 8.5 mm -69.21 -44.09 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.568 0.747 . . . . 0.0 109.899 173.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -61.21 -27.2 68.26 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.586 -1.321 . . . . 0.0 109.83 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -5.29 21.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.012 1.725 . . . . 0.0 113.525 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -37.91 11.99 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.811 1.187 . . . . 0.0 110.927 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 61.93 -28.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.264 2.226 . . . . 0.0 114.345 -174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -28.45 33.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.215 1.37 . . . . 0.0 110.591 169.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 3' ' ' HIS . 21.8 m -63.94 113.39 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.123 1.439 . . . . 0.0 109.704 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -64.48 131.32 46.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.407 1.883 . . . . 0.0 108.08 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.24 92.49 2.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -80.31 97.97 7.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.598 1.559 . . . . 0.0 108.388 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.96 104.2 8.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.557 -0.714 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 176' ' ' LEU . 0.4 OUTLIER -59.2 146.69 9.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.3 1.048 . . . . 0.0 108.735 167.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -122.82 149.82 43.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -51.63 -25.05 6.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.192 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -76.05 -25.24 55.42 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.67 0.606 . . . . 0.0 110.725 -170.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.72 28.91 3.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.545 1.538 . . . . 0.0 112.341 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 168' ' ' VAL . 28.4 ptt-85 -66.13 -20.18 66.07 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -171.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.17 29.04 8.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.597 1.559 . . . . 0.0 109.393 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -135.84 15.95 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.405 1.482 . . . . 0.0 113.386 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.677 ' HB3' HD13 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -84.68 -9.14 58.52 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.095 1.771 . . . . 0.0 112.364 -176.197 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -58.59 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.493 1.517 . . . . 0.0 110.996 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -29.52 67.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.016 1.756 . . . . 0.0 113.716 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.82 -42.6 97.61 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 140' ' ' LEU . 11.9 mt -67.31 -44.1 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 108.156 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.05 -42.74 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 119.196 0.907 . . . . 0.0 109.727 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 84.9 m -59.25 -50.91 72.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.126 0.876 . . . . 0.0 109.744 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -29.61 69.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.471 0.578 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.38 -43.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.504 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -63.75 -34.77 78.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.014 1.734 . . . . 0.0 110.85 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.407 ' O ' ' HE3' ' A' ' 189' ' ' LYS . 0.6 OUTLIER -43.92 -65.61 0.48 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.368 1.867 . . . . 0.0 110.799 -167.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 t 65.55 -59.8 0.28 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.259 1.823 . . . . 0.0 112.204 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 -8.43 6.74 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.949 2.499 . . . . 0.0 113.075 -170.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 186' ' ' SER . 5.7 ptpt . . . . . 0 C--O 1.248 0.976 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -150.45 166.55 29.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.704 0.684 . . . . 0.0 110.541 161.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -49.8 155.8 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.844 2.058 . . . . 0.0 111.459 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.3 t -131.27 145.52 35.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -133.57 144.94 49.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.019 0.927 . . . . 0.0 109.193 164.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -106.87 146.13 31.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 t -151.98 -177.54 6.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.48 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.18 175.17 13.9 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.159 1.838 . . . . 0.0 111.351 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.77 169.22 15.03 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 125.013 3.809 . . . . 0.0 111.659 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.13 162.09 20.75 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.175 2.583 . . . . 0.0 112.314 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.09 -53.72 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.093 0 O-C-N 121.25 -0.906 . . . . 0.0 112.346 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.5 t 63.66 94.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 O-C-N 126.061 1.683 . . . . 0.0 109.13 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.28 -35.3 0.48 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.204 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -56.93 -17.79 10.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 m -34.04 -51.03 0.41 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.69 1.596 . . . . 0.0 111.23 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -53.99 -28.03 35.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 124.909 1.284 . . . . 0.0 112.54 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -56.86 6.27 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -61.16 -40.67 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.435 1.016 . . . . 0.0 110.181 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -48.68 65.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.5 mttm -73.66 -14.46 61.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.455 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.8 98.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 108.601 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.1 p -63.29 -44.02 96.24 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.593 0.633 . . . . 0.0 110.145 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.32 -42.18 84.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' LYS . 71.9 t -63.86 -50.78 76.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 109.771 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.64 -38.54 69.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -72.02 -35.07 69.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 119.119 -0.467 . . . . 0.0 112.252 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 -15.17 25.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 126.426 1.89 . . . . 0.0 115.181 162.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.49 3.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.312 2.245 . . . . 0.0 112.491 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.6 72.39 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.426 1.012 . . . . 0.0 113.61 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.05 121.47 71.54 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.317 1.559 . . . . 0.0 107.259 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.82 90.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.622 -171.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -73.22 146.54 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.379 1.472 . . . . 0.0 108.545 168.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.84 175.68 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 146.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.34 -153.37 24.39 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 124.888 1.232 . . . . 0.0 110.138 170.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -136.13 165.3 26.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.921 0.888 . . . . 0.0 109.36 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -137.49 168.33 19.87 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 159.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -135.87 104.58 5.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -102.93 159.17 15.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.75 121.34 20.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.99 107.52 2.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 167.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -125.03 91.46 3.44 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.298 1.439 . . . . 0.0 108.169 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -79.21 76.97 5.73 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 124.162 0.914 . . . . 0.0 111.513 -168.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.37 60.64 6.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 -162.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.41 15.78 81.0 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -115.54 113.3 23.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.012 1.906 . . . . 0.0 111.26 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -65.73 107.13 1.68 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.192 0.997 . . . . 0.0 109.806 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 pt -130.49 -10.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.48 -167.25 40.34 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.464 1.029 . . . . 0.0 110.933 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.61 159.19 37.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.4 139.19 35.24 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.004 0.522 . . . . 0.0 110.301 170.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.06 93.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.36 152.11 8.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 p -116.6 154.77 29.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 166.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.664 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -74.16 -10.84 60.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.496 -0.753 . . . . 0.0 110.257 171.362 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -66.33 -19.77 65.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.725 2.41 . . . . 0.0 110.485 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 1.63 57.95 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.708 1.147 . . . . 0.0 113.997 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.438 HG22 HD23 ' A' ' 90' ' ' LEU . 3.8 m -85.5 159.81 19.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 0.0 108.637 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.56 131.34 20.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.776 1.63 . . . . 0.0 108.02 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -111.65 149.22 18.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 118.557 -1.135 . . . . 0.0 110.453 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.58 -3.84 13.64 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.127 2.552 . . . . 0.0 114.881 -164.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 40.58 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 131.348 3.859 . . . . 0.0 116.816 168.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.71 116.99 7.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 119.232 0.924 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -126.78 145.54 50.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.845 0.858 . . . . 0.0 110.097 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.82 129.21 37.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.306 1.043 . . . . 0.0 108.854 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.28 50.94 0.67 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.299 -164.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.65 -175.5 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.175 1.488 . . . . 0.0 110.93 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -64.75 151.51 92.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.1 138.26 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.867 3.045 . . . . 0.0 110.832 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.06 159.87 47.32 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.182 2.588 . . . . 0.0 111.236 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.94 147.33 84.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.583 2.189 . . . . 0.0 111.179 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.78 4.53 20.41 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.371 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -128.35 0.11 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.278 1.539 . . . . 0.0 108.119 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 57.35 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.761 2.025 . . . . 0.0 114.067 169.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.79 -16.21 15.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -174.67 170.55 3.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.824 1.65 . . . . 0.0 108.81 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 2.1 ppt_? -170.51 160.32 7.31 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.33 1.452 . . . . 0.0 111.244 151.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.75 -8.59 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 110.701 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.92 -104.46 0.26 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.02 -37.39 76.81 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.592 0.819 . . . . 0.0 109.919 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.09 161.87 13.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.545 1.538 . . . . 0.0 111.855 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 1.0 OUTLIER -105.34 116.02 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.263 2.225 . . . . 0.0 106.334 170.033 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.83 162.62 4.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 168.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.02 116.36 11.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.86 -28.98 64.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.249 1.386 . . . . 0.0 110.409 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 m -59.36 -36.83 76.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.323 1.449 . . . . 0.0 112.472 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.2 p -72.31 -22.77 61.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 120.732 1.605 . . . . 0.0 112.477 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -69.98 -57.11 5.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.931 162.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.8 -29.86 20.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.076 0.853 . . . . 0.0 112.474 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -50.21 -34.03 21.41 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.647 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.83 -44.03 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.217 0.462 . . . . 0.0 111.643 -174.139 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.6 48.79 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.468 1.907 . . . . 0.0 109.88 -171.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -144.12 -65.12 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.396 1.478 . . . . 0.0 108.359 -175.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 34.8 Cg_endo -62.55 -24.09 75.07 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 121.287 1.495 . . . . 0.0 113.214 172.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.96 -35.52 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 119.941 1.246 . . . . 0.0 111.141 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.49 -53.05 6.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.979 1.312 . . . . 0.0 107.565 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -120.75 84.39 2.22 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 109.234 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -78.05 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.532 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.34 134.53 55.13 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 96.14 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 128.092 2.557 . . . . 0.0 115.122 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 48.1 t -144.82 110.93 5.5 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.389 1.075 . . . . 0.0 109.539 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -159.41 164.88 34.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -151.04 -30.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.371 1.069 . . . . 0.0 112.616 160.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -139.04 -81.9 0.08 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.442 1.019 . . . . 0.0 112.502 -171.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.67 -179.7 4.41 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.471 2.781 . . . . 0.0 111.101 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.98 -62.73 1.65 Allowed Glycine 0 CA--C 1.519 0.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 170.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -69.7 153.78 42.91 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.664 0.786 . . . . 0.0 112.019 -168.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.95 169.59 11.94 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 129.626 3.17 . . . . 0.0 107.006 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.27 146.66 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.2 m -128.59 150.12 50.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.202 0.456 . . . . 0.0 111.273 166.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.99 124.44 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.101 1.361 . . . . 0.0 108.344 -162.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.8 68.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.62 -35.09 76.84 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.661 -1.274 . . . . 0.0 112.331 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.12 86.55 4.62 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.06 -1.025 . . . . 0.0 110.713 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.8 mt -131.58 114.95 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 147.47 -67.49 0.39 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -57.03 -33.33 67.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.134 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mmt -85.68 3.11 42.54 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.692 -1.623 . . . . 0.0 113.042 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -32.89 -65.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.248 1.819 . . . . 0.0 113.845 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -39.48 64.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.083 0.553 . . . . 0.0 110.825 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.58 -23.42 61.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.291 0.95 . . . . 0.0 112.502 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.2 m -52.44 115.04 1.57 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.364 1.866 . . . . 0.0 110.232 -170.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.87 -86.44 0.65 Allowed 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.43 -21.32 35.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.083 0.953 . . . . 0.0 112.361 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.39 -61.56 2.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.012 1.325 . . . . 0.0 110.76 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -39.91 -57.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.239 1.381 . . . . 0.0 112.472 171.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -55.7 31.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.018 0.826 . . . . 0.0 111.239 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.82 92.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.508 0.67 . . . . 0.0 111.21 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.98 -48.64 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.805 1.242 . . . . 0.0 107.862 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -57.69 -37.91 74.28 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -64.28 -42.92 96.18 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.134 0.425 . . . . 0.0 111.138 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -67.35 -40.83 85.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.904 0.775 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 160' ' ' ARG . 8.7 mp -57.82 -21.11 40.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.523 1.529 . . . . 0.0 111.567 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.9 m -102.55 -6.3 22.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.394 1.878 . . . . 0.0 112.826 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.1 m -70.06 133.97 87.68 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.1 -45.89 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.769 2.312 . . . . 0.0 109.872 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.45 40.57 3.04 Favored Glycine 0 C--O 1.216 -0.974 0 CA-C-O 117.389 -1.784 . . . . 0.0 113.682 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.5 m -135.8 163.84 29.29 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.934 2.367 . . . . 0.0 107.088 169.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.93 103.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.82 132.32 31.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 122.825 0.45 . . . . 0.0 110.134 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.9 tp -126.37 147.88 49.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.257 2.623 . . . . 0.0 105.579 159.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.43 168.93 37.22 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 120.8 1.636 . . . . 0.0 113.358 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.0 m -112.66 121.82 45.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.629 0.715 . . . . 0.0 109.899 -166.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.73 153.39 47.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.662 1.185 . . . . 0.0 109.727 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.89 154.06 67.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.724 1.616 . . . . 0.0 110.461 172.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.59 126.12 92.39 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.34 152.24 44.04 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.284 2.656 . . . . 0.0 111.766 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -47.38 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.593 1.557 . . . . 0.0 110.576 172.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.48 -147.08 13.38 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 124.815 1.198 . . . . 0.0 110.768 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -63.61 158.11 61.56 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 121.974 -0.721 . . . . 0.0 110.638 171.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.66 139.96 41.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.028 2.485 . . . . 0.0 109.941 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.73 145.36 27.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.469 1.508 . . . . 0.0 109.702 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.32 -84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.006 2.922 . . . . 0.0 114.769 -170.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -52.58 -41.1 63.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.088 0.858 . . . . 0.0 109.028 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.8 -41.21 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.629 -1.177 . . . . 0.0 110.278 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.63 -35.37 80.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.866 1.666 . . . . 0.0 110.866 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.58 -20.76 58.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.748 0.819 . . . . 0.0 111.422 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mt -103.4 -42.98 8.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.623 1.569 . . . . 0.0 109.964 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.73 -19.98 60.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.257 1.423 . . . . 0.0 110.965 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.43 -30.99 61.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.989 0.516 . . . . 0.0 111.022 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HD2' HD23 ' A' ' 132' ' ' LEU . 16.2 mtp85 -83.99 -38.07 21.42 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.476 -156.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.17 -15.81 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.242 3.017 . . . . 0.0 116.726 174.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.81 -25.36 60.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.487 1.915 . . . . 0.0 111.122 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.4 m -52.73 141.12 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.407 1.883 . . . . 0.0 110.541 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 2.7 tppt? -60.56 143.46 53.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 158.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.87 100.96 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 19.2 m-85 -86.62 89.32 7.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.44 111.44 1.79 Allowed 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.48 166.7 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 119.335 0.97 . . . . 0.0 108.532 176.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.2 p -128.52 155.21 45.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 163.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -57.69 -34.58 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 162.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.94 -44.7 91.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.947 2.099 . . . . 0.0 109.996 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.01 18.26 18.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 113.237 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -38.29 -52.92 1.5 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.308 1.443 . . . . 0.0 113.664 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.94 6.48 48.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.552 1.141 . . . . 0.0 112.812 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -96.34 -3.25 44.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 111.987 166.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.581 HD23 HD11 ' A' ' 180' ' ' ILE . 3.9 tp -76.45 -35.97 58.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.179 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.3 -58.14 9.74 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.942 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.83 -25.29 53.12 Favored 'Trans proline' 0 C--N 1.352 0.725 0 CA-C-N 122.105 1.787 . . . . 0.0 112.34 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.25 -43.17 71.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 109.91 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.581 HD11 HD23 ' A' ' 176' ' ' LEU . 27.9 mt -56.88 -50.8 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.869 1.267 . . . . 0.0 108.67 171.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.51 -45.25 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.991 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.3 m -59.3 -43.93 92.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.521 1.055 . . . . 0.0 110.465 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.6 t -62.16 -38.77 90.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.533 0.733 . . . . 0.0 110.431 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.7 t -75.18 -45.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.951 0.9 . . . . 0.0 110.208 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -67.58 -14.28 62.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.467 1.031 . . . . 0.0 112.636 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.2 t -34.7 -50.95 0.48 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 128.103 2.561 . . . . 0.0 114.157 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.8 m 38.16 -101.11 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.603 1.161 . . . . 0.0 110.027 -168.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 ptt85 -147.99 61.1 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.539 1.536 . . . . 0.0 112.01 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.418 ' HE3' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.018 128.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.54 -155.7 0.62 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.292 0.637 . . . . 0.0 110.133 -164.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.428 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 31.5 m-70 -48.43 140.8 7.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.83 2.052 . . . . 0.0 109.605 166.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 164' ' ' LYS . 96.9 t -126.72 149.58 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.886 1.221 . . . . 0.0 112.259 164.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 157' ' ' ILE . 9.8 m-85 -137.51 162.47 33.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.905 2.082 . . . . 0.0 111.38 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD11 HD11 ' A' ' 180' ' ' ILE . 3.4 mm? -115.34 135.92 53.64 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.727 1.611 . . . . 0.0 108.442 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -137.24 -178.92 5.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.026 1.73 . . . . 0.0 107.206 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.64 176.05 38.49 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.743 -1.223 . . . . 0.0 112.947 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.14 138.88 34.39 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.63 2.886 . . . . 0.0 112.957 -164.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.01 92.59 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.408 3.406 . . . . 0.0 111.579 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.63 -75.51 0.37 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.81 -42.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.03 83.69 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -172.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -35.02 79.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 118.001 -0.999 . . . . 0.0 108.516 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -47.92 -63.46 1.06 Allowed 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 125.664 1.852 . . . . 0.0 107.298 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -42.21 -49.89 4.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.16 1.784 . . . . 0.0 112.671 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -47.9 57.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.681 0.673 . . . . 0.0 109.64 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.782 HD11 HD23 ' A' ' 6' ' ' LEU . 5.0 mm -62.44 -49.12 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.82 0.736 . . . . 0.0 110.951 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.78 -49.68 65.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.547 1.539 . . . . 0.0 107.847 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -57.58 -42.39 83.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.618 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.27 -39.97 70.45 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.949 0.795 . . . . 0.0 110.636 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 19.5 m -67.17 -56.08 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -47.94 -39.58 19.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.609 1.563 . . . . 0.0 114.211 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.81 -61.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.516 1.126 . . . . 0.0 108.675 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 mt -61.71 -34.67 76.18 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 118.675 -0.678 . . . . 0.0 109.854 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HE2' HD12 ' A' ' 54' ' ' LEU . 70.7 mttt -54.36 -48.49 71.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.42 1.088 . . . . 0.0 108.242 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -65.22 -24.56 67.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.711 0.404 . . . . 0.0 110.489 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -81.06 8.39 8.68 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.121 1.768 . . . . 0.0 114.831 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 18.79 68.0 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.279 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -53.32 148.62 15.91 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 118.109 0.955 . . . . 0.0 109.294 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.95 112.14 3.49 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.103 1.202 . . . . 0.0 108.991 155.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.56 144.24 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.952 0.882 . . . . 0.0 110.156 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -145.12 157.36 44.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.499 1.92 . . . . 0.0 107.636 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.56 -157.39 24.05 Favored Glycine 0 C--O 1.238 0.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -147.81 161.48 41.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 109.946 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -130.88 146.48 52.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -100.95 109.63 21.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.34 169.62 14.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.077 0.951 . . . . 0.0 111.216 -165.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.01 106.72 16.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 109.408 -162.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.0 93.79 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -111.93 113.96 26.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.529 1.531 . . . . 0.0 107.345 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -87.44 78.81 8.58 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 -133.52 18.92 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -166.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.69 27.17 5.44 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.598 -1.668 . . . . 0.0 115.615 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.23 159.38 44.48 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.145 2.473 . . . . 0.0 110.725 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.47 137.21 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.276 1.43 . . . . 0.0 110.158 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.73 -9.39 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.94 -172.05 38.0 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -137.71 155.0 49.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -123.82 -177.32 3.71 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 124.551 1.157 . . . . 0.0 108.268 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.97 89.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.46 117.75 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -81.08 153.99 27.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.1 mm? -71.01 6.36 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.039 -1.038 . . . . 0.0 113.083 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -95.06 5.64 51.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.766 1.626 . . . . 0.0 112.009 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.41 72.43 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.49 -1.381 . . . . 0.0 113.148 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -101.08 172.45 7.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.374 1.069 . . . . 0.0 108.2 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -152.8 130.05 11.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.992 0.917 . . . . 0.0 108.908 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 90' ' ' LEU . . . -98.97 145.19 17.6 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.6 67.86 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.634 2.889 . . . . 0.0 111.59 -173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.29 -51.83 6.06 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.327 2.251 . . . . 0.0 111.913 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -152.36 151.79 31.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.546 0.528 . . . . 0.0 111.168 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -140.61 161.74 37.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.553 1.541 . . . . 0.0 109.122 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.48 126.69 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.51 -143.7 7.32 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 127.345 2.402 . . . . 0.0 108.746 167.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tp -88.55 168.44 12.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.485 1.143 . . . . 0.0 109.955 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -74.89 151.16 86.43 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 158.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.78 124.65 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.232 2.621 . . . . 0.0 111.456 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -70.77 167.93 24.32 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 111.53 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.96 125.13 14.7 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.592 1.528 . . . . 0.0 109.949 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.82 80.79 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.64 -1.089 . . . . 0.0 114.313 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 118.99 10.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.209 1.505 . . . . 0.0 106.982 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -140.03 176.89 8.38 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.868 0.467 . . . . 0.0 112.148 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -149.92 -161.95 1.45 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 162.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.5 m -52.18 130.38 30.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.027 1.331 . . . . 0.0 109.401 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -147.91 125.84 12.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HB ' ' HE2' ' A' ' 116' ' ' LYS . 16.2 m -113.74 77.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 123.409 1.576 . . . . 0.0 108.757 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.16 -2.26 1.12 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.655 2.074 . . . . 0.0 116.191 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 176.57 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.113 2.565 . . . . 0.0 109.884 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.88 160.52 21.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 109.539 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.76 112.82 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 165.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.43 165.28 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 119.651 1.114 . . . . 0.0 110.252 163.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -142.19 151.79 42.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.316 0.646 . . . . 0.0 109.538 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.17 -29.68 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.837 2.055 . . . . 0.0 110.447 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.5 m -53.22 -43.65 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.085 1.354 . . . . 0.0 108.769 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.6 t -62.25 -23.01 66.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.108 0.867 . . . . 0.0 112.726 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.23 -56.42 4.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -51.86 -30.09 22.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.637 1.575 . . . . 0.0 112.642 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -45.19 -49.33 12.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.019 2.527 . . . . 0.0 113.714 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.46 HD21 ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -150.98 -34.17 0.15 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.51 0.724 . . . . 0.0 112.371 -166.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.85 45.18 1.13 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.792 1.637 . . . . 0.0 108.719 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.436 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -133.01 -63.47 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.12 1.368 . . . . 0.0 107.405 -174.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 61.5 Cg_endo -66.94 -22.45 48.42 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.748 2.299 . . . . 0.0 112.742 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.21 -34.86 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.491 1.496 . . . . 0.0 110.787 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.2 -15.57 62.6 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.875 0.87 . . . . 0.0 111.576 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -147.76 77.38 1.42 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.652 1.569 . . . . 0.0 108.826 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.61 159.53 24.02 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.951 1.701 . . . . 0.0 108.054 160.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.71 143.55 41.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.57 0.748 . . . . 0.0 110.451 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.404 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.88 175.93 9.84 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.931 1.293 . . . . 0.0 109.464 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.43 47.24 1.59 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 111.897 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.91 145.29 53.79 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.822 -1.174 . . . . 0.0 109.112 153.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -74.43 167.17 22.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.56 1.144 . . . . 0.0 108.227 165.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.42 171.89 36.5 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.21 1.386 . . . . 0.0 112.235 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.68 113.01 3.69 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.849 2.366 . . . . 0.0 109.638 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.25 75.33 0.26 Allowed Glycine 0 C--O 1.225 -0.467 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -72.48 125.97 28.72 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' NH2' ' H ' ' A' ' 99' ' ' ASP . 41.5 mtt85 -61.91 97.94 0.09 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.75 2.42 . . . . 0.0 110.637 -169.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.02 116.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.46 157.88 26.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.2 t -140.48 114.99 6.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -144.03 102.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.19 176.52 7.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 63.24 -77.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.954 2.502 . . . . 0.0 109.261 -149.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.324 30.2 mt 55.04 -8.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 128.063 2.545 . . . . 0.0 114.445 -169.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.97 -81.4 0.38 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 121.234 1.834 . . . . 0.0 111.477 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 77' ' ' VAL . 2.0 ttpm? -59.29 -28.35 66.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -163.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -22.47 65.41 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.843 -2.027 . . . . 0.0 111.258 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -24.85 -67.06 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.617 2.367 . . . . 0.0 113.936 -174.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.67 -15.64 60.79 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.744 2.018 . . . . 0.0 110.168 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.2 t -47.54 105.21 0.07 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 129.532 3.133 . . . . 0.0 108.439 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.18 -89.77 0.59 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 123' ' ' LEU . 1.5 pp -56.75 -13.35 2.45 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.073 171.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -66.5 0.37 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.543 1.537 . . . . 0.0 110.69 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -33.84 -55.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.698 1.199 . . . . 0.0 111.362 168.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.54 -54.66 36.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.072 0.851 . . . . 0.0 112.477 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.55 66.88 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.33 -45.8 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -56.53 -39.15 72.89 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.297 -1.502 . . . . 0.0 112.294 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.03 -16.7 33.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.806 1.185 . . . . 0.0 113.667 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.9 m -128.2 -17.91 4.2 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.429 1.092 . . . . 0.0 111.952 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.48 -49.88 73.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 146.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -82.87 49.79 1.58 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.421 1.888 . . . . 0.0 110.067 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -141.43 133.76 13.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 162.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.9 -37.37 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 121.858 1.705 . . . . 0.0 111.353 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.64 17.02 2.2 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.822 1.201 . . . . 0.0 114.989 -174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.9 m -118.31 167.16 11.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.64 1.72 . . . . 0.0 108.475 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mt -129.94 101.5 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.9 133.16 25.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD11 ' CG2' ' A' ' 180' ' ' ILE . 6.9 tp -132.71 147.52 52.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 159.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.81 177.89 45.2 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.2 m -114.19 148.08 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.24 127.8 19.11 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.53 145.52 76.79 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.415 1.41 . . . . 0.0 110.511 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.48 134.42 88.72 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.146 0.979 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -67.59 -55.37 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.206 2.604 . . . . 0.0 109.987 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 64.9 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.281 1.832 . . . . 0.0 108.301 -167.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.12 -102.91 0.5 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.671 1.123 . . . . 0.0 110.41 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -76.92 159.09 79.43 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 117.852 0.826 . . . . 0.0 110.364 -173.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 149' ' ' LYS . 60.2 Cg_endo -77.14 -175.95 2.94 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.733 2.955 . . . . 0.0 108.918 167.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -126.48 144.89 50.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.21 -66.68 0.36 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.667 1.987 . . . . 0.0 113.119 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.2 -39.21 66.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.494 1.118 . . . . 0.0 111.254 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.54 -36.5 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.076 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -63.21 -29.19 70.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.27 1.395 . . . . 0.0 111.778 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -56.94 -39.43 74.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.555 0.693 . . . . 0.0 110.352 174.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.479 HG21 ' CE2' ' A' ' 5' ' ' PHE . 5.4 mt -86.17 -36.81 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.913 1.685 . . . . 0.0 109.909 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -66.44 -34.17 77.33 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.225 -1.547 . . . . 0.0 110.969 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -62.7 -30.58 71.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.787 0.835 . . . . 0.0 109.682 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -58.29 -40.26 81.49 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.355 0.662 . . . . 0.0 109.473 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 -17.68 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.318 3.047 . . . . 0.0 115.677 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.88 -5.55 58.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.723 1.209 . . . . 0.0 111.652 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.36 127.49 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.043 1.337 . . . . 0.0 109.967 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.574 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 13.6 tptm -65.0 120.4 12.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 164.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 92.15 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 18.9 m-85 -66.62 98.1 0.49 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.534 1.133 . . . . 0.0 108.182 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 106.46 2.9 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.98 162.81 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.3 p -129.86 156.28 44.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 165.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -59.69 -22.91 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.335 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -83.06 -36.73 24.68 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 110.313 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.73 80.79 1.93 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.659 3.184 . . . . 0.0 102.877 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -106.59 -35.46 7.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.37 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -113.27 3.3 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.369 1.441 . . . . 0.0 113.312 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -101.61 0.2 35.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.365 1.866 . . . . 0.0 111.425 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -77.62 -31.62 52.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.122 -0.986 . . . . 0.0 111.247 -173.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 tp -39.31 -61.6 0.96 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.768 1.227 . . . . 0.0 110.462 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -68.29 -23.16 39.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.589 1.603 . . . . 0.0 115.495 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.75 -45.39 82.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.917 1.235 . . . . 0.0 108.323 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.85 HD11 HD11 ' A' ' 6' ' ' LEU . 7.3 mt -62.38 -49.46 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.042 0.937 . . . . 0.0 109.623 173.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.93 -41.69 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 119.824 1.193 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 58.0 m -64.36 -35.77 81.96 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 7.9 t -66.34 -34.73 78.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.083 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.95 -58.56 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.346 0.976 . . . . 0.0 108.399 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.05 -12.55 3.49 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 113.789 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.7 t -57.31 -32.98 67.22 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.925 -1.11 . . . . 0.0 110.832 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 t -137.45 93.2 2.78 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.572 -1.33 . . . . 0.0 108.819 -158.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.433 ' C ' ' HE2' ' A' ' 189' ' ' LYS . 53.3 mtt180 54.72 160.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.585 2.354 . . . . 0.0 112.653 -159.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.433 ' HE2' ' C ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 118.637 -0.696 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -125.95 176.65 6.84 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.714 1.143 . . . . 0.0 110.571 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.451 ' HB2' HG12 ' A' ' 163' ' ' VAL . 10.1 m-70 -34.45 143.66 0.04 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 128.065 2.546 . . . . 0.0 111.037 163.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.31 127.28 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.758 0.708 . . . . 0.0 109.634 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 139' ' ' ILE . 13.9 m-85 -140.03 134.0 30.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.874 0.87 . . . . 0.0 109.934 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 18' ' ' ILE . 4.0 mm? -82.08 161.47 22.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.791 1.636 . . . . 0.0 109.152 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -155.6 165.28 37.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.007 0.923 . . . . 0.0 108.818 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.69 -158.95 15.52 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.394 -1.225 . . . . 0.0 111.82 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.08 117.07 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.15 3.233 . . . . 0.0 112.248 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.47 172.51 13.44 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.771 2.981 . . . . 0.0 111.776 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.22 -63.77 0.29 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 167.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.41 125.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.31 -37.72 1.81 Allowed Glycine 0 C--O 1.223 -0.533 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 159.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.724 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -62.3 -29.74 70.65 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 117.887 0.843 . . . . 0.0 110.387 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -61.14 -48.43 81.63 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -55.17 -40.11 70.3 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 128.123 2.569 . . . . 0.0 107.873 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD22 ' H ' ' A' ' 177' ' ' LEU . 54.5 mt -62.37 -61.99 2.07 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 117.9 -1.047 . . . . 0.0 109.841 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 6' ' ' LEU . 1.5 mp -60.61 -45.64 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 119.6 1.091 . . . . 0.0 110.06 -174.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -59.24 4.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.692 1.597 . . . . 0.0 108.247 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 24' ' ' VAL . 59.7 mttm -63.11 -30.4 71.56 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.425 -1.274 . . . . 0.0 111.954 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.36 -32.75 68.85 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 119.878 1.217 . . . . 0.0 109.802 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -71.77 -44.66 63.64 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.192 0.451 . . . . 0.0 110.103 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -61.71 -22.31 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.06 0.944 . . . . 0.0 111.639 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' LYS . 3.0 t -69.08 -50.82 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 120.898 -1.126 . . . . 0.0 110.677 169.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.27 -36.81 84.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.505 0.722 . . . . 0.0 110.22 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -59.18 -48.83 80.18 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -67.74 -3.42 9.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.277 1.831 . . . . 0.0 112.799 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -120.38 11.78 11.52 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.786 1.634 . . . . 0.0 112.773 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.05 38.68 22.07 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 120.122 1.328 . . . . 0.0 113.689 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.46 118.63 37.11 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 107.489 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.49 99.08 0.8 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.77 2.98 . . . . 0.0 110.111 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.4 156.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.14 175.39 9.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.412 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 124.31 -170.64 16.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.89 156.89 46.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.465 0.65 . . . . 0.0 109.811 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -131.59 131.28 43.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 m -83.2 125.37 31.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.437 0.0 OUTLIER -103.7 -130.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 116.593 -1.67 . . . . 0.0 109.645 176.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -157.71 108.48 2.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 122.678 2.49 . . . . 0.0 110.037 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 107.52 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -128.89 113.32 15.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.47 -63.07 1.43 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.692 0.678 . . . . 0.0 109.245 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.49 68.91 0.34 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 106.409 -2.676 . . . . 0.0 106.409 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 -11.08 72.95 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.751 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 135.15 40.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.277 2.038 . . . . 0.0 109.899 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -67.45 141.18 57.07 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 167.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -148.99 -2.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.022 1.329 . . . . 0.0 112.846 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.84 -167.54 32.69 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 119.878 1.217 . . . . 0.0 110.973 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -137.97 154.04 49.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 117.141 0.47 . . . . 0.0 110.52 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -135.95 155.91 49.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 129.484 3.114 . . . . 0.0 106.221 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.76 108.34 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.72 122.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -165.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -72.1 155.24 40.5 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.5 mm? -62.58 -28.44 69.89 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.803 -1.186 . . . . 0.0 110.938 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -68.91 -20.8 64.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 128.033 2.533 . . . . 0.0 111.508 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.42 39.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.652 -1.082 . . . . 0.0 114.409 163.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.8 m -71.23 164.4 25.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.822 1.811 . . . . 0.0 107.491 160.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -141.56 136.38 31.04 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.134 0.974 . . . . 0.0 108.523 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.68 47.87 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.45 -177.53 1.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 145.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 -60.04 0.07 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 p -146.34 158.31 43.87 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.913 0.885 . . . . 0.0 109.122 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -143.37 165.43 27.54 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.863 2.065 . . . . 0.0 106.895 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.54 147.48 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 41.85 0.22 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.775 1.655 . . . . 0.0 110.706 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt 55.96 -167.62 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.798 1.299 . . . . 0.0 111.487 -173.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.4 142.54 25.13 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.836 0.854 . . . . 0.0 108.862 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.05 134.57 25.55 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.629 1.553 . . . . 0.0 109.825 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.86 159.25 54.62 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.006 2.471 . . . . 0.0 109.449 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.06 -6.37 18.09 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.521 2.147 . . . . 0.0 113.989 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.34 7.28 12.6 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.493 1.521 . . . . 0.0 113.622 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -138.49 88.07 2.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.384 2.092 . . . . 0.0 107.16 173.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.21 150.87 33.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.69 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.39 63.84 0.12 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.515 1.126 . . . . 0.0 108.534 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 59.8 m 47.78 -143.97 0.38 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.93 -1.106 . . . . 0.0 110.719 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.1 155.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 1 C-N-CA 133.701 4.801 . . . . 0.0 106.11 175.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.34 25.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 121.115 1.78 . . . . 0.0 111.017 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.2 111.73 0.94 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 64.05 -48.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.911 2.484 . . . . 0.0 113.953 -167.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.87 178.37 4.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.12 2.568 . . . . 0.0 108.717 -173.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.26 143.29 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 126.708 2.003 . . . . 0.0 106.53 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.11 176.65 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 119.708 1.14 . . . . 0.0 110.394 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -140.3 156.1 46.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 157.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.07 -33.93 38.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.88 0.872 . . . . 0.0 108.954 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.9 m -68.3 -33.35 74.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.843 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.9 m -60.69 -32.01 71.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 121.277 1.853 . . . . 0.0 109.846 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -69.11 -57.46 5.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -53.19 -24.09 10.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -48.81 -34.72 12.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.097 1.359 . . . . 0.0 112.827 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -31.98 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.3 44.08 0.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.281 1.432 . . . . 0.0 110.847 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.43 -61.69 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 127.186 2.195 . . . . 0.0 108.414 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.3 -24.18 16.94 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.04 1.827 . . . . 0.0 113.54 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.5 -30.32 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 119.463 1.029 . . . . 0.0 111.188 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.6 mt -76.46 -6.75 53.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.705 2.002 . . . . 0.0 111.316 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 92.16 2.1 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.46 1.504 . . . . 0.0 109.86 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.59 135.79 54.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.635 1.574 . . . . 0.0 110.321 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.57 126.82 32.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.851 1.26 . . . . 0.0 111.552 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 107' ' ' ARG . 9.3 t70 -109.01 -88.51 0.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.908 1.283 . . . . 0.0 109.036 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.9 t 95.19 102.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.816 3.246 . . . . 0.0 107.246 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.4 m -142.74 104.1 4.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.653 1.181 . . . . 0.0 108.083 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 m -66.73 -14.44 62.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.256 1.023 . . . . 0.0 112.731 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.65 -133.22 2.93 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -61.8 149.46 89.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.432 2.088 . . . . 0.0 110.356 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.66 -62.92 0.19 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -164.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 48.07 -152.25 0.11 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.901 0.851 . . . . 0.0 108.914 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -157.27 170.47 22.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 128.247 2.619 . . . . 0.0 105.947 160.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 130.1 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 10.5 m -124.99 109.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 t -83.16 140.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 125.742 1.617 . . . . 0.0 111.203 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -151.67 85.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.516 1.126 . . . . 0.0 108.645 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.53 127.42 53.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.336 -1.478 . . . . 0.0 113.218 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 95.54 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 1 C-N-CA 133.585 4.754 . . . . 0.0 108.153 -173.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.87 57.5 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.653 2.381 . . . . 0.0 106.271 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.97 -33.96 0.03 OUTLIER Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.539 -1.351 . . . . 0.0 112.47 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -62.25 -17.98 59.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 119.612 -2.111 . . . . 0.0 113.822 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 9.81 28.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.879 1.672 . . . . 0.0 111.283 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -57.71 -13.57 4.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.65 -41.05 4.15 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.772 1.229 . . . . 0.0 111.917 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.4 -22.28 44.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.581 0.628 . . . . 0.0 112.39 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -50.44 135.23 22.62 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -136.92 -77.41 0.41 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.126 0.57 . . . . 0.0 111.009 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.28 -29.88 69.59 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 116.859 -1.543 . . . . 0.0 110.549 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.91 -54.58 12.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.051 -1.452 . . . . 0.0 111.69 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.3 mp -38.51 -63.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 126.566 1.946 . . . . 0.0 111.649 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.51 -51.59 68.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.13 72.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.0 p -87.95 -32.18 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.74 0.816 . . . . 0.0 110.373 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -36.95 32.47 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.042 165.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -48.2 -53.21 17.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.005 1.275 . . . . 0.0 109.529 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -41.63 61.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.791 2.036 . . . . 0.0 112.343 -175.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.47 -41.29 98.67 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.605 1.548 . . . . 0.0 110.606 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 t -78.46 25.26 0.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.948 1.699 . . . . 0.0 111.064 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.5 m -126.79 134.31 25.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.524 -1.36 . . . . 0.0 110.271 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.68 158.81 46.72 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.433 2.755 . . . . 0.0 109.888 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.93 3.78 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -61.84 148.03 44.62 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.227 1.014 . . . . 0.0 112.066 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.6 mt -130.2 108.26 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.444 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 18.0 mm -66.6 139.29 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mt -133.7 97.03 3.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.405 1.482 . . . . 0.0 107.878 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.19 -172.45 18.15 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 118.032 0.378 . . . . 0.0 113.209 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 m -142.26 136.39 29.75 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.931 1.292 . . . . 0.0 107.62 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.78 167.56 18.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.691 1.596 . . . . 0.0 110.079 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 160.05 51.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.562 1.508 . . . . 0.0 111.116 158.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.2 152.71 96.53 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.543 -0.723 . . . . 0.0 110.075 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -26.13 18.92 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.01 2.473 . . . . 0.0 111.983 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -50.71 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 128.394 2.678 . . . . 0.0 110.029 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.54 -118.79 1.65 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -167.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 171.23 7.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.225 1.41 . . . . 0.0 110.743 -171.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -57.4 170.98 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.456 2.104 . . . . 0.0 110.39 158.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -147.9 178.6 8.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.83 2.852 . . . . 0.0 105.396 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.1 -82.0 0.11 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 118.903 0.774 . . . . 0.0 109.096 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.83 -32.68 74.34 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 120.444 -1.41 . . . . 0.0 113.073 -171.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.81 -34.93 71.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 117.441 -1.266 . . . . 0.0 109.165 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.15 -34.18 73.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 111.153 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 125' ' ' ILE . 5.3 tp10 -54.33 -50.27 67.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.043 0.937 . . . . 0.0 109.76 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.0 -35.66 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -62.46 -25.62 68.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.13 0.877 . . . . 0.0 111.111 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.07 -14.17 61.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.258 1.023 . . . . 0.0 113.556 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -117.19 55.89 0.83 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.447 1.499 . . . . 0.0 107.898 -166.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 4.7 mmpt? -57.62 -10.32 1.51 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.426 1.491 . . . . 0.0 114.951 -166.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.0 -25.36 43.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.977 0.808 . . . . 0.0 112.163 167.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 3' ' ' HIS . 34.3 m -47.73 118.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 125.901 1.68 . . . . 0.0 109.185 164.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 134.34 53.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.519 1.928 . . . . 0.0 108.501 169.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.63 80.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.168 0.894 . . . . 0.0 108.78 -168.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.15 104.21 1.39 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.179 1.792 . . . . 0.0 109.135 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.58 116.17 17.02 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.906 -1.121 . . . . 0.0 109.52 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.73 166.73 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.983 0.897 . . . . 0.0 109.577 170.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.0 p -120.05 151.19 39.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 163.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -64.49 -21.08 66.57 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.386 -0.821 . . . . 0.0 109.477 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -67.74 -74.21 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.704 2.002 . . . . 0.0 109.135 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -91.06 31.9 1.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.924 1.289 . . . . 0.0 109.998 -175.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.79 -24.31 61.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.737 1.215 . . . . 0.0 112.115 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -114.93 21.9 13.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.19 2.596 . . . . 0.0 111.593 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -136.46 6.51 3.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.588 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' LEU . 2.7 tt -82.42 -13.27 57.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 117.436 -1.706 . . . . 0.0 110.627 -170.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.3 tp -36.39 -59.91 0.79 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 127.591 2.356 . . . . 0.0 112.533 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.2 -25.29 31.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 122.108 1.789 . . . . 0.0 112.087 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.2 -43.44 78.05 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.73 -53.01 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.02 -43.73 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.22 1.408 . . . . 0.0 110.264 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.1 m -60.83 -32.72 72.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.516 1.126 . . . . 0.0 111.569 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -65.33 -45.67 83.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.948 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.28 -48.29 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.998 0.919 . . . . 0.0 109.217 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -65.95 -24.5 66.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.7 t -67.96 -24.8 65.2 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.112 0.965 . . . . 0.0 109.992 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 21.46 0.06 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.32 1.048 . . . . 0.0 113.022 167.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.427 ' HA ' ' HE2' ' A' ' 189' ' ' LYS . 0.0 OUTLIER 53.28 83.13 0.07 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.691 1.996 . . . . 0.0 110.409 -167.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 C-N-CA 130.959 3.704 . . . . 0.0 114.839 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.75 172.6 11.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 170.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -64.38 139.5 58.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.475 1.11 . . . . 0.0 109.315 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.46 138.25 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 14.9 m-85 -129.03 146.76 50.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.694 0.759 . . . . 0.0 109.899 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.866 HD21 HD11 ' A' ' 18' ' ' ILE . 1.8 mm? -100.65 131.16 46.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -121.59 175.44 6.22 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.64 0.733 . . . . 0.0 109.4 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.86 -135.73 8.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 125.462 1.506 . . . . 0.0 109.644 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.25 159.74 52.58 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.696 2.264 . . . . 0.0 111.761 -160.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.43 -9.67 25.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.951 3.101 . . . . 0.0 114.266 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.32 19.69 14.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.103 0.858 . . . . 0.0 112.464 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' LYS 0.301 46.9 t 74.29 -65.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.136 3.374 . . . . 0.0 109.272 168.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.37 5.05 26.74 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.236 1.398 . . . . 0.0 110.822 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 24.3 mtmt -121.76 -8.31 8.97 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 116.368 -1.777 . . . . 0.0 115.225 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.8 m -47.14 -41.19 17.13 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.769 1.622 . . . . 0.0 112.015 -166.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -43.63 -48.83 7.77 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.475 2.71 . . . . 0.0 109.906 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.542 ' CD1' ' H ' ' A' ' 176' ' ' LEU . 41.9 mt -69.54 -57.27 5.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 125.56 1.544 . . . . 0.0 109.743 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 6' ' ' LEU . 23.1 mm -57.74 -46.72 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.971 0.805 . . . . 0.0 109.118 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 -56.51 7.57 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.959 0.904 . . . . 0.0 111.321 171.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -68.58 -25.63 64.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.322 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -52.58 -39.6 61.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.442 1.097 . . . . 0.0 110.224 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -70.08 -35.07 73.93 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -58.67 -45.31 89.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.879 0.872 . . . . 0.0 109.124 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -60.53 -53.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.151 0.98 . . . . 0.0 110.213 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.93 -41.02 90.86 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.143 0.577 . . . . 0.0 109.449 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -69.59 -40.72 76.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.978 0.354 . . . . 0.0 110.126 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -61.18 -30.15 70.24 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.027 169.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -84.92 1.68 46.18 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.4 1.48 . . . . 0.0 112.858 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.75 1.46 66.94 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.236 1.398 . . . . 0.0 114.282 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.44 110.52 11.69 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.079 1.94 . . . . 0.0 107.809 -172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.93 119.33 6.39 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.555 2.17 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.95 118.17 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 109.033 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.27 170.79 9.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 126.234 1.813 . . . . 0.0 109.797 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 120.55 -156.5 16.01 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 163.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -149.46 167.79 25.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -141.42 -175.97 4.55 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -118.52 133.74 55.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.822 1.647 . . . . 0.0 107.086 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.45 33.78 5.41 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.584 -1.322 . . . . 0.0 112.222 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.04 -172.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.994 2.118 . . . . 0.0 110.51 -171.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.37 144.2 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 152.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -125.22 161.63 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.278 1.831 . . . . 0.0 107.758 167.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -108.79 45.88 1.01 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.079 1.352 . . . . 0.0 107.367 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 104.95 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -163.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.69 -51.93 3.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.944 1.259 . . . . 0.0 114.56 171.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.13 139.46 30.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 110.392 -162.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -70.15 134.77 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.47 -8.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -176.34 38.43 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 119.558 1.072 . . . . 0.0 110.613 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.57 148.84 51.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.77 135.14 32.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.8 155.73 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 C-N-CA 125.953 1.701 . . . . 0.0 108.536 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 m -141.51 143.09 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.972 165.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.9 p -82.87 161.97 21.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.406 1.003 . . . . 0.0 109.871 174.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.1 mm? -74.63 -14.27 60.75 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.529 -0.732 . . . . 0.0 112.935 176.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 t -69.14 -25.47 64.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.935 0.789 . . . . 0.0 109.49 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.56 9.65 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.079 0.847 . . . . 0.0 112.546 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -83.66 167.22 17.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 1.3 mpt_? -137.53 163.23 31.66 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -151.18 175.47 30.09 Favored Glycine 0 C--O 1.223 -0.571 0 CA-C-N 120.843 1.656 . . . . 0.0 110.531 158.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.71 161.6 35.14 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 109.749 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.4 -59.98 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.61 144.29 49.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -143.34 162.16 36.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.263 1.425 . . . . 0.0 108.053 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 149.79 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.22 157.4 28.27 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 166.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.47 162.87 7.47 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 161.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.67 150.63 81.11 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.42 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.22 124.87 11.3 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.334 2.023 . . . . 0.0 110.447 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.04 165.84 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.945 2.43 . . . . 0.0 109.465 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.97 101.75 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 108.549 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.45 -68.18 0.48 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.562 1.077 . . . . 0.0 110.421 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -76.72 125.31 29.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.87 7.94 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -135.61 41.42 2.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.179 1.392 . . . . 0.0 107.312 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.0 m 59.1 -161.61 0.26 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.771 2.028 . . . . 0.0 112.291 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 170.78 157.27 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.426 3.091 . . . . 0.0 109.5 175.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.01 0.53 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.93 140.41 11.03 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 -169.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.65 -69.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.965 1.706 . . . . 0.0 110.718 -158.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.11 148.92 21.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.785 1.234 . . . . 0.0 110.164 -167.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.6 t -91.26 139.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 162.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.93 -175.8 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 O-C-N 120.774 -1.204 . . . . 0.0 109.066 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.39 119.82 6.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 153.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.94 -34.61 71.95 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 112.117 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.9 m -51.51 -39.67 58.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.775 1.63 . . . . 0.0 110.35 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.09 -29.05 70.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.743 0.417 . . . . 0.0 110.597 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -71.53 -60.23 2.34 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.913 1.285 . . . . 0.0 108.006 170.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -49.25 -21.42 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.675 1.99 . . . . 0.0 113.778 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -57.34 -58.26 9.03 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.709 -1.244 . . . . 0.0 112.065 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -123.07 -34.15 3.2 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.833 1.253 . . . . 0.0 112.646 -164.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.45 55.92 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.693 1.597 . . . . 0.0 109.074 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 -58.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.679 -173.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.37 -27.06 19.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.893 2.395 . . . . 0.0 113.055 168.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 p -63.41 -27.87 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.914 -1.116 . . . . 0.0 110.659 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 84.4 1.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? 51.51 80.28 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.43 2.292 . . . . 0.0 113.163 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -62.09 136.4 57.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.747 1.619 . . . . 0.0 108.124 153.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.49 62.3 7.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.183 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -90.25 -54.73 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 109.609 -163.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.72 165.78 27.58 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.554 1.141 . . . . 0.0 109.989 165.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -161.42 106.18 1.31 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.742 162.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 m -155.06 152.06 29.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.797 1.18 . . . . 0.0 110.547 168.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.78 -157.44 52.15 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.103 0.859 . . . . 0.0 113.413 164.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.15 111.9 1.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.377 2.051 . . . . 0.0 107.702 164.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 153.24 68.51 0.01 OUTLIER Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -173.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -75.42 161.93 28.8 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -79.31 156.21 28.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 160.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.2 149.31 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 150.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 19.5 t -127.93 163.56 24.21 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.898 1.226 . . . . 0.0 109.771 160.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.6 t -145.53 125.91 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.49 1.516 . . . . 0.0 107.137 -166.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.06 63.34 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.14 97.19 9.21 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.34 -31.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.128 0.571 . . . . 0.0 110.106 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.5 mt -60.26 120.31 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.537 1.135 . . . . 0.0 110.145 -159.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.41 -15.41 1.65 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.68 1.133 . . . . 0.0 112.479 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -100.22 -35.8 9.51 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.722 1.261 . . . . 0.0 110.461 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -87.92 19.97 3.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.024 1.73 . . . . 0.0 111.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -46.12 -33.43 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.677 1.126 . . . . 0.0 114.023 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -102.67 -45.32 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.518 2.327 . . . . 0.0 110.196 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.27 -21.52 63.88 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 124' ' ' PHE . 4.1 m -56.17 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.522 1.529 . . . . 0.0 111.331 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -84.16 -84.18 0.14 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.12 0.568 . . . . 0.0 110.051 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -60.52 -13.58 14.71 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.306 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' SER . 3.2 m-85 -54.77 -51.44 65.7 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 120.885 1.675 . . . . 0.0 111.61 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -52.11 -22.02 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 112.466 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.0 -58.97 2.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.719 -1.238 . . . . 0.0 108.713 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.46 -50.6 72.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.427 1.491 . . . . 0.0 111.594 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 t -61.56 -47.53 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.379 1.072 . . . . 0.0 108.412 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -57.7 -38.55 75.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -39.88 81.21 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.307 0.958 . . . . 0.0 110.758 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -71.03 -39.59 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.94 -14.32 61.88 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.31 1.044 . . . . 0.0 111.776 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -63.07 -50.1 71.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 120.396 1.453 . . . . 0.0 110.038 164.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -60.13 134.33 90.47 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.63 -33.91 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.878 1.719 . . . . 0.0 112.763 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.74 7.68 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 118.346 -1.252 . . . . 0.0 110.781 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 51.8 m -48.51 115.5 1.25 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.097 1.359 . . . . 0.0 111.286 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.1 mt -96.25 85.91 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 102.781 -3.044 . . . . 0.0 102.781 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.1 mm -52.91 117.85 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.438 HD21 HG23 ' A' ' 180' ' ' ILE . 14.6 mt -97.65 146.75 25.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 144.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.19 156.62 27.07 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 156.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 12' ' ' VAL . 95.0 m -91.31 149.48 21.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 164.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.3 pt -136.33 163.02 53.01 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.837 2.055 . . . . 0.0 108.72 166.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.51 165.01 23.34 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.34 2.693 . . . . 0.0 110.443 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.29 149.16 97.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.008 -1.058 . . . . 0.0 109.544 162.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.0 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.104 2.536 . . . . 0.0 109.354 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt 48.34 38.38 10.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.801 1.64 . . . . 0.0 112.872 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.59 -121.01 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 159.61 83.05 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 117.118 0.459 . . . . 0.0 110.145 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.49 166.61 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.95 1.766 . . . . 0.0 107.931 159.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.4 -163.86 1.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.85 -61.34 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.128 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -51.75 19.99 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.04 -22.7 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.74 1.155 . . . . 0.0 111.748 -169.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -42.16 80.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.564 2.346 . . . . 0.0 111.866 171.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.314 0.3 OUTLIER -58.53 -53.35 59.29 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 121.862 0.839 . . . . 0.0 110.006 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 5.3 mt -67.98 -26.54 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.793 0.837 . . . . 0.0 111.2 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -70.73 -20.51 62.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 120.345 -1.472 . . . . 0.0 111.422 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.2 -14.57 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 111.504 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -81.72 85.38 6.61 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 11.3 mmpt? -63.05 -20.46 65.35 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 111.714 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.29 -35.17 59.81 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.065 1.746 . . . . 0.0 113.236 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.26 124.1 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.4 1.48 . . . . 0.0 110.854 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -59.11 147.42 35.06 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.56 97.61 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -85.04 104.11 14.67 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.479 1.911 . . . . 0.0 108.203 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.55 103.0 13.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.309 1.443 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.53 163.02 4.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.665 1.222 . . . . 0.0 111.411 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.26 134.9 45.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.566 2.347 . . . . 0.0 106.16 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -46.55 -30.2 2.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.519 1.128 . . . . 0.0 111.489 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.06 -31.14 72.22 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 125.378 1.673 . . . . 0.0 110.591 -172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -131.7 18.29 4.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.026 1.33 . . . . 0.0 111.037 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -60.51 -21.88 62.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -167.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -102.02 11.73 37.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.08 1.352 . . . . 0.0 113.416 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -127.25 24.16 6.34 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.345 1.058 . . . . 0.0 110.973 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.542 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -83.5 -12.02 56.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.511 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.0 tt -47.11 -57.34 9.53 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.566 1.946 . . . . 0.0 112.068 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.43 -22.95 24.27 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 121.56 1.593 . . . . 0.0 113.08 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.61 -45.97 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.438 HG23 HD21 ' A' ' 140' ' ' LEU . 14.8 mt -63.78 -52.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.49 1.516 . . . . 0.0 109.441 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -55.56 -45.53 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.3 1.409 . . . . 0.0 109.654 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.3 m -56.92 -43.49 81.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.604 1.162 . . . . 0.0 110.366 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.8 t -65.35 -38.73 90.98 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.098 0.959 . . . . 0.0 111.855 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.64 -51.61 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 119.234 0.925 . . . . 0.0 108.833 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -66.59 -12.74 59.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.314 -0.851 . . . . 0.0 112.638 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 86.2 p -48.09 -45.17 32.36 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.757 1.223 . . . . 0.0 111.167 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.72 -58.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 1 C-N-CA 133.283 4.633 . . . . 0.0 115.775 -175.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -92.63 -29.19 16.25 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 114.09 172.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? . . . . . 0 C--O 1.248 0.998 0 CA-C-O 116.698 -1.62 . . . . 0.0 109.996 -173.587 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -140.77 135.36 31.42 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.338 0.972 . . . . 0.0 109.107 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.408 ' HB2' HG12 ' A' ' 163' ' ' VAL . 12.4 m-70 -34.18 138.84 0.08 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.29 3.036 . . . . 0.0 111.194 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 t -131.38 141.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 157' ' ' ILE . 28.3 m-85 -135.03 143.98 47.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.956 0.902 . . . . 0.0 109.435 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 176' ' ' LEU . 1.4 mm? -105.14 151.08 24.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.695 0.798 . . . . 0.0 110.778 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -156.67 -177.87 6.92 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 123.315 0.384 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.45 -141.08 13.87 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.275 2.369 . . . . 0.0 109.443 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.31 145.14 64.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.963 1.776 . . . . 0.0 111.109 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.28 160.56 44.78 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.27 1.98 . . . . 0.0 110.259 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.95 4.23 7.15 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.072 1.32 . . . . 0.0 115.795 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 5.8 p -74.16 22.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 119.67 1.735 . . . . 0.0 115.472 -160.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.18 -0.33 78.33 Favored Glycine 0 N--CA 1.464 0.545 0 O-C-N 120.013 -1.679 . . . . 0.0 112.062 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -21.15 64.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.944 1.298 . . . . 0.0 113.73 -171.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -50.36 -37.25 36.15 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 120.026 1.285 . . . . 0.0 110.666 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.4 m -57.03 -36.28 70.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.95 1.7 . . . . 0.0 113.51 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD11 ' HD2' ' A' ' 173' ' ' ARG . 0.5 OUTLIER -68.47 -52.44 32.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -178.421 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -36.0 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 O-C-N 122.088 -0.382 . . . . 0.0 111.085 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -54.21 -51.87 63.05 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.4 mttm -54.64 -43.0 71.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.286 173.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -33.74 68.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.998 1.272 . . . . 0.0 111.476 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -68.18 -53.78 22.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.99 -34.08 77.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.5 1.12 . . . . 0.0 112.59 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 20' ' ' LYS . 74.2 t -62.86 -49.27 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.45 1.5 . . . . 0.0 110.733 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.5 -40.92 98.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.8 -42.37 98.92 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.47 69.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 112.407 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -83.23 -0.62 50.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.971 -1.08 . . . . 0.0 112.136 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.02 36.08 57.3 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.786 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.77 109.13 40.09 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.3 143.92 78.69 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.88 132.52 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.55 174.51 5.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.512 1.525 . . . . 0.0 107.667 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.16 -161.76 23.1 Favored Glycine 0 CA--C 1.508 -0.402 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.79 163.72 37.94 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 117.343 0.571 . . . . 0.0 111.444 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -138.28 168.34 19.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.4 p -109.87 91.32 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.58 -4.26 22.24 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.919 -1.113 . . . . 0.0 113.664 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 84.14 167.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 130.61 3.564 . . . . 0.0 110.357 -158.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.14 118.54 11.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 164.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -111.03 148.33 32.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 163.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -142.66 116.77 9.45 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 156.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.18 26.84 64.25 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.965 0.802 . . . . 0.0 111.486 -166.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.74 -20.0 2.45 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.411 1.325 . . . . 0.0 116.411 172.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.79 7.35 2.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.073 2.437 . . . . 0.0 116.498 -157.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.651 1.98 . . . . 0.0 110.998 -165.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.63 -11.63 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.732 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.84 -147.19 16.73 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.341 -1.903 . . . . 0.0 108.341 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -141.7 163.18 33.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.554 1.542 . . . . 0.0 109.551 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -120.36 166.23 13.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.935 1.694 . . . . 0.0 106.839 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -126.47 104.9 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 123.849 0.859 . . . . 0.0 108.717 174.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.5 117.55 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -164.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 p -66.19 161.84 21.16 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 109.293 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.87 -1.32 6.98 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.83 -1.169 . . . . 0.0 112.324 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -105.14 7.21 33.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.475 1.91 . . . . 0.0 112.479 168.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.28 6.59 83.78 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 120.385 -1.447 . . . . 0.0 115.015 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 149.63 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 156.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 18.9 ptt-85 -150.45 149.57 30.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.108 1.322 . . . . 0.0 111.041 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.8 158.74 18.43 Favored Glycine 0 C--O 1.22 -0.768 0 CA-C-O 116.879 -2.067 . . . . 0.0 111.325 -172.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.95 9.79 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.457 3.438 . . . . 0.0 113.791 -164.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 24.54 -74.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 131.415 3.886 . . . . 0.0 116.301 171.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 p -136.44 143.25 43.81 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 164.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.48 67.87 0.46 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.508 0.594 . . . . 0.0 110.039 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.5 t 48.66 134.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 130.348 3.459 . . . . 0.0 114.798 -172.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.34 52.79 0.49 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 53.5 -178.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.227 1.811 . . . . 0.0 111.783 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -80.91 158.35 70.45 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 159.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.03 140.14 14.02 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.153 2.568 . . . . 0.0 110.356 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.21 175.29 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.992 3.128 . . . . 0.0 110.578 165.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.63 150.87 86.03 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.021 1.147 . . . . 0.0 109.27 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.86 -73.26 0.66 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.059 0.837 . . . . 0.0 112.582 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 115.45 5.03 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.232 1.016 . . . . 0.0 109.049 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -173.62 153.37 2.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.89 2.076 . . . . 0.0 106.785 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.75 -27.61 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 151.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 65.8 m -152.13 143.59 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.622 1.569 . . . . 0.0 109.442 -170.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.65 139.32 4.49 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.29 85.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 172.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.38 -67.2 0.25 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.092 1.806 . . . . 0.0 112.041 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -144.72 -18.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.368 2.267 . . . . 0.0 113.402 -167.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -106.57 125.81 51.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.84 130.98 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 167.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.62 168.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.449 1.022 . . . . 0.0 108.598 165.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.11 111.13 14.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.71 -31.53 66.5 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.689 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.2 m -60.81 -38.15 84.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.707 1.603 . . . . 0.0 111.493 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.7 m -58.84 -36.38 74.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.7 1.136 . . . . 0.0 110.446 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.34 -49.8 65.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.074 0.95 . . . . 0.0 111.478 171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.511 ' HA ' HD13 ' A' ' 92' ' ' LEU . 52.0 mt-10 -53.38 -25.44 15.53 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.161 0.891 . . . . 0.0 113.1 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.68 -50.84 65.4 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.237 1.38 . . . . 0.0 111.934 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.18 -25.59 1.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.773 -166.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.55 59.61 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.275 1.398 . . . . 0.0 109.402 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 88' ' ' GLU . 3.1 mp -49.9 -45.96 80.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.095 -1.431 . . . . 0.0 114.045 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.87 -27.33 7.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 CA-C-N 121.733 1.655 . . . . 0.0 113.834 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.3 -29.75 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.737 1.153 . . . . 0.0 111.26 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.7 34.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.021 2.128 . . . . 0.0 111.007 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.275 4.8 mmm-85 173.84 -134.7 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 130.851 3.66 . . . . 0.0 107.238 -164.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 63.79 167.82 0.15 Allowed 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.041 1.736 . . . . 0.0 111.408 -153.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.65 107.95 5.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.611 1.165 . . . . 0.0 109.174 -170.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -150.04 175.92 11.27 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.455 1.902 . . . . 0.0 107.919 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.2 t -178.12 -34.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 0.0 108.715 157.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t 59.41 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 127.741 2.417 . . . . 0.0 111.302 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 p -71.46 -179.06 2.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.374 1.469 . . . . 0.0 110.392 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.95 -88.11 1.94 Allowed Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.08 -1.012 . . . . 0.0 113.393 -165.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.61 116.92 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.556 2.171 . . . . 0.0 108.944 173.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.29 -33.55 0.15 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 57.19 -150.7 0.44 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.131 0.973 . . . . 0.0 109.083 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.37 163.76 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.84 145.2 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 168.01 10.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.421 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.11 129.46 50.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.367 1.067 . . . . 0.0 108.32 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -133.56 67.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -79.83 67.94 5.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.869 0.868 . . . . 0.0 109.706 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -95.06 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 153' ' ' LEU 0.286 78.6 mt 41.45 53.57 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 128.117 2.567 . . . . 0.0 109.864 177.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.66 -61.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 121.466 -0.771 . . . . 0.0 112.396 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -20.69 64.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.42 2.11 . . . . 0.0 113.613 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.77 18.02 21.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.615 1.566 . . . . 0.0 109.713 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.54 -18.17 2.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -166.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.41 -30.49 8.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.105 0.866 . . . . 0.0 111.321 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -90.21 -20.02 23.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.368 1.067 . . . . 0.0 112.669 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m -59.83 103.92 0.25 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.579 0.752 . . . . 0.0 110.792 -166.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.81 -81.72 0.47 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.256 0.935 . . . . 0.0 111.821 -163.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.93 -10.05 8.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.028 1.731 . . . . 0.0 112.28 169.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.53 -61.77 1.85 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.327 1.451 . . . . 0.0 110.901 174.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.2 mp -38.08 -64.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.841 2.056 . . . . 0.0 112.16 172.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -53.75 54.6 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.406 0.548 . . . . 0.0 110.012 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.76 72.64 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.44 -173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 157' ' ' ILE . 2.7 t -49.09 -55.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.296 1.839 . . . . 0.0 109.275 172.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -62.98 -36.5 83.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.957 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.9 -44.84 88.3 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.122 0.874 . . . . 0.0 110.068 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.1 m -65.74 -34.83 79.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.094 0.957 . . . . 0.0 111.003 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.61 -30.31 69.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.429 1.492 . . . . 0.0 112.104 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.3 m -107.9 14.29 25.49 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.626 1.57 . . . . 0.0 112.082 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.4 m -76.97 133.78 69.01 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -77.33 109.5 2.81 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 108.096 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 125.1 -87.42 0.37 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 107.246 -2.342 . . . . 0.0 107.246 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 m -43.83 146.24 0.6 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.847 1.659 . . . . 0.0 112.375 -171.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.95 107.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 134.66 26.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.45 142.48 50.78 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 163.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.97 172.24 45.31 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 120.741 -1.224 . . . . 0.0 110.673 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.9 m -121.62 135.49 54.98 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.724 1.21 . . . . 0.0 108.403 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.1 pt -125.93 151.18 70.99 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.911 1.684 . . . . 0.0 110.156 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.82 150.57 49.93 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 109.194 169.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.85 118.92 59.57 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 123.112 0.565 . . . . 0.0 110.596 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.14 117.72 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.102 2.534 . . . . 0.0 107.63 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -152.92 -35.03 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.199 0.999 . . . . 0.0 110.624 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.64 -152.9 6.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 164.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 140.34 93.81 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.543 -0.975 . . . . 0.0 109.726 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.33 120.11 4.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.812 3.675 . . . . 0.0 111.407 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.0 155.88 38.13 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.827 1.651 . . . . 0.0 113.123 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.31 -60.21 2.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.886 2.074 . . . . 0.0 113.802 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.405 HD13 HG23 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -62.13 -47.07 86.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.59 -41.03 52.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.09 -36.15 74.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.94 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -55.16 -49.27 72.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.944 1.247 . . . . 0.0 110.035 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 128' ' ' VAL . 5.2 mp -75.82 -46.13 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.069 0.548 . . . . 0.0 109.619 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -39.49 74.74 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.402 1.081 . . . . 0.0 109.55 -174.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -60.05 -23.51 63.8 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.123 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -63.41 -42.15 98.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.576 1.08 . . . . 0.0 111.624 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 8.9 mmpt? 61.91 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.591 2.356 . . . . 0.0 115.055 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -28.63 67.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.448 1.022 . . . . 0.0 110.911 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 3' ' ' HIS . 36.0 m -57.32 123.92 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.193 0.997 . . . . 0.0 108.845 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -71.08 106.21 3.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.5 t -84.25 95.53 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -83.46 112.95 20.42 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.55 120.61 17.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.406 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -65.68 164.61 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 82.8 p -122.28 163.2 20.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.07 -21.57 64.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.788 -1.195 . . . . 0.0 109.805 161.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -79.9 -47.84 14.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.67 0.788 . . . . 0.0 111.097 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.93 32.01 5.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.939 1.696 . . . . 0.0 110.433 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 17' ' ' LEU . 3.0 tmm_? -48.52 -59.86 3.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.249 1.419 . . . . 0.0 109.668 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -76.63 4.15 10.04 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -116.92 4.61 12.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.002 1.721 . . . . 0.0 110.878 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 6.0 tp -80.26 -40.22 27.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.307 0.503 . . . . 0.0 112.044 170.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.79 -57.92 0.73 Allowed Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 126.177 1.791 . . . . 0.0 110.222 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.08 -25.21 44.08 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.203 1.936 . . . . 0.0 114.994 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.14 -38.79 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.061 -1.025 . . . . 0.0 109.587 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 5.9 mt -62.65 -47.95 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.38 -40.93 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.76 1.224 . . . . 0.0 110.443 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.8 m -65.13 -43.26 92.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.247 1.019 . . . . 0.0 110.04 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 10.3 t -68.61 -33.24 73.69 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.096 -1.002 . . . . 0.0 112.229 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.8 t -63.07 -64.91 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -35.86 80.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.078 -171.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 t -24.47 -86.28 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.942 2.897 . . . . 0.0 113.563 -165.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.5 m 64.35 -64.79 0.14 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.921 2.488 . . . . 0.0 113.198 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.24 -5.72 9.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 117.168 -1.396 . . . . 0.0 112.291 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-N 121.082 1.765 . . . . 0.0 109.222 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -167.81 139.18 2.95 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 147.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -73.76 151.79 40.53 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.37 155.95 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 109.082 170.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -142.2 165.04 28.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.289 1.036 . . . . 0.0 109.81 171.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 18' ' ' ILE . 4.4 mm? -100.96 150.39 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.188 2.195 . . . . 0.0 108.736 169.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -156.16 -162.76 1.34 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.86 -174.07 26.28 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.18 1.848 . . . . 0.0 112.251 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.25 149.76 81.47 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.443 2.762 . . . . 0.0 111.477 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.16 119.42 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.071 2.514 . . . . 0.0 109.307 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.48 -17.15 27.33 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 117.927 -1.485 . . . . 0.0 110.583 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 64.85 113.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.051 1.74 . . . . 0.0 109.164 -169.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.39 65.86 0.75 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -97.94 -33.47 11.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.16 0.584 . . . . 0.0 110.841 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -53.28 -38.5 63.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.92 2.088 . . . . 0.0 111.983 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.9 m -62.92 -40.64 98.22 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.581 -0.699 . . . . 0.0 112.609 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -45.37 87.34 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 120.253 -1.53 . . . . 0.0 108.041 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 HD23 ' A' ' 6' ' ' LEU . 9.2 mm -55.56 -46.83 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.875 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -54.52 -50.9 66.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.178 1.354 . . . . 0.0 108.996 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -50.54 -43.91 56.26 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 110.627 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.6 69.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.069 0.849 . . . . 0.0 111.232 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.487 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.26 -39.32 69.65 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.001 0.92 . . . . 0.0 111.326 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.64 -48.94 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 O-C-N 121.451 -0.781 . . . . 0.0 109.745 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.4 mt -60.56 -41.44 94.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -60.58 -41.43 94.66 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -68.59 -25.27 64.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.046 1.338 . . . . 0.0 112.652 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -73.07 -24.23 60.65 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.928 173.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.69 2.75 10.42 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.124 1.821 . . . . 0.0 113.418 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.7 t -88.17 122.97 69.5 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.452 1.626 . . . . 0.0 109.616 -161.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.83 84.93 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.549 2.166 . . . . 0.0 109.001 161.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.13 141.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 125.48 1.512 . . . . 0.0 107.561 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -127.1 175.47 8.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.289 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.85 -160.88 16.16 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 120.623 1.556 . . . . 0.0 111.42 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.27 154.63 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.363 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -119.56 178.78 4.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.688 1.595 . . . . 0.0 106.903 165.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -143.38 144.25 31.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 168.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.92 161.03 36.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 109.914 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.37 129.92 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.505 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.95 97.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -117.74 97.99 6.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.995 1.718 . . . . 0.0 106.461 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -64.21 99.45 0.28 Allowed 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.82 -59.57 2.58 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.483 1.04 . . . . 0.0 111.568 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.67 40.77 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.362 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -127.8 132.28 49.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -63.08 114.61 3.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 -23.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.704 0.802 . . . . 0.0 112.876 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.95 -170.86 42.14 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 120.261 1.391 . . . . 0.0 111.716 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -119.32 170.08 9.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 157.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.265 31.4 p30 -129.85 159.75 35.62 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.114 -0.367 . . . . 0.0 110.798 158.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.51 109.92 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.33 113.77 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 p -80.04 157.38 26.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.9 3.36 3.36 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.016 -1.052 . . . . 0.0 112.44 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.4 m -72.41 -11.51 60.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.198 0.999 . . . . 0.0 111.942 160.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.15 76.77 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.289 -0.882 . . . . 0.0 111.943 -167.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.568 HG22 HD23 ' A' ' 90' ' ' LEU . 31.0 m -102.76 154.81 18.81 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.551 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -143.48 141.35 30.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.069 0.85 . . . . 0.0 111.0 -163.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.24 142.12 13.25 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 74.9 1.98 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 125.075 3.85 . . . . 0.0 111.405 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.4 HD22 ' CG2' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -49.16 -49.66 41.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.195 0.998 . . . . 0.0 110.18 -177.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.41 126.06 13.37 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -144.64 92.96 2.35 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 65' ' ' GLY 0.433 4.0 m 34.86 -126.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 113.606 -174.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' H ' HG23 ' A' ' 64' ' ' VAL . . . 110.02 149.32 12.48 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 120.181 1.355 . . . . 0.0 110.991 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.77 152.19 32.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -77.35 164.67 56.99 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.109 0.964 . . . . 0.0 110.009 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.98 124.49 8.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.376 2.05 . . . . 0.0 107.151 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -66.24 169.92 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.949 1.766 . . . . 0.0 108.957 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.39 119.22 6.21 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.748 1.632 . . . . 0.0 108.268 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.11 -68.71 0.54 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.621 1.105 . . . . 0.0 110.705 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -68.02 149.87 49.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 1.151 . . . . 0.0 109.013 178.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.16 156.91 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 164.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 13.9 pt-20 -158.05 -163.19 1.26 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.545 1.938 . . . . 0.0 106.839 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.18 -165.94 1.38 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.052 1.341 . . . . 0.0 108.952 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 3.6 tmm_? 146.62 140.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.104 3.362 . . . . 0.0 107.428 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.22 -24.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.75 104.76 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 107.071 -2.412 . . . . 0.0 107.071 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 65.31 -55.42 0.32 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 129.031 2.932 . . . . 0.0 111.828 -163.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -84.52 137.69 33.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.777 0.831 . . . . 0.0 110.624 -168.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 4.9 p -82.07 110.91 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 172.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.4 ' CG2' HD22 ' A' ' 61' ' ' LEU . 1.4 p -71.46 162.89 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -143.8 125.2 14.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 167.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.93 -26.37 65.9 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.943 0.897 . . . . 0.0 111.668 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -55.31 -35.24 64.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.778 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -60.86 -40.11 91.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.119 0.872 . . . . 0.0 110.521 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -61.27 -50.93 71.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.557 0.617 . . . . 0.0 109.341 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.49 -21.41 62.37 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.92 -45.67 91.82 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.747 0.703 . . . . 0.0 111.843 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -154.31 -28.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -161.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.26 20.59 1.59 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.628 1.171 . . . . 0.0 110.416 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.674 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -121.9 -47.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.973 2.509 . . . . 0.0 112.682 -172.352 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -64.3 -25.14 64.48 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.65 1.566 . . . . 0.0 111.203 166.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.0 -29.08 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.497 -0.752 . . . . 0.0 113.007 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 mm? -62.7 -51.47 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.906 0.775 . . . . 0.0 109.534 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -127.47 99.23 5.53 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -74.13 177.17 5.93 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.847 1.259 . . . . 0.0 111.445 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.49 104.56 16.68 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.9 1.28 . . . . 0.0 109.536 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -157.17 143.38 17.93 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.625 1.97 . . . . 0.0 106.044 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.9 m 37.76 -141.86 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.42 2.288 . . . . 0.0 113.002 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.3 p -138.97 176.29 8.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.806 0.843 . . . . 0.0 108.883 161.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -66.81 109.62 2.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.249 1.42 . . . . 0.0 110.079 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.19 -104.88 0.18 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.771 -1.572 . . . . 0.0 109.435 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.78 179.38 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.436 3.424 . . . . 0.0 110.83 168.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.69 86.22 1.73 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -73.0 152.12 41.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.519 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -140.2 177.63 7.85 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.458 1.903 . . . . 0.0 108.371 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.5 t -133.95 147.22 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 168.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.2 162.19 17.84 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.1 0.96 . . . . 0.0 110.047 172.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.19 130.61 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.003 1.721 . . . . 0.0 107.421 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.3 mt -149.12 106.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -98.32 177.23 5.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.272 -1.518 . . . . 0.0 108.52 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.01 27.65 15.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.406 2.682 . . . . 0.0 113.402 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.59 98.15 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.95 -77.91 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-O 118.795 -1.003 . . . . 0.0 110.748 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -53.97 -30.26 46.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.782 1.233 . . . . 0.0 113.913 -164.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -64.19 -16.17 61.41 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 126.387 1.875 . . . . 0.0 112.156 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -24.31 -59.6 0.05 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.573 2.749 . . . . 0.0 116.2 -163.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.82 -34.8 67.08 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.921 1.288 . . . . 0.0 111.904 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -81.15 -27.68 35.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.702 1.601 . . . . 0.0 111.613 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.6 m -52.09 110.52 0.49 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.467 1.507 . . . . 0.0 109.233 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.67 -8.56 0.49 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.97 -31.35 2.89 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 125.717 1.607 . . . . 0.0 108.996 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -27.64 -73.73 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 129.102 2.961 . . . . 0.0 110.928 164.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -34.33 -63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 128.22 2.608 . . . . 0.0 113.84 172.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.05 -43.05 83.68 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.866 1.212 . . . . 0.0 111.175 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.53 99.42 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.461 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.72 -36.45 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.006 0.922 . . . . 0.0 109.394 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.19 -26.75 63.17 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.232 -1.543 . . . . 0.0 113.941 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -55.49 -56.95 14.29 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.523 1.056 . . . . 0.0 108.91 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 m -66.78 -34.73 78.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.631 1.572 . . . . 0.0 112.489 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.85 -27.81 69.12 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.492 -0.755 . . . . 0.0 109.743 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 t -85.74 -23.6 27.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.709 1.603 . . . . 0.0 111.614 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.8 m -58.38 139.03 85.01 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.2 1.364 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -86.21 107.27 0.84 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.768 2.979 . . . . 0.0 109.16 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 128.87 -43.33 1.33 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.603 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.2 m -57.13 157.54 5.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.158 1.479 . . . . 0.0 110.579 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.22 102.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.91 129.73 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 166.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.25 111.65 11.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.56 174.82 25.41 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.086 0.857 . . . . 0.0 113.08 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.0 m -117.54 122.07 42.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.391 1.096 . . . . 0.0 110.092 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.51 143.25 29.03 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.618 1.167 . . . . 0.0 109.094 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.59 141.25 54.53 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.017 1.811 . . . . 0.0 108.393 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.13 114.5 12.82 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.5 149.55 27.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.367 2.711 . . . . 0.0 109.063 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -140.67 -72.11 0.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.694 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.76 -66.1 2.64 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 146.8 54.65 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 117.639 0.719 . . . . 0.0 109.44 174.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.83 161.26 21.36 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.929 2.419 . . . . 0.0 107.976 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -93.14 155.8 17.25 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -38.9 -50.89 1.76 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.316 2.246 . . . . 0.0 114.146 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 124' ' ' PHE . 4.4 mm? -80.17 -38.19 31.82 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.063 0.545 . . . . 0.0 109.976 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.12 -17.46 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.287 -1.508 . . . . 0.0 110.279 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.64 -61.73 1.75 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.799 -1.188 . . . . 0.0 109.634 161.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.325 0.2 OUTLIER -53.73 -54.35 39.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.092 0.948 . . . . 0.0 112.709 -174.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.27 -30.8 49.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 124.903 1.281 . . . . 0.0 111.788 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -31.29 70.66 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.118 -0.989 . . . . 0.0 110.888 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -69.27 -6.73 31.24 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.484 0.584 . . . . 0.0 110.718 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -69.24 -30.28 68.38 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.368 -0.833 . . . . 0.0 112.878 170.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -43.67 0.28 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.355 2.262 . . . . 0.0 115.322 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -89.46 64.1 6.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.375 2.27 . . . . 0.0 108.638 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.58 122.95 48.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 tppm? -65.23 110.51 2.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 158.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 m -96.94 88.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 180' ' ' ILE . 19.4 m-85 -61.2 101.58 0.17 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.505 1.122 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.32 93.73 1.53 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.57 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -57.11 166.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.0 p -131.72 162.45 30.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 165.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -61.07 -30.7 70.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.733 -0.604 . . . . 0.0 109.393 159.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.82 -67.07 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.348 1.859 . . . . 0.0 110.266 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.0 33.57 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.891 1.676 . . . . 0.0 110.141 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -56.42 -62.82 1.46 Allowed 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.028 -1.045 . . . . 0.0 111.066 -170.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.77 3.29 12.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.82 -1.24 56.94 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.66 1.584 . . . . 0.0 111.364 172.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 168' ' ' VAL . 7.3 tp -87.37 -32.23 19.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 118.822 -1.151 . . . . 0.0 112.369 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.4 -58.31 3.06 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.739 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.87 -21.92 27.7 Favored 'Trans proline' 0 C--N 1.354 0.85 0 CA-C-N 121.383 1.529 . . . . 0.0 112.798 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -40.66 75.69 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.662 1.985 . . . . 0.0 109.005 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 4.3 mt -66.76 -50.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.212 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.505 ' HA ' HG23 ' A' ' 184' ' ' VAL . 42.0 t -50.9 -29.94 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.741 1.617 . . . . 0.0 109.473 174.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.8 m -75.09 -18.32 60.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 119.999 -1.688 . . . . 0.0 112.973 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -52.71 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -56.61 -60.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.694 1.998 . . . . 0.0 109.453 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.64 -22.02 61.29 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.069 -1.02 . . . . 0.0 113.19 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' A' ' 189' ' ' LYS . 37.1 m -73.08 -59.76 2.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.906 0.882 . . . . 0.0 111.316 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.79 17.95 0.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.837 -168.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -157.39 -37.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.378 1.471 . . . . 0.0 112.199 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 186' ' ' SER . 26.0 mmtt . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.395 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.795 0.807 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 8.4 tpp180 -151.29 179.0 8.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 149.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 83.3 m-70 -51.32 156.08 1.27 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.613 1.565 . . . . 0.0 111.076 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -129.94 142.13 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 157' ' ' ILE . 24.4 m-85 -135.55 158.34 44.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 160.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mt -93.21 150.62 20.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -154.41 -172.48 4.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.28 -175.12 24.59 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.971 1.272 . . . . 0.0 110.951 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.12 162.02 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.239 2.626 . . . . 0.0 111.557 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.02 153.95 67.19 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.288 1.325 . . . . 0.0 109.481 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.33 -5.64 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 126.61 2.052 . . . . 0.0 110.712 162.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.26 30.2 t 67.1 126.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.616 1.198 . . . . 0.0 110.527 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.41 -9.94 10.8 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.27 164.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -54.9 -31.12 59.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.224 1.012 . . . . 0.0 111.141 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -56.48 -35.72 68.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.646 1.578 . . . . 0.0 110.31 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -67.44 -24.23 65.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.301 -1.499 . . . . 0.0 113.09 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -55.22 20.48 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 170.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -57.05 -46.07 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.319 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -47.83 -57.79 5.18 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.736 0.814 . . . . 0.0 110.023 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -62.57 -40.8 98.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.67 55.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.089 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 p -71.59 -47.81 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.976 1.262 . . . . 0.0 109.97 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.9 -36.42 74.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 110.727 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.45 -53.03 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 125.383 1.473 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -57.81 -42.4 84.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -63.05 -36.31 83.14 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.351 0.26 . . . . 0.0 110.661 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 m -77.37 -10.78 59.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.586 1.954 . . . . 0.0 112.714 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.9 m -100.08 6.08 44.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.627 2.371 . . . . 0.0 111.676 168.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.47 11.79 84.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.708 -1.051 . . . . 0.0 114.633 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.51 139.06 44.28 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 119.557 1.678 . . . . 0.0 109.242 -170.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.82 89.6 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.91 3.073 . . . . 0.0 111.608 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.93 148.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.154 1.382 . . . . 0.0 109.297 172.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -147.53 -176.0 5.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.044 2.138 . . . . 0.0 109.984 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA3' ' H ' ' A' ' 110' ' ' VAL . . . 123.43 -156.81 17.8 Favored Glycine 0 C--O 1.24 0.514 0 C-N-CA 127.88 2.657 . . . . 0.0 108.138 174.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.52 171.3 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.976 0.888 . . . . 0.0 110.231 171.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -137.08 -178.41 5.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 165.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.5 p -130.41 154.32 47.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 160.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.47 13.69 3.78 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 112.63 -172.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.275 12.6 pt-20 50.65 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 127.1 2.16 . . . . 0.0 110.783 -156.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.713 HG13 HG13 ' A' ' 47' ' ' ILE . 11.0 p -63.11 138.61 22.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -122.97 164.81 17.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.668 1.187 . . . . 0.0 108.404 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.67 96.67 2.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.34 -66.45 1.49 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.61 12.11 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.652 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.96 143.17 47.19 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 118.597 1.198 . . . . 0.0 109.1 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -63.09 154.75 29.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 124.671 1.232 . . . . 0.0 108.873 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.713 HG13 HG13 ' A' ' 40' ' ' VAL . 1.1 pt -140.3 -13.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.791 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 157.27 -142.82 8.94 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.141 -2.383 . . . . 0.0 107.141 173.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -142.35 66.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.229 1.515 . . . . 0.0 110.602 -172.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -53.15 143.88 16.91 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.55 114.85 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 118.568 0.622 . . . . 0.0 109.559 -160.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.33 109.68 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -150.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -59.87 146.02 43.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.02 -11.51 39.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.278 168.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 -14.56 61.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.516 1.926 . . . . 0.0 111.618 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 67.82 1.47 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 119.412 1.005 . . . . 0.0 111.148 -177.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -157.32 151.43 24.73 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.707 3.203 . . . . 0.0 104.706 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.41 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -142.63 154.44 44.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 121.278 1.853 . . . . 0.0 109.714 -173.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.02 156.86 19.78 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.083 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.98 54.32 4.82 Favored 'Trans proline' 0 CA--C 1.539 0.762 1 C-N-CA 125.695 4.264 . . . . 0.0 113.21 -173.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -51.44 -52.36 46.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.656 1.582 . . . . 0.0 111.137 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 p -150.16 133.05 16.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.34 43.15 0.52 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.351 0.26 . . . . 0.0 110.624 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t 60.43 154.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 129.045 2.938 . . . . 0.0 110.641 -167.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.02 160.1 31.7 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 105.481 -3.048 . . . . 0.0 105.481 166.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.28 164.78 12.77 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.006 0.908 . . . . 0.0 110.461 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -63.83 148.65 94.42 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.134 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.32 133.24 17.41 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.452 2.768 . . . . 0.0 110.184 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.34 174.26 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.347 2.698 . . . . 0.0 110.875 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.4 -24.69 64.05 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.095 1.196 . . . . 0.0 113.282 -176.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.22 -1.68 47.95 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.698 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -148.06 143.98 27.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.137 1.969 . . . . 0.0 108.581 -172.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.01 149.89 27.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.507 ' HG3' ' HE2' ' A' ' 72' ' ' LYS . 22.2 mt-10 -132.47 162.36 31.36 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.359 1.863 . . . . 0.0 109.537 168.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.71 136.26 57.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.687 1.195 . . . . 0.0 109.211 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.39 154.64 41.86 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.263 -172.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.96 119.74 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.25 -107.3 1.64 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.49 -10.76 15.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 112.868 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.09 140.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.87 163.22 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 160.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.55 173.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 O-C-N 120.501 -1.374 . . . . 0.0 109.889 171.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.77 98.71 4.25 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.89 -35.7 71.37 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.101 -0.999 . . . . 0.0 110.701 173.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -66.35 -30.63 71.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.616 0.766 . . . . 0.0 109.966 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.8 t -62.01 -23.91 66.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 120.041 1.291 . . . . 0.0 111.891 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -73.09 -62.73 1.36 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.24 -13.7 13.94 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -53.82 -42.71 68.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 111.623 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.64 -35.67 0.49 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.052 0.541 . . . . 0.0 112.242 -168.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 63.67 4.46 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -65.25 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 127.708 2.403 . . . . 0.0 105.766 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 -18.11 36.93 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.383 2.055 . . . . 0.0 114.348 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 95' ' ' LEU . 20.0 m -67.5 -64.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.595 1.089 . . . . 0.0 108.697 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 94' ' ' VAL . 76.5 mt -45.62 -56.13 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.657 2.383 . . . . 0.0 108.506 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.16 89.16 3.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.13 0.491 . . . . 0.0 110.742 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.91 127.17 30.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 118.044 -1.463 . . . . 0.0 107.62 158.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.41 8.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.532 1.133 . . . . 0.0 108.793 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -156.04 142.86 18.83 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 6.8 t -146.88 76.79 1.44 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.527 1.058 . . . . 0.0 110.916 -167.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -123.77 134.57 53.63 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 125.125 1.37 . . . . 0.0 107.709 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -74.92 151.37 38.9 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 160.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 136.14 173.53 13.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.486 1.517 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.63 136.29 17.05 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.084 2.523 . . . . 0.0 110.399 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.46 66.13 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 121.194 -0.941 . . . . 0.0 112.29 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.1 150.88 28.23 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 110.357 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -124.6 164.77 19.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.899 1.68 . . . . 0.0 107.209 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -124.42 141.4 44.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.401 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 8.9 t -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.406 ' H ' ' HA3' ' A' ' 34' ' ' GLY . 90.6 t -141.14 128.95 22.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.486 1.514 . . . . 0.0 107.138 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.52 68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.19 -168.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.81 18.85 0.55 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.037 1.735 . . . . 0.0 114.634 -171.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -67.51 129.47 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 119.327 -2.108 . . . . 0.0 107.404 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.05 -75.63 0.22 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-O 119.496 -0.614 . . . . 0.0 112.141 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -64.54 -26.9 68.62 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.074 0.937 . . . . 0.0 112.022 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.8 mmm -63.66 -7.68 8.06 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 116.55 -1.69 . . . . 0.0 114.03 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -42.23 -44.73 3.89 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.519 1.963 . . . . 0.0 114.517 -165.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.51 -39.1 28.51 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.422 0.689 . . . . 0.0 111.736 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -84.06 -21.21 31.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.24 1.016 . . . . 0.0 110.987 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.2 t -42.16 123.09 2.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 129.762 3.225 . . . . 0.0 110.569 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.45 -88.61 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 107.605 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.88 -1.86 8.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.587 -0.72 . . . . 0.0 112.131 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -71.82 0.11 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.654 1.115 . . . . 0.0 110.188 160.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.33 -31.42 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 126.002 1.721 . . . . 0.0 113.105 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -60.56 2.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 120.664 -1.273 . . . . 0.0 112.813 171.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.26 67.23 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 111.828 -166.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.86 -51.17 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -57.78 -40.14 79.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 120.301 1.41 . . . . 0.0 113.412 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -56.73 -20.53 22.5 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.313 1.045 . . . . 0.0 112.515 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -108.71 -27.87 9.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.977 1.311 . . . . 0.0 110.234 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.187 1.395 . . . . 0.0 111.633 168.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.7 t -58.3 -44.68 88.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.477 0.711 . . . . 0.0 109.442 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.1 m -77.3 133.43 68.15 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.92 -30.04 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.439 2.76 . . . . 0.0 111.3 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.75 -65.38 3.62 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.712 2.101 . . . . 0.0 111.634 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 20.1 m -59.46 143.33 50.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.91 169.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.19 96.8 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mm -56.7 130.9 19.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 142.33 50.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.726 2.411 . . . . 0.0 105.304 167.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.37 175.28 45.58 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.281 0.946 . . . . 0.0 110.945 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.1 m -115.94 94.64 4.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.151 1.476 . . . . 0.0 113.105 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 5' ' ' PHE . 1.2 pp -89.84 122.44 67.95 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.094 -1.004 . . . . 0.0 111.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.12 153.13 67.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.827 1.684 . . . . 0.0 110.532 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.84 151.88 95.13 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 122.057 -0.402 . . . . 0.0 110.431 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.15 -55.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.135 3.223 . . . . 0.0 111.907 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 26.17 77.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.48 2.712 . . . . 0.0 110.923 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.03 -111.53 3.13 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 135.03 90.38 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 117.584 0.692 . . . . 0.0 109.654 -170.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.72 171.07 12.67 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.237 1.958 . . . . 0.0 110.619 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.83 160.93 28.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.952 2.501 . . . . 0.0 105.193 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.34 -66.27 0.91 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.852 0.861 . . . . 0.0 110.082 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.18 -46.79 87.48 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.42 0.688 . . . . 0.0 109.203 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.95 -41.68 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.292 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.55 -17.66 60.01 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.593 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -36.08 76.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.686 1.194 . . . . 0.0 108.771 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.3 mt -84.72 -52.18 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 109.487 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -23.44 65.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.932 1.293 . . . . 0.0 110.265 -172.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -40.05 13.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 174.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 162' ' ' ASP . 30.0 mtp85 -68.9 -36.09 77.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 123.88 0.872 . . . . 0.0 110.545 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? 60.63 -18.67 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.675 1.99 . . . . 0.0 113.86 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -71.85 48.77 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 1 C-N-CA 133.124 4.569 . . . . 0.0 110.755 173.628 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.77 128.89 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -69.71 105.45 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 160.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.38 87.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 16.0 m-85 -58.5 100.19 0.06 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 107.64 5.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.05 147.81 10.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.8 p -99.02 166.12 11.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 158.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.83 -14.01 61.85 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 120.002 -1.686 . . . . 0.0 111.031 161.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -88.66 -65.03 1.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.07 0.948 . . . . 0.0 110.416 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.66 29.14 2.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.96 2.104 . . . . 0.0 108.146 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -50.28 -57.02 8.79 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.561 1.144 . . . . 0.0 108.009 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -82.92 17.67 1.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -116.55 48.19 1.32 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 8.6 tp -129.0 -37.36 1.71 Allowed 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.158 174.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -55.04 13.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 117.305 -1.331 . . . . 0.0 109.629 176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.64 -26.06 39.91 Favored 'Trans proline' 0 C--N 1.356 0.962 0 CA-C-N 121.926 1.724 . . . . 0.0 113.482 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.49 -45.11 63.37 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.22 1.408 . . . . 0.0 109.85 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 14.5 mt -54.82 -52.78 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 125.406 1.482 . . . . 0.0 109.19 167.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.74 -44.59 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.458 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.1 m -62.04 -42.23 98.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.564 1.075 . . . . 0.0 109.726 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.4 t -67.03 -44.18 80.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.017 0.826 . . . . 0.0 110.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.56 -53.73 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.595 -0.691 . . . . 0.0 109.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -16.08 63.63 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.997 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -57.29 10.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m 55.1 -73.8 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 -167.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -117.98 5.14 12.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.629 1.104 . . . . 0.0 112.843 173.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? . . . . . 0 C--O 1.247 0.934 0 CA-C-N 120.479 1.491 . . . . 0.0 108.756 164.776 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 121.075 0.464 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.648 ' HB2' HG12 ' A' ' 163' ' ' VAL . 17.7 m-70 -58.49 156.28 10.74 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.608 1.963 . . . . 0.0 111.729 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.23 130.56 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CE1' HG21 ' A' ' 157' ' ' ILE . 38.9 m-85 -125.29 139.93 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.413 0.685 . . . . 0.0 111.399 173.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.52 155.15 33.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.347 1.459 . . . . 0.0 107.991 167.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -152.12 175.84 12.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.86 -163.47 25.02 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.6 146.73 15.29 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.62 2.213 . . . . 0.0 110.321 168.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.77 153.7 77.05 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.722 1.615 . . . . 0.0 109.421 165.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.61 5.83 0.03 OUTLIER Glycine 0 CA--C 1.524 0.63 0 CA-C-O 119.053 -0.859 . . . . 0.0 112.491 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.254 97.1 t 65.56 115.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 127.027 2.131 . . . . 0.0 112.503 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.41 -41.9 0.21 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.962 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -50.18 -31.86 14.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.719 1.607 . . . . 0.0 112.535 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -45.23 -47.27 12.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 129.005 2.922 . . . . 0.0 110.038 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -86.06 -23.99 26.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.774 1.23 . . . . 0.0 110.728 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.07 -37.04 78.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 118.211 -0.9 . . . . 0.0 109.693 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.4 -46.32 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 117.902 -1.046 . . . . 0.0 108.732 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -53.62 -44.82 69.8 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.616 1.553 . . . . 0.0 111.428 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -62.05 -40.28 95.22 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.449 0.7 . . . . 0.0 110.769 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 177' ' ' LEU . . . -60.82 -23.64 65.24 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.426 0.557 . . . . 0.0 112.019 172.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 m -89.62 12.06 17.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.072 1.749 . . . . 0.0 112.183 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -113.05 -23.36 10.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.912 1.685 . . . . 0.0 111.838 168.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.44 -44.09 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.273 -0.892 . . . . 0.0 113.199 -161.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.72 -35.4 72.63 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 166.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.19 -39.6 82.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.97 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -70.48 -18.11 62.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.467 0.707 . . . . 0.0 111.21 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -96.03 6.02 49.82 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.155 2.182 . . . . 0.0 111.856 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.4 18.61 75.71 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.281 -0.887 . . . . 0.0 113.518 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.29 100.31 15.18 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.731 2.012 . . . . 0.0 106.758 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.52 90.38 1.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.933 2.422 . . . . 0.0 110.73 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.47 154.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.519 1.928 . . . . 0.0 109.518 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.33 176.6 9.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.085 0.954 . . . . 0.0 110.469 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.91 -149.97 17.08 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.02 1.295 . . . . 0.0 111.147 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -145.4 160.85 40.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.777 0.831 . . . . 0.0 111.697 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -144.18 131.19 20.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.56 1.544 . . . . 0.0 106.96 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 p -74.25 146.7 43.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 117.62 -1.181 . . . . 0.0 107.882 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.57 159.12 35.58 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.605 1.548 . . . . 0.0 109.102 167.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.38 96.01 7.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.565 1.146 . . . . 0.0 107.972 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.56 101.63 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.567 1.175 . . . . 0.0 108.806 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -121.95 84.95 2.33 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 125.758 1.623 . . . . 0.0 108.64 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -58.99 109.67 0.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.71 34.63 21.71 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.652 -0.527 . . . . 0.0 113.129 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.42 38.45 14.63 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.556 1.678 . . . . 0.0 115.273 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 136.09 45.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.357 2.078 . . . . 0.0 107.663 159.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -67.28 111.82 4.2 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.901 0.88 . . . . 0.0 108.872 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 pt -115.62 -10.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.942 0.897 . . . . 0.0 112.483 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -165.4 35.84 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 107.996 -2.041 . . . . 0.0 107.996 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -124.48 167.53 14.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.701 1.6 . . . . 0.0 107.644 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -120.67 -178.83 3.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.544 1.538 . . . . 0.0 109.584 167.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.83 96.34 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 162.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.33 151.0 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 p -115.8 154.6 29.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.43 -6.78 15.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.174 0.897 . . . . 0.0 111.909 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -86.39 3.14 44.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.155 2.582 . . . . 0.0 111.784 171.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.71 5.83 88.37 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.277 -1.515 . . . . 0.0 114.377 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 151.23 30.7 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 169.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 136.79 26.96 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.796 1.18 . . . . 0.0 111.496 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -87.16 176.41 47.02 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 121.398 0.443 . . . . 0.0 112.945 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.18 167.5 21.8 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 146.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -142.92 -69.98 0.33 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -128.45 161.5 29.35 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.906 0.882 . . . . 0.0 109.936 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -149.7 169.52 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.813 1.245 . . . . 0.0 108.118 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 t -60.29 149.81 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.498 0.719 . . . . 0.0 109.382 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.08 165.2 32.54 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 160.67 16.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.493 1.117 . . . . 0.0 109.586 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.99 155.62 93.19 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.6 124.82 11.09 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.994 2.463 . . . . 0.0 108.014 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.36 162.95 36.5 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 108.549 -1.366 . . . . 0.0 108.549 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.92 -11.34 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.766 1.644 . . . . 0.0 113.783 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.16 -40.72 4.77 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.192 1.377 . . . . 0.0 113.707 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.0 112.45 25.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.977 1.389 . . . . 0.0 107.688 -170.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -71.19 135.42 47.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.91 176.16 11.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.539 1.936 . . . . 0.0 106.342 166.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 83.0 m -124.4 74.79 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.559 0.695 . . . . 0.0 111.001 -165.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 138.99 33.88 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.479 1.112 . . . . 0.0 108.664 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.8 -27.65 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.325 0.584 . . . . 0.0 111.334 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.82 -71.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 105.136 -3.186 . . . . 0.0 105.136 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -108.43 -51.84 2.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.616 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.06 163.13 28.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.888 1.222 . . . . 0.0 109.249 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.68 119.94 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.53 172.92 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.665 0.786 . . . . 0.0 108.928 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.52 146.26 31.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 162.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.23 -32.42 71.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.236 0.615 . . . . 0.0 110.737 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 m -64.55 -32.71 74.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.156 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.2 m -61.37 -34.94 76.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.682 1.128 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.472 0.709 . . . . 0.0 110.139 167.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -24.02 9.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.444 1.097 . . . . 0.0 113.477 -170.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -50.17 -35.59 26.81 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.994 1.318 . . . . 0.0 113.158 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -145.23 -33.84 0.35 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.026 -0.512 . . . . 0.0 112.005 -175.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.57 1.948 . . . . 0.0 111.508 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -135.69 -55.16 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.43 1.492 . . . . 0.0 110.168 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 49.3 Cg_endo -69.97 -37.57 8.49 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.751 1.634 . . . . 0.0 112.318 170.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.26 -24.64 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -45.14 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.999 0.519 . . . . 0.0 110.649 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.62 70.89 0.91 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 165.683 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -155.07 165.56 36.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.479 1.512 . . . . 0.0 107.19 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.47 136.35 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.0 t -123.52 108.57 12.79 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.569 1.148 . . . . 0.0 109.519 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.85 130.14 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 125.643 1.577 . . . . 0.0 109.572 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.39 86.61 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.51 158.47 35.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 163.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER 51.14 90.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.959 2.504 . . . . 0.0 112.587 -174.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.89 75.72 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 164.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.88 -45.95 0.02 OUTLIER Glycine 0 C--N 1.334 0.437 0 O-C-N 120.952 -1.092 . . . . 0.0 113.383 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 9.4 tptt -66.49 -37.33 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.74 0.77 . . . . 0.0 110.39 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.5 mmt -79.46 0.52 29.15 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 115.559 -2.162 . . . . 0.0 114.253 -172.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.26 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 -170.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tp -117.85 -44.76 2.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.916 1.686 . . . . 0.0 110.131 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -73.89 -20.57 60.37 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.267 1.027 . . . . 0.0 111.41 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 p -53.4 115.29 1.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.379 2.272 . . . . 0.0 109.986 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.23 -71.49 0.54 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.585 1.154 . . . . 0.0 108.884 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.3 -21.4 59.74 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.424 1.09 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -69.14 0.12 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.309 1.443 . . . . 0.0 110.19 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.2 mp -37.73 -48.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.388 1.875 . . . . 0.0 112.683 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -63.89 -64.88 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.699 0.799 . . . . 0.0 112.48 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.5 90.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.072 0.949 . . . . 0.0 110.452 -170.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.55 -44.61 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.556 1.142 . . . . 0.0 109.367 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -67.66 -31.99 72.36 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.011 -1.681 . . . . 0.0 112.353 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -37.73 83.57 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.981 1.718 . . . . 0.0 110.512 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.434 ' CG2' HD11 ' A' ' 139' ' ' ILE . 1.5 m -65.92 -47.89 73.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.881 0.472 . . . . 0.0 110.866 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.33 -19.74 66.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 111.261 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -39.58 78.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.044 0.938 . . . . 0.0 109.477 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.7 m -64.81 134.02 95.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 123.565 0.746 . . . . 0.0 109.414 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.0 -29.27 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.661 2.907 . . . . 0.0 112.025 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.7 -53.75 7.09 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 145.03 54.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.222 1.011 . . . . 0.0 112.28 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.16 98.76 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 102.949 -2.982 . . . . 0.0 102.949 -169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 131' ' ' THR . 44.0 mm -61.06 131.65 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.41 116.26 8.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.566 1.947 . . . . 0.0 106.508 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.05 -179.61 39.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.7 m -123.53 100.28 6.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.9 pt -97.19 161.74 25.13 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 179.98 4.54 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.401 2.734 . . . . 0.0 110.47 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.5 150.36 79.45 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 121.172 -0.955 . . . . 0.0 110.773 164.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.01 109.47 2.7 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 123.188 2.592 . . . . 0.0 108.883 164.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.16 119.72 15.0 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 164.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.09 -131.02 36.0 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.59 137.55 96.46 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.845 -158.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 131.27 22.71 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.621 2.214 . . . . 0.0 109.009 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.98 121.87 21.71 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 13.33 0.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.122 2.569 . . . . 0.0 115.634 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.4 tp -131.67 -39.83 1.11 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.388 1.875 . . . . 0.0 109.39 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.83 -23.77 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 120.825 -1.172 . . . . 0.0 109.006 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.54 -40.43 78.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.578 1.151 . . . . 0.0 110.73 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.82 -31.03 72.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.689 1.996 . . . . 0.0 110.471 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.481 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.4 mp -90.56 -41.61 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.535 1.534 . . . . 0.0 109.337 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -52.56 -39.05 61.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.971 1.709 . . . . 0.0 109.823 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -33.4 -47.54 0.22 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 127.968 2.507 . . . . 0.0 113.033 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -66.5 -40.75 89.41 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.342 -1.313 . . . . 0.0 112.436 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.75 -40.71 0.22 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.53 1.932 . . . . 0.0 113.482 -167.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.94 -22.49 60.1 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.68 2.392 . . . . 0.0 113.563 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 3' ' ' HIS . 5.6 m -66.0 138.79 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.487 ' HE3' ' CE1' ' A' ' 166' ' ' PHE . 28.3 tptt -65.07 142.73 58.3 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.85 102.29 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.487 ' CE1' ' HE3' ' A' ' 164' ' ' LYS . 13.7 m-85 -93.53 96.69 10.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.042 1.337 . . . . 0.0 111.051 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 104.94 2.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 172.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.59 163.05 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.988 0.813 . . . . 0.0 108.816 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.4 p -123.57 169.04 11.84 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.205 1.802 . . . . 0.0 106.305 160.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -77.51 -10.6 59.58 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.344 1.458 . . . . 0.0 112.275 158.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -79.99 -74.0 0.33 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.79 32.39 0.74 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.221 1.408 . . . . 0.0 109.913 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -54.91 -51.76 65.03 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.732 -1.23 . . . . 0.0 110.405 -169.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -75.33 4.04 7.92 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.95 -19.0 31.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.707 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -21.58 45.79 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.913 -164.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -47.71 -63.13 1.6 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.951 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.72 -28.78 76.69 Favored 'Trans proline' 0 C--N 1.35 0.616 0 CA-C-N 121.853 1.697 . . . . 0.0 112.929 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -33.97 75.0 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.608 0.763 . . . . 0.0 109.678 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.16 -52.17 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.071 0.948 . . . . 0.0 109.82 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.89 -34.77 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 118.42 0.554 . . . . 0.0 110.225 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.7 m -55.92 -44.61 78.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.389 1.076 . . . . 0.0 110.263 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -70.97 -41.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.684 -0.635 . . . . 0.0 110.278 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.27 -59.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 123.405 0.682 . . . . 0.0 109.811 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -3.18 20.42 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.273 1.029 . . . . 0.0 112.684 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -60.47 -21.35 62.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.883 -1.135 . . . . 0.0 110.592 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.342 0.268 0 CA-C-N 119.999 1.272 . . . . 0.0 107.636 164.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HB2' HG12 ' A' ' 163' ' ' VAL . 40.3 m-70 -24.63 119.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.55 3.14 . . . . 0.0 111.624 166.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 t -105.08 137.86 32.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 157' ' ' ILE . 54.5 m-85 -127.86 153.91 46.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.576 0.75 . . . . 0.0 109.151 163.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 164.24 12.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.838 2.055 . . . . 0.0 108.313 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -159.5 -173.45 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.11 53.7 6.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 127.214 2.34 . . . . 0.0 112.136 -160.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.11 123.51 8.88 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 119.786 1.793 . . . . 0.0 110.266 -171.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.6 -1.6 8.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.511 2.141 . . . . 0.0 112.238 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.93 4.03 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -170.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.4 97.99 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 125.396 2.522 . . . . 0.0 107.48 -168.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.85 -45.49 0.55 Allowed Glycine 0 C--N 1.309 -0.938 0 CA-C-N 111.345 -2.661 . . . . 0.0 108.414 163.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.533 ' HD3' HG21 ' A' ' 142' ' ' THR . 0.1 OUTLIER -47.31 -48.42 25.13 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.327 1.851 . . . . 0.0 112.958 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.3 m -60.31 -52.93 63.19 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.207 0.912 . . . . 0.0 108.898 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 m -59.67 -40.29 87.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.736 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -53.14 48.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.468 1.485 . . . . 0.0 109.284 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.25 -26.07 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.581 0.752 . . . . 0.0 111.06 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -66.12 -57.16 8.3 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.034 -1.666 . . . . 0.0 109.332 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -11.29 29.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.01 45.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.908 1.283 . . . . 0.0 112.468 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.2 p -67.23 -47.51 70.6 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -171.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.07 -39.98 66.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.199 1.8 . . . . 0.0 112.246 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.87 -54.41 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.457 1.103 . . . . 0.0 109.236 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 30' ' ' VAL . 25.9 mt -69.6 -36.57 76.32 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.316 0.646 . . . . 0.0 109.351 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.68 -39.0 86.84 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.971 -1.706 . . . . 0.0 109.89 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.97 -34.66 70.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.512 1.525 . . . . 0.0 110.342 168.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 4.32 4.99 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.308 2.243 . . . . 0.0 115.389 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.62 20.22 55.84 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.282 0.946 . . . . 0.0 112.204 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 25' ' ' LEU . 5.7 p -56.55 140.85 73.46 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.918 1.287 . . . . 0.0 108.741 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -79.16 84.72 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 CA-C-N 121.701 1.643 . . . . 0.0 111.347 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.07 156.78 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.159 0.983 . . . . 0.0 109.127 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -156.25 174.25 15.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.984 1.713 . . . . 0.0 107.471 164.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.43 -148.14 19.07 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 125.487 1.518 . . . . 0.0 111.31 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -148.68 171.56 16.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 111.216 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 9.1 p90 -146.22 172.38 13.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.29 1.436 . . . . 0.0 108.349 165.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.5 90.6 2.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.158 1.783 . . . . 0.0 106.326 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 18.8 mt-10 -74.89 -22.73 58.47 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.462 -0.774 . . . . 0.0 112.705 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 96.17 164.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.347 4.259 . . . . 0.0 109.747 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.32 104.01 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -121.42 105.25 10.33 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.831 1.253 . . . . 0.0 107.754 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -79.65 116.12 19.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.95 -56.03 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 120.529 1.513 . . . . 0.0 114.115 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.21 11.44 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.837 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 137.15 28.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.189 1.995 . . . . 0.0 109.484 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -66.61 144.92 56.12 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.28 -12.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.79 1.236 . . . . 0.0 112.965 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.91 -168.56 41.69 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -129.46 138.04 51.19 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -114.84 158.45 21.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD13 ' A' ' 90' ' ' LEU . 14.2 p -116.67 94.84 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -166.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.14 116.53 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.94 1.696 . . . . 0.0 108.235 -162.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.4 p -88.75 150.77 22.79 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.398 0.999 . . . . 0.0 109.271 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -24.94 67.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.051 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -32.9 72.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.492 1.117 . . . . 0.0 109.302 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.99 -14.85 2.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.702 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 163.59 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.969 2.108 . . . . 0.0 110.785 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.25 156.63 42.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 121.379 -0.826 . . . . 0.0 109.534 156.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -127.28 159.75 21.36 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.82 64.9 7.31 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.66 3.574 . . . . 0.0 111.642 -166.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.64 -56.08 2.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 127.079 2.152 . . . . 0.0 110.677 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 147.8 34.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 109.516 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -147.4 161.67 40.57 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.029 1.332 . . . . 0.0 108.691 172.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -62.55 159.95 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.833 0.853 . . . . 0.0 109.744 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.55 -155.88 7.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.75 166.11 22.84 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.81 149.31 40.14 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.993 0.815 . . . . 0.0 109.457 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.01 124.45 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.066 1.844 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.62 164.7 33.21 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.525 2.816 . . . . 0.0 110.891 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.16 -12.43 27.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.475 2.116 . . . . 0.0 113.749 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.28 7.87 73.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.258 0.932 . . . . 0.0 112.879 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -140.65 170.13 16.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 130.389 3.476 . . . . 0.0 104.221 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -139.47 149.65 44.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 153.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -151.24 149.95 30.01 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.14 97.88 4.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.093 1.357 . . . . 0.0 110.113 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.2 161.8 19.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.049 1.295 . . . . 0.0 111.168 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.66 -4.13 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -161.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.22 77.21 0.09 OUTLIER Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 86.59 -31.44 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.076 2.95 . . . . 0.0 111.491 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -105.94 146.11 30.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.11 132.32 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.33 175.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.624 1.57 . . . . 0.0 108.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.68 135.51 22.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.54 -37.86 85.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 164.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -51.29 -42.46 61.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.081 1.352 . . . . 0.0 110.802 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.8 m -75.98 -15.27 60.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.614 -1.304 . . . . 0.0 112.914 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.5 -59.03 2.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.791 -1.1 . . . . 0.0 108.444 161.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -57.79 -17.27 14.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.481 1.491 . . . . 0.0 114.009 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -52.61 -41.48 63.72 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.665 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -142.26 -37.54 0.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.831 0.852 . . . . 0.0 112.688 -171.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 94' ' ' VAL . . . -77.98 51.02 0.92 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.159 1.784 . . . . 0.0 109.373 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.03 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.894 2.477 . . . . 0.0 105.698 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.55 -35.7 37.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.817 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 91' ' ' ALA . 22.5 m -62.28 -21.08 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.883 1.219 . . . . 0.0 113.303 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.11 -33.86 68.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.197 0.453 . . . . 0.0 109.781 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.42 107.02 3.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.786 -1.196 . . . . 0.0 111.545 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 159.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 122.241 1.019 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -84.28 162.79 19.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.099 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.06 154.95 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.31 149.85 52.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.254 1.022 . . . . 0.0 108.698 163.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.68 122.55 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 123.17 0.588 . . . . 0.0 109.423 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.02 84.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -171.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -74.09 171.15 14.05 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.39 -1.444 . . . . 0.0 109.785 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 34.33 69.23 0.16 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.882 3.273 . . . . 0.0 114.301 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.424 HG23 HD23 ' A' ' 153' ' ' LEU . 19.7 mt -89.27 91.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.41 -81.05 0.04 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 118.473 0.579 . . . . 0.0 112.032 -170.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -53.4 -35.43 60.36 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.614 1.166 . . . . 0.0 113.06 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -3.43 16.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.963 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -39.44 -52.43 2.1 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 121.514 1.961 . . . . 0.0 112.389 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -45.3 95.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.524 0.73 . . . . 0.0 111.375 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.49 -9.65 55.78 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.23 2.212 . . . . 0.0 113.6 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.5 m -55.64 109.87 0.63 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.351 1.46 . . . . 0.0 112.017 -164.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -120.35 -83.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.491 0.587 . . . . 0.0 111.189 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.57 -19.66 63.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.886 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -74.26 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.765 2.026 . . . . 0.0 110.339 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.8 mp -33.99 -58.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-N 120.169 1.35 . . . . 0.0 112.737 170.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.92 -58.04 10.16 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.354 0.979 . . . . 0.0 111.911 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.01 91.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.002 0.814 . . . . 0.0 109.513 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 157' ' ' ILE . 41.1 t -55.97 -50.91 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.432 1.493 . . . . 0.0 109.247 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -65.3 -28.97 69.69 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.729 -1.232 . . . . 0.0 112.563 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -54.18 -58.53 7.01 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 m -60.51 -38.51 84.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.128 2.571 . . . . 0.0 112.453 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.33 -33.83 75.46 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.88 0.472 . . . . 0.0 110.285 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.4 -8.11 58.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.849 0.46 . . . . 0.0 111.231 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 m -89.97 133.72 33.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.5 -37.15 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.275 2.65 . . . . 0.0 112.76 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -48.52 80.64 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -63.49 153.67 34.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.157 1.783 . . . . 0.0 111.497 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.8 mt -139.29 106.28 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.6 mm -65.43 147.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -144.32 94.49 2.58 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.909 2.083 . . . . 0.0 106.581 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.68 173.97 19.95 Favored Glycine 0 N--CA 1.465 0.628 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.455 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.533 HG21 ' HD3' ' A' ' 14' ' ' LYS . 29.2 m -131.36 98.87 4.66 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.632 1.216 . . . . 0.0 112.52 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.6 pt -80.15 140.81 53.42 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.827 -1.17 . . . . 0.0 111.375 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.8 137.9 43.16 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.044 1.83 . . . . 0.0 108.435 166.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.89 134.45 95.92 Favored Pre-proline 0 N--CA 1.444 -0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.166 -166.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.78 129.92 19.58 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.818 2.345 . . . . 0.0 108.958 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.95 -61.24 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.731 1.213 . . . . 0.0 108.426 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.88 -126.91 0.74 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 157.03 90.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.569 0.685 . . . . 0.0 111.313 -170.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.63 103.2 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.785 2.323 . . . . 0.0 108.711 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.04 124.46 21.67 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.682 -0.636 . . . . 0.0 110.131 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.53 -59.82 4.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.166 1.386 . . . . 0.0 113.3 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 114' ' ' ILE . 65.0 tp -63.5 -30.59 71.68 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.478 -1.389 . . . . 0.0 111.259 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.16 -44.24 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 121.297 -0.877 . . . . 0.0 108.888 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.01 -37.66 66.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.988 1.715 . . . . 0.0 110.829 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -57.85 -28.61 64.29 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.659 0.663 . . . . 0.0 112.344 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.512 HG21 ' CE1' ' A' ' 5' ' ' PHE . 9.2 mt -107.56 -32.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.602 1.161 . . . . 0.0 109.975 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -32.99 72.25 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.033 -1.042 . . . . 0.0 109.166 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.28 -6.45 23.97 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -76.53 -39.65 52.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 120.884 1.674 . . . . 0.0 110.057 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? 62.2 -23.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.121 2.169 . . . . 0.0 114.648 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.59 -28.7 69.54 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.288 1.435 . . . . 0.0 111.997 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 3' ' ' HIS . 27.7 m -55.36 135.82 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.451 1.5 . . . . 0.0 110.566 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.74 145.63 54.55 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 168.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.23 89.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 180' ' ' ILE . 30.7 m-85 -79.2 104.75 10.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.786 0.835 . . . . 0.0 109.087 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.65 105.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.429 HG23 HD22 ' A' ' 176' ' ' LEU . 0.7 OUTLIER -59.91 155.84 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 164.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.3 p -134.83 162.59 31.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 154.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.76 -14.64 61.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.494 165.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.62 -54.27 4.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -101.92 10.69 39.53 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.288 1.435 . . . . 0.0 110.746 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 ptt85 -29.71 -65.16 0.11 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.034 2.134 . . . . 0.0 111.612 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -80.3 3.45 20.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -169.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -105.18 -6.97 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.099 2.16 . . . . 0.0 111.033 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 168' ' ' VAL . 6.8 tp -81.15 -45.77 15.91 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 119.189 0.904 . . . . 0.0 110.65 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.8 tp -32.51 -61.91 0.31 Allowed Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.716 2.006 . . . . 0.0 109.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.14 -28.63 28.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 122.438 1.906 . . . . 0.0 114.94 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -68.14 -35.07 77.5 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.872 1.215 . . . . 0.0 109.847 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.51 HG12 ' CD2' ' A' ' 166' ' ' PHE . 12.0 mt -65.34 -46.34 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.835 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.89 -45.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 119.349 0.977 . . . . 0.0 108.761 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.0 m -58.53 -51.09 71.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.623 0.769 . . . . 0.0 111.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.15 -31.32 69.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.229 1.377 . . . . 0.0 112.106 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.65 -62.03 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -70.14 -18.23 63.22 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -19.06 56.32 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 119.457 1.026 . . . . 0.0 111.56 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 120.633 1.56 . . . . 0.0 111.978 175.048 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -46.39 137.96 6.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 0.0 110.511 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.33 143.2 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.927 0.891 . . . . 0.0 109.536 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -141.54 146.94 36.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.953 1.701 . . . . 0.0 108.637 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -104.69 157.31 17.27 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.648 1.113 . . . . 0.0 111.287 173.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -149.73 177.22 9.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.45 1.1 . . . . 0.0 109.092 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.28 -176.41 19.62 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.136 1.35 . . . . 0.0 112.701 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.65 166.05 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.476 3.451 . . . . 0.0 110.751 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.58 93.91 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.435 2.09 . . . . 0.0 111.054 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.18 -34.99 15.97 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.493 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.55 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.17 2.588 . . . . 0.0 110.063 -153.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.4 17.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.826 -1.541 . . . . 0.0 113.833 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -94.17 -55.82 3.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.531 1.665 . . . . 0.0 110.731 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.0 m -51.8 -41.54 61.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.329 1.851 . . . . 0.0 109.724 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -58.04 -41.7 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 113.73 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -48.28 61.24 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.1 mm -57.71 -41.55 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -56.0 -55.95 26.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.509 -0.745 . . . . 0.0 110.214 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -59.48 -31.78 69.65 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.137 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -50.96 -44.28 60.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.915 0.78 . . . . 0.0 109.947 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 m -58.54 -47.29 84.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.89 -23.47 63.25 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.794 2.038 . . . . 0.0 111.73 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.4 t -83.71 -48.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.382 1.873 . . . . 0.0 109.362 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.06 -44.72 87.62 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -60.77 -43.44 98.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.882 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -62.09 -26.58 68.37 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.918 0.781 . . . . 0.0 112.279 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 t -88.69 1.7 54.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.898 1.679 . . . . 0.0 112.271 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.4 11.31 85.62 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.971 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.25 118.3 70.87 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.885 1.843 . . . . 0.0 106.979 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.39 123.19 11.98 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.909 1.739 . . . . 0.0 110.647 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.16 160.64 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.82 177.53 8.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 159.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 110' ' ' VAL . . . 141.04 -163.82 26.59 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 119.579 -1.951 . . . . 0.0 113.199 166.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -151.03 155.19 38.5 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.234 1.016 . . . . 0.0 110.325 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -118.72 -179.01 3.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.4 m -161.86 94.71 0.95 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -164.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.42 156.68 17.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -68.25 109.39 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.17 109.33 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -119.29 104.74 10.66 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.932 2.093 . . . . 0.0 107.443 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -91.84 102.47 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.26 50.68 7.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.183 0.897 . . . . 0.0 113.558 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.88 -6.88 57.69 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.419 1.485 . . . . 0.0 114.925 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.43 122.05 23.96 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.061 1.931 . . . . 0.0 107.506 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 123.84 23.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 159.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -10.63 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.789 0.836 . . . . 0.0 112.729 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.13 -164.11 35.26 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -139.44 143.09 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.66 145.6 41.83 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.62 154.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.03 123.37 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.5 p -72.48 179.25 3.58 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.563 -1.336 . . . . 0.0 109.927 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.51 HD21 ' CG1' ' A' ' 110' ' ' VAL . 1.2 mm? -88.3 -13.68 40.21 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.299 -0.875 . . . . 0.0 111.492 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 t -70.83 -50.41 35.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 49.43 0.1 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -144.82 147.49 32.92 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.641 1.976 . . . . 0.0 107.592 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.77 161.41 20.17 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 128.494 2.717 . . . . 0.0 108.999 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -143.12 134.42 5.93 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.841 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.48 61.94 2.8 Favored 'Trans proline' 0 CA--C 1.55 1.284 1 C-N-CA 126.371 4.714 . . . . 0.0 114.053 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.3 -63.02 1.2 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.57 1.948 . . . . 0.0 111.581 -169.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 p -130.11 136.5 49.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.306 0.957 . . . . 0.0 108.872 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -148.94 169.34 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.434 1.494 . . . . 0.0 107.889 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.461 HG12 HE21 ' A' ' 79' ' ' GLN . 3.3 m -56.32 152.34 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.679 1.191 . . . . 0.0 109.884 172.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.49 46.87 0.07 OUTLIER Glycine 0 C--N 1.333 0.403 0 CA-C-O 119.335 -0.703 . . . . 0.0 111.612 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.0 -169.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.971 1.708 . . . . 0.0 111.7 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.58 147.53 43.87 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 110.871 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -69.73 123.83 10.5 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.728 2.286 . . . . 0.0 107.971 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.24 170.49 19.47 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.627 2.885 . . . . 0.0 110.853 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.48 -9.75 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.28 1.987 . . . . 0.0 114.196 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.47 -12.49 51.0 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.535 -1.147 . . . . 0.0 114.291 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 138.1 36.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.34 2.07 . . . . 0.0 108.138 -168.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -119.07 122.32 41.84 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.104 0.562 . . . . 0.0 110.0 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 172.25 13.67 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 126.026 1.731 . . . . 0.0 107.655 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 95.3 m -68.4 147.81 51.55 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.815 -0.553 . . . . 0.0 109.725 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -153.29 143.83 22.57 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.528 -0.732 . . . . 0.0 109.472 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.766 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.37 1.06 0.15 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 127.437 2.446 . . . . 0.0 117.596 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.461 HE21 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER 177.04 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.225 2.21 . . . . 0.0 106.713 -175.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -80.57 166.64 20.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.339 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -110.61 133.59 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.8 166.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -139.39 105.17 5.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.6 -24.23 63.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.322 -0.861 . . . . 0.0 111.592 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -34.4 77.99 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.624 171.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -57.42 -48.45 79.09 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 119.989 1.268 . . . . 0.0 109.941 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -56.04 -50.62 70.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -19.67 66.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.057 0.844 . . . . 0.0 112.439 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.66 ' HB2' HD23 ' A' ' 90' ' ' LEU . 19.5 mt-30 -66.36 -45.25 80.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.721 1.146 . . . . 0.0 112.059 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -123.35 -39.86 2.42 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.59 51.18 2.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.072 1.749 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 -60.35 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 125.721 1.608 . . . . 0.0 108.0 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -38.36 42.37 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.607 1.538 . . . . 0.0 112.043 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -36.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 123.909 0.883 . . . . 0.0 110.591 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.148 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 108.26 0.13 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.983 1.713 . . . . 0.0 106.764 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 C--N 1.322 -0.63 0 C-N-CA 125.142 1.377 . . . . 0.0 108.129 163.242 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.379 0.609 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -89.0 97.21 11.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 126.613 1.965 . . . . 0.0 110.019 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.9 t -74.97 94.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 121.656 2.026 . . . . 0.0 107.577 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.5 m -72.24 165.24 24.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.51 ' CG1' HD21 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -144.61 139.67 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.576 -177.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mt -152.22 103.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.651 1.219 . . . . 0.0 108.501 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -105.69 -169.61 1.61 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 42.75 48.75 4.91 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.014 2.526 . . . . 0.0 112.163 -168.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.71 110.56 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.13 -63.97 0.32 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-O 117.554 -1.692 . . . . 0.0 112.493 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -24.15 65.92 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.913 2.357 . . . . 0.0 110.44 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.3 mmt -69.02 -10.39 57.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 116.671 -1.633 . . . . 0.0 113.404 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -24.63 -68.42 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.535 2.334 . . . . 0.0 114.593 -171.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -45.96 63.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 0.0 111.361 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.66 -27.99 66.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.615 1.166 . . . . 0.0 112.181 -170.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.4 t -41.64 114.01 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 129.222 3.009 . . . . 0.0 111.715 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -127.44 -87.71 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.412 0.551 . . . . 0.0 111.465 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.6 -16.8 61.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.793 0.724 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.99 -68.02 0.22 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.839 2.055 . . . . 0.0 111.168 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -36.83 -57.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.628 1.571 . . . . 0.0 112.148 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.9 -54.49 41.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.308 0.643 . . . . 0.0 111.025 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.82 99.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 124.148 0.905 . . . . 0.0 109.299 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.13 -47.15 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.227 1.411 . . . . 0.0 109.538 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.41 -44.6 96.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.203 1.365 . . . . 0.0 111.265 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -57.62 -38.71 75.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.153 0.888 . . . . 0.0 110.435 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 137' ' ' THR . 63.4 m -74.24 -38.99 63.35 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.364 -0.835 . . . . 0.0 112.103 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.2 mt -61.06 -35.76 77.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.21 1.368 . . . . 0.0 109.932 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.8 t -71.94 -22.05 61.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.221 1.808 . . . . 0.0 110.605 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 137' ' ' THR . 96.3 m -76.26 134.0 71.05 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.03 -42.71 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.032 2.488 . . . . 0.0 112.319 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.35 -2.75 63.59 Favored Glycine 0 C--O 1.216 -0.97 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.384 -168.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.534 HG21 ' CG2' ' A' ' 131' ' ' THR . 21.9 m -80.48 160.84 25.14 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.965 2.382 . . . . 0.0 106.139 154.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.6 mt -122.92 138.37 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.72 136.99 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' CG2' ' A' ' 180' ' ' ILE . 10.5 tp -140.07 113.45 8.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.92 32.89 Favored Glycine 0 N--CA 1.462 0.412 0 C-N-CA 119.287 -1.435 . . . . 0.0 114.656 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.0 m -137.11 133.4 35.29 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.93 147.61 66.24 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.821 1.648 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.71 148.92 59.96 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 111.167 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.34 131.55 86.6 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.241 0.617 . . . . 0.0 110.083 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.69 108.82 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.402 2.735 . . . . 0.0 108.443 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -64.75 0.79 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -112.27 -109.47 3.02 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 166.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 149.69 98.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 118.72 1.26 . . . . 0.0 111.966 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.55 -164.9 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.37 1 C-N-CA 125.966 4.444 . . . . 0.0 112.247 164.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.79 168.25 10.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.601 1.96 . . . . 0.0 109.183 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.29 -67.07 0.31 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.037 2.535 . . . . 0.0 113.287 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.4 tm? -59.48 -46.32 89.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.56 -35.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.36 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.07 -28.11 68.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.869 1.668 . . . . 0.0 112.086 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.52 -34.74 77.51 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.769 0.713 . . . . 0.0 110.007 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.32 -39.09 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.3 1.44 . . . . 0.0 109.564 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.66 -26.68 65.44 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.426 -1.422 . . . . 0.0 111.105 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -59.32 -37.58 78.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.315 0.646 . . . . 0.0 111.44 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -61.58 -36.78 81.64 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.908 0.883 . . . . 0.0 112.019 -167.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -40.24 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.971 2.908 . . . . 0.0 115.676 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -59.93 -28.9 68.01 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.189 1.359 . . . . 0.0 110.626 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.0 m -50.36 108.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.503 1.521 . . . . 0.0 109.28 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -65.69 123.21 19.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 m -111.94 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 C-N-CA 124.683 1.193 . . . . 0.0 108.778 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -72.12 118.83 15.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.142 0.977 . . . . 0.0 110.538 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.61 97.81 5.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.789 1.235 . . . . 0.0 110.631 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.427 HG23 HD12 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -67.86 132.79 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 p -94.93 151.22 19.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 158.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -57.85 -29.8 65.28 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.064 -0.397 . . . . 0.0 110.389 165.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.07 -53.87 15.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 110.848 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.82 23.06 13.41 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.025 -1.047 . . . . 0.0 110.91 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -47.26 -44.55 23.11 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.448 1.099 . . . . 0.0 112.464 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.27 3.56 8.68 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -118.29 62.54 0.77 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 168' ' ' VAL . 0.5 OUTLIER -140.25 -39.79 0.44 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.37 160.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tp -40.03 -58.37 2.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 117.625 -1.179 . . . . 0.0 110.355 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.84 -28.24 51.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.436 1.424 . . . . 0.0 113.386 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.24 -38.26 68.96 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.282 -0.886 . . . . 0.0 109.219 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.595 HD11 HD11 ' A' ' 6' ' ' LEU . 14.4 mt -66.89 -47.34 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.488 1.515 . . . . 0.0 107.974 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 92.2 t -56.04 -43.99 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.225 0.92 . . . . 0.0 109.171 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.0 m -57.97 -47.81 81.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.962 1.305 . . . . 0.0 109.129 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.45 -37.78 88.73 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.731 -0.606 . . . . 0.0 111.693 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.64 -55.52 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.911 0.778 . . . . 0.0 109.428 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -28.32 69.69 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.034 -174.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.51 -50.85 0.34 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.235 2.214 . . . . 0.0 111.637 -176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 125.594 1.557 . . . . 0.0 107.814 -175.525 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.227 -0.099 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.507 ' HB2' HG12 ' A' ' 163' ' ' VAL . 48.7 m-70 -92.88 159.5 15.33 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.375 1.87 . . . . 0.0 109.282 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.65 148.41 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 19.9 m-85 -144.11 158.02 43.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.909 1.684 . . . . 0.0 109.537 172.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.916 HD11 HD11 ' A' ' 180' ' ' ILE . 4.2 mm? -109.38 135.3 50.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.83 -172.5 3.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.82 -172.31 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.265 -0.897 . . . . 0.0 111.295 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.44 163.34 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.19 2.593 . . . . 0.0 113.611 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.82 72.05 6.29 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.804 3.67 . . . . 0.0 111.736 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.18 25.14 21.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 124.411 1.005 . . . . 0.0 112.494 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m 42.51 35.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.513 2.725 . . . . 0.0 116.308 161.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.87 9.91 3.1 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.514 1.531 . . . . 0.0 112.184 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -75.19 -49.87 18.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 109.956 -168.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -57.66 -35.25 70.31 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.391 0.676 . . . . 0.0 109.71 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.5 m -63.49 -38.78 92.46 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.284 -0.885 . . . . 0.0 112.45 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -49.55 57.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.89 1.223 . . . . 0.0 108.593 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.689 HD11 HD23 ' A' ' 6' ' ' LEU . 5.8 mm -58.08 -40.94 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.562 0.619 . . . . 0.0 111.045 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -50.28 -45.84 54.7 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.317 0.962 . . . . 0.0 110.067 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -70.05 -20.04 63.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.23 0.612 . . . . 0.0 112.207 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.328 0.967 . . . . 0.0 110.627 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -81.51 -42.8 19.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.02 -39.22 68.89 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.103 0.561 . . . . 0.0 111.211 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.21 -51.24 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.334 1.053 . . . . 0.0 110.291 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 61.3 mt -63.25 -35.5 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.33 -38.33 89.79 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.074 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -4.8 14.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.495 1.118 . . . . 0.0 112.912 172.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 m -109.61 -5.08 15.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.701 1.6 . . . . 0.0 111.638 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.72 18.46 74.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.015 1.293 . . . . 0.0 112.981 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 24.7 t -64.71 133.76 95.82 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.665 1.733 . . . . 0.0 107.131 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.22 95.22 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.575 2.183 . . . . 0.0 110.072 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.56 136.73 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.78 173.79 11.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.604 2.362 . . . . 0.0 105.883 169.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.98 -156.79 26.15 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -142.06 166.02 25.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.912 1.356 . . . . 0.0 111.434 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -142.14 179.62 6.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.4 p -134.98 136.67 42.38 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.91 27.17 4.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.278 6.8 pm0 49.81 -178.71 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.357 2.263 . . . . 0.0 112.79 -164.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.81 119.56 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -129.27 106.47 8.84 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 70.63 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.58 75.51 0.51 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -161.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.19 -40.21 2.68 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 148.47 42.38 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.719 1.76 . . . . 0.0 111.135 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -69.81 132.24 45.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 162.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.55 -27.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.72 -174.05 41.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 119.608 1.095 . . . . 0.0 110.677 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CZ ' ' HE2' ' A' ' 116' ' ' LYS . 25.1 m-85 -126.53 153.25 45.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 160.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -117.97 162.42 18.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 167.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 90' ' ' LEU . 2.1 p -114.97 145.35 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.907 1.683 . . . . 0.0 107.923 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.2 108.95 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 120.55 1.523 . . . . 0.0 109.858 -167.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.483 HG23 HD12 ' A' ' 90' ' ' LEU . 76.1 p -69.61 145.05 52.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.31 -5.74 30.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -84.68 7.53 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.549 1.068 . . . . 0.0 111.32 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.67 3.41 83.75 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.223 -1.548 . . . . 0.0 114.984 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 m -80.83 166.08 21.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.783 1.291 . . . . 0.0 109.358 163.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -146.39 169.78 18.16 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -150.42 -176.23 23.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.722 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -108.93 14.41 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.116 1.21 . . . . 0.0 114.284 -144.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mt 23.61 -74.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 130.898 3.679 . . . . 0.0 116.446 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -147.83 159.93 43.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 165.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -143.58 53.12 1.32 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.845 2.058 . . . . 0.0 110.652 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 64.99 160.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.663 1.985 . . . . 0.0 111.554 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.51 150.96 11.9 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.73 150.86 26.68 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.756 1.222 . . . . 0.0 108.67 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.4 156.37 30.99 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 109.603 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.74 132.21 24.5 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.182 1.921 . . . . 0.0 110.102 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.72 155.03 59.16 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.696 2.931 . . . . 0.0 110.068 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.44 111.53 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.087 2.525 . . . . 0.0 109.823 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.64 -60.43 0.67 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 142.33 52.95 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -147.26 146.04 29.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -160.35 -175.34 4.98 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.736 0.647 . . . . 0.0 112.616 -165.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.0 m -60.67 101.7 0.15 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.779 2.032 . . . . 0.0 110.752 171.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -142.14 119.61 11.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.57 -89.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.38 -47.78 0.25 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.772 1.169 . . . . 0.0 112.013 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -144.58 4.05 1.15 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.355 . . . . 0.0 111.436 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.44 139.11 51.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.268 1.027 . . . . 0.0 108.379 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.63 88.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.2 174.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -147.56 133.17 18.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.306 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.57 -35.42 74.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.356 -0.84 . . . . 0.0 109.595 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.3 m -55.24 -43.81 74.94 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 110.923 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.5 p -63.58 -29.5 70.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.401 1.455 . . . . 0.0 110.659 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -69.4 -53.2 20.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.824 1.25 . . . . 0.0 110.477 167.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -47.47 -35.03 8.09 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.193 0.997 . . . . 0.0 112.157 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 10.9 mt-30 -58.55 -32.11 68.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -144.97 -36.21 0.31 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -171.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.78 31.57 0.53 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.504 2.322 . . . . 0.0 111.447 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -124.65 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 126.751 2.02 . . . . 0.0 108.41 178.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 30.2 Cg_endo -61.41 -27.03 82.12 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 121.428 1.546 . . . . 0.0 113.225 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.74 -26.46 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.245 0.93 . . . . 0.0 113.328 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 127' ' ' ALA . 1.2 mm? -73.14 -23.92 60.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.335 0.97 . . . . 0.0 111.369 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -165.65 116.53 1.07 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 120.289 1.404 . . . . 0.0 108.192 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.148 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 122.489 1.137 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -91.59 173.01 8.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.67 2.788 . . . . 0.0 110.807 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -120.11 135.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 163.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.69 153.39 18.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -134.43 130.12 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -137.5 94.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.83 80.64 1.47 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 123.176 1.465 . . . . 0.0 112.768 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -158.31 -84.37 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 130.16 3.384 . . . . 0.0 104.989 165.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.402 HG21 HG22 ' A' ' 143' ' ' ILE 0.363 1.5 mt 52.96 -17.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 1 C-N-CA 131.829 4.051 . . . . 0.0 114.44 -174.56 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.22 6.63 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 120.975 1.716 . . . . 0.0 113.582 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 41.6 mttp -71.36 -17.58 62.42 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 118.259 -2.906 . . . . 0.0 113.663 -165.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tpp -106.87 20.99 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.501 1.521 . . . . 0.0 110.904 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.45 -20.63 7.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.825 1.65 . . . . 0.0 114.636 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.39 -31.28 2.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.259 1.824 . . . . 0.0 110.677 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.02 -4.23 58.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.191 -0.943 . . . . 0.0 113.173 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.26 139.47 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.208 3.003 . . . . 0.0 110.347 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -40.08 0.27 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -100.71 -22.12 15.0 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.773 -1.108 . . . . 0.0 110.731 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -63.57 0.9 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.122 1.769 . . . . 0.0 110.508 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' H ' ' A' ' 125' ' ' ILE . 2.8 mp -33.01 -59.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.76 2.024 . . . . 0.0 113.096 170.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -68.85 -55.28 11.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.781 1.232 . . . . 0.0 108.191 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 95' ' ' LEU . . . -62.45 -34.49 76.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.443 0.697 . . . . 0.0 111.163 -172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.03 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.068 1.347 . . . . 0.0 107.663 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -57.75 -36.66 72.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.369 -171.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -54.66 -61.83 2.05 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.516 1.053 . . . . 0.0 109.08 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.4 m -78.64 -13.88 59.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.052 0.941 . . . . 0.0 113.205 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.52 -18.02 63.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.574 1.079 . . . . 0.0 110.321 166.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -132.46 32.36 3.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.285 1.434 . . . . 0.0 108.983 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.77 134.84 53.0 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.27 107.01 2.36 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.861 3.041 . . . . 0.0 107.885 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.34 34.57 3.87 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.931 -1.483 . . . . 0.0 114.747 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.9 m -136.23 171.19 14.84 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 161.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.3 mt -141.09 106.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.15 135.88 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 119.028 0.831 . . . . 0.0 110.241 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.5 tp -132.7 148.81 52.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.205 2.202 . . . . 0.0 106.605 159.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.36 -171.92 44.94 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 119.198 0.908 . . . . 0.0 112.26 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -118.59 154.83 31.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.9 0.85 . . . . 0.0 111.458 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.402 HG22 HG21 ' A' ' 114' ' ' ILE . 8.7 pt -136.61 125.38 15.27 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.398 2.279 . . . . 0.0 108.223 170.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.08 150.11 87.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.59 1.527 . . . . 0.0 110.55 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.97 130.06 64.97 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.28 -51.4 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.53 2.82 . . . . 0.0 110.457 -165.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 40.51 55.97 2.8 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.999 1.72 . . . . 0.0 110.982 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 157.6 -153.02 24.28 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 126.897 2.189 . . . . 0.0 107.648 -159.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.6 OUTLIER -63.93 166.85 8.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.092 0.446 . . . . 0.0 110.237 172.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.65 168.69 22.97 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.563 1.509 . . . . 0.0 109.182 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.75 176.81 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.772 2.029 . . . . 0.0 106.259 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.17 -79.15 0.37 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.3 tp -51.02 -44.07 60.97 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.984 1.313 . . . . 0.0 112.255 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.06 -31.16 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.265 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.75 -34.24 75.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.327 1.422 . . . . 0.0 109.805 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.11 -43.8 87.36 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.262 0.937 . . . . 0.0 111.271 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.6 mp -80.57 -39.56 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.029 0.532 . . . . 0.0 109.834 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -60.78 -32.4 71.73 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.508 -1.37 . . . . 0.0 110.338 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -74.23 8.43 2.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.513 1.525 . . . . 0.0 113.501 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -34.74 10.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.556 1.526 . . . . 0.0 111.62 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 63.1 -19.67 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 128.602 2.761 . . . . 0.0 115.339 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -72.6 -30.67 64.57 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.639 3.175 . . . . 0.0 111.615 168.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' A' ' 3' ' ' HIS . 29.5 m -54.18 125.13 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.108 1.763 . . . . 0.0 107.618 169.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.35 112.17 5.06 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -97.93 96.13 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 120.856 1.662 . . . . 0.0 106.575 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.3 m-85 -69.52 98.25 1.11 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.037 0.935 . . . . 0.0 108.743 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.17 99.49 0.9 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.85 165.82 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.92 . . . . 0.0 109.192 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.7 p -138.68 156.38 47.47 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.836 1.303 . . . . 0.0 108.288 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -42.27 -31.64 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.867 156.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -80.29 -55.8 4.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.469 0.577 . . . . 0.0 109.79 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -119.95 16.66 12.56 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.876 0.87 . . . . 0.0 110.288 -160.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -39.71 -63.06 0.62 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.791 2.036 . . . . 0.0 111.155 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -70.56 8.48 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 113.704 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.48 15.92 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.405 2.282 . . . . 0.0 110.201 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -32.04 10.36 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.632 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -37.98 -55.99 2.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.489 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.52 -23.27 57.76 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.335 1.512 . . . . 0.0 114.59 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -80.26 -38.54 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.454 1.501 . . . . 0.0 110.425 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.916 HD11 HD11 ' A' ' 6' ' ' LEU . 7.6 mt -59.74 -52.14 64.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.359 -0.838 . . . . 0.0 108.863 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.74 -43.77 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.149 0.98 . . . . 0.0 109.41 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.7 m -59.06 -43.65 91.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.114 0.87 . . . . 0.0 111.032 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.0 -48.13 81.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.104 0.562 . . . . 0.0 109.676 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.43 -52.45 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.301 1.04 . . . . 0.0 109.893 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -69.46 -5.94 27.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.8 t -64.34 -71.2 0.18 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 128.276 2.63 . . . . 0.0 116.013 -164.249 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 23.43 91.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.092 2.157 . . . . 0.0 111.342 141.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.71 124.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -165.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -117.86 161.01 20.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 110.378 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 18' ' ' ILE . 45.7 mt -124.84 154.57 40.82 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.203 1.401 . . . . 0.0 109.823 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -158.11 169.72 23.91 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.69 63.09 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 128.668 3.033 . . . . 0.0 111.874 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -54.21 118.49 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.468 3.445 . . . . 0.0 111.455 -166.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.24 -81.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.301 2.001 . . . . 0.0 114.451 -163.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.6 37.71 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t 50.99 68.77 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.919 1.688 . . . . 0.0 110.254 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.92 23.35 1.45 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.605 1.098 . . . . 0.0 111.039 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 142' ' ' THR . 2.0 pttm -83.91 -31.55 25.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.911 -0.758 . . . . 0.0 111.901 -170.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -59.79 -38.16 81.1 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -56.99 -35.08 68.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 112.553 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -33.73 70.33 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 HD11 HD11 ' A' ' 6' ' ' LEU . 4.4 mm -77.16 -31.07 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.6 1.091 . . . . 0.0 109.984 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -54.33 -51.42 64.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.706 1.593 . . . . 0.0 107.507 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -66.13 -15.18 62.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.7 -1.137 . . . . 0.0 112.374 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.2 64.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.45 1.023 . . . . 0.0 111.137 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -78.25 -48.35 15.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.284 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -50.34 -40.76 50.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.162 0.585 . . . . 0.0 111.172 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.65 -61.37 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 123.955 0.902 . . . . 0.0 109.486 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -55.48 -42.3 74.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 123.232 0.613 . . . . 0.0 109.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -60.39 -47.99 83.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -59.93 -42.05 93.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.168 0.987 . . . . 0.0 109.921 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -71.97 -7.28 47.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.593 1.557 . . . . 0.0 113.417 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.07 9.96 60.2 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.637 -1.09 . . . . 0.0 113.153 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.5 t -99.77 105.86 36.99 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.43 97.16 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.403 2.736 . . . . 0.0 110.948 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.59 147.27 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.686 1.194 . . . . 0.0 108.637 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -137.99 170.41 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.072 150.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.95 -162.58 28.1 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.227 0.917 . . . . 0.0 111.08 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -140.4 162.71 34.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.869 0.843 . . . . 0.0 111.128 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.2 157.83 45.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.932 1.293 . . . . 0.0 107.558 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.9 100.79 11.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -79.13 159.31 27.51 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.959 1.361 . . . . 0.0 109.086 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.17 99.78 8.73 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.348 169.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 47' ' ' ILE . 7.6 p -58.71 107.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.828 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -108.96 103.1 12.08 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 120.917 -1.115 . . . . 0.0 109.348 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.639 ' HB2' HD13 ' A' ' 47' ' ' ILE . 23.7 tp60 -64.84 -37.86 89.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.786 0.721 . . . . 0.0 110.713 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.3 63.58 0.11 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.88 15.15 68.84 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.87 -1.517 . . . . 0.0 115.805 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 140.81 52.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.835 1.817 . . . . 0.0 107.075 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -78.12 98.23 5.72 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 42' ' ' GLN . 35.2 pt -78.18 -12.94 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 121.39 -0.819 . . . . 0.0 111.995 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.95 -126.96 1.3 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 165.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -132.93 158.82 41.65 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.33 134.03 35.58 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.522 1.129 . . . . 0.0 109.715 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.6 101.97 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -167.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -90.03 132.76 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.3 p -95.96 156.26 16.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.2 8.99 3.4 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.291 -0.881 . . . . 0.0 112.541 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 t -109.89 4.34 21.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.996 1.319 . . . . 0.0 111.51 161.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.2 3.45 65.3 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.367 -1.458 . . . . 0.0 114.768 161.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -71.84 148.84 45.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.538 1.669 . . . . 0.0 107.194 162.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -139.32 131.79 28.62 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.926 1.29 . . . . 0.0 108.462 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -118.99 174.08 15.2 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.731 1.15 . . . . 0.0 113.861 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.75 165.18 21.69 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.609 1.539 . . . . 0.0 108.631 162.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 tp -140.74 -70.18 0.38 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.9 p -134.49 158.07 44.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.071 0.857 . . . . 0.0 108.927 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -147.43 157.64 43.66 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.535 1.134 . . . . 0.0 110.137 169.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 t -62.14 137.1 24.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 109.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.51 165.4 30.94 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.82 153.78 7.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.734 0.814 . . . . 0.0 109.504 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.12 163.99 56.62 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.669 0.388 . . . . 0.0 111.297 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -83.58 140.52 9.45 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.001 2.467 . . . . 0.0 110.739 -170.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.43 164.26 26.47 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.691 2.26 . . . . 0.0 110.524 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.63 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.841 2.361 . . . . 0.0 113.056 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.54 10.34 26.02 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.173 1.844 . . . . 0.0 113.114 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.63 165.67 26.33 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.951 1.875 . . . . 0.0 109.025 169.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.8 157.85 42.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.201 0.601 . . . . 0.0 110.275 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -166.92 -170.11 1.47 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 128.502 2.721 . . . . 0.0 105.95 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 92.6 m -98.02 126.73 43.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 139.7 33.19 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.884 -1.135 . . . . 0.0 108.718 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.2 92.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.871 1.669 . . . . 0.0 107.604 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.12 -73.93 1.92 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.37 0.986 . . . . 0.0 112.308 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.22 -25.65 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.439 1.495 . . . . 0.0 110.768 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.29 118.63 25.86 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.31 131.1 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 162.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.44 178.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 125.273 1.429 . . . . 0.0 108.745 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -147.28 155.53 42.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.46 161.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.79 -28.92 36.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.642 0.777 . . . . 0.0 110.448 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 m -64.28 -36.87 85.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.683 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.9 m -60.45 -31.74 70.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.591 1.087 . . . . 0.0 110.931 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -71.86 -53.9 11.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.518 167.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.05 -23.87 22.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.327 1.051 . . . . 0.0 113.488 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -42.54 -53.4 4.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.197 1.799 . . . . 0.0 112.04 167.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.714 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.12 -31.88 0.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.369 1.068 . . . . 0.0 112.63 -167.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.38 52.52 2.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.653 1.181 . . . . 0.0 108.664 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.417 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -146.47 -57.49 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 126.197 1.799 . . . . 0.0 109.606 -176.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 72.6 Cg_endo -71.47 -37.18 5.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.834 1.689 . . . . 0.0 112.122 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 m -56.04 -35.73 42.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.935 0.894 . . . . 0.0 112.304 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -63.33 -38.29 90.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.54 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -129.5 76.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.823 1.249 . . . . 0.0 109.6 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 124.903 1.281 . . . . 0.0 111.388 -172.65 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 . . . . . 0 C--O 1.238 0.452 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 179.21 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.17 139.26 51.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 167.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.1 158.11 34.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.491 1.116 . . . . 0.0 108.461 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.7 t -142.19 127.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.411 1.085 . . . . 0.0 109.919 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CG2' HD11 ' A' ' 114' ' ' ILE . 8.9 mt -149.48 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 125.659 1.583 . . . . 0.0 107.736 -167.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -79.77 174.65 11.37 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.347 -1.471 . . . . 0.0 112.476 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 57.02 20.12 5.19 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.109 2.564 . . . . 0.0 115.036 167.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 111' ' ' ILE . 38.6 mt -55.61 125.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.512 -1.368 . . . . 0.0 108.257 174.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.52 -34.56 1.96 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.063 1.316 . . . . 0.0 111.721 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -41.94 98.98 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.658 2.229 . . . . 0.0 110.469 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -83.48 16.72 2.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.915 1.686 . . . . 0.0 112.178 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -49.53 -39.74 35.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.644 1.565 . . . . 0.0 111.518 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.12 -49.8 6.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.544 0.738 . . . . 0.0 110.346 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -67.35 -24.02 65.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -55.66 141.32 38.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.544 1.138 . . . . 0.0 112.123 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -138.07 -82.0 0.33 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.817 0.847 . . . . 0.0 109.648 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.04 -12.45 60.33 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -60.0 3.64 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 111.482 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.7 mp -35.89 -58.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 126.164 1.786 . . . . 0.0 112.338 170.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.31 -51.49 65.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.206 0.527 . . . . 0.0 110.188 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.56 83.65 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.472 -171.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.92 -46.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 121.878 -0.514 . . . . 0.0 110.148 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -52.31 -36.21 52.6 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.901 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -27.31 66.93 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 m -100.47 -31.72 11.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 116.669 -1.634 . . . . 0.0 111.49 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.74 -18.87 57.26 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.228 1.831 . . . . 0.0 111.505 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -68.33 -29.57 68.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.649 1.579 . . . . 0.0 110.082 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.6 m -63.82 142.33 98.07 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 126.435 1.894 . . . . 0.0 106.869 172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.21 16.67 0.29 Allowed 'Trans proline' 0 CA--C 1.541 0.867 1 C-N-CA 126.173 4.582 . . . . 0.0 111.608 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.79 -161.44 11.9 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -155.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.7 177.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.101 0.953 . . . . 0.0 109.808 -140.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.3 mt -137.25 103.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 1 N-CA-C 99.614 -4.217 . . . . 0.0 99.614 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 141.31 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.6 133.76 50.96 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.35 45.4 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.463 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.434 HG21 ' HE2' ' A' ' 14' ' ' LYS . 40.0 m -129.32 123.29 31.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.446 0.698 . . . . 0.0 109.177 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.67 165.46 32.93 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.945 1.698 . . . . 0.0 108.809 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.54 165.46 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.378 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.94 142.4 76.3 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.525 1.13 . . . . 0.0 108.518 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.35 104.09 1.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 121.409 1.406 . . . . 0.0 111.331 -156.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -99.44 162.04 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.479 1.112 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -24.88 -77.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 127.25 2.357 . . . . 0.0 114.967 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 138.08 22.63 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.86 164.23 35.42 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.809 1.673 . . . . 0.0 109.512 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.06 171.59 7.29 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.704 1.601 . . . . 0.0 109.31 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.53 -77.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 114.032 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 114' ' ' ILE . 1.7 tm? -59.02 -33.09 70.34 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.68 -35.54 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 O-C-N 121.149 -0.969 . . . . 0.0 110.412 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.46 -23.08 65.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.39 1.476 . . . . 0.0 111.291 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -70.67 -42.36 70.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.737 1.153 . . . . 0.0 109.542 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.07 -48.28 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.769 0.828 . . . . 0.0 109.654 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.44 -22.24 66.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 110.486 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -28.56 68.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.994 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -65.63 -34.15 77.56 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.766 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? 67.66 -57.15 0.46 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.183 2.593 . . . . 0.0 111.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.87 77.68 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.248 1.819 . . . . 0.0 107.693 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.73 135.99 48.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 128.748 2.819 . . . . 0.0 105.064 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.87 136.76 38.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 164.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.33 96.8 4.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 120.157 1.344 . . . . 0.0 107.767 170.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.451 ' HB3' HD11 ' A' ' 176' ' ' LEU . 32.4 m-85 -76.95 104.36 7.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.802 0.81 . . . . 0.0 109.039 173.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.71 106.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 160.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.14 154.05 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 167.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 22.5 p -102.88 159.93 15.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 157.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.22 -16.98 56.91 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.602 166.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -98.38 -56.77 2.37 Favored 'General case' 0 N--CA 1.458 -0.038 0 CA-C-N 118.386 0.539 . . . . 0.0 111.147 -166.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.5 17.66 5.19 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.484 1.114 . . . . 0.0 110.121 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -40.91 -46.11 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.283 1.833 . . . . 0.0 111.595 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.8 6.16 9.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 114.204 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.23 43.43 3.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.438 1.895 . . . . 0.0 109.887 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 166' ' ' PHE . 9.6 tp -118.68 -42.2 2.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.23 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.96 -55.41 6.18 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.867 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.22 -27.21 56.4 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.419 1.9 . . . . 0.0 113.398 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -72.66 -42.07 64.73 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.704 1.202 . . . . 0.0 109.804 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.76 -52.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.912 1.685 . . . . 0.0 108.486 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.55 -44.01 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.388 0.994 . . . . 0.0 109.686 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.2 m -62.03 -49.22 76.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.898 0.772 . . . . 0.0 109.703 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.4 -42.17 91.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.504 1.122 . . . . 0.0 112.151 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.51 -53.74 29.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.576 1.951 . . . . 0.0 109.529 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -68.07 -23.49 64.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.849 0.86 . . . . 0.0 111.544 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.08 -52.45 4.27 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 127.698 2.399 . . . . 0.0 112.685 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 CA--C 1.54 0.58 0 CA-C-N 120.052 1.296 . . . . 0.0 110.891 -158.764 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 163' ' ' VAL . 27.4 m-70 -64.42 146.75 54.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.934 1.694 . . . . 0.0 109.249 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -127.55 144.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD2' HG13 ' A' ' 163' ' ' VAL . 15.1 m-85 -141.38 123.05 15.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.401 0.68 . . . . 0.0 110.784 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.468 HD21 HD11 ' A' ' 180' ' ' ILE . 11.1 mt -70.4 152.5 44.01 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 t -152.93 -174.7 5.02 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.07 176.55 15.15 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.086 1.803 . . . . 0.0 111.316 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -73.98 156.02 47.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.528 2.152 . . . . 0.0 109.464 164.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 154.71 48.87 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.566 2.178 . . . . 0.0 111.103 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.96 8.51 6.38 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.315 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.274 82.2 t 66.29 120.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 127.536 2.334 . . . . 0.0 111.341 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.9 29.75 14.74 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.75 1.167 . . . . 0.0 112.586 -173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -63.77 -49.07 74.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.153 1.477 . . . . 0.0 111.838 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -45.13 -38.78 5.44 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.566 1.947 . . . . 0.0 111.221 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.3 m -49.31 -43.57 43.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.163 1.785 . . . . 0.0 111.9 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -32.79 64.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.165 1.348 . . . . 0.0 110.345 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.37 -45.13 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -50.6 72.57 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.957 1.703 . . . . 0.0 109.15 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.3 mttm -65.97 -34.4 78.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.994 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.25 60.5 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.734 1.152 . . . . 0.0 111.62 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -71.58 -48.93 45.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.354 0.662 . . . . 0.0 111.117 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.03 -33.88 69.45 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.34 1.056 . . . . 0.0 111.64 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 20' ' ' LYS . 53.0 t -58.67 -53.71 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.419 1.488 . . . . 0.0 108.431 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.53 -38.9 89.1 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.456 0.703 . . . . 0.0 109.823 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HA ' HG12 ' A' ' 30' ' ' VAL . 11.9 mttt -59.74 -43.48 94.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.911 0.778 . . . . 0.0 110.25 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -23.27 56.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.366 1.066 . . . . 0.0 111.837 169.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 m -97.72 18.08 16.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.825 2.05 . . . . 0.0 115.487 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.09 35.12 86.6 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.811 1.187 . . . . 0.0 111.435 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.4 p -71.24 158.79 87.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 120.846 -1.385 . . . . 0.0 109.884 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.23 101.7 0.63 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.588 2.859 . . . . 0.0 110.249 145.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 30' ' ' VAL . 18.6 t -105.11 149.62 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 -179.03 7.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.533 0.733 . . . . 0.0 110.085 155.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.35 -151.0 22.31 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.893 1.235 . . . . 0.0 110.034 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' CZ ' HG23 ' A' ' 111' ' ' ILE . 55.2 p90 -138.06 174.25 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.185 1.794 . . . . 0.0 109.457 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -143.6 159.49 42.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -116.15 74.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -157.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -71.89 137.97 47.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.861 0.838 . . . . 0.0 110.772 -163.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -68.95 113.77 6.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.626 1.571 . . . . 0.0 108.554 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.18 91.08 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -109.42 102.38 11.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.34 62.18 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.94 0.896 . . . . 0.0 110.168 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 66.4 1.92 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -162.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.66 -22.12 15.25 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -169.43 0.83 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.569 1.685 . . . . 0.0 110.561 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 89.79 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.685 1.584 . . . . 0.0 111.354 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.44 -10.07 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.195 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 -167.96 40.96 Favored Glycine 0 C--N 1.337 0.583 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.7 158.65 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.033 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -137.73 159.64 41.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.841 1.656 . . . . 0.0 108.288 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -100.9 100.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 121.236 1.835 . . . . 0.0 107.806 169.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -82.25 123.8 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -89.19 163.45 15.41 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.188 -0.945 . . . . 0.0 108.546 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.56 -16.63 60.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 120.637 -1.29 . . . . 0.0 112.005 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 t -63.21 -36.89 85.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.689 1.131 . . . . 0.0 108.334 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.79 6.26 17.09 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.108 0.861 . . . . 0.0 112.465 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.6 25.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.432 ' C ' HD21 ' A' ' 90' ' ' LEU . 25.5 ptt180 -144.13 135.79 25.99 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.5 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.48 135.64 12.25 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.04 67.71 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 125.129 3.886 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.588 HD21 ' CE2' ' A' ' 87' ' ' PHE . 2.6 mt -55.36 -67.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 125.317 1.447 . . . . 0.0 112.719 -164.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 p -139.7 154.85 47.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.207 1.004 . . . . 0.0 110.657 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.07 159.72 43.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.268 1.827 . . . . 0.0 106.419 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 64' ' ' VAL . 3.8 m -54.9 160.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 121.913 -0.492 . . . . 0.0 110.457 160.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.67 -142.15 3.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.22 174.55 7.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.529 1.132 . . . . 0.0 109.915 164.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -124.24 156.88 66.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.216 1.406 . . . . 0.0 110.842 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.05 142.55 8.8 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.037 1.824 . . . . 0.0 110.544 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.79 166.26 20.81 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.115 2.543 . . . . 0.0 110.699 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.92 69.19 4.67 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.427 3.418 . . . . 0.0 112.931 -172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -55.35 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 125.447 1.499 . . . . 0.0 109.691 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -55.54 157.73 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.839 2.056 . . . . 0.0 110.15 163.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.93 153.74 37.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.667 1.987 . . . . 0.0 106.98 159.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -155.18 96.23 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 96.1 m 46.03 35.45 2.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.269 2.628 . . . . 0.0 115.665 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.19 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.542 -1.349 . . . . 0.0 108.008 -170.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.49 87.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 -67.78 1.36 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.823 1.201 . . . . 0.0 112.242 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -137.1 -36.0 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.151 2.18 . . . . 0.0 111.22 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.68 170.02 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.348 0.976 . . . . 0.0 108.937 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.59 120.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.555 HG22 ' H ' ' A' ' 83' ' ' ASP . 1.4 p -81.33 176.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.914 0.864 . . . . 0.0 110.136 170.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.555 ' H ' HG22 ' A' ' 82' ' ' VAL . 28.9 t70 -142.62 109.94 5.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -32.49 74.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.589 1.156 . . . . 0.0 109.609 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -54.0 -48.97 69.87 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.26 1.824 . . . . 0.0 108.618 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.6 t -55.88 -22.44 25.57 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 120.409 1.458 . . . . 0.0 113.316 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 61' ' ' LEU . 20.9 m-85 -79.11 -60.84 2.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.521 1.055 . . . . 0.0 109.182 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.51 -26.78 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.745 2.018 . . . . 0.0 113.139 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -61.8 -28.36 69.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 114.676 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -163.39 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.616 0.766 . . . . 0.0 112.924 -171.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.55 52.81 1.01 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.563 1.145 . . . . 0.0 108.798 166.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -140.62 -61.1 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 126.437 1.895 . . . . 0.0 108.444 -177.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -42.01 36.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.187 1.925 . . . . 0.0 112.459 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.28 -20.62 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.898 0.772 . . . . 0.0 113.037 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.74 74.28 6.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.19 94.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.443 2.697 . . . . 0.0 111.741 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 125.681 1.592 . . . . 0.0 108.132 174.1 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 120.464 0.173 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -142.47 170.34 15.89 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 127.209 2.204 . . . . 0.0 108.121 -169.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.19 128.27 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 36.6 t -108.85 154.22 22.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -137.73 123.35 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.616 0.767 . . . . 0.0 110.203 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.456 HG23 ' CZ ' ' A' ' 35' ' ' PHE . 21.4 mt -148.46 85.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.455 1.502 . . . . 0.0 108.693 -169.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -86.46 164.75 16.79 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.918 -1.739 . . . . 0.0 111.164 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 56.6 58.02 4.43 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.587 2.355 . . . . 0.0 111.992 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.3 mt -87.12 49.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 121.03 -1.044 . . . . 0.0 108.687 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.74 3.93 1.38 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-O 118.257 -1.302 . . . . 0.0 115.082 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -103.64 -77.76 0.56 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.455 2.127 . . . . 0.0 110.848 -173.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -52.46 -18.76 1.81 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.317 1.447 . . . . 0.0 113.771 168.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -32.24 -60.6 0.27 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.523 2.329 . . . . 0.0 113.105 -167.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.55 -29.34 69.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.318 0.963 . . . . 0.0 112.254 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -95.34 -17.64 21.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.807 1.643 . . . . 0.0 112.746 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.0 p -54.56 151.94 7.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.915 1.286 . . . . 0.0 110.88 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -132.54 -89.68 0.42 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.468 1.107 . . . . 0.0 109.27 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -56.08 -21.33 21.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 117.098 -1.43 . . . . 0.0 112.296 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -62.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 120.906 1.685 . . . . 0.0 110.707 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.402 HG23 ' HG3' ' A' ' 156' ' ' GLU . 3.5 mp -41.81 -58.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.135 1.374 . . . . 0.0 110.364 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -65.31 -39.15 92.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -166.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.05 -51.91 12.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.14 0.9 . . . . 0.0 108.936 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.57 -34.07 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 O-C-N 121.909 -0.494 . . . . 0.0 111.054 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.33 -43.45 61.73 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.217 169.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.19 -45.35 83.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.568 1.531 . . . . 0.0 111.167 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.7 m -65.74 -46.86 77.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.945 0.898 . . . . 0.0 110.892 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.2 mt -62.87 -25.7 68.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 110.938 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 t -76.9 -9.08 58.44 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.588 1.555 . . . . 0.0 110.766 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.0 m -91.41 134.24 29.92 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.34 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.949 2.432 . . . . 0.0 111.577 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.7 -32.57 49.93 Favored Glycine 0 C--O 1.218 -0.896 0 CA-C-O 117.242 -1.866 . . . . 0.0 112.811 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.0 m -66.74 138.69 57.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 122.101 2.951 . . . . 0.0 107.975 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -122.65 84.44 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 101.51 -3.515 . . . . 0.0 101.51 -166.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.98 117.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mt -102.87 133.09 48.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 151.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.68 171.23 29.06 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 44.2 m -122.23 101.67 7.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.906 0.853 . . . . 0.0 108.72 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.9 pt -86.35 151.22 53.32 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.036 0.934 . . . . 0.0 108.785 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.7 145.3 36.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.927 2.418 . . . . 0.0 110.043 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.86 139.65 93.63 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 165.27 32.5 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.171 2.581 . . . . 0.0 110.601 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.77 -38.24 0.28 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.154 0.981 . . . . 0.0 111.041 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.77 139.5 4.69 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.479 -1.849 . . . . 0.0 108.479 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.09 163.75 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.729 1.611 . . . . 0.0 113.505 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.44 165.76 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.53 3.486 . . . . 0.0 109.959 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.03 171.58 7.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.32 -82.58 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.797 0.726 . . . . 0.0 109.214 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.31 -40.88 65.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.25 -0.906 . . . . 0.0 113.166 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.86 -28.06 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.544 -0.722 . . . . 0.0 110.48 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.92 -32.05 72.41 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.915 0.78 . . . . 0.0 109.632 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 125' ' ' ILE . 64.8 mm-40 -60.98 -33.88 73.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.566 1.076 . . . . 0.0 112.137 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 108.54 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -59.05 -34.74 72.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.612 0.642 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.93 -25.71 58.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.219 1.807 . . . . 0.0 112.809 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.828 1.195 . . . . 0.0 111.483 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -54.47 0.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.782 2.033 . . . . 0.0 113.758 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -72.3 42.91 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.691 2.796 . . . . 0.0 111.486 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 3' ' ' HIS . 1.9 t -120.66 103.21 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 130.503 3.521 . . . . 0.0 104.796 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.45 131.97 48.67 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.05 116.78 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.236 1.014 . . . . 0.0 109.159 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -106.17 82.09 1.71 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.578 2.351 . . . . 0.0 107.664 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 117.81 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 120.906 -1.121 . . . . 0.0 108.102 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.49 HG23 HD13 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -81.43 153.78 4.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 p -110.7 158.22 18.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -66.32 -19.01 65.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.25 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -83.29 -38.02 22.68 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 118.099 0.409 . . . . 0.0 111.18 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.11 15.18 19.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.699 1.2 . . . . 0.0 111.325 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -49.49 -52.13 31.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.314 1.046 . . . . 0.0 109.315 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.3 4.57 2.78 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -124.47 3.4 8.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.132 0.973 . . . . 0.0 113.127 172.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.49 HD13 HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -83.2 -19.11 37.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.398 0.999 . . . . 0.0 113.624 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -56.01 26.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.52 -1.228 . . . . 0.0 110.183 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.37 -27.15 63.12 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.623 1.615 . . . . 0.0 113.302 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.76 -40.67 75.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.601 1.16 . . . . 0.0 109.435 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.468 HD11 HD21 ' A' ' 6' ' ' LEU . 25.9 mt -63.95 -53.05 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.701 1.2 . . . . 0.0 107.977 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.25 -42.71 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.695 1.198 . . . . 0.0 109.767 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -55.13 39.13 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 125.479 1.512 . . . . 0.0 108.857 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 9.1 t -52.99 -41.3 64.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.123 0.874 . . . . 0.0 111.311 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.92 -53.51 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.691 1.196 . . . . 0.0 108.994 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -62.52 -34.59 77.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.075 1.307 . . . . 0.0 113.124 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.3 m -64.9 8.25 0.13 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 129.987 3.315 . . . . 0.0 113.482 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.2 p . . . . . 0 C--O 1.236 0.359 0 O-C-N 120.856 -1.153 . . . . 0.0 108.156 172.015 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -50.37 156.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.088 2.155 . . . . 0.0 111.214 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.1 t -141.7 143.17 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -142.92 161.83 37.09 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.97 1.708 . . . . 0.0 110.006 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -98.25 157.57 16.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 160.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -141.78 -178.96 5.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.815 1.646 . . . . 0.0 107.469 162.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.86 -170.73 14.99 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.02 115.86 4.51 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.356 2.704 . . . . 0.0 108.669 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.32 97.28 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.654 1.569 . . . . 0.0 110.601 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.39 -57.95 16.75 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t 176.09 -45.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 129.086 2.954 . . . . 0.0 109.309 163.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.44 8.99 30.42 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 123.706 0.669 . . . . 0.0 114.22 -167.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE3' ' H ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -57.64 -38.67 75.43 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.728 1.264 . . . . 0.0 111.759 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.472 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 55.0 m -64.8 -37.12 86.53 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.34 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -64.77 -33.58 76.31 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.498 1.499 . . . . 0.0 110.222 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.664 HD13 ' HB3' ' A' ' 176' ' ' LEU . 59.9 mt -60.65 -57.52 12.35 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.199 0.599 . . . . 0.0 109.754 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 mm -70.76 -38.39 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 122.989 0.516 . . . . 0.0 109.693 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.93 -61.93 1.86 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.159 2.184 . . . . 0.0 108.587 172.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.3 -32.15 72.85 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.435 -1.269 . . . . 0.0 111.853 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.31 78.45 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 120.16 1.346 . . . . 0.0 109.265 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.434 ' C ' ' HE3' ' A' ' 26' ' ' LYS . 58.7 p -70.96 -45.1 64.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.097 -0.954 . . . . 0.0 108.991 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.35 -37.54 70.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.49 1.495 . . . . 0.0 112.139 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.56 -54.85 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 125.879 1.672 . . . . 0.0 108.848 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.18 -32.94 74.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.76 -0.588 . . . . 0.0 109.92 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 30' ' ' VAL . 26.8 mtmt -62.68 -36.39 82.77 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.008 -1.683 . . . . 0.0 110.738 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -38.13 85.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 110.081 165.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.52 5.36 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.121 1.369 . . . . 0.0 114.251 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.16 52.56 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 120.274 1.397 . . . . 0.0 111.662 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.5 p -55.03 142.06 57.79 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.62 94.26 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.316 1.344 . . . . 0.0 109.086 160.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.15 139.58 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.268 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.02 169.6 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.461 1.505 . . . . 0.0 107.818 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.44 25.74 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -143.83 162.93 34.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.002 1.321 . . . . 0.0 107.513 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -140.59 110.28 6.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.402 ' CG2' HD22 ' A' ' 61' ' ' LEU . 9.1 m -70.23 134.41 48.01 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.05 44.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.52 -0.737 . . . . 0.0 110.832 -171.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.34 146.15 50.69 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -122.58 105.22 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -123.14 80.06 1.73 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 126.486 1.915 . . . . 0.0 110.005 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -65.04 -24.26 67.43 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.836 -1.165 . . . . 0.0 112.666 -166.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.97 45.64 0.73 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 166.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.31 89.24 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.717 -1.046 . . . . 0.0 114.21 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.64 124.7 46.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 119.55 1.675 . . . . 0.0 108.459 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -60.75 92.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.675 1.59 . . . . 0.0 110.608 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.64 -16.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 111.127 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.49 -166.17 39.37 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -130.9 160.98 32.87 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.084 1.753 . . . . 0.0 106.404 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.86 161.49 30.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.775 2.03 . . . . 0.0 105.998 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.97 110.02 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 167.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.32 162.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.976 1.262 . . . . 0.0 108.06 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -125.43 160.0 30.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.011 1.324 . . . . 0.0 108.154 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.9 mm? -68.18 -21.38 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.452 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -62.25 -26.48 68.41 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.63 1.105 . . . . 0.0 111.062 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.01 5.77 57.22 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.187 1.375 . . . . 0.0 111.864 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -84.34 159.77 20.82 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 120.987 -1.302 . . . . 0.0 107.774 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 147.83 26.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -174.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -145.82 -178.09 21.03 Favored Glycine 0 CA--C 1.521 0.44 0 O-C-N 123.948 0.78 . . . . 0.0 112.726 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.24 169.31 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.737 2.958 . . . . 0.0 112.429 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 7.6 tp -150.0 -66.93 0.21 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.98 -1.075 . . . . 0.0 109.705 161.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -150.11 125.62 10.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -128.55 165.71 20.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.617 1.167 . . . . 0.0 108.198 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.6 120.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.73 -119.73 2.06 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.77 157.3 47.19 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.39 1.476 . . . . 0.0 107.44 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -86.65 166.43 27.4 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.641 1.576 . . . . 0.0 110.808 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.77 139.47 14.01 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.434 2.756 . . . . 0.0 108.699 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.43 172.22 14.83 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.766 2.311 . . . . 0.0 110.765 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.21 99.54 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.86 1.706 . . . . 0.0 108.245 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.44 -79.11 0.35 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 124.902 1.239 . . . . 0.0 110.494 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.73 125.56 23.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.364 1.082 . . . . 0.0 108.752 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 138.47 32.56 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.62 -163.16 1.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.42 -178.31 3.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 157.41 167.16 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 131.133 3.773 . . . . 0.0 105.849 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 -13.21 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 123.866 0.729 . . . . 0.0 109.663 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.96 134.43 3.57 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.044 -2.822 . . . . 0.0 106.044 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.51 -68.02 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.626 2.37 . . . . 0.0 111.571 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.03 149.38 30.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.857 1.663 . . . . 0.0 108.205 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 2.1 p -121.01 132.05 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.45 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.773 0.829 . . . . 0.0 110.275 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -154.39 105.39 2.66 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -21.62 65.06 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.149 -0.97 . . . . 0.0 111.865 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.1 m -37.24 -45.82 0.68 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.526 1.93 . . . . 0.0 112.243 156.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 p -76.66 -34.43 58.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.395 0.998 . . . . 0.0 109.175 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 14.5 m-85 -60.2 -41.81 93.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.98 -1.075 . . . . 0.0 109.718 173.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 92' ' ' LEU . 11.2 pt-20 -76.84 -9.1 58.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.832 1.196 . . . . 0.0 113.625 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.46 -68.18 0.38 Allowed 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 161.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 59' ' ' GLY . 2.1 mp -102.22 -44.8 5.32 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.814 -0.554 . . . . 0.0 111.539 -158.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.48 49.3 1.77 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.463 1.905 . . . . 0.0 108.553 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.852 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -134.52 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 109.864 -176.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 41.1 Cg_endo -65.61 -33.47 45.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.883 1.722 . . . . 0.0 112.517 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -59.82 -24.73 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.533 1.133 . . . . 0.0 112.868 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.06 -11.17 60.45 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.301 0.501 . . . . 0.0 111.269 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 88.02 1.99 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.321 -0.649 0 C-N-CA 123.86 0.864 . . . . 0.0 109.166 167.059 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 121.924 0.868 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' HD3' ' H ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -60.61 164.9 4.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.517 1.127 . . . . 0.0 108.812 172.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.69 146.82 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 139' ' ' ILE . 5.7 p -115.84 163.78 15.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.938 0.875 . . . . 0.0 110.449 161.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.8 125.88 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.508 HD13 ' CG2' ' A' ' 128' ' ' VAL . 2.5 mt -141.52 74.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.04 167.47 21.75 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.88 27.95 10.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 114.103 164.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 153' ' ' LEU . 16.7 mt -70.14 75.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.186 1.394 . . . . 0.0 108.227 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.2 -47.58 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.826 -1.171 . . . . 0.0 113.45 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -69.75 -40.14 76.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.345 2.073 . . . . 0.0 111.914 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -12.72 60.94 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 116.291 -1.814 . . . . 0.0 112.618 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -47.07 -24.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -156.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 -22.19 13.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.426 1.09 . . . . 0.0 112.119 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -99.06 -29.01 13.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.964 1.706 . . . . 0.0 109.745 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -45.45 114.5 0.76 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.803 2.841 . . . . 0.0 108.348 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.13 -86.59 0.5 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 119.864 1.211 . . . . 0.0 111.16 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.852 HD11 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -69.54 -10.35 57.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.934 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -53.06 -52.14 59.5 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 120.866 1.666 . . . . 0.0 112.151 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mt -39.17 -54.63 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 127.384 2.274 . . . . 0.0 112.552 164.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -63.63 -54.26 38.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.904 1.229 . . . . 0.0 110.593 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.48 -49.26 78.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 123.24 0.338 . . . . 0.0 111.095 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.508 ' CG2' HD13 ' A' ' 111' ' ' ILE . 2.5 p -65.62 -30.06 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.907 0.883 . . . . 0.0 111.611 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -40.02 60.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.493 168.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -38.07 86.9 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.663 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.51 -48.8 63.45 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.923 1.238 . . . . 0.0 110.472 175.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 139' ' ' ILE . 12.3 mt -58.02 -32.47 67.98 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.464 1.906 . . . . 0.0 111.98 -175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.5 m -129.32 30.24 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.62 1.568 . . . . 0.0 110.019 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.437 HG23 ' HD2' ' A' ' 135' ' ' PRO . 1.3 m -76.45 165.1 55.39 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 149.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 134' ' ' THR . 44.3 Cg_endo -87.33 126.48 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.541 2.828 . . . . 0.0 109.298 168.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.07 89.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 116.929 -2.039 . . . . 0.0 116.263 158.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 m -72.14 166.9 21.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 121.827 2.814 . . . . 0.0 108.492 155.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.0 mt -131.83 104.25 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.539 HD13 ' SG ' ' A' ' 109' ' ' CYS . 41.2 mm -67.5 132.08 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.42 1.075 . . . . 0.0 108.117 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tp -140.56 136.06 32.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 107.82 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.61 41.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 113.341 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -128.56 130.73 47.8 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.169 0.987 . . . . 0.0 108.863 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.73 163.87 18.22 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.967 1.707 . . . . 0.0 108.152 165.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.01 161.07 11.72 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.37 2.713 . . . . 0.0 111.332 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.61 139.34 93.95 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 165.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.01 159.5 33.99 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.489 2.793 . . . . 0.0 108.891 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -142.3 -65.94 0.4 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.81 -122.93 0.94 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 125.208 1.385 . . . . 0.0 111.096 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.402 ' HE3' ' CA ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -62.52 171.1 1.88 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.38 172.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.52 168.0 19.3 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.271 1.314 . . . . 0.0 109.099 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.54 137.07 52.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.84 -63.36 1.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.93 0.892 . . . . 0.0 111.751 -156.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 114' ' ' ILE . 3.5 tp -62.95 -40.8 98.75 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 114' ' ' ILE . 76.4 t -65.93 -28.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.686 -0.634 . . . . 0.0 110.269 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.83 -29.92 63.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.724 0.81 . . . . 0.0 110.807 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.17 -38.79 90.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.539 1.063 . . . . 0.0 112.095 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.95 -41.94 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.86 1.264 . . . . 0.0 108.338 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -18.36 65.34 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.087 -1.633 . . . . 0.0 111.532 -174.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.76 -22.01 61.66 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.825 0.739 . . . . 0.0 110.273 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -73.9 83.93 1.7 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.35 -28.77 69.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.851 -1.156 . . . . 0.0 109.305 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -76.12 56.62 1.03 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.47 3.108 . . . . 0.0 110.651 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.77 126.5 62.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 105.05 1.34 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 161.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.1 t -88.91 98.1 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -68.41 147.24 52.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.77 125.06 48.36 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.67 159.87 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 167.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 p -128.13 149.76 50.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -58.23 -16.08 12.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.953 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -80.68 -68.75 0.65 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.195 0.907 . . . . 0.0 108.569 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.19 28.46 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.887 1.275 . . . . 0.0 109.523 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -59.58 -23.44 62.94 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.24 9.75 21.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.749 1.62 . . . . 0.0 112.057 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.63 -13.48 15.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 115.94 -1.981 . . . . 0.0 113.86 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.664 ' HB3' HD13 ' A' ' 17' ' ' LEU . 1.1 tt -84.58 -20.04 32.11 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 116.167 -2.213 . . . . 0.0 111.795 -154.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 17' ' ' LEU . 12.1 tp -25.27 -64.99 0.1 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 128.872 2.869 . . . . 0.0 113.529 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.09 -28.03 85.15 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.854 2.369 . . . . 0.0 113.18 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.84 -42.53 90.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.676 1.125 . . . . 0.0 109.538 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 6' ' ' LEU . 8.6 mt -68.62 -50.07 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 125.382 1.473 . . . . 0.0 108.032 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.83 -37.0 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.5 1.045 . . . . 0.0 111.035 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 86.8 m -60.46 -47.51 85.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 6.9 t -62.8 -29.02 70.4 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.004 0.82 . . . . 0.0 111.344 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.65 -52.19 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.232 1.013 . . . . 0.0 110.316 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -34.4 71.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.98 1.264 . . . . 0.0 111.368 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 -8.81 48.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.677 1.991 . . . . 0.0 111.813 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 O-C-N 120.647 -1.283 . . . . 0.0 111.452 166.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 123.25 1.5 . . . . 0.0 107.555 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.617 ' HB2' HG12 ' A' ' 163' ' ' VAL . 24.2 m-70 -72.99 149.61 43.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.99 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.5 t -126.78 133.85 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.499 ' CE1' HG21 ' A' ' 157' ' ' ILE . 15.6 m-85 -136.37 121.16 18.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.501 0.667 . . . . 0.0 110.611 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.21 155.75 34.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.908 1.283 . . . . 0.0 109.101 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -161.46 -179.43 7.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.978 164.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.57 -107.29 1.12 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.383 1.944 . . . . 0.0 109.465 170.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.06 174.67 8.57 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.811 3.007 . . . . 0.0 111.746 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.21 -177.8 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.817 2.344 . . . . 0.0 110.681 164.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.73 55.44 1.32 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 126.764 2.126 . . . . 0.0 110.771 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.27 52.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.004 1.321 . . . . 0.0 107.857 156.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.63 59.78 1.41 Allowed Glycine 0 C--N 1.335 0.481 0 O-C-N 119.801 -1.812 . . . . 0.0 110.364 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -38.99 4.15 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.5 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.2 m -55.44 -44.0 75.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.71 1.204 . . . . 0.0 109.893 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.7 m -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.355 -1.466 . . . . 0.0 113.295 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -44.54 72.39 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 120.722 1.601 . . . . 0.0 108.559 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.34 -37.41 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.945 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -53.12 -47.81 68.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.386 0.994 . . . . 0.0 110.361 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -30.41 70.68 Favored 'General case' 0 C--O 1.227 -0.088 0 O-C-N 122.338 -0.226 . . . . 0.0 110.95 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -27.2 69.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.379 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.9 p -74.91 -53.38 9.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.656 1.116 . . . . 0.0 108.02 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -48.88 -45.47 41.21 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.582 1.953 . . . . 0.0 112.11 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.64 -45.51 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.258 0.551 . . . . 0.0 110.956 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 108' ' ' VAL . 84.1 mt -69.69 -37.0 76.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.024 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.77 -43.66 81.02 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -26.77 67.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.667 1.187 . . . . 0.0 112.81 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -5.73 53.45 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.761 0.824 . . . . 0.0 112.092 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.12 88.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.763 1.173 . . . . 0.0 113.643 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.32 127.6 85.99 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 119.589 1.694 . . . . 0.0 107.681 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.98 130.31 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.844 2.363 . . . . 0.0 109.577 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.65 137.6 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.78 167.87 16.68 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.528 1.531 . . . . 0.0 107.673 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 94' ' ' VAL . . . 129.92 -160.76 22.93 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.35 165.44 27.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -128.09 -178.6 4.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 162.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -140.12 137.43 34.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.35 156.3 44.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.56 111.97 7.29 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.72 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.71 124.91 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -124.61 125.42 44.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.91 1.684 . . . . 0.0 107.627 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -69.18 -39.4 78.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.944 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.21 39.16 0.41 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.969 1.747 . . . . 0.0 109.545 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.14 26.07 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.536 1.541 . . . . 0.0 114.855 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 142.84 35.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.816 1.308 . . . . 0.0 110.833 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -64.82 129.98 41.76 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 125.162 1.538 . . . . 0.0 111.539 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.5 pt -137.23 -11.77 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.874 1.67 . . . . 0.0 112.973 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.18 -167.37 36.09 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 119.255 0.934 . . . . 0.0 112.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -139.26 123.97 18.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.127 2.171 . . . . 0.0 106.79 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.74 144.72 25.4 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.37 111.96 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 119.729 1.15 . . . . 0.0 108.367 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.34 110.46 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.603 0.361 . . . . 0.0 110.056 -152.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -74.74 155.65 37.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.713 1.244 . . . . 0.0 108.808 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.8 mm? -69.19 -13.63 62.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.103 169.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.98 9.85 15.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.904 1.682 . . . . 0.0 111.791 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.1 82.4 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 120.738 -1.226 . . . . 0.0 114.27 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.21 161.21 19.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.839 1.319 . . . . 0.0 107.589 169.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.98 144.38 26.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 117.737 -1.125 . . . . 0.0 109.534 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.94 154.19 21.23 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.16 1.345 . . . . 0.0 111.89 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.07 66.98 8.76 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.022 3.815 . . . . 0.0 111.98 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -57.8 8.9 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 126.761 2.024 . . . . 0.0 111.128 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.87 141.38 29.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.02 164.65 31.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.086 0.954 . . . . 0.0 109.55 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.62 136.79 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.21 165.55 30.37 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.753 -2.939 . . . . 0.0 105.753 171.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 165.54 13.64 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -69.04 153.41 96.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.658 -0.652 . . . . 0.0 109.67 166.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.17 125.56 10.4 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.735 2.957 . . . . 0.0 110.98 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.01 174.84 11.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.557 2.838 . . . . 0.0 111.446 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.65 125.61 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 108.835 -1.256 . . . . 0.0 108.835 169.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.31 5.2 82.9 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.833 -0.981 . . . . 0.0 114.755 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 132.59 20.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.189 1.995 . . . . 0.0 105.618 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -152.55 -179.46 7.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 164.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.89 -160.8 1.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 7.4 m -88.84 160.66 17.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.653 1.115 . . . . 0.0 108.879 162.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 158.91 40.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -165.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.98 99.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 32.16 81.32 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.104 2.288 . . . . 0.0 115.605 166.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 97.06 -57.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.431 0 C-N-CA 130.168 3.387 . . . . 0.0 109.554 -171.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -82.58 155.98 24.19 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.917 -0.489 . . . . 0.0 110.346 -169.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.92 133.58 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 165.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.0 167.84 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.81 116.0 7.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.229 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -27.6 66.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.233 0.47 . . . . 0.0 111.247 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -41.18 -47.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.136 1.774 . . . . 0.0 111.103 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.8 p -70.15 -36.69 74.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.538 -0.726 . . . . 0.0 111.135 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.39 -52.01 67.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -66.69 -10.11 43.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.922 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.61 -38.25 83.69 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 120.717 -1.24 . . . . 0.0 113.05 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 -41.62 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.609 0.64 . . . . 0.0 110.129 -167.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.32 53.38 2.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.013 0.925 . . . . 0.0 109.441 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 12.2 mt -116.4 -66.09 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.66 1.184 . . . . 0.0 109.325 156.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 98.8 Cg_endo -69.43 -11.11 30.54 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.798 2.332 . . . . 0.0 113.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -67.64 -26.06 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.143 -1.598 . . . . 0.0 110.651 172.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.8 -13.53 60.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.537 1.135 . . . . 0.0 111.634 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -179.44 119.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.824 2.45 . . . . 0.0 109.154 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 127.427 2.291 . . . . 0.0 107.308 176.616 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 122.399 1.095 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -108.01 172.47 6.82 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.536 2.335 . . . . 0.0 108.886 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 25' ' ' LEU . 29.6 t -135.35 149.48 28.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.8 t -123.27 107.75 12.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.4 0.68 . . . . 0.0 109.351 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.1 124.88 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.431 1.092 . . . . 0.0 108.305 165.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -142.26 125.18 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -145.26 -179.39 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.417 -0.802 . . . . 0.0 109.665 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.27 40.64 10.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.752 1.621 . . . . 0.0 110.573 -167.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.51 78.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.38 -83.77 0.05 OUTLIER Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -61.34 -19.15 61.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.167 1.484 . . . . 0.0 113.98 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 89.3 mmm -76.31 7.06 4.66 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.196 -1.383 . . . . 0.0 112.526 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -47.68 -26.82 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.12 -18.76 12.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.361 1.064 . . . . 0.0 111.912 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -19.97 18.03 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.648 0.779 . . . . 0.0 110.568 -171.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 m -50.17 116.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.556 1.543 . . . . 0.0 107.963 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.21 -80.7 0.37 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.256 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.44 -23.95 66.21 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.82 1.191 . . . . 0.0 110.694 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -65.12 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.907 2.083 . . . . 0.0 111.472 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -39.45 -62.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 126.204 1.802 . . . . 0.0 111.932 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.81 -50.8 72.4 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.43 0.559 . . . . 0.0 110.641 -172.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.45 -50.14 68.69 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.181 0.992 . . . . 0.0 109.715 -170.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 HD13 ' A' ' 132' ' ' LEU . 82.4 t -60.24 -46.34 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.149 0.979 . . . . 0.0 108.466 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.055 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -58.01 -49.88 75.32 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.111 1.323 . . . . 0.0 110.941 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -63.24 -29.08 70.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.448 -0.783 . . . . 0.0 111.132 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.44 HD13 HG12 ' A' ' 128' ' ' VAL . 7.9 mp -70.6 -30.63 67.36 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.909 -1.12 . . . . 0.0 111.053 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -23.56 64.1 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.26 0.936 . . . . 0.0 110.934 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.8 m -79.96 133.7 57.7 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -32.67 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.21 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.45 -17.63 33.26 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.879 -1.512 . . . . 0.0 114.643 -166.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.6 m -77.72 165.55 24.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.107 2.453 . . . . 0.0 107.697 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.0 mt -136.94 101.83 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -172.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.3 mm -72.08 135.24 28.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.56 124.23 19.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.257 1.823 . . . . 0.0 106.988 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.12 28.81 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-N 120.909 1.686 . . . . 0.0 114.826 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -129.25 113.21 14.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.86 152.73 42.5 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.63 0.772 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -70.42 149.97 63.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.784 1.656 . . . . 0.0 108.476 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.03 126.07 92.21 Favored Pre-proline 0 N--CA 1.441 -0.906 0 O-C-N 121.925 -0.485 . . . . 0.0 110.617 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.18 108.39 2.47 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 108.328 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -152.8 -36.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.778 0.831 . . . . 0.0 110.126 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.28 -66.91 0.85 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.695 1.14 . . . . 0.0 111.512 -167.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 158.2 75.69 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 124.286 1.034 . . . . 0.0 108.242 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.38 149.51 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.956 3.104 . . . . 0.0 109.875 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.51 135.44 52.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -64.37 0.84 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.304 1.442 . . . . 0.0 111.528 -172.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.29 -35.4 75.46 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.648 -0.657 . . . . 0.0 111.417 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 -43.65 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 119.109 0.868 . . . . 0.0 109.4 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -55.43 -41.55 72.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -55.76 -28.81 57.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.667 1.121 . . . . 0.0 113.087 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.499 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.7 mt -100.14 -39.64 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.486 1.514 . . . . 0.0 109.415 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.19 62.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.768 1.227 . . . . 0.0 110.19 177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.71 -39.77 5.41 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 127.786 2.434 . . . . 0.0 112.769 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.77 -32.13 70.47 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.062 -1.023 . . . . 0.0 111.093 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.7 -36.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.63 2.372 . . . . 0.0 113.389 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -63.32 -30.19 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.548 1.539 . . . . 0.0 114.154 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 3' ' ' HIS . 2.2 m -55.2 130.37 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.124 1.329 . . . . 0.0 110.793 -169.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.47 ' HE3' ' CD1' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -55.15 115.81 2.44 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.67 102.08 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 171.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' HE3' ' A' ' 164' ' ' LYS . 32.0 m-85 -83.38 87.11 6.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 162.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 94.07 0.3 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 162.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 176' ' ' LEU . 3.1 p -64.89 167.08 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p -124.6 153.07 42.74 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 165.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -61.46 -14.4 28.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.616 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.19 -62.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.824 1.193 . . . . 0.0 108.696 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.36 18.92 3.49 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 124.601 1.16 . . . . 0.0 111.561 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -50.11 -43.84 51.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.979 -1.075 . . . . 0.0 113.305 -161.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -86.34 13.88 7.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.934 2.493 . . . . 0.0 114.806 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -131.66 16.94 4.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.511 1.924 . . . . 0.0 111.813 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 166' ' ' PHE . 10.6 tp -84.09 -42.98 15.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.094 172.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -42.88 -58.78 3.55 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.377 1.871 . . . . 0.0 110.781 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.8 -25.02 78.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.036 2.491 . . . . 0.0 115.44 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.8 -46.6 57.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.431 1.493 . . . . 0.0 108.247 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.79 -53.37 45.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.245 1.418 . . . . 0.0 109.847 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.88 -45.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.823 0.738 . . . . 0.0 109.691 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.2 m -57.9 -45.63 86.14 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.57 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.95 -40.59 76.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.016 1.28 . . . . 0.0 110.859 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.06 -51.61 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.338 1.055 . . . . 0.0 109.83 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -31.2 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.519 0.728 . . . . 0.0 112.116 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 m -57.05 -51.72 68.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.549 1.14 . . . . 0.0 108.197 170.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.541 0.611 0 O-C-N 120.554 -1.341 . . . . 0.0 113.818 178.243 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 3' ' ' HIS . 31.0 m-70 -67.07 158.45 31.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.008 1.723 . . . . 0.0 108.377 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.45 139.09 48.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' A' ' 141' ' ' GLY . 17.7 m-85 -130.63 136.74 49.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.281 1.032 . . . . 0.0 109.265 172.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 180' ' ' ILE . 16.2 mt -78.17 157.82 29.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -152.07 169.44 22.37 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.543 0.687 . . . . 0.0 110.887 163.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.94 -171.93 37.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.09 168.37 22.17 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.785 2.323 . . . . 0.0 110.104 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.51 160.08 49.55 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.836 1.691 . . . . 0.0 111.074 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 39.73 72.88 0.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 126.999 2.238 . . . . 0.0 112.937 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.319 0.9 OUTLIER -131.11 -2.54 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.551 0.741 . . . . 0.0 112.835 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.29 19.24 19.27 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.973 -1.079 . . . . 0.0 112.634 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -51.75 67.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.432 1.616 . . . . 0.0 109.265 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -64.36 -29.56 70.63 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.788 -0.625 . . . . 0.0 109.666 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -58.48 -47.57 83.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.836 1.198 . . . . 0.0 111.681 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -46.92 87.27 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -68.2 -38.51 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.272 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -53.44 -55.9 21.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.148 1.379 . . . . 0.0 108.269 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -51.2 -42.82 61.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.065 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.81 57.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.368 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -60.9 -56.98 14.77 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.933 0.788 . . . . 0.0 108.982 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.84 -31.8 68.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.319 2.248 . . . . 0.0 110.982 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.75 -50.96 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.848 1.659 . . . . 0.0 110.537 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.56 -34.47 77.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.982 0.81 . . . . 0.0 109.311 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -71.08 -20.9 62.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.649 1.18 . . . . 0.0 113.199 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -86.8 -7.56 58.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.873 1.669 . . . . 0.0 111.82 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -114.4 2.66 14.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.789 1.236 . . . . 0.0 112.792 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.43 43.18 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 119.657 1.117 . . . . 0.0 112.07 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.15 108.19 24.52 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.26 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.335 2.69 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 32' ' ' VAL . 2.4 t -69.59 169.03 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.145 0.978 . . . . 0.0 109.987 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 162.48 39.97 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.994 154.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.97 -165.66 31.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.353 0.977 . . . . 0.0 111.032 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.08 168.09 20.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.452 0.644 . . . . 0.0 111.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -143.31 152.97 42.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 108.352 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.0 p -77.11 124.9 28.47 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 157.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -104.7 139.11 40.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 160.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -73.67 147.03 44.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.602 0.715 . . . . 0.0 110.052 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.41 98.7 4.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -125.53 153.39 43.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -128.29 -60.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.083 1.353 . . . . 0.0 107.728 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.57 31.87 8.21 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.703 1.62 . . . . 0.0 110.69 167.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.61 14.67 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.288 1.423 . . . . 0.0 114.409 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' H ' ' HD2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -80.27 142.89 34.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.498 1.649 . . . . 0.0 108.691 176.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -65.08 135.23 55.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.952 0.796 . . . . 0.0 108.893 171.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -124.67 -17.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.776 1.23 . . . . 0.0 111.997 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.09 -152.99 21.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.69 161.89 36.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.286 5.9 p30 -131.26 142.8 50.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 90' ' ' LEU . 2.4 p -90.28 93.55 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 125.457 1.503 . . . . 0.0 108.004 -173.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 t -84.97 147.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -107.23 162.89 13.48 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.751 1.22 . . . . 0.0 109.223 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -31.41 72.13 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.343 -0.848 . . . . 0.0 111.56 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.8 t -65.09 -25.29 67.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.229 1.011 . . . . 0.0 110.101 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.0 -2.64 44.5 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.666 -1.074 . . . . 0.0 112.976 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.9 m -60.74 151.09 30.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.3 1.55 . . . . 0.0 108.478 163.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 155.33 50.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.891 1.277 . . . . 0.0 111.685 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.615 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -139.22 164.71 25.85 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.034 0.834 . . . . 0.0 113.685 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.13 -2.56 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.945 3.097 . . . . 0.0 115.109 -165.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 24.93 -79.26 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.76 3.624 . . . . 0.0 115.311 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 p -130.2 147.87 51.98 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.006 0.821 . . . . 0.0 110.279 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -148.17 158.87 44.32 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.097 1.359 . . . . 0.0 108.67 -172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -62.57 148.76 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.44 71.55 0.02 OUTLIER Glycine 0 C--N 1.34 0.781 0 CA-C-N 119.487 1.039 . . . . 0.0 114.503 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.42 -159.34 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.789 1.236 . . . . 0.0 110.163 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.71 156.67 62.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.907 1.683 . . . . 0.0 109.848 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 132.72 22.39 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 110.7 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -66.7 175.64 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.651 2.234 . . . . 0.0 111.708 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.43 -36.43 15.55 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.05 1.833 . . . . 0.0 111.318 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.33 -59.31 6.37 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -168.42 1.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.438 0.619 . . . . 0.0 110.985 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.37 147.75 32.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.0 0.92 . . . . 0.0 109.314 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -165.01 -163.69 0.72 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.361 1.465 . . . . 0.0 107.668 151.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 78.4 m -109.61 110.73 21.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.423 1.889 . . . . 0.0 108.97 -172.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.69 136.67 53.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.966 1.257 . . . . 0.0 108.746 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 t -125.63 102.75 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 24.91 84.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 C-N-CA 128.139 2.781 . . . . 0.0 114.781 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 95.73 -59.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.675 3.59 . . . . 0.0 109.219 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.46 146.91 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.648 1.179 . . . . 0.0 109.761 -166.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.12 112.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 166.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ASP . 2.7 p -71.98 -179.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 O-C-N 121.266 -0.896 . . . . 0.0 109.012 166.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 86' ' ' SER . 6.2 t0 -150.75 145.64 25.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 161.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.5 -39.12 77.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.843 1.257 . . . . 0.0 107.709 167.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.6 m -54.02 -44.89 71.34 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.114 0.566 . . . . 0.0 109.875 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 70.6 m -64.31 -17.69 63.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.19 0.905 . . . . 0.0 112.43 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.24 -60.42 2.37 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.715 0.806 . . . . 0.0 109.928 161.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -45.05 -33.05 1.94 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.09 2.156 . . . . 0.0 113.525 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.65 -40.36 62.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.696 0.68 . . . . 0.0 112.021 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.615 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -140.48 -32.29 0.59 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -168.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 41.1 0.96 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.768 2.027 . . . . 0.0 109.557 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -137.82 -59.63 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 125.544 1.538 . . . . 0.0 108.496 -171.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 29.1 Cg_endo -57.48 -37.78 96.2 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.951 1.767 . . . . 0.0 111.926 170.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.4 m -55.64 -31.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.91 0.777 . . . . 0.0 112.435 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.69 -36.42 60.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.412 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -156.1 92.43 1.35 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.198 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.098 0.475 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -139.09 -179.38 5.82 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.547 1.139 . . . . 0.0 108.993 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.0 t -127.48 144.37 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.5 t -125.85 143.08 51.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.873 2.069 . . . . 0.0 106.977 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.3 t -138.96 132.87 40.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.28 135.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 33.5 t0 -133.06 -172.95 3.06 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.125 -1.609 . . . . 0.0 107.462 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 2.3 mm-40 56.45 -81.46 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 129.202 3.001 . . . . 0.0 110.675 -156.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.291 38.4 mt 53.98 -10.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 128.133 2.573 . . . . 0.0 112.944 -169.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 113' ' ' GLU . . . -83.46 -59.78 2.09 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.942 2.211 . . . . 0.0 111.103 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -52.54 -29.19 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.387 1.475 . . . . 0.0 114.035 -168.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.35 4.73 41.82 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.216 -1.373 . . . . 0.0 112.657 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -24.81 -64.24 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 129.108 2.963 . . . . 0.0 114.594 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.86 -34.31 17.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.928 0.491 . . . . 0.0 111.16 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.75 -27.34 61.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.571 1.148 . . . . 0.0 112.444 -169.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.3 p -51.16 120.48 5.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.367 1.867 . . . . 0.0 111.727 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.7 -92.92 0.52 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.74 -6.36 15.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.752 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -65.38 0.6 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.331 1.453 . . . . 0.0 110.386 171.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.5 mp -35.76 -59.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.158 1.783 . . . . 0.0 112.724 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -59.75 -52.12 66.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.48 87.54 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.83 -59.07 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.858 1.263 . . . . 0.0 109.253 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -57.9 -37.91 74.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.504 1.047 . . . . 0.0 111.913 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -34.44 76.8 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.804 -0.56 . . . . 0.0 110.712 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.406 ' CG2' HG21 ' A' ' 137' ' ' THR . 45.0 m -81.53 -30.29 33.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.27 0.941 . . . . 0.0 111.336 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.83 -21.33 63.07 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.41 1.005 . . . . 0.0 110.83 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 t -93.16 -8.97 41.0 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.458 2.303 . . . . 0.0 112.363 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.5 m -62.06 135.5 94.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.19 -36.32 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.401 2.067 . . . . 0.0 111.425 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.09 6.28 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.406 HG21 ' CG2' ' A' ' 131' ' ' THR . 58.9 m 43.52 166.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.784 2.434 . . . . 0.0 113.272 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.8 mt -144.91 114.0 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.9 131.69 34.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.4 96.46 5.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 158.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -113.95 171.9 14.05 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.26 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.4 m -134.63 134.22 40.97 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.34 156.93 66.3 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.712 1.605 . . . . 0.0 109.572 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.13 150.31 37.42 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.86 1.707 . . . . 0.0 110.209 169.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.69 151.75 60.82 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 123.77 0.828 . . . . 0.0 110.733 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.1 162.73 38.84 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.702 2.935 . . . . 0.0 108.901 166.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -156.97 -61.01 0.09 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -118.45 -118.67 2.84 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 151.85 88.77 Favored Pre-proline 0 C--O 1.237 0.436 0 CA-C-N 117.966 0.883 . . . . 0.0 111.329 -172.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -59.04 156.25 35.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.173 2.582 . . . . 0.0 109.936 167.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.95 139.38 49.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.057 1.343 . . . . 0.0 107.408 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -70.35 0.11 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.901 1.68 . . . . 0.0 113.174 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 tp -56.7 -39.77 74.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.522 -0.736 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.0 -31.13 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.218 0.917 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -61.78 -29.4 70.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.378 1.444 . . . . 0.0 110.289 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.07 -23.07 67.28 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.317 0.962 . . . . 0.0 112.089 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.05 -47.0 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -68.1 -11.55 59.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.989 -1.07 . . . . 0.0 112.393 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -76.58 -10.51 59.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 123.911 0.884 . . . . 0.0 113.144 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -74.56 87.54 2.12 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.728 1.149 . . . . 0.0 109.292 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 52.02 0.49 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.482 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -153.48 -12.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 111.2 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.51 137.84 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.566 -1.334 . . . . 0.0 109.965 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -73.47 134.46 43.92 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 164.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.7 t -115.22 79.49 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.466 ' CG ' HD21 ' A' ' 176' ' ' LEU . 6.2 m-85 -67.31 91.09 0.24 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.676 1.59 . . . . 0.0 110.765 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.75 147.18 52.36 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 164.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.539 HG22 ' H ' ' A' ' 169' ' ' THR . 1.8 p -122.31 171.69 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 123.253 1.501 . . . . 0.0 109.238 168.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.21 128.18 29.5 Favored 'General case' 0 N--CA 1.435 -1.214 1 C-N-CA 131.864 4.066 . . . . 0.0 102.888 -178.322 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -46.05 -24.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.288 1.835 . . . . 0.0 112.248 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.69 -70.76 0.41 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.911 0.884 . . . . 0.0 109.472 -172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.09 17.58 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.352 2.261 . . . . 0.0 111.852 -173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -52.5 -44.93 65.97 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -162.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -77.66 3.43 13.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -87.93 -8.04 56.3 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.608 1.163 . . . . 0.0 111.72 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.466 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -83.1 -34.34 26.15 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 120.672 1.578 . . . . 0.0 112.441 177.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -57.6 7.39 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.17 -1.395 . . . . 0.0 109.89 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.97 -27.48 58.2 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.179 1.814 . . . . 0.0 113.114 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.4 -42.35 65.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.343 0.974 . . . . 0.0 109.261 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 6' ' ' LEU . 15.6 mt -53.12 -55.86 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 125.313 1.445 . . . . 0.0 109.297 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.12 -33.84 66.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.785 0.72 . . . . 0.0 110.523 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 88.6 m -63.78 -48.96 74.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.876 0.87 . . . . 0.0 108.715 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -56.32 -37.24 69.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.161 1.384 . . . . 0.0 110.12 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.25 -55.92 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.988 0.915 . . . . 0.0 110.681 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.46 -21.46 65.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.722 1.146 . . . . 0.0 112.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 73.9 m -58.0 -33.78 69.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.261 0.937 . . . . 0.0 113.045 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 CA--C 1.539 0.54 0 CA-C-N 119.238 0.927 . . . . 0.0 112.42 175.315 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.435 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.516 ' HB2' HG12 ' A' ' 163' ' ' VAL . 10.5 m-70 59.38 164.75 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.016 2.526 . . . . 0.0 112.116 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -138.74 139.96 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 O-C-N 120.139 -1.6 . . . . 0.0 107.953 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 20.3 m-85 -138.65 157.01 46.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.022 0.929 . . . . 0.0 110.993 168.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.811 HD11 HD11 ' A' ' 180' ' ' ILE . 2.8 mm? -111.04 131.02 55.41 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.627 1.171 . . . . 0.0 108.257 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.57 165.5 25.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.797 0.439 . . . . 0.0 110.375 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 68.56 1.61 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.01 1.29 . . . . 0.0 112.431 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.55 121.55 8.06 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 CA-C-N 120.652 2.226 . . . . 0.0 109.616 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.57 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.968 1.778 . . . . 0.0 113.148 -171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.47 15.59 6.35 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.141 -0.81 . . . . 0.0 111.726 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t 65.75 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.985 1.85 . . . . 0.0 109.412 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.43 -11.51 0.04 OUTLIER Glycine 0 CA--C 1.529 0.937 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.753 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -15.99 7.03 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.27 -1.135 . . . . 0.0 113.225 172.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -38.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.066 2.146 . . . . 0.0 110.608 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 m -71.05 -29.59 65.52 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.286 -0.884 . . . . 0.0 109.103 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 177' ' ' LEU . 69.5 mt -61.78 -52.81 62.7 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mm -58.96 -43.9 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -49.17 -63.59 1.06 Allowed 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -59.77 -36.68 77.17 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.67 0.606 . . . . 0.0 111.754 177.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.77 88.57 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 120.262 1.392 . . . . 0.0 109.723 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -67.89 -47.69 68.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.751 0.82 . . . . 0.0 109.458 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.3 -36.56 61.34 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.678 1.191 . . . . 0.0 112.234 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 20' ' ' LYS . 89.7 t -63.5 -45.32 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.592 -0.693 . . . . 0.0 110.494 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.17 -36.75 80.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.82 -44.74 90.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.4 t -58.76 -36.47 74.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.89 1.676 . . . . 0.0 110.446 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 t -77.24 -2.37 34.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.813 1.645 . . . . 0.0 112.556 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.04 13.04 72.38 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.589 1.086 . . . . 0.0 113.102 -174.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.8 122.95 87.36 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 119.247 1.524 . . . . 0.0 107.19 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.14 118.83 5.87 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.842 2.362 . . . . 0.0 109.63 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -115.66 141.12 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 107.761 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.09 167.88 16.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 163.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.11 -161.96 25.98 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -145.07 166.95 23.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.783 1.292 . . . . 0.0 111.794 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -137.43 177.82 7.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.445 1.02 . . . . 0.0 110.004 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.6 p -139.65 74.62 1.48 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.016 1.389 . . . . 0.0 110.534 -168.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -76.35 23.63 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.118 2.167 . . . . 0.0 115.581 -163.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.316 7.8 pt-20 51.72 113.67 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.795 2.838 . . . . 0.0 114.023 -162.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.566 HG13 HG13 ' A' ' 47' ' ' ILE . 8.0 p -71.86 121.28 21.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.087 -1.008 . . . . 0.0 108.439 176.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -131.6 120.71 23.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -86.62 -2.61 58.65 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.359 0.6 . . . . 0.0 111.186 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.66 65.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 -171.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.61 -5.36 1.7 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.486 2.469 . . . . 0.0 117.075 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -92.02 147.5 22.91 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 120.023 1.912 . . . . 0.0 108.278 177.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -74.4 139.21 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 161.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -132.05 -17.53 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.863 1.265 . . . . 0.0 111.587 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 168.6 -128.63 1.73 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 165.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -138.91 153.62 48.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 171.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -130.39 152.63 49.59 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.294 2.638 . . . . 0.0 106.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.52 107.91 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 119.539 1.063 . . . . 0.0 110.511 -162.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.1 109.4 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.879 -157.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.3 p -75.97 145.79 40.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -15.54 62.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.643 . . . . 0.0 111.735 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t -62.05 -45.41 93.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 108.912 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.78 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.037 0.827 . . . . 0.0 112.587 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 169.35 15.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.125 1.37 . . . . 0.0 110.167 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -152.65 138.7 18.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.109 1.764 . . . . 0.0 107.881 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.85 173.08 22.01 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 120.142 1.337 . . . . 0.0 112.022 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 168.04 18.35 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.607 2.205 . . . . 0.0 109.176 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -157.54 -59.33 0.08 Allowed 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -141.42 153.4 44.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.461 0.573 . . . . 0.0 109.711 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -138.47 159.26 42.52 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.334 1.054 . . . . 0.0 109.296 170.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.97 128.89 24.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.8 164.27 26.77 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.56 167.03 4.68 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.751 0.786 . . . . 0.0 109.45 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.83 144.95 80.26 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.59 132.7 27.76 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.279 1.986 . . . . 0.0 109.175 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 165.8 29.64 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.548 2.165 . . . . 0.0 110.009 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 80.16 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.75 2.3 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.02 -83.65 0.11 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 131.72 49.82 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -146.67 137.41 23.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -159.26 63.23 0.39 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.7 m 59.45 -159.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.573 1.549 . . . . 0.0 109.585 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER 157.57 155.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 1 C-N-CA 131.75 4.02 . . . . 0.0 109.758 166.268 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.33 100.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -170.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.36 -63.4 2.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.296 1.427 . . . . 0.0 113.684 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.33 -18.94 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 111.556 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.09 169.35 10.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 25.6 t -110.68 115.08 48.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 166.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.5 170.63 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 166.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.41 141.77 39.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 163.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.11 -34.6 73.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.905 0.882 . . . . 0.0 109.298 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -36.72 84.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.695 0.679 . . . . 0.0 111.27 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 m -61.08 -34.99 75.8 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.538 1.063 . . . . 0.0 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 61' ' ' LEU . 4.9 m-85 -63.51 -61.87 2.04 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.219 0.208 . . . . 0.0 110.614 165.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -22.42 25.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.196 1.398 . . . . 0.0 113.216 -169.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -45.87 -48.98 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.086 0.954 . . . . 0.0 112.121 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -31.21 0.95 Allowed 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.84 1.256 . . . . 0.0 111.239 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.96 86.04 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 119.615 1.098 . . . . 0.0 110.587 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -52.38 68.11 Favored Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 120.285 -1.509 . . . . 0.0 112.168 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.32 -16.94 21.79 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.503 1.469 . . . . 0.0 113.797 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -41.97 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 122.022 2.192 . . . . 0.0 109.042 169.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.39 -38.48 78.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -155.39 91.02 1.29 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.993 1.269 . . . . 0.0 111.172 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 t30 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 154.252 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.283 0.563 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 -137.54 171.52 14.33 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.138 1.775 . . . . 0.0 108.103 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.96 151.26 34.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.12 153.0 39.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.9 t -135.89 117.84 20.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 108.223 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.69 63.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -65.98 -48.72 70.32 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.74 65.64 2.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.467 1.507 . . . . 0.0 112.668 -167.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 90.8 mt -108.64 147.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 120.159 -1.588 . . . . 0.0 107.016 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 -80.14 0.36 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-O 118.827 -0.985 . . . . 0.0 111.353 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -59.65 -25.58 64.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.205 1.503 . . . . 0.0 111.842 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.86 -10.29 51.82 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 115.118 -2.372 . . . . 0.0 113.353 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -49.62 -17.32 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -159.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.82 -23.17 9.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.831 1.252 . . . . 0.0 112.557 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -87.88 -31.33 19.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.356 1.462 . . . . 0.0 111.154 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.53 117.8 2.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.944 1.698 . . . . 0.0 109.553 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -120.56 -64.21 1.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.642 0.656 . . . . 0.0 111.808 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.37 -14.86 60.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.552 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.56 -73.42 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.646 1.978 . . . . 0.0 112.128 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -42.66 -37.41 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.856 1.662 . . . . 0.0 113.294 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -73.58 -68.97 0.46 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.187 0.903 . . . . 0.0 110.558 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.65 -41.65 77.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 112.29 -167.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.3 -51.46 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.201 1.4 . . . . 0.0 108.407 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -63.3 -30.99 72.02 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.062 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.05 -57.02 14.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.245 1.384 . . . . 0.0 108.943 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 m -65.51 -29.51 70.16 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.845 -0.534 . . . . 0.0 112.359 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.0 -30.15 66.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.711 0.687 . . . . 0.0 110.495 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.9 t -64.12 -35.2 80.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.322 1.049 . . . . 0.0 109.543 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.0 m -73.16 133.08 81.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.807 0.731 . . . . 0.0 109.906 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.09 -30.21 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.824 2.349 . . . . 0.0 112.854 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.48 -31.25 34.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.208 -1.329 . . . . 0.0 113.398 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 m -73.26 162.87 28.87 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.672 1.736 . . . . 0.0 108.395 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.0 mt -140.57 98.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.74 145.49 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.426 0.557 . . . . 0.0 109.715 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 115.24 11.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.042 2.137 . . . . 0.0 106.495 167.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.12 25.01 Favored Glycine 0 N--CA 1.464 0.543 0 CA-C-N 120.34 1.427 . . . . 0.0 112.708 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.9 m -117.36 87.42 2.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.34 110.73 16.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.36 158.52 57.17 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.79 153.11 95.68 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.36 -77.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.413 2.075 . . . . 0.0 107.926 166.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? 153.45 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.392 1 C-N-CA 131.798 4.039 . . . . 0.0 104.234 -168.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.53 0.05 OUTLIER Glycine 0 CA--C 1.5 -0.845 0 O-C-N 124.105 0.878 . . . . 0.0 114.908 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.443 ' HG2' ' HD2' ' A' ' 150' ' ' PRO 0.33 0.0 OUTLIER -165.31 172.28 4.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 130.391 3.476 . . . . 0.0 105.903 163.067 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.443 ' HD2' ' HG2' ' A' ' 149' ' ' LYS . 57.2 Cg_endo -67.96 162.16 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 1 C-N-CA 125.337 4.025 . . . . 0.0 109.466 165.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.52 175.27 5.54 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.054 -1.029 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.62 16.75 25.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 112.447 172.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.48 -53.52 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.421 1.088 . . . . 0.0 108.268 168.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.78 -21.14 27.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.661 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -48.18 -39.9 22.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.472 1.109 . . . . 0.0 111.357 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -25.72 66.21 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.848 1.259 . . . . 0.0 111.136 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.5 mp -102.01 -38.05 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.244 1.418 . . . . 0.0 108.901 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -28.44 69.33 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.802 -1.186 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -52.71 -47.93 66.96 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 125.069 1.348 . . . . 0.0 110.565 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 78.2 5.9 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -56.94 -13.48 2.71 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.559 0.743 . . . . 0.0 111.557 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -39.04 56.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.193 2.197 . . . . 0.0 111.955 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 3' ' ' HIS . 18.9 m -48.55 128.82 4.77 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 125.602 1.561 . . . . 0.0 109.025 176.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 46.8 tptt -61.13 106.68 0.63 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 166.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -83.52 105.34 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 163.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 6' ' ' LEU . 36.8 m-85 -75.9 92.89 3.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 163.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 107.15 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 162.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.76 163.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.6 p -122.92 154.33 38.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.217 0.917 . . . . 0.0 108.999 164.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.65 1.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.784 1.633 . . . . 0.0 113.034 162.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -92.58 -36.81 12.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.347 0.976 . . . . 0.0 111.243 171.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.73 HD21 HD12 ' A' ' 176' ' ' LEU . 2.3 p-10 -127.0 7.57 6.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 113.665 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -44.36 -55.36 5.03 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.613 1.565 . . . . 0.0 115.064 -164.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -83.8 18.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.923 1.238 . . . . 0.0 113.164 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -131.56 13.95 4.96 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 117.244 -1.36 . . . . 0.0 113.788 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.73 HD12 HD21 ' A' ' 172' ' ' ASN . 0.7 OUTLIER -88.1 -13.9 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.663 1.574 . . . . 0.0 112.483 -177.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 17' ' ' LEU . 6.1 tp -30.44 -62.06 0.24 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.826 2.05 . . . . 0.0 111.627 173.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.78 -27.81 43.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.935 1.756 . . . . 0.0 112.774 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -70.05 -39.54 75.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.363 0.983 . . . . 0.0 108.988 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 6' ' ' LEU . 3.7 mt -57.93 -58.8 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 117.583 -1.199 . . . . 0.0 107.942 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.531 ' HA ' HG23 ' A' ' 184' ' ' VAL . 9.1 t -57.12 -27.55 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.897 0.771 . . . . 0.0 111.521 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.7 m -67.48 -29.16 68.52 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.756 -1.215 . . . . 0.0 112.35 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 25.9 t -90.66 -33.72 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.393 -1.442 . . . . 0.0 108.514 -167.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -63.9 -63.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 125.244 1.418 . . . . 0.0 108.423 164.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -15.43 63.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 112.984 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.3 t -49.56 -37.97 29.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.229 1.412 . . . . 0.0 110.138 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-N 118.84 0.746 . . . . 0.0 112.078 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.425 ' HB2' HG12 ' A' ' 163' ' ' VAL . 51.0 m-70 -131.57 153.11 50.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.47 140.85 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.937 1.244 . . . . 0.0 108.9 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 143' ' ' ILE . 16.3 m-85 -133.87 146.92 51.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.152 0.981 . . . . 0.0 109.799 177.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 180' ' ' ILE . 87.7 mt -93.44 151.38 19.78 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 123.897 0.748 . . . . 0.0 109.265 157.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -151.08 179.89 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.29 1.436 . . . . 0.0 107.994 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.92 -176.92 24.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 122.22 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.856 2.371 . . . . 0.0 112.337 -167.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.82 91.09 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.944 3.763 . . . . 0.0 112.972 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.96 74.76 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.263 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 10.2 p 22.8 78.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.568 2.747 . . . . 0.0 113.542 159.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.31 -36.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.901 1.715 . . . . 0.0 109.348 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.88 -34.85 76.77 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.25 177.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 m -56.48 -44.5 80.69 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.323 -1.322 . . . . 0.0 108.948 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.409 HG22 ' HD3' ' A' ' 20' ' ' LYS . 31.1 m -53.9 -36.97 63.29 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 120.067 1.303 . . . . 0.0 111.904 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.17 69.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.942 1.247 . . . . 0.0 110.614 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.24 -43.36 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -52.42 65.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.214 1.406 . . . . 0.0 109.37 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 16' ' ' THR . 4.6 mptp? -53.03 -45.68 68.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.655 171.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.85 27.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.638 -1.173 . . . . 0.0 113.943 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.5 p -80.54 -51.53 8.66 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 120.056 1.298 . . . . 0.0 110.296 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 4.0 pt-20 -57.87 -32.46 67.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.06 0.544 . . . . 0.0 111.067 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.87 -64.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.006 1.322 . . . . 0.0 108.367 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 mt -52.22 -41.31 62.62 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.965 1.306 . . . . 0.0 110.09 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 23' ' ' GLU . 45.3 mtmt -66.47 -46.26 76.96 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -34.29 75.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.019 0.927 . . . . 0.0 110.54 172.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 m -61.8 -41.73 98.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.446 1.021 . . . . 0.0 110.433 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.44 9.21 10.5 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 126.343 1.925 . . . . 0.0 112.745 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.46 130.81 73.15 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.04 139.61 43.17 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.908 1.739 . . . . 0.0 109.106 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.65 157.35 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.574 1.55 . . . . 0.0 107.804 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 174.76 13.71 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.109 -0.37 . . . . 0.0 111.916 163.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.83 -158.07 22.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 124.92 1.248 . . . . 0.0 111.087 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -146.13 162.82 37.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.115 1.366 . . . . 0.0 108.753 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -149.54 125.36 10.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.687 1.195 . . . . 0.0 107.961 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -84.73 70.46 10.81 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 120.919 -1.113 . . . . 0.0 109.559 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -79.44 48.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -166.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 52.14 -174.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.431 2.062 . . . . 0.0 112.62 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.0 t -125.13 93.58 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 150.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -91.42 103.5 16.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 160.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -79.6 104.4 10.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 165.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.93 50.71 11.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.33 0.968 . . . . 0.0 111.713 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.27 -13.95 18.33 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 117.369 -1.795 . . . . 0.0 115.891 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.73 129.43 39.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.254 2.527 . . . . 0.0 109.369 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -86.35 68.18 10.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.433 1.111 . . . . 0.0 112.735 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 pt -89.63 -2.46 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -168.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.67 -166.07 32.22 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 120.187 1.358 . . . . 0.0 111.797 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -138.54 149.54 45.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.9 153.65 51.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.86 154.47 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 164.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -140.32 154.81 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.841 2.057 . . . . 0.0 106.639 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.7 p -117.77 174.95 5.89 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.755 2.07 . . . . 0.0 110.7 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 54' ' ' LEU . 2.1 mm? -79.81 21.3 0.55 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.915 -1.115 . . . . 0.0 112.537 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -126.38 -12.76 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 -2.31 27.74 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.61 1.096 . . . . 0.0 112.935 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.87 160.41 32.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.865 1.832 . . . . 0.0 110.065 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.22 164.22 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.517 1.927 . . . . 0.0 107.251 165.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.75 140.63 9.66 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -82.78 63.89 8.01 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.282 3.988 . . . . 0.0 111.745 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.96 -63.66 1.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.104 1.761 . . . . 0.0 111.598 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 p -143.59 152.49 41.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.867 1.212 . . . . 0.0 109.764 172.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 168.83 18.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.04 129.08 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.17 45.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 -164.74 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.701 1.6 . . . . 0.0 109.219 -175.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 76' ' ' ARG . 6.6 mt-10 -129.11 154.87 80.52 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.09 125.31 12.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.604 2.203 . . . . 0.0 111.612 -163.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.56 162.94 39.98 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.225 1.95 . . . . 0.0 110.488 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.47 137.35 46.41 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.038 1.825 . . . . 0.0 109.639 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.36 -1.99 73.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.968 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -99.43 163.0 12.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.534 1.667 . . . . 0.0 107.544 163.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -141.3 145.66 35.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 162.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -155.23 -175.33 5.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.9 2.08 . . . . 0.0 107.179 166.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.68 162.56 28.78 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 119.679 -1.888 . . . . 0.0 109.98 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -168.87 135.04 1.75 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.757 1.223 . . . . 0.0 107.705 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.27 15.59 6.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 118.112 0.414 . . . . 0.0 110.294 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 76' ' ' ARG . . . 94.9 114.76 2.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.837 -2.505 . . . . 0.0 106.837 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 68.32 -51.42 0.55 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.588 2.355 . . . . 0.0 113.602 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.54 157.7 16.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.737 2.015 . . . . 0.0 108.391 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.86 123.17 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 171.26 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 110.555 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -156.61 107.71 2.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.918 0.781 . . . . 0.0 112.881 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.6 -35.48 4.05 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.857 1.662 . . . . 0.0 113.054 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -34.45 74.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.936 -1.102 . . . . 0.0 112.048 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.8 t -58.15 -38.66 77.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.622 1.556 . . . . 0.0 110.562 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -64.46 -46.63 82.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.513 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -52.38 -30.1 27.26 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.739 0.699 . . . . 0.0 111.91 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 90' ' ' LEU . 2.6 mt-30 -69.76 -29.97 67.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.23 -0.919 . . . . 0.0 113.184 -173.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -141.15 -44.68 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.439 0.563 . . . . 0.0 111.862 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.97 37.54 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.998 1.719 . . . . 0.0 112.05 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.432 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -129.99 -65.18 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 127.068 2.147 . . . . 0.0 108.053 175.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 31.2 Cg_endo -62.09 -27.48 79.07 Favored 'Trans proline' 0 C--N 1.351 0.676 0 CA-C-N 121.562 1.593 . . . . 0.0 112.965 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.31 -24.71 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.727 0.811 . . . . 0.0 112.599 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.109 0.868 . . . . 0.0 111.335 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -133.31 72.95 1.49 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.692 1.234 . . . . 0.0 108.705 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.367 169.593 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -115.52 98.18 6.58 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.253 1.021 . . . . 0.0 109.991 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.53 110.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 26.7 t -108.0 108.22 19.24 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.84 127.88 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.463 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.677 HD13 HG23 ' A' ' 128' ' ' VAL . 4.2 mt -141.04 74.97 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -77.14 174.9 10.18 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.099 1.318 . . . . 0.0 110.015 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 42.38 67.19 0.63 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.893 2.477 . . . . 0.0 114.368 169.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 111' ' ' ILE 0.258 6.7 mt -86.6 -0.39 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 120.521 -1.362 . . . . 0.0 111.707 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.01 -61.68 2.62 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.703 -1.248 . . . . 0.0 113.527 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -54.74 -41.69 70.72 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.583 1.691 . . . . 0.0 114.304 -160.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mmt -78.9 -5.54 53.91 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.289 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -41.16 -41.49 1.81 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -161.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 119' ' ' LEU . 4.4 mp -68.44 -60.1 2.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.009 0.924 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.18 -30.07 71.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.761 1.624 . . . . 0.0 111.826 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 t -39.84 107.92 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.032 2.933 . . . . 0.0 110.1 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.71 -78.6 0.56 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.622 1.169 . . . . 0.0 109.276 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.27 -31.21 61.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.623 0.769 . . . . 0.0 110.782 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -60.01 3.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 125.474 1.51 . . . . 0.0 111.424 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 mp -41.14 -58.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.113 1.765 . . . . 0.0 111.922 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -65.05 -47.37 77.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 118.588 0.631 . . . . 0.0 110.483 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.83 66.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 124.144 0.903 . . . . 0.0 110.083 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.677 HG23 HD13 ' A' ' 111' ' ' ILE . 2.4 p -62.05 -32.38 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 121.527 -0.733 . . . . 0.0 110.24 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.49 -35.57 60.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.41 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -38.77 79.01 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.564 1.074 . . . . 0.0 110.486 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.53 -44.28 24.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.328 1.051 . . . . 0.0 110.41 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.82 -18.19 64.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.537 1.062 . . . . 0.0 112.543 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.7 m -82.12 -22.15 36.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.046 0.839 . . . . 0.0 111.92 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.5 m -87.31 133.17 39.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -79.35 -27.47 4.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.547 2.831 . . . . 0.0 111.487 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.07 81.95 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.993 -0.893 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 5.4 m -67.08 150.09 49.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.056 1.928 . . . . 0.0 110.068 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.77 107.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -69.82 133.35 32.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 140' ' ' LEU . 12.4 tp -142.56 97.82 3.18 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.799 1.312 . . . . 0.0 108.25 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.6 -172.1 17.35 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 114.616 0.606 . . . . 0.0 114.616 -169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.8 m -136.63 112.0 9.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.66 1.184 . . . . 0.0 113.296 175.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 5' ' ' PHE . 19.7 pt -108.89 154.32 41.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.251 1.02 . . . . 0.0 110.906 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.03 159.73 52.15 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.727 1.618 . . . . 0.0 111.749 172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.71 149.79 97.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.456 168.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.5 104.09 1.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.155 1.903 . . . . 0.0 109.489 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -82.77 -63.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.06 107.9 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.99 168.52 0.11 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.602 1.961 . . . . 0.0 111.483 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.68 169.78 1.62 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.335 3.357 . . . . 0.0 111.292 165.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mp -126.42 153.71 44.63 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.13 -44.9 83.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -165.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.459 ' CD1' HD11 ' A' ' 157' ' ' ILE . 0.4 OUTLIER -80.43 -33.77 36.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.928 0.785 . . . . 0.0 109.362 173.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.57 -23.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.213 -1.555 . . . . 0.0 110.348 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -58.02 10.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.904 2.082 . . . . 0.0 109.398 166.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.48 63.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.896 1.279 . . . . 0.0 111.534 177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.459 HD11 ' CD1' ' A' ' 153' ' ' LEU . 4.7 mm -73.98 -51.39 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 118.465 0.575 . . . . 0.0 110.268 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -24.56 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.723 0.809 . . . . 0.0 110.322 -170.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -55.88 -26.43 47.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.754 1.222 . . . . 0.0 111.611 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -66.45 -35.87 81.37 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.824 -1.173 . . . . 0.0 111.514 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 53.87 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.657 2.783 . . . . 0.0 115.758 -167.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.4 41.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.736 2.014 . . . . 0.0 111.273 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 3' ' ' HIS . 12.3 m -87.2 134.15 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 119.853 -1.78 . . . . 0.0 106.734 166.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -74.22 112.0 9.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 165.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.83 90.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 32.7 m-85 -75.05 118.95 18.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 167.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 89.56 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.29 143.98 14.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.5 p -121.29 147.99 44.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -54.96 -14.66 1.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.366 166.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -81.82 -56.68 3.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.1 0.864 . . . . 0.0 108.882 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.7 6.01 49.53 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.606 -171.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -32.36 -57.26 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.276 2.23 . . . . 0.0 112.219 -172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -84.09 5.05 27.55 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.29 -17.35 21.73 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.05 1.34 . . . . 0.0 112.231 165.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -80.73 -23.63 39.33 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.042 -169.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -57.9 9.27 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.196 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.45 -22.35 52.17 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.75 2.3 . . . . 0.0 114.271 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.22 73.64 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 6' ' ' LEU . 11.3 mt -67.72 -46.63 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.196 0.998 . . . . 0.0 109.262 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.8 t -50.41 -49.15 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.26 1.024 . . . . 0.0 109.21 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 97.6 m -58.14 -51.28 70.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.15 0.887 . . . . 0.0 108.857 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.95 -27.09 69.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.64 -68.4 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 117.294 -1.336 . . . . 0.0 107.944 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -53.54 -24.54 13.75 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.477 1.511 . . . . 0.0 112.558 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.81 -41.97 5.32 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.179 1.792 . . . . 0.0 112.073 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.053 1.341 . . . . 0.0 107.465 -162.744 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.82 174.6 6.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.046 0.938 . . . . 0.0 110.232 -167.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.86 143.98 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -139.88 150.38 44.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.608 1.163 . . . . 0.0 109.036 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.09 142.62 38.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 125.445 1.498 . . . . 0.0 107.817 -171.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 t -156.82 -169.69 3.06 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 123.541 0.526 . . . . 0.0 110.694 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 145' ' ' VAL . . . 110.69 -174.9 17.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.826 1.679 . . . . 0.0 110.378 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.45 161.45 45.97 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.339 2.026 . . . . 0.0 110.14 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 140.94 46.94 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.33 2.02 . . . . 0.0 110.848 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.24 16.39 4.15 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.713 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.297 5.8 m 44.23 33.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.485 2.314 . . . . 0.0 115.543 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.1 20.54 0.25 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.03 -1.428 . . . . 0.0 113.085 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -69.25 0.21 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.148 1.474 . . . . 0.0 110.308 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -30.5 71.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.333 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 97.1 m -52.51 -52.21 55.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.293 1.406 . . . . 0.0 109.187 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -48.52 78.9 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.389 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -66.39 -45.65 88.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.861 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -44.72 84.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.024 1.283 . . . . 0.0 107.893 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -64.69 -23.76 67.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 124.135 0.897 . . . . 0.0 111.417 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.1 -38.81 26.67 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 125.331 1.453 . . . . 0.0 110.323 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -62.89 -53.12 59.0 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.28 -34.56 72.43 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.07 -49.08 85.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.786 0.834 . . . . 0.0 109.178 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.93 -39.39 76.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' A' ' 54' ' ' LEU . 76.5 mttt -57.31 -49.12 77.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.428 1.013 . . . . 0.0 109.406 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 t -49.92 -51.57 39.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.381 2.273 . . . . 0.0 106.949 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -65.56 15.67 0.03 OUTLIER 'General case' 0 C--O 1.236 0.35 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 173.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.8 19.78 56.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.913 1.244 . . . . 0.0 112.84 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 26' ' ' LYS . 6.0 p -56.87 149.8 41.59 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.78 109.68 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.799 1.666 . . . . 0.0 109.613 159.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.95 171.85 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.596 0.758 . . . . 0.0 109.102 169.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.07 172.61 18.1 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.067 2.547 . . . . 0.0 105.109 165.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.82 -159.11 22.1 Favored Glycine 0 C--O 1.237 0.304 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.68 169.72 17.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.522 0.661 . . . . 0.0 111.994 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -135.73 165.86 24.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -125.62 80.52 1.9 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.9 155.23 40.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 167.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -71.18 125.92 28.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.9 t -80.26 126.36 39.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -127.38 167.18 16.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.533 1.133 . . . . 0.0 110.295 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.48 29.34 2.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.349 1.46 . . . . 0.0 109.728 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.48 -21.19 0.4 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.456 -1.402 . . . . 0.0 114.045 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.22 6.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.416 1.484 . . . . 0.0 110.308 -163.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 140.01 46.43 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 118.522 1.161 . . . . 0.0 108.467 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.517 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.28 135.34 51.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 160.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.0 pt -133.41 -2.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 111.548 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.6 -157.93 27.55 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.22 135.04 30.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.112 2.165 . . . . 0.0 106.12 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.55 164.04 13.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.931 1.293 . . . . 0.0 107.945 168.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.3 p -113.73 104.8 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.02 112.26 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 123.872 0.869 . . . . 0.0 109.889 -160.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -68.59 152.63 45.1 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 109.219 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.3 mm? -68.73 -2.6 9.66 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.808 170.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -110.56 18.94 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.254 1.822 . . . . 0.0 111.531 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.89 0.96 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.371 -0.83 . . . . 0.0 114.709 160.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 m -115.29 166.12 12.2 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.702 1.251 . . . . 0.0 108.133 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -154.09 142.61 20.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.31 -1.494 . . . . 0.0 108.377 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.26 142.7 14.29 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 118.457 -1.191 . . . . 0.0 111.656 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.84 64.78 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 126.144 4.563 . . . . 0.0 113.565 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.93 -59.89 4.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 112.231 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.8 p -146.75 140.28 25.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 120.608 1.549 . . . . 0.0 108.227 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptt-85 -155.81 65.28 0.59 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.845 0.748 . . . . 0.0 110.725 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.827 HG12 ' H ' ' A' ' 65' ' ' GLY 0.335 41.8 t 58.71 -153.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -170.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.827 ' H ' HG12 ' A' ' 64' ' ' VAL . . . 134.08 141.88 4.58 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 129.21 3.291 . . . . 0.0 107.333 -166.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 147.23 53.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 155.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 146.65 99.06 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.54 127.75 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.003 1.802 . . . . 0.0 110.233 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.34 169.2 22.22 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.682 2.921 . . . . 0.0 110.718 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.94 -0.92 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.523 2.148 . . . . 0.0 114.306 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.48 5.34 29.76 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.987 1.28 . . . . 0.0 113.844 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 156.87 43.19 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 120.599 2.199 . . . . 0.0 109.598 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -154.13 155.69 35.84 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 162.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -149.68 26.04 0.84 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.188 1.795 . . . . 0.0 107.808 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.3 m 55.67 -179.39 0.04 OUTLIER 'General case' 0 C--N 1.345 0.405 0 C-N-CA 127.699 2.399 . . . . 0.0 112.501 -165.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.04 170.19 13.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 109.737 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 77' ' ' VAL . 24.1 m -127.97 77.62 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 107.822 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.54 -113.36 4.14 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -162.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -29.2 54.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -166.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.81 146.15 23.99 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 121.601 2.0 . . . . 0.0 107.368 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.2 t -95.08 137.93 22.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.03 177.25 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 123.612 0.765 . . . . 0.0 109.815 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -148.85 113.59 5.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 157.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -25.06 67.38 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.949 -1.094 . . . . 0.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 m -55.85 -31.76 63.04 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.814 1.246 . . . . 0.0 110.235 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.4 t -62.0 -37.23 84.04 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.931 1.241 . . . . 0.0 110.203 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -64.62 -50.83 65.61 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -18.7 37.41 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.103 -0.998 . . . . 0.0 113.53 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -64.47 -57.88 7.98 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.86 -1.15 . . . . 0.0 110.47 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -128.72 -33.32 2.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.786 1.234 . . . . 0.0 112.334 -166.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.17 46.92 0.75 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.68 1.192 . . . . 0.0 108.895 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -61.05 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.051 2.14 . . . . 0.0 107.844 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.17 -21.68 48.15 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.779 1.653 . . . . 0.0 112.962 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.67 -34.32 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 119.394 0.997 . . . . 0.0 112.053 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.85 3.83 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -168.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -112.12 87.19 2.51 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.864 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.806 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.471 HE21 HD11 ' A' ' 138' ' ' ILE . 7.1 mt-30 . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.53 168.07 12.89 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.626 0.771 . . . . 0.0 110.772 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.2 158.03 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 159.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.21 153.58 50.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 163.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.9 120.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -166.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.32 86.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -171.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.47 175.62 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.242 -0.912 . . . . 0.0 109.898 -169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 56.25 39.8 30.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.416 1.086 . . . . 0.0 112.352 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CG2' HD12 ' A' ' 153' ' ' LEU . 17.4 mt -81.68 59.35 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 119.725 -1.859 . . . . 0.0 109.685 -175.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.48 -54.64 0.26 Allowed Glycine 0 N--CA 1.465 0.598 0 O-C-N 120.164 -1.585 . . . . 0.0 113.649 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 8.23 3.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -114.81 13.36 17.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.867 1.212 . . . . 0.0 110.266 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -40.51 -42.19 1.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.635 2.374 . . . . 0.0 113.0 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.62 -17.03 10.67 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 124.048 0.939 . . . . 0.0 111.997 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.76 -12.72 23.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.569 0.622 . . . . 0.0 111.069 -171.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -61.24 101.61 0.17 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 119.215 0.916 . . . . 0.0 109.907 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -99.7 -78.33 0.51 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.4 mt -56.42 -24.78 47.36 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.88 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -71.5 0.07 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.2 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.3 mp -30.9 -54.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.969 1.708 . . . . 0.0 112.238 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -71.14 -62.77 1.27 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.569 0.348 . . . . 0.0 111.347 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.59 91.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.903 0.858 . . . . 0.0 109.902 -167.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.77 -54.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 117.328 -1.32 . . . . 0.0 107.943 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -57.69 -31.2 66.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.287 2.312 . . . . 0.0 113.799 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -59.62 -45.65 91.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.031 0.932 . . . . 0.0 108.944 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.8 m -63.42 -42.5 98.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.408 1.483 . . . . 0.0 111.078 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.15 -35.28 74.96 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.169 -0.957 . . . . 0.0 110.63 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.7 m -90.27 1.47 56.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.474 1.51 . . . . 0.0 112.992 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.7 m -72.18 134.08 83.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.2 118.14 5.52 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 123.154 2.569 . . . . 0.0 108.051 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.37 -3.96 86.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 117.36 -1.8 . . . . 0.0 114.64 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.3 m -67.68 153.24 44.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.555 2.178 . . . . 0.0 107.468 163.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 HE21 ' A' ' 106' ' ' GLN . 49.7 mt -134.64 95.2 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -166.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.49 140.57 19.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.2 100.95 5.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.374 1.87 . . . . 0.0 106.207 163.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -124.38 166.78 16.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.4 m -124.21 117.49 24.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.01 132.84 24.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.485 2.314 . . . . 0.0 109.448 -173.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.36 137.5 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.429 2.086 . . . . 0.0 110.557 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 8' ' ' GLY . 4.5 p -64.49 122.1 76.5 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 110.695 -168.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.42 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.411 2.741 . . . . 0.0 109.411 -171.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -138.6 110.14 7.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 166.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.02 -26.08 6.37 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-O 116.544 -2.253 . . . . 0.0 114.909 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 132.82 24.39 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 121.684 2.742 . . . . 0.0 112.274 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.26 96.44 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.701 2.934 . . . . 0.0 108.538 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 112.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.72 -59.77 3.74 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 113.997 -168.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 114' ' ' ILE . 1.6 tm? -63.44 -41.42 98.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.898 0.772 . . . . 0.0 109.925 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.29 -30.05 47.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.716 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.75 -35.51 74.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.621 172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.71 -56.59 17.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.766 1.621 . . . . 0.0 109.062 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.73 -29.61 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.159 0.984 . . . . 0.0 111.125 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.79 -37.85 76.47 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 120.606 -1.309 . . . . 0.0 109.516 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.63 -19.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.174 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -23.25 50.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.934 1.243 . . . . 0.0 110.886 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.37 -55.26 0.26 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 127.623 2.369 . . . . 0.0 113.43 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -60.26 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 1 C-N-CA 132.726 4.411 . . . . 0.0 113.077 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 t -138.95 121.52 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 15.2 tptm -64.94 123.16 18.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.6 t -102.33 91.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 9.7 m-85 -81.92 102.88 11.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.837 0.855 . . . . 0.0 110.216 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.62 98.13 6.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.125 0.97 . . . . 0.0 109.105 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.32 158.3 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 50.0 p -121.54 158.72 27.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -57.87 -24.42 57.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.111 163.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.65 -72.43 0.43 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.825 0.85 . . . . 0.0 110.539 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -86.85 30.82 0.72 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.864 1.265 . . . . 0.0 109.798 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -48.2 -60.48 2.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.679 1.592 . . . . 0.0 109.898 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -77.37 4.21 11.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -97.54 -6.01 34.49 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.843 1.657 . . . . 0.0 111.852 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.1 tp -74.13 -39.97 62.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.506 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 tp -40.87 -64.05 0.67 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 111.54 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.13 -25.22 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 121.482 1.565 . . . . 0.0 111.806 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.08 -38.63 75.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.584 1.554 . . . . 0.0 109.858 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.95 -54.09 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 109.484 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.34 -41.7 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.436 0.562 . . . . 0.0 109.54 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.5 m -56.0 -47.85 76.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.972 1.309 . . . . 0.0 109.101 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -47.79 84.29 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.944 0.793 . . . . 0.0 110.826 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.57 -48.32 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.304 0.642 . . . . 0.0 109.97 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.59 55.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.881 1.273 . . . . 0.0 110.102 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 t -55.94 -40.51 73.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.903 1.281 . . . . 0.0 109.644 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 112.745 178.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.445 ' HB2' HG12 ' A' ' 163' ' ' VAL . 66.0 m-70 -89.32 155.84 19.11 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.287 1.435 . . . . 0.0 109.493 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -129.37 132.29 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.774 1.23 . . . . 0.0 108.989 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 5.3 m-85 -141.78 136.06 30.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.455 1.102 . . . . 0.0 108.574 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.42 147.79 22.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 t -143.35 161.89 37.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.827 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.46 -175.52 20.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.351 0.977 . . . . 0.0 111.176 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.87 166.47 29.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 111.78 -171.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.44 157.09 62.28 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.462 2.108 . . . . 0.0 110.355 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.22 -9.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 117.608 -1.662 . . . . 0.0 115.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t 61.74 102.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.217 1.807 . . . . 0.0 109.535 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.35 -7.36 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.33 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -32.69 69.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.72 1.76 . . . . 0.0 110.901 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 m -61.98 -39.82 93.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -1.11 1.55 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.133 2.573 . . . . 0.0 112.676 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' A' ' 176' ' ' LEU . 19.8 mt -101.87 -66.39 0.92 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 167.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 HD22 ' A' ' 140' ' ' LEU . 1.6 mp -63.13 -41.45 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.263 0.938 . . . . 0.0 111.797 -168.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.6 64.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -67.89 -32.07 72.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.183 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.09 80.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.888 0.875 . . . . 0.0 110.607 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 t -63.52 -58.25 7.59 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 108.798 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.0 -45.74 32.09 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.256 1.822 . . . . 0.0 112.083 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.43 -54.77 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.98 -0.45 . . . . 0.0 110.321 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.56 -32.78 74.33 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.916 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 mttt -59.47 -44.09 93.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.351 0.978 . . . . 0.0 109.044 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -12.3 61.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.877 0.871 . . . . 0.0 111.118 172.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -93.35 8.99 38.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.284 1.834 . . . . 0.0 114.646 170.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.82 21.24 71.12 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.346 -0.846 . . . . 0.0 111.947 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 26' ' ' LYS . 9.0 p -57.64 147.04 62.89 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.518 1.159 . . . . 0.0 109.096 169.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.81 106.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.883 2.388 . . . . 0.0 109.4 153.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.45 140.59 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 3.5 m-20 -151.48 138.87 19.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.944 0.898 . . . . 0.0 109.185 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.93 30.38 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 106.459 -2.656 . . . . 0.0 106.459 -166.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.8 176.23 10.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.862 1.331 . . . . 0.0 112.144 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -138.36 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -131.02 76.24 1.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 152.72 40.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.62 115.93 14.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.377 1.084 . . . . 0.0 111.993 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.3 t -78.22 96.4 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -102.3 119.27 38.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 167.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -75.21 -78.74 0.1 Allowed 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.01 59.24 0.36 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.03 -9.45 1.52 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.063 -171.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 137.79 32.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.808 1.804 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 143.14 46.14 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 pt -144.06 -6.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.231 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.74 -151.85 23.43 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 119.562 1.074 . . . . 0.0 111.688 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -138.57 164.54 29.2 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.072 1.749 . . . . 0.0 109.156 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.13 142.93 48.94 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 128.336 2.654 . . . . 0.0 104.6 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.13 152.34 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.63 1.172 . . . . 0.0 109.335 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.24 111.81 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 120.198 1.363 . . . . 0.0 112.048 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.431 HG22 HG11 ' A' ' 94' ' ' VAL . 80.6 p -63.78 145.97 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.634 0.773 . . . . 0.0 109.954 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.404 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.2 mm? -64.53 -16.88 63.32 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.55 -0.719 . . . . 0.0 112.336 169.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 t -66.48 -32.47 73.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.792 1.637 . . . . 0.0 109.635 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.78 21.23 3.28 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.053 -0.859 . . . . 0.0 114.827 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.6 m -128.71 152.2 48.68 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.661 1.73 . . . . 0.0 109.516 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -128.83 168.81 15.38 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.89 1.276 . . . . 0.0 112.087 -173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -150.67 179.97 26.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.898 170.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.6 174.48 6.38 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.809 3.006 . . . . 0.0 111.439 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -165.14 -64.51 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.806 -1.184 . . . . 0.0 110.135 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.91 141.43 29.04 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.3 38.55 0.25 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.251 15.2 t 62.54 176.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.499 1.519 . . . . 0.0 109.246 -167.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.93 152.13 6.05 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.428 1.966 . . . . 0.0 108.782 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 158.65 16.7 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.592 0.757 . . . . 0.0 111.522 -174.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.41 145.04 99.11 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.595 -0.691 . . . . 0.0 109.64 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.91 132.26 15.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.552 2.168 . . . . 0.0 110.105 -168.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 158.5 56.65 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.496 2.131 . . . . 0.0 110.659 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.36 121.52 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.41 2.073 . . . . 0.0 110.489 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.05 9.55 59.39 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.777 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -120.35 156.48 31.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.084 1.354 . . . . 0.0 107.62 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 156.35 40.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.381 1.472 . . . . 0.0 108.057 160.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -135.52 174.48 10.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.951 2.5 . . . . 0.0 105.334 160.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.9 m -73.17 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.342 1.057 . . . . 0.0 108.388 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.58 148.12 28.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.696 -1.252 . . . . 0.0 110.412 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.7 19.83 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -151.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.01 98.28 2.27 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 61.29 -69.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.551 1.94 . . . . 0.0 110.907 -159.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.86 139.04 57.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 111.237 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.23 132.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 159.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.15 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.774 1.23 . . . . 0.0 108.833 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.31 112.61 10.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.032 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.6 -35.77 79.6 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.025 -1.047 . . . . 0.0 109.86 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -64.63 -36.22 83.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.924 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.4 p -62.51 -33.99 75.99 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.08 1.309 . . . . 0.0 109.939 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.71 -55.37 17.72 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.28 1.032 . . . . 0.0 109.65 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.34 -13.38 0.34 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.252 1.421 . . . . 0.0 113.495 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.443 ' HB2' HD23 ' A' ' 90' ' ' LEU . 9.5 mt-30 -78.23 -24.97 46.76 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.351 -1.468 . . . . 0.0 114.277 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -147.15 -35.37 0.24 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.12 46.24 0.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.41 1.884 . . . . 0.0 111.498 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -64.92 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 116.877 -1.535 . . . . 0.0 108.095 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.95 -23.96 46.36 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.681 2.254 . . . . 0.0 113.511 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 53' ' ' THR . 15.4 m -58.47 -31.56 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 120.283 -1.511 . . . . 0.0 111.569 175.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.84 -10.35 59.42 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.473 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 167.95 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.943 2.497 . . . . 0.0 107.545 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 N--CA 1.451 -0.382 0 C-N-CA 123.756 0.823 . . . . 0.0 110.582 176.567 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.238 0.484 0 CA-C-O 121.392 0.615 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.32 164.43 38.77 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.007 2.523 . . . . 0.0 106.089 166.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -120.15 146.32 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.7 p -118.93 168.78 10.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.39 123.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -148.74 92.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -77.54 171.28 15.15 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.663 1.185 . . . . 0.0 109.804 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.8 27.28 4.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.482 1.513 . . . . 0.0 114.56 161.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD21 ' A' ' 153' ' ' LEU . 54.2 mt -74.34 76.94 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.887 1.327 . . . . 0.0 108.227 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.54 -42.99 0.04 OUTLIER Glycine 0 C--O 1.221 -0.684 0 CA-C-O 117.249 -1.862 . . . . 0.0 115.844 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -32.02 71.25 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 122.391 3.095 . . . . 0.0 111.181 175.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.1 mmt -78.35 1.52 21.63 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 116.863 -1.541 . . . . 0.0 114.003 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -34.97 -51.17 0.51 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.565 1.946 . . . . 0.0 114.593 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.57 -27.89 13.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 112.283 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.28 -23.23 51.17 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.023 0.929 . . . . 0.0 111.969 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.5 t -49.81 128.46 18.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.518 2.327 . . . . 0.0 111.149 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.15 -95.88 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.99 -15.99 26.93 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.993 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.92 -71.38 0.07 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 110.374 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.5 mt -32.59 -55.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 127.658 2.383 . . . . 0.0 110.871 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.03 -66.77 0.49 Allowed 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.31 -40.07 73.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.696 1.198 . . . . 0.0 111.515 -170.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.55 -51.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.892 2.077 . . . . 0.0 108.965 174.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -54.75 -40.7 69.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.838 1.199 . . . . 0.0 111.214 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -58.82 -46.33 87.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.78 0.832 . . . . 0.0 109.487 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.42 ' HB ' HD11 ' A' ' 139' ' ' ILE . 5.6 m -65.28 -40.64 94.16 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.737 0.699 . . . . 0.0 111.81 173.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.52 -25.16 67.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.249 0.932 . . . . 0.0 110.839 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.8 m -108.17 -5.49 16.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 0.0 112.73 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.2 m -64.8 139.53 97.8 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 125.75 1.62 . . . . 0.0 108.594 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.75 155.44 53.93 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.573 2.182 . . . . 0.0 110.721 171.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.36 -47.53 1.39 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.122 1.82 . . . . 0.0 114.072 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.3 m -59.99 155.67 16.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.467 1.633 . . . . 0.0 110.518 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.26 136.75 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.447 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.8 OUTLIER -93.4 128.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 173.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -115.26 135.33 54.27 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 165.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.51 -179.17 40.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.095 -1.05 . . . . 0.0 115.7 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.0 m -129.9 124.36 32.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.117 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.3 pt -117.9 154.52 51.3 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.203 1.401 . . . . 0.0 108.155 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.33 158.7 14.93 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.194 2.596 . . . . 0.0 110.497 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.21 137.45 78.68 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 165.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.08 156.01 63.52 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.575 2.85 . . . . 0.0 109.72 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -129.17 -14.34 4.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.835 1.654 . . . . 0.0 112.563 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.25 -85.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 O-C-N 120.711 -1.243 . . . . 0.0 110.02 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.29 153.79 39.39 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.453 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.74 157.15 27.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.815 1.676 . . . . 0.0 111.475 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.52 135.36 53.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.663 0.602 . . . . 0.0 111.815 -154.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 114' ' ' ILE . 10.8 tp -61.59 -46.7 88.76 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.029 0.931 . . . . 0.0 110.198 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.91 -34.86 70.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 119.209 0.913 . . . . 0.0 111.252 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -66.87 -26.65 67.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.903 1.229 . . . . 0.0 111.565 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.77 -43.83 92.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.415 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.585 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 8.5 mm -69.21 -44.09 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.568 0.747 . . . . 0.0 109.899 173.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -61.21 -27.2 68.26 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.586 -1.321 . . . . 0.0 109.83 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -5.29 21.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.012 1.725 . . . . 0.0 113.525 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -37.91 11.99 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.811 1.187 . . . . 0.0 110.927 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 61.93 -28.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.264 2.226 . . . . 0.0 114.345 -174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -28.45 33.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.215 1.37 . . . . 0.0 110.591 169.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 3' ' ' HIS . 21.8 m -63.94 113.39 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.123 1.439 . . . . 0.0 109.704 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -64.48 131.32 46.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.407 1.883 . . . . 0.0 108.08 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.24 92.49 2.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -80.31 97.97 7.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.598 1.559 . . . . 0.0 108.388 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.96 104.2 8.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.557 -0.714 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 176' ' ' LEU . 0.4 OUTLIER -59.2 146.69 9.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.3 1.048 . . . . 0.0 108.735 167.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -122.82 149.82 43.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -51.63 -25.05 6.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.192 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -76.05 -25.24 55.42 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.67 0.606 . . . . 0.0 110.725 -170.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.72 28.91 3.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.545 1.538 . . . . 0.0 112.341 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 168' ' ' VAL . 28.4 ptt-85 -66.13 -20.18 66.07 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -171.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.17 29.04 8.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.597 1.559 . . . . 0.0 109.393 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -135.84 15.95 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.405 1.482 . . . . 0.0 113.386 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.677 ' HB3' HD13 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -84.68 -9.14 58.52 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.095 1.771 . . . . 0.0 112.364 -176.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -58.59 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.493 1.517 . . . . 0.0 110.996 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -29.52 67.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.016 1.756 . . . . 0.0 113.716 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.82 -42.6 97.61 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 140' ' ' LEU . 11.9 mt -67.31 -44.1 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 108.156 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.05 -42.74 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 119.196 0.907 . . . . 0.0 109.727 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 84.9 m -59.25 -50.91 72.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.126 0.876 . . . . 0.0 109.744 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -29.61 69.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.471 0.578 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.38 -43.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.504 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -63.75 -34.77 78.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.014 1.734 . . . . 0.0 110.85 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.92 -65.61 0.48 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.368 1.867 . . . . 0.0 110.799 -167.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 126.259 1.823 . . . . 0.0 112.204 -179.247 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.007 0.432 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -49.8 155.8 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.844 2.058 . . . . 0.0 111.459 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.3 t -131.27 145.52 35.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -133.57 144.94 49.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.019 0.927 . . . . 0.0 109.193 164.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -106.87 146.13 31.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 t -151.98 -177.54 6.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.48 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.18 175.17 13.9 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.159 1.838 . . . . 0.0 111.351 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.77 169.22 15.03 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 125.013 3.809 . . . . 0.0 111.659 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.13 162.09 20.75 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.175 2.583 . . . . 0.0 112.314 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.09 -53.72 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.093 0 O-C-N 121.25 -0.906 . . . . 0.0 112.346 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.5 t 63.66 94.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 O-C-N 126.061 1.683 . . . . 0.0 109.13 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.28 -35.3 0.48 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.204 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -56.93 -17.79 10.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 m -34.04 -51.03 0.41 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.69 1.596 . . . . 0.0 111.23 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -53.99 -28.03 35.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 124.909 1.284 . . . . 0.0 112.54 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -56.86 6.27 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -61.16 -40.67 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.435 1.016 . . . . 0.0 110.181 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -48.68 65.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.5 mttm -73.66 -14.46 61.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.455 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.8 98.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 108.601 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.1 p -63.29 -44.02 96.24 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.593 0.633 . . . . 0.0 110.145 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.32 -42.18 84.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' LYS . 71.9 t -63.86 -50.78 76.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 109.771 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.64 -38.54 69.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -72.02 -35.07 69.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 119.119 -0.467 . . . . 0.0 112.252 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 -15.17 25.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 126.426 1.89 . . . . 0.0 115.181 162.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.49 3.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.312 2.245 . . . . 0.0 112.491 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.6 72.39 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.426 1.012 . . . . 0.0 113.61 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.05 121.47 71.54 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.317 1.559 . . . . 0.0 107.259 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.82 90.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.622 -171.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -73.22 146.54 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.379 1.472 . . . . 0.0 108.545 168.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.84 175.68 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 146.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.34 -153.37 24.39 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 124.888 1.232 . . . . 0.0 110.138 170.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -136.13 165.3 26.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.921 0.888 . . . . 0.0 109.36 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -137.49 168.33 19.87 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 159.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -135.87 104.58 5.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -102.93 159.17 15.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.75 121.34 20.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.99 107.52 2.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 167.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -125.03 91.46 3.44 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.298 1.439 . . . . 0.0 108.169 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -79.21 76.97 5.73 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 124.162 0.914 . . . . 0.0 111.513 -168.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.37 60.64 6.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 -162.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.41 15.78 81.0 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -115.54 113.3 23.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.012 1.906 . . . . 0.0 111.26 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -65.73 107.13 1.68 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.192 0.997 . . . . 0.0 109.806 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 pt -130.49 -10.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.48 -167.25 40.34 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.464 1.029 . . . . 0.0 110.933 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.61 159.19 37.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.4 139.19 35.24 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.004 0.522 . . . . 0.0 110.301 170.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.06 93.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.36 152.11 8.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 p -116.6 154.77 29.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 166.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.664 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -74.16 -10.84 60.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.496 -0.753 . . . . 0.0 110.257 171.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -66.33 -19.77 65.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.725 2.41 . . . . 0.0 110.485 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 1.63 57.95 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.708 1.147 . . . . 0.0 113.997 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.438 HG22 HD23 ' A' ' 90' ' ' LEU . 3.8 m -85.5 159.81 19.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 0.0 108.637 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.56 131.34 20.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.776 1.63 . . . . 0.0 108.02 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -111.65 149.22 18.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 118.557 -1.135 . . . . 0.0 110.453 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.58 -3.84 13.64 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.127 2.552 . . . . 0.0 114.881 -164.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 40.58 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 131.348 3.859 . . . . 0.0 116.816 168.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.71 116.99 7.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 119.232 0.924 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -126.78 145.54 50.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.845 0.858 . . . . 0.0 110.097 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.82 129.21 37.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.306 1.043 . . . . 0.0 108.854 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.28 50.94 0.67 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.299 -164.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.65 -175.5 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.175 1.488 . . . . 0.0 110.93 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -64.75 151.51 92.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.1 138.26 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.867 3.045 . . . . 0.0 110.832 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.06 159.87 47.32 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.182 2.588 . . . . 0.0 111.236 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.94 147.33 84.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.583 2.189 . . . . 0.0 111.179 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.78 4.53 20.41 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.371 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -128.35 0.11 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.278 1.539 . . . . 0.0 108.119 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 57.35 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.761 2.025 . . . . 0.0 114.067 169.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.79 -16.21 15.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -174.67 170.55 3.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.824 1.65 . . . . 0.0 108.81 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 2.1 ppt_? -170.51 160.32 7.31 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.33 1.452 . . . . 0.0 111.244 151.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.75 -8.59 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 110.701 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.92 -104.46 0.26 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.02 -37.39 76.81 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.592 0.819 . . . . 0.0 109.919 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.09 161.87 13.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.545 1.538 . . . . 0.0 111.855 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 1.0 OUTLIER -105.34 116.02 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.263 2.225 . . . . 0.0 106.334 170.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.83 162.62 4.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 168.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.02 116.36 11.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.86 -28.98 64.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.249 1.386 . . . . 0.0 110.409 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 m -59.36 -36.83 76.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.323 1.449 . . . . 0.0 112.472 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.2 p -72.31 -22.77 61.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 120.732 1.605 . . . . 0.0 112.477 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -69.98 -57.11 5.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.931 162.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.8 -29.86 20.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.076 0.853 . . . . 0.0 112.474 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -50.21 -34.03 21.41 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.647 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.83 -44.03 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.217 0.462 . . . . 0.0 111.643 -174.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.6 48.79 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.468 1.907 . . . . 0.0 109.88 -171.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -144.12 -65.12 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.396 1.478 . . . . 0.0 108.359 -175.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 34.8 Cg_endo -62.55 -24.09 75.07 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 121.287 1.495 . . . . 0.0 113.214 172.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.96 -35.52 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 119.941 1.246 . . . . 0.0 111.141 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.49 -53.05 6.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.979 1.312 . . . . 0.0 107.565 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -120.75 84.39 2.22 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 109.234 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.532 162.803 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.429 0.633 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.95 169.59 11.94 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 129.626 3.17 . . . . 0.0 107.006 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.27 146.66 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.2 m -128.59 150.12 50.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.202 0.456 . . . . 0.0 111.273 166.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.99 124.44 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.101 1.361 . . . . 0.0 108.344 -162.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.8 68.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.62 -35.09 76.84 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.661 -1.274 . . . . 0.0 112.331 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.12 86.55 4.62 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.06 -1.025 . . . . 0.0 110.713 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.8 mt -131.58 114.95 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 147.47 -67.49 0.39 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -57.03 -33.33 67.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.134 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mmt -85.68 3.11 42.54 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.692 -1.623 . . . . 0.0 113.042 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -32.89 -65.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.248 1.819 . . . . 0.0 113.845 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -39.48 64.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.083 0.553 . . . . 0.0 110.825 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.58 -23.42 61.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.291 0.95 . . . . 0.0 112.502 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.2 m -52.44 115.04 1.57 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.364 1.866 . . . . 0.0 110.232 -170.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.87 -86.44 0.65 Allowed 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.43 -21.32 35.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.083 0.953 . . . . 0.0 112.361 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.39 -61.56 2.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.012 1.325 . . . . 0.0 110.76 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -39.91 -57.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.239 1.381 . . . . 0.0 112.472 171.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -55.7 31.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.018 0.826 . . . . 0.0 111.239 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.82 92.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.508 0.67 . . . . 0.0 111.21 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.98 -48.64 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.805 1.242 . . . . 0.0 107.862 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -57.69 -37.91 74.28 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -64.28 -42.92 96.18 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.134 0.425 . . . . 0.0 111.138 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -67.35 -40.83 85.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.904 0.775 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 160' ' ' ARG . 8.7 mp -57.82 -21.11 40.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.523 1.529 . . . . 0.0 111.567 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.9 m -102.55 -6.3 22.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.394 1.878 . . . . 0.0 112.826 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.1 m -70.06 133.97 87.68 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.1 -45.89 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.769 2.312 . . . . 0.0 109.872 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.45 40.57 3.04 Favored Glycine 0 C--O 1.216 -0.974 0 CA-C-O 117.389 -1.784 . . . . 0.0 113.682 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.5 m -135.8 163.84 29.29 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.934 2.367 . . . . 0.0 107.088 169.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.93 103.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.82 132.32 31.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 122.825 0.45 . . . . 0.0 110.134 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.9 tp -126.37 147.88 49.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.257 2.623 . . . . 0.0 105.579 159.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.43 168.93 37.22 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 120.8 1.636 . . . . 0.0 113.358 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.0 m -112.66 121.82 45.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.629 0.715 . . . . 0.0 109.899 -166.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.73 153.39 47.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.662 1.185 . . . . 0.0 109.727 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.89 154.06 67.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.724 1.616 . . . . 0.0 110.461 172.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.59 126.12 92.39 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.34 152.24 44.04 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.284 2.656 . . . . 0.0 111.766 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -47.38 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.593 1.557 . . . . 0.0 110.576 172.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.48 -147.08 13.38 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 124.815 1.198 . . . . 0.0 110.768 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -63.61 158.11 61.56 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 121.974 -0.721 . . . . 0.0 110.638 171.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.66 139.96 41.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.028 2.485 . . . . 0.0 109.941 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.73 145.36 27.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.469 1.508 . . . . 0.0 109.702 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.32 -84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.006 2.922 . . . . 0.0 114.769 -170.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -52.58 -41.1 63.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.088 0.858 . . . . 0.0 109.028 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.8 -41.21 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.629 -1.177 . . . . 0.0 110.278 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.63 -35.37 80.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.866 1.666 . . . . 0.0 110.866 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.58 -20.76 58.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.748 0.819 . . . . 0.0 111.422 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mt -103.4 -42.98 8.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.623 1.569 . . . . 0.0 109.964 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.73 -19.98 60.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.257 1.423 . . . . 0.0 110.965 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.43 -30.99 61.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.989 0.516 . . . . 0.0 111.022 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HD2' HD23 ' A' ' 132' ' ' LEU . 16.2 mtp85 -83.99 -38.07 21.42 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.476 -156.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.17 -15.81 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.242 3.017 . . . . 0.0 116.726 174.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.81 -25.36 60.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.487 1.915 . . . . 0.0 111.122 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.4 m -52.73 141.12 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.407 1.883 . . . . 0.0 110.541 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 2.7 tppt? -60.56 143.46 53.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 158.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.87 100.96 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 19.2 m-85 -86.62 89.32 7.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.44 111.44 1.79 Allowed 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.48 166.7 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 119.335 0.97 . . . . 0.0 108.532 176.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.2 p -128.52 155.21 45.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 163.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -57.69 -34.58 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 162.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.94 -44.7 91.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.947 2.099 . . . . 0.0 109.996 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.01 18.26 18.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 113.237 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -38.29 -52.92 1.5 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.308 1.443 . . . . 0.0 113.664 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.94 6.48 48.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.552 1.141 . . . . 0.0 112.812 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -96.34 -3.25 44.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 111.987 166.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.581 HD23 HD11 ' A' ' 180' ' ' ILE . 3.9 tp -76.45 -35.97 58.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.179 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.3 -58.14 9.74 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.942 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.83 -25.29 53.12 Favored 'Trans proline' 0 C--N 1.352 0.725 0 CA-C-N 122.105 1.787 . . . . 0.0 112.34 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.25 -43.17 71.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 109.91 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.581 HD11 HD23 ' A' ' 176' ' ' LEU . 27.9 mt -56.88 -50.8 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.869 1.267 . . . . 0.0 108.67 171.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.51 -45.25 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.991 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.3 m -59.3 -43.93 92.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.521 1.055 . . . . 0.0 110.465 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.6 t -62.16 -38.77 90.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.533 0.733 . . . . 0.0 110.431 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.7 t -75.18 -45.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.951 0.9 . . . . 0.0 110.208 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -67.58 -14.28 62.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.467 1.031 . . . . 0.0 112.636 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.2 t -34.7 -50.95 0.48 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 128.103 2.561 . . . . 0.0 114.157 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.237 0.406 0 C-N-CA 124.603 1.161 . . . . 0.0 110.027 -168.542 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.428 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 31.5 m-70 -48.43 140.8 7.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.83 2.052 . . . . 0.0 109.605 166.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 164' ' ' LYS . 96.9 t -126.72 149.58 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.886 1.221 . . . . 0.0 112.259 164.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 157' ' ' ILE . 9.8 m-85 -137.51 162.47 33.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.905 2.082 . . . . 0.0 111.38 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD11 HD11 ' A' ' 180' ' ' ILE . 3.4 mm? -115.34 135.92 53.64 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.727 1.611 . . . . 0.0 108.442 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -137.24 -178.92 5.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.026 1.73 . . . . 0.0 107.206 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.64 176.05 38.49 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.743 -1.223 . . . . 0.0 112.947 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.14 138.88 34.39 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.63 2.886 . . . . 0.0 112.957 -164.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.01 92.59 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.408 3.406 . . . . 0.0 111.579 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.63 -75.51 0.37 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.81 -42.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.03 83.69 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -172.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -35.02 79.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 118.001 -0.999 . . . . 0.0 108.516 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -47.92 -63.46 1.06 Allowed 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 125.664 1.852 . . . . 0.0 107.298 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -42.21 -49.89 4.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.16 1.784 . . . . 0.0 112.671 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -47.9 57.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.681 0.673 . . . . 0.0 109.64 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.782 HD11 HD23 ' A' ' 6' ' ' LEU . 5.0 mm -62.44 -49.12 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.82 0.736 . . . . 0.0 110.951 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -52.78 -49.68 65.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.547 1.539 . . . . 0.0 107.847 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -57.58 -42.39 83.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.618 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.27 -39.97 70.45 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.949 0.795 . . . . 0.0 110.636 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 19.5 m -67.17 -56.08 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -47.94 -39.58 19.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.609 1.563 . . . . 0.0 114.211 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.81 -61.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.516 1.126 . . . . 0.0 108.675 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 mt -61.71 -34.67 76.18 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 118.675 -0.678 . . . . 0.0 109.854 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HE2' HD12 ' A' ' 54' ' ' LEU . 70.7 mttt -54.36 -48.49 71.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.42 1.088 . . . . 0.0 108.242 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -65.22 -24.56 67.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.711 0.404 . . . . 0.0 110.489 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -81.06 8.39 8.68 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.121 1.768 . . . . 0.0 114.831 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 18.79 68.0 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.279 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -53.32 148.62 15.91 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 118.109 0.955 . . . . 0.0 109.294 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.95 112.14 3.49 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.103 1.202 . . . . 0.0 108.991 155.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.56 144.24 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.952 0.882 . . . . 0.0 110.156 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -145.12 157.36 44.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.499 1.92 . . . . 0.0 107.636 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.56 -157.39 24.05 Favored Glycine 0 C--O 1.238 0.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -147.81 161.48 41.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 109.946 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -130.88 146.48 52.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -100.95 109.63 21.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.34 169.62 14.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.077 0.951 . . . . 0.0 111.216 -165.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.01 106.72 16.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 109.408 -162.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.0 93.79 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -111.93 113.96 26.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.529 1.531 . . . . 0.0 107.345 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.44 78.81 8.58 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 -133.52 18.92 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -166.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.69 27.17 5.44 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.598 -1.668 . . . . 0.0 115.615 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.23 159.38 44.48 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.145 2.473 . . . . 0.0 110.725 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.47 137.21 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.276 1.43 . . . . 0.0 110.158 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.73 -9.39 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.94 -172.05 38.0 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -137.71 155.0 49.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -123.82 -177.32 3.71 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 124.551 1.157 . . . . 0.0 108.268 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.97 89.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.46 117.75 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -81.08 153.99 27.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.1 mm? -71.01 6.36 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.039 -1.038 . . . . 0.0 113.083 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -95.06 5.64 51.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.766 1.626 . . . . 0.0 112.009 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.41 72.43 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.49 -1.381 . . . . 0.0 113.148 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -101.08 172.45 7.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.374 1.069 . . . . 0.0 108.2 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -152.8 130.05 11.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.992 0.917 . . . . 0.0 108.908 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 90' ' ' LEU . . . -98.97 145.19 17.6 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.6 67.86 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.634 2.889 . . . . 0.0 111.59 -173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.29 -51.83 6.06 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.327 2.251 . . . . 0.0 111.913 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -152.36 151.79 31.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.546 0.528 . . . . 0.0 111.168 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -140.61 161.74 37.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.553 1.541 . . . . 0.0 109.122 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.48 126.69 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.51 -143.7 7.32 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 127.345 2.402 . . . . 0.0 108.746 167.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tp -88.55 168.44 12.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.485 1.143 . . . . 0.0 109.955 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -74.89 151.16 86.43 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 158.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.78 124.65 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.232 2.621 . . . . 0.0 111.456 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -70.77 167.93 24.32 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 111.53 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.96 125.13 14.7 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.592 1.528 . . . . 0.0 109.949 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.82 80.79 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.64 -1.089 . . . . 0.0 114.313 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 118.99 10.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.209 1.505 . . . . 0.0 106.982 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -140.03 176.89 8.38 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.868 0.467 . . . . 0.0 112.148 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -149.92 -161.95 1.45 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 162.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.5 m -52.18 130.38 30.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.027 1.331 . . . . 0.0 109.401 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -147.91 125.84 12.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HB ' ' HE2' ' A' ' 116' ' ' LYS . 16.2 m -113.74 77.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 123.409 1.576 . . . . 0.0 108.757 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.16 -2.26 1.12 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.655 2.074 . . . . 0.0 116.191 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 176.57 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.113 2.565 . . . . 0.0 109.884 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.88 160.52 21.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 109.539 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.76 112.82 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 165.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.43 165.28 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 119.651 1.114 . . . . 0.0 110.252 163.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -142.19 151.79 42.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.316 0.646 . . . . 0.0 109.538 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.17 -29.68 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.837 2.055 . . . . 0.0 110.447 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.5 m -53.22 -43.65 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.085 1.354 . . . . 0.0 108.769 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.6 t -62.25 -23.01 66.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.108 0.867 . . . . 0.0 112.726 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.23 -56.42 4.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -51.86 -30.09 22.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.637 1.575 . . . . 0.0 112.642 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -45.19 -49.33 12.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.019 2.527 . . . . 0.0 113.714 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.46 HD21 ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -150.98 -34.17 0.15 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.51 0.724 . . . . 0.0 112.371 -166.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.85 45.18 1.13 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.792 1.637 . . . . 0.0 108.719 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.436 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -133.01 -63.47 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.12 1.368 . . . . 0.0 107.405 -174.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 61.5 Cg_endo -66.94 -22.45 48.42 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.748 2.299 . . . . 0.0 112.742 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.21 -34.86 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.491 1.496 . . . . 0.0 110.787 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.2 -15.57 62.6 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.875 0.87 . . . . 0.0 111.576 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -147.76 77.38 1.42 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.652 1.569 . . . . 0.0 108.826 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 . . . . . 0 C--O 1.239 0.538 0 C-N-CA 125.951 1.701 . . . . 0.0 108.054 160.681 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 . . . . . 0 C--O 1.227 -0.11 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.5 mtt85 -61.91 97.94 0.09 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.75 2.42 . . . . 0.0 110.637 -169.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.02 116.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.46 157.88 26.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.2 t -140.48 114.99 6.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -144.03 102.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.19 176.52 7.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 63.24 -77.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.954 2.502 . . . . 0.0 109.261 -149.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.324 30.2 mt 55.04 -8.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 128.063 2.545 . . . . 0.0 114.445 -169.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.97 -81.4 0.38 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 121.234 1.834 . . . . 0.0 111.477 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 77' ' ' VAL . 2.0 ttpm? -59.29 -28.35 66.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -163.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -22.47 65.41 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.843 -2.027 . . . . 0.0 111.258 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -24.85 -67.06 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.617 2.367 . . . . 0.0 113.936 -174.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.67 -15.64 60.79 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.744 2.018 . . . . 0.0 110.168 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.2 t -47.54 105.21 0.07 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 129.532 3.133 . . . . 0.0 108.439 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.18 -89.77 0.59 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 123' ' ' LEU . 1.5 pp -56.75 -13.35 2.45 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.073 171.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -66.5 0.37 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.543 1.537 . . . . 0.0 110.69 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -33.84 -55.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.698 1.199 . . . . 0.0 111.362 168.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.54 -54.66 36.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.072 0.851 . . . . 0.0 112.477 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.55 66.88 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.33 -45.8 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -56.53 -39.15 72.89 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.297 -1.502 . . . . 0.0 112.294 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.03 -16.7 33.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.806 1.185 . . . . 0.0 113.667 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.9 m -128.2 -17.91 4.2 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.429 1.092 . . . . 0.0 111.952 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.48 -49.88 73.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 146.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -82.87 49.79 1.58 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.421 1.888 . . . . 0.0 110.067 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -141.43 133.76 13.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 162.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.9 -37.37 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 121.858 1.705 . . . . 0.0 111.353 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.64 17.02 2.2 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.822 1.201 . . . . 0.0 114.989 -174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.9 m -118.31 167.16 11.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.64 1.72 . . . . 0.0 108.475 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mt -129.94 101.5 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.9 133.16 25.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD11 ' CG2' ' A' ' 180' ' ' ILE . 6.9 tp -132.71 147.52 52.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 159.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.81 177.89 45.2 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.2 m -114.19 148.08 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.24 127.8 19.11 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.53 145.52 76.79 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.415 1.41 . . . . 0.0 110.511 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.48 134.42 88.72 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.146 0.979 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -67.59 -55.37 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.206 2.604 . . . . 0.0 109.987 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 64.9 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.281 1.832 . . . . 0.0 108.301 -167.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.12 -102.91 0.5 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.671 1.123 . . . . 0.0 110.41 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -76.92 159.09 79.43 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 117.852 0.826 . . . . 0.0 110.364 -173.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 149' ' ' LYS . 60.2 Cg_endo -77.14 -175.95 2.94 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.733 2.955 . . . . 0.0 108.918 167.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -126.48 144.89 50.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.21 -66.68 0.36 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.667 1.987 . . . . 0.0 113.119 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.2 -39.21 66.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.494 1.118 . . . . 0.0 111.254 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.54 -36.5 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.076 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -63.21 -29.19 70.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.27 1.395 . . . . 0.0 111.778 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -56.94 -39.43 74.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.555 0.693 . . . . 0.0 110.352 174.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.479 HG21 ' CE2' ' A' ' 5' ' ' PHE . 5.4 mt -86.17 -36.81 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.913 1.685 . . . . 0.0 109.909 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -66.44 -34.17 77.33 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.225 -1.547 . . . . 0.0 110.969 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -62.7 -30.58 71.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.787 0.835 . . . . 0.0 109.682 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -58.29 -40.26 81.49 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.355 0.662 . . . . 0.0 109.473 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 -17.68 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.318 3.047 . . . . 0.0 115.677 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.88 -5.55 58.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.723 1.209 . . . . 0.0 111.652 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.36 127.49 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.043 1.337 . . . . 0.0 109.967 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.574 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 13.6 tptm -65.0 120.4 12.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 164.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 92.15 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 18.9 m-85 -66.62 98.1 0.49 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.534 1.133 . . . . 0.0 108.182 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 106.46 2.9 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.98 162.81 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.3 p -129.86 156.28 44.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 165.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -59.69 -22.91 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.335 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -83.06 -36.73 24.68 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 110.313 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.73 80.79 1.93 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.659 3.184 . . . . 0.0 102.877 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -106.59 -35.46 7.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.37 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -113.27 3.3 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.369 1.441 . . . . 0.0 113.312 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -101.61 0.2 35.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.365 1.866 . . . . 0.0 111.425 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -77.62 -31.62 52.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.122 -0.986 . . . . 0.0 111.247 -173.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 tp -39.31 -61.6 0.96 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.768 1.227 . . . . 0.0 110.462 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -68.29 -23.16 39.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.589 1.603 . . . . 0.0 115.495 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.75 -45.39 82.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.917 1.235 . . . . 0.0 108.323 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.85 HD11 HD11 ' A' ' 6' ' ' LEU . 7.3 mt -62.38 -49.46 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.042 0.937 . . . . 0.0 109.623 173.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.93 -41.69 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 119.824 1.193 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 58.0 m -64.36 -35.77 81.96 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 7.9 t -66.34 -34.73 78.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.083 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.95 -58.56 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.346 0.976 . . . . 0.0 108.399 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.05 -12.55 3.49 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 113.789 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.7 t -57.31 -32.98 67.22 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.925 -1.11 . . . . 0.0 110.832 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.167 0 O-C-N 120.572 -1.33 . . . . 0.0 108.819 -158.079 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.75 0.309 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.451 ' HB2' HG12 ' A' ' 163' ' ' VAL . 10.1 m-70 -34.45 143.66 0.04 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 128.065 2.546 . . . . 0.0 111.037 163.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.31 127.28 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.758 0.708 . . . . 0.0 109.634 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 139' ' ' ILE . 13.9 m-85 -140.03 134.0 30.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.874 0.87 . . . . 0.0 109.934 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 18' ' ' ILE . 4.0 mm? -82.08 161.47 22.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.791 1.636 . . . . 0.0 109.152 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -155.6 165.28 37.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.007 0.923 . . . . 0.0 108.818 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.69 -158.95 15.52 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.394 -1.225 . . . . 0.0 111.82 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.08 117.07 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.15 3.233 . . . . 0.0 112.248 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.47 172.51 13.44 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.771 2.981 . . . . 0.0 111.776 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.22 -63.77 0.29 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 167.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.41 125.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.31 -37.72 1.81 Allowed Glycine 0 C--O 1.223 -0.533 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 159.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.724 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -62.3 -29.74 70.65 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 117.887 0.843 . . . . 0.0 110.387 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -61.14 -48.43 81.63 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -55.17 -40.11 70.3 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 128.123 2.569 . . . . 0.0 107.873 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD22 ' H ' ' A' ' 177' ' ' LEU . 54.5 mt -62.37 -61.99 2.07 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 117.9 -1.047 . . . . 0.0 109.841 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 6' ' ' LEU . 1.5 mp -60.61 -45.64 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 119.6 1.091 . . . . 0.0 110.06 -174.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -59.24 4.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.692 1.597 . . . . 0.0 108.247 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 24' ' ' VAL . 59.7 mttm -63.11 -30.4 71.56 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.425 -1.274 . . . . 0.0 111.954 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.36 -32.75 68.85 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 119.878 1.217 . . . . 0.0 109.802 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -71.77 -44.66 63.64 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.192 0.451 . . . . 0.0 110.103 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -61.71 -22.31 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.06 0.944 . . . . 0.0 111.639 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' LYS . 3.0 t -69.08 -50.82 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 120.898 -1.126 . . . . 0.0 110.677 169.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.27 -36.81 84.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.505 0.722 . . . . 0.0 110.22 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -59.18 -48.83 80.18 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -67.74 -3.42 9.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.277 1.831 . . . . 0.0 112.799 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -120.38 11.78 11.52 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.786 1.634 . . . . 0.0 112.773 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.05 38.68 22.07 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 120.122 1.328 . . . . 0.0 113.689 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.46 118.63 37.11 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 107.489 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.49 99.08 0.8 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.77 2.98 . . . . 0.0 110.111 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.4 156.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.14 175.39 9.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.412 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 124.31 -170.64 16.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.89 156.89 46.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.465 0.65 . . . . 0.0 109.811 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -131.59 131.28 43.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 m -83.2 125.37 31.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.437 0.0 OUTLIER -103.7 -130.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 116.593 -1.67 . . . . 0.0 109.645 176.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -157.71 108.48 2.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 122.678 2.49 . . . . 0.0 110.037 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 107.52 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -128.89 113.32 15.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.47 -63.07 1.43 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.692 0.678 . . . . 0.0 109.245 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.49 68.91 0.34 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 106.409 -2.676 . . . . 0.0 106.409 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 -11.08 72.95 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.751 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 135.15 40.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.277 2.038 . . . . 0.0 109.899 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -67.45 141.18 57.07 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 167.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -148.99 -2.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.022 1.329 . . . . 0.0 112.846 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.84 -167.54 32.69 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 119.878 1.217 . . . . 0.0 110.973 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -137.97 154.04 49.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 117.141 0.47 . . . . 0.0 110.52 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -135.95 155.91 49.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 129.484 3.114 . . . . 0.0 106.221 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.76 108.34 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.72 122.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -165.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -72.1 155.24 40.5 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.5 mm? -62.58 -28.44 69.89 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.803 -1.186 . . . . 0.0 110.938 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -68.91 -20.8 64.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 128.033 2.533 . . . . 0.0 111.508 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.42 39.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.652 -1.082 . . . . 0.0 114.409 163.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.8 m -71.23 164.4 25.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.822 1.811 . . . . 0.0 107.491 160.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -141.56 136.38 31.04 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.134 0.974 . . . . 0.0 108.523 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.68 47.87 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.45 -177.53 1.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 145.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 -60.04 0.07 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 p -146.34 158.31 43.87 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.913 0.885 . . . . 0.0 109.122 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -143.37 165.43 27.54 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.863 2.065 . . . . 0.0 106.895 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.54 147.48 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 41.85 0.22 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.775 1.655 . . . . 0.0 110.706 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt 55.96 -167.62 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.798 1.299 . . . . 0.0 111.487 -173.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.4 142.54 25.13 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.836 0.854 . . . . 0.0 108.862 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.05 134.57 25.55 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.629 1.553 . . . . 0.0 109.825 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.86 159.25 54.62 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.006 2.471 . . . . 0.0 109.449 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.06 -6.37 18.09 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.521 2.147 . . . . 0.0 113.989 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.34 7.28 12.6 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.493 1.521 . . . . 0.0 113.622 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -138.49 88.07 2.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.384 2.092 . . . . 0.0 107.16 173.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.21 150.87 33.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.69 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.39 63.84 0.12 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.515 1.126 . . . . 0.0 108.534 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 59.8 m 47.78 -143.97 0.38 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.93 -1.106 . . . . 0.0 110.719 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.1 155.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 1 C-N-CA 133.701 4.801 . . . . 0.0 106.11 175.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.34 25.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 121.115 1.78 . . . . 0.0 111.017 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.2 111.73 0.94 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 64.05 -48.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.911 2.484 . . . . 0.0 113.953 -167.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.87 178.37 4.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.12 2.568 . . . . 0.0 108.717 -173.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.26 143.29 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 126.708 2.003 . . . . 0.0 106.53 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.11 176.65 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 119.708 1.14 . . . . 0.0 110.394 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -140.3 156.1 46.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 157.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.07 -33.93 38.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.88 0.872 . . . . 0.0 108.954 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.9 m -68.3 -33.35 74.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.843 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.9 m -60.69 -32.01 71.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 121.277 1.853 . . . . 0.0 109.846 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -69.11 -57.46 5.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -53.19 -24.09 10.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -48.81 -34.72 12.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.097 1.359 . . . . 0.0 112.827 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -31.98 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.3 44.08 0.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.281 1.432 . . . . 0.0 110.847 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.43 -61.69 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 127.186 2.195 . . . . 0.0 108.414 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.3 -24.18 16.94 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.04 1.827 . . . . 0.0 113.54 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.5 -30.32 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 119.463 1.029 . . . . 0.0 111.188 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.6 mt -76.46 -6.75 53.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.705 2.002 . . . . 0.0 111.316 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 92.16 2.1 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.46 1.504 . . . . 0.0 109.86 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 C--O 1.234 0.281 0 C-N-CA 125.635 1.574 . . . . 0.0 110.321 -175.016 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.27 170.47 22.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 128.247 2.619 . . . . 0.0 105.947 160.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 130.1 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 10.5 m -124.99 109.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 t -83.16 140.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 125.742 1.617 . . . . 0.0 111.203 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -151.67 85.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.516 1.126 . . . . 0.0 108.645 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.53 127.42 53.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.336 -1.478 . . . . 0.0 113.218 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 95.54 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 1 C-N-CA 133.585 4.754 . . . . 0.0 108.153 -173.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.87 57.5 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.653 2.381 . . . . 0.0 106.271 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.97 -33.96 0.03 OUTLIER Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.539 -1.351 . . . . 0.0 112.47 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -62.25 -17.98 59.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 119.612 -2.111 . . . . 0.0 113.822 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 9.81 28.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.879 1.672 . . . . 0.0 111.283 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -57.71 -13.57 4.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.65 -41.05 4.15 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.772 1.229 . . . . 0.0 111.917 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.4 -22.28 44.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.581 0.628 . . . . 0.0 112.39 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -50.44 135.23 22.62 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -136.92 -77.41 0.41 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.126 0.57 . . . . 0.0 111.009 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.28 -29.88 69.59 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 116.859 -1.543 . . . . 0.0 110.549 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.91 -54.58 12.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.051 -1.452 . . . . 0.0 111.69 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.3 mp -38.51 -63.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 126.566 1.946 . . . . 0.0 111.649 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.51 -51.59 68.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.13 72.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.0 p -87.95 -32.18 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.74 0.816 . . . . 0.0 110.373 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -36.95 32.47 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.042 165.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -48.2 -53.21 17.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.005 1.275 . . . . 0.0 109.529 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -41.63 61.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.791 2.036 . . . . 0.0 112.343 -175.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.47 -41.29 98.67 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.605 1.548 . . . . 0.0 110.606 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 t -78.46 25.26 0.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.948 1.699 . . . . 0.0 111.064 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.5 m -126.79 134.31 25.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.524 -1.36 . . . . 0.0 110.271 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.68 158.81 46.72 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.433 2.755 . . . . 0.0 109.888 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.93 3.78 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -61.84 148.03 44.62 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.227 1.014 . . . . 0.0 112.066 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.6 mt -130.2 108.26 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.444 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 18.0 mm -66.6 139.29 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mt -133.7 97.03 3.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.405 1.482 . . . . 0.0 107.878 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.19 -172.45 18.15 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 118.032 0.378 . . . . 0.0 113.209 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 m -142.26 136.39 29.75 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.931 1.292 . . . . 0.0 107.62 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.78 167.56 18.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.691 1.596 . . . . 0.0 110.079 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 160.05 51.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.562 1.508 . . . . 0.0 111.116 158.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.2 152.71 96.53 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.543 -0.723 . . . . 0.0 110.075 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -26.13 18.92 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.01 2.473 . . . . 0.0 111.983 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -50.71 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 128.394 2.678 . . . . 0.0 110.029 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.54 -118.79 1.65 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -167.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 171.23 7.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.225 1.41 . . . . 0.0 110.743 -171.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -57.4 170.98 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.456 2.104 . . . . 0.0 110.39 158.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -147.9 178.6 8.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.83 2.852 . . . . 0.0 105.396 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.1 -82.0 0.11 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 118.903 0.774 . . . . 0.0 109.096 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.83 -32.68 74.34 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 120.444 -1.41 . . . . 0.0 113.073 -171.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.81 -34.93 71.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 117.441 -1.266 . . . . 0.0 109.165 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.15 -34.18 73.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 111.153 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 125' ' ' ILE . 5.3 tp10 -54.33 -50.27 67.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.043 0.937 . . . . 0.0 109.76 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.0 -35.66 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -62.46 -25.62 68.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.13 0.877 . . . . 0.0 111.111 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.07 -14.17 61.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.258 1.023 . . . . 0.0 113.556 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -117.19 55.89 0.83 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.447 1.499 . . . . 0.0 107.898 -166.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 4.7 mmpt? -57.62 -10.32 1.51 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.426 1.491 . . . . 0.0 114.951 -166.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.0 -25.36 43.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.977 0.808 . . . . 0.0 112.163 167.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 3' ' ' HIS . 34.3 m -47.73 118.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 125.901 1.68 . . . . 0.0 109.185 164.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 134.34 53.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.519 1.928 . . . . 0.0 108.501 169.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.63 80.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.168 0.894 . . . . 0.0 108.78 -168.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.15 104.21 1.39 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.179 1.792 . . . . 0.0 109.135 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.58 116.17 17.02 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.906 -1.121 . . . . 0.0 109.52 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.73 166.73 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.983 0.897 . . . . 0.0 109.577 170.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.0 p -120.05 151.19 39.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 163.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -64.49 -21.08 66.57 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.386 -0.821 . . . . 0.0 109.477 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -67.74 -74.21 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.704 2.002 . . . . 0.0 109.135 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -91.06 31.9 1.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.924 1.289 . . . . 0.0 109.998 -175.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.79 -24.31 61.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.737 1.215 . . . . 0.0 112.115 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -114.93 21.9 13.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.19 2.596 . . . . 0.0 111.593 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -136.46 6.51 3.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.588 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' LEU . 2.7 tt -82.42 -13.27 57.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 117.436 -1.706 . . . . 0.0 110.627 -170.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.3 tp -36.39 -59.91 0.79 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 127.591 2.356 . . . . 0.0 112.533 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.2 -25.29 31.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 122.108 1.789 . . . . 0.0 112.087 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.2 -43.44 78.05 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.73 -53.01 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.02 -43.73 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.22 1.408 . . . . 0.0 110.264 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.1 m -60.83 -32.72 72.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.516 1.126 . . . . 0.0 111.569 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -65.33 -45.67 83.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.948 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.28 -48.29 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.998 0.919 . . . . 0.0 109.217 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -65.95 -24.5 66.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.7 t -67.96 -24.8 65.2 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.112 0.965 . . . . 0.0 109.992 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 124.32 1.048 . . . . 0.0 113.022 167.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -64.38 139.5 58.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.475 1.11 . . . . 0.0 109.315 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.46 138.25 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 14.9 m-85 -129.03 146.76 50.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.694 0.759 . . . . 0.0 109.899 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.866 HD21 HD11 ' A' ' 18' ' ' ILE . 1.8 mm? -100.65 131.16 46.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -121.59 175.44 6.22 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.64 0.733 . . . . 0.0 109.4 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.86 -135.73 8.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 125.462 1.506 . . . . 0.0 109.644 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.25 159.74 52.58 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.696 2.264 . . . . 0.0 111.761 -160.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.43 -9.67 25.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.951 3.101 . . . . 0.0 114.266 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.32 19.69 14.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.103 0.858 . . . . 0.0 112.464 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' LYS 0.301 46.9 t 74.29 -65.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.136 3.374 . . . . 0.0 109.272 168.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.37 5.05 26.74 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.236 1.398 . . . . 0.0 110.822 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 24.3 mtmt -121.76 -8.31 8.97 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 116.368 -1.777 . . . . 0.0 115.225 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.8 m -47.14 -41.19 17.13 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.769 1.622 . . . . 0.0 112.015 -166.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -43.63 -48.83 7.77 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.475 2.71 . . . . 0.0 109.906 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.542 ' CD1' ' H ' ' A' ' 176' ' ' LEU . 41.9 mt -69.54 -57.27 5.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 125.56 1.544 . . . . 0.0 109.743 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 6' ' ' LEU . 23.1 mm -57.74 -46.72 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.971 0.805 . . . . 0.0 109.118 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 -56.51 7.57 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.959 0.904 . . . . 0.0 111.321 171.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -68.58 -25.63 64.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.322 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -52.58 -39.6 61.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.442 1.097 . . . . 0.0 110.224 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -70.08 -35.07 73.93 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -58.67 -45.31 89.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.879 0.872 . . . . 0.0 109.124 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -60.53 -53.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.151 0.98 . . . . 0.0 110.213 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.93 -41.02 90.86 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.143 0.577 . . . . 0.0 109.449 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -69.59 -40.72 76.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.978 0.354 . . . . 0.0 110.126 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -61.18 -30.15 70.24 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.027 169.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -84.92 1.68 46.18 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.4 1.48 . . . . 0.0 112.858 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.75 1.46 66.94 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.236 1.398 . . . . 0.0 114.282 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.44 110.52 11.69 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.079 1.94 . . . . 0.0 107.809 -172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.93 119.33 6.39 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.555 2.17 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.95 118.17 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 109.033 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.27 170.79 9.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 126.234 1.813 . . . . 0.0 109.797 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 120.55 -156.5 16.01 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 163.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -149.46 167.79 25.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -141.42 -175.97 4.55 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -118.52 133.74 55.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.822 1.647 . . . . 0.0 107.086 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.45 33.78 5.41 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.584 -1.322 . . . . 0.0 112.222 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.04 -172.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.994 2.118 . . . . 0.0 110.51 -171.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.37 144.2 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 152.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -125.22 161.63 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.278 1.831 . . . . 0.0 107.758 167.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -108.79 45.88 1.01 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.079 1.352 . . . . 0.0 107.367 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 104.95 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -163.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.69 -51.93 3.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.944 1.259 . . . . 0.0 114.56 171.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.13 139.46 30.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 110.392 -162.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -70.15 134.77 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.47 -8.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -176.34 38.43 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 119.558 1.072 . . . . 0.0 110.613 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.57 148.84 51.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.77 135.14 32.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.8 155.73 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 C-N-CA 125.953 1.701 . . . . 0.0 108.536 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 m -141.51 143.09 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.972 165.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.9 p -82.87 161.97 21.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.406 1.003 . . . . 0.0 109.871 174.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.1 mm? -74.63 -14.27 60.75 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.529 -0.732 . . . . 0.0 112.935 176.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 t -69.14 -25.47 64.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.935 0.789 . . . . 0.0 109.49 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.56 9.65 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.079 0.847 . . . . 0.0 112.546 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -83.66 167.22 17.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 1.3 mpt_? -137.53 163.23 31.66 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -151.18 175.47 30.09 Favored Glycine 0 C--O 1.223 -0.571 0 CA-C-N 120.843 1.656 . . . . 0.0 110.531 158.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.71 161.6 35.14 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 109.749 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.4 -59.98 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.61 144.29 49.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -143.34 162.16 36.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.263 1.425 . . . . 0.0 108.053 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 149.79 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.22 157.4 28.27 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 166.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.47 162.87 7.47 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 161.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.67 150.63 81.11 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.42 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.22 124.87 11.3 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.334 2.023 . . . . 0.0 110.447 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.04 165.84 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.945 2.43 . . . . 0.0 109.465 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.97 101.75 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 108.549 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.45 -68.18 0.48 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.562 1.077 . . . . 0.0 110.421 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -76.72 125.31 29.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.87 7.94 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -135.61 41.42 2.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.179 1.392 . . . . 0.0 107.312 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.0 m 59.1 -161.61 0.26 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.771 2.028 . . . . 0.0 112.291 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 170.78 157.27 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.426 3.091 . . . . 0.0 109.5 175.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.01 0.53 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.93 140.41 11.03 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 -169.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.65 -69.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.965 1.706 . . . . 0.0 110.718 -158.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.11 148.92 21.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.785 1.234 . . . . 0.0 110.164 -167.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.6 t -91.26 139.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 162.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.93 -175.8 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 O-C-N 120.774 -1.204 . . . . 0.0 109.066 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.39 119.82 6.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 153.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.94 -34.61 71.95 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 112.117 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.9 m -51.51 -39.67 58.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.775 1.63 . . . . 0.0 110.35 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.09 -29.05 70.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.743 0.417 . . . . 0.0 110.597 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -71.53 -60.23 2.34 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.913 1.285 . . . . 0.0 108.006 170.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -49.25 -21.42 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.675 1.99 . . . . 0.0 113.778 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -57.34 -58.26 9.03 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.709 -1.244 . . . . 0.0 112.065 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -123.07 -34.15 3.2 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.833 1.253 . . . . 0.0 112.646 -164.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.45 55.92 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.693 1.597 . . . . 0.0 109.074 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 -58.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.679 -173.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.37 -27.06 19.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.893 2.395 . . . . 0.0 113.055 168.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 p -63.41 -27.87 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.914 -1.116 . . . . 0.0 110.659 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 84.4 1.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? 51.51 80.28 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.43 2.292 . . . . 0.0 113.163 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t30 . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 125.747 1.619 . . . . 0.0 108.124 153.657 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -79.31 156.21 28.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 160.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.2 149.31 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 150.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 19.5 t -127.93 163.56 24.21 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.898 1.226 . . . . 0.0 109.771 160.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.6 t -145.53 125.91 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.49 1.516 . . . . 0.0 107.137 -166.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.06 63.34 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.14 97.19 9.21 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.34 -31.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.128 0.571 . . . . 0.0 110.106 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.5 mt -60.26 120.31 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.537 1.135 . . . . 0.0 110.145 -159.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.41 -15.41 1.65 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.68 1.133 . . . . 0.0 112.479 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -100.22 -35.8 9.51 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.722 1.261 . . . . 0.0 110.461 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -87.92 19.97 3.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.024 1.73 . . . . 0.0 111.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -46.12 -33.43 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.677 1.126 . . . . 0.0 114.023 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -102.67 -45.32 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.518 2.327 . . . . 0.0 110.196 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.27 -21.52 63.88 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 124' ' ' PHE . 4.1 m -56.17 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.522 1.529 . . . . 0.0 111.331 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -84.16 -84.18 0.14 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.12 0.568 . . . . 0.0 110.051 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -60.52 -13.58 14.71 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.306 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' SER . 3.2 m-85 -54.77 -51.44 65.7 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 120.885 1.675 . . . . 0.0 111.61 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -52.11 -22.02 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 112.466 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.0 -58.97 2.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.719 -1.238 . . . . 0.0 108.713 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.46 -50.6 72.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.427 1.491 . . . . 0.0 111.594 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 t -61.56 -47.53 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.379 1.072 . . . . 0.0 108.412 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -57.7 -38.55 75.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -39.88 81.21 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.307 0.958 . . . . 0.0 110.758 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -71.03 -39.59 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.94 -14.32 61.88 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.31 1.044 . . . . 0.0 111.776 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -63.07 -50.1 71.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 120.396 1.453 . . . . 0.0 110.038 164.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -60.13 134.33 90.47 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.63 -33.91 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.878 1.719 . . . . 0.0 112.763 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.74 7.68 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 118.346 -1.252 . . . . 0.0 110.781 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 51.8 m -48.51 115.5 1.25 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.097 1.359 . . . . 0.0 111.286 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.1 mt -96.25 85.91 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 102.781 -3.044 . . . . 0.0 102.781 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.1 mm -52.91 117.85 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.438 HD21 HG23 ' A' ' 180' ' ' ILE . 14.6 mt -97.65 146.75 25.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 144.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.19 156.62 27.07 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 156.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 12' ' ' VAL . 95.0 m -91.31 149.48 21.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 164.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.3 pt -136.33 163.02 53.01 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.837 2.055 . . . . 0.0 108.72 166.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.51 165.01 23.34 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.34 2.693 . . . . 0.0 110.443 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.29 149.16 97.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.008 -1.058 . . . . 0.0 109.544 162.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.0 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.104 2.536 . . . . 0.0 109.354 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt 48.34 38.38 10.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.801 1.64 . . . . 0.0 112.872 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.59 -121.01 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 159.61 83.05 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 117.118 0.459 . . . . 0.0 110.145 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.49 166.61 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.95 1.766 . . . . 0.0 107.931 159.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.4 -163.86 1.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.85 -61.34 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.128 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -51.75 19.99 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.04 -22.7 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.74 1.155 . . . . 0.0 111.748 -169.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -42.16 80.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.564 2.346 . . . . 0.0 111.866 171.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.314 0.3 OUTLIER -58.53 -53.35 59.29 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 121.862 0.839 . . . . 0.0 110.006 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 5.3 mt -67.98 -26.54 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.793 0.837 . . . . 0.0 111.2 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -70.73 -20.51 62.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 120.345 -1.472 . . . . 0.0 111.422 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.2 -14.57 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 111.504 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -81.72 85.38 6.61 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 11.3 mmpt? -63.05 -20.46 65.35 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 111.714 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.29 -35.17 59.81 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.065 1.746 . . . . 0.0 113.236 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.26 124.1 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.4 1.48 . . . . 0.0 110.854 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -59.11 147.42 35.06 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.56 97.61 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -85.04 104.11 14.67 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.479 1.911 . . . . 0.0 108.203 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.55 103.0 13.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.309 1.443 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.53 163.02 4.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.665 1.222 . . . . 0.0 111.411 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.26 134.9 45.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.566 2.347 . . . . 0.0 106.16 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -46.55 -30.2 2.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.519 1.128 . . . . 0.0 111.489 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.06 -31.14 72.22 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 125.378 1.673 . . . . 0.0 110.591 -172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -131.7 18.29 4.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.026 1.33 . . . . 0.0 111.037 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -60.51 -21.88 62.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -167.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -102.02 11.73 37.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.08 1.352 . . . . 0.0 113.416 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -127.25 24.16 6.34 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.345 1.058 . . . . 0.0 110.973 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.542 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -83.5 -12.02 56.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.511 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.0 tt -47.11 -57.34 9.53 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.566 1.946 . . . . 0.0 112.068 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.43 -22.95 24.27 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 121.56 1.593 . . . . 0.0 113.08 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.61 -45.97 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.438 HG23 HD21 ' A' ' 140' ' ' LEU . 14.8 mt -63.78 -52.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.49 1.516 . . . . 0.0 109.441 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -55.56 -45.53 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.3 1.409 . . . . 0.0 109.654 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.3 m -56.92 -43.49 81.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.604 1.162 . . . . 0.0 110.366 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.8 t -65.35 -38.73 90.98 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.098 0.959 . . . . 0.0 111.855 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.64 -51.61 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 119.234 0.925 . . . . 0.0 108.833 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -66.59 -12.74 59.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.314 -0.851 . . . . 0.0 112.638 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 86.2 p -48.09 -45.17 32.36 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.757 1.223 . . . . 0.0 111.167 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.339 1 C-N-CA 133.283 4.633 . . . . 0.0 115.775 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 . . . . . 0 CA--C 1.514 -0.416 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.408 ' HB2' HG12 ' A' ' 163' ' ' VAL . 12.4 m-70 -34.18 138.84 0.08 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.29 3.036 . . . . 0.0 111.194 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 t -131.38 141.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 157' ' ' ILE . 28.3 m-85 -135.03 143.98 47.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.956 0.902 . . . . 0.0 109.435 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 176' ' ' LEU . 1.4 mm? -105.14 151.08 24.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.695 0.798 . . . . 0.0 110.778 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -156.67 -177.87 6.92 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 123.315 0.384 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.45 -141.08 13.87 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.275 2.369 . . . . 0.0 109.443 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.31 145.14 64.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.963 1.776 . . . . 0.0 111.109 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.28 160.56 44.78 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.27 1.98 . . . . 0.0 110.259 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.95 4.23 7.15 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.072 1.32 . . . . 0.0 115.795 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 5.8 p -74.16 22.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 119.67 1.735 . . . . 0.0 115.472 -160.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.18 -0.33 78.33 Favored Glycine 0 N--CA 1.464 0.545 0 O-C-N 120.013 -1.679 . . . . 0.0 112.062 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -21.15 64.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.944 1.298 . . . . 0.0 113.73 -171.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -50.36 -37.25 36.15 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 120.026 1.285 . . . . 0.0 110.666 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.4 m -57.03 -36.28 70.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.95 1.7 . . . . 0.0 113.51 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD11 ' HD2' ' A' ' 173' ' ' ARG . 0.5 OUTLIER -68.47 -52.44 32.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -178.421 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -36.0 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 O-C-N 122.088 -0.382 . . . . 0.0 111.085 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -54.21 -51.87 63.05 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.4 mttm -54.64 -43.0 71.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.286 173.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -33.74 68.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.998 1.272 . . . . 0.0 111.476 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -68.18 -53.78 22.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.99 -34.08 77.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.5 1.12 . . . . 0.0 112.59 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 20' ' ' LYS . 74.2 t -62.86 -49.27 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.45 1.5 . . . . 0.0 110.733 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.5 -40.92 98.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.8 -42.37 98.92 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.47 69.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 112.407 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -83.23 -0.62 50.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.971 -1.08 . . . . 0.0 112.136 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.02 36.08 57.3 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.786 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.77 109.13 40.09 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.3 143.92 78.69 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.88 132.52 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.55 174.51 5.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.512 1.525 . . . . 0.0 107.667 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.16 -161.76 23.1 Favored Glycine 0 CA--C 1.508 -0.402 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.79 163.72 37.94 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 117.343 0.571 . . . . 0.0 111.444 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -138.28 168.34 19.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.4 p -109.87 91.32 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.58 -4.26 22.24 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.919 -1.113 . . . . 0.0 113.664 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 84.14 167.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 130.61 3.564 . . . . 0.0 110.357 -158.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.14 118.54 11.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 164.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -111.03 148.33 32.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 163.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -142.66 116.77 9.45 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 156.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.18 26.84 64.25 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.965 0.802 . . . . 0.0 111.486 -166.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.74 -20.0 2.45 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.411 1.325 . . . . 0.0 116.411 172.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.79 7.35 2.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.073 2.437 . . . . 0.0 116.498 -157.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.651 1.98 . . . . 0.0 110.998 -165.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.63 -11.63 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.732 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.84 -147.19 16.73 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.341 -1.903 . . . . 0.0 108.341 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -141.7 163.18 33.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.554 1.542 . . . . 0.0 109.551 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -120.36 166.23 13.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.935 1.694 . . . . 0.0 106.839 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -126.47 104.9 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 123.849 0.859 . . . . 0.0 108.717 174.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.5 117.55 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -164.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 p -66.19 161.84 21.16 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 109.293 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.87 -1.32 6.98 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.83 -1.169 . . . . 0.0 112.324 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -105.14 7.21 33.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.475 1.91 . . . . 0.0 112.479 168.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.28 6.59 83.78 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 120.385 -1.447 . . . . 0.0 115.015 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 149.63 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 156.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 18.9 ptt-85 -150.45 149.57 30.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.108 1.322 . . . . 0.0 111.041 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.8 158.74 18.43 Favored Glycine 0 C--O 1.22 -0.768 0 CA-C-O 116.879 -2.067 . . . . 0.0 111.325 -172.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.95 9.79 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.457 3.438 . . . . 0.0 113.791 -164.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 24.54 -74.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 131.415 3.886 . . . . 0.0 116.301 171.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 p -136.44 143.25 43.81 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 164.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.48 67.87 0.46 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.508 0.594 . . . . 0.0 110.039 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.5 t 48.66 134.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 130.348 3.459 . . . . 0.0 114.798 -172.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.34 52.79 0.49 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 53.5 -178.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.227 1.811 . . . . 0.0 111.783 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -80.91 158.35 70.45 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 159.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.03 140.14 14.02 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.153 2.568 . . . . 0.0 110.356 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.21 175.29 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.992 3.128 . . . . 0.0 110.578 165.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.63 150.87 86.03 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.021 1.147 . . . . 0.0 109.27 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.86 -73.26 0.66 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.059 0.837 . . . . 0.0 112.582 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 115.45 5.03 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.232 1.016 . . . . 0.0 109.049 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -173.62 153.37 2.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.89 2.076 . . . . 0.0 106.785 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.75 -27.61 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 151.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 65.8 m -152.13 143.59 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.622 1.569 . . . . 0.0 109.442 -170.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.65 139.32 4.49 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.29 85.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 172.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.38 -67.2 0.25 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.092 1.806 . . . . 0.0 112.041 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -144.72 -18.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.368 2.267 . . . . 0.0 113.402 -167.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -106.57 125.81 51.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.84 130.98 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 167.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.62 168.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.449 1.022 . . . . 0.0 108.598 165.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.11 111.13 14.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.71 -31.53 66.5 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.689 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.2 m -60.81 -38.15 84.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.707 1.603 . . . . 0.0 111.493 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.7 m -58.84 -36.38 74.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.7 1.136 . . . . 0.0 110.446 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.34 -49.8 65.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.074 0.95 . . . . 0.0 111.478 171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.511 ' HA ' HD13 ' A' ' 92' ' ' LEU . 52.0 mt-10 -53.38 -25.44 15.53 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.161 0.891 . . . . 0.0 113.1 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.68 -50.84 65.4 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.237 1.38 . . . . 0.0 111.934 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.18 -25.59 1.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.773 -166.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.55 59.61 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.275 1.398 . . . . 0.0 109.402 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 88' ' ' GLU . 3.1 mp -49.9 -45.96 80.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.095 -1.431 . . . . 0.0 114.045 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.87 -27.33 7.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 CA-C-N 121.733 1.655 . . . . 0.0 113.834 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.3 -29.75 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.737 1.153 . . . . 0.0 111.26 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.7 34.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.021 2.128 . . . . 0.0 111.007 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.275 4.8 mmm-85 173.84 -134.7 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 130.851 3.66 . . . . 0.0 107.238 -164.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 . . . . . 0 N--CA 1.438 -1.031 0 C-N-CA 126.041 1.736 . . . . 0.0 111.408 -153.613 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.37 163.76 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.84 145.2 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 168.01 10.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.421 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.11 129.46 50.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.367 1.067 . . . . 0.0 108.32 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -133.56 67.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -79.83 67.94 5.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.869 0.868 . . . . 0.0 109.706 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -95.06 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 153' ' ' LEU 0.286 78.6 mt 41.45 53.57 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 128.117 2.567 . . . . 0.0 109.864 177.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.66 -61.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 121.466 -0.771 . . . . 0.0 112.396 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -20.69 64.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.42 2.11 . . . . 0.0 113.613 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.77 18.02 21.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.615 1.566 . . . . 0.0 109.713 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.54 -18.17 2.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -166.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.41 -30.49 8.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.105 0.866 . . . . 0.0 111.321 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -90.21 -20.02 23.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.368 1.067 . . . . 0.0 112.669 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m -59.83 103.92 0.25 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.579 0.752 . . . . 0.0 110.792 -166.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.81 -81.72 0.47 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.256 0.935 . . . . 0.0 111.821 -163.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.93 -10.05 8.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.028 1.731 . . . . 0.0 112.28 169.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.53 -61.77 1.85 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.327 1.451 . . . . 0.0 110.901 174.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.2 mp -38.08 -64.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.841 2.056 . . . . 0.0 112.16 172.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -53.75 54.6 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.406 0.548 . . . . 0.0 110.012 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.76 72.64 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.44 -173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 157' ' ' ILE . 2.7 t -49.09 -55.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.296 1.839 . . . . 0.0 109.275 172.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -62.98 -36.5 83.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.957 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.9 -44.84 88.3 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.122 0.874 . . . . 0.0 110.068 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.1 m -65.74 -34.83 79.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.094 0.957 . . . . 0.0 111.003 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.61 -30.31 69.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.429 1.492 . . . . 0.0 112.104 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.3 m -107.9 14.29 25.49 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.626 1.57 . . . . 0.0 112.082 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.4 m -76.97 133.78 69.01 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -77.33 109.5 2.81 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 108.096 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 125.1 -87.42 0.37 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 107.246 -2.342 . . . . 0.0 107.246 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 m -43.83 146.24 0.6 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.847 1.659 . . . . 0.0 112.375 -171.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.95 107.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 134.66 26.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.45 142.48 50.78 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 163.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.97 172.24 45.31 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 120.741 -1.224 . . . . 0.0 110.673 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.9 m -121.62 135.49 54.98 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.724 1.21 . . . . 0.0 108.403 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.1 pt -125.93 151.18 70.99 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.911 1.684 . . . . 0.0 110.156 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.82 150.57 49.93 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 109.194 169.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.85 118.92 59.57 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 123.112 0.565 . . . . 0.0 110.596 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.14 117.72 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.102 2.534 . . . . 0.0 107.63 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -152.92 -35.03 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.199 0.999 . . . . 0.0 110.624 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.64 -152.9 6.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 164.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 140.34 93.81 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.543 -0.975 . . . . 0.0 109.726 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.33 120.11 4.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.812 3.675 . . . . 0.0 111.407 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.0 155.88 38.13 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.827 1.651 . . . . 0.0 113.123 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.31 -60.21 2.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.886 2.074 . . . . 0.0 113.802 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.405 HD13 HG23 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -62.13 -47.07 86.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.59 -41.03 52.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.09 -36.15 74.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.94 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -55.16 -49.27 72.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.944 1.247 . . . . 0.0 110.035 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 128' ' ' VAL . 5.2 mp -75.82 -46.13 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.069 0.548 . . . . 0.0 109.619 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -39.49 74.74 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.402 1.081 . . . . 0.0 109.55 -174.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -60.05 -23.51 63.8 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.123 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -63.41 -42.15 98.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.576 1.08 . . . . 0.0 111.624 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 8.9 mmpt? 61.91 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.591 2.356 . . . . 0.0 115.055 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -28.63 67.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.448 1.022 . . . . 0.0 110.911 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 3' ' ' HIS . 36.0 m -57.32 123.92 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.193 0.997 . . . . 0.0 108.845 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -71.08 106.21 3.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.5 t -84.25 95.53 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -83.46 112.95 20.42 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.55 120.61 17.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.406 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -65.68 164.61 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 82.8 p -122.28 163.2 20.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.07 -21.57 64.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.788 -1.195 . . . . 0.0 109.805 161.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -79.9 -47.84 14.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.67 0.788 . . . . 0.0 111.097 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.93 32.01 5.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.939 1.696 . . . . 0.0 110.433 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 17' ' ' LEU . 3.0 tmm_? -48.52 -59.86 3.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.249 1.419 . . . . 0.0 109.668 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -76.63 4.15 10.04 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -116.92 4.61 12.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.002 1.721 . . . . 0.0 110.878 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 6.0 tp -80.26 -40.22 27.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.307 0.503 . . . . 0.0 112.044 170.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.79 -57.92 0.73 Allowed Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 126.177 1.791 . . . . 0.0 110.222 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.08 -25.21 44.08 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.203 1.936 . . . . 0.0 114.994 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.14 -38.79 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.061 -1.025 . . . . 0.0 109.587 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 5.9 mt -62.65 -47.95 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.38 -40.93 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.76 1.224 . . . . 0.0 110.443 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.8 m -65.13 -43.26 92.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.247 1.019 . . . . 0.0 110.04 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 10.3 t -68.61 -33.24 73.69 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.096 -1.002 . . . . 0.0 112.229 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.8 t -63.07 -64.91 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -35.86 80.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.078 -171.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 t -24.47 -86.28 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.942 2.897 . . . . 0.0 113.563 -165.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.462 0.171 0 C-N-CA 127.921 2.488 . . . . 0.0 113.198 177.271 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 . . . . . 0 C--O 1.235 0.336 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -73.76 151.79 40.53 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.37 155.95 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 109.082 170.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -142.2 165.04 28.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.289 1.036 . . . . 0.0 109.81 171.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 18' ' ' ILE . 4.4 mm? -100.96 150.39 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.188 2.195 . . . . 0.0 108.736 169.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -156.16 -162.76 1.34 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.86 -174.07 26.28 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.18 1.848 . . . . 0.0 112.251 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.25 149.76 81.47 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.443 2.762 . . . . 0.0 111.477 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.16 119.42 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.071 2.514 . . . . 0.0 109.307 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.48 -17.15 27.33 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 117.927 -1.485 . . . . 0.0 110.583 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 64.85 113.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.051 1.74 . . . . 0.0 109.164 -169.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.39 65.86 0.75 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -97.94 -33.47 11.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.16 0.584 . . . . 0.0 110.841 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -53.28 -38.5 63.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.92 2.088 . . . . 0.0 111.983 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.9 m -62.92 -40.64 98.22 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.581 -0.699 . . . . 0.0 112.609 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -45.37 87.34 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 120.253 -1.53 . . . . 0.0 108.041 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 HD23 ' A' ' 6' ' ' LEU . 9.2 mm -55.56 -46.83 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.875 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -54.52 -50.9 66.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.178 1.354 . . . . 0.0 108.996 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -50.54 -43.91 56.26 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 110.627 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.6 69.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.069 0.849 . . . . 0.0 111.232 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.487 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.26 -39.32 69.65 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.001 0.92 . . . . 0.0 111.326 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.64 -48.94 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 O-C-N 121.451 -0.781 . . . . 0.0 109.745 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.4 mt -60.56 -41.44 94.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -60.58 -41.43 94.66 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -68.59 -25.27 64.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.046 1.338 . . . . 0.0 112.652 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -73.07 -24.23 60.65 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.928 173.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.69 2.75 10.42 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.124 1.821 . . . . 0.0 113.418 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.7 t -88.17 122.97 69.5 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.452 1.626 . . . . 0.0 109.616 -161.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.83 84.93 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.549 2.166 . . . . 0.0 109.001 161.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.13 141.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 125.48 1.512 . . . . 0.0 107.561 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -127.1 175.47 8.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.289 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.85 -160.88 16.16 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 120.623 1.556 . . . . 0.0 111.42 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.27 154.63 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.363 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -119.56 178.78 4.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.688 1.595 . . . . 0.0 106.903 165.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -143.38 144.25 31.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 168.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.92 161.03 36.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 109.914 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.37 129.92 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.505 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.95 97.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -117.74 97.99 6.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.995 1.718 . . . . 0.0 106.461 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -64.21 99.45 0.28 Allowed 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.82 -59.57 2.58 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.483 1.04 . . . . 0.0 111.568 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.67 40.77 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.362 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -127.8 132.28 49.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -63.08 114.61 3.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 -23.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.704 0.802 . . . . 0.0 112.876 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.95 -170.86 42.14 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 120.261 1.391 . . . . 0.0 111.716 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -119.32 170.08 9.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 157.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.265 31.4 p30 -129.85 159.75 35.62 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.114 -0.367 . . . . 0.0 110.798 158.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.51 109.92 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.33 113.77 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 p -80.04 157.38 26.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.9 3.36 3.36 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.016 -1.052 . . . . 0.0 112.44 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.4 m -72.41 -11.51 60.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.198 0.999 . . . . 0.0 111.942 160.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.15 76.77 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.289 -0.882 . . . . 0.0 111.943 -167.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.568 HG22 HD23 ' A' ' 90' ' ' LEU . 31.0 m -102.76 154.81 18.81 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.551 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -143.48 141.35 30.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.069 0.85 . . . . 0.0 111.0 -163.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.24 142.12 13.25 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 74.9 1.98 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 125.075 3.85 . . . . 0.0 111.405 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.4 HD22 ' CG2' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -49.16 -49.66 41.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.195 0.998 . . . . 0.0 110.18 -177.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.41 126.06 13.37 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -144.64 92.96 2.35 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 65' ' ' GLY 0.433 4.0 m 34.86 -126.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 113.606 -174.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' H ' HG23 ' A' ' 64' ' ' VAL . . . 110.02 149.32 12.48 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 120.181 1.355 . . . . 0.0 110.991 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.77 152.19 32.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -77.35 164.67 56.99 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.109 0.964 . . . . 0.0 110.009 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.98 124.49 8.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.376 2.05 . . . . 0.0 107.151 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -66.24 169.92 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.949 1.766 . . . . 0.0 108.957 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.39 119.22 6.21 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.748 1.632 . . . . 0.0 108.268 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.11 -68.71 0.54 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.621 1.105 . . . . 0.0 110.705 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -68.02 149.87 49.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 1.151 . . . . 0.0 109.013 178.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.16 156.91 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 164.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 13.9 pt-20 -158.05 -163.19 1.26 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.545 1.938 . . . . 0.0 106.839 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.18 -165.94 1.38 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.052 1.341 . . . . 0.0 108.952 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 3.6 tmm_? 146.62 140.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.104 3.362 . . . . 0.0 107.428 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.22 -24.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.75 104.76 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 107.071 -2.412 . . . . 0.0 107.071 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 65.31 -55.42 0.32 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 129.031 2.932 . . . . 0.0 111.828 -163.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -84.52 137.69 33.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.777 0.831 . . . . 0.0 110.624 -168.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 4.9 p -82.07 110.91 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 172.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.4 ' CG2' HD22 ' A' ' 61' ' ' LEU . 1.4 p -71.46 162.89 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -143.8 125.2 14.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 167.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.93 -26.37 65.9 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.943 0.897 . . . . 0.0 111.668 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -55.31 -35.24 64.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.778 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -60.86 -40.11 91.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.119 0.872 . . . . 0.0 110.521 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -61.27 -50.93 71.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.557 0.617 . . . . 0.0 109.341 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.49 -21.41 62.37 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.92 -45.67 91.82 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.747 0.703 . . . . 0.0 111.843 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -154.31 -28.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -161.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.26 20.59 1.59 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.628 1.171 . . . . 0.0 110.416 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.674 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -121.9 -47.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.973 2.509 . . . . 0.0 112.682 -172.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -64.3 -25.14 64.48 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.65 1.566 . . . . 0.0 111.203 166.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.0 -29.08 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.497 -0.752 . . . . 0.0 113.007 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 mm? -62.7 -51.47 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.906 0.775 . . . . 0.0 109.534 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -127.47 99.23 5.53 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 p30 . . . . . 0 N--CA 1.444 -0.757 0 C-N-CA 124.847 1.259 . . . . 0.0 111.445 179.158 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -140.2 177.63 7.85 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.458 1.903 . . . . 0.0 108.371 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.5 t -133.95 147.22 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 168.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.2 162.19 17.84 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.1 0.96 . . . . 0.0 110.047 172.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.19 130.61 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.003 1.721 . . . . 0.0 107.421 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.3 mt -149.12 106.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -98.32 177.23 5.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.272 -1.518 . . . . 0.0 108.52 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.01 27.65 15.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.406 2.682 . . . . 0.0 113.402 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.59 98.15 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.95 -77.91 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-O 118.795 -1.003 . . . . 0.0 110.748 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -53.97 -30.26 46.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.782 1.233 . . . . 0.0 113.913 -164.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -64.19 -16.17 61.41 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 126.387 1.875 . . . . 0.0 112.156 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -24.31 -59.6 0.05 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.573 2.749 . . . . 0.0 116.2 -163.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.82 -34.8 67.08 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.921 1.288 . . . . 0.0 111.904 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -81.15 -27.68 35.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.702 1.601 . . . . 0.0 111.613 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.6 m -52.09 110.52 0.49 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.467 1.507 . . . . 0.0 109.233 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.67 -8.56 0.49 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.97 -31.35 2.89 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 125.717 1.607 . . . . 0.0 108.996 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -27.64 -73.73 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 129.102 2.961 . . . . 0.0 110.928 164.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -34.33 -63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 128.22 2.608 . . . . 0.0 113.84 172.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.05 -43.05 83.68 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.866 1.212 . . . . 0.0 111.175 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.53 99.42 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.461 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.72 -36.45 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.006 0.922 . . . . 0.0 109.394 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.19 -26.75 63.17 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.232 -1.543 . . . . 0.0 113.941 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -55.49 -56.95 14.29 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.523 1.056 . . . . 0.0 108.91 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 m -66.78 -34.73 78.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.631 1.572 . . . . 0.0 112.489 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.85 -27.81 69.12 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.492 -0.755 . . . . 0.0 109.743 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 t -85.74 -23.6 27.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.709 1.603 . . . . 0.0 111.614 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.8 m -58.38 139.03 85.01 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.2 1.364 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -86.21 107.27 0.84 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.768 2.979 . . . . 0.0 109.16 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 128.87 -43.33 1.33 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.603 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.2 m -57.13 157.54 5.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.158 1.479 . . . . 0.0 110.579 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.22 102.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.91 129.73 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 166.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.25 111.65 11.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.56 174.82 25.41 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.086 0.857 . . . . 0.0 113.08 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.0 m -117.54 122.07 42.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.391 1.096 . . . . 0.0 110.092 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.51 143.25 29.03 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.618 1.167 . . . . 0.0 109.094 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.59 141.25 54.53 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.017 1.811 . . . . 0.0 108.393 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.13 114.5 12.82 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.5 149.55 27.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.367 2.711 . . . . 0.0 109.063 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -140.67 -72.11 0.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.694 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.76 -66.1 2.64 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 146.8 54.65 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 117.639 0.719 . . . . 0.0 109.44 174.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.83 161.26 21.36 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.929 2.419 . . . . 0.0 107.976 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -93.14 155.8 17.25 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -38.9 -50.89 1.76 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.316 2.246 . . . . 0.0 114.146 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 124' ' ' PHE . 4.4 mm? -80.17 -38.19 31.82 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.063 0.545 . . . . 0.0 109.976 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.12 -17.46 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.287 -1.508 . . . . 0.0 110.279 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.64 -61.73 1.75 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.799 -1.188 . . . . 0.0 109.634 161.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.325 0.2 OUTLIER -53.73 -54.35 39.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.092 0.948 . . . . 0.0 112.709 -174.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.27 -30.8 49.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 124.903 1.281 . . . . 0.0 111.788 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -31.29 70.66 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.118 -0.989 . . . . 0.0 110.888 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.27 -6.73 31.24 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.484 0.584 . . . . 0.0 110.718 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -69.24 -30.28 68.38 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.368 -0.833 . . . . 0.0 112.878 170.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -43.67 0.28 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.355 2.262 . . . . 0.0 115.322 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -89.46 64.1 6.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.375 2.27 . . . . 0.0 108.638 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.58 122.95 48.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 tppm? -65.23 110.51 2.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 158.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 m -96.94 88.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 180' ' ' ILE . 19.4 m-85 -61.2 101.58 0.17 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.505 1.122 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.32 93.73 1.53 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.57 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -57.11 166.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.0 p -131.72 162.45 30.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 165.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -61.07 -30.7 70.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.733 -0.604 . . . . 0.0 109.393 159.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.82 -67.07 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.348 1.859 . . . . 0.0 110.266 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.0 33.57 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.891 1.676 . . . . 0.0 110.141 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -56.42 -62.82 1.46 Allowed 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.028 -1.045 . . . . 0.0 111.066 -170.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.77 3.29 12.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.82 -1.24 56.94 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.66 1.584 . . . . 0.0 111.364 172.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 168' ' ' VAL . 7.3 tp -87.37 -32.23 19.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 118.822 -1.151 . . . . 0.0 112.369 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.4 -58.31 3.06 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.739 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.87 -21.92 27.7 Favored 'Trans proline' 0 C--N 1.354 0.85 0 CA-C-N 121.383 1.529 . . . . 0.0 112.798 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -40.66 75.69 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.662 1.985 . . . . 0.0 109.005 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 4.3 mt -66.76 -50.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.212 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.505 ' HA ' HG23 ' A' ' 184' ' ' VAL . 42.0 t -50.9 -29.94 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.741 1.617 . . . . 0.0 109.473 174.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.8 m -75.09 -18.32 60.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 119.999 -1.688 . . . . 0.0 112.973 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -52.71 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -56.61 -60.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.694 1.998 . . . . 0.0 109.453 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.64 -22.02 61.29 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.069 -1.02 . . . . 0.0 113.19 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 37.1 m -73.08 -59.76 2.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.906 0.882 . . . . 0.0 111.316 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.837 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 8.4 tpp180 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 83.3 m-70 -51.32 156.08 1.27 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.613 1.565 . . . . 0.0 111.076 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -129.94 142.13 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 157' ' ' ILE . 24.4 m-85 -135.55 158.34 44.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 160.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mt -93.21 150.62 20.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -154.41 -172.48 4.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.28 -175.12 24.59 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.971 1.272 . . . . 0.0 110.951 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.12 162.02 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.239 2.626 . . . . 0.0 111.557 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.02 153.95 67.19 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.288 1.325 . . . . 0.0 109.481 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.33 -5.64 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 126.61 2.052 . . . . 0.0 110.712 162.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.26 30.2 t 67.1 126.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.616 1.198 . . . . 0.0 110.527 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.41 -9.94 10.8 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.27 164.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -54.9 -31.12 59.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.224 1.012 . . . . 0.0 111.141 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -56.48 -35.72 68.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.646 1.578 . . . . 0.0 110.31 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -67.44 -24.23 65.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.301 -1.499 . . . . 0.0 113.09 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -55.22 20.48 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 170.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -57.05 -46.07 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.319 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -47.83 -57.79 5.18 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.736 0.814 . . . . 0.0 110.023 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -62.57 -40.8 98.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.67 55.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.089 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 p -71.59 -47.81 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.976 1.262 . . . . 0.0 109.97 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.9 -36.42 74.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 110.727 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.45 -53.03 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 125.383 1.473 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -57.81 -42.4 84.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -63.05 -36.31 83.14 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.351 0.26 . . . . 0.0 110.661 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 m -77.37 -10.78 59.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.586 1.954 . . . . 0.0 112.714 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.9 m -100.08 6.08 44.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.627 2.371 . . . . 0.0 111.676 168.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.47 11.79 84.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.708 -1.051 . . . . 0.0 114.633 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.51 139.06 44.28 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 119.557 1.678 . . . . 0.0 109.242 -170.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.82 89.6 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.91 3.073 . . . . 0.0 111.608 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.93 148.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.154 1.382 . . . . 0.0 109.297 172.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -147.53 -176.0 5.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.044 2.138 . . . . 0.0 109.984 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA3' ' H ' ' A' ' 110' ' ' VAL . . . 123.43 -156.81 17.8 Favored Glycine 0 C--O 1.24 0.514 0 C-N-CA 127.88 2.657 . . . . 0.0 108.138 174.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.52 171.3 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.976 0.888 . . . . 0.0 110.231 171.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -137.08 -178.41 5.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 165.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.5 p -130.41 154.32 47.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 160.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.47 13.69 3.78 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 112.63 -172.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.275 12.6 pt-20 50.65 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 127.1 2.16 . . . . 0.0 110.783 -156.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.713 HG13 HG13 ' A' ' 47' ' ' ILE . 11.0 p -63.11 138.61 22.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -122.97 164.81 17.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.668 1.187 . . . . 0.0 108.404 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.67 96.67 2.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.34 -66.45 1.49 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.61 12.11 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.652 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.96 143.17 47.19 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 118.597 1.198 . . . . 0.0 109.1 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -63.09 154.75 29.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 124.671 1.232 . . . . 0.0 108.873 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.713 HG13 HG13 ' A' ' 40' ' ' VAL . 1.1 pt -140.3 -13.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.791 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 157.27 -142.82 8.94 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.141 -2.383 . . . . 0.0 107.141 173.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -142.35 66.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.229 1.515 . . . . 0.0 110.602 -172.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -53.15 143.88 16.91 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.55 114.85 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 118.568 0.622 . . . . 0.0 109.559 -160.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.33 109.68 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -150.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -59.87 146.02 43.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.02 -11.51 39.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.278 168.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 -14.56 61.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.516 1.926 . . . . 0.0 111.618 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 67.82 1.47 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 119.412 1.005 . . . . 0.0 111.148 -177.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -157.32 151.43 24.73 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.707 3.203 . . . . 0.0 104.706 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.41 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -142.63 154.44 44.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 121.278 1.853 . . . . 0.0 109.714 -173.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.02 156.86 19.78 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.083 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.98 54.32 4.82 Favored 'Trans proline' 0 CA--C 1.539 0.762 1 C-N-CA 125.695 4.264 . . . . 0.0 113.21 -173.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -51.44 -52.36 46.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.656 1.582 . . . . 0.0 111.137 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 p -150.16 133.05 16.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.34 43.15 0.52 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.351 0.26 . . . . 0.0 110.624 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t 60.43 154.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 129.045 2.938 . . . . 0.0 110.641 -167.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.02 160.1 31.7 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 105.481 -3.048 . . . . 0.0 105.481 166.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.28 164.78 12.77 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.006 0.908 . . . . 0.0 110.461 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -63.83 148.65 94.42 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.134 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.32 133.24 17.41 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.452 2.768 . . . . 0.0 110.184 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.34 174.26 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.347 2.698 . . . . 0.0 110.875 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.4 -24.69 64.05 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.095 1.196 . . . . 0.0 113.282 -176.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.22 -1.68 47.95 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.698 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -148.06 143.98 27.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.137 1.969 . . . . 0.0 108.581 -172.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.01 149.89 27.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.507 ' HG3' ' HE2' ' A' ' 72' ' ' LYS . 22.2 mt-10 -132.47 162.36 31.36 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.359 1.863 . . . . 0.0 109.537 168.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.71 136.26 57.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.687 1.195 . . . . 0.0 109.211 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.39 154.64 41.86 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.263 -172.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.96 119.74 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.25 -107.3 1.64 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.49 -10.76 15.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 112.868 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.09 140.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.87 163.22 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 160.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.55 173.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 O-C-N 120.501 -1.374 . . . . 0.0 109.889 171.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.77 98.71 4.25 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.89 -35.7 71.37 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.101 -0.999 . . . . 0.0 110.701 173.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -66.35 -30.63 71.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.616 0.766 . . . . 0.0 109.966 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.8 t -62.01 -23.91 66.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 120.041 1.291 . . . . 0.0 111.891 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -73.09 -62.73 1.36 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.24 -13.7 13.94 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -53.82 -42.71 68.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 111.623 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.64 -35.67 0.49 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.052 0.541 . . . . 0.0 112.242 -168.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 63.67 4.46 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -65.25 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 127.708 2.403 . . . . 0.0 105.766 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 -18.11 36.93 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.383 2.055 . . . . 0.0 114.348 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 95' ' ' LEU . 20.0 m -67.5 -64.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.595 1.089 . . . . 0.0 108.697 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 94' ' ' VAL . 76.5 mt -45.62 -56.13 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.657 2.383 . . . . 0.0 108.506 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.16 89.16 3.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.13 0.491 . . . . 0.0 110.742 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.442 -0.864 0 C-N-CA 118.044 -1.463 . . . . 0.0 107.62 158.556 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 . . . . . 0 CA--C 1.525 0.006 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -124.6 164.77 19.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.899 1.68 . . . . 0.0 107.209 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -124.42 141.4 44.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.401 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 8.9 t -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.406 ' H ' ' HA3' ' A' ' 34' ' ' GLY . 90.6 t -141.14 128.95 22.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.486 1.514 . . . . 0.0 107.138 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.52 68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.19 -168.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.81 18.85 0.55 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.037 1.735 . . . . 0.0 114.634 -171.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -67.51 129.47 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 119.327 -2.108 . . . . 0.0 107.404 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.05 -75.63 0.22 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-O 119.496 -0.614 . . . . 0.0 112.141 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -64.54 -26.9 68.62 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.074 0.937 . . . . 0.0 112.022 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.8 mmm -63.66 -7.68 8.06 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 116.55 -1.69 . . . . 0.0 114.03 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -42.23 -44.73 3.89 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.519 1.963 . . . . 0.0 114.517 -165.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.51 -39.1 28.51 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.422 0.689 . . . . 0.0 111.736 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -84.06 -21.21 31.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.24 1.016 . . . . 0.0 110.987 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.2 t -42.16 123.09 2.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 129.762 3.225 . . . . 0.0 110.569 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.45 -88.61 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 107.605 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.88 -1.86 8.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.587 -0.72 . . . . 0.0 112.131 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -71.82 0.11 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.654 1.115 . . . . 0.0 110.188 160.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.33 -31.42 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 126.002 1.721 . . . . 0.0 113.105 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -60.56 2.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 120.664 -1.273 . . . . 0.0 112.813 171.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.26 67.23 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 111.828 -166.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.86 -51.17 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -57.78 -40.14 79.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 120.301 1.41 . . . . 0.0 113.412 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -56.73 -20.53 22.5 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.313 1.045 . . . . 0.0 112.515 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -108.71 -27.87 9.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.977 1.311 . . . . 0.0 110.234 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.187 1.395 . . . . 0.0 111.633 168.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.7 t -58.3 -44.68 88.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.477 0.711 . . . . 0.0 109.442 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.1 m -77.3 133.43 68.15 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.92 -30.04 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.439 2.76 . . . . 0.0 111.3 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.75 -65.38 3.62 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.712 2.101 . . . . 0.0 111.634 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 20.1 m -59.46 143.33 50.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.91 169.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.19 96.8 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mm -56.7 130.9 19.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 142.33 50.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.726 2.411 . . . . 0.0 105.304 167.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.37 175.28 45.58 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.281 0.946 . . . . 0.0 110.945 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.1 m -115.94 94.64 4.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.151 1.476 . . . . 0.0 113.105 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 5' ' ' PHE . 1.2 pp -89.84 122.44 67.95 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.094 -1.004 . . . . 0.0 111.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.12 153.13 67.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.827 1.684 . . . . 0.0 110.532 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.84 151.88 95.13 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 122.057 -0.402 . . . . 0.0 110.431 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.15 -55.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.135 3.223 . . . . 0.0 111.907 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 26.17 77.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.48 2.712 . . . . 0.0 110.923 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.03 -111.53 3.13 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 135.03 90.38 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 117.584 0.692 . . . . 0.0 109.654 -170.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.72 171.07 12.67 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.237 1.958 . . . . 0.0 110.619 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.83 160.93 28.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.952 2.501 . . . . 0.0 105.193 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.34 -66.27 0.91 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.852 0.861 . . . . 0.0 110.082 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.18 -46.79 87.48 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.42 0.688 . . . . 0.0 109.203 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.95 -41.68 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.292 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.55 -17.66 60.01 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.593 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -36.08 76.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.686 1.194 . . . . 0.0 108.771 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.3 mt -84.72 -52.18 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 109.487 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -23.44 65.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.932 1.293 . . . . 0.0 110.265 -172.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -40.05 13.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 174.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 162' ' ' ASP . 30.0 mtp85 -68.9 -36.09 77.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 123.88 0.872 . . . . 0.0 110.545 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? 60.63 -18.67 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.675 1.99 . . . . 0.0 113.86 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -71.85 48.77 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 1 C-N-CA 133.124 4.569 . . . . 0.0 110.755 173.628 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.77 128.89 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -69.71 105.45 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 160.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.38 87.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 16.0 m-85 -58.5 100.19 0.06 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 107.64 5.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.05 147.81 10.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.8 p -99.02 166.12 11.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 158.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.83 -14.01 61.85 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 120.002 -1.686 . . . . 0.0 111.031 161.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -88.66 -65.03 1.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.07 0.948 . . . . 0.0 110.416 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.66 29.14 2.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.96 2.104 . . . . 0.0 108.146 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -50.28 -57.02 8.79 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.561 1.144 . . . . 0.0 108.009 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -82.92 17.67 1.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -116.55 48.19 1.32 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 8.6 tp -129.0 -37.36 1.71 Allowed 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.158 174.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -55.04 13.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 117.305 -1.331 . . . . 0.0 109.629 176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.64 -26.06 39.91 Favored 'Trans proline' 0 C--N 1.356 0.962 0 CA-C-N 121.926 1.724 . . . . 0.0 113.482 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.49 -45.11 63.37 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.22 1.408 . . . . 0.0 109.85 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 14.5 mt -54.82 -52.78 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 125.406 1.482 . . . . 0.0 109.19 167.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.74 -44.59 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.458 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.1 m -62.04 -42.23 98.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.564 1.075 . . . . 0.0 109.726 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.4 t -67.03 -44.18 80.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.017 0.826 . . . . 0.0 110.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.56 -53.73 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.595 -0.691 . . . . 0.0 109.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -16.08 63.63 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.997 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -57.29 10.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 -167.427 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -145.73 172.85 12.7 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.447 1.021 . . . . 0.0 110.535 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.648 ' HB2' HG12 ' A' ' 163' ' ' VAL . 17.7 m-70 -58.49 156.28 10.74 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.608 1.963 . . . . 0.0 111.729 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.23 130.56 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CE1' HG21 ' A' ' 157' ' ' ILE . 38.9 m-85 -125.29 139.93 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.413 0.685 . . . . 0.0 111.399 173.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.52 155.15 33.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.347 1.459 . . . . 0.0 107.991 167.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -152.12 175.84 12.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.86 -163.47 25.02 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.6 146.73 15.29 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.62 2.213 . . . . 0.0 110.321 168.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.77 153.7 77.05 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.722 1.615 . . . . 0.0 109.421 165.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.61 5.83 0.03 OUTLIER Glycine 0 CA--C 1.524 0.63 0 CA-C-O 119.053 -0.859 . . . . 0.0 112.491 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.254 97.1 t 65.56 115.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 127.027 2.131 . . . . 0.0 112.503 171.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.41 -41.9 0.21 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 113.723 -1.58 . . . . 0.0 110.962 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -50.18 -31.86 14.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.719 1.607 . . . . 0.0 112.535 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -45.23 -47.27 12.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 129.005 2.922 . . . . 0.0 110.038 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -86.06 -23.99 26.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.774 1.23 . . . . 0.0 110.728 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.07 -37.04 78.28 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 118.211 -0.9 . . . . 0.0 109.693 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.4 -46.32 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 117.902 -1.046 . . . . 0.0 108.732 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -53.62 -44.82 69.8 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.616 1.553 . . . . 0.0 111.428 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -62.05 -40.28 95.22 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.449 0.7 . . . . 0.0 110.769 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 177' ' ' LEU . . . -60.82 -23.64 65.24 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.426 0.557 . . . . 0.0 112.019 172.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 m -89.62 12.06 17.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.072 1.749 . . . . 0.0 112.183 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -113.05 -23.36 10.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.912 1.685 . . . . 0.0 111.838 168.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.44 -44.09 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.273 -0.892 . . . . 0.0 113.199 -161.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.72 -35.4 72.63 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 166.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.19 -39.6 82.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.97 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -70.48 -18.11 62.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.467 0.707 . . . . 0.0 111.21 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -96.03 6.02 49.82 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.155 2.182 . . . . 0.0 111.856 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.4 18.61 75.71 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.281 -0.887 . . . . 0.0 113.518 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.29 100.31 15.18 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.731 2.012 . . . . 0.0 106.758 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.52 90.38 1.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.933 2.422 . . . . 0.0 110.73 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.47 154.32 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 126.519 1.928 . . . . 0.0 109.518 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.33 176.6 9.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.085 0.954 . . . . 0.0 110.469 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.91 -149.97 17.08 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.02 1.295 . . . . 0.0 111.147 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -145.4 160.85 40.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.777 0.831 . . . . 0.0 111.697 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -144.18 131.19 20.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.56 1.544 . . . . 0.0 106.96 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 p -74.25 146.7 43.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 117.62 -1.181 . . . . 0.0 107.882 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.57 159.12 35.58 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.605 1.548 . . . . 0.0 109.102 167.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.38 96.01 7.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.565 1.146 . . . . 0.0 107.972 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.56 101.63 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.567 1.175 . . . . 0.0 108.806 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -121.95 84.95 2.33 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 125.758 1.623 . . . . 0.0 108.64 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -58.99 109.67 0.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.71 34.63 21.71 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.652 -0.527 . . . . 0.0 113.129 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.42 38.45 14.63 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.556 1.678 . . . . 0.0 115.273 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 136.09 45.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.357 2.078 . . . . 0.0 107.663 159.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -67.28 111.82 4.2 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.901 0.88 . . . . 0.0 108.872 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 pt -115.62 -10.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.942 0.897 . . . . 0.0 112.483 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -165.4 35.84 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 107.996 -2.041 . . . . 0.0 107.996 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -124.48 167.53 14.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.701 1.6 . . . . 0.0 107.644 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -120.67 -178.83 3.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.544 1.538 . . . . 0.0 109.584 167.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.83 96.34 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 162.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.33 151.0 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 p -115.8 154.6 29.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.43 -6.78 15.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.174 0.897 . . . . 0.0 111.909 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -86.39 3.14 44.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.155 2.582 . . . . 0.0 111.784 171.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.71 5.83 88.37 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.277 -1.515 . . . . 0.0 114.377 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 151.23 30.7 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 169.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 136.79 26.96 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.796 1.18 . . . . 0.0 111.496 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -87.16 176.41 47.02 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 121.398 0.443 . . . . 0.0 112.945 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.18 167.5 21.8 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 146.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -142.92 -69.98 0.33 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -128.45 161.5 29.35 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.906 0.882 . . . . 0.0 109.936 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -149.7 169.52 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.813 1.245 . . . . 0.0 108.118 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 t -60.29 149.81 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.498 0.719 . . . . 0.0 109.382 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.08 165.2 32.54 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 160.67 16.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.493 1.117 . . . . 0.0 109.586 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.99 155.62 93.19 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.6 124.82 11.09 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.994 2.463 . . . . 0.0 108.014 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.36 162.95 36.5 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 108.549 -1.366 . . . . 0.0 108.549 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.92 -11.34 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.766 1.644 . . . . 0.0 113.783 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.16 -40.72 4.77 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.192 1.377 . . . . 0.0 113.707 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.0 112.45 25.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.977 1.389 . . . . 0.0 107.688 -170.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -71.19 135.42 47.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.91 176.16 11.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.539 1.936 . . . . 0.0 106.342 166.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 83.0 m -124.4 74.79 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.559 0.695 . . . . 0.0 111.001 -165.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 138.99 33.88 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.479 1.112 . . . . 0.0 108.664 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.8 -27.65 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.325 0.584 . . . . 0.0 111.334 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.82 -71.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 105.136 -3.186 . . . . 0.0 105.136 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -108.43 -51.84 2.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.616 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.06 163.13 28.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 119.888 1.222 . . . . 0.0 109.249 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.68 119.94 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.53 172.92 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.665 0.786 . . . . 0.0 108.928 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.52 146.26 31.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 162.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.23 -32.42 71.65 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.236 0.615 . . . . 0.0 110.737 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.6 m -64.55 -32.71 74.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.156 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.2 m -61.37 -34.94 76.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.682 1.128 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.472 0.709 . . . . 0.0 110.139 167.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -24.02 9.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.444 1.097 . . . . 0.0 113.477 -170.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -50.17 -35.59 26.81 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.994 1.318 . . . . 0.0 113.158 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -145.23 -33.84 0.35 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.026 -0.512 . . . . 0.0 112.005 -175.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.57 1.948 . . . . 0.0 111.508 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -135.69 -55.16 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.43 1.492 . . . . 0.0 110.168 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 49.3 Cg_endo -69.97 -37.57 8.49 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.751 1.634 . . . . 0.0 112.318 170.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.26 -24.64 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -45.14 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.999 0.519 . . . . 0.0 110.649 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.62 70.89 0.91 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.38 120.18 19.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 165.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.29 174.09 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.784 2.034 . . . . 0.0 114.387 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -161.79 148.14 13.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.419 2.688 . . . . 0.0 104.047 160.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.8 -170.23 0.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.175 2.19 . . . . 0.0 106.623 157.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m 71.36 -67.69 0.25 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.503 1.921 . . . . 0.0 113.879 158.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.61 -174.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.89 2.076 . . . . 0.0 111.64 -169.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.24 -127.3 8.09 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.66 137.35 38.61 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 119.853 1.826 . . . . 0.0 109.216 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.97 -61.37 0.62 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.349 -1.901 . . . . 0.0 108.349 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 51.51 -156.97 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -167.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -155.07 165.56 36.33 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.479 1.512 . . . . 0.0 107.19 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.47 136.35 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.0 t -123.52 108.57 12.79 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.569 1.148 . . . . 0.0 109.519 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.85 130.14 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 125.643 1.577 . . . . 0.0 109.572 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.39 86.61 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.51 158.47 35.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 163.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER 51.14 90.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.959 2.504 . . . . 0.0 112.587 -174.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.89 75.72 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 164.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.88 -45.95 0.02 OUTLIER Glycine 0 C--N 1.334 0.437 0 O-C-N 120.952 -1.092 . . . . 0.0 113.383 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 9.4 tptt -66.49 -37.33 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.74 0.77 . . . . 0.0 110.39 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.5 mmt -79.46 0.52 29.15 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 115.559 -2.162 . . . . 0.0 114.253 -172.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.26 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 -170.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tp -117.85 -44.76 2.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.916 1.686 . . . . 0.0 110.131 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -73.89 -20.57 60.37 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.267 1.027 . . . . 0.0 111.41 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 p -53.4 115.29 1.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.379 2.272 . . . . 0.0 109.986 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.23 -71.49 0.54 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.585 1.154 . . . . 0.0 108.884 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.3 -21.4 59.74 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.424 1.09 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -69.14 0.12 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.309 1.443 . . . . 0.0 110.19 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.2 mp -37.73 -48.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.388 1.875 . . . . 0.0 112.683 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -63.89 -64.88 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.699 0.799 . . . . 0.0 112.48 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.5 90.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.072 0.949 . . . . 0.0 110.452 -170.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.55 -44.61 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.556 1.142 . . . . 0.0 109.367 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -67.66 -31.99 72.36 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.011 -1.681 . . . . 0.0 112.353 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -37.73 83.57 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.981 1.718 . . . . 0.0 110.512 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.434 ' CG2' HD11 ' A' ' 139' ' ' ILE . 1.5 m -65.92 -47.89 73.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.881 0.472 . . . . 0.0 110.866 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.33 -19.74 66.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 111.261 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -39.58 78.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.044 0.938 . . . . 0.0 109.477 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.7 m -64.81 134.02 95.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 123.565 0.746 . . . . 0.0 109.414 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.0 -29.27 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.661 2.907 . . . . 0.0 112.025 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.7 -53.75 7.09 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 145.03 54.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.222 1.011 . . . . 0.0 112.28 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.16 98.76 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 102.949 -2.982 . . . . 0.0 102.949 -169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 131' ' ' THR . 44.0 mm -61.06 131.65 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.41 116.26 8.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.566 1.947 . . . . 0.0 106.508 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.05 -179.61 39.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.7 m -123.53 100.28 6.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.9 pt -97.19 161.74 25.13 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 179.98 4.54 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.401 2.734 . . . . 0.0 110.47 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.5 150.36 79.45 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 121.172 -0.955 . . . . 0.0 110.773 164.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.01 109.47 2.7 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 123.188 2.592 . . . . 0.0 108.883 164.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.16 119.72 15.0 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 164.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.09 -131.02 36.0 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.59 137.55 96.46 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.845 -158.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 131.27 22.71 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.621 2.214 . . . . 0.0 109.009 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.98 121.87 21.71 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 13.33 0.06 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.122 2.569 . . . . 0.0 115.634 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.4 tp -131.67 -39.83 1.11 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.388 1.875 . . . . 0.0 109.39 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.83 -23.77 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 120.825 -1.172 . . . . 0.0 109.006 173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.54 -40.43 78.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.578 1.151 . . . . 0.0 110.73 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.82 -31.03 72.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.689 1.996 . . . . 0.0 110.471 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.481 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.4 mp -90.56 -41.61 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.535 1.534 . . . . 0.0 109.337 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -52.56 -39.05 61.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.971 1.709 . . . . 0.0 109.823 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -33.4 -47.54 0.22 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 127.968 2.507 . . . . 0.0 113.033 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -66.5 -40.75 89.41 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.342 -1.313 . . . . 0.0 112.436 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.75 -40.71 0.22 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.53 1.932 . . . . 0.0 113.482 -167.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.94 -22.49 60.1 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.68 2.392 . . . . 0.0 113.563 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 3' ' ' HIS . 5.6 m -66.0 138.79 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.487 ' HE3' ' CE1' ' A' ' 166' ' ' PHE . 28.3 tptt -65.07 142.73 58.3 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.85 102.29 11.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.487 ' CE1' ' HE3' ' A' ' 164' ' ' LYS . 13.7 m-85 -93.53 96.69 10.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.042 1.337 . . . . 0.0 111.051 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 104.94 2.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 172.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.59 163.05 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.988 0.813 . . . . 0.0 108.816 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.4 p -123.57 169.04 11.84 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.205 1.802 . . . . 0.0 106.305 160.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -77.51 -10.6 59.58 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.344 1.458 . . . . 0.0 112.275 158.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -79.99 -74.0 0.33 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.79 32.39 0.74 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.221 1.408 . . . . 0.0 109.913 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -54.91 -51.76 65.03 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.732 -1.23 . . . . 0.0 110.405 -169.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -75.33 4.04 7.92 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.95 -19.0 31.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.707 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -21.58 45.79 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.913 -164.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -47.71 -63.13 1.6 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.951 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.72 -28.78 76.69 Favored 'Trans proline' 0 C--N 1.35 0.616 0 CA-C-N 121.853 1.697 . . . . 0.0 112.929 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -33.97 75.0 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.608 0.763 . . . . 0.0 109.678 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.16 -52.17 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.071 0.948 . . . . 0.0 109.82 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.4 t -57.89 -34.77 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 118.42 0.554 . . . . 0.0 110.225 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.7 m -55.92 -44.61 78.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.389 1.076 . . . . 0.0 110.263 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -70.97 -41.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.684 -0.635 . . . . 0.0 110.278 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.27 -59.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 123.405 0.682 . . . . 0.0 109.811 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -3.18 20.42 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.273 1.029 . . . . 0.0 112.684 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -60.47 -21.35 62.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.883 -1.135 . . . . 0.0 110.592 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.82 126.54 29.74 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.999 1.272 . . . . 0.0 107.636 164.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -40.58 109.28 0.11 Allowed 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.022 1.329 . . . . 0.0 111.994 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.538 ' CE ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 156.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.5 178.79 9.19 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 163.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HB2' HG12 ' A' ' 163' ' ' VAL . 40.3 m-70 -24.63 119.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.55 3.14 . . . . 0.0 111.624 166.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 t -105.08 137.86 32.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 157' ' ' ILE . 54.5 m-85 -127.86 153.91 46.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.576 0.75 . . . . 0.0 109.151 163.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 164.24 12.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.838 2.055 . . . . 0.0 108.313 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -159.5 -173.45 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.11 53.7 6.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 127.214 2.34 . . . . 0.0 112.136 -160.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.11 123.51 8.88 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 119.786 1.793 . . . . 0.0 110.266 -171.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.6 -1.6 8.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.511 2.141 . . . . 0.0 112.238 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.93 4.03 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -170.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.4 97.99 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 125.396 2.522 . . . . 0.0 107.48 -168.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.85 -45.49 0.55 Allowed Glycine 0 C--N 1.309 -0.938 0 CA-C-N 111.345 -2.661 . . . . 0.0 108.414 163.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.533 ' HD3' HG21 ' A' ' 142' ' ' THR . 0.1 OUTLIER -47.31 -48.42 25.13 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.327 1.851 . . . . 0.0 112.958 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.3 m -60.31 -52.93 63.19 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.207 0.912 . . . . 0.0 108.898 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 m -59.67 -40.29 87.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.736 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -53.14 48.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.468 1.485 . . . . 0.0 109.284 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.25 -26.07 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.581 0.752 . . . . 0.0 111.06 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -66.12 -57.16 8.3 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.034 -1.666 . . . . 0.0 109.332 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -11.29 29.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.01 45.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.908 1.283 . . . . 0.0 112.468 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.2 p -67.23 -47.51 70.6 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -171.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.07 -39.98 66.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.199 1.8 . . . . 0.0 112.246 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.87 -54.41 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.457 1.103 . . . . 0.0 109.236 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 30' ' ' VAL . 25.9 mt -69.6 -36.57 76.32 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.316 0.646 . . . . 0.0 109.351 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -60.68 -39.0 86.84 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.971 -1.706 . . . . 0.0 109.89 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.97 -34.66 70.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.512 1.525 . . . . 0.0 110.342 168.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 4.32 4.99 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.308 2.243 . . . . 0.0 115.389 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.62 20.22 55.84 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.282 0.946 . . . . 0.0 112.204 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 25' ' ' LEU . 5.7 p -56.55 140.85 73.46 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.918 1.287 . . . . 0.0 108.741 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -79.16 84.72 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 CA-C-N 121.701 1.643 . . . . 0.0 111.347 168.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.07 156.78 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.159 0.983 . . . . 0.0 109.127 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -156.25 174.25 15.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.984 1.713 . . . . 0.0 107.471 164.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.43 -148.14 19.07 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 125.487 1.518 . . . . 0.0 111.31 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -148.68 171.56 16.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 111.216 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 9.1 p90 -146.22 172.38 13.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.29 1.436 . . . . 0.0 108.349 165.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.5 90.6 2.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.158 1.783 . . . . 0.0 106.326 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 18.8 mt-10 -74.89 -22.73 58.47 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.462 -0.774 . . . . 0.0 112.705 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 96.17 164.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.347 4.259 . . . . 0.0 109.747 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.32 104.01 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -121.42 105.25 10.33 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.831 1.253 . . . . 0.0 107.754 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -79.65 116.12 19.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.95 -56.03 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 120.529 1.513 . . . . 0.0 114.115 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.21 11.44 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.837 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 137.15 28.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.189 1.995 . . . . 0.0 109.484 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.2 mtm-85 -66.61 144.92 56.12 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.28 -12.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.79 1.236 . . . . 0.0 112.965 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.91 -168.56 41.69 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -129.46 138.04 51.19 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -114.84 158.45 21.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD13 ' A' ' 90' ' ' LEU . 14.2 p -116.67 94.84 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -166.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.14 116.53 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.94 1.696 . . . . 0.0 108.235 -162.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.4 p -88.75 150.77 22.79 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.398 0.999 . . . . 0.0 109.271 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.17 -24.94 67.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.051 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -32.9 72.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.492 1.117 . . . . 0.0 109.302 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.99 -14.85 2.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.702 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 163.59 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.969 2.108 . . . . 0.0 110.785 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.25 156.63 42.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 121.379 -0.826 . . . . 0.0 109.534 156.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -127.28 159.75 21.36 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.82 64.9 7.31 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.66 3.574 . . . . 0.0 111.642 -166.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.64 -56.08 2.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 127.079 2.152 . . . . 0.0 110.677 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 147.8 34.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 109.516 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -147.4 161.67 40.57 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.029 1.332 . . . . 0.0 108.691 172.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -62.55 159.95 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 123.833 0.853 . . . . 0.0 109.744 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.55 -155.88 7.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.75 166.11 22.84 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.81 149.31 40.14 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.993 0.815 . . . . 0.0 109.457 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.01 124.45 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.066 1.844 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.62 164.7 33.21 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.525 2.816 . . . . 0.0 110.891 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.16 -12.43 27.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.475 2.116 . . . . 0.0 113.749 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.28 7.87 73.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.258 0.932 . . . . 0.0 112.879 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -140.65 170.13 16.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 130.389 3.476 . . . . 0.0 104.221 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -139.47 149.65 44.25 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 153.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -151.24 149.95 30.01 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.14 97.88 4.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.093 1.357 . . . . 0.0 110.113 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.2 161.8 19.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.049 1.295 . . . . 0.0 111.168 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.66 -4.13 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -161.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.22 77.21 0.09 OUTLIER Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 86.59 -31.44 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.076 2.95 . . . . 0.0 111.491 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -105.94 146.11 30.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.11 132.32 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.33 175.18 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.624 1.57 . . . . 0.0 108.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.68 135.51 22.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.54 -37.86 85.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 164.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -51.29 -42.46 61.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.081 1.352 . . . . 0.0 110.802 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.8 m -75.98 -15.27 60.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.614 -1.304 . . . . 0.0 112.914 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.5 -59.03 2.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.791 -1.1 . . . . 0.0 108.444 161.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -57.79 -17.27 14.8 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.481 1.491 . . . . 0.0 114.009 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -52.61 -41.48 63.72 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.665 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -142.26 -37.54 0.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.831 0.852 . . . . 0.0 112.688 -171.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 94' ' ' VAL . . . -77.98 51.02 0.92 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.159 1.784 . . . . 0.0 109.373 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.03 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.894 2.477 . . . . 0.0 105.698 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.55 -35.7 37.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.817 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 91' ' ' ALA . 22.5 m -62.28 -21.08 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.883 1.219 . . . . 0.0 113.303 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.11 -33.86 68.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.197 0.453 . . . . 0.0 109.781 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.42 107.02 3.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.786 -1.196 . . . . 0.0 111.545 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -78.59 144.84 35.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 159.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.1 122.91 12.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 109.885 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -109.82 -65.84 1.12 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 58.8 m 53.53 -156.68 0.19 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.31 1.044 . . . . 0.0 109.928 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.6 m -84.26 77.63 9.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.169 0.895 . . . . 0.0 110.613 -166.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.4 p -86.07 -170.44 3.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.985 2.514 . . . . 0.0 111.464 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.27 179.7 53.42 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.362 -1.461 . . . . 0.0 111.989 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.95 150.84 87.55 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.786 2.324 . . . . 0.0 109.039 166.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.9 84.08 0.08 OUTLIER Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.0 130.54 42.1 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.241 1.019 . . . . 0.0 109.487 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -84.28 162.79 19.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.099 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.06 154.95 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.31 149.85 52.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.254 1.022 . . . . 0.0 108.698 163.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.68 122.55 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 123.17 0.588 . . . . 0.0 109.423 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.02 84.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -171.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -74.09 171.15 14.05 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.39 -1.444 . . . . 0.0 109.785 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 34.33 69.23 0.16 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.882 3.273 . . . . 0.0 114.301 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.424 HG23 HD23 ' A' ' 153' ' ' LEU . 19.7 mt -89.27 91.81 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -163.41 -81.05 0.04 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 118.473 0.579 . . . . 0.0 112.032 -170.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -53.4 -35.43 60.36 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.614 1.166 . . . . 0.0 113.06 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -3.43 16.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.963 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -39.44 -52.43 2.1 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 121.514 1.961 . . . . 0.0 112.389 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -45.3 95.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.524 0.73 . . . . 0.0 111.375 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.49 -9.65 55.78 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.23 2.212 . . . . 0.0 113.6 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.5 m -55.64 109.87 0.63 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.351 1.46 . . . . 0.0 112.017 -164.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -120.35 -83.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.491 0.587 . . . . 0.0 111.189 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.57 -19.66 63.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.886 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -74.26 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.765 2.026 . . . . 0.0 110.339 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.8 mp -33.99 -58.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-N 120.169 1.35 . . . . 0.0 112.737 170.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.92 -58.04 10.16 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.354 0.979 . . . . 0.0 111.911 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.01 91.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.002 0.814 . . . . 0.0 109.513 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 157' ' ' ILE . 41.1 t -55.97 -50.91 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.432 1.493 . . . . 0.0 109.247 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -65.3 -28.97 69.69 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.729 -1.232 . . . . 0.0 112.563 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -54.18 -58.53 7.01 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 m -60.51 -38.51 84.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.128 2.571 . . . . 0.0 112.453 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.33 -33.83 75.46 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.88 0.472 . . . . 0.0 110.285 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.4 -8.11 58.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.849 0.46 . . . . 0.0 111.231 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 m -89.97 133.72 33.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.5 -37.15 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.275 2.65 . . . . 0.0 112.76 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -48.52 80.64 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -63.49 153.67 34.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.157 1.783 . . . . 0.0 111.497 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.8 mt -139.29 106.28 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.6 mm -65.43 147.45 12.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.4 tp -144.32 94.49 2.58 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.909 2.083 . . . . 0.0 106.581 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.68 173.97 19.95 Favored Glycine 0 N--CA 1.465 0.628 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.455 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.533 HG21 ' HD3' ' A' ' 14' ' ' LYS . 29.2 m -131.36 98.87 4.66 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.632 1.216 . . . . 0.0 112.52 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.6 pt -80.15 140.81 53.42 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 120.827 -1.17 . . . . 0.0 111.375 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.8 137.9 43.16 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.044 1.83 . . . . 0.0 108.435 166.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.89 134.45 95.92 Favored Pre-proline 0 N--CA 1.444 -0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.166 -166.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.78 129.92 19.58 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.818 2.345 . . . . 0.0 108.958 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.95 -61.24 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.731 1.213 . . . . 0.0 108.426 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.88 -126.91 0.74 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 157.03 90.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.569 0.685 . . . . 0.0 111.313 -170.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.63 103.2 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.785 2.323 . . . . 0.0 108.711 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.04 124.46 21.67 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.682 -0.636 . . . . 0.0 110.131 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.53 -59.82 4.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.166 1.386 . . . . 0.0 113.3 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 114' ' ' ILE . 65.0 tp -63.5 -30.59 71.68 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.478 -1.389 . . . . 0.0 111.259 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.16 -44.24 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 121.297 -0.877 . . . . 0.0 108.888 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.01 -37.66 66.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.988 1.715 . . . . 0.0 110.829 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -57.85 -28.61 64.29 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.659 0.663 . . . . 0.0 112.344 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.512 HG21 ' CE1' ' A' ' 5' ' ' PHE . 9.2 mt -107.56 -32.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.602 1.161 . . . . 0.0 109.975 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -32.99 72.25 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.033 -1.042 . . . . 0.0 109.166 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.28 -6.45 23.97 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -76.53 -39.65 52.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 120.884 1.674 . . . . 0.0 110.057 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? 62.2 -23.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.121 2.169 . . . . 0.0 114.648 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.59 -28.7 69.54 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.288 1.435 . . . . 0.0 111.997 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 3' ' ' HIS . 27.7 m -55.36 135.82 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.451 1.5 . . . . 0.0 110.566 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.74 145.63 54.55 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 168.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.23 89.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.51 ' CD2' HG12 ' A' ' 180' ' ' ILE . 30.7 m-85 -79.2 104.75 10.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.786 0.835 . . . . 0.0 109.087 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.65 105.14 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.429 HG23 HD22 ' A' ' 176' ' ' LEU . 0.7 OUTLIER -59.91 155.84 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 164.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.3 p -134.83 162.59 31.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 154.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.76 -14.64 61.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.494 165.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.62 -54.27 4.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -101.92 10.69 39.53 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.288 1.435 . . . . 0.0 110.746 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 ptt85 -29.71 -65.16 0.11 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.034 2.134 . . . . 0.0 111.612 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -80.3 3.45 20.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -169.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -105.18 -6.97 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.099 2.16 . . . . 0.0 111.033 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 168' ' ' VAL . 6.8 tp -81.15 -45.77 15.91 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 119.189 0.904 . . . . 0.0 110.65 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.8 tp -32.51 -61.91 0.31 Allowed Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.716 2.006 . . . . 0.0 109.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.14 -28.63 28.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 122.438 1.906 . . . . 0.0 114.94 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -68.14 -35.07 77.5 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.872 1.215 . . . . 0.0 109.847 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.51 HG12 ' CD2' ' A' ' 166' ' ' PHE . 12.0 mt -65.34 -46.34 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.835 171.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.89 -45.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 119.349 0.977 . . . . 0.0 108.761 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.0 m -58.53 -51.09 71.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.623 0.769 . . . . 0.0 111.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.15 -31.32 69.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 120.229 1.377 . . . . 0.0 112.106 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.65 -62.03 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -70.14 -18.23 63.22 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -19.06 56.32 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 119.457 1.026 . . . . 0.0 111.56 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.0 t -70.57 -14.67 62.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.633 1.56 . . . . 0.0 111.978 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -86.51 -48.65 8.2 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.899 0.88 . . . . 0.0 109.821 167.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 11.0 mmpt? . . . . . 0 C--O 1.25 1.094 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.944 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 -166.05 1.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.356 2.262 . . . . 0.0 107.256 161.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -46.39 137.96 6.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.477 1.911 . . . . 0.0 110.511 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.7 t -126.33 143.2 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.927 0.891 . . . . 0.0 109.536 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -141.54 146.94 36.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.953 1.701 . . . . 0.0 108.637 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -104.69 157.31 17.27 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.648 1.113 . . . . 0.0 111.287 173.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -149.73 177.22 9.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.45 1.1 . . . . 0.0 109.092 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.28 -176.41 19.62 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.136 1.35 . . . . 0.0 112.701 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -69.65 166.05 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.476 3.451 . . . . 0.0 110.751 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.58 93.91 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.435 2.09 . . . . 0.0 111.054 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.18 -34.99 15.97 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-O 118.88 -0.956 . . . . 0.0 111.493 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.55 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.17 2.588 . . . . 0.0 110.063 -153.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.4 17.46 0.03 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.826 -1.541 . . . . 0.0 113.833 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -94.17 -55.82 3.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.531 1.665 . . . . 0.0 110.731 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.0 m -51.8 -41.54 61.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.329 1.851 . . . . 0.0 109.724 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -58.04 -41.7 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 113.73 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -48.28 61.24 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.1 mm -57.71 -41.55 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -56.0 -55.95 26.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.509 -0.745 . . . . 0.0 110.214 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -59.48 -31.78 69.65 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.137 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -50.96 -44.28 60.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.915 0.78 . . . . 0.0 109.947 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 m -58.54 -47.29 84.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.89 -23.47 63.25 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.794 2.038 . . . . 0.0 111.73 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.4 t -83.71 -48.15 17.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.382 1.873 . . . . 0.0 109.362 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.06 -44.72 87.62 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -60.77 -43.44 98.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.882 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -62.09 -26.58 68.37 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.918 0.781 . . . . 0.0 112.279 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.9 t -88.69 1.7 54.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.898 1.679 . . . . 0.0 112.271 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.4 11.31 85.62 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.971 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.3 t -84.25 118.3 70.87 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.885 1.843 . . . . 0.0 106.979 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.39 123.19 11.98 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.909 1.739 . . . . 0.0 110.647 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.16 160.64 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.82 177.53 8.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 159.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 110' ' ' VAL . . . 141.04 -163.82 26.59 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 119.579 -1.951 . . . . 0.0 113.199 166.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -151.03 155.19 38.5 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.234 1.016 . . . . 0.0 110.325 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -118.72 -179.01 3.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 162.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.4 m -161.86 94.71 0.95 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -164.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.42 156.68 17.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -68.25 109.39 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.17 109.33 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -119.29 104.74 10.66 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.932 2.093 . . . . 0.0 107.443 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -91.84 102.47 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.26 50.68 7.81 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.183 0.897 . . . . 0.0 113.558 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.88 -6.88 57.69 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.419 1.485 . . . . 0.0 114.925 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.43 122.05 23.96 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.061 1.931 . . . . 0.0 107.506 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 123.84 23.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 159.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -10.63 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.789 0.836 . . . . 0.0 112.729 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.13 -164.11 35.26 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -139.44 143.09 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.66 145.6 41.83 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.62 154.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.03 123.37 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.5 p -72.48 179.25 3.58 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.563 -1.336 . . . . 0.0 109.927 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.51 HD21 ' CG1' ' A' ' 110' ' ' VAL . 1.2 mm? -88.3 -13.68 40.21 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.299 -0.875 . . . . 0.0 111.492 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 t -70.83 -50.41 35.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 49.43 0.1 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -169.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -144.82 147.49 32.92 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.641 1.976 . . . . 0.0 107.592 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.77 161.41 20.17 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 128.494 2.717 . . . . 0.0 108.999 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -143.12 134.42 5.93 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.841 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.48 61.94 2.8 Favored 'Trans proline' 0 CA--C 1.55 1.284 1 C-N-CA 126.371 4.714 . . . . 0.0 114.053 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.3 -63.02 1.2 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.57 1.948 . . . . 0.0 111.581 -169.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 p -130.11 136.5 49.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.306 0.957 . . . . 0.0 108.872 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -148.94 169.34 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.434 1.494 . . . . 0.0 107.889 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.461 HG12 HE21 ' A' ' 79' ' ' GLN . 3.3 m -56.32 152.34 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.679 1.191 . . . . 0.0 109.884 172.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.49 46.87 0.07 OUTLIER Glycine 0 C--N 1.333 0.403 0 CA-C-O 119.335 -0.703 . . . . 0.0 111.612 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.0 -169.12 0.06 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.971 1.708 . . . . 0.0 111.7 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.58 147.53 43.87 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 110.871 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -69.73 123.83 10.5 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.728 2.286 . . . . 0.0 107.971 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.24 170.49 19.47 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.627 2.885 . . . . 0.0 110.853 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.48 -9.75 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.28 1.987 . . . . 0.0 114.196 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.47 -12.49 51.0 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.535 -1.147 . . . . 0.0 114.291 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 138.1 36.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.34 2.07 . . . . 0.0 108.138 -168.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -119.07 122.32 41.84 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.104 0.562 . . . . 0.0 110.0 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 172.25 13.67 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 126.026 1.731 . . . . 0.0 107.655 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 95.3 m -68.4 147.81 51.55 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.815 -0.553 . . . . 0.0 109.725 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -153.29 143.83 22.57 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.528 -0.732 . . . . 0.0 109.472 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.766 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.37 1.06 0.15 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 127.437 2.446 . . . . 0.0 117.596 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.461 HE21 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER 177.04 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.225 2.21 . . . . 0.0 106.713 -175.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -80.57 166.64 20.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.339 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -110.61 133.59 55.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.8 166.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -139.39 105.17 5.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.6 -24.23 63.62 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.322 -0.861 . . . . 0.0 111.592 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -34.4 77.99 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.624 171.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -57.42 -48.45 79.09 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 119.989 1.268 . . . . 0.0 109.941 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -56.04 -50.62 70.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -19.67 66.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.057 0.844 . . . . 0.0 112.439 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.66 ' HB2' HD23 ' A' ' 90' ' ' LEU . 19.5 mt-30 -66.36 -45.25 80.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.721 1.146 . . . . 0.0 112.059 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -123.35 -39.86 2.42 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.59 51.18 2.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.072 1.749 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 -60.35 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 125.721 1.608 . . . . 0.0 108.0 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -38.36 42.37 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.607 1.538 . . . . 0.0 112.043 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -36.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 123.909 0.883 . . . . 0.0 110.591 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.0 72.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.148 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 108.26 0.13 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.983 1.713 . . . . 0.0 106.764 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -103.3 166.9 10.16 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.142 1.377 . . . . 0.0 108.129 163.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -150.12 51.95 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.512 -0.743 . . . . 0.0 111.242 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.97 169.7 17.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.414 1.486 . . . . 0.0 109.924 -169.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 15.5 t 62.85 107.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.718 2.407 . . . . 0.0 111.35 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 p -73.49 49.53 0.29 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.147 2.579 . . . . 0.0 113.233 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -101.34 169.19 9.05 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.67 1.188 . . . . 0.0 110.389 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -37.84 140.46 0.43 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 128.017 2.722 . . . . 0.0 116.213 -171.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.55 -176.13 2.93 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 125.202 3.935 . . . . 0.0 111.836 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 132.52 -141.4 12.76 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 104.798 -3.321 . . . . 0.0 104.798 -159.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -138.27 153.39 49.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.702 1.601 . . . . 0.0 111.528 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -89.0 97.21 11.08 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 126.613 1.965 . . . . 0.0 110.019 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.9 t -74.97 94.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 121.656 2.026 . . . . 0.0 107.577 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.5 m -72.24 165.24 24.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.51 ' CG1' HD21 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -144.61 139.67 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 118.139 -0.934 . . . . 0.0 111.576 -177.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mt -152.22 103.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.651 1.219 . . . . 0.0 108.501 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -105.69 -169.61 1.61 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 42.75 48.75 4.91 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.014 2.526 . . . . 0.0 112.163 -168.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.71 110.56 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.13 -63.97 0.32 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-O 117.554 -1.692 . . . . 0.0 112.493 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -24.15 65.92 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.913 2.357 . . . . 0.0 110.44 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.3 mmt -69.02 -10.39 57.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 116.671 -1.633 . . . . 0.0 113.404 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -24.63 -68.42 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.535 2.334 . . . . 0.0 114.593 -171.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -45.96 63.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 0.0 111.361 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.66 -27.99 66.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.615 1.166 . . . . 0.0 112.181 -170.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.4 t -41.64 114.01 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 129.222 3.009 . . . . 0.0 111.715 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -127.44 -87.71 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.412 0.551 . . . . 0.0 111.465 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.6 -16.8 61.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.793 0.724 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.99 -68.02 0.22 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.839 2.055 . . . . 0.0 111.168 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -36.83 -57.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.628 1.571 . . . . 0.0 112.148 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.9 -54.49 41.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.308 0.643 . . . . 0.0 111.025 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.82 99.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 124.148 0.905 . . . . 0.0 109.299 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.13 -47.15 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.227 1.411 . . . . 0.0 109.538 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -62.41 -44.6 96.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.203 1.365 . . . . 0.0 111.265 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -57.62 -38.71 75.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.153 0.888 . . . . 0.0 110.435 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 137' ' ' THR . 63.4 m -74.24 -38.99 63.35 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.364 -0.835 . . . . 0.0 112.103 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.2 mt -61.06 -35.76 77.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.21 1.368 . . . . 0.0 109.932 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.8 t -71.94 -22.05 61.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.221 1.808 . . . . 0.0 110.605 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 137' ' ' THR . 96.3 m -76.26 134.0 71.05 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.03 -42.71 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.032 2.488 . . . . 0.0 112.319 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -94.35 -2.75 63.59 Favored Glycine 0 C--O 1.216 -0.97 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.384 -168.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.534 HG21 ' CG2' ' A' ' 131' ' ' THR . 21.9 m -80.48 160.84 25.14 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.965 2.382 . . . . 0.0 106.139 154.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.6 mt -122.92 138.37 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 102.83 -3.026 . . . . 0.0 102.83 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mm -92.72 136.99 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' CG2' ' A' ' 180' ' ' ILE . 10.5 tp -140.07 113.45 8.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.92 32.89 Favored Glycine 0 N--CA 1.462 0.412 0 C-N-CA 119.287 -1.435 . . . . 0.0 114.656 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.0 m -137.11 133.4 35.29 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.93 147.61 66.24 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.821 1.648 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.71 148.92 59.96 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 111.167 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.34 131.55 86.6 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.241 0.617 . . . . 0.0 110.083 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.69 108.82 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.402 2.735 . . . . 0.0 108.443 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -64.75 0.79 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -112.27 -109.47 3.02 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 166.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 149.69 98.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 118.72 1.26 . . . . 0.0 111.966 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.55 -164.9 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.37 1 C-N-CA 125.966 4.444 . . . . 0.0 112.247 164.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.79 168.25 10.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 126.601 1.96 . . . . 0.0 109.183 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.29 -67.07 0.31 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.037 2.535 . . . . 0.0 113.287 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.4 tm? -59.48 -46.32 89.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -56.56 -35.38 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.36 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.07 -28.11 68.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.869 1.668 . . . . 0.0 112.086 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.52 -34.74 77.51 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.769 0.713 . . . . 0.0 110.007 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.32 -39.09 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.3 1.44 . . . . 0.0 109.564 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.66 -26.68 65.44 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.426 -1.422 . . . . 0.0 111.105 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -59.32 -37.58 78.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.315 0.646 . . . . 0.0 111.44 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -61.58 -36.78 81.64 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.908 0.883 . . . . 0.0 112.019 -167.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -40.24 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.971 2.908 . . . . 0.0 115.676 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -59.93 -28.9 68.01 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.189 1.359 . . . . 0.0 110.626 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.0 m -50.36 108.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.503 1.521 . . . . 0.0 109.28 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -65.69 123.21 19.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 m -111.94 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 C-N-CA 124.683 1.193 . . . . 0.0 108.778 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -72.12 118.83 15.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.142 0.977 . . . . 0.0 110.538 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.61 97.81 5.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.789 1.235 . . . . 0.0 110.631 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.427 HG23 HD12 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -67.86 132.79 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 p -94.93 151.22 19.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 158.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -57.85 -29.8 65.28 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.064 -0.397 . . . . 0.0 110.389 165.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.07 -53.87 15.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 110.848 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.82 23.06 13.41 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.025 -1.047 . . . . 0.0 110.91 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -47.26 -44.55 23.11 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.448 1.099 . . . . 0.0 112.464 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.27 3.56 8.68 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -118.29 62.54 0.77 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 168' ' ' VAL . 0.5 OUTLIER -140.25 -39.79 0.44 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.37 160.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tp -40.03 -58.37 2.27 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 117.625 -1.179 . . . . 0.0 110.355 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.84 -28.24 51.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.436 1.424 . . . . 0.0 113.386 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.24 -38.26 68.96 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.282 -0.886 . . . . 0.0 109.219 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.595 HD11 HD11 ' A' ' 6' ' ' LEU . 14.4 mt -66.89 -47.34 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.488 1.515 . . . . 0.0 107.974 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 92.2 t -56.04 -43.99 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.225 0.92 . . . . 0.0 109.171 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.0 m -57.97 -47.81 81.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.962 1.305 . . . . 0.0 109.129 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.45 -37.78 88.73 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.731 -0.606 . . . . 0.0 111.693 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.64 -55.52 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.911 0.778 . . . . 0.0 109.428 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -28.32 69.69 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.034 -174.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.51 -50.85 0.34 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.235 2.214 . . . . 0.0 111.637 -176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 t 61.98 -86.01 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.594 1.557 . . . . 0.0 107.814 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -75.7 -44.57 41.42 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 119.194 0.907 . . . . 0.0 111.343 162.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.111 0.964 . . . . 0.0 112.321 -116.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 -105.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.507 ' HB2' HG12 ' A' ' 163' ' ' VAL . 48.7 m-70 -92.88 159.5 15.33 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.375 1.87 . . . . 0.0 109.282 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.65 148.41 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 19.9 m-85 -144.11 158.02 43.97 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.909 1.684 . . . . 0.0 109.537 172.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.916 HD11 HD11 ' A' ' 180' ' ' ILE . 4.2 mm? -109.38 135.3 50.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.83 -172.5 3.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.82 -172.31 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.265 -0.897 . . . . 0.0 111.295 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.44 163.34 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.19 2.593 . . . . 0.0 113.611 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.82 72.05 6.29 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.804 3.67 . . . . 0.0 111.736 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.18 25.14 21.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 124.411 1.005 . . . . 0.0 112.494 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m 42.51 35.06 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.513 2.725 . . . . 0.0 116.308 161.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.87 9.91 3.1 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.514 1.531 . . . . 0.0 112.184 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -75.19 -49.87 18.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 109.956 -168.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -57.66 -35.25 70.31 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.391 0.676 . . . . 0.0 109.71 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.5 m -63.49 -38.78 92.46 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.284 -0.885 . . . . 0.0 112.45 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -49.55 57.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.89 1.223 . . . . 0.0 108.593 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.689 HD11 HD23 ' A' ' 6' ' ' LEU . 5.8 mm -58.08 -40.94 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.562 0.619 . . . . 0.0 111.045 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -50.28 -45.84 54.7 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.317 0.962 . . . . 0.0 110.067 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -70.05 -20.04 63.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.23 0.612 . . . . 0.0 112.207 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.328 0.967 . . . . 0.0 110.627 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -81.51 -42.8 19.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.02 -39.22 68.89 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.103 0.561 . . . . 0.0 111.211 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.21 -51.24 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.334 1.053 . . . . 0.0 110.291 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 61.3 mt -63.25 -35.5 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.33 -38.33 89.79 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.074 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -4.8 14.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.495 1.118 . . . . 0.0 112.912 172.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 m -109.61 -5.08 15.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.701 1.6 . . . . 0.0 111.638 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.72 18.46 74.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.015 1.293 . . . . 0.0 112.981 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 24.7 t -64.71 133.76 95.82 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.665 1.733 . . . . 0.0 107.131 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.22 95.22 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.575 2.183 . . . . 0.0 110.072 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.56 136.73 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.78 173.79 11.27 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.604 2.362 . . . . 0.0 105.883 169.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.98 -156.79 26.15 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -142.06 166.02 25.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.912 1.356 . . . . 0.0 111.434 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -142.14 179.62 6.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.4 p -134.98 136.67 42.38 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.91 27.17 4.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.278 6.8 pm0 49.81 -178.71 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.357 2.263 . . . . 0.0 112.79 -164.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.81 119.56 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -129.27 106.47 8.84 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 70.63 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.58 75.51 0.51 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -161.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.19 -40.21 2.68 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 148.47 42.38 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.719 1.76 . . . . 0.0 111.135 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -69.81 132.24 45.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 162.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.55 -27.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.72 -174.05 41.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 119.608 1.095 . . . . 0.0 110.677 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CZ ' ' HE2' ' A' ' 116' ' ' LYS . 25.1 m-85 -126.53 153.25 45.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 160.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -117.97 162.42 18.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 167.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 90' ' ' LEU . 2.1 p -114.97 145.35 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.907 1.683 . . . . 0.0 107.923 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.2 108.95 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 120.55 1.523 . . . . 0.0 109.858 -167.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.483 HG23 HD12 ' A' ' 90' ' ' LEU . 76.1 p -69.61 145.05 52.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.31 -5.74 30.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -84.68 7.53 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.549 1.068 . . . . 0.0 111.32 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.67 3.41 83.75 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.223 -1.548 . . . . 0.0 114.984 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 m -80.83 166.08 21.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.783 1.291 . . . . 0.0 109.358 163.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -146.39 169.78 18.16 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 90' ' ' LEU . . . -150.42 -176.23 23.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.722 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -108.93 14.41 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.116 1.21 . . . . 0.0 114.284 -144.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mt 23.61 -74.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 130.898 3.679 . . . . 0.0 116.446 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -147.83 159.93 43.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 165.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -143.58 53.12 1.32 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.845 2.058 . . . . 0.0 110.652 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 64.99 160.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.663 1.985 . . . . 0.0 111.554 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.51 150.96 11.9 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.73 150.86 26.68 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.756 1.222 . . . . 0.0 108.67 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.4 156.37 30.99 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 109.603 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.74 132.21 24.5 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.182 1.921 . . . . 0.0 110.102 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.72 155.03 59.16 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.696 2.931 . . . . 0.0 110.068 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.44 111.53 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.087 2.525 . . . . 0.0 109.823 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.64 -60.43 0.67 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -173.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 142.33 52.95 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -147.26 146.04 29.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -160.35 -175.34 4.98 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.736 0.647 . . . . 0.0 112.616 -165.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.0 m -60.67 101.7 0.15 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.779 2.032 . . . . 0.0 110.752 171.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -142.14 119.61 11.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.57 -89.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.38 -47.78 0.25 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.772 1.169 . . . . 0.0 112.013 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -144.58 4.05 1.15 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.355 . . . . 0.0 111.436 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.44 139.11 51.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.268 1.027 . . . . 0.0 108.379 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.63 88.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.2 174.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -147.56 133.17 18.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.306 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.57 -35.42 74.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.356 -0.84 . . . . 0.0 109.595 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.3 m -55.24 -43.81 74.94 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 110.923 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.5 p -63.58 -29.5 70.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.401 1.455 . . . . 0.0 110.659 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -69.4 -53.2 20.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.824 1.25 . . . . 0.0 110.477 167.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -47.47 -35.03 8.09 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.193 0.997 . . . . 0.0 112.157 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 10.9 mt-30 -58.55 -32.11 68.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -144.97 -36.21 0.31 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -171.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.78 31.57 0.53 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.504 2.322 . . . . 0.0 111.447 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -124.65 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 126.751 2.02 . . . . 0.0 108.41 178.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 30.2 Cg_endo -61.41 -27.03 82.12 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 121.428 1.546 . . . . 0.0 113.225 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.74 -26.46 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.245 0.93 . . . . 0.0 113.328 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.496 HD23 ' HB1' ' A' ' 127' ' ' ALA . 1.2 mm? -73.14 -23.92 60.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.335 0.97 . . . . 0.0 111.369 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -165.65 116.53 1.07 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 120.289 1.404 . . . . 0.0 108.192 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -106.23 156.59 18.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 91.7 3.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -159.34 120.05 3.18 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.258 1.423 . . . . 0.0 107.806 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.72 58.5 4.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.767 0.827 . . . . 0.0 110.397 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -47.95 122.09 4.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.693 1.997 . . . . 0.0 109.682 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 m -54.06 130.31 37.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.666 1.186 . . . . 0.0 109.96 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.6 77.85 1.01 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.735 1.159 . . . . 0.0 110.347 -164.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -53.67 -172.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.413 3.408 . . . . 0.0 114.329 159.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.16 -111.96 1.62 Allowed Glycine 0 N--CA 1.437 -1.254 1 N-CA-C 102.046 -4.421 . . . . 0.0 102.046 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -146.4 153.22 40.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.645 1.223 . . . . 0.0 112.785 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -91.59 173.01 8.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.67 2.788 . . . . 0.0 110.807 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -120.11 135.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 163.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.69 153.39 18.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -134.43 130.12 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -137.5 94.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.83 80.64 1.47 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 123.176 1.465 . . . . 0.0 112.768 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -158.31 -84.37 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 130.16 3.384 . . . . 0.0 104.989 165.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.402 HG21 HG22 ' A' ' 143' ' ' ILE 0.363 1.5 mt 52.96 -17.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 1 C-N-CA 131.829 4.051 . . . . 0.0 114.44 -174.56 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.22 6.63 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 120.975 1.716 . . . . 0.0 113.582 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 41.6 mttp -71.36 -17.58 62.42 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 118.259 -2.906 . . . . 0.0 113.663 -165.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tpp -106.87 20.99 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.501 1.521 . . . . 0.0 110.904 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.45 -20.63 7.96 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.825 1.65 . . . . 0.0 114.636 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.39 -31.28 2.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.259 1.824 . . . . 0.0 110.677 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.02 -4.23 58.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.191 -0.943 . . . . 0.0 113.173 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.26 139.47 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.208 3.003 . . . . 0.0 110.347 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -40.08 0.27 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -100.71 -22.12 15.0 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.773 -1.108 . . . . 0.0 110.731 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -63.57 0.9 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.122 1.769 . . . . 0.0 110.508 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.515 HD12 ' H ' ' A' ' 125' ' ' ILE . 2.8 mp -33.01 -59.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.76 2.024 . . . . 0.0 113.096 170.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -68.85 -55.28 11.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.781 1.232 . . . . 0.0 108.191 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.496 ' HB1' HD23 ' A' ' 95' ' ' LEU . . . -62.45 -34.49 76.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 123.443 0.697 . . . . 0.0 111.163 -172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.03 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.068 1.347 . . . . 0.0 107.663 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -57.75 -36.66 72.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.369 -171.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -54.66 -61.83 2.05 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.516 1.053 . . . . 0.0 109.08 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.4 m -78.64 -13.88 59.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.052 0.941 . . . . 0.0 113.205 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 mt -63.52 -18.02 63.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.574 1.079 . . . . 0.0 110.321 166.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 t -132.46 32.36 3.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.285 1.434 . . . . 0.0 108.983 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.77 134.84 53.0 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.27 107.01 2.36 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.861 3.041 . . . . 0.0 107.885 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.34 34.57 3.87 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.931 -1.483 . . . . 0.0 114.747 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.9 m -136.23 171.19 14.84 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 161.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.3 mt -141.09 106.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.15 135.88 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 119.028 0.831 . . . . 0.0 110.241 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.5 tp -132.7 148.81 52.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.205 2.202 . . . . 0.0 106.605 159.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.36 -171.92 44.94 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 119.198 0.908 . . . . 0.0 112.26 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -118.59 154.83 31.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.9 0.85 . . . . 0.0 111.458 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.402 HG22 HG21 ' A' ' 114' ' ' ILE . 8.7 pt -136.61 125.38 15.27 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.398 2.279 . . . . 0.0 108.223 170.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.08 150.11 87.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.59 1.527 . . . . 0.0 110.55 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.97 130.06 64.97 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.28 -51.4 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.53 2.82 . . . . 0.0 110.457 -165.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 40.51 55.97 2.8 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.999 1.72 . . . . 0.0 110.982 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 157.6 -153.02 24.28 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 126.897 2.189 . . . . 0.0 107.648 -159.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.6 OUTLIER -63.93 166.85 8.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.092 0.446 . . . . 0.0 110.237 172.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.65 168.69 22.97 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.563 1.509 . . . . 0.0 109.182 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.75 176.81 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.772 2.029 . . . . 0.0 106.259 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.17 -79.15 0.37 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.3 tp -51.02 -44.07 60.97 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.984 1.313 . . . . 0.0 112.255 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.06 -31.16 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.064 -0.969 . . . . 0.0 111.265 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.75 -34.24 75.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.327 1.422 . . . . 0.0 109.805 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.11 -43.8 87.36 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.262 0.937 . . . . 0.0 111.271 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.6 mp -80.57 -39.56 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.029 0.532 . . . . 0.0 109.834 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -60.78 -32.4 71.73 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.508 -1.37 . . . . 0.0 110.338 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -74.23 8.43 2.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.513 1.525 . . . . 0.0 113.501 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -34.74 10.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.556 1.526 . . . . 0.0 111.62 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 63.1 -19.67 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 128.602 2.761 . . . . 0.0 115.339 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -72.6 -30.67 64.57 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.639 3.175 . . . . 0.0 111.615 168.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' A' ' 3' ' ' HIS . 29.5 m -54.18 125.13 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.108 1.763 . . . . 0.0 107.618 169.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.35 112.17 5.06 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -97.93 96.13 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 120.856 1.662 . . . . 0.0 106.575 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 6' ' ' LEU . 19.3 m-85 -69.52 98.25 1.11 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.037 0.935 . . . . 0.0 108.743 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.17 99.49 0.9 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.85 165.82 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.92 . . . . 0.0 109.192 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.7 p -138.68 156.38 47.47 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.836 1.303 . . . . 0.0 108.288 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -42.27 -31.64 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.867 156.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -80.29 -55.8 4.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.469 0.577 . . . . 0.0 109.79 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -119.95 16.66 12.56 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.876 0.87 . . . . 0.0 110.288 -160.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -39.71 -63.06 0.62 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.791 2.036 . . . . 0.0 111.155 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -70.56 8.48 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 113.704 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.48 15.92 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.405 2.282 . . . . 0.0 110.201 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.02 -32.04 10.36 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.632 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -37.98 -55.99 2.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.489 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.52 -23.27 57.76 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.335 1.512 . . . . 0.0 114.59 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -80.26 -38.54 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.454 1.501 . . . . 0.0 110.425 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.916 HD11 HD11 ' A' ' 6' ' ' LEU . 7.6 mt -59.74 -52.14 64.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.359 -0.838 . . . . 0.0 108.863 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 77.2 t -53.74 -43.77 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.149 0.98 . . . . 0.0 109.41 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.7 m -59.06 -43.65 91.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.114 0.87 . . . . 0.0 111.032 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.0 -48.13 81.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.104 0.562 . . . . 0.0 109.676 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.43 -52.45 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.301 1.04 . . . . 0.0 109.893 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -69.46 -5.94 27.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 27.8 t -64.34 -71.2 0.18 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.6 t 48.75 -12.82 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.276 2.63 . . . . 0.0 116.013 -164.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.05 -15.14 0.21 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 120.332 1.424 . . . . 0.0 113.604 -157.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 C--O 1.246 0.88 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.904 -175.395 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 113.47 26.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 166.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 23.43 91.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.092 2.157 . . . . 0.0 111.342 141.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.71 124.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -165.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -117.86 161.01 20.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 110.378 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 18' ' ' ILE . 45.7 mt -124.84 154.57 40.82 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.203 1.401 . . . . 0.0 109.823 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -158.11 169.72 23.91 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.69 63.09 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 128.668 3.033 . . . . 0.0 111.874 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -54.21 118.49 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.468 3.445 . . . . 0.0 111.455 -166.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.24 -81.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.301 2.001 . . . . 0.0 114.451 -163.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.6 37.71 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t 50.99 68.77 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.919 1.688 . . . . 0.0 110.254 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.92 23.35 1.45 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.605 1.098 . . . . 0.0 111.039 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 142' ' ' THR . 2.0 pttm -83.91 -31.55 25.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.911 -0.758 . . . . 0.0 111.901 -170.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -59.79 -38.16 81.1 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -56.99 -35.08 68.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 112.553 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -33.73 70.33 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 HD11 HD11 ' A' ' 6' ' ' LEU . 4.4 mm -77.16 -31.07 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.6 1.091 . . . . 0.0 109.984 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -54.33 -51.42 64.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.706 1.593 . . . . 0.0 107.507 170.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -66.13 -15.18 62.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.7 -1.137 . . . . 0.0 112.374 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.2 64.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.45 1.023 . . . . 0.0 111.137 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -78.25 -48.35 15.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.284 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -50.34 -40.76 50.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.162 0.585 . . . . 0.0 111.172 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.65 -61.37 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 123.955 0.902 . . . . 0.0 109.486 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -55.48 -42.3 74.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 123.232 0.613 . . . . 0.0 109.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -60.39 -47.99 83.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -59.93 -42.05 93.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.168 0.987 . . . . 0.0 109.921 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -71.97 -7.28 47.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.593 1.557 . . . . 0.0 113.417 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.07 9.96 60.2 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.637 -1.09 . . . . 0.0 113.153 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.5 t -99.77 105.86 36.99 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -72.43 97.16 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.403 2.736 . . . . 0.0 110.948 -168.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.59 147.27 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.686 1.194 . . . . 0.0 108.637 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -137.99 170.41 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.072 150.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.95 -162.58 28.1 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.227 0.917 . . . . 0.0 111.08 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -140.4 162.71 34.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.869 0.843 . . . . 0.0 111.128 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.2 157.83 45.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.932 1.293 . . . . 0.0 107.558 168.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.9 100.79 11.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -79.13 159.31 27.51 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.959 1.361 . . . . 0.0 109.086 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.17 99.78 8.73 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.348 169.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 47' ' ' ILE . 7.6 p -58.71 107.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.828 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -108.96 103.1 12.08 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 120.917 -1.115 . . . . 0.0 109.348 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.639 ' HB2' HD13 ' A' ' 47' ' ' ILE . 23.7 tp60 -64.84 -37.86 89.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.786 0.721 . . . . 0.0 110.713 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.3 63.58 0.11 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.88 15.15 68.84 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.87 -1.517 . . . . 0.0 115.805 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.82 140.81 52.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.835 1.817 . . . . 0.0 107.075 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -78.12 98.23 5.72 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 42' ' ' GLN . 35.2 pt -78.18 -12.94 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 121.39 -0.819 . . . . 0.0 111.995 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.95 -126.96 1.3 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 165.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -132.93 158.82 41.65 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -137.33 134.03 35.58 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.522 1.129 . . . . 0.0 109.715 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.6 101.97 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -167.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -90.03 132.76 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.3 p -95.96 156.26 16.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.2 8.99 3.4 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.291 -0.881 . . . . 0.0 112.541 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 t -109.89 4.34 21.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.996 1.319 . . . . 0.0 111.51 161.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.2 3.45 65.3 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.367 -1.458 . . . . 0.0 114.768 161.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -71.84 148.84 45.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.538 1.669 . . . . 0.0 107.194 162.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -139.32 131.79 28.62 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.926 1.29 . . . . 0.0 108.462 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -118.99 174.08 15.2 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 119.731 1.15 . . . . 0.0 113.861 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.75 165.18 21.69 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.609 1.539 . . . . 0.0 108.631 162.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 tp -140.74 -70.18 0.38 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.9 p -134.49 158.07 44.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.071 0.857 . . . . 0.0 108.927 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -147.43 157.64 43.66 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.535 1.134 . . . . 0.0 110.137 169.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 t -62.14 137.1 24.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 109.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.51 165.4 30.94 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.82 153.78 7.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.734 0.814 . . . . 0.0 109.504 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.12 163.99 56.62 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.669 0.388 . . . . 0.0 111.297 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -83.58 140.52 9.45 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.001 2.467 . . . . 0.0 110.739 -170.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.43 164.26 26.47 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.691 2.26 . . . . 0.0 110.524 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.63 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.841 2.361 . . . . 0.0 113.056 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.54 10.34 26.02 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.173 1.844 . . . . 0.0 113.114 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.63 165.67 26.33 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.951 1.875 . . . . 0.0 109.025 169.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.8 157.85 42.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.201 0.601 . . . . 0.0 110.275 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -166.92 -170.11 1.47 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 128.502 2.721 . . . . 0.0 105.95 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 92.6 m -98.02 126.73 43.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 139.7 33.19 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.884 -1.135 . . . . 0.0 108.718 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.2 92.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.871 1.669 . . . . 0.0 107.604 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.12 -73.93 1.92 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.37 0.986 . . . . 0.0 112.308 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -134.22 -25.65 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.439 1.495 . . . . 0.0 110.768 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.29 118.63 25.86 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.31 131.1 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 162.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -94.44 178.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 125.273 1.429 . . . . 0.0 108.745 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -147.28 155.53 42.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.46 161.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.79 -28.92 36.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.642 0.777 . . . . 0.0 110.448 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 m -64.28 -36.87 85.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.683 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.9 m -60.45 -31.74 70.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.591 1.087 . . . . 0.0 110.931 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -71.86 -53.9 11.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.518 167.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.05 -23.87 22.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.327 1.051 . . . . 0.0 113.488 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -42.54 -53.4 4.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.197 1.799 . . . . 0.0 112.04 167.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.714 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.12 -31.88 0.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.369 1.068 . . . . 0.0 112.63 -167.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.38 52.52 2.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.653 1.181 . . . . 0.0 108.664 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -146.47 -57.49 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 126.197 1.799 . . . . 0.0 109.606 -176.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 72.6 Cg_endo -71.47 -37.18 5.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.834 1.689 . . . . 0.0 112.122 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 m -56.04 -35.73 42.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.935 0.894 . . . . 0.0 112.304 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -63.33 -38.29 90.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.54 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -129.5 76.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.823 1.249 . . . . 0.0 109.6 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -118.02 9.57 12.8 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.903 1.281 . . . . 0.0 111.388 -172.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.3 166.29 31.55 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.037 0.935 . . . . 0.0 112.042 160.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.83 -43.55 5.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.511 1.524 . . . . 0.0 110.768 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 6.0 t 60.09 54.13 4.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.124 2.169 . . . . 0.0 111.846 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -14.38 62.73 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -172.97 175.77 3.19 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.274 2.23 . . . . 0.0 108.325 168.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.36 130.88 5.7 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.322 1.439 . . . . 0.0 109.535 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.58 -179.72 3.95 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.304 2.003 . . . . 0.0 110.478 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.77 83.06 1.61 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 105.904 -2.878 . . . . 0.0 105.904 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -56.73 133.83 54.38 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 179.21 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.17 139.26 51.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 167.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.1 158.11 34.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.491 1.116 . . . . 0.0 108.461 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.7 t -142.19 127.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.411 1.085 . . . . 0.0 109.919 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CG2' HD11 ' A' ' 114' ' ' ILE . 8.9 mt -149.48 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 125.659 1.583 . . . . 0.0 107.736 -167.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -79.77 174.65 11.37 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.347 -1.471 . . . . 0.0 112.476 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 57.02 20.12 5.19 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.109 2.564 . . . . 0.0 115.036 167.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 111' ' ' ILE . 38.6 mt -55.61 125.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.512 -1.368 . . . . 0.0 108.257 174.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.52 -34.56 1.96 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.063 1.316 . . . . 0.0 111.721 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -41.94 98.98 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.658 2.229 . . . . 0.0 110.469 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -83.48 16.72 2.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.915 1.686 . . . . 0.0 112.178 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -49.53 -39.74 35.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.644 1.565 . . . . 0.0 111.518 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.12 -49.8 6.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.544 0.738 . . . . 0.0 110.346 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -67.35 -24.02 65.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -55.66 141.32 38.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.544 1.138 . . . . 0.0 112.123 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -138.07 -82.0 0.33 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.817 0.847 . . . . 0.0 109.648 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.04 -12.45 60.33 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -60.0 3.64 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 111.482 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.7 mp -35.89 -58.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 126.164 1.786 . . . . 0.0 112.338 170.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.31 -51.49 65.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.206 0.527 . . . . 0.0 110.188 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.56 83.65 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.472 -171.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.92 -46.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 121.878 -0.514 . . . . 0.0 110.148 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -52.31 -36.21 52.6 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.901 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -27.31 66.93 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 m -100.47 -31.72 11.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 116.669 -1.634 . . . . 0.0 111.49 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.74 -18.87 57.26 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.228 1.831 . . . . 0.0 111.505 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -68.33 -29.57 68.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.649 1.579 . . . . 0.0 110.082 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.6 m -63.82 142.33 98.07 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 126.435 1.894 . . . . 0.0 106.869 172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.21 16.67 0.29 Allowed 'Trans proline' 0 CA--C 1.541 0.867 1 C-N-CA 126.173 4.582 . . . . 0.0 111.608 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.79 -161.44 11.9 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -155.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.7 177.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.101 0.953 . . . . 0.0 109.808 -140.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.3 mt -137.25 103.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 1 N-CA-C 99.614 -4.217 . . . . 0.0 99.614 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 141.31 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.6 133.76 50.96 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.35 45.4 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.463 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.434 HG21 ' HE2' ' A' ' 14' ' ' LYS . 40.0 m -129.32 123.29 31.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.446 0.698 . . . . 0.0 109.177 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.67 165.46 32.93 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.945 1.698 . . . . 0.0 108.809 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.54 165.46 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.378 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.94 142.4 76.3 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.525 1.13 . . . . 0.0 108.518 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.35 104.09 1.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 121.409 1.406 . . . . 0.0 111.331 -156.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -99.44 162.04 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.479 1.112 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -24.88 -77.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 127.25 2.357 . . . . 0.0 114.967 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 138.08 22.63 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.86 164.23 35.42 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.809 1.673 . . . . 0.0 109.512 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.06 171.59 7.29 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.704 1.601 . . . . 0.0 109.31 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.53 -77.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 114.032 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 114' ' ' ILE . 1.7 tm? -59.02 -33.09 70.34 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.68 -35.54 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 O-C-N 121.149 -0.969 . . . . 0.0 110.412 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.46 -23.08 65.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.39 1.476 . . . . 0.0 111.291 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -70.67 -42.36 70.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.737 1.153 . . . . 0.0 109.542 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.07 -48.28 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.769 0.828 . . . . 0.0 109.654 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.44 -22.24 66.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 110.486 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -28.56 68.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.994 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -65.63 -34.15 77.56 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.766 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? 67.66 -57.15 0.46 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.183 2.593 . . . . 0.0 111.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.87 77.68 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.248 1.819 . . . . 0.0 107.693 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.73 135.99 48.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 128.748 2.819 . . . . 0.0 105.064 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.87 136.76 38.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 164.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.33 96.8 4.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 120.157 1.344 . . . . 0.0 107.767 170.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.451 ' HB3' HD11 ' A' ' 176' ' ' LEU . 32.4 m-85 -76.95 104.36 7.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.802 0.81 . . . . 0.0 109.039 173.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.71 106.5 2.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 160.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.14 154.05 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 167.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 22.5 p -102.88 159.93 15.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 157.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.22 -16.98 56.91 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.602 166.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -98.38 -56.77 2.37 Favored 'General case' 0 N--CA 1.458 -0.038 0 CA-C-N 118.386 0.539 . . . . 0.0 111.147 -166.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.5 17.66 5.19 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.484 1.114 . . . . 0.0 110.121 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -40.91 -46.11 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.283 1.833 . . . . 0.0 111.595 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.8 6.16 9.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 114.204 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.23 43.43 3.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.438 1.895 . . . . 0.0 109.887 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 166' ' ' PHE . 9.6 tp -118.68 -42.2 2.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.23 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.96 -55.41 6.18 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.867 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.22 -27.21 56.4 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.419 1.9 . . . . 0.0 113.398 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -72.66 -42.07 64.73 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.704 1.202 . . . . 0.0 109.804 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.76 -52.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.912 1.685 . . . . 0.0 108.486 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.55 -44.01 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.388 0.994 . . . . 0.0 109.686 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.2 m -62.03 -49.22 76.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.898 0.772 . . . . 0.0 109.703 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.4 -42.17 91.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.504 1.122 . . . . 0.0 112.151 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.51 -53.74 29.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.576 1.951 . . . . 0.0 109.529 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -68.07 -23.49 64.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.849 0.86 . . . . 0.0 111.544 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.08 -52.45 4.27 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 127.698 2.399 . . . . 0.0 112.685 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.1 m 46.18 -96.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.052 1.296 . . . . 0.0 110.891 -158.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -122.33 -0.11 9.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.635 2.374 . . . . 0.0 112.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 11.4 mmpt? . . . . . 0 C--O 1.245 0.835 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.82 140.48 44.24 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 126.119 1.768 . . . . 0.0 108.397 -171.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 163' ' ' VAL . 27.4 m-70 -64.42 146.75 54.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.934 1.694 . . . . 0.0 109.249 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -127.55 144.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD2' HG13 ' A' ' 163' ' ' VAL . 15.1 m-85 -141.38 123.05 15.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.401 0.68 . . . . 0.0 110.784 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.468 HD21 HD11 ' A' ' 180' ' ' ILE . 11.1 mt -70.4 152.5 44.01 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 t -152.93 -174.7 5.02 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.07 176.55 15.15 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.086 1.803 . . . . 0.0 111.316 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -73.98 156.02 47.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.528 2.152 . . . . 0.0 109.464 164.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 154.71 48.87 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.566 2.178 . . . . 0.0 111.103 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.96 8.51 6.38 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.315 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.274 82.2 t 66.29 120.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 127.536 2.334 . . . . 0.0 111.341 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.9 29.75 14.74 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.75 1.167 . . . . 0.0 112.586 -173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -63.77 -49.07 74.4 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.153 1.477 . . . . 0.0 111.838 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -45.13 -38.78 5.44 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.566 1.947 . . . . 0.0 111.221 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.3 m -49.31 -43.57 43.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.163 1.785 . . . . 0.0 111.9 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -32.79 64.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.165 1.348 . . . . 0.0 110.345 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.37 -45.13 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -50.6 72.57 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.957 1.703 . . . . 0.0 109.15 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.3 mttm -65.97 -34.4 78.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.994 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.25 60.5 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.734 1.152 . . . . 0.0 111.62 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -71.58 -48.93 45.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.354 0.662 . . . . 0.0 111.117 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.03 -33.88 69.45 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.34 1.056 . . . . 0.0 111.64 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 20' ' ' LYS . 53.0 t -58.67 -53.71 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.419 1.488 . . . . 0.0 108.431 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.53 -38.9 89.1 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 123.456 0.703 . . . . 0.0 109.823 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HA ' HG12 ' A' ' 30' ' ' VAL . 11.9 mttt -59.74 -43.48 94.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.911 0.778 . . . . 0.0 110.25 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -23.27 56.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.366 1.066 . . . . 0.0 111.837 169.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 m -97.72 18.08 16.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.825 2.05 . . . . 0.0 115.487 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.09 35.12 86.6 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.811 1.187 . . . . 0.0 111.435 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.4 p -71.24 158.79 87.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 120.846 -1.385 . . . . 0.0 109.884 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.23 101.7 0.63 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.588 2.859 . . . . 0.0 110.249 145.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 30' ' ' VAL . 18.6 t -105.11 149.62 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 -179.03 7.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.533 0.733 . . . . 0.0 110.085 155.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.35 -151.0 22.31 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.893 1.235 . . . . 0.0 110.034 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' CZ ' HG23 ' A' ' 111' ' ' ILE . 55.2 p90 -138.06 174.25 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.185 1.794 . . . . 0.0 109.457 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -143.6 159.49 42.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -116.15 74.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -157.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -71.89 137.97 47.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.861 0.838 . . . . 0.0 110.772 -163.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -68.95 113.77 6.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.626 1.571 . . . . 0.0 108.554 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.18 91.08 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -109.42 102.38 11.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.34 62.18 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.94 0.896 . . . . 0.0 110.168 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 66.4 1.92 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -162.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.66 -22.12 15.25 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -169.43 0.83 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.569 1.685 . . . . 0.0 110.561 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 89.79 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.685 1.584 . . . . 0.0 111.354 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.44 -10.07 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.195 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 -167.96 40.96 Favored Glycine 0 C--N 1.337 0.583 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.7 158.65 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.033 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -137.73 159.64 41.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.841 1.656 . . . . 0.0 108.288 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -100.9 100.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 121.236 1.835 . . . . 0.0 107.806 169.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -82.25 123.8 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -89.19 163.45 15.41 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.188 -0.945 . . . . 0.0 108.546 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.56 -16.63 60.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 120.637 -1.29 . . . . 0.0 112.005 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 t -63.21 -36.89 85.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.689 1.131 . . . . 0.0 108.334 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.79 6.26 17.09 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.108 0.861 . . . . 0.0 112.465 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.6 25.73 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.432 ' C ' HD21 ' A' ' 90' ' ' LEU . 25.5 ptt180 -144.13 135.79 25.99 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.5 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.48 135.64 12.25 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.04 67.71 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 125.129 3.886 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.588 HD21 ' CE2' ' A' ' 87' ' ' PHE . 2.6 mt -55.36 -67.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 125.317 1.447 . . . . 0.0 112.719 -164.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 p -139.7 154.85 47.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.207 1.004 . . . . 0.0 110.657 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.07 159.72 43.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.268 1.827 . . . . 0.0 106.419 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 64' ' ' VAL . 3.8 m -54.9 160.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 121.913 -0.492 . . . . 0.0 110.457 160.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.67 -142.15 3.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.22 174.55 7.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.529 1.132 . . . . 0.0 109.915 164.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -124.24 156.88 66.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.216 1.406 . . . . 0.0 110.842 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.05 142.55 8.8 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.037 1.824 . . . . 0.0 110.544 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.79 166.26 20.81 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.115 2.543 . . . . 0.0 110.699 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.92 69.19 4.67 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.427 3.418 . . . . 0.0 112.931 -172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -55.35 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 125.447 1.499 . . . . 0.0 109.691 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -55.54 157.73 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.839 2.056 . . . . 0.0 110.15 163.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.93 153.74 37.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.667 1.987 . . . . 0.0 106.98 159.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -155.18 96.23 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 96.1 m 46.03 35.45 2.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.269 2.628 . . . . 0.0 115.665 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.19 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.542 -1.349 . . . . 0.0 108.008 -170.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.49 87.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 -67.78 1.36 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.823 1.201 . . . . 0.0 112.242 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -137.1 -36.0 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.151 2.18 . . . . 0.0 111.22 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -78.68 170.02 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.348 0.976 . . . . 0.0 108.937 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.59 120.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.555 HG22 ' H ' ' A' ' 83' ' ' ASP . 1.4 p -81.33 176.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.914 0.864 . . . . 0.0 110.136 170.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.555 ' H ' HG22 ' A' ' 82' ' ' VAL . 28.9 t70 -142.62 109.94 5.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -32.49 74.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.589 1.156 . . . . 0.0 109.609 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -54.0 -48.97 69.87 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.26 1.824 . . . . 0.0 108.618 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.6 t -55.88 -22.44 25.57 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 120.409 1.458 . . . . 0.0 113.316 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 61' ' ' LEU . 20.9 m-85 -79.11 -60.84 2.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.521 1.055 . . . . 0.0 109.182 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -47.51 -26.78 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.745 2.018 . . . . 0.0 113.139 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -61.8 -28.36 69.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 114.676 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -163.39 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.616 0.766 . . . . 0.0 112.924 -171.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.55 52.81 1.01 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.563 1.145 . . . . 0.0 108.798 166.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -140.62 -61.1 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 126.437 1.895 . . . . 0.0 108.444 -177.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -42.01 36.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.187 1.925 . . . . 0.0 112.459 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.28 -20.62 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.898 0.772 . . . . 0.0 113.037 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.74 74.28 6.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.19 94.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.443 2.697 . . . . 0.0 111.741 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -128.19 120.17 26.72 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.681 1.592 . . . . 0.0 108.132 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.47 15.56 2.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.75 -30.31 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.187 3.795 . . . . 0.0 116.885 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 23.5 t -69.28 -77.6 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -154.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.4 m 57.5 -26.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.187 2.291 . . . . 0.0 117.187 -168.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m 58.17 163.8 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.5 1.5 . . . . 0.0 111.894 -145.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.31 -87.04 0.52 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -167.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.64 145.49 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 119.781 1.791 . . . . 0.0 109.556 168.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.62 -7.53 55.55 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -147.55 166.1 28.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.195 0.997 . . . . 0.0 111.428 -169.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -142.47 170.34 15.89 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 127.209 2.204 . . . . 0.0 108.121 -169.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.19 128.27 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 36.6 t -108.85 154.22 22.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -137.73 123.35 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.616 0.767 . . . . 0.0 110.203 -169.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.456 HG23 ' CZ ' ' A' ' 35' ' ' PHE . 21.4 mt -148.46 85.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.455 1.502 . . . . 0.0 108.693 -169.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -86.46 164.75 16.79 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.918 -1.739 . . . . 0.0 111.164 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 56.6 58.02 4.43 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.587 2.355 . . . . 0.0 111.992 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.3 mt -87.12 49.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 121.03 -1.044 . . . . 0.0 108.687 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.74 3.93 1.38 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-O 118.257 -1.302 . . . . 0.0 115.082 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -103.64 -77.76 0.56 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.455 2.127 . . . . 0.0 110.848 -173.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -52.46 -18.76 1.81 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.317 1.447 . . . . 0.0 113.771 168.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -32.24 -60.6 0.27 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.523 2.329 . . . . 0.0 113.105 -167.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.55 -29.34 69.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.318 0.963 . . . . 0.0 112.254 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -95.34 -17.64 21.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.807 1.643 . . . . 0.0 112.746 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.0 p -54.56 151.94 7.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.915 1.286 . . . . 0.0 110.88 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -132.54 -89.68 0.42 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.468 1.107 . . . . 0.0 109.27 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -56.08 -21.33 21.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 117.098 -1.43 . . . . 0.0 112.296 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -62.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 120.906 1.685 . . . . 0.0 110.707 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.402 HG23 ' HG3' ' A' ' 156' ' ' GLU . 3.5 mp -41.81 -58.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.135 1.374 . . . . 0.0 110.364 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -65.31 -39.15 92.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -166.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.05 -51.91 12.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 124.14 0.9 . . . . 0.0 108.936 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.57 -34.07 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 O-C-N 121.909 -0.494 . . . . 0.0 111.054 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.33 -43.45 61.73 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.217 169.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.19 -45.35 83.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.568 1.531 . . . . 0.0 111.167 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.7 m -65.74 -46.86 77.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.945 0.898 . . . . 0.0 110.892 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.2 mt -62.87 -25.7 68.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 110.938 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 t -76.9 -9.08 58.44 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.588 1.555 . . . . 0.0 110.766 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.0 m -91.41 134.24 29.92 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.34 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.949 2.432 . . . . 0.0 111.577 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.7 -32.57 49.93 Favored Glycine 0 C--O 1.218 -0.896 0 CA-C-O 117.242 -1.866 . . . . 0.0 112.811 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.0 m -66.74 138.69 57.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 122.101 2.951 . . . . 0.0 107.975 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -122.65 84.44 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 101.51 -3.515 . . . . 0.0 101.51 -166.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.98 117.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 mt -102.87 133.09 48.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 151.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.68 171.23 29.06 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 44.2 m -122.23 101.67 7.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.906 0.853 . . . . 0.0 108.72 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.9 pt -86.35 151.22 53.32 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.036 0.934 . . . . 0.0 108.785 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.7 145.3 36.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.927 2.418 . . . . 0.0 110.043 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.86 139.65 93.63 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 165.27 32.5 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.171 2.581 . . . . 0.0 110.601 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.77 -38.24 0.28 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.154 0.981 . . . . 0.0 111.041 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.77 139.5 4.69 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.479 -1.849 . . . . 0.0 108.479 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.09 163.75 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.729 1.611 . . . . 0.0 113.505 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.44 165.76 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.53 3.486 . . . . 0.0 109.959 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.2 mp -108.03 171.58 7.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 165.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.32 -82.58 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.797 0.726 . . . . 0.0 109.214 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.31 -40.88 65.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.25 -0.906 . . . . 0.0 113.166 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.86 -28.06 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.544 -0.722 . . . . 0.0 110.48 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.92 -32.05 72.41 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.915 0.78 . . . . 0.0 109.632 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 125' ' ' ILE . 64.8 mm-40 -60.98 -33.88 73.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.566 1.076 . . . . 0.0 112.137 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 108.54 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -59.05 -34.74 72.29 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.612 0.642 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.93 -25.71 58.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.219 1.807 . . . . 0.0 112.809 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.828 1.195 . . . . 0.0 111.483 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -54.47 0.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.782 2.033 . . . . 0.0 113.758 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -72.3 42.91 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.691 2.796 . . . . 0.0 111.486 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 3' ' ' HIS . 1.9 t -120.66 103.21 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 130.503 3.521 . . . . 0.0 104.796 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.45 131.97 48.67 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.05 116.78 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.236 1.014 . . . . 0.0 109.159 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -106.17 82.09 1.71 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.578 2.351 . . . . 0.0 107.664 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 117.81 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 120.906 -1.121 . . . . 0.0 108.102 167.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.49 HG23 HD13 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -81.43 153.78 4.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 170.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 p -110.7 158.22 18.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -66.32 -19.01 65.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.25 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -83.29 -38.02 22.68 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 118.099 0.409 . . . . 0.0 111.18 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.11 15.18 19.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.699 1.2 . . . . 0.0 111.325 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -49.49 -52.13 31.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.314 1.046 . . . . 0.0 109.315 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.3 4.57 2.78 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -124.47 3.4 8.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.132 0.973 . . . . 0.0 113.127 172.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.49 HD13 HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -83.2 -19.11 37.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.398 0.999 . . . . 0.0 113.624 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.31 -56.01 26.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.52 -1.228 . . . . 0.0 110.183 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.37 -27.15 63.12 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.623 1.615 . . . . 0.0 113.302 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.76 -40.67 75.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.601 1.16 . . . . 0.0 109.435 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.468 HD11 HD21 ' A' ' 6' ' ' LEU . 25.9 mt -63.95 -53.05 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.701 1.2 . . . . 0.0 107.977 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.25 -42.71 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.695 1.198 . . . . 0.0 109.767 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -55.13 39.13 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 125.479 1.512 . . . . 0.0 108.857 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 9.1 t -52.99 -41.3 64.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.123 0.874 . . . . 0.0 111.311 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.92 -53.51 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.691 1.196 . . . . 0.0 108.994 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -62.52 -34.59 77.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.075 1.307 . . . . 0.0 113.124 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.3 m -64.9 8.25 0.13 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 129.987 3.315 . . . . 0.0 113.482 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.2 p -123.12 145.94 48.16 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.856 -1.153 . . . . 0.0 108.156 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 58.76 -20.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.418 2.687 . . . . 0.0 115.528 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt . . . . . 0 C--O 1.251 1.15 0 CA-C-N 121.156 1.798 . . . . 0.0 106.952 164.696 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -163.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.052 1.741 . . . . 0.0 108.43 160.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -50.37 156.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.088 2.155 . . . . 0.0 111.214 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.1 t -141.7 143.17 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -142.92 161.83 37.09 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.97 1.708 . . . . 0.0 110.006 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 180' ' ' ILE . 1.7 mm? -98.25 157.57 16.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 160.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -141.78 -178.96 5.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.815 1.646 . . . . 0.0 107.469 162.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.86 -170.73 14.99 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.02 115.86 4.51 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.356 2.704 . . . . 0.0 108.669 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.32 97.28 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.654 1.569 . . . . 0.0 110.601 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.39 -57.95 16.75 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t 176.09 -45.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 129.086 2.954 . . . . 0.0 109.309 163.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.44 8.99 30.42 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 123.706 0.669 . . . . 0.0 114.22 -167.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE3' ' H ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -57.64 -38.67 75.43 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.728 1.264 . . . . 0.0 111.759 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.472 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 55.0 m -64.8 -37.12 86.53 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.34 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -64.77 -33.58 76.31 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.498 1.499 . . . . 0.0 110.222 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.664 HD13 ' HB3' ' A' ' 176' ' ' LEU . 59.9 mt -60.65 -57.52 12.35 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.199 0.599 . . . . 0.0 109.754 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 mm -70.76 -38.39 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 122.989 0.516 . . . . 0.0 109.693 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.93 -61.93 1.86 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.159 2.184 . . . . 0.0 108.587 172.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.3 -32.15 72.85 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.435 -1.269 . . . . 0.0 111.853 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.31 78.45 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 120.16 1.346 . . . . 0.0 109.265 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.434 ' C ' ' HE3' ' A' ' 26' ' ' LYS . 58.7 p -70.96 -45.1 64.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.097 -0.954 . . . . 0.0 108.991 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.35 -37.54 70.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.49 1.495 . . . . 0.0 112.139 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.56 -54.85 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 125.879 1.672 . . . . 0.0 108.848 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.18 -32.94 74.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.76 -0.588 . . . . 0.0 109.92 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 30' ' ' VAL . 26.8 mtmt -62.68 -36.39 82.77 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.008 -1.683 . . . . 0.0 110.738 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -38.13 85.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 110.081 165.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.52 5.36 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.121 1.369 . . . . 0.0 114.251 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.16 52.56 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 120.274 1.397 . . . . 0.0 111.662 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 26' ' ' LYS . 8.5 p -55.03 142.06 57.79 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.62 94.26 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.316 1.344 . . . . 0.0 109.086 160.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.15 139.58 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.268 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.02 169.6 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.461 1.505 . . . . 0.0 107.818 168.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.44 25.74 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 169.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -143.83 162.93 34.81 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.002 1.321 . . . . 0.0 107.513 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -140.59 110.28 6.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.402 ' CG2' HD22 ' A' ' 61' ' ' LEU . 9.1 m -70.23 134.41 48.01 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.05 44.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.52 -0.737 . . . . 0.0 110.832 -171.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.34 146.15 50.69 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -122.58 105.22 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -123.14 80.06 1.73 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 126.486 1.915 . . . . 0.0 110.005 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -65.04 -24.26 67.43 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.836 -1.165 . . . . 0.0 112.666 -166.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.97 45.64 0.73 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 166.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.31 89.24 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.717 -1.046 . . . . 0.0 114.21 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.64 124.7 46.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 119.55 1.675 . . . . 0.0 108.459 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -60.75 92.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.675 1.59 . . . . 0.0 110.608 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.64 -16.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 111.127 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.49 -166.17 39.37 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -130.9 160.98 32.87 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.084 1.753 . . . . 0.0 106.404 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.86 161.49 30.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.775 2.03 . . . . 0.0 105.998 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.97 110.02 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 167.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.32 162.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.976 1.262 . . . . 0.0 108.06 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -125.43 160.0 30.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.011 1.324 . . . . 0.0 108.154 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.9 mm? -68.18 -21.38 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.452 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -62.25 -26.48 68.41 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.63 1.105 . . . . 0.0 111.062 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.01 5.77 57.22 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.187 1.375 . . . . 0.0 111.864 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -84.34 159.77 20.82 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 120.987 -1.302 . . . . 0.0 107.774 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 147.83 26.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -174.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -145.82 -178.09 21.03 Favored Glycine 0 CA--C 1.521 0.44 0 O-C-N 123.948 0.78 . . . . 0.0 112.726 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.24 169.31 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.737 2.958 . . . . 0.0 112.429 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 7.6 tp -150.0 -66.93 0.21 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.98 -1.075 . . . . 0.0 109.705 161.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -150.11 125.62 10.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -128.55 165.71 20.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.617 1.167 . . . . 0.0 108.198 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.6 120.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.73 -119.73 2.06 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.77 157.3 47.19 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.39 1.476 . . . . 0.0 107.44 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -86.65 166.43 27.4 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.641 1.576 . . . . 0.0 110.808 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.77 139.47 14.01 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.434 2.756 . . . . 0.0 108.699 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.43 172.22 14.83 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.766 2.311 . . . . 0.0 110.765 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.21 99.54 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.86 1.706 . . . . 0.0 108.245 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.44 -79.11 0.35 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 124.902 1.239 . . . . 0.0 110.494 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.73 125.56 23.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.364 1.082 . . . . 0.0 108.752 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 138.47 32.56 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.62 -163.16 1.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.42 -178.31 3.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 157.41 167.16 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 131.133 3.773 . . . . 0.0 105.849 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.68 -13.21 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 123.866 0.729 . . . . 0.0 109.663 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.96 134.43 3.57 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.044 -2.822 . . . . 0.0 106.044 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.51 -68.02 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.626 2.37 . . . . 0.0 111.571 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.03 149.38 30.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.857 1.663 . . . . 0.0 108.205 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 2.1 p -121.01 132.05 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.45 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.773 0.829 . . . . 0.0 110.275 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -154.39 105.39 2.66 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -21.62 65.06 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.149 -0.97 . . . . 0.0 111.865 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.1 m -37.24 -45.82 0.68 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.526 1.93 . . . . 0.0 112.243 156.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 p -76.66 -34.43 58.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.395 0.998 . . . . 0.0 109.175 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 14.5 m-85 -60.2 -41.81 93.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.98 -1.075 . . . . 0.0 109.718 173.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 92' ' ' LEU . 11.2 pt-20 -76.84 -9.1 58.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.832 1.196 . . . . 0.0 113.625 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.46 -68.18 0.38 Allowed 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 161.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 59' ' ' GLY . 2.1 mp -102.22 -44.8 5.32 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.814 -0.554 . . . . 0.0 111.539 -158.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.48 49.3 1.77 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.463 1.905 . . . . 0.0 108.553 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.852 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -134.52 -62.26 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 109.864 -176.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 41.1 Cg_endo -65.61 -33.47 45.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.883 1.722 . . . . 0.0 112.517 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.2 m -59.82 -24.73 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.533 1.133 . . . . 0.0 112.868 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.06 -11.17 60.45 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.301 0.501 . . . . 0.0 111.269 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 88.02 1.99 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.97 159.42 15.33 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.86 0.864 . . . . 0.0 109.166 167.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.81 157.38 45.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.609 1.164 . . . . 0.0 110.13 167.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.459 ' N ' HH12 ' A' ' 107' ' ' ARG . 2.1 m-20 -159.05 -67.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.629 1.571 . . . . 0.0 107.446 167.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.16 -176.95 5.3 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.264 1.425 . . . . 0.0 109.628 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.4 t -65.74 157.46 30.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.449 0.7 . . . . 0.0 109.172 165.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.8 m -50.86 -54.08 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.824 1.649 . . . . 0.0 112.134 -164.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.09 -169.64 1.8 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.245 1.402 . . . . 0.0 113.093 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.33 110.71 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 108.08 -1.546 . . . . 0.0 108.08 162.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 154.7 -81.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 68.4 124.46 0.03 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.012 2.125 . . . . 0.0 108.845 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.459 HH12 ' N ' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -60.61 164.9 4.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.517 1.127 . . . . 0.0 108.812 172.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.69 146.82 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 139' ' ' ILE . 5.7 p -115.84 163.78 15.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.938 0.875 . . . . 0.0 110.449 161.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.8 125.88 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.508 HD13 ' CG2' ' A' ' 128' ' ' VAL . 2.5 mt -141.52 74.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.04 167.47 21.75 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.88 27.95 10.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 114.103 164.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 153' ' ' LEU . 16.7 mt -70.14 75.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.186 1.394 . . . . 0.0 108.227 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.2 -47.58 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.826 -1.171 . . . . 0.0 113.45 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -69.75 -40.14 76.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.345 2.073 . . . . 0.0 111.914 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -12.72 60.94 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 116.291 -1.814 . . . . 0.0 112.618 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -47.07 -24.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -156.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 -22.19 13.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.426 1.09 . . . . 0.0 112.119 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -99.06 -29.01 13.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.964 1.706 . . . . 0.0 109.745 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -45.45 114.5 0.76 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.803 2.841 . . . . 0.0 108.348 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.13 -86.59 0.5 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 119.864 1.211 . . . . 0.0 111.16 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.852 HD11 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -69.54 -10.35 57.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.934 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -53.06 -52.14 59.5 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 120.866 1.666 . . . . 0.0 112.151 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mt -39.17 -54.63 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 127.384 2.274 . . . . 0.0 112.552 164.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -63.63 -54.26 38.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.904 1.229 . . . . 0.0 110.593 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.48 -49.26 78.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 123.24 0.338 . . . . 0.0 111.095 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.508 ' CG2' HD13 ' A' ' 111' ' ' ILE . 2.5 p -65.62 -30.06 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.907 0.883 . . . . 0.0 111.611 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -40.02 60.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.493 168.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -38.07 86.9 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.663 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.51 -48.8 63.45 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.923 1.238 . . . . 0.0 110.472 175.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 139' ' ' ILE . 12.3 mt -58.02 -32.47 67.98 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.464 1.906 . . . . 0.0 111.98 -175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.5 m -129.32 30.24 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.62 1.568 . . . . 0.0 110.019 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.437 HG23 ' HD2' ' A' ' 135' ' ' PRO . 1.3 m -76.45 165.1 55.39 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 149.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 134' ' ' THR . 44.3 Cg_endo -87.33 126.48 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.541 2.828 . . . . 0.0 109.298 168.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.07 89.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 116.929 -2.039 . . . . 0.0 116.263 158.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 m -72.14 166.9 21.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 121.827 2.814 . . . . 0.0 108.492 155.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.0 mt -131.83 104.25 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.539 HD13 ' SG ' ' A' ' 109' ' ' CYS . 41.2 mm -67.5 132.08 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.42 1.075 . . . . 0.0 108.117 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tp -140.56 136.06 32.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.326 1.85 . . . . 0.0 107.82 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.61 41.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 113.341 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -128.56 130.73 47.8 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.169 0.987 . . . . 0.0 108.863 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.73 163.87 18.22 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.967 1.707 . . . . 0.0 108.152 165.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.01 161.07 11.72 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.37 2.713 . . . . 0.0 111.332 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.61 139.34 93.95 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 165.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.01 159.5 33.99 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.489 2.793 . . . . 0.0 108.891 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -142.3 -65.94 0.4 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.81 -122.93 0.94 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 125.208 1.385 . . . . 0.0 111.096 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.402 ' HE3' ' CA ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -62.52 171.1 1.88 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.38 172.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.52 168.0 19.3 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.271 1.314 . . . . 0.0 109.099 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.54 137.07 52.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.84 -63.36 1.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.93 0.892 . . . . 0.0 111.751 -156.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 114' ' ' ILE . 3.5 tp -62.95 -40.8 98.75 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 114' ' ' ILE . 76.4 t -65.93 -28.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.686 -0.634 . . . . 0.0 110.269 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.83 -29.92 63.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.724 0.81 . . . . 0.0 110.807 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.17 -38.79 90.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.539 1.063 . . . . 0.0 112.095 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.95 -41.94 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.86 1.264 . . . . 0.0 108.338 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -18.36 65.34 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.087 -1.633 . . . . 0.0 111.532 -174.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.76 -22.01 61.66 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.825 0.739 . . . . 0.0 110.273 173.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -73.9 83.93 1.7 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.35 -28.77 69.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.851 -1.156 . . . . 0.0 109.305 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -76.12 56.62 1.03 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.47 3.108 . . . . 0.0 110.651 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.77 126.5 62.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 105.05 1.34 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 161.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.1 t -88.91 98.1 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -68.41 147.24 52.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.77 125.06 48.36 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.67 159.87 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 167.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 p -128.13 149.76 50.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -58.23 -16.08 12.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.953 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -80.68 -68.75 0.65 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.195 0.907 . . . . 0.0 108.569 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.19 28.46 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.887 1.275 . . . . 0.0 109.523 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -59.58 -23.44 62.94 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.24 9.75 21.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.749 1.62 . . . . 0.0 112.057 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.63 -13.48 15.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 115.94 -1.981 . . . . 0.0 113.86 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.664 ' HB3' HD13 ' A' ' 17' ' ' LEU . 1.1 tt -84.58 -20.04 32.11 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 116.167 -2.213 . . . . 0.0 111.795 -154.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 17' ' ' LEU . 12.1 tp -25.27 -64.99 0.1 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 128.872 2.869 . . . . 0.0 113.529 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.09 -28.03 85.15 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.854 2.369 . . . . 0.0 113.18 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.84 -42.53 90.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.676 1.125 . . . . 0.0 109.538 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 6' ' ' LEU . 8.6 mt -68.62 -50.07 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 125.382 1.473 . . . . 0.0 108.032 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.83 -37.0 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.5 1.045 . . . . 0.0 111.035 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 86.8 m -60.46 -47.51 85.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 6.9 t -62.8 -29.02 70.4 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.004 0.82 . . . . 0.0 111.344 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.65 -52.19 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.232 1.013 . . . . 0.0 110.316 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -34.4 71.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.98 1.264 . . . . 0.0 111.368 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 -8.81 48.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.677 1.991 . . . . 0.0 111.813 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -79.13 -15.84 57.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.647 -1.283 . . . . 0.0 111.452 166.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -85.43 -53.72 5.02 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.97 163.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.429 -1.748 . . . . 0.0 109.073 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.503 ' HA ' ' CB ' ' A' ' 187' ' ' SER . . . . . . . . 0 CA--C 1.504 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.44 173.7 3.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 123.25 1.5 . . . . 0.0 107.555 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.617 ' HB2' HG12 ' A' ' 163' ' ' VAL . 24.2 m-70 -72.99 149.61 43.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.99 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.5 t -126.78 133.85 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.499 ' CE1' HG21 ' A' ' 157' ' ' ILE . 15.6 m-85 -136.37 121.16 18.57 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.501 0.667 . . . . 0.0 110.611 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.21 155.75 34.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.908 1.283 . . . . 0.0 109.101 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -161.46 -179.43 7.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.978 164.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.57 -107.29 1.12 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.383 1.944 . . . . 0.0 109.465 170.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.06 174.67 8.57 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.811 3.007 . . . . 0.0 111.746 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.21 -177.8 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.817 2.344 . . . . 0.0 110.681 164.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.73 55.44 1.32 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 126.764 2.126 . . . . 0.0 110.771 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.27 52.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.004 1.321 . . . . 0.0 107.857 156.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.63 59.78 1.41 Allowed Glycine 0 C--N 1.335 0.481 0 O-C-N 119.801 -1.812 . . . . 0.0 110.364 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -38.99 4.15 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.5 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.2 m -55.44 -44.0 75.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.71 1.204 . . . . 0.0 109.893 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.7 m -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.355 -1.466 . . . . 0.0 113.295 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -44.54 72.39 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 120.722 1.601 . . . . 0.0 108.559 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.34 -37.41 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.945 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -53.12 -47.81 68.36 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.386 0.994 . . . . 0.0 110.361 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -30.41 70.68 Favored 'General case' 0 C--O 1.227 -0.088 0 O-C-N 122.338 -0.226 . . . . 0.0 110.95 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -27.2 69.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.379 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.9 p -74.91 -53.38 9.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.656 1.116 . . . . 0.0 108.02 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -48.88 -45.47 41.21 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.582 1.953 . . . . 0.0 112.11 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.64 -45.51 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.258 0.551 . . . . 0.0 110.956 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 108' ' ' VAL . 84.1 mt -69.69 -37.0 76.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.024 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.77 -43.66 81.02 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -26.77 67.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.667 1.187 . . . . 0.0 112.81 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -5.73 53.45 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.761 0.824 . . . . 0.0 112.092 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.12 88.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.763 1.173 . . . . 0.0 113.643 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.32 127.6 85.99 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 119.589 1.694 . . . . 0.0 107.681 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.98 130.31 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.844 2.363 . . . . 0.0 109.577 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.65 137.6 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.78 167.87 16.68 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.528 1.531 . . . . 0.0 107.673 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 94' ' ' VAL . . . 129.92 -160.76 22.93 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.35 165.44 27.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 168.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -128.09 -178.6 4.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 162.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -140.12 137.43 34.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.35 156.3 44.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.56 111.97 7.29 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.72 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.71 124.91 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -124.61 125.42 44.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.91 1.684 . . . . 0.0 107.627 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -69.18 -39.4 78.73 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.944 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.21 39.16 0.41 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.969 1.747 . . . . 0.0 109.545 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.14 26.07 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.536 1.541 . . . . 0.0 114.855 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 142.84 35.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.816 1.308 . . . . 0.0 110.833 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -64.82 129.98 41.76 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 125.162 1.538 . . . . 0.0 111.539 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.5 pt -137.23 -11.77 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.874 1.67 . . . . 0.0 112.973 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.18 -167.37 36.09 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 119.255 0.934 . . . . 0.0 112.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -139.26 123.97 18.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.127 2.171 . . . . 0.0 106.79 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.74 144.72 25.4 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.37 111.96 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 119.729 1.15 . . . . 0.0 108.367 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.34 110.46 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.603 0.361 . . . . 0.0 110.056 -152.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -74.74 155.65 37.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 122.713 1.244 . . . . 0.0 108.808 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.8 mm? -69.19 -13.63 62.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.103 169.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.98 9.85 15.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.904 1.682 . . . . 0.0 111.791 170.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.1 82.4 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 120.738 -1.226 . . . . 0.0 114.27 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.21 161.21 19.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.839 1.319 . . . . 0.0 107.589 169.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.98 144.38 26.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 117.737 -1.125 . . . . 0.0 109.534 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.94 154.19 21.23 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.16 1.345 . . . . 0.0 111.89 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.07 66.98 8.76 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 125.022 3.815 . . . . 0.0 111.98 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -57.8 8.9 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 126.761 2.024 . . . . 0.0 111.128 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.87 141.38 29.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.02 164.65 31.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.086 0.954 . . . . 0.0 109.55 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.62 136.79 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.21 165.55 30.37 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.753 -2.939 . . . . 0.0 105.753 171.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 165.54 13.64 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -69.04 153.41 96.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.658 -0.652 . . . . 0.0 109.67 166.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.17 125.56 10.4 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.735 2.957 . . . . 0.0 110.98 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.01 174.84 11.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.557 2.838 . . . . 0.0 111.446 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.65 125.61 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 108.835 -1.256 . . . . 0.0 108.835 169.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.31 5.2 82.9 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.833 -0.981 . . . . 0.0 114.755 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 132.59 20.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.189 1.995 . . . . 0.0 105.618 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -152.55 -179.46 7.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 164.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.89 -160.8 1.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 7.4 m -88.84 160.66 17.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.653 1.115 . . . . 0.0 108.879 162.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 158.91 40.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -165.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.98 99.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 32.16 81.32 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.104 2.288 . . . . 0.0 115.605 166.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 97.06 -57.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.431 0 C-N-CA 130.168 3.387 . . . . 0.0 109.554 -171.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -82.58 155.98 24.19 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.917 -0.489 . . . . 0.0 110.346 -169.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.92 133.58 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 165.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.0 167.84 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.81 116.0 7.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.229 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -27.6 66.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.233 0.47 . . . . 0.0 111.247 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m -41.18 -47.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.136 1.774 . . . . 0.0 111.103 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.8 p -70.15 -36.69 74.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.538 -0.726 . . . . 0.0 111.135 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.39 -52.01 67.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -66.69 -10.11 43.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.922 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.61 -38.25 83.69 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 120.717 -1.24 . . . . 0.0 113.05 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 -41.62 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.609 0.64 . . . . 0.0 110.129 -167.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.32 53.38 2.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.013 0.925 . . . . 0.0 109.441 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 12.2 mt -116.4 -66.09 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.66 1.184 . . . . 0.0 109.325 156.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 98.8 Cg_endo -69.43 -11.11 30.54 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.798 2.332 . . . . 0.0 113.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -67.64 -26.06 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 120.143 -1.598 . . . . 0.0 110.651 172.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.8 -13.53 60.0 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.537 1.135 . . . . 0.0 111.634 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -179.44 119.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.824 2.45 . . . . 0.0 109.154 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.23 139.08 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.427 2.291 . . . . 0.0 107.308 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 50.48 -160.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.273 1.029 . . . . 0.0 110.863 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 156.78 88.04 0.0 OUTLIER 'General case' 0 C--O 1.234 0.276 0 C-N-CA 130.308 3.443 . . . . 0.0 108.573 164.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.27 170.85 15.49 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.972 2.509 . . . . 0.0 108.695 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 p -72.35 98.16 2.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.528 1.058 . . . . 0.0 109.218 170.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.1 m -151.49 -60.94 0.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.009 -1.057 . . . . 0.0 111.548 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.73 65.89 0.42 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-O 117.725 -1.597 . . . . 0.0 110.935 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.13 177.05 8.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.377 3.385 . . . . 0.0 111.213 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 103.35 -154.95 18.04 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -150.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -141.27 152.88 44.87 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.048 -1.266 . . . . 0.0 111.324 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -108.01 172.47 6.82 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.536 2.335 . . . . 0.0 108.886 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 25' ' ' LEU . 29.6 t -135.35 149.48 28.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.8 t -123.27 107.75 12.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.4 0.68 . . . . 0.0 109.351 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.1 124.88 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.431 1.092 . . . . 0.0 108.305 165.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -142.26 125.18 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -145.26 -179.39 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.417 -0.802 . . . . 0.0 109.665 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.27 40.64 10.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.752 1.621 . . . . 0.0 110.573 -167.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.51 78.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.38 -83.77 0.05 OUTLIER Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -61.34 -19.15 61.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.167 1.484 . . . . 0.0 113.98 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 89.3 mmm -76.31 7.06 4.66 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.196 -1.383 . . . . 0.0 112.526 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -47.68 -26.82 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.12 -18.76 12.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.361 1.064 . . . . 0.0 111.912 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -19.97 18.03 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.648 0.779 . . . . 0.0 110.568 -171.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.0 m -50.17 116.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.556 1.543 . . . . 0.0 107.963 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.21 -80.7 0.37 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.256 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.44 -23.95 66.21 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.82 1.191 . . . . 0.0 110.694 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -65.12 0.46 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.907 2.083 . . . . 0.0 111.472 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -39.45 -62.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 126.204 1.802 . . . . 0.0 111.932 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.81 -50.8 72.4 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.43 0.559 . . . . 0.0 110.641 -172.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.45 -50.14 68.69 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.181 0.992 . . . . 0.0 109.715 -170.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 HD13 ' A' ' 132' ' ' LEU . 82.4 t -60.24 -46.34 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.149 0.979 . . . . 0.0 108.466 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.055 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -58.01 -49.88 75.32 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.111 1.323 . . . . 0.0 110.941 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -63.24 -29.08 70.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.448 -0.783 . . . . 0.0 111.132 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.44 HD13 HG12 ' A' ' 128' ' ' VAL . 7.9 mp -70.6 -30.63 67.36 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.909 -1.12 . . . . 0.0 111.053 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -23.56 64.1 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.26 0.936 . . . . 0.0 110.934 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.8 m -79.96 133.7 57.7 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -32.67 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.21 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.45 -17.63 33.26 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.879 -1.512 . . . . 0.0 114.643 -166.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.6 m -77.72 165.55 24.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.107 2.453 . . . . 0.0 107.697 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.0 mt -136.94 101.83 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -172.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 22.3 mm -72.08 135.24 28.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.56 124.23 19.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.257 1.823 . . . . 0.0 106.988 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.12 28.81 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-N 120.909 1.686 . . . . 0.0 114.826 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -129.25 113.21 14.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.86 152.73 42.5 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.63 0.772 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -70.42 149.97 63.48 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.784 1.656 . . . . 0.0 108.476 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.03 126.07 92.21 Favored Pre-proline 0 N--CA 1.441 -0.906 0 O-C-N 121.925 -0.485 . . . . 0.0 110.617 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.18 108.39 2.47 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 108.328 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -152.8 -36.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.778 0.831 . . . . 0.0 110.126 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.28 -66.91 0.85 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.695 1.14 . . . . 0.0 111.512 -167.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 158.2 75.69 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 124.286 1.034 . . . . 0.0 108.242 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.38 149.51 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.956 3.104 . . . . 0.0 109.875 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.51 135.44 52.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -64.37 0.84 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.304 1.442 . . . . 0.0 111.528 -172.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.29 -35.4 75.46 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.648 -0.657 . . . . 0.0 111.417 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 -43.65 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 119.109 0.868 . . . . 0.0 109.4 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -55.43 -41.55 72.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -55.76 -28.81 57.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.667 1.121 . . . . 0.0 113.087 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.499 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.7 mt -100.14 -39.64 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.486 1.514 . . . . 0.0 109.415 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.19 62.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.768 1.227 . . . . 0.0 110.19 177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.71 -39.77 5.41 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 127.786 2.434 . . . . 0.0 112.769 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.77 -32.13 70.47 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.062 -1.023 . . . . 0.0 111.093 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.7 -36.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.63 2.372 . . . . 0.0 113.389 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -63.32 -30.19 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.548 1.539 . . . . 0.0 114.154 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 3' ' ' HIS . 2.2 m -55.2 130.37 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.124 1.329 . . . . 0.0 110.793 -169.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.47 ' HE3' ' CD1' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -55.15 115.81 2.44 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.67 102.08 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 171.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' HE3' ' A' ' 164' ' ' LYS . 32.0 m-85 -83.38 87.11 6.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 162.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 94.07 0.3 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 162.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 176' ' ' LEU . 3.1 p -64.89 167.08 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p -124.6 153.07 42.74 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 165.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -61.46 -14.4 28.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.616 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.19 -62.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.824 1.193 . . . . 0.0 108.696 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.36 18.92 3.49 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 124.601 1.16 . . . . 0.0 111.561 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -50.11 -43.84 51.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.979 -1.075 . . . . 0.0 113.305 -161.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -86.34 13.88 7.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.934 2.493 . . . . 0.0 114.806 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -131.66 16.94 4.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.511 1.924 . . . . 0.0 111.813 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 166' ' ' PHE . 10.6 tp -84.09 -42.98 15.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.094 172.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -42.88 -58.78 3.55 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.377 1.871 . . . . 0.0 110.781 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.8 -25.02 78.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.036 2.491 . . . . 0.0 115.44 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.8 -46.6 57.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.431 1.493 . . . . 0.0 108.247 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.79 -53.37 45.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.245 1.418 . . . . 0.0 109.847 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.88 -45.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.823 0.738 . . . . 0.0 109.691 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 52.2 m -57.9 -45.63 86.14 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.57 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.95 -40.59 76.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.016 1.28 . . . . 0.0 110.859 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.06 -51.61 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.338 1.055 . . . . 0.0 109.83 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -31.2 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.519 0.728 . . . . 0.0 112.116 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 m -57.05 -51.72 68.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.549 1.14 . . . . 0.0 108.197 170.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 8.4 t -63.07 -14.33 46.89 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.554 -1.341 . . . . 0.0 113.818 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -75.86 -51.96 11.4 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 120.474 1.488 . . . . 0.0 110.812 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.485 -1.245 . . . . 0.0 110.176 178.655 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' HA ' ' CB ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -77.66 127.58 32.7 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 161.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 3' ' ' HIS . 31.0 m-70 -67.07 158.45 31.06 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.008 1.723 . . . . 0.0 108.377 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.45 139.09 48.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' A' ' 141' ' ' GLY . 17.7 m-85 -130.63 136.74 49.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.281 1.032 . . . . 0.0 109.265 172.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 180' ' ' ILE . 16.2 mt -78.17 157.82 29.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -152.07 169.44 22.37 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.543 0.687 . . . . 0.0 110.887 163.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.94 -171.93 37.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.09 168.37 22.17 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.785 2.323 . . . . 0.0 110.104 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.51 160.08 49.55 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.836 1.691 . . . . 0.0 111.074 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 39.73 72.88 0.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 126.999 2.238 . . . . 0.0 112.937 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.319 0.9 OUTLIER -131.11 -2.54 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.551 0.741 . . . . 0.0 112.835 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.29 19.24 19.27 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.973 -1.079 . . . . 0.0 112.634 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -51.75 67.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.432 1.616 . . . . 0.0 109.265 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -64.36 -29.56 70.63 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.788 -0.625 . . . . 0.0 109.666 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -58.48 -47.57 83.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.836 1.198 . . . . 0.0 111.681 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -46.92 87.27 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -68.2 -38.51 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.272 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -53.44 -55.9 21.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.148 1.379 . . . . 0.0 108.269 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -51.2 -42.82 61.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.065 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.81 57.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.368 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -60.9 -56.98 14.77 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.933 0.788 . . . . 0.0 108.982 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.84 -31.8 68.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.319 2.248 . . . . 0.0 110.982 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.75 -50.96 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.848 1.659 . . . . 0.0 110.537 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.56 -34.47 77.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.982 0.81 . . . . 0.0 109.311 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -71.08 -20.9 62.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.649 1.18 . . . . 0.0 113.199 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -86.8 -7.56 58.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.873 1.669 . . . . 0.0 111.82 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -114.4 2.66 14.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.789 1.236 . . . . 0.0 112.792 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.43 43.18 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 119.657 1.117 . . . . 0.0 112.07 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.15 108.19 24.52 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.26 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.335 2.69 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 32' ' ' VAL . 2.4 t -69.59 169.03 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.145 0.978 . . . . 0.0 109.987 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 162.48 39.97 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.994 154.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.97 -165.66 31.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.353 0.977 . . . . 0.0 111.032 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.08 168.09 20.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.452 0.644 . . . . 0.0 111.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -143.31 152.97 42.26 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 108.352 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.0 p -77.11 124.9 28.47 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 157.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -104.7 139.11 40.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 160.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -73.67 147.03 44.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.602 0.715 . . . . 0.0 110.052 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.41 98.7 4.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -125.53 153.39 43.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -128.29 -60.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.083 1.353 . . . . 0.0 107.728 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.57 31.87 8.21 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.703 1.62 . . . . 0.0 110.69 167.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.61 14.67 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.288 1.423 . . . . 0.0 114.409 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HD2' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -80.27 142.89 34.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.498 1.649 . . . . 0.0 108.691 176.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -65.08 135.23 55.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.952 0.796 . . . . 0.0 108.893 171.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -124.67 -17.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.776 1.23 . . . . 0.0 111.997 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.09 -152.99 21.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.69 161.89 36.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.286 5.9 p30 -131.26 142.8 50.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 90' ' ' LEU . 2.4 p -90.28 93.55 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 125.457 1.503 . . . . 0.0 108.004 -173.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 t -84.97 147.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -107.23 162.89 13.48 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.751 1.22 . . . . 0.0 109.223 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -31.41 72.13 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.343 -0.848 . . . . 0.0 111.56 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.8 t -65.09 -25.29 67.72 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.229 1.011 . . . . 0.0 110.101 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.0 -2.64 44.5 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.666 -1.074 . . . . 0.0 112.976 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.9 m -60.74 151.09 30.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.3 1.55 . . . . 0.0 108.478 163.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 155.33 50.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.891 1.277 . . . . 0.0 111.685 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.615 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -139.22 164.71 25.85 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.034 0.834 . . . . 0.0 113.685 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.13 -2.56 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.945 3.097 . . . . 0.0 115.109 -165.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 24.93 -79.26 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.76 3.624 . . . . 0.0 115.311 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 p -130.2 147.87 51.98 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.006 0.821 . . . . 0.0 110.279 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -148.17 158.87 44.32 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.097 1.359 . . . . 0.0 108.67 -172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -62.57 148.76 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.44 71.55 0.02 OUTLIER Glycine 0 C--N 1.34 0.781 0 CA-C-N 119.487 1.039 . . . . 0.0 114.503 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.42 -159.34 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.789 1.236 . . . . 0.0 110.163 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.71 156.67 62.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.907 1.683 . . . . 0.0 109.848 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 132.72 22.39 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 110.7 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -66.7 175.64 5.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.651 2.234 . . . . 0.0 111.708 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.43 -36.43 15.55 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.05 1.833 . . . . 0.0 111.318 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.33 -59.31 6.37 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -168.42 1.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.438 0.619 . . . . 0.0 110.985 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.37 147.75 32.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.0 0.92 . . . . 0.0 109.314 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -165.01 -163.69 0.72 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.361 1.465 . . . . 0.0 107.668 151.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 78.4 m -109.61 110.73 21.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.423 1.889 . . . . 0.0 108.97 -172.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.69 136.67 53.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.966 1.257 . . . . 0.0 108.746 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 t -125.63 102.75 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 24.91 84.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 C-N-CA 128.139 2.781 . . . . 0.0 114.781 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 95.73 -59.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.675 3.59 . . . . 0.0 109.219 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.46 146.91 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.648 1.179 . . . . 0.0 109.761 -166.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.12 112.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 166.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ASP . 2.7 p -71.98 -179.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 O-C-N 121.266 -0.896 . . . . 0.0 109.012 166.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 86' ' ' SER . 6.2 t0 -150.75 145.64 25.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 161.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.5 -39.12 77.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.843 1.257 . . . . 0.0 107.709 167.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.6 m -54.02 -44.89 71.34 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.114 0.566 . . . . 0.0 109.875 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 70.6 m -64.31 -17.69 63.9 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.19 0.905 . . . . 0.0 112.43 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.24 -60.42 2.37 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.715 0.806 . . . . 0.0 109.928 161.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -45.05 -33.05 1.94 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.09 2.156 . . . . 0.0 113.525 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.65 -40.36 62.74 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.696 0.68 . . . . 0.0 112.021 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.615 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.8 OUTLIER -140.48 -32.29 0.59 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -168.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 41.1 0.96 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.768 2.027 . . . . 0.0 109.557 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -137.82 -59.63 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 125.544 1.538 . . . . 0.0 108.496 -171.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 29.1 Cg_endo -57.48 -37.78 96.2 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.951 1.767 . . . . 0.0 111.926 170.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.4 m -55.64 -31.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.91 0.777 . . . . 0.0 112.435 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.69 -36.42 60.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.412 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -156.1 92.43 1.35 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -71.98 164.39 26.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.41 119.92 23.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.723 0.809 . . . . 0.0 109.652 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -80.18 127.98 32.97 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.382 0.673 . . . . 0.0 111.867 -163.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.17 164.26 36.11 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.704 1.202 . . . . 0.0 109.467 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.01 127.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.236 2.615 . . . . 0.0 111.722 172.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.6 p -66.63 163.17 19.47 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.594 0.758 . . . . 0.0 111.162 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 150.45 -97.93 0.18 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.63 -177.7 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.411 2.741 . . . . 0.0 110.769 168.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -117.67 -62.26 0.3 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -70.84 167.6 18.6 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.059 0.944 . . . . 0.0 110.232 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.9 mtp85 -139.09 -179.38 5.82 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.547 1.139 . . . . 0.0 108.993 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.0 t -127.48 144.37 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.5 t -125.85 143.08 51.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.873 2.069 . . . . 0.0 106.977 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.3 t -138.96 132.87 40.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.28 135.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 33.5 t0 -133.06 -172.95 3.06 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.125 -1.609 . . . . 0.0 107.462 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 2.3 mm-40 56.45 -81.46 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 129.202 3.001 . . . . 0.0 110.675 -156.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.291 38.4 mt 53.98 -10.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 128.133 2.573 . . . . 0.0 112.944 -169.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 113' ' ' GLU . . . -83.46 -59.78 2.09 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.942 2.211 . . . . 0.0 111.103 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -52.54 -29.19 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.387 1.475 . . . . 0.0 114.035 -168.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.35 4.73 41.82 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.216 -1.373 . . . . 0.0 112.657 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -24.81 -64.24 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 129.108 2.963 . . . . 0.0 114.594 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.86 -34.31 17.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.928 0.491 . . . . 0.0 111.16 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -72.75 -27.34 61.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.571 1.148 . . . . 0.0 112.444 -169.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.3 p -51.16 120.48 5.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.367 1.867 . . . . 0.0 111.727 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.7 -92.92 0.52 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.74 -6.36 15.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.752 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -65.38 0.6 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.331 1.453 . . . . 0.0 110.386 171.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.5 mp -35.76 -59.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.158 1.783 . . . . 0.0 112.724 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -59.75 -52.12 66.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.48 87.54 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.83 -59.07 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.858 1.263 . . . . 0.0 109.253 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -57.9 -37.91 74.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.504 1.047 . . . . 0.0 111.913 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -34.44 76.8 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.804 -0.56 . . . . 0.0 110.712 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.406 ' CG2' HG21 ' A' ' 137' ' ' THR . 45.0 m -81.53 -30.29 33.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.27 0.941 . . . . 0.0 111.336 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.83 -21.33 63.07 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.41 1.005 . . . . 0.0 110.83 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 t -93.16 -8.97 41.0 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 127.458 2.303 . . . . 0.0 112.363 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.5 m -62.06 135.5 94.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.19 -36.32 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.401 2.067 . . . . 0.0 111.425 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.09 6.28 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.406 HG21 ' CG2' ' A' ' 131' ' ' THR . 58.9 m 43.52 166.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.784 2.434 . . . . 0.0 113.272 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.8 mt -144.91 114.0 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.9 131.69 34.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.4 96.46 5.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 158.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -113.95 171.9 14.05 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.26 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.4 m -134.63 134.22 40.97 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.34 156.93 66.3 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.712 1.605 . . . . 0.0 109.572 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.13 150.31 37.42 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.86 1.707 . . . . 0.0 110.209 169.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.69 151.75 60.82 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 123.77 0.828 . . . . 0.0 110.733 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.1 162.73 38.84 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.702 2.935 . . . . 0.0 108.901 166.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -156.97 -61.01 0.09 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -118.45 -118.67 2.84 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 151.85 88.77 Favored Pre-proline 0 C--O 1.237 0.436 0 CA-C-N 117.966 0.883 . . . . 0.0 111.329 -172.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -59.04 156.25 35.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.173 2.582 . . . . 0.0 109.936 167.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.95 139.38 49.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.057 1.343 . . . . 0.0 107.408 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -70.35 0.11 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.901 1.68 . . . . 0.0 113.174 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 tp -56.7 -39.77 74.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.522 -0.736 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.0 -31.13 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.218 0.917 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -61.78 -29.4 70.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.378 1.444 . . . . 0.0 110.289 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.07 -23.07 67.28 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.317 0.962 . . . . 0.0 112.089 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.05 -47.0 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -68.1 -11.55 59.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.989 -1.07 . . . . 0.0 112.393 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -76.58 -10.51 59.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 123.911 0.884 . . . . 0.0 113.144 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -74.56 87.54 2.12 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.728 1.149 . . . . 0.0 109.292 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 52.02 0.49 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.482 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -153.48 -12.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 111.2 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.51 137.84 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 120.566 -1.334 . . . . 0.0 109.965 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.9 OUTLIER -73.47 134.46 43.92 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 164.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.7 t -115.22 79.49 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.466 ' CG ' HD21 ' A' ' 176' ' ' LEU . 6.2 m-85 -67.31 91.09 0.24 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.676 1.59 . . . . 0.0 110.765 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.75 147.18 52.36 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 164.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.539 HG22 ' H ' ' A' ' 169' ' ' THR . 1.8 p -122.31 171.69 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 123.253 1.501 . . . . 0.0 109.238 168.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.21 128.18 29.5 Favored 'General case' 0 N--CA 1.435 -1.214 1 C-N-CA 131.864 4.066 . . . . 0.0 102.888 -178.322 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -46.05 -24.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.288 1.835 . . . . 0.0 112.248 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.69 -70.76 0.41 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.911 0.884 . . . . 0.0 109.472 -172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -85.09 17.58 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.352 2.261 . . . . 0.0 111.852 -173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -52.5 -44.93 65.97 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -162.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -77.66 3.43 13.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -87.93 -8.04 56.3 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.608 1.163 . . . . 0.0 111.72 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.466 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -83.1 -34.34 26.15 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 120.672 1.578 . . . . 0.0 112.441 177.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -57.6 7.39 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.17 -1.395 . . . . 0.0 109.89 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.97 -27.48 58.2 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.179 1.814 . . . . 0.0 113.114 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.4 -42.35 65.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.343 0.974 . . . . 0.0 109.261 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 6' ' ' LEU . 15.6 mt -53.12 -55.86 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 125.313 1.445 . . . . 0.0 109.297 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.12 -33.84 66.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.785 0.72 . . . . 0.0 110.523 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 88.6 m -63.78 -48.96 74.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.876 0.87 . . . . 0.0 108.715 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -56.32 -37.24 69.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.161 1.384 . . . . 0.0 110.12 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.25 -55.92 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.988 0.915 . . . . 0.0 110.681 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.46 -21.46 65.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.722 1.146 . . . . 0.0 112.493 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 73.9 m -58.0 -33.78 69.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.261 0.937 . . . . 0.0 113.045 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.445 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 47.5 m -92.01 -5.89 52.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.238 0.927 . . . . 0.0 112.42 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -86.44 -51.74 6.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.117 -0.989 . . . . 0.0 110.356 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 O-C-N 123.944 0.777 . . . . 0.0 110.985 -156.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HD3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.89 73.25 7.91 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.516 ' HB2' HG12 ' A' ' 163' ' ' VAL . 10.5 m-70 59.38 164.75 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.016 2.526 . . . . 0.0 112.116 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -138.74 139.96 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 O-C-N 120.139 -1.6 . . . . 0.0 107.953 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 20.3 m-85 -138.65 157.01 46.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.022 0.929 . . . . 0.0 110.993 168.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.811 HD11 HD11 ' A' ' 180' ' ' ILE . 2.8 mm? -111.04 131.02 55.41 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.627 1.171 . . . . 0.0 108.257 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.57 165.5 25.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.797 0.439 . . . . 0.0 110.375 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 68.56 1.61 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.01 1.29 . . . . 0.0 112.431 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.55 121.55 8.06 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 CA-C-N 120.652 2.226 . . . . 0.0 109.616 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.57 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.968 1.778 . . . . 0.0 113.148 -171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.47 15.59 6.35 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.141 -0.81 . . . . 0.0 111.726 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t 65.75 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.985 1.85 . . . . 0.0 109.412 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.43 -11.51 0.04 OUTLIER Glycine 0 CA--C 1.529 0.937 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.753 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -15.99 7.03 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.27 -1.135 . . . . 0.0 113.225 172.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -38.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.066 2.146 . . . . 0.0 110.608 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 m -71.05 -29.59 65.52 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.286 -0.884 . . . . 0.0 109.103 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 177' ' ' LEU . 69.5 mt -61.78 -52.81 62.7 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 mm -58.96 -43.9 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -49.17 -63.59 1.06 Allowed 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -59.77 -36.68 77.17 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.67 0.606 . . . . 0.0 111.754 177.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.77 88.57 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 120.262 1.392 . . . . 0.0 109.723 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.9 m -67.89 -47.69 68.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 123.751 0.82 . . . . 0.0 109.458 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.3 -36.56 61.34 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.678 1.191 . . . . 0.0 112.234 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 20' ' ' LYS . 89.7 t -63.5 -45.32 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 121.592 -0.693 . . . . 0.0 110.494 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.17 -36.75 80.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -58.82 -44.74 90.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.4 t -58.76 -36.47 74.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.89 1.676 . . . . 0.0 110.446 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 t -77.24 -2.37 34.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.813 1.645 . . . . 0.0 112.556 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.04 13.04 72.38 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.589 1.086 . . . . 0.0 113.102 -174.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.8 122.95 87.36 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 119.247 1.524 . . . . 0.0 107.19 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.14 118.83 5.87 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.842 2.362 . . . . 0.0 109.63 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -115.66 141.12 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 107.761 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.09 167.88 16.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 163.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 139.11 -161.96 25.98 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -145.07 166.95 23.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.783 1.292 . . . . 0.0 111.794 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -137.43 177.82 7.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.445 1.02 . . . . 0.0 110.004 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.6 p -139.65 74.62 1.48 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.016 1.389 . . . . 0.0 110.534 -168.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -76.35 23.63 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.118 2.167 . . . . 0.0 115.581 -163.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.316 7.8 pt-20 51.72 113.67 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.795 2.838 . . . . 0.0 114.023 -162.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.566 HG13 HG13 ' A' ' 47' ' ' ILE . 8.0 p -71.86 121.28 21.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.087 -1.008 . . . . 0.0 108.439 176.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -131.6 120.71 23.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -86.62 -2.61 58.65 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.359 0.6 . . . . 0.0 111.186 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.66 65.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 -171.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.61 -5.36 1.7 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.486 2.469 . . . . 0.0 117.075 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -92.02 147.5 22.91 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 120.023 1.912 . . . . 0.0 108.278 177.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -74.4 139.21 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 161.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -132.05 -17.53 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.863 1.265 . . . . 0.0 111.587 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 168.6 -128.63 1.73 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 165.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -138.91 153.62 48.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 171.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -130.39 152.63 49.59 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.294 2.638 . . . . 0.0 106.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.52 107.91 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 119.539 1.063 . . . . 0.0 110.511 -162.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.1 109.4 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.879 -157.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.3 p -75.97 145.79 40.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -15.54 62.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.643 . . . . 0.0 111.735 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t -62.05 -45.41 93.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 108.912 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.78 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.037 0.827 . . . . 0.0 112.587 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 169.35 15.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.125 1.37 . . . . 0.0 110.167 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -152.65 138.7 18.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.109 1.764 . . . . 0.0 107.881 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.85 173.08 22.01 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 120.142 1.337 . . . . 0.0 112.022 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.03 168.04 18.35 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.607 2.205 . . . . 0.0 109.176 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -157.54 -59.33 0.08 Allowed 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -141.42 153.4 44.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.461 0.573 . . . . 0.0 109.711 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -138.47 159.26 42.52 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.334 1.054 . . . . 0.0 109.296 170.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.97 128.89 24.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.8 164.27 26.77 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.56 167.03 4.68 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.751 0.786 . . . . 0.0 109.45 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.83 144.95 80.26 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.59 132.7 27.76 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.279 1.986 . . . . 0.0 109.175 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 165.8 29.64 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.548 2.165 . . . . 0.0 110.009 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 80.16 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.75 2.3 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.02 -83.65 0.11 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 131.72 49.82 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -146.67 137.41 23.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -159.26 63.23 0.39 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.7 m 59.45 -159.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.573 1.549 . . . . 0.0 109.585 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER 157.57 155.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 1 C-N-CA 131.75 4.02 . . . . 0.0 109.758 166.268 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.33 100.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -170.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.36 -63.4 2.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.296 1.427 . . . . 0.0 113.684 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.33 -18.94 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 111.556 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.09 169.35 10.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 25.6 t -110.68 115.08 48.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 166.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.5 170.63 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 166.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.41 141.77 39.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 163.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.11 -34.6 73.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.905 0.882 . . . . 0.0 109.298 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -36.72 84.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.695 0.679 . . . . 0.0 111.27 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 m -61.08 -34.99 75.8 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.538 1.063 . . . . 0.0 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 61' ' ' LEU . 4.9 m-85 -63.51 -61.87 2.04 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.219 0.208 . . . . 0.0 110.614 165.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -22.42 25.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.196 1.398 . . . . 0.0 113.216 -169.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -45.87 -48.98 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.086 0.954 . . . . 0.0 112.121 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -31.21 0.95 Allowed 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.84 1.256 . . . . 0.0 111.239 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.96 86.04 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 119.615 1.098 . . . . 0.0 110.587 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -52.38 68.11 Favored Pre-proline 0 N--CA 1.471 0.593 0 O-C-N 120.285 -1.509 . . . . 0.0 112.168 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.32 -16.94 21.79 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.503 1.469 . . . . 0.0 113.797 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -41.97 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 122.022 2.192 . . . . 0.0 109.042 169.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.39 -38.48 78.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -155.39 91.02 1.29 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.993 1.269 . . . . 0.0 111.172 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -95.73 163.81 13.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 154.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 23.97 101.88 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.33 2.652 . . . . 0.0 115.1 158.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.59 -61.14 2.63 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.8 p 36.79 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.351 3.46 . . . . 0.0 118.088 159.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 m -41.59 -44.71 3.13 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.638 1.975 . . . . 0.0 112.361 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 m 46.68 83.58 0.03 OUTLIER 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.47 2.308 . . . . 0.0 111.58 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.97 -167.58 34.49 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -160.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.12 119.2 6.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.234 2.622 . . . . 0.0 109.573 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -136.64 99.2 0.3 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -73.38 159.05 33.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.382 1.091 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 -137.54 171.52 14.33 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.138 1.775 . . . . 0.0 108.103 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.96 151.26 34.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.12 153.0 39.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.9 t -135.89 117.84 20.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 108.223 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.69 63.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -65.98 -48.72 70.32 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.74 65.64 2.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.467 1.507 . . . . 0.0 112.668 -167.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 90.8 mt -108.64 147.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 120.159 -1.588 . . . . 0.0 107.016 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 -80.14 0.36 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-O 118.827 -0.985 . . . . 0.0 111.353 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -59.65 -25.58 64.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.205 1.503 . . . . 0.0 111.842 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.86 -10.29 51.82 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 115.118 -2.372 . . . . 0.0 113.353 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -49.62 -17.32 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -159.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.82 -23.17 9.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.831 1.252 . . . . 0.0 112.557 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -87.88 -31.33 19.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.356 1.462 . . . . 0.0 111.154 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.53 117.8 2.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.944 1.698 . . . . 0.0 109.553 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -120.56 -64.21 1.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.642 0.656 . . . . 0.0 111.808 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.37 -14.86 60.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.552 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.56 -73.42 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.646 1.978 . . . . 0.0 112.128 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -42.66 -37.41 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.856 1.662 . . . . 0.0 113.294 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -73.58 -68.97 0.46 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.187 0.903 . . . . 0.0 110.558 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.65 -41.65 77.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 112.29 -167.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.3 -51.46 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.201 1.4 . . . . 0.0 108.407 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -63.3 -30.99 72.02 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.062 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.05 -57.02 14.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.245 1.384 . . . . 0.0 108.943 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 m -65.51 -29.51 70.16 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.845 -0.534 . . . . 0.0 112.359 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.0 -30.15 66.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.711 0.687 . . . . 0.0 110.495 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.9 t -64.12 -35.2 80.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.322 1.049 . . . . 0.0 109.543 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.0 m -73.16 133.08 81.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.807 0.731 . . . . 0.0 109.906 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.09 -30.21 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.824 2.349 . . . . 0.0 112.854 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.48 -31.25 34.13 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.208 -1.329 . . . . 0.0 113.398 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 m -73.26 162.87 28.87 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.672 1.736 . . . . 0.0 108.395 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.0 mt -140.57 98.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.0 mm -62.74 145.49 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.426 0.557 . . . . 0.0 109.715 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 115.24 11.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.042 2.137 . . . . 0.0 106.495 167.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.12 25.01 Favored Glycine 0 N--CA 1.464 0.543 0 CA-C-N 120.34 1.427 . . . . 0.0 112.708 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.9 m -117.36 87.42 2.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.34 110.73 16.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.36 158.52 57.17 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.79 153.11 95.68 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.36 -77.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.413 2.075 . . . . 0.0 107.926 166.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? 153.45 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.392 1 C-N-CA 131.798 4.039 . . . . 0.0 104.234 -168.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.53 0.05 OUTLIER Glycine 0 CA--C 1.5 -0.845 0 O-C-N 124.105 0.878 . . . . 0.0 114.908 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.443 ' HG2' ' HD2' ' A' ' 150' ' ' PRO 0.33 0.0 OUTLIER -165.31 172.28 4.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 130.391 3.476 . . . . 0.0 105.903 163.067 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.443 ' HD2' ' HG2' ' A' ' 149' ' ' LYS . 57.2 Cg_endo -67.96 162.16 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 1 C-N-CA 125.337 4.025 . . . . 0.0 109.466 165.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.52 175.27 5.54 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.054 -1.029 . . . . 0.0 108.303 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.62 16.75 25.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 112.447 172.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.48 -53.52 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.421 1.088 . . . . 0.0 108.268 168.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.78 -21.14 27.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.661 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -48.18 -39.9 22.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.472 1.109 . . . . 0.0 111.357 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -25.72 66.21 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.848 1.259 . . . . 0.0 111.136 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 4.5 mp -102.01 -38.05 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.244 1.418 . . . . 0.0 108.901 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -28.44 69.33 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.802 -1.186 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -52.71 -47.93 66.96 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 125.069 1.348 . . . . 0.0 110.565 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 78.2 5.9 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -56.94 -13.48 2.71 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.559 0.743 . . . . 0.0 111.557 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -39.04 56.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.193 2.197 . . . . 0.0 111.955 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 3' ' ' HIS . 18.9 m -48.55 128.82 4.77 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 125.602 1.561 . . . . 0.0 109.025 176.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 46.8 tptt -61.13 106.68 0.63 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 166.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 m -83.52 105.34 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 163.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 6' ' ' LEU . 36.8 m-85 -75.9 92.89 3.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 163.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 107.15 0.95 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 162.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.76 163.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.6 p -122.92 154.33 38.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.217 0.917 . . . . 0.0 108.999 164.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.65 1.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.784 1.633 . . . . 0.0 113.034 162.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -92.58 -36.81 12.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.347 0.976 . . . . 0.0 111.243 171.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.73 HD21 HD12 ' A' ' 176' ' ' LEU . 2.3 p-10 -127.0 7.57 6.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 113.665 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -44.36 -55.36 5.03 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.613 1.565 . . . . 0.0 115.064 -164.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -83.8 18.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.923 1.238 . . . . 0.0 113.164 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -131.56 13.95 4.96 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 117.244 -1.36 . . . . 0.0 113.788 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.73 HD12 HD21 ' A' ' 172' ' ' ASN . 0.7 OUTLIER -88.1 -13.9 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.663 1.574 . . . . 0.0 112.483 -177.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 17' ' ' LEU . 6.1 tp -30.44 -62.06 0.24 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.826 2.05 . . . . 0.0 111.627 173.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.78 -27.81 43.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.935 1.756 . . . . 0.0 112.774 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -70.05 -39.54 75.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.363 0.983 . . . . 0.0 108.988 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 6' ' ' LEU . 3.7 mt -57.93 -58.8 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 117.583 -1.199 . . . . 0.0 107.942 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.531 ' HA ' HG23 ' A' ' 184' ' ' VAL . 9.1 t -57.12 -27.55 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.897 0.771 . . . . 0.0 111.521 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.7 m -67.48 -29.16 68.52 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.756 -1.215 . . . . 0.0 112.35 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 25.9 t -90.66 -33.72 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.393 -1.442 . . . . 0.0 108.514 -167.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -63.9 -63.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 125.244 1.418 . . . . 0.0 108.423 164.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -15.43 63.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.473 1.033 . . . . 0.0 112.984 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.3 t -49.56 -37.97 29.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.229 1.412 . . . . 0.0 110.138 169.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -30.53 70.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.84 0.746 . . . . 0.0 112.078 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.71 -3.08 58.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.8 1.24 . . . . 0.0 112.003 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? . . . . . 0 C--O 1.249 1.079 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 167.07 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 -104.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.425 ' HB2' HG12 ' A' ' 163' ' ' VAL . 51.0 m-70 -131.57 153.11 50.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.47 140.85 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.937 1.244 . . . . 0.0 108.9 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 143' ' ' ILE . 16.3 m-85 -133.87 146.92 51.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.152 0.981 . . . . 0.0 109.799 177.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 180' ' ' ILE . 87.7 mt -93.44 151.38 19.78 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 123.897 0.748 . . . . 0.0 109.265 157.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -151.08 179.89 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.29 1.436 . . . . 0.0 107.994 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.92 -176.92 24.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 122.22 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.856 2.371 . . . . 0.0 112.337 -167.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.82 91.09 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.944 3.763 . . . . 0.0 112.972 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.96 74.76 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.263 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 10.2 p 22.8 78.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.568 2.747 . . . . 0.0 113.542 159.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.31 -36.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.901 1.715 . . . . 0.0 109.348 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.88 -34.85 76.77 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.25 177.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 m -56.48 -44.5 80.69 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 117.323 -1.322 . . . . 0.0 108.948 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.409 HG22 ' HD3' ' A' ' 20' ' ' LYS . 31.1 m -53.9 -36.97 63.29 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 120.067 1.303 . . . . 0.0 111.904 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.17 69.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.942 1.247 . . . . 0.0 110.614 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.24 -43.36 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -52.42 65.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.214 1.406 . . . . 0.0 109.37 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 16' ' ' THR . 4.6 mptp? -53.03 -45.68 68.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.655 171.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.85 27.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.638 -1.173 . . . . 0.0 113.943 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.5 p -80.54 -51.53 8.66 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 120.056 1.298 . . . . 0.0 110.296 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 4.0 pt-20 -57.87 -32.46 67.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.06 0.544 . . . . 0.0 111.067 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.87 -64.65 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.006 1.322 . . . . 0.0 108.367 174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 mt -52.22 -41.31 62.62 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.965 1.306 . . . . 0.0 110.09 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 23' ' ' GLU . 45.3 mtmt -66.47 -46.26 76.96 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.37 -34.29 75.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.019 0.927 . . . . 0.0 110.54 172.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 m -61.8 -41.73 98.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.446 1.021 . . . . 0.0 110.433 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.44 9.21 10.5 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 126.343 1.925 . . . . 0.0 112.745 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.46 130.81 73.15 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.04 139.61 43.17 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.908 1.739 . . . . 0.0 109.106 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.65 157.35 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.574 1.55 . . . . 0.0 107.804 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 174.76 13.71 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.109 -0.37 . . . . 0.0 111.916 163.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.83 -158.07 22.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 124.92 1.248 . . . . 0.0 111.087 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -146.13 162.82 37.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.115 1.366 . . . . 0.0 108.753 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -149.54 125.36 10.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.687 1.195 . . . . 0.0 107.961 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -84.73 70.46 10.81 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 120.919 -1.113 . . . . 0.0 109.559 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -79.44 48.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -166.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 52.14 -174.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.431 2.062 . . . . 0.0 112.62 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.0 t -125.13 93.58 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 150.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -91.42 103.5 16.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 160.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -79.6 104.4 10.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 165.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.93 50.71 11.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.33 0.968 . . . . 0.0 111.713 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.27 -13.95 18.33 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 117.369 -1.795 . . . . 0.0 115.891 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.73 129.43 39.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.254 2.527 . . . . 0.0 109.369 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -86.35 68.18 10.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.433 1.111 . . . . 0.0 112.735 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 pt -89.63 -2.46 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -168.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.67 -166.07 32.22 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 120.187 1.358 . . . . 0.0 111.797 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -138.54 149.54 45.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.9 153.65 51.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.86 154.47 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 164.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -140.32 154.81 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.841 2.057 . . . . 0.0 106.639 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.7 p -117.77 174.95 5.89 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.755 2.07 . . . . 0.0 110.7 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 54' ' ' LEU . 2.1 mm? -79.81 21.3 0.55 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.915 -1.115 . . . . 0.0 112.537 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -126.38 -12.76 6.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 -2.31 27.74 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.61 1.096 . . . . 0.0 112.935 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.87 160.41 32.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.865 1.832 . . . . 0.0 110.065 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.22 164.22 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.517 1.927 . . . . 0.0 107.251 165.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.75 140.63 9.66 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -82.78 63.89 8.01 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.282 3.988 . . . . 0.0 111.745 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.96 -63.66 1.08 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.104 1.761 . . . . 0.0 111.598 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 p -143.59 152.49 41.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.867 1.212 . . . . 0.0 109.764 172.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 168.83 18.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.04 129.08 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.17 45.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 -164.74 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.701 1.6 . . . . 0.0 109.219 -175.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 76' ' ' ARG . 6.6 mt-10 -129.11 154.87 80.52 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.09 125.31 12.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.604 2.203 . . . . 0.0 111.612 -163.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.56 162.94 39.98 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.225 1.95 . . . . 0.0 110.488 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.47 137.35 46.41 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.038 1.825 . . . . 0.0 109.639 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.36 -1.99 73.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.968 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -99.43 163.0 12.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.534 1.667 . . . . 0.0 107.544 163.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -141.3 145.66 35.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 162.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -155.23 -175.33 5.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.9 2.08 . . . . 0.0 107.179 166.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.68 162.56 28.78 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 119.679 -1.888 . . . . 0.0 109.98 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -168.87 135.04 1.75 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.757 1.223 . . . . 0.0 107.705 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.27 15.59 6.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 118.112 0.414 . . . . 0.0 110.294 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 76' ' ' ARG . . . 94.9 114.76 2.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.837 -2.505 . . . . 0.0 106.837 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 68.32 -51.42 0.55 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.588 2.355 . . . . 0.0 113.602 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.54 157.7 16.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.737 2.015 . . . . 0.0 108.391 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.86 123.17 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 171.26 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 110.555 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -156.61 107.71 2.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.918 0.781 . . . . 0.0 112.881 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.6 -35.48 4.05 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.857 1.662 . . . . 0.0 113.054 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -34.45 74.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.936 -1.102 . . . . 0.0 112.048 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.8 t -58.15 -38.66 77.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.622 1.556 . . . . 0.0 110.562 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -64.46 -46.63 82.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.513 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -52.38 -30.1 27.26 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.739 0.699 . . . . 0.0 111.91 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 90' ' ' LEU . 2.6 mt-30 -69.76 -29.97 67.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.23 -0.919 . . . . 0.0 113.184 -173.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -141.15 -44.68 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.439 0.563 . . . . 0.0 111.862 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.97 37.54 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.998 1.719 . . . . 0.0 112.05 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.432 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -129.99 -65.18 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 127.068 2.147 . . . . 0.0 108.053 175.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 31.2 Cg_endo -62.09 -27.48 79.07 Favored 'Trans proline' 0 C--N 1.351 0.676 0 CA-C-N 121.562 1.593 . . . . 0.0 112.965 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.31 -24.71 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.727 0.811 . . . . 0.0 112.599 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.109 0.868 . . . . 0.0 111.335 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -133.31 72.95 1.49 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.692 1.234 . . . . 0.0 108.705 171.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.11 129.49 34.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.367 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.83 166.87 18.23 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.743 168.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -166.26 -174.62 2.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.332 1.853 . . . . 0.0 106.788 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 5.3 p 52.27 -0.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 131.369 3.868 . . . . 0.0 117.855 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t 87.74 15.0 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.809 2.844 . . . . 0.0 110.879 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.35 33.4 p 77.87 108.13 0.08 Allowed 'General case' 0 N--CA 1.458 -0.073 1 C-N-CA 132.196 4.198 . . . . 0.0 114.186 176.391 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 176.48 -151.21 11.16 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.684 -168.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.55 170.58 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.998 3.799 . . . . 0.0 112.163 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.61 106.19 3.09 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 105.785 -2.926 . . . . 0.0 105.785 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -66.59 151.9 46.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -115.52 98.18 6.58 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.253 1.021 . . . . 0.0 109.991 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.53 110.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 26.7 t -108.0 108.22 19.24 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.84 127.88 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.463 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.677 HD13 HG23 ' A' ' 128' ' ' VAL . 4.2 mt -141.04 74.97 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -77.14 174.9 10.18 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.099 1.318 . . . . 0.0 110.015 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 42.38 67.19 0.63 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.893 2.477 . . . . 0.0 114.368 169.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 111' ' ' ILE 0.258 6.7 mt -86.6 -0.39 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 O-C-N 120.521 -1.362 . . . . 0.0 111.707 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.01 -61.68 2.62 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.703 -1.248 . . . . 0.0 113.527 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -54.74 -41.69 70.72 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.583 1.691 . . . . 0.0 114.304 -160.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mmt -78.9 -5.54 53.91 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.289 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -41.16 -41.49 1.81 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -161.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 119' ' ' LEU . 4.4 mp -68.44 -60.1 2.68 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.009 0.924 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.18 -30.07 71.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.761 1.624 . . . . 0.0 111.826 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 t -39.84 107.92 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.032 2.933 . . . . 0.0 110.1 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.71 -78.6 0.56 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.622 1.169 . . . . 0.0 109.276 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 mt -55.27 -31.21 61.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.623 0.769 . . . . 0.0 110.782 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -60.01 3.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 125.474 1.51 . . . . 0.0 111.424 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 mp -41.14 -58.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.113 1.765 . . . . 0.0 111.922 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -65.05 -47.37 77.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 118.588 0.631 . . . . 0.0 110.483 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.83 66.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 124.144 0.903 . . . . 0.0 110.083 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.677 HG23 HD13 ' A' ' 111' ' ' ILE . 2.4 p -62.05 -32.38 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 121.527 -0.733 . . . . 0.0 110.24 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.49 -35.57 60.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.41 171.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -38.77 79.01 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.564 1.074 . . . . 0.0 110.486 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.53 -44.28 24.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.328 1.051 . . . . 0.0 110.41 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.82 -18.19 64.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.537 1.062 . . . . 0.0 112.543 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.7 m -82.12 -22.15 36.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.046 0.839 . . . . 0.0 111.92 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.5 m -87.31 133.17 39.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -79.35 -27.47 4.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.547 2.831 . . . . 0.0 111.487 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.07 81.95 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.993 -0.893 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 5.4 m -67.08 150.09 49.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.056 1.928 . . . . 0.0 110.068 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.77 107.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -69.82 133.35 32.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 140' ' ' LEU . 12.4 tp -142.56 97.82 3.18 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.799 1.312 . . . . 0.0 108.25 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.6 -172.1 17.35 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 114.616 0.606 . . . . 0.0 114.616 -169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.8 m -136.63 112.0 9.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.66 1.184 . . . . 0.0 113.296 175.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 5' ' ' PHE . 19.7 pt -108.89 154.32 41.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.251 1.02 . . . . 0.0 110.906 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.03 159.73 52.15 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.727 1.618 . . . . 0.0 111.749 172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.71 149.79 97.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.456 168.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.5 104.09 1.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.155 1.903 . . . . 0.0 109.489 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -82.77 -63.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.06 107.9 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.99 168.52 0.11 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.602 1.961 . . . . 0.0 111.483 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.68 169.78 1.62 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.335 3.357 . . . . 0.0 111.292 165.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mp -126.42 153.71 44.63 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.13 -44.9 83.77 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -165.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.459 ' CD1' HD11 ' A' ' 157' ' ' ILE . 0.4 OUTLIER -80.43 -33.77 36.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.928 0.785 . . . . 0.0 109.362 173.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.57 -23.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.213 -1.555 . . . . 0.0 110.348 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -58.02 10.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.904 2.082 . . . . 0.0 109.398 166.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.48 63.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.896 1.279 . . . . 0.0 111.534 177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.459 HD11 ' CD1' ' A' ' 153' ' ' LEU . 4.7 mm -73.98 -51.39 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 118.465 0.575 . . . . 0.0 110.268 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -24.56 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.723 0.809 . . . . 0.0 110.322 -170.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -55.88 -26.43 47.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.754 1.222 . . . . 0.0 111.611 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -66.45 -35.87 81.37 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.824 -1.173 . . . . 0.0 111.514 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 53.87 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.657 2.783 . . . . 0.0 115.758 -167.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.4 41.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.736 2.014 . . . . 0.0 111.273 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 3' ' ' HIS . 12.3 m -87.2 134.15 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 119.853 -1.78 . . . . 0.0 106.734 166.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -74.22 112.0 9.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 165.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.83 90.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 32.7 m-85 -75.05 118.95 18.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 167.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 89.56 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.29 143.98 14.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.5 p -121.29 147.99 44.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -54.96 -14.66 1.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.366 166.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -81.82 -56.68 3.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.1 0.864 . . . . 0.0 108.882 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.7 6.01 49.53 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.606 -171.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -32.36 -57.26 0.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.276 2.23 . . . . 0.0 112.219 -172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -84.09 5.05 27.55 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.29 -17.35 21.73 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.05 1.34 . . . . 0.0 112.231 165.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -80.73 -23.63 39.33 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.042 -169.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -57.9 9.27 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.196 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.45 -22.35 52.17 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.75 2.3 . . . . 0.0 114.271 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.22 73.64 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 6' ' ' LEU . 11.3 mt -67.72 -46.63 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.196 0.998 . . . . 0.0 109.262 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.8 t -50.41 -49.15 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.26 1.024 . . . . 0.0 109.21 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 97.6 m -58.14 -51.28 70.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.15 0.887 . . . . 0.0 108.857 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.95 -27.09 69.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.64 -68.4 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 117.294 -1.336 . . . . 0.0 107.944 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -53.54 -24.54 13.75 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.477 1.511 . . . . 0.0 112.558 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.81 -41.97 5.32 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.179 1.792 . . . . 0.0 112.073 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 t 44.88 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.053 1.341 . . . . 0.0 107.465 -162.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -50.21 -57.12 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.328 2.251 . . . . 0.0 115.428 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.007 -1.949 . . . . 0.0 112.729 -146.847 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.992 -0.527 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -131.8 171.06 13.98 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.006 0.821 . . . . 0.0 111.751 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.82 174.6 6.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.046 0.938 . . . . 0.0 110.232 -167.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.86 143.98 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -139.88 150.38 44.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.608 1.163 . . . . 0.0 109.036 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.09 142.62 38.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 125.445 1.498 . . . . 0.0 107.817 -171.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 t -156.82 -169.69 3.06 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 123.541 0.526 . . . . 0.0 110.694 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 145' ' ' VAL . . . 110.69 -174.9 17.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.826 1.679 . . . . 0.0 110.378 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.45 161.45 45.97 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.339 2.026 . . . . 0.0 110.14 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 140.94 46.94 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.33 2.02 . . . . 0.0 110.848 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.24 16.39 4.15 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.713 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.297 5.8 m 44.23 33.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.485 2.314 . . . . 0.0 115.543 -176.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.1 20.54 0.25 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.03 -1.428 . . . . 0.0 113.085 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -69.25 0.21 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.148 1.474 . . . . 0.0 110.308 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -30.5 71.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.333 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 97.1 m -52.51 -52.21 55.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.293 1.406 . . . . 0.0 109.187 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -48.52 78.9 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.389 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -66.39 -45.65 88.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.861 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -44.72 84.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 120.024 1.283 . . . . 0.0 107.893 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -64.69 -23.76 67.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 124.135 0.897 . . . . 0.0 111.417 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.1 -38.81 26.67 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 125.331 1.453 . . . . 0.0 110.323 177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -62.89 -53.12 59.0 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.28 -34.56 72.43 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.07 -49.08 85.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.786 0.834 . . . . 0.0 109.178 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.93 -39.39 76.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' A' ' 54' ' ' LEU . 76.5 mttt -57.31 -49.12 77.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.428 1.013 . . . . 0.0 109.406 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 t -49.92 -51.57 39.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.381 2.273 . . . . 0.0 106.949 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -65.56 15.67 0.03 OUTLIER 'General case' 0 C--O 1.236 0.35 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 173.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.8 19.78 56.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.913 1.244 . . . . 0.0 112.84 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 26' ' ' LYS . 6.0 p -56.87 149.8 41.59 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.78 109.68 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.799 1.666 . . . . 0.0 109.613 159.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.95 171.85 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.596 0.758 . . . . 0.0 109.102 169.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.07 172.61 18.1 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.067 2.547 . . . . 0.0 105.109 165.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.82 -159.11 22.1 Favored Glycine 0 C--O 1.237 0.304 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -141.68 169.72 17.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.522 0.661 . . . . 0.0 111.994 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -135.73 165.86 24.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -125.62 80.52 1.9 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.9 155.23 40.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 167.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -71.18 125.92 28.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.9 t -80.26 126.36 39.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -127.38 167.18 16.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.533 1.133 . . . . 0.0 110.295 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.48 29.34 2.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.349 1.46 . . . . 0.0 109.728 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.48 -21.19 0.4 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.456 -1.402 . . . . 0.0 114.045 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.22 6.43 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.416 1.484 . . . . 0.0 110.308 -163.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 140.01 46.43 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 118.522 1.161 . . . . 0.0 108.467 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.28 135.34 51.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 160.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.0 pt -133.41 -2.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 111.548 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.6 -157.93 27.55 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.22 135.04 30.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.112 2.165 . . . . 0.0 106.12 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.55 164.04 13.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.931 1.293 . . . . 0.0 107.945 168.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.3 p -113.73 104.8 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.02 112.26 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 123.872 0.869 . . . . 0.0 109.889 -160.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -68.59 152.63 45.1 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 109.219 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.3 mm? -68.73 -2.6 9.66 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.808 170.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -110.56 18.94 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.254 1.822 . . . . 0.0 111.531 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.89 0.96 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.371 -0.83 . . . . 0.0 114.709 160.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 m -115.29 166.12 12.2 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.702 1.251 . . . . 0.0 108.133 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -154.09 142.61 20.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.31 -1.494 . . . . 0.0 108.377 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.26 142.7 14.29 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 118.457 -1.191 . . . . 0.0 111.656 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.84 64.78 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 126.144 4.563 . . . . 0.0 113.565 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.93 -59.89 4.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 112.231 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.8 p -146.75 140.28 25.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 120.608 1.549 . . . . 0.0 108.227 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptt-85 -155.81 65.28 0.59 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.845 0.748 . . . . 0.0 110.725 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.827 HG12 ' H ' ' A' ' 65' ' ' GLY 0.335 41.8 t 58.71 -153.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -170.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.827 ' H ' HG12 ' A' ' 64' ' ' VAL . . . 134.08 141.88 4.58 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 129.21 3.291 . . . . 0.0 107.333 -166.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 147.23 53.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 155.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 146.65 99.06 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.54 127.75 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.003 1.802 . . . . 0.0 110.233 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.34 169.2 22.22 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.682 2.921 . . . . 0.0 110.718 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.94 -0.92 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.523 2.148 . . . . 0.0 114.306 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.48 5.34 29.76 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.987 1.28 . . . . 0.0 113.844 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 156.87 43.19 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 120.599 2.199 . . . . 0.0 109.598 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -154.13 155.69 35.84 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 162.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -149.68 26.04 0.84 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.188 1.795 . . . . 0.0 107.808 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.3 m 55.67 -179.39 0.04 OUTLIER 'General case' 0 C--N 1.345 0.405 0 C-N-CA 127.699 2.399 . . . . 0.0 112.501 -165.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.04 170.19 13.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.178 0.991 . . . . 0.0 109.737 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 77' ' ' VAL . 24.1 m -127.97 77.62 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 107.822 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.54 -113.36 4.14 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -162.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.18 -29.2 54.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -166.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.81 146.15 23.99 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 121.601 2.0 . . . . 0.0 107.368 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.2 t -95.08 137.93 22.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.03 177.25 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 123.612 0.765 . . . . 0.0 109.815 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -148.85 113.59 5.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 157.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -25.06 67.38 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.949 -1.094 . . . . 0.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 m -55.85 -31.76 63.04 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.814 1.246 . . . . 0.0 110.235 170.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.4 t -62.0 -37.23 84.04 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.931 1.241 . . . . 0.0 110.203 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -64.62 -50.83 65.61 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -18.7 37.41 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.103 -0.998 . . . . 0.0 113.53 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -64.47 -57.88 7.98 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.86 -1.15 . . . . 0.0 110.47 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -128.72 -33.32 2.06 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.786 1.234 . . . . 0.0 112.334 -166.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.17 46.92 0.75 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.68 1.192 . . . . 0.0 108.895 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.83 -61.05 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.051 2.14 . . . . 0.0 107.844 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.17 -21.68 48.15 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.779 1.653 . . . . 0.0 112.962 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.67 -34.32 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 119.394 0.997 . . . . 0.0 112.053 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.85 3.83 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -168.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -112.12 87.19 2.51 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.59 143.69 56.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.806 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 33.05 -113.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.456 2.303 . . . . 0.0 111.225 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.18 -76.63 0.41 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.6 t -157.99 -54.04 0.07 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.768 0.713 . . . . 0.0 110.068 159.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.2 m 50.23 40.2 21.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.712 1.205 . . . . 0.0 111.476 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.8 m -155.25 -74.52 0.11 Allowed 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.114 1.366 . . . . 0.0 109.363 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.76 -117.02 2.65 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.3 173.88 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.888 2.392 . . . . 0.0 111.756 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 139.75 -50.4 0.77 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.733 2.111 . . . . 0.0 107.977 -166.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.471 HE21 HD11 ' A' ' 138' ' ' ILE . 7.1 mt-30 62.4 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 129.08 2.952 . . . . 0.0 112.481 -172.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.53 168.07 12.89 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.626 0.771 . . . . 0.0 110.772 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.2 158.03 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 159.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.21 153.58 50.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 163.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.9 120.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -166.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.32 86.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -171.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.47 175.62 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.242 -0.912 . . . . 0.0 109.898 -169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 56.25 39.8 30.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.416 1.086 . . . . 0.0 112.352 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CG2' HD12 ' A' ' 153' ' ' LEU . 17.4 mt -81.68 59.35 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 119.725 -1.859 . . . . 0.0 109.685 -175.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.48 -54.64 0.26 Allowed Glycine 0 N--CA 1.465 0.598 0 O-C-N 120.164 -1.585 . . . . 0.0 113.649 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 8.23 3.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -114.81 13.36 17.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.867 1.212 . . . . 0.0 110.266 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -40.51 -42.19 1.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.635 2.374 . . . . 0.0 113.0 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.62 -17.03 10.67 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 124.048 0.939 . . . . 0.0 111.997 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.76 -12.72 23.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.569 0.622 . . . . 0.0 111.069 -171.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -61.24 101.61 0.17 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 119.215 0.916 . . . . 0.0 109.907 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -99.7 -78.33 0.51 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.4 mt -56.42 -24.78 47.36 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.88 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -71.5 0.07 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.2 176.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.3 mp -30.9 -54.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.969 1.708 . . . . 0.0 112.238 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -71.14 -62.77 1.27 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.569 0.348 . . . . 0.0 111.347 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.59 91.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.903 0.858 . . . . 0.0 109.902 -167.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.77 -54.8 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 117.328 -1.32 . . . . 0.0 107.943 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -57.69 -31.2 66.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.287 2.312 . . . . 0.0 113.799 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -59.62 -45.65 91.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.031 0.932 . . . . 0.0 108.944 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.8 m -63.42 -42.5 98.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.408 1.483 . . . . 0.0 111.078 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.15 -35.28 74.96 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.169 -0.957 . . . . 0.0 110.63 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.7 m -90.27 1.47 56.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.474 1.51 . . . . 0.0 112.992 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.7 m -72.18 134.08 83.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.2 118.14 5.52 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 123.154 2.569 . . . . 0.0 108.051 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.37 -3.96 86.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 117.36 -1.8 . . . . 0.0 114.64 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.3 m -67.68 153.24 44.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.555 2.178 . . . . 0.0 107.468 163.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 HE21 ' A' ' 106' ' ' GLN . 49.7 mt -134.64 95.2 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -166.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.49 140.57 19.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.2 100.95 5.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.374 1.87 . . . . 0.0 106.207 163.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -124.38 166.78 16.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.4 m -124.21 117.49 24.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.01 132.84 24.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.485 2.314 . . . . 0.0 109.448 -173.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.36 137.5 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.429 2.086 . . . . 0.0 110.557 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 8' ' ' GLY . 4.5 p -64.49 122.1 76.5 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 110.695 -168.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.42 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.411 2.741 . . . . 0.0 109.411 -171.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -138.6 110.14 7.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 166.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.02 -26.08 6.37 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-O 116.544 -2.253 . . . . 0.0 114.909 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 132.82 24.39 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 121.684 2.742 . . . . 0.0 112.274 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.26 96.44 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.701 2.934 . . . . 0.0 108.538 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 112.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.72 -59.77 3.74 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 113.997 -168.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.507 HD12 ' CG2' ' A' ' 114' ' ' ILE . 1.6 tm? -63.44 -41.42 98.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.898 0.772 . . . . 0.0 109.925 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.29 -30.05 47.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.716 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.75 -35.51 74.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.621 172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.71 -56.59 17.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.766 1.621 . . . . 0.0 109.062 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.73 -29.61 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.159 0.984 . . . . 0.0 111.125 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.79 -37.85 76.47 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 120.606 -1.309 . . . . 0.0 109.516 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -63.63 -19.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.174 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -23.25 50.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.934 1.243 . . . . 0.0 110.886 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.37 -55.26 0.26 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 127.623 2.369 . . . . 0.0 113.43 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -60.26 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 1 C-N-CA 132.726 4.411 . . . . 0.0 113.077 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 t -138.95 121.52 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 15.2 tptm -64.94 123.16 18.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.6 t -102.33 91.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 9.7 m-85 -81.92 102.88 11.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.837 0.855 . . . . 0.0 110.216 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.62 98.13 6.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.125 0.97 . . . . 0.0 109.105 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.32 158.3 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 171.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 50.0 p -121.54 158.72 27.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -57.87 -24.42 57.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.111 163.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.65 -72.43 0.43 Allowed 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.825 0.85 . . . . 0.0 110.539 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -86.85 30.82 0.72 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.864 1.265 . . . . 0.0 109.798 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -48.2 -60.48 2.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.679 1.592 . . . . 0.0 109.898 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -77.37 4.21 11.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -97.54 -6.01 34.49 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.843 1.657 . . . . 0.0 111.852 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.1 tp -74.13 -39.97 62.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.506 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.6 tp -40.87 -64.05 0.67 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.131 1.772 . . . . 0.0 111.54 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.13 -25.22 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 121.482 1.565 . . . . 0.0 111.806 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.08 -38.63 75.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.584 1.554 . . . . 0.0 109.858 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.95 -54.09 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 109.484 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.34 -41.7 81.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.436 0.562 . . . . 0.0 109.54 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.5 m -56.0 -47.85 76.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.972 1.309 . . . . 0.0 109.101 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -47.79 84.29 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.944 0.793 . . . . 0.0 110.826 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.57 -48.32 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.304 0.642 . . . . 0.0 109.97 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.59 55.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.881 1.273 . . . . 0.0 110.102 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 t -55.94 -40.51 73.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.903 1.281 . . . . 0.0 109.644 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.5 t -72.23 -2.13 17.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 112.745 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -111.11 -7.39 14.49 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.903 1.281 . . . . 0.0 112.686 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? . . . . . 0 C--O 1.252 1.22 0 CA-C-N 119.505 1.048 . . . . 0.0 108.202 166.506 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.13 162.46 32.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.263 0.938 . . . . 0.0 109.811 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.445 ' HB2' HG12 ' A' ' 163' ' ' VAL . 66.0 m-70 -89.32 155.84 19.11 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.287 1.435 . . . . 0.0 109.493 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -129.37 132.29 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.774 1.23 . . . . 0.0 108.989 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 5.3 m-85 -141.78 136.06 30.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.455 1.102 . . . . 0.0 108.574 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.42 147.79 22.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 t -143.35 161.89 37.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.827 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.46 -175.52 20.92 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.351 0.977 . . . . 0.0 111.176 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.87 166.47 29.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 111.78 -171.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.44 157.09 62.28 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.462 2.108 . . . . 0.0 110.355 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.22 -9.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 117.608 -1.662 . . . . 0.0 115.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t 61.74 102.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.217 1.807 . . . . 0.0 109.535 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.35 -7.36 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.33 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -32.69 69.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.72 1.76 . . . . 0.0 110.901 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 m -61.98 -39.82 93.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -1.11 1.55 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.133 2.573 . . . . 0.0 112.676 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' A' ' 176' ' ' LEU . 19.8 mt -101.87 -66.39 0.92 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 167.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 HD22 ' A' ' 140' ' ' LEU . 1.6 mp -63.13 -41.45 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.263 0.938 . . . . 0.0 111.797 -168.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.6 64.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -67.89 -32.07 72.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.183 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.09 80.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.888 0.875 . . . . 0.0 110.607 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 t -63.52 -58.25 7.59 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 108.798 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.0 -45.74 32.09 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.256 1.822 . . . . 0.0 112.083 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.43 -54.77 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.98 -0.45 . . . . 0.0 110.321 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.56 -32.78 74.33 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.916 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 mttt -59.47 -44.09 93.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.351 0.978 . . . . 0.0 109.044 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -12.3 61.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.877 0.871 . . . . 0.0 111.118 172.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -93.35 8.99 38.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.284 1.834 . . . . 0.0 114.646 170.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.82 21.24 71.12 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.346 -0.846 . . . . 0.0 111.947 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 26' ' ' LYS . 9.0 p -57.64 147.04 62.89 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.518 1.159 . . . . 0.0 109.096 169.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.81 106.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.883 2.388 . . . . 0.0 109.4 153.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.45 140.59 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 3.5 m-20 -151.48 138.87 19.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.944 0.898 . . . . 0.0 109.185 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.92 -160.93 30.38 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 106.459 -2.656 . . . . 0.0 106.459 -166.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.8 176.23 10.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.862 1.331 . . . . 0.0 112.144 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -138.36 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -131.02 76.24 1.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 152.72 40.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -74.62 115.93 14.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.377 1.084 . . . . 0.0 111.993 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.3 t -78.22 96.4 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -102.3 119.27 38.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 167.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -75.21 -78.74 0.1 Allowed 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.01 59.24 0.36 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.03 -9.45 1.52 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.063 -171.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.88 137.79 32.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.808 1.804 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 143.14 46.14 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 pt -144.06 -6.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.231 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.74 -151.85 23.43 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 119.562 1.074 . . . . 0.0 111.688 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -138.57 164.54 29.2 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.072 1.749 . . . . 0.0 109.156 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.13 142.93 48.94 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 128.336 2.654 . . . . 0.0 104.6 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.13 152.34 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.63 1.172 . . . . 0.0 109.335 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.24 111.81 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 120.198 1.363 . . . . 0.0 112.048 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.431 HG22 HG11 ' A' ' 94' ' ' VAL . 80.6 p -63.78 145.97 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.634 0.773 . . . . 0.0 109.954 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.404 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.2 mm? -64.53 -16.88 63.32 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.55 -0.719 . . . . 0.0 112.336 169.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 t -66.48 -32.47 73.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.792 1.637 . . . . 0.0 109.635 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.78 21.23 3.28 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.053 -0.859 . . . . 0.0 114.827 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.6 m -128.71 152.2 48.68 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.661 1.73 . . . . 0.0 109.516 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -128.83 168.81 15.38 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.89 1.276 . . . . 0.0 112.087 -173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -150.67 179.97 26.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.898 170.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.6 174.48 6.38 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.809 3.006 . . . . 0.0 111.439 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -165.14 -64.51 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.806 -1.184 . . . . 0.0 110.135 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.91 141.43 29.04 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.3 38.55 0.25 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.251 15.2 t 62.54 176.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.499 1.519 . . . . 0.0 109.246 -167.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.93 152.13 6.05 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.428 1.966 . . . . 0.0 108.782 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 158.65 16.7 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.592 0.757 . . . . 0.0 111.522 -174.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.41 145.04 99.11 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.595 -0.691 . . . . 0.0 109.64 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.91 132.26 15.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.552 2.168 . . . . 0.0 110.105 -168.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 158.5 56.65 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.496 2.131 . . . . 0.0 110.659 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.36 121.52 8.82 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.41 2.073 . . . . 0.0 110.489 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.05 9.55 59.39 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.777 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -120.35 156.48 31.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.084 1.354 . . . . 0.0 107.62 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 156.35 40.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.381 1.472 . . . . 0.0 108.057 160.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -135.52 174.48 10.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 127.951 2.5 . . . . 0.0 105.334 160.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.9 m -73.17 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.342 1.057 . . . . 0.0 108.388 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.58 148.12 28.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.696 -1.252 . . . . 0.0 110.412 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.7 19.83 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -151.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.01 98.28 2.27 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 61.29 -69.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.551 1.94 . . . . 0.0 110.907 -159.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.86 139.04 57.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.049 1.74 . . . . 0.0 111.237 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.23 132.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 159.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.15 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.774 1.23 . . . . 0.0 108.833 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.31 112.61 10.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.032 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.6 -35.77 79.6 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.025 -1.047 . . . . 0.0 109.86 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -64.63 -36.22 83.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.924 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.4 p -62.51 -33.99 75.99 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.08 1.309 . . . . 0.0 109.939 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.71 -55.37 17.72 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.28 1.032 . . . . 0.0 109.65 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.34 -13.38 0.34 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.252 1.421 . . . . 0.0 113.495 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.443 ' HB2' HD23 ' A' ' 90' ' ' LEU . 9.5 mt-30 -78.23 -24.97 46.76 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.351 -1.468 . . . . 0.0 114.277 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -147.15 -35.37 0.24 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.12 46.24 0.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.41 1.884 . . . . 0.0 111.498 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -64.92 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 116.877 -1.535 . . . . 0.0 108.095 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.95 -23.96 46.36 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.681 2.254 . . . . 0.0 113.511 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 53' ' ' THR . 15.4 m -58.47 -31.56 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 120.283 -1.511 . . . . 0.0 111.569 175.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.84 -10.35 59.42 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.003 -0.998 . . . . 0.0 112.473 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 167.95 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.943 2.497 . . . . 0.0 107.545 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -143.42 112.95 6.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.756 0.823 . . . . 0.0 110.582 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 56.43 44.2 24.78 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.214 2.205 . . . . 0.0 114.242 166.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 90.44 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 109.764 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.5 t -163.07 11.15 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 159.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.49 -38.0 0.41 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.577 1.535 . . . . 0.0 112.444 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.0 t -57.57 144.8 35.88 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.106 0.866 . . . . 0.0 110.849 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -50.76 134.76 30.48 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.93 1.252 . . . . 0.0 112.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.75 139.53 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.902 2.401 . . . . 0.0 109.675 174.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.73 37.77 0.02 OUTLIER Glycine 0 CA--C 1.518 0.224 0 O-C-N 121.59 -0.694 . . . . 0.0 111.371 -171.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 52.09 -169.34 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.888 1.675 . . . . 0.0 110.828 -162.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.32 164.43 38.77 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.007 2.523 . . . . 0.0 106.089 166.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -120.15 146.32 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.7 p -118.93 168.78 10.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.39 123.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -148.74 92.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -77.54 171.28 15.15 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.663 1.185 . . . . 0.0 109.804 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.8 27.28 4.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.482 1.513 . . . . 0.0 114.56 161.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD21 ' A' ' 153' ' ' LEU . 54.2 mt -74.34 76.94 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.887 1.327 . . . . 0.0 108.227 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.54 -42.99 0.04 OUTLIER Glycine 0 C--O 1.221 -0.684 0 CA-C-O 117.249 -1.862 . . . . 0.0 115.844 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -32.02 71.25 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 122.391 3.095 . . . . 0.0 111.181 175.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.1 mmt -78.35 1.52 21.63 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 116.863 -1.541 . . . . 0.0 114.003 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -34.97 -51.17 0.51 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.565 1.946 . . . . 0.0 114.593 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.57 -27.89 13.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 112.283 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.28 -23.23 51.17 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.023 0.929 . . . . 0.0 111.969 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.5 t -49.81 128.46 18.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.518 2.327 . . . . 0.0 111.149 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.15 -95.88 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.99 -15.99 26.93 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.993 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.92 -71.38 0.07 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 110.374 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.5 mt -32.59 -55.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 127.658 2.383 . . . . 0.0 110.871 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.03 -66.77 0.49 Allowed 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.31 -40.07 73.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.696 1.198 . . . . 0.0 111.515 -170.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.55 -51.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.892 2.077 . . . . 0.0 108.965 174.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -54.75 -40.7 69.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.838 1.199 . . . . 0.0 111.214 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -58.82 -46.33 87.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.78 0.832 . . . . 0.0 109.487 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.42 ' HB ' HD11 ' A' ' 139' ' ' ILE . 5.6 m -65.28 -40.64 94.16 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.737 0.699 . . . . 0.0 111.81 173.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.52 -25.16 67.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.249 0.932 . . . . 0.0 110.839 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.8 m -108.17 -5.49 16.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 0.0 112.73 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.2 m -64.8 139.53 97.8 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 125.75 1.62 . . . . 0.0 108.594 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.75 155.44 53.93 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.573 2.182 . . . . 0.0 110.721 171.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.36 -47.53 1.39 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.122 1.82 . . . . 0.0 114.072 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.3 m -59.99 155.67 16.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.467 1.633 . . . . 0.0 110.518 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.26 136.75 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.447 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.8 OUTLIER -93.4 128.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 173.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -115.26 135.33 54.27 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 165.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.51 -179.17 40.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.095 -1.05 . . . . 0.0 115.7 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.0 m -129.9 124.36 32.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.117 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.3 pt -117.9 154.52 51.3 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.203 1.401 . . . . 0.0 108.155 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.33 158.7 14.93 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.194 2.596 . . . . 0.0 110.497 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.21 137.45 78.68 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 165.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.08 156.01 63.52 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.575 2.85 . . . . 0.0 109.72 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -129.17 -14.34 4.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.835 1.654 . . . . 0.0 112.563 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.25 -85.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 O-C-N 120.711 -1.243 . . . . 0.0 110.02 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.29 153.79 39.39 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.453 -171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.74 157.15 27.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.815 1.676 . . . . 0.0 111.475 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.52 135.36 53.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.663 0.602 . . . . 0.0 111.815 -154.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 114' ' ' ILE . 10.8 tp -61.59 -46.7 88.76 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.029 0.931 . . . . 0.0 110.198 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.91 -34.86 70.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 119.209 0.913 . . . . 0.0 111.252 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -66.87 -26.65 67.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.903 1.229 . . . . 0.0 111.565 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.77 -43.83 92.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.415 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.585 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 8.5 mm -69.21 -44.09 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.568 0.747 . . . . 0.0 109.899 173.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -61.21 -27.2 68.26 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.586 -1.321 . . . . 0.0 109.83 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.19 -5.29 21.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.012 1.725 . . . . 0.0 113.525 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -37.91 11.99 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.811 1.187 . . . . 0.0 110.927 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 61.93 -28.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.264 2.226 . . . . 0.0 114.345 -174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -28.45 33.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.215 1.37 . . . . 0.0 110.591 169.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 3' ' ' HIS . 21.8 m -63.94 113.39 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.123 1.439 . . . . 0.0 109.704 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -64.48 131.32 46.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.407 1.883 . . . . 0.0 108.08 166.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.24 92.49 2.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -80.31 97.97 7.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.598 1.559 . . . . 0.0 108.388 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.96 104.2 8.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.557 -0.714 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 176' ' ' LEU . 0.4 OUTLIER -59.2 146.69 9.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.3 1.048 . . . . 0.0 108.735 167.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -122.82 149.82 43.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 168.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -51.63 -25.05 6.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.192 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -76.05 -25.24 55.42 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.67 0.606 . . . . 0.0 110.725 -170.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.72 28.91 3.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.545 1.538 . . . . 0.0 112.341 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 168' ' ' VAL . 28.4 ptt-85 -66.13 -20.18 66.07 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -171.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.17 29.04 8.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.597 1.559 . . . . 0.0 109.393 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -135.84 15.95 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.405 1.482 . . . . 0.0 113.386 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.677 ' HB3' HD13 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -84.68 -9.14 58.52 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.095 1.771 . . . . 0.0 112.364 -176.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -58.59 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.493 1.517 . . . . 0.0 110.996 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -29.52 67.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.016 1.756 . . . . 0.0 113.716 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.82 -42.6 97.61 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 140' ' ' LEU . 11.9 mt -67.31 -44.1 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 108.156 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.05 -42.74 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 119.196 0.907 . . . . 0.0 109.727 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 84.9 m -59.25 -50.91 72.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.126 0.876 . . . . 0.0 109.744 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -29.61 69.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.471 0.578 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.38 -43.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.504 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -63.75 -34.77 78.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.014 1.734 . . . . 0.0 110.85 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.407 ' O ' ' HE3' ' A' ' 189' ' ' LYS . 0.6 OUTLIER -43.92 -65.61 0.48 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.368 1.867 . . . . 0.0 110.799 -167.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 t 65.55 -59.8 0.28 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.259 1.823 . . . . 0.0 112.204 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 -8.43 6.74 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.949 2.499 . . . . 0.0 113.075 -170.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 186' ' ' SER . 5.7 ptpt . . . . . 0 C--O 1.248 0.976 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -150.45 166.55 29.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.704 0.684 . . . . 0.0 110.541 161.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -49.8 155.8 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.844 2.058 . . . . 0.0 111.459 168.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.3 t -131.27 145.52 35.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -133.57 144.94 49.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.019 0.927 . . . . 0.0 109.193 164.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -106.87 146.13 31.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 t -151.98 -177.54 6.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.48 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.18 175.17 13.9 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.159 1.838 . . . . 0.0 111.351 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.77 169.22 15.03 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 125.013 3.809 . . . . 0.0 111.659 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.13 162.09 20.75 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.175 2.583 . . . . 0.0 112.314 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.09 -53.72 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.093 0 O-C-N 121.25 -0.906 . . . . 0.0 112.346 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.5 t 63.66 94.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 O-C-N 126.061 1.683 . . . . 0.0 109.13 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.28 -35.3 0.48 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.204 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -56.93 -17.79 10.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 -170.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 m -34.04 -51.03 0.41 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.69 1.596 . . . . 0.0 111.23 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -53.99 -28.03 35.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 124.909 1.284 . . . . 0.0 112.54 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -56.86 6.27 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -61.16 -40.67 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.435 1.016 . . . . 0.0 110.181 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -48.68 65.93 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.5 mttm -73.66 -14.46 61.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.455 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.8 98.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 108.601 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.1 p -63.29 -44.02 96.24 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.593 0.633 . . . . 0.0 110.145 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.32 -42.18 84.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' LYS . 71.9 t -63.86 -50.78 76.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 109.771 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.64 -38.54 69.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -72.02 -35.07 69.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 119.119 -0.467 . . . . 0.0 112.252 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 -15.17 25.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 126.426 1.89 . . . . 0.0 115.181 162.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.49 3.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.312 2.245 . . . . 0.0 112.491 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.6 72.39 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.426 1.012 . . . . 0.0 113.61 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.05 121.47 71.54 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.317 1.559 . . . . 0.0 107.259 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.82 90.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.622 -171.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -73.22 146.54 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.379 1.472 . . . . 0.0 108.545 168.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.84 175.68 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 146.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.34 -153.37 24.39 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 124.888 1.232 . . . . 0.0 110.138 170.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -136.13 165.3 26.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.921 0.888 . . . . 0.0 109.36 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -137.49 168.33 19.87 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 159.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -135.87 104.58 5.78 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -102.93 159.17 15.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.75 121.34 20.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.99 107.52 2.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 167.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -125.03 91.46 3.44 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.298 1.439 . . . . 0.0 108.169 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -79.21 76.97 5.73 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 124.162 0.914 . . . . 0.0 111.513 -168.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.37 60.64 6.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 -162.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.41 15.78 81.0 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -115.54 113.3 23.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.012 1.906 . . . . 0.0 111.26 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -65.73 107.13 1.68 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.192 0.997 . . . . 0.0 109.806 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 pt -130.49 -10.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.48 -167.25 40.34 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.464 1.029 . . . . 0.0 110.933 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.61 159.19 37.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.4 139.19 35.24 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.004 0.522 . . . . 0.0 110.301 170.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.06 93.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.36 152.11 8.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 p -116.6 154.77 29.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 166.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.664 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -74.16 -10.84 60.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.496 -0.753 . . . . 0.0 110.257 171.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -66.33 -19.77 65.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.725 2.41 . . . . 0.0 110.485 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 1.63 57.95 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.708 1.147 . . . . 0.0 113.997 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.438 HG22 HD23 ' A' ' 90' ' ' LEU . 3.8 m -85.5 159.81 19.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 0.0 108.637 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.56 131.34 20.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.776 1.63 . . . . 0.0 108.02 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 90' ' ' LEU . . . -111.65 149.22 18.07 Favored Glycine 0 C--O 1.221 -0.681 0 CA-C-O 118.557 -1.135 . . . . 0.0 110.453 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.58 -3.84 13.64 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.127 2.552 . . . . 0.0 114.881 -164.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 40.58 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 131.348 3.859 . . . . 0.0 116.816 168.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.71 116.99 7.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 119.232 0.924 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -126.78 145.54 50.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.845 0.858 . . . . 0.0 110.097 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.82 129.21 37.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.306 1.043 . . . . 0.0 108.854 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.28 50.94 0.67 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.299 -164.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.65 -175.5 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.175 1.488 . . . . 0.0 110.93 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -64.75 151.51 92.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.1 138.26 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.867 3.045 . . . . 0.0 110.832 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.06 159.87 47.32 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.182 2.588 . . . . 0.0 111.236 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.94 147.33 84.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.583 2.189 . . . . 0.0 111.179 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.78 4.53 20.41 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.371 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.2 -128.35 0.11 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.278 1.539 . . . . 0.0 108.119 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 57.35 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.761 2.025 . . . . 0.0 114.067 169.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.79 -16.21 15.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -174.67 170.55 3.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.824 1.65 . . . . 0.0 108.81 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 2.1 ppt_? -170.51 160.32 7.31 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.33 1.452 . . . . 0.0 111.244 151.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.75 -8.59 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 110.701 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.92 -104.46 0.26 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.02 -37.39 76.81 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.592 0.819 . . . . 0.0 109.919 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.09 161.87 13.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.545 1.538 . . . . 0.0 111.855 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 1.0 OUTLIER -105.34 116.02 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.263 2.225 . . . . 0.0 106.334 170.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.83 162.62 4.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 168.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.02 116.36 11.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.86 -28.98 64.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.249 1.386 . . . . 0.0 110.409 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.5 m -59.36 -36.83 76.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.323 1.449 . . . . 0.0 112.472 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.2 p -72.31 -22.77 61.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 120.732 1.605 . . . . 0.0 112.477 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -69.98 -57.11 5.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.931 162.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.8 -29.86 20.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.076 0.853 . . . . 0.0 112.474 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -50.21 -34.03 21.41 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.647 HD11 ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -143.83 -44.03 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.217 0.462 . . . . 0.0 111.643 -174.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.6 48.79 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.468 1.907 . . . . 0.0 109.88 -171.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -144.12 -65.12 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.396 1.478 . . . . 0.0 108.359 -175.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 34.8 Cg_endo -62.55 -24.09 75.07 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 121.287 1.495 . . . . 0.0 113.214 172.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.96 -35.52 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 119.941 1.246 . . . . 0.0 111.141 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.49 -53.05 6.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.979 1.312 . . . . 0.0 107.565 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -120.75 84.39 2.22 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 109.234 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -78.05 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.532 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.34 134.53 55.13 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 96.14 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 128.092 2.557 . . . . 0.0 115.122 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 48.1 t -144.82 110.93 5.5 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.389 1.075 . . . . 0.0 109.539 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -159.41 164.88 34.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -151.04 -30.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.371 1.069 . . . . 0.0 112.616 160.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -139.04 -81.9 0.08 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.442 1.019 . . . . 0.0 112.502 -171.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.67 -179.7 4.41 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.471 2.781 . . . . 0.0 111.101 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.98 -62.73 1.65 Allowed Glycine 0 CA--C 1.519 0.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 170.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -69.7 153.78 42.91 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.664 0.786 . . . . 0.0 112.019 -168.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.95 169.59 11.94 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 129.626 3.17 . . . . 0.0 107.006 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.27 146.66 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 23.2 m -128.59 150.12 50.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.202 0.456 . . . . 0.0 111.273 166.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.99 124.44 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.101 1.361 . . . . 0.0 108.344 -162.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.8 68.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.62 -35.09 76.84 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.661 -1.274 . . . . 0.0 112.331 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.12 86.55 4.62 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.06 -1.025 . . . . 0.0 110.713 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.8 mt -131.58 114.95 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 147.47 -67.49 0.39 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -57.03 -33.33 67.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.134 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mmt -85.68 3.11 42.54 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.692 -1.623 . . . . 0.0 113.042 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -32.89 -65.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.248 1.819 . . . . 0.0 113.845 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -39.48 64.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.083 0.553 . . . . 0.0 110.825 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.58 -23.42 61.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.291 0.95 . . . . 0.0 112.502 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.2 m -52.44 115.04 1.57 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.364 1.866 . . . . 0.0 110.232 -170.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.87 -86.44 0.65 Allowed 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.43 -21.32 35.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.083 0.953 . . . . 0.0 112.361 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.39 -61.56 2.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.012 1.325 . . . . 0.0 110.76 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -39.91 -57.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.239 1.381 . . . . 0.0 112.472 171.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -55.7 31.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.018 0.826 . . . . 0.0 111.239 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.82 92.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.508 0.67 . . . . 0.0 111.21 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.98 -48.64 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.805 1.242 . . . . 0.0 107.862 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -57.69 -37.91 74.28 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -64.28 -42.92 96.18 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.134 0.425 . . . . 0.0 111.138 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -67.35 -40.83 85.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.904 0.775 . . . . 0.0 110.925 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 160' ' ' ARG . 8.7 mp -57.82 -21.11 40.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.523 1.529 . . . . 0.0 111.567 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.9 m -102.55 -6.3 22.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.394 1.878 . . . . 0.0 112.826 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.1 m -70.06 133.97 87.68 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.1 -45.89 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.769 2.312 . . . . 0.0 109.872 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.45 40.57 3.04 Favored Glycine 0 C--O 1.216 -0.974 0 CA-C-O 117.389 -1.784 . . . . 0.0 113.682 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.5 m -135.8 163.84 29.29 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.934 2.367 . . . . 0.0 107.088 169.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.93 103.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.82 132.32 31.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 122.825 0.45 . . . . 0.0 110.134 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.9 tp -126.37 147.88 49.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.257 2.623 . . . . 0.0 105.579 159.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.43 168.93 37.22 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 120.8 1.636 . . . . 0.0 113.358 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.0 m -112.66 121.82 45.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.629 0.715 . . . . 0.0 109.899 -166.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.73 153.39 47.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.662 1.185 . . . . 0.0 109.727 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.89 154.06 67.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.724 1.616 . . . . 0.0 110.461 172.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.59 126.12 92.39 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.34 152.24 44.04 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.284 2.656 . . . . 0.0 111.766 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -47.38 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.593 1.557 . . . . 0.0 110.576 172.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.48 -147.08 13.38 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 124.815 1.198 . . . . 0.0 110.768 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -63.61 158.11 61.56 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 121.974 -0.721 . . . . 0.0 110.638 171.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.66 139.96 41.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.028 2.485 . . . . 0.0 109.941 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.73 145.36 27.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.469 1.508 . . . . 0.0 109.702 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.32 -84.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.006 2.922 . . . . 0.0 114.769 -170.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -52.58 -41.1 63.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.088 0.858 . . . . 0.0 109.028 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.8 -41.21 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.629 -1.177 . . . . 0.0 110.278 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -63.63 -35.37 80.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.866 1.666 . . . . 0.0 110.866 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.58 -20.76 58.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.748 0.819 . . . . 0.0 111.422 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mt -103.4 -42.98 8.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.623 1.569 . . . . 0.0 109.964 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.73 -19.98 60.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.257 1.423 . . . . 0.0 110.965 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.43 -30.99 61.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.989 0.516 . . . . 0.0 111.022 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.421 ' HD2' HD23 ' A' ' 132' ' ' LEU . 16.2 mtp85 -83.99 -38.07 21.42 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.476 -156.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.17 -15.81 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.242 3.017 . . . . 0.0 116.726 174.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.81 -25.36 60.06 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.487 1.915 . . . . 0.0 111.122 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.4 m -52.73 141.12 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.407 1.883 . . . . 0.0 110.541 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 2.7 tppt? -60.56 143.46 53.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 158.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.87 100.96 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 19.2 m-85 -86.62 89.32 7.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.44 111.44 1.79 Allowed 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.48 166.7 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 119.335 0.97 . . . . 0.0 108.532 176.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.2 p -128.52 155.21 45.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 163.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -57.69 -34.58 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 162.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.94 -44.7 91.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.947 2.099 . . . . 0.0 109.996 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.01 18.26 18.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 113.237 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -38.29 -52.92 1.5 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.308 1.443 . . . . 0.0 113.664 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.94 6.48 48.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.552 1.141 . . . . 0.0 112.812 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -96.34 -3.25 44.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 111.987 166.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.581 HD23 HD11 ' A' ' 180' ' ' ILE . 3.9 tp -76.45 -35.97 58.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.179 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.3 -58.14 9.74 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.942 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.83 -25.29 53.12 Favored 'Trans proline' 0 C--N 1.352 0.725 0 CA-C-N 122.105 1.787 . . . . 0.0 112.34 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.25 -43.17 71.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 109.91 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.581 HD11 HD23 ' A' ' 176' ' ' LEU . 27.9 mt -56.88 -50.8 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.869 1.267 . . . . 0.0 108.67 171.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.51 -45.25 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.991 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.3 m -59.3 -43.93 92.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.521 1.055 . . . . 0.0 110.465 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 1.6 t -62.16 -38.77 90.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.533 0.733 . . . . 0.0 110.431 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.7 t -75.18 -45.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.951 0.9 . . . . 0.0 110.208 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -67.58 -14.28 62.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.467 1.031 . . . . 0.0 112.636 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.2 t -34.7 -50.95 0.48 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 128.103 2.561 . . . . 0.0 114.157 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.8 m 38.16 -101.11 0.03 OUTLIER 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.603 1.161 . . . . 0.0 110.027 -168.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 ptt85 -147.99 61.1 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.539 1.536 . . . . 0.0 112.01 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.418 ' HE3' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.018 128.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.54 -155.7 0.62 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.292 0.637 . . . . 0.0 110.133 -164.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.428 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 31.5 m-70 -48.43 140.8 7.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.83 2.052 . . . . 0.0 109.605 166.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 164' ' ' LYS . 96.9 t -126.72 149.58 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.886 1.221 . . . . 0.0 112.259 164.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 157' ' ' ILE . 9.8 m-85 -137.51 162.47 33.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.905 2.082 . . . . 0.0 111.38 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD11 HD11 ' A' ' 180' ' ' ILE . 3.4 mm? -115.34 135.92 53.64 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.727 1.611 . . . . 0.0 108.442 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -137.24 -178.92 5.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.026 1.73 . . . . 0.0 107.206 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.64 176.05 38.49 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.743 -1.223 . . . . 0.0 112.947 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.14 138.88 34.39 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.63 2.886 . . . . 0.0 112.957 -164.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.01 92.59 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.408 3.406 . . . . 0.0 111.579 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.63 -75.51 0.37 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.81 -42.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.03 83.69 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -172.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -35.02 79.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 118.001 -0.999 . . . . 0.0 108.516 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -47.92 -63.46 1.06 Allowed 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 125.664 1.852 . . . . 0.0 107.298 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -42.21 -49.89 4.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.16 1.784 . . . . 0.0 112.671 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -47.9 57.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.681 0.673 . . . . 0.0 109.64 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.782 HD11 HD23 ' A' ' 6' ' ' LEU . 5.0 mm -62.44 -49.12 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.82 0.736 . . . . 0.0 110.951 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -52.78 -49.68 65.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.547 1.539 . . . . 0.0 107.847 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -57.58 -42.39 83.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.618 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.27 -39.97 70.45 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.949 0.795 . . . . 0.0 110.636 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 19.5 m -67.17 -56.08 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -47.94 -39.58 19.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.609 1.563 . . . . 0.0 114.211 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.81 -61.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.516 1.126 . . . . 0.0 108.675 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 mt -61.71 -34.67 76.18 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 118.675 -0.678 . . . . 0.0 109.854 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HE2' HD12 ' A' ' 54' ' ' LEU . 70.7 mttt -54.36 -48.49 71.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.42 1.088 . . . . 0.0 108.242 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -65.22 -24.56 67.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.711 0.404 . . . . 0.0 110.489 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -81.06 8.39 8.68 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.121 1.768 . . . . 0.0 114.831 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 18.79 68.0 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.279 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -53.32 148.62 15.91 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 118.109 0.955 . . . . 0.0 109.294 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.95 112.14 3.49 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.103 1.202 . . . . 0.0 108.991 155.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.56 144.24 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.952 0.882 . . . . 0.0 110.156 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -145.12 157.36 44.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.499 1.92 . . . . 0.0 107.636 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.56 -157.39 24.05 Favored Glycine 0 C--O 1.238 0.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -147.81 161.48 41.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 109.946 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -130.88 146.48 52.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -100.95 109.63 21.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.34 169.62 14.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.077 0.951 . . . . 0.0 111.216 -165.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.01 106.72 16.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 109.408 -162.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.0 93.79 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -111.93 113.96 26.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.529 1.531 . . . . 0.0 107.345 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.44 78.81 8.58 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 -133.52 18.92 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -166.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.69 27.17 5.44 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.598 -1.668 . . . . 0.0 115.615 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.23 159.38 44.48 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.145 2.473 . . . . 0.0 110.725 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.47 137.21 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.276 1.43 . . . . 0.0 110.158 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.73 -9.39 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.94 -172.05 38.0 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -137.71 155.0 49.57 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -123.82 -177.32 3.71 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 124.551 1.157 . . . . 0.0 108.268 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.97 89.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.46 117.75 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -81.08 153.99 27.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' HE2' ' A' ' 26' ' ' LYS . 3.1 mm? -71.01 6.36 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.039 -1.038 . . . . 0.0 113.083 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -95.06 5.64 51.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.766 1.626 . . . . 0.0 112.009 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.06 15.41 72.43 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.49 -1.381 . . . . 0.0 113.148 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -101.08 172.45 7.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.374 1.069 . . . . 0.0 108.2 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -152.8 130.05 11.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.992 0.917 . . . . 0.0 108.908 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 90' ' ' LEU . . . -98.97 145.19 17.6 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.6 67.86 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.634 2.889 . . . . 0.0 111.59 -173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.29 -51.83 6.06 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.327 2.251 . . . . 0.0 111.913 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -152.36 151.79 31.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.546 0.528 . . . . 0.0 111.168 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -140.61 161.74 37.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.553 1.541 . . . . 0.0 109.122 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.48 126.69 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.51 -143.7 7.32 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 127.345 2.402 . . . . 0.0 108.746 167.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tp -88.55 168.44 12.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.485 1.143 . . . . 0.0 109.955 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -74.89 151.16 86.43 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 158.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.78 124.65 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.232 2.621 . . . . 0.0 111.456 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -70.77 167.93 24.32 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 111.53 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.96 125.13 14.7 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.592 1.528 . . . . 0.0 109.949 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.82 80.79 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.64 -1.089 . . . . 0.0 114.313 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 118.99 10.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.209 1.505 . . . . 0.0 106.982 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -140.03 176.89 8.38 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.868 0.467 . . . . 0.0 112.148 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -149.92 -161.95 1.45 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 162.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.5 m -52.18 130.38 30.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.027 1.331 . . . . 0.0 109.401 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -147.91 125.84 12.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HB ' ' HE2' ' A' ' 116' ' ' LYS . 16.2 m -113.74 77.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 123.409 1.576 . . . . 0.0 108.757 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.16 -2.26 1.12 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.655 2.074 . . . . 0.0 116.191 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 176.57 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.113 2.565 . . . . 0.0 109.884 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.88 160.52 21.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.87 0.868 . . . . 0.0 109.539 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.76 112.82 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 165.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.43 165.28 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 119.651 1.114 . . . . 0.0 110.252 163.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -142.19 151.79 42.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.316 0.646 . . . . 0.0 109.538 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.17 -29.68 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.837 2.055 . . . . 0.0 110.447 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.5 m -53.22 -43.65 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.085 1.354 . . . . 0.0 108.769 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.6 t -62.25 -23.01 66.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.108 0.867 . . . . 0.0 112.726 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.23 -56.42 4.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -51.86 -30.09 22.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.637 1.575 . . . . 0.0 112.642 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -45.19 -49.33 12.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.019 2.527 . . . . 0.0 113.714 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.46 HD21 ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -150.98 -34.17 0.15 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.51 0.724 . . . . 0.0 112.371 -166.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.85 45.18 1.13 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.792 1.637 . . . . 0.0 108.719 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.436 ' HB3' ' CD ' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -133.01 -63.47 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.12 1.368 . . . . 0.0 107.405 -174.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' CD ' ' HB3' ' A' ' 92' ' ' LEU . 61.5 Cg_endo -66.94 -22.45 48.42 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.748 2.299 . . . . 0.0 112.742 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.21 -34.86 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.491 1.496 . . . . 0.0 110.787 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.2 -15.57 62.6 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.875 0.87 . . . . 0.0 111.576 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -147.76 77.38 1.42 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.652 1.569 . . . . 0.0 108.826 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.61 159.53 24.02 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.951 1.701 . . . . 0.0 108.054 160.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.71 143.55 41.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.57 0.748 . . . . 0.0 110.451 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.404 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.88 175.93 9.84 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.931 1.293 . . . . 0.0 109.464 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.43 47.24 1.59 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 111.897 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.91 145.29 53.79 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.822 -1.174 . . . . 0.0 109.112 153.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -74.43 167.17 22.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.56 1.144 . . . . 0.0 108.227 165.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.42 171.89 36.5 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.21 1.386 . . . . 0.0 112.235 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.68 113.01 3.69 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.849 2.366 . . . . 0.0 109.638 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.25 75.33 0.26 Allowed Glycine 0 C--O 1.225 -0.467 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -72.48 125.97 28.72 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' NH2' ' H ' ' A' ' 99' ' ' ASP . 41.5 mtt85 -61.91 97.94 0.09 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.75 2.42 . . . . 0.0 110.637 -169.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.02 116.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.46 157.88 26.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.2 t -140.48 114.99 6.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -144.03 102.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.19 176.52 7.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 63.24 -77.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.954 2.502 . . . . 0.0 109.261 -149.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.324 30.2 mt 55.04 -8.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 128.063 2.545 . . . . 0.0 114.445 -169.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.97 -81.4 0.38 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 121.234 1.834 . . . . 0.0 111.477 173.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 77' ' ' VAL . 2.0 ttpm? -59.29 -28.35 66.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -163.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -22.47 65.41 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.843 -2.027 . . . . 0.0 111.258 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -24.85 -67.06 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.617 2.367 . . . . 0.0 113.936 -174.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.67 -15.64 60.79 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.744 2.018 . . . . 0.0 110.168 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.2 t -47.54 105.21 0.07 Allowed 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 129.532 3.133 . . . . 0.0 108.439 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.18 -89.77 0.59 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 123' ' ' LEU . 1.5 pp -56.75 -13.35 2.45 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.073 171.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -66.5 0.37 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.543 1.537 . . . . 0.0 110.69 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.6 mp -33.84 -55.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.698 1.199 . . . . 0.0 111.362 168.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.54 -54.66 36.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.072 0.851 . . . . 0.0 112.477 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.55 66.88 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.33 -45.8 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -56.53 -39.15 72.89 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.297 -1.502 . . . . 0.0 112.294 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.03 -16.7 33.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.806 1.185 . . . . 0.0 113.667 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.9 m -128.2 -17.91 4.2 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.429 1.092 . . . . 0.0 111.952 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.48 -49.88 73.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 146.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -82.87 49.79 1.58 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.421 1.888 . . . . 0.0 110.067 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -141.43 133.76 13.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 162.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.9 -37.37 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 121.858 1.705 . . . . 0.0 111.353 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.64 17.02 2.2 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.822 1.201 . . . . 0.0 114.989 -174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.9 m -118.31 167.16 11.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.64 1.72 . . . . 0.0 108.475 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mt -129.94 101.5 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 21.4 mm -59.9 133.16 25.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD11 ' CG2' ' A' ' 180' ' ' ILE . 6.9 tp -132.71 147.52 52.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 159.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.81 177.89 45.2 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.2 m -114.19 148.08 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.24 127.8 19.11 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.53 145.52 76.79 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.415 1.41 . . . . 0.0 110.511 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.48 134.42 88.72 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.146 0.979 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -67.59 -55.37 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.206 2.604 . . . . 0.0 109.987 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 64.9 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.281 1.832 . . . . 0.0 108.301 -167.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.12 -102.91 0.5 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.671 1.123 . . . . 0.0 110.41 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HG3' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -76.92 159.09 79.43 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 117.852 0.826 . . . . 0.0 110.364 -173.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 149' ' ' LYS . 60.2 Cg_endo -77.14 -175.95 2.94 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.733 2.955 . . . . 0.0 108.918 167.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 mp -126.48 144.89 50.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -48.21 -66.68 0.36 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.667 1.987 . . . . 0.0 113.119 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.2 -39.21 66.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.494 1.118 . . . . 0.0 111.254 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.54 -36.5 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.076 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -63.21 -29.19 70.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.27 1.395 . . . . 0.0 111.778 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -56.94 -39.43 74.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.555 0.693 . . . . 0.0 110.352 174.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.479 HG21 ' CE2' ' A' ' 5' ' ' PHE . 5.4 mt -86.17 -36.81 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.913 1.685 . . . . 0.0 109.909 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -66.44 -34.17 77.33 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.225 -1.547 . . . . 0.0 110.969 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -62.7 -30.58 71.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.787 0.835 . . . . 0.0 109.682 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -58.29 -40.26 81.49 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.355 0.662 . . . . 0.0 109.473 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 -17.68 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.318 3.047 . . . . 0.0 115.677 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.88 -5.55 58.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.723 1.209 . . . . 0.0 111.652 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.36 127.49 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.043 1.337 . . . . 0.0 109.967 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.574 ' HE2' ' CE1' ' A' ' 166' ' ' PHE . 13.6 tptm -65.0 120.4 12.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 164.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 92.15 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' A' ' 164' ' ' LYS . 18.9 m-85 -66.62 98.1 0.49 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.534 1.133 . . . . 0.0 108.182 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 106.46 2.9 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.98 162.81 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.3 p -129.86 156.28 44.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 165.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -59.69 -22.91 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.335 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -83.06 -36.73 24.68 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 110.313 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.73 80.79 1.93 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.659 3.184 . . . . 0.0 102.877 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -106.59 -35.46 7.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.37 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -113.27 3.3 15.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.369 1.441 . . . . 0.0 113.312 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -101.61 0.2 35.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.365 1.866 . . . . 0.0 111.425 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -77.62 -31.62 52.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.122 -0.986 . . . . 0.0 111.247 -173.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 tp -39.31 -61.6 0.96 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.768 1.227 . . . . 0.0 110.462 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -68.29 -23.16 39.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.589 1.603 . . . . 0.0 115.495 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.75 -45.39 82.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.917 1.235 . . . . 0.0 108.323 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.85 HD11 HD11 ' A' ' 6' ' ' LEU . 7.3 mt -62.38 -49.46 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.042 0.937 . . . . 0.0 109.623 173.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.93 -41.69 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 119.824 1.193 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 58.0 m -64.36 -35.77 81.96 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 7.9 t -66.34 -34.73 78.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.083 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.95 -58.56 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.346 0.976 . . . . 0.0 108.399 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.05 -12.55 3.49 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 113.789 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.7 t -57.31 -32.98 67.22 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.925 -1.11 . . . . 0.0 110.832 168.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.5 t -137.45 93.2 2.78 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.572 -1.33 . . . . 0.0 108.819 -158.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.433 ' C ' ' HE2' ' A' ' 189' ' ' LYS . 53.3 mtt180 54.72 160.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.585 2.354 . . . . 0.0 112.653 -159.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.433 ' HE2' ' C ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -168.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 118.637 -0.696 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -125.95 176.65 6.84 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.714 1.143 . . . . 0.0 110.571 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.451 ' HB2' HG12 ' A' ' 163' ' ' VAL . 10.1 m-70 -34.45 143.66 0.04 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 128.065 2.546 . . . . 0.0 111.037 163.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.31 127.28 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.758 0.708 . . . . 0.0 109.634 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 139' ' ' ILE . 13.9 m-85 -140.03 134.0 30.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.874 0.87 . . . . 0.0 109.934 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 18' ' ' ILE . 4.0 mm? -82.08 161.47 22.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.791 1.636 . . . . 0.0 109.152 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -155.6 165.28 37.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.007 0.923 . . . . 0.0 108.818 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.69 -158.95 15.52 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.394 -1.225 . . . . 0.0 111.82 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.08 117.07 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.15 3.233 . . . . 0.0 112.248 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.47 172.51 13.44 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.771 2.981 . . . . 0.0 111.776 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.22 -63.77 0.29 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 167.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.41 125.66 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.31 -37.72 1.81 Allowed Glycine 0 C--O 1.223 -0.533 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 159.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.724 ' H ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -62.3 -29.74 70.65 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 117.887 0.843 . . . . 0.0 110.387 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -61.14 -48.43 81.63 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -55.17 -40.11 70.3 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 128.123 2.569 . . . . 0.0 107.873 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD22 ' H ' ' A' ' 177' ' ' LEU . 54.5 mt -62.37 -61.99 2.07 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 117.9 -1.047 . . . . 0.0 109.841 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 6' ' ' LEU . 1.5 mp -60.61 -45.64 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 119.6 1.091 . . . . 0.0 110.06 -174.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -59.24 4.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.692 1.597 . . . . 0.0 108.247 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 24' ' ' VAL . 59.7 mttm -63.11 -30.4 71.56 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.425 -1.274 . . . . 0.0 111.954 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.36 -32.75 68.85 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 119.878 1.217 . . . . 0.0 109.802 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -71.77 -44.66 63.64 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.192 0.451 . . . . 0.0 110.103 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -61.71 -22.31 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.06 0.944 . . . . 0.0 111.639 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' LYS . 3.0 t -69.08 -50.82 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 120.898 -1.126 . . . . 0.0 110.677 169.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.27 -36.81 84.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.505 0.722 . . . . 0.0 110.22 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -59.18 -48.83 80.18 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -67.74 -3.42 9.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.277 1.831 . . . . 0.0 112.799 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -120.38 11.78 11.52 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.786 1.634 . . . . 0.0 112.773 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.05 38.68 22.07 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 120.122 1.328 . . . . 0.0 113.689 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.46 118.63 37.11 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 107.489 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.49 99.08 0.8 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.77 2.98 . . . . 0.0 110.111 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.4 156.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.14 175.39 9.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.412 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 124.31 -170.64 16.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.89 156.89 46.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.465 0.65 . . . . 0.0 109.811 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -131.59 131.28 43.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 m -83.2 125.37 31.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.437 0.0 OUTLIER -103.7 -130.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 116.593 -1.67 . . . . 0.0 109.645 176.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -157.71 108.48 2.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 122.678 2.49 . . . . 0.0 110.037 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 107.52 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -128.89 113.32 15.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.47 -63.07 1.43 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.692 0.678 . . . . 0.0 109.245 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.49 68.91 0.34 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 106.409 -2.676 . . . . 0.0 106.409 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 -11.08 72.95 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.751 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 135.15 40.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.277 2.038 . . . . 0.0 109.899 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -67.45 141.18 57.07 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 167.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 pt -148.99 -2.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.022 1.329 . . . . 0.0 112.846 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.84 -167.54 32.69 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 119.878 1.217 . . . . 0.0 110.973 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -137.97 154.04 49.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 117.141 0.47 . . . . 0.0 110.52 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -135.95 155.91 49.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 129.484 3.114 . . . . 0.0 106.221 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.76 108.34 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.72 122.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -165.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -72.1 155.24 40.5 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.5 mm? -62.58 -28.44 69.89 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.803 -1.186 . . . . 0.0 110.938 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -68.91 -20.8 64.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 128.033 2.533 . . . . 0.0 111.508 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.42 39.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 118.652 -1.082 . . . . 0.0 114.409 163.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.8 m -71.23 164.4 25.74 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.822 1.811 . . . . 0.0 107.491 160.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -141.56 136.38 31.04 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.134 0.974 . . . . 0.0 108.523 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.68 47.87 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.45 -177.53 1.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 145.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 -60.04 0.07 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 p -146.34 158.31 43.87 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.913 0.885 . . . . 0.0 109.122 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -143.37 165.43 27.54 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.863 2.065 . . . . 0.0 106.895 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.54 147.48 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 41.85 0.22 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.775 1.655 . . . . 0.0 110.706 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 mt 55.96 -167.62 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.798 1.299 . . . . 0.0 111.487 -173.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.4 142.54 25.13 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.836 0.854 . . . . 0.0 108.862 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.05 134.57 25.55 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.629 1.553 . . . . 0.0 109.825 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.86 159.25 54.62 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.006 2.471 . . . . 0.0 109.449 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.06 -6.37 18.09 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.521 2.147 . . . . 0.0 113.989 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.34 7.28 12.6 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.493 1.521 . . . . 0.0 113.622 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -138.49 88.07 2.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.384 2.092 . . . . 0.0 107.16 173.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.21 150.87 33.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.69 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.39 63.84 0.12 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.515 1.126 . . . . 0.0 108.534 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 59.8 m 47.78 -143.97 0.38 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.93 -1.106 . . . . 0.0 110.719 -170.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 156.1 155.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 1 C-N-CA 133.701 4.801 . . . . 0.0 106.11 175.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.34 25.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 121.115 1.78 . . . . 0.0 111.017 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.2 111.73 0.94 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 64.05 -48.69 0.28 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.911 2.484 . . . . 0.0 113.953 -167.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.87 178.37 4.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.12 2.568 . . . . 0.0 108.717 -173.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.26 143.29 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 126.708 2.003 . . . . 0.0 106.53 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -81.11 176.65 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 119.708 1.14 . . . . 0.0 110.394 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -140.3 156.1 46.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 157.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.07 -33.93 38.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.88 0.872 . . . . 0.0 108.954 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.9 m -68.3 -33.35 74.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.843 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.9 m -60.69 -32.01 71.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 121.277 1.853 . . . . 0.0 109.846 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -69.11 -57.46 5.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -53.19 -24.09 10.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -48.81 -34.72 12.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.097 1.359 . . . . 0.0 112.827 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -31.98 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.3 44.08 0.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.281 1.432 . . . . 0.0 110.847 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.43 -61.69 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 127.186 2.195 . . . . 0.0 108.414 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.3 -24.18 16.94 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.04 1.827 . . . . 0.0 113.54 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.5 -30.32 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 119.463 1.029 . . . . 0.0 111.188 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.6 mt -76.46 -6.75 53.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.705 2.002 . . . . 0.0 111.316 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.96 92.16 2.1 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.46 1.504 . . . . 0.0 109.86 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.59 135.79 54.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.635 1.574 . . . . 0.0 110.321 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.57 126.82 32.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.851 1.26 . . . . 0.0 111.552 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 107' ' ' ARG . 9.3 t70 -109.01 -88.51 0.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.908 1.283 . . . . 0.0 109.036 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.9 t 95.19 102.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.816 3.246 . . . . 0.0 107.246 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.4 m -142.74 104.1 4.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.653 1.181 . . . . 0.0 108.083 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 m -66.73 -14.44 62.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.256 1.023 . . . . 0.0 112.731 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.65 -133.22 2.93 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -61.8 149.46 89.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.432 2.088 . . . . 0.0 110.356 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.66 -62.92 0.19 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -164.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 48.07 -152.25 0.11 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.901 0.851 . . . . 0.0 108.914 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -157.27 170.47 22.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 128.247 2.619 . . . . 0.0 105.947 160.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 130.1 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 10.5 m -124.99 109.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 t -83.16 140.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 125.742 1.617 . . . . 0.0 111.203 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -151.67 85.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.516 1.126 . . . . 0.0 108.645 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.53 127.42 53.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.336 -1.478 . . . . 0.0 113.218 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 95.54 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 1 C-N-CA 133.585 4.754 . . . . 0.0 108.153 -173.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.87 57.5 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.653 2.381 . . . . 0.0 106.271 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.97 -33.96 0.03 OUTLIER Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.539 -1.351 . . . . 0.0 112.47 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -62.25 -17.98 59.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 119.612 -2.111 . . . . 0.0 113.822 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 9.81 28.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.879 1.672 . . . . 0.0 111.283 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -57.71 -13.57 4.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 mp -111.65 -41.05 4.15 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.772 1.229 . . . . 0.0 111.917 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.4 -22.28 44.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.581 0.628 . . . . 0.0 112.39 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -50.44 135.23 22.62 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -136.92 -77.41 0.41 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.126 0.57 . . . . 0.0 111.009 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.28 -29.88 69.59 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 116.859 -1.543 . . . . 0.0 110.549 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.91 -54.58 12.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 117.051 -1.452 . . . . 0.0 111.69 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.3 mp -38.51 -63.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 126.566 1.946 . . . . 0.0 111.649 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.51 -51.59 68.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.13 72.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.0 p -87.95 -32.18 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.74 0.816 . . . . 0.0 110.373 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -36.95 32.47 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.042 165.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -48.2 -53.21 17.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.005 1.275 . . . . 0.0 109.529 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -41.63 61.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.791 2.036 . . . . 0.0 112.343 -175.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.47 -41.29 98.67 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.605 1.548 . . . . 0.0 110.606 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 t -78.46 25.26 0.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.948 1.699 . . . . 0.0 111.064 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.5 m -126.79 134.31 25.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.524 -1.36 . . . . 0.0 110.271 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.68 158.81 46.72 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.433 2.755 . . . . 0.0 109.888 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.93 3.78 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -61.84 148.03 44.62 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.227 1.014 . . . . 0.0 112.066 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.6 mt -130.2 108.26 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.444 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 18.0 mm -66.6 139.29 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mt -133.7 97.03 3.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.405 1.482 . . . . 0.0 107.878 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.19 -172.45 18.15 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 118.032 0.378 . . . . 0.0 113.209 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 m -142.26 136.39 29.75 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.931 1.292 . . . . 0.0 107.62 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.78 167.56 18.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.691 1.596 . . . . 0.0 110.079 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 160.05 51.12 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.562 1.508 . . . . 0.0 111.116 158.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.2 152.71 96.53 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.543 -0.723 . . . . 0.0 110.075 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -26.13 18.92 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.01 2.473 . . . . 0.0 111.983 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -50.71 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 128.394 2.678 . . . . 0.0 110.029 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.54 -118.79 1.65 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -167.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 171.23 7.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.225 1.41 . . . . 0.0 110.743 -171.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -57.4 170.98 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.456 2.104 . . . . 0.0 110.39 158.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -147.9 178.6 8.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.83 2.852 . . . . 0.0 105.396 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.1 -82.0 0.11 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 118.903 0.774 . . . . 0.0 109.096 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.83 -32.68 74.34 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 120.444 -1.41 . . . . 0.0 113.073 -171.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.81 -34.93 71.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 117.441 -1.266 . . . . 0.0 109.165 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.15 -34.18 73.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 111.153 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 125' ' ' ILE . 5.3 tp10 -54.33 -50.27 67.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.043 0.937 . . . . 0.0 109.76 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.0 -35.66 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -62.46 -25.62 68.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.13 0.877 . . . . 0.0 111.111 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.07 -14.17 61.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.258 1.023 . . . . 0.0 113.556 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -117.19 55.89 0.83 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.447 1.499 . . . . 0.0 107.898 -166.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 4.7 mmpt? -57.62 -10.32 1.51 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.426 1.491 . . . . 0.0 114.951 -166.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.0 -25.36 43.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.977 0.808 . . . . 0.0 112.163 167.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 3' ' ' HIS . 34.3 m -47.73 118.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 125.901 1.68 . . . . 0.0 109.185 164.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 134.34 53.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.519 1.928 . . . . 0.0 108.501 169.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.63 80.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.168 0.894 . . . . 0.0 108.78 -168.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.15 104.21 1.39 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.179 1.792 . . . . 0.0 109.135 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.58 116.17 17.02 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.906 -1.121 . . . . 0.0 109.52 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.73 166.73 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.983 0.897 . . . . 0.0 109.577 170.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.0 p -120.05 151.19 39.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 163.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -64.49 -21.08 66.57 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.386 -0.821 . . . . 0.0 109.477 168.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -67.74 -74.21 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.704 2.002 . . . . 0.0 109.135 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -91.06 31.9 1.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.924 1.289 . . . . 0.0 109.998 -175.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.79 -24.31 61.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.737 1.215 . . . . 0.0 112.115 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -114.93 21.9 13.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.19 2.596 . . . . 0.0 111.593 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -136.46 6.51 3.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.588 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' LEU . 2.7 tt -82.42 -13.27 57.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 117.436 -1.706 . . . . 0.0 110.627 -170.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.3 tp -36.39 -59.91 0.79 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 127.591 2.356 . . . . 0.0 112.533 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.2 -25.29 31.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 122.108 1.789 . . . . 0.0 112.087 -169.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.2 -43.44 78.05 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.73 -53.01 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.02 -43.73 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.22 1.408 . . . . 0.0 110.264 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 85.1 m -60.83 -32.72 72.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.516 1.126 . . . . 0.0 111.569 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.8 t -65.33 -45.67 83.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.948 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.28 -48.29 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.998 0.919 . . . . 0.0 109.217 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -65.95 -24.5 66.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.7 t -67.96 -24.8 65.2 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.112 0.965 . . . . 0.0 109.992 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 21.46 0.06 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.32 1.048 . . . . 0.0 113.022 167.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.427 ' HA ' ' HE2' ' A' ' 189' ' ' LYS . 0.0 OUTLIER 53.28 83.13 0.07 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.691 1.996 . . . . 0.0 110.409 -167.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 C-N-CA 130.959 3.704 . . . . 0.0 114.839 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.75 172.6 11.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 170.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -64.38 139.5 58.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.475 1.11 . . . . 0.0 109.315 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.46 138.25 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 157' ' ' ILE . 14.9 m-85 -129.03 146.76 50.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.694 0.759 . . . . 0.0 109.899 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.866 HD21 HD11 ' A' ' 18' ' ' ILE . 1.8 mm? -100.65 131.16 46.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -121.59 175.44 6.22 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.64 0.733 . . . . 0.0 109.4 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.86 -135.73 8.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 125.462 1.506 . . . . 0.0 109.644 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.25 159.74 52.58 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.696 2.264 . . . . 0.0 111.761 -160.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.43 -9.67 25.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.951 3.101 . . . . 0.0 114.266 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.32 19.69 14.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.103 0.858 . . . . 0.0 112.464 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 14' ' ' LYS 0.301 46.9 t 74.29 -65.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.136 3.374 . . . . 0.0 109.272 168.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.37 5.05 26.74 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.236 1.398 . . . . 0.0 110.822 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.772 ' H ' HG12 ' A' ' 12' ' ' VAL . 24.3 mtmt -121.76 -8.31 8.97 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 116.368 -1.777 . . . . 0.0 115.225 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.8 m -47.14 -41.19 17.13 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.769 1.622 . . . . 0.0 112.015 -166.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -43.63 -48.83 7.77 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.475 2.71 . . . . 0.0 109.906 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.542 ' CD1' ' H ' ' A' ' 176' ' ' LEU . 41.9 mt -69.54 -57.27 5.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 125.56 1.544 . . . . 0.0 109.743 -171.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 6' ' ' LEU . 23.1 mm -57.74 -46.72 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.971 0.805 . . . . 0.0 109.118 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 -56.51 7.57 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.959 0.904 . . . . 0.0 111.321 171.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -68.58 -25.63 64.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.322 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . . . -52.58 -39.6 61.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.442 1.097 . . . . 0.0 110.224 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.3 p -70.08 -35.07 73.93 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -58.67 -45.31 89.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.879 0.872 . . . . 0.0 109.124 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -60.53 -53.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.151 0.98 . . . . 0.0 110.213 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.93 -41.02 90.86 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.143 0.577 . . . . 0.0 109.449 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -69.59 -40.72 76.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.978 0.354 . . . . 0.0 110.126 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -61.18 -30.15 70.24 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.027 169.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -84.92 1.68 46.18 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.4 1.48 . . . . 0.0 112.858 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.75 1.46 66.94 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.236 1.398 . . . . 0.0 114.282 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.44 110.52 11.69 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.079 1.94 . . . . 0.0 107.809 -172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.93 119.33 6.39 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.555 2.17 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.95 118.17 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.857 0.863 . . . . 0.0 109.033 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.27 170.79 9.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 126.234 1.813 . . . . 0.0 109.797 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' C ' HD23 ' A' ' 54' ' ' LEU . . . 120.55 -156.5 16.01 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 163.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -149.46 167.79 25.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -141.42 -175.97 4.55 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -118.52 133.74 55.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.822 1.647 . . . . 0.0 107.086 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.45 33.78 5.41 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.584 -1.322 . . . . 0.0 112.222 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.04 -172.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.994 2.118 . . . . 0.0 110.51 -171.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.37 144.2 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 152.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -125.22 161.63 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.278 1.831 . . . . 0.0 107.758 167.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -108.79 45.88 1.01 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.079 1.352 . . . . 0.0 107.367 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 104.95 0.09 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -163.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.69 -51.93 3.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.944 1.259 . . . . 0.0 114.56 171.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.13 139.46 30.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.096 1.448 . . . . 0.0 110.392 -162.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -70.15 134.77 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.47 -8.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.99 -176.34 38.43 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 119.558 1.072 . . . . 0.0 110.613 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.57 148.84 51.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.77 135.14 32.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.8 155.73 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 C-N-CA 125.953 1.701 . . . . 0.0 108.536 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 m -141.51 143.09 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.972 165.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.9 p -82.87 161.97 21.74 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.406 1.003 . . . . 0.0 109.871 174.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 34' ' ' GLY . 4.1 mm? -74.63 -14.27 60.75 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.529 -0.732 . . . . 0.0 112.935 176.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 t -69.14 -25.47 64.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.935 0.789 . . . . 0.0 109.49 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.56 9.65 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.079 0.847 . . . . 0.0 112.546 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -83.66 167.22 17.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 1.3 mpt_? -137.53 163.23 31.66 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 90' ' ' LEU . . . -151.18 175.47 30.09 Favored Glycine 0 C--O 1.223 -0.571 0 CA-C-N 120.843 1.656 . . . . 0.0 110.531 158.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.71 161.6 35.14 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 109.749 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.4 -59.98 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.61 144.29 49.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -143.34 162.16 36.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.263 1.425 . . . . 0.0 108.053 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 149.79 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.22 157.4 28.27 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 166.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.47 162.87 7.47 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 161.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.67 150.63 81.11 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.42 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.22 124.87 11.3 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.334 2.023 . . . . 0.0 110.447 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.04 165.84 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.945 2.43 . . . . 0.0 109.465 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.97 101.75 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 108.549 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.45 -68.18 0.48 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.562 1.077 . . . . 0.0 110.421 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -76.72 125.31 29.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.87 7.94 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -135.61 41.42 2.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.179 1.392 . . . . 0.0 107.312 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.0 m 59.1 -161.61 0.26 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.771 2.028 . . . . 0.0 112.291 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 170.78 157.27 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.426 3.091 . . . . 0.0 109.5 175.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.01 0.53 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.93 140.41 11.03 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 -169.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.65 -69.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.965 1.706 . . . . 0.0 110.718 -158.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.11 148.92 21.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.785 1.234 . . . . 0.0 110.164 -167.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.6 t -91.26 139.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 162.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.93 -175.8 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 O-C-N 120.774 -1.204 . . . . 0.0 109.066 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.39 119.82 6.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 153.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.94 -34.61 71.95 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 112.117 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.9 m -51.51 -39.67 58.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.775 1.63 . . . . 0.0 110.35 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.09 -29.05 70.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.743 0.417 . . . . 0.0 110.597 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -71.53 -60.23 2.34 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.913 1.285 . . . . 0.0 108.006 170.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -49.25 -21.42 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.675 1.99 . . . . 0.0 113.778 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -57.34 -58.26 9.03 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.709 -1.244 . . . . 0.0 112.065 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -123.07 -34.15 3.2 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.833 1.253 . . . . 0.0 112.646 -164.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.45 55.92 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.693 1.597 . . . . 0.0 109.074 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 -58.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.679 -173.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.37 -27.06 19.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.893 2.395 . . . . 0.0 113.055 168.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 p -63.41 -27.87 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.914 -1.116 . . . . 0.0 110.659 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 84.4 1.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? 51.51 80.28 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.43 2.292 . . . . 0.0 113.163 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -62.09 136.4 57.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.747 1.619 . . . . 0.0 108.124 153.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.49 62.3 7.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.183 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -90.25 -54.73 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 109.609 -163.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.72 165.78 27.58 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.554 1.141 . . . . 0.0 109.989 165.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -161.42 106.18 1.31 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.742 162.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 m -155.06 152.06 29.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.797 1.18 . . . . 0.0 110.547 168.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.78 -157.44 52.15 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.103 0.859 . . . . 0.0 113.413 164.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.15 111.9 1.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.377 2.051 . . . . 0.0 107.702 164.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 153.24 68.51 0.01 OUTLIER Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -173.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -75.42 161.93 28.8 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -79.31 156.21 28.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 160.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.2 149.31 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 150.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 19.5 t -127.93 163.56 24.21 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.898 1.226 . . . . 0.0 109.771 160.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.6 t -145.53 125.91 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.49 1.516 . . . . 0.0 107.137 -166.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.06 63.34 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.14 97.19 9.21 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.34 -31.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.128 0.571 . . . . 0.0 110.106 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.5 mt -60.26 120.31 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.537 1.135 . . . . 0.0 110.145 -159.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.41 -15.41 1.65 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.68 1.133 . . . . 0.0 112.479 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -100.22 -35.8 9.51 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.722 1.261 . . . . 0.0 110.461 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -87.92 19.97 3.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.024 1.73 . . . . 0.0 111.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -46.12 -33.43 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.677 1.126 . . . . 0.0 114.023 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -102.67 -45.32 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.518 2.327 . . . . 0.0 110.196 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.27 -21.52 63.88 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 124' ' ' PHE . 4.1 m -56.17 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.522 1.529 . . . . 0.0 111.331 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -84.16 -84.18 0.14 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.12 0.568 . . . . 0.0 110.051 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -60.52 -13.58 14.71 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.306 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' SER . 3.2 m-85 -54.77 -51.44 65.7 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 120.885 1.675 . . . . 0.0 111.61 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -52.11 -22.02 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 112.466 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.0 -58.97 2.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.719 -1.238 . . . . 0.0 108.713 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.46 -50.6 72.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.427 1.491 . . . . 0.0 111.594 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 t -61.56 -47.53 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.379 1.072 . . . . 0.0 108.412 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -57.7 -38.55 75.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -39.88 81.21 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.307 0.958 . . . . 0.0 110.758 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -71.03 -39.59 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.94 -14.32 61.88 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.31 1.044 . . . . 0.0 111.776 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -63.07 -50.1 71.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 120.396 1.453 . . . . 0.0 110.038 164.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -60.13 134.33 90.47 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.63 -33.91 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.878 1.719 . . . . 0.0 112.763 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.74 7.68 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 118.346 -1.252 . . . . 0.0 110.781 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 51.8 m -48.51 115.5 1.25 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.097 1.359 . . . . 0.0 111.286 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.1 mt -96.25 85.91 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 102.781 -3.044 . . . . 0.0 102.781 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.1 mm -52.91 117.85 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.438 HD21 HG23 ' A' ' 180' ' ' ILE . 14.6 mt -97.65 146.75 25.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 144.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.19 156.62 27.07 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 156.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 12' ' ' VAL . 95.0 m -91.31 149.48 21.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 164.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.3 pt -136.33 163.02 53.01 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.837 2.055 . . . . 0.0 108.72 166.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.51 165.01 23.34 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.34 2.693 . . . . 0.0 110.443 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.29 149.16 97.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.008 -1.058 . . . . 0.0 109.544 162.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.0 -71.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.104 2.536 . . . . 0.0 109.354 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt 48.34 38.38 10.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.801 1.64 . . . . 0.0 112.872 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.59 -121.01 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 159.61 83.05 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 117.118 0.459 . . . . 0.0 110.145 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.49 166.61 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.95 1.766 . . . . 0.0 107.931 159.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.4 -163.86 1.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.85 -61.34 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.128 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -51.75 19.99 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.04 -22.7 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.74 1.155 . . . . 0.0 111.748 -169.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -42.16 80.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.564 2.346 . . . . 0.0 111.866 171.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.314 0.3 OUTLIER -58.53 -53.35 59.29 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 121.862 0.839 . . . . 0.0 110.006 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 5.3 mt -67.98 -26.54 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.793 0.837 . . . . 0.0 111.2 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -70.73 -20.51 62.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 120.345 -1.472 . . . . 0.0 111.422 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.2 -14.57 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.744 0.702 . . . . 0.0 111.504 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -81.72 85.38 6.61 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 161' ' ' LYS . 11.3 mmpt? -63.05 -20.46 65.35 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 111.714 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.29 -35.17 59.81 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.065 1.746 . . . . 0.0 113.236 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.26 124.1 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.4 1.48 . . . . 0.0 110.854 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -59.11 147.42 35.06 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.56 97.61 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -85.04 104.11 14.67 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.479 1.911 . . . . 0.0 108.203 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.55 103.0 13.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.309 1.443 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.53 163.02 4.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.665 1.222 . . . . 0.0 111.411 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.26 134.9 45.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.566 2.347 . . . . 0.0 106.16 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -46.55 -30.2 2.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.519 1.128 . . . . 0.0 111.489 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.06 -31.14 72.22 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 125.378 1.673 . . . . 0.0 110.591 -172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -131.7 18.29 4.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.026 1.33 . . . . 0.0 111.037 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -60.51 -21.88 62.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -167.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -102.02 11.73 37.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.08 1.352 . . . . 0.0 113.416 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -127.25 24.16 6.34 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.345 1.058 . . . . 0.0 110.973 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.542 ' H ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -83.5 -12.02 56.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.511 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.0 tt -47.11 -57.34 9.53 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.566 1.946 . . . . 0.0 112.068 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.43 -22.95 24.27 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 121.56 1.593 . . . . 0.0 113.08 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.61 -45.97 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.438 HG23 HD21 ' A' ' 140' ' ' LEU . 14.8 mt -63.78 -52.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.49 1.516 . . . . 0.0 109.441 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -55.56 -45.53 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.3 1.409 . . . . 0.0 109.654 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.3 m -56.92 -43.49 81.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.604 1.162 . . . . 0.0 110.366 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 2.8 t -65.35 -38.73 90.98 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.098 0.959 . . . . 0.0 111.855 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.64 -51.61 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 119.234 0.925 . . . . 0.0 108.833 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -66.59 -12.74 59.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.314 -0.851 . . . . 0.0 112.638 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 86.2 p -48.09 -45.17 32.36 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.757 1.223 . . . . 0.0 111.167 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.72 -58.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 1 C-N-CA 133.283 4.633 . . . . 0.0 115.775 -175.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -92.63 -29.19 16.25 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 114.09 172.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? . . . . . 0 C--O 1.248 0.998 0 CA-C-O 116.698 -1.62 . . . . 0.0 109.996 -173.587 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -140.77 135.36 31.42 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.338 0.972 . . . . 0.0 109.107 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.408 ' HB2' HG12 ' A' ' 163' ' ' VAL . 12.4 m-70 -34.18 138.84 0.08 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.29 3.036 . . . . 0.0 111.194 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 t -131.38 141.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 157' ' ' ILE . 28.3 m-85 -135.03 143.98 47.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.956 0.902 . . . . 0.0 109.435 172.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 176' ' ' LEU . 1.4 mm? -105.14 151.08 24.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.695 0.798 . . . . 0.0 110.778 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -156.67 -177.87 6.92 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 123.315 0.384 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.45 -141.08 13.87 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.275 2.369 . . . . 0.0 109.443 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.31 145.14 64.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.963 1.776 . . . . 0.0 111.109 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.28 160.56 44.78 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.27 1.98 . . . . 0.0 110.259 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.95 4.23 7.15 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.072 1.32 . . . . 0.0 115.795 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 5.8 p -74.16 22.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 119.67 1.735 . . . . 0.0 115.472 -160.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.18 -0.33 78.33 Favored Glycine 0 N--CA 1.464 0.545 0 O-C-N 120.013 -1.679 . . . . 0.0 112.062 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -21.15 64.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.944 1.298 . . . . 0.0 113.73 -171.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -50.36 -37.25 36.15 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 120.026 1.285 . . . . 0.0 110.666 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.4 m -57.03 -36.28 70.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.95 1.7 . . . . 0.0 113.51 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD11 ' HD2' ' A' ' 173' ' ' ARG . 0.5 OUTLIER -68.47 -52.44 32.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -178.421 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -36.0 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 O-C-N 122.088 -0.382 . . . . 0.0 111.085 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -54.21 -51.87 63.05 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 24' ' ' VAL . 45.4 mttm -54.64 -43.0 71.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.286 173.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -33.74 68.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.998 1.272 . . . . 0.0 111.476 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -68.18 -53.78 22.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.99 -34.08 77.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.5 1.12 . . . . 0.0 112.59 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 20' ' ' LYS . 74.2 t -62.86 -49.27 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.45 1.5 . . . . 0.0 110.733 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.5 -40.92 98.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.8 -42.37 98.92 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.47 69.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.503 1.121 . . . . 0.0 112.407 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -83.23 -0.62 50.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.971 -1.08 . . . . 0.0 112.136 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.02 36.08 57.3 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.786 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.77 109.13 40.09 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.3 143.92 78.69 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.88 132.52 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.55 174.51 5.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.512 1.525 . . . . 0.0 107.667 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.16 -161.76 23.1 Favored Glycine 0 CA--C 1.508 -0.402 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.79 163.72 37.94 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 117.343 0.571 . . . . 0.0 111.444 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -138.28 168.34 19.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.4 p -109.87 91.32 3.6 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.58 -4.26 22.24 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.919 -1.113 . . . . 0.0 113.664 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 84.14 167.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 130.61 3.564 . . . . 0.0 110.357 -158.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.14 118.54 11.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 164.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -111.03 148.33 32.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 163.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -142.66 116.77 9.45 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 156.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.18 26.84 64.25 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.965 0.802 . . . . 0.0 111.486 -166.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.74 -20.0 2.45 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.411 1.325 . . . . 0.0 116.411 172.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.79 7.35 2.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.073 2.437 . . . . 0.0 116.498 -157.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.651 1.98 . . . . 0.0 110.998 -165.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.63 -11.63 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.732 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.84 -147.19 16.73 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.341 -1.903 . . . . 0.0 108.341 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -141.7 163.18 33.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.554 1.542 . . . . 0.0 109.551 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -120.36 166.23 13.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.935 1.694 . . . . 0.0 106.839 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -126.47 104.9 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 123.849 0.859 . . . . 0.0 108.717 174.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.5 117.55 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -164.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 p -66.19 161.84 21.16 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 109.293 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.87 -1.32 6.98 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.83 -1.169 . . . . 0.0 112.324 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -105.14 7.21 33.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.475 1.91 . . . . 0.0 112.479 168.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.28 6.59 83.78 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 120.385 -1.447 . . . . 0.0 115.015 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 149.63 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 156.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 18.9 ptt-85 -150.45 149.57 30.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.108 1.322 . . . . 0.0 111.041 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.8 158.74 18.43 Favored Glycine 0 C--O 1.22 -0.768 0 CA-C-O 116.879 -2.067 . . . . 0.0 111.325 -172.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.95 9.79 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.457 3.438 . . . . 0.0 113.791 -164.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 24.54 -74.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 131.415 3.886 . . . . 0.0 116.301 171.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.3 p -136.44 143.25 43.81 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 164.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.48 67.87 0.46 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.508 0.594 . . . . 0.0 110.039 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.5 t 48.66 134.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 130.348 3.459 . . . . 0.0 114.798 -172.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.34 52.79 0.49 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 53.5 -178.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.227 1.811 . . . . 0.0 111.783 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -80.91 158.35 70.45 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 159.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -80.03 140.14 14.02 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.153 2.568 . . . . 0.0 110.356 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.21 175.29 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.992 3.128 . . . . 0.0 110.578 165.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.63 150.87 86.03 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.021 1.147 . . . . 0.0 109.27 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.86 -73.26 0.66 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.059 0.837 . . . . 0.0 112.582 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 115.45 5.03 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.232 1.016 . . . . 0.0 109.049 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -173.62 153.37 2.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.89 2.076 . . . . 0.0 106.785 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.75 -27.61 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 151.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 65.8 m -152.13 143.59 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.622 1.569 . . . . 0.0 109.442 -170.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.65 139.32 4.49 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.29 85.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 172.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.38 -67.2 0.25 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.092 1.806 . . . . 0.0 112.041 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -144.72 -18.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.368 2.267 . . . . 0.0 113.402 -167.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -106.57 125.81 51.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.84 130.98 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 167.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.62 168.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.449 1.022 . . . . 0.0 108.598 165.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -126.11 111.13 14.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.71 -31.53 66.5 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.689 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.2 m -60.81 -38.15 84.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.707 1.603 . . . . 0.0 111.493 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.7 m -58.84 -36.38 74.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.7 1.136 . . . . 0.0 110.446 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.34 -49.8 65.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.074 0.95 . . . . 0.0 111.478 171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.511 ' HA ' HD13 ' A' ' 92' ' ' LEU . 52.0 mt-10 -53.38 -25.44 15.53 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.161 0.891 . . . . 0.0 113.1 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.68 -50.84 65.4 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.237 1.38 . . . . 0.0 111.934 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.18 -25.59 1.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.773 -166.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.55 59.61 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.275 1.398 . . . . 0.0 109.402 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 88' ' ' GLU . 3.1 mp -49.9 -45.96 80.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.095 -1.431 . . . . 0.0 114.045 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.87 -27.33 7.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 CA-C-N 121.733 1.655 . . . . 0.0 113.834 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.3 -29.75 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.737 1.153 . . . . 0.0 111.26 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.7 34.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.021 2.128 . . . . 0.0 111.007 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.275 4.8 mmm-85 173.84 -134.7 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 130.851 3.66 . . . . 0.0 107.238 -164.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 63.79 167.82 0.15 Allowed 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.041 1.736 . . . . 0.0 111.408 -153.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.65 107.95 5.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.611 1.165 . . . . 0.0 109.174 -170.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -150.04 175.92 11.27 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.455 1.902 . . . . 0.0 107.919 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.2 t -178.12 -34.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.003 2.521 . . . . 0.0 108.715 157.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t 59.41 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 127.741 2.417 . . . . 0.0 111.302 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 p -71.46 -179.06 2.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.374 1.469 . . . . 0.0 110.392 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.95 -88.11 1.94 Allowed Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.08 -1.012 . . . . 0.0 113.393 -165.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.61 116.92 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.556 2.171 . . . . 0.0 108.944 173.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.29 -33.55 0.15 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 57.19 -150.7 0.44 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.131 0.973 . . . . 0.0 109.083 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.37 163.76 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.84 145.2 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 168.01 10.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.421 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.11 129.46 50.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.367 1.067 . . . . 0.0 108.32 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -133.56 67.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -79.83 67.94 5.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.869 0.868 . . . . 0.0 109.706 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.42 -95.06 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 153' ' ' LEU 0.286 78.6 mt 41.45 53.57 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 128.117 2.567 . . . . 0.0 109.864 177.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.66 -61.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 121.466 -0.771 . . . . 0.0 112.396 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -20.69 64.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.42 2.11 . . . . 0.0 113.613 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.77 18.02 21.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.615 1.566 . . . . 0.0 109.713 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.54 -18.17 2.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -166.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.41 -30.49 8.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.105 0.866 . . . . 0.0 111.321 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -90.21 -20.02 23.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.368 1.067 . . . . 0.0 112.669 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.2 m -59.83 103.92 0.25 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.579 0.752 . . . . 0.0 110.792 -166.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.81 -81.72 0.47 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.256 0.935 . . . . 0.0 111.821 -163.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.93 -10.05 8.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.028 1.731 . . . . 0.0 112.28 169.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.53 -61.77 1.85 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.327 1.451 . . . . 0.0 110.901 174.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 125' ' ' ILE . 3.2 mp -38.08 -64.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.841 2.056 . . . . 0.0 112.16 172.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -53.75 54.6 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.406 0.548 . . . . 0.0 110.012 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.76 72.64 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.44 -173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 157' ' ' ILE . 2.7 t -49.09 -55.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.296 1.839 . . . . 0.0 109.275 172.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -62.98 -36.5 83.7 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.957 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.9 -44.84 88.3 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.122 0.874 . . . . 0.0 110.068 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.1 m -65.74 -34.83 79.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.094 0.957 . . . . 0.0 111.003 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.61 -30.31 69.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.429 1.492 . . . . 0.0 112.104 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.3 m -107.9 14.29 25.49 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.626 1.57 . . . . 0.0 112.082 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.4 m -76.97 133.78 69.01 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -77.33 109.5 2.81 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 108.096 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 125.1 -87.42 0.37 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 107.246 -2.342 . . . . 0.0 107.246 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 m -43.83 146.24 0.6 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.847 1.659 . . . . 0.0 112.375 -171.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.95 107.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.31 134.66 26.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.45 142.48 50.78 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 163.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.97 172.24 45.31 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 120.741 -1.224 . . . . 0.0 110.673 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.9 m -121.62 135.49 54.98 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.724 1.21 . . . . 0.0 108.403 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.1 pt -125.93 151.18 70.99 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.911 1.684 . . . . 0.0 110.156 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.82 150.57 49.93 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 109.194 169.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.85 118.92 59.57 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 123.112 0.565 . . . . 0.0 110.596 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.14 117.72 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.102 2.534 . . . . 0.0 107.63 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -152.92 -35.03 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.199 0.999 . . . . 0.0 110.624 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.64 -152.9 6.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 164.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 140.34 93.81 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.543 -0.975 . . . . 0.0 109.726 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.33 120.11 4.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 124.812 3.675 . . . . 0.0 111.407 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.0 155.88 38.13 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.827 1.651 . . . . 0.0 113.123 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.31 -60.21 2.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.886 2.074 . . . . 0.0 113.802 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.405 HD13 HG23 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -62.13 -47.07 86.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.59 -41.03 52.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.09 -36.15 74.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.94 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -55.16 -49.27 72.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.944 1.247 . . . . 0.0 110.035 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 128' ' ' VAL . 5.2 mp -75.82 -46.13 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.069 0.548 . . . . 0.0 109.619 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -39.49 74.74 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.402 1.081 . . . . 0.0 109.55 -174.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -60.05 -23.51 63.8 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.123 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -63.41 -42.15 98.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.576 1.08 . . . . 0.0 111.624 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 8.9 mmpt? 61.91 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.591 2.356 . . . . 0.0 115.055 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -28.63 67.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.448 1.022 . . . . 0.0 110.911 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 3' ' ' HIS . 36.0 m -57.32 123.92 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.193 0.997 . . . . 0.0 108.845 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -71.08 106.21 3.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.5 t -84.25 95.53 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -83.46 112.95 20.42 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.55 120.61 17.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.406 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -65.68 164.61 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 82.8 p -122.28 163.2 20.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.07 -21.57 64.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.788 -1.195 . . . . 0.0 109.805 161.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -79.9 -47.84 14.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.67 0.788 . . . . 0.0 111.097 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.93 32.01 5.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.939 1.696 . . . . 0.0 110.433 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 17' ' ' LEU . 3.0 tmm_? -48.52 -59.86 3.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.249 1.419 . . . . 0.0 109.668 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -76.63 4.15 10.04 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -116.92 4.61 12.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.002 1.721 . . . . 0.0 110.878 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 6.0 tp -80.26 -40.22 27.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.307 0.503 . . . . 0.0 112.044 170.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.79 -57.92 0.73 Allowed Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 126.177 1.791 . . . . 0.0 110.222 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.08 -25.21 44.08 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.203 1.936 . . . . 0.0 114.994 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -71.14 -38.79 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.061 -1.025 . . . . 0.0 109.587 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 5.9 mt -62.65 -47.95 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.38 -40.93 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.76 1.224 . . . . 0.0 110.443 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.8 m -65.13 -43.26 92.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.247 1.019 . . . . 0.0 110.04 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 10.3 t -68.61 -33.24 73.69 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.096 -1.002 . . . . 0.0 112.229 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.8 t -63.07 -64.91 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -35.86 80.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.078 -171.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 t -24.47 -86.28 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.942 2.897 . . . . 0.0 113.563 -165.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.5 m 64.35 -64.79 0.14 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.921 2.488 . . . . 0.0 113.198 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.24 -5.72 9.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 117.168 -1.396 . . . . 0.0 112.291 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-N 121.082 1.765 . . . . 0.0 109.222 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -167.81 139.18 2.95 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 147.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -73.76 151.79 40.53 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.37 155.95 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 109.082 170.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -142.2 165.04 28.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.289 1.036 . . . . 0.0 109.81 171.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 18' ' ' ILE . 4.4 mm? -100.96 150.39 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.188 2.195 . . . . 0.0 108.736 169.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -156.16 -162.76 1.34 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.86 -174.07 26.28 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.18 1.848 . . . . 0.0 112.251 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.25 149.76 81.47 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.443 2.762 . . . . 0.0 111.477 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.16 119.42 6.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.071 2.514 . . . . 0.0 109.307 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.48 -17.15 27.33 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 117.927 -1.485 . . . . 0.0 110.583 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 64.85 113.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.051 1.74 . . . . 0.0 109.164 -169.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.39 65.86 0.75 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -97.94 -33.47 11.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.16 0.584 . . . . 0.0 110.841 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -53.28 -38.5 63.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.92 2.088 . . . . 0.0 111.983 -171.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.9 m -62.92 -40.64 98.22 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.581 -0.699 . . . . 0.0 112.609 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -45.37 87.34 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 120.253 -1.53 . . . . 0.0 108.041 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 HD23 ' A' ' 6' ' ' LEU . 9.2 mm -55.56 -46.83 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.875 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -54.52 -50.9 66.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.178 1.354 . . . . 0.0 108.996 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -50.54 -43.91 56.26 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 110.627 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.6 69.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.069 0.849 . . . . 0.0 111.232 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.487 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.26 -39.32 69.65 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.001 0.92 . . . . 0.0 111.326 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.64 -48.94 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 O-C-N 121.451 -0.781 . . . . 0.0 109.745 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.4 mt -60.56 -41.44 94.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -60.58 -41.43 94.66 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -68.59 -25.27 64.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.046 1.338 . . . . 0.0 112.652 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -73.07 -24.23 60.65 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.928 173.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.69 2.75 10.42 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.124 1.821 . . . . 0.0 113.418 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.7 t -88.17 122.97 69.5 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.452 1.626 . . . . 0.0 109.616 -161.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.83 84.93 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.549 2.166 . . . . 0.0 109.001 161.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.13 141.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 125.48 1.512 . . . . 0.0 107.561 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -127.1 175.47 8.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.289 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.85 -160.88 16.16 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 120.623 1.556 . . . . 0.0 111.42 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.27 154.63 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.363 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -119.56 178.78 4.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.688 1.595 . . . . 0.0 106.903 165.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -143.38 144.25 31.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 168.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.92 161.03 36.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 109.914 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.37 129.92 40.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.505 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.95 97.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -117.74 97.99 6.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.995 1.718 . . . . 0.0 106.461 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -64.21 99.45 0.28 Allowed 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.82 -59.57 2.58 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.483 1.04 . . . . 0.0 111.568 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.67 40.77 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.362 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -127.8 132.28 49.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -63.08 114.61 3.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -131.43 -23.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.704 0.802 . . . . 0.0 112.876 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.95 -170.86 42.14 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 120.261 1.391 . . . . 0.0 111.716 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -119.32 170.08 9.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 157.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.265 31.4 p30 -129.85 159.75 35.62 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.114 -0.367 . . . . 0.0 110.798 158.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.51 109.92 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.33 113.77 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 p -80.04 157.38 26.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.9 3.36 3.36 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.016 -1.052 . . . . 0.0 112.44 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.4 m -72.41 -11.51 60.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.198 0.999 . . . . 0.0 111.942 160.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.15 76.77 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.289 -0.882 . . . . 0.0 111.943 -167.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.568 HG22 HD23 ' A' ' 90' ' ' LEU . 31.0 m -102.76 154.81 18.81 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.551 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -143.48 141.35 30.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.069 0.85 . . . . 0.0 111.0 -163.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.24 142.12 13.25 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 74.9 1.98 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 125.075 3.85 . . . . 0.0 111.405 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.4 HD22 ' CG2' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -49.16 -49.66 41.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.195 0.998 . . . . 0.0 110.18 -177.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.41 126.06 13.37 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -144.64 92.96 2.35 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 65' ' ' GLY 0.433 4.0 m 34.86 -126.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 113.606 -174.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' H ' HG23 ' A' ' 64' ' ' VAL . . . 110.02 149.32 12.48 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 120.181 1.355 . . . . 0.0 110.991 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.77 152.19 32.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -77.35 164.67 56.99 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.109 0.964 . . . . 0.0 110.009 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.98 124.49 8.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.376 2.05 . . . . 0.0 107.151 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -66.24 169.92 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.949 1.766 . . . . 0.0 108.957 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.39 119.22 6.21 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.748 1.632 . . . . 0.0 108.268 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.11 -68.71 0.54 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.621 1.105 . . . . 0.0 110.705 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -68.02 149.87 49.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 1.151 . . . . 0.0 109.013 178.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.16 156.91 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 164.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 13.9 pt-20 -158.05 -163.19 1.26 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.545 1.938 . . . . 0.0 106.839 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.18 -165.94 1.38 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.052 1.341 . . . . 0.0 108.952 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 3.6 tmm_? 146.62 140.58 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.104 3.362 . . . . 0.0 107.428 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.22 -24.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.75 104.76 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 107.071 -2.412 . . . . 0.0 107.071 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 65.31 -55.42 0.32 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 129.031 2.932 . . . . 0.0 111.828 -163.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -84.52 137.69 33.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.777 0.831 . . . . 0.0 110.624 -168.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 4.9 p -82.07 110.91 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 172.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.4 ' CG2' HD22 ' A' ' 61' ' ' LEU . 1.4 p -71.46 162.89 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -143.8 125.2 14.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 167.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.93 -26.37 65.9 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.943 0.897 . . . . 0.0 111.668 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 m -55.31 -35.24 64.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.778 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -60.86 -40.11 91.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.119 0.872 . . . . 0.0 110.521 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -61.27 -50.93 71.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.557 0.617 . . . . 0.0 109.341 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.49 -21.41 62.37 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.92 -45.67 91.82 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.747 0.703 . . . . 0.0 111.843 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -154.31 -28.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -161.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.26 20.59 1.59 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.628 1.171 . . . . 0.0 110.416 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.674 ' H ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -121.9 -47.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.973 2.509 . . . . 0.0 112.682 -172.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -64.3 -25.14 64.48 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.65 1.566 . . . . 0.0 111.203 166.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.0 -29.08 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.497 -0.752 . . . . 0.0 113.007 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 mm? -62.7 -51.47 67.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.906 0.775 . . . . 0.0 109.534 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -127.47 99.23 5.53 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -74.13 177.17 5.93 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.847 1.259 . . . . 0.0 111.445 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.49 104.56 16.68 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.9 1.28 . . . . 0.0 109.536 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -157.17 143.38 17.93 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.625 1.97 . . . . 0.0 106.044 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.9 m 37.76 -141.86 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.42 2.288 . . . . 0.0 113.002 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.3 p -138.97 176.29 8.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.806 0.843 . . . . 0.0 108.883 161.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -66.81 109.62 2.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.249 1.42 . . . . 0.0 110.079 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.19 -104.88 0.18 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.771 -1.572 . . . . 0.0 109.435 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.78 179.38 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.436 3.424 . . . . 0.0 110.83 168.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.69 86.22 1.73 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -73.0 152.12 41.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.519 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -140.2 177.63 7.85 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.458 1.903 . . . . 0.0 108.371 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.5 t -133.95 147.22 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 168.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.2 162.19 17.84 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.1 0.96 . . . . 0.0 110.047 172.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.19 130.61 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.003 1.721 . . . . 0.0 107.421 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.3 mt -149.12 106.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -98.32 177.23 5.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.272 -1.518 . . . . 0.0 108.52 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.01 27.65 15.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.406 2.682 . . . . 0.0 113.402 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.59 98.15 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.95 -77.91 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-O 118.795 -1.003 . . . . 0.0 110.748 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -53.97 -30.26 46.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.782 1.233 . . . . 0.0 113.913 -164.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -64.19 -16.17 61.41 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 126.387 1.875 . . . . 0.0 112.156 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -24.31 -59.6 0.05 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.573 2.749 . . . . 0.0 116.2 -163.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.82 -34.8 67.08 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.921 1.288 . . . . 0.0 111.904 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -81.15 -27.68 35.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.702 1.601 . . . . 0.0 111.613 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.6 m -52.09 110.52 0.49 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.467 1.507 . . . . 0.0 109.233 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.67 -8.56 0.49 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.97 -31.35 2.89 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 125.717 1.607 . . . . 0.0 108.996 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -27.64 -73.73 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 129.102 2.961 . . . . 0.0 110.928 164.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -34.33 -63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 128.22 2.608 . . . . 0.0 113.84 172.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.05 -43.05 83.68 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.866 1.212 . . . . 0.0 111.175 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.53 99.42 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.461 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.72 -36.45 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.006 0.922 . . . . 0.0 109.394 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.19 -26.75 63.17 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.232 -1.543 . . . . 0.0 113.941 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -55.49 -56.95 14.29 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.523 1.056 . . . . 0.0 108.91 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.9 m -66.78 -34.73 78.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.631 1.572 . . . . 0.0 112.489 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.85 -27.81 69.12 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.492 -0.755 . . . . 0.0 109.743 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 t -85.74 -23.6 27.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.709 1.603 . . . . 0.0 111.614 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.8 m -58.38 139.03 85.01 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.2 1.364 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -86.21 107.27 0.84 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.768 2.979 . . . . 0.0 109.16 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 128.87 -43.33 1.33 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.603 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.2 m -57.13 157.54 5.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.158 1.479 . . . . 0.0 110.579 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.22 102.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.91 129.73 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 166.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.25 111.65 11.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.56 174.82 25.41 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.086 0.857 . . . . 0.0 113.08 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.0 m -117.54 122.07 42.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.391 1.096 . . . . 0.0 110.092 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.51 143.25 29.03 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.618 1.167 . . . . 0.0 109.094 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.59 141.25 54.53 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.017 1.811 . . . . 0.0 108.393 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.13 114.5 12.82 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.5 149.55 27.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.367 2.711 . . . . 0.0 109.063 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -140.67 -72.11 0.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.694 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.76 -66.1 2.64 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 146.8 54.65 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 117.639 0.719 . . . . 0.0 109.44 174.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.83 161.26 21.36 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.929 2.419 . . . . 0.0 107.976 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -93.14 155.8 17.25 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -38.9 -50.89 1.76 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.316 2.246 . . . . 0.0 114.146 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 124' ' ' PHE . 4.4 mm? -80.17 -38.19 31.82 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.063 0.545 . . . . 0.0 109.976 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.12 -17.46 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.287 -1.508 . . . . 0.0 110.279 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.64 -61.73 1.75 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.799 -1.188 . . . . 0.0 109.634 161.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . 0.325 0.2 OUTLIER -53.73 -54.35 39.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.092 0.948 . . . . 0.0 112.709 -174.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.27 -30.8 49.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 124.903 1.281 . . . . 0.0 111.788 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -31.29 70.66 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.118 -0.989 . . . . 0.0 110.888 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.27 -6.73 31.24 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.484 0.584 . . . . 0.0 110.718 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -69.24 -30.28 68.38 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.368 -0.833 . . . . 0.0 112.878 170.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -43.67 0.28 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.355 2.262 . . . . 0.0 115.322 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -89.46 64.1 6.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.375 2.27 . . . . 0.0 108.638 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.58 122.95 48.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 tppm? -65.23 110.51 2.6 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 158.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 m -96.94 88.65 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 180' ' ' ILE . 19.4 m-85 -61.2 101.58 0.17 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.505 1.122 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.32 93.73 1.53 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.57 HG23 HD22 ' A' ' 176' ' ' LEU . 0.3 OUTLIER -57.11 166.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.0 p -131.72 162.45 30.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 165.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -61.07 -30.7 70.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.733 -0.604 . . . . 0.0 109.393 159.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -66.82 -67.07 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.348 1.859 . . . . 0.0 110.266 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.0 33.57 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.891 1.676 . . . . 0.0 110.141 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -56.42 -62.82 1.46 Allowed 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.028 -1.045 . . . . 0.0 111.066 -170.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.77 3.29 12.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.82 -1.24 56.94 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.66 1.584 . . . . 0.0 111.364 172.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 168' ' ' VAL . 7.3 tp -87.37 -32.23 19.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 118.822 -1.151 . . . . 0.0 112.369 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.4 -58.31 3.06 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.739 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.87 -21.92 27.7 Favored 'Trans proline' 0 C--N 1.354 0.85 0 CA-C-N 121.383 1.529 . . . . 0.0 112.798 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -40.66 75.69 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.662 1.985 . . . . 0.0 109.005 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 4.3 mt -66.76 -50.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.212 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.505 ' HA ' HG23 ' A' ' 184' ' ' VAL . 42.0 t -50.9 -29.94 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.741 1.617 . . . . 0.0 109.473 174.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 90.8 m -75.09 -18.32 60.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 119.999 -1.688 . . . . 0.0 112.973 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -52.71 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -56.61 -60.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.694 1.998 . . . . 0.0 109.453 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.64 -22.02 61.29 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.069 -1.02 . . . . 0.0 113.19 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' A' ' 189' ' ' LYS . 37.1 m -73.08 -59.76 2.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.906 0.882 . . . . 0.0 111.316 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.79 17.95 0.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.837 -168.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -157.39 -37.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.378 1.471 . . . . 0.0 112.199 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 186' ' ' SER . 26.0 mmtt . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.395 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.795 0.807 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 8.4 tpp180 -151.29 179.0 8.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 149.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 83.3 m-70 -51.32 156.08 1.27 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.613 1.565 . . . . 0.0 111.076 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -129.94 142.13 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 157' ' ' ILE . 24.4 m-85 -135.55 158.34 44.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 160.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mt -93.21 150.62 20.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -154.41 -172.48 4.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.28 -175.12 24.59 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.971 1.272 . . . . 0.0 110.951 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.12 162.02 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.239 2.626 . . . . 0.0 111.557 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.02 153.95 67.19 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.288 1.325 . . . . 0.0 109.481 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.33 -5.64 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 126.61 2.052 . . . . 0.0 110.712 162.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.26 30.2 t 67.1 126.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.616 1.198 . . . . 0.0 110.527 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.41 -9.94 10.8 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.27 164.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -54.9 -31.12 59.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.224 1.012 . . . . 0.0 111.141 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -56.48 -35.72 68.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.646 1.578 . . . . 0.0 110.31 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -67.44 -24.23 65.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.301 -1.499 . . . . 0.0 113.09 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -55.22 20.48 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 170.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mm -57.05 -46.07 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.319 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -47.83 -57.79 5.18 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.736 0.814 . . . . 0.0 110.023 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -62.57 -40.8 98.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.67 55.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.089 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 p -71.59 -47.81 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.976 1.262 . . . . 0.0 109.97 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.9 -36.42 74.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 110.727 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.45 -53.03 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 125.383 1.473 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -57.81 -42.4 84.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -63.05 -36.31 83.14 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.351 0.26 . . . . 0.0 110.661 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 m -77.37 -10.78 59.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.586 1.954 . . . . 0.0 112.714 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.9 m -100.08 6.08 44.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.627 2.371 . . . . 0.0 111.676 168.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.47 11.79 84.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.708 -1.051 . . . . 0.0 114.633 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.51 139.06 44.28 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 119.557 1.678 . . . . 0.0 109.242 -170.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.82 89.6 0.86 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.91 3.073 . . . . 0.0 111.608 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.93 148.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.154 1.382 . . . . 0.0 109.297 172.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -147.53 -176.0 5.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.044 2.138 . . . . 0.0 109.984 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA3' ' H ' ' A' ' 110' ' ' VAL . . . 123.43 -156.81 17.8 Favored Glycine 0 C--O 1.24 0.514 0 C-N-CA 127.88 2.657 . . . . 0.0 108.138 174.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.52 171.3 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.976 0.888 . . . . 0.0 110.231 171.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -137.08 -178.41 5.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 165.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.5 p -130.41 154.32 47.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 160.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.47 13.69 3.78 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 112.63 -172.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.275 12.6 pt-20 50.65 103.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 127.1 2.16 . . . . 0.0 110.783 -156.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.713 HG13 HG13 ' A' ' 47' ' ' ILE . 11.0 p -63.11 138.61 22.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -122.97 164.81 17.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.668 1.187 . . . . 0.0 108.404 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.67 96.67 2.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.34 -66.45 1.49 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.61 12.11 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.652 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.96 143.17 47.19 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 118.597 1.198 . . . . 0.0 109.1 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -63.09 154.75 29.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 124.671 1.232 . . . . 0.0 108.873 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.713 HG13 HG13 ' A' ' 40' ' ' VAL . 1.1 pt -140.3 -13.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.791 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 40' ' ' VAL . . . 157.27 -142.82 8.94 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.141 -2.383 . . . . 0.0 107.141 173.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -142.35 66.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.229 1.515 . . . . 0.0 110.602 -172.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -53.15 143.88 16.91 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.677 0.791 . . . . 0.0 110.325 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.55 114.85 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 118.568 0.622 . . . . 0.0 109.559 -160.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.33 109.68 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -150.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -59.87 146.02 43.57 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.02 -11.51 39.96 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.278 168.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 -14.56 61.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.516 1.926 . . . . 0.0 111.618 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 67.82 1.47 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 119.412 1.005 . . . . 0.0 111.148 -177.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -157.32 151.43 24.73 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.707 3.203 . . . . 0.0 104.706 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.41 ' C ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -142.63 154.44 44.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 121.278 1.853 . . . . 0.0 109.714 -173.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.02 156.86 19.78 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.083 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.98 54.32 4.82 Favored 'Trans proline' 0 CA--C 1.539 0.762 1 C-N-CA 125.695 4.264 . . . . 0.0 113.21 -173.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -51.44 -52.36 46.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.656 1.582 . . . . 0.0 111.137 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 p -150.16 133.05 16.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.34 43.15 0.52 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.351 0.26 . . . . 0.0 110.624 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t 60.43 154.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 129.045 2.938 . . . . 0.0 110.641 -167.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.02 160.1 31.7 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 105.481 -3.048 . . . . 0.0 105.481 166.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.28 164.78 12.77 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.006 0.908 . . . . 0.0 110.461 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -63.83 148.65 94.42 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.134 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.32 133.24 17.41 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.452 2.768 . . . . 0.0 110.184 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.34 174.26 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.347 2.698 . . . . 0.0 110.875 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.4 -24.69 64.05 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.095 1.196 . . . . 0.0 113.282 -176.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.22 -1.68 47.95 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.736 -1.036 . . . . 0.0 114.698 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -148.06 143.98 27.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.137 1.969 . . . . 0.0 108.581 -172.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.01 149.89 27.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.507 ' HG3' ' HE2' ' A' ' 72' ' ' LYS . 22.2 mt-10 -132.47 162.36 31.36 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.359 1.863 . . . . 0.0 109.537 168.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.71 136.26 57.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.687 1.195 . . . . 0.0 109.211 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.39 154.64 41.86 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.263 -172.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.96 119.74 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.25 -107.3 1.64 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.49 -10.76 15.23 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 112.868 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.09 140.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.87 163.22 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 160.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.55 173.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 O-C-N 120.501 -1.374 . . . . 0.0 109.889 171.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.77 98.71 4.25 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.89 -35.7 71.37 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.101 -0.999 . . . . 0.0 110.701 173.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -66.35 -30.63 71.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.616 0.766 . . . . 0.0 109.966 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.8 t -62.01 -23.91 66.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 120.041 1.291 . . . . 0.0 111.891 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -73.09 -62.73 1.36 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.24 -13.7 13.94 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -53.82 -42.71 68.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 111.623 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.64 -35.67 0.49 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.052 0.541 . . . . 0.0 112.242 -168.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 63.67 4.46 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -65.25 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 127.708 2.403 . . . . 0.0 105.766 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 -18.11 36.93 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.383 2.055 . . . . 0.0 114.348 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 95' ' ' LEU . 20.0 m -67.5 -64.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.595 1.089 . . . . 0.0 108.697 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 94' ' ' VAL . 76.5 mt -45.62 -56.13 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.657 2.383 . . . . 0.0 108.506 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.16 89.16 3.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.13 0.491 . . . . 0.0 110.742 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.91 127.17 30.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 118.044 -1.463 . . . . 0.0 107.62 158.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.24 104.41 8.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.532 1.133 . . . . 0.0 108.793 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -156.04 142.86 18.83 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 6.8 t -146.88 76.79 1.44 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.527 1.058 . . . . 0.0 110.916 -167.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -123.77 134.57 53.63 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 125.125 1.37 . . . . 0.0 107.709 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -74.92 151.37 38.9 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 160.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 136.14 173.53 13.01 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.486 1.517 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.63 136.29 17.05 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.084 2.523 . . . . 0.0 110.399 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.46 66.13 0.04 OUTLIER Glycine 0 C--N 1.333 0.366 0 O-C-N 121.194 -0.941 . . . . 0.0 112.29 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -60.1 150.88 28.23 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 110.357 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -124.6 164.77 19.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.899 1.68 . . . . 0.0 107.209 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -124.42 141.4 44.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.401 ' HB2' ' CG2' ' A' ' 137' ' ' THR . 8.9 t -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.406 ' H ' ' HA3' ' A' ' 34' ' ' GLY . 90.6 t -141.14 128.95 22.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.486 1.514 . . . . 0.0 107.138 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.52 68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.19 -168.65 1.91 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.81 18.85 0.55 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.037 1.735 . . . . 0.0 114.634 -171.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.2 mt -67.51 129.47 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 119.327 -2.108 . . . . 0.0 107.404 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.05 -75.63 0.22 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-O 119.496 -0.614 . . . . 0.0 112.141 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -64.54 -26.9 68.62 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.074 0.937 . . . . 0.0 112.022 -171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.8 mmm -63.66 -7.68 8.06 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 116.55 -1.69 . . . . 0.0 114.03 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -42.23 -44.73 3.89 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.519 1.963 . . . . 0.0 114.517 -165.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.51 -39.1 28.51 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.422 0.689 . . . . 0.0 111.736 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -84.06 -21.21 31.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.24 1.016 . . . . 0.0 110.987 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.2 t -42.16 123.09 2.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 129.762 3.225 . . . . 0.0 110.569 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.45 -88.61 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 107.605 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.88 -1.86 8.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.587 -0.72 . . . . 0.0 112.131 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -71.82 0.11 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.654 1.115 . . . . 0.0 110.188 160.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.33 -31.42 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 126.002 1.721 . . . . 0.0 113.105 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -60.56 2.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 120.664 -1.273 . . . . 0.0 112.813 171.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.26 67.23 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 111.828 -166.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.86 -51.17 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -57.78 -40.14 79.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 120.301 1.41 . . . . 0.0 113.412 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -56.73 -20.53 22.5 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.313 1.045 . . . . 0.0 112.515 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.2 m -108.71 -27.87 9.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.977 1.311 . . . . 0.0 110.234 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.0 -22.52 66.46 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.187 1.395 . . . . 0.0 111.633 168.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.7 t -58.3 -44.68 88.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.477 0.711 . . . . 0.0 109.442 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.1 m -77.3 133.43 68.15 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.92 -30.04 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.439 2.76 . . . . 0.0 111.3 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.75 -65.38 3.62 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.712 2.101 . . . . 0.0 111.634 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 109' ' ' CYS . 20.1 m -59.46 143.33 50.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.827 1.251 . . . . 0.0 109.91 169.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.19 96.8 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mm -56.7 130.9 19.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 142.33 50.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.726 2.411 . . . . 0.0 105.304 167.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.37 175.28 45.58 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 119.281 0.946 . . . . 0.0 110.945 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.1 m -115.94 94.64 4.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.151 1.476 . . . . 0.0 113.105 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 5' ' ' PHE . 1.2 pp -89.84 122.44 67.95 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.094 -1.004 . . . . 0.0 111.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.12 153.13 67.58 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.827 1.684 . . . . 0.0 110.532 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.84 151.88 95.13 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 122.057 -0.402 . . . . 0.0 110.431 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.15 -55.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.135 3.223 . . . . 0.0 111.907 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 26.17 77.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.48 2.712 . . . . 0.0 110.923 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.03 -111.53 3.13 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 135.03 90.38 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 117.584 0.692 . . . . 0.0 109.654 -170.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.72 171.07 12.67 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.237 1.958 . . . . 0.0 110.619 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.83 160.93 28.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.952 2.501 . . . . 0.0 105.193 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.34 -66.27 0.91 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.852 0.861 . . . . 0.0 110.082 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.18 -46.79 87.48 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.42 0.688 . . . . 0.0 109.203 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.95 -41.68 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.292 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.55 -17.66 60.01 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.593 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -36.08 76.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.686 1.194 . . . . 0.0 108.771 175.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 5' ' ' PHE . 5.3 mt -84.72 -52.18 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 109.487 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -23.44 65.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.932 1.293 . . . . 0.0 110.265 -172.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -40.05 13.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 174.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 162' ' ' ASP . 30.0 mtp85 -68.9 -36.09 77.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 123.88 0.872 . . . . 0.0 110.545 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? 60.63 -18.67 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.675 1.99 . . . . 0.0 113.86 -170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -71.85 48.77 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 1 C-N-CA 133.124 4.569 . . . . 0.0 110.755 173.628 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.77 128.89 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -69.71 105.45 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 160.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.38 87.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 164' ' ' LYS . 16.0 m-85 -58.5 100.19 0.06 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 107.64 5.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.05 147.81 10.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.8 p -99.02 166.12 11.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 158.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.83 -14.01 61.85 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 120.002 -1.686 . . . . 0.0 111.031 161.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -88.66 -65.03 1.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.07 0.948 . . . . 0.0 110.416 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.66 29.14 2.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.96 2.104 . . . . 0.0 108.146 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -50.28 -57.02 8.79 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.561 1.144 . . . . 0.0 108.009 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -82.92 17.67 1.84 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -116.55 48.19 1.32 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 180' ' ' ILE . 8.6 tp -129.0 -37.36 1.71 Allowed 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.158 174.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -55.04 13.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 117.305 -1.331 . . . . 0.0 109.629 176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.64 -26.06 39.91 Favored 'Trans proline' 0 C--N 1.356 0.962 0 CA-C-N 121.926 1.724 . . . . 0.0 113.482 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.49 -45.11 63.37 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.22 1.408 . . . . 0.0 109.85 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 176' ' ' LEU . 14.5 mt -54.82 -52.78 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 125.406 1.482 . . . . 0.0 109.19 167.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.74 -44.59 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.458 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.1 m -62.04 -42.23 98.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.564 1.075 . . . . 0.0 109.726 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' CYS . . . . . . . . . . . . . 3.4 t -67.03 -44.18 80.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.017 0.826 . . . . 0.0 110.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.56 -53.73 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.595 -0.691 . . . . 0.0 109.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -16.08 63.63 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.997 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -57.29 10.31 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m 55.1 -73.8 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 -167.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -117.98 5.14 12.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.629 1.104 . . . . 0.0 112.843 173.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? . . . . . 0 C--O 1.247 0.934 0 CA-C-N 120.479 1.491 . . . . 0.0 108.756 164.776 . . . . . . . . 0 0 . 1 stop_ save_